ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification -...

214
13.12.2019 - EEA AGREEMENT - ANNEX II p. 127 ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING AND CERTIFICATION TABLE OF CONTENTS - PART II XIII Medicinal Products XIV Fertilizers XV Dangerous Substances XVI Cosmetics XVII Environment Protection XVIII Information Technology, Telecommunication and Data Processing XIX General Provisions in the Technical Barriers to Trade XX Free Movement of Goods - General XXI Construction Products XXII Personal Protective Equipment XXIII Toys XXIV Machinery XXV Tobacco XXVI Energy XXVII Spirit Drinks XXVIII Cultural Goods XXIX Explosives for Civil Use XXX Medical Devices XXXI Recreational Craft XXXII Marine Equipement - Appendices I-XII EEA Annexes: Annex 2: Technical Regulations, Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according to its working procedures, two observers entitled to participate in the tasks of the Committee which are described in Article 2, first indent of the Council Decision 75/320/EEC of 20 May 1975 setting up a pharmaceutical committee. Notwithstanding Article 101 of the Agreement, the EC Commission shall invite experts from the EFTA States according to Article 99 of the Agreement, to participate in the tasks which are described in Article 2, second indent of the Council Decision 75/320/EEC. The EC Commission shall, in due time, inform the EFTA Surveillance Authority about the date of the meeting of the Committee and transmit the relevant documentation. {1}When decisions on approval of medicinal products are taken according to the Community procedures laid down in Regulation (EC) No 726/2004 of the European Parliament and of the Council, Directive 2001/83/EC of the European Parliament and of the Council, as amended by Directive 2004/27/EC of the European Parliament and of the Council, and Directive 2001/82/EC of the European Parliament and of the Council, as amended by Directive 2004/28/EC of the European Parliament and of the Council, the EFTA States shall simultaneously and within 30 days of the Community Decision, take corresponding decisions on the basis of the relevant acts. The EEA Joint Committee shall be informed and shall periodically publish lists of such decisions in the EEA Supplement to the Official Journal. The EFTA Surveillance Authority shall monitor the application of the decisions taken by the EFTA States as provided for in Article 109 of the Agreement. { 1 } Paragraphs up to “Acts referred to” inserted by Decision No 74/1999 (OJ L 284, 9.11.2000, p. 65 and EEA Supplement No 51, 9.11.2000, p. 76), e.i.f. 1.1.2000 was replaced by text by Decision No 61/2009(OJ L 232, 3.9.2009, p. 13 and EEA Supplement No 47, 3.9.2009, p.14), e.i.f. 23.12.2009. For Liechtenstein, Decision No 61/2009 entered into force 1.12.2010 which is the day of entry into force of the Agreement between Liechtenstein and Austria laying down the technical details for Liechtenstein’s recognition of Austrian marketing authorisati ons within the decentralized procedure (DCP) and the mutual recognition procedure (MRP).

Transcript of ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification -...

Page 1: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 127

ANNEX II

TECHNICAL REGULATIONS, STANDARDS, TESTING AND

CERTIFICATION

TABLE OF CONTENTS - PART II

XIII Medicinal Products

XIV Fertilizers

XV Dangerous Substances

XVI Cosmetics

XVII Environment Protection

XVIII Information Technology, Telecommunication and Data Processing

XIX General Provisions in the Technical Barriers to Trade

XX Free Movement of Goods - General

XXI Construction Products

XXII Personal Protective Equipment

XXIII Toys

XXIV Machinery

XXV Tobacco

XXVI Energy

XXVII Spirit Drinks

XXVIII Cultural Goods

XXIX Explosives for Civil Use

XXX Medical Devices

XXXI Recreational Craft

XXXII Marine Equipement

- Appendices

I-XII EEA Annexes: Annex 2: Technical Regulations,

Standards, Testing and Certification - Part I

XIII. MEDICINAL PRODUCTS

The EFTA Surveillance Authority may designate, according to its working procedures, two observers entitled to

participate in the tasks of the Committee which are described in Article 2, first indent of the Council Decision

75/320/EEC of 20 May 1975 setting up a pharmaceutical committee.

Notwithstanding Article 101 of the Agreement, the EC Commission shall invite experts from the EFTA States according

to Article 99 of the Agreement, to participate in the tasks which are described in Article 2, second indent of the Council

Decision 75/320/EEC.

The EC Commission shall, in due time, inform the EFTA Surveillance Authority about the date of the meeting of the

Committee and transmit the relevant documentation.

{1}When decisions on approval of medicinal products are taken according to the Community procedures laid down in

Regulation (EC) No 726/2004 of the European Parliament and of the Council, Directive 2001/83/EC of the European

Parliament and of the Council, as amended by Directive 2004/27/EC of the European Parliament and of the Council, and

Directive 2001/82/EC of the European Parliament and of the Council, as amended by Directive 2004/28/EC of the

European Parliament and of the Council, the EFTA States shall simultaneously and within 30 days of the Community

Decision, take corresponding decisions on the basis of the relevant acts. The EEA Joint Committee shall be informed and

shall periodically publish lists of such decisions in the EEA Supplement to the Official Journal.

The EFTA Surveillance Authority shall monitor the application of the decisions taken by the EFTA States as provided

for in Article 109 of the Agreement.

{1} Paragraphs up to “Acts referred to” inserted by Decision No 74/1999 (OJ L 284, 9.11.2000, p. 65 and EEA Supplement No 51, 9.11.2000,

p. 76), e.i.f. 1.1.2000 was replaced by text by Decision No 61/2009(OJ L 232, 3.9.2009, p. 13 and EEA Supplement No 47, 3.9.2009, p.14),

e.i.f. 23.12.2009. For Liechtenstein, Decision No 61/2009 entered into force 1.12.2010 which is the day of entry into force of the Agreement

between Liechtenstein and Austria laying down the technical details for Liechtenstein’s recognition of Austrian marketing authorisations

within the decentralized procedure (DCP) and the mutual recognition procedure (MRP).

Page 2: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 128

Where any of the relevant acts provide for Community procedures on the granting, suspension and withdrawal of a

marketing authorisation as well as supervision, including pharmacovigilance, and inspections and sanctions, these and

similar tasks shall be carried out by the competent authorities in the EFTA States, on the basis of the same obligations as

those of the competent authorities of EC Member States.

Should any disagreement between the contracting parties arise as to the administration of these provisions, Part VII of

the Agreement shall apply mutatis mutandis.

The EFTA States shall participate in the work of the European Medicines Agency, hereinafter referred to as ‘the

Agency’, as set up by Regulation (EC) No 726/2004 of the European Parliament and of the Council.

The financial provisions of Title IV, Chapter 2, of Regulation (EC) No 726/2004 of the European Parliament and of the

Council shall apply to the participation of the EFTA States in the work of the Agency.

The EFTA States shall therefore participate in the Community contribution referred to in Article 67(3) of Regulation

(EC) No 726/2004 of the European Parliament and of the Council.

For this purpose the procedures laid down in Article 82(1)(a) and Protocol 32 of the Agreement shall apply mutatis

mutandis with regard to the financial contribution of the EFTA States to the above mentioned Community contribution.

The EFTA States may send observers to meetings of the Agency's Management Board.

The EFTA States shall be fully associated with the work of the Committee for Medicinal Products for Human Use

(CHMP), the Committee for Medicinal Products for Veterinary Use (CVMP), the Committee on Orphan Medicinal

Products (COMP), the Paediatric Committee{2}, the Pharmacovigilance Risk Assessment Committee (PRAC){3} and the

Committee on Herbal Medicinal Products (HMPC). The detailed arrangements of participation for the representatives of

EFTA States shall be in accordance with the provisions of Title IV, chapter 1, of Regulation (EC) No 726/2004 of the

European Parliament and of the Council. Such representatives shall, however, not participate in the voting and their

positions shall be recorded separately. The position of Chairman shall be reserved for a member nominated by an EC

Member State.

The EFTA States shall be fully associated with the work of the Coordination Group as set up by Article 27 of Directive

2001/83/EC of the European Parliament and of the Council, as amended by Directive 2004/27/EC of the European

Parliament and of the Council, and Article 31 of Directive 2001/82/EC of the European Parliament and of the Council,

as amended by Directive 2004/28/EC of the European Parliament and of the Council. The representatives of the EFTA

States shall, however, not participate in the voting and their positions shall be recorded separately. The position of

Chairman shall be reserved for a member nominated by an EC Member State.

An EFTA State may request the Agency to initiate an arbitration procedure according to Title III, Chapter 4 of Directive

2001/83/EC of the European Parliament and of the Council, as amended by Directive 2004/27/EC of the European

Parliament and of the Council, and according to Title III, Chapter 4 of Directive 2001/82/EC of the European Parliament

and of the Council, as amended by Directive 2004/28/EC of the European Parliament and of the Council. Such a request

shall, in the first place, be addressed to the Commission which shall, where it considers that the request is of

common interest, forward it to the Agency for further processing.

The EFTA States shall fully participate in the Telematic Exchange of Information on Medicinal Products (IMP)

programme.

Iceland and Norway shall provide their national competent authorities and the marketing authorisation holders with the

linguistic version of the marketing authorisations required to access their own market.

A marketing authorisation granted for a medicinal product following an opinion adopted by the competent EMEA

scientific Committee in accordance with Article 9 or Article 34 of Regulation (EC) No 726/2004 of the European

Parliament and of the Council shall not be subject to any fees other than those referred to in Article 67(3) and Article 70

of Regulation (EC) No 726/2004 of the European Parliament and of the Council.

The Agency having legal personality shall enjoy in all the States of the Contracting Parties the most extensive legal

capacity accorded to legal persons under their laws.

The EFTA States shall apply to the Agency the Protocol of Privileges and Immunities of the European Communities.

{2} Text added by Decision No 92/2017 (OJ L 36, 7.2.2019, p. 41 and EEA Supplement No 11, 7.2.2019, p. 49), e.i.f. 1.6.2018.

{3} Text added by Decision No 158/2013 (OJ L 58, 27.2.2014, p. 10 and EEA Supplement No 13, 27.2.2014, p. 11), e.i.f. 28.5.2014.

Page 3: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 129

Regulation (EC) No 1049/2001 of the European Parliament and the Council of 30 May 2001 regarding public access to

European Parliament, Council and Commission documents shall, for the application of Regulation (EC) No 726/2004 of

the European Parliament and of the Council, apply to any documents of the Agency regarding the EFTA States as well.

By way of derogation from Article 12(2)(a) of the Conditions of employment of other servants of the European

Communities, nationals of the EFTA States enjoying their full rights as citizens may be engaged under contract by the

Executive Director of the Agency.

ACTS REFERRED TO

1.{4} [ ]

2.{5} [ ]

3.{6} [ ]

4. {7} 32009 L 0035: Directive 2009/35/EC of the European Parliament and of the Council of 23 April 2009 on the

colouring matters which may be added to medicinal products (OJ L 109, 30.4.2009, p. 10).

5.{8} [ ]

6.{9} [ ]

7.{10} 32010 L 0063: Directive 2010/63/EU of the European Parliament and of the Council of 22 September 2010

on the protection of animals used for scientific purposes (OJ L 276, 20.10.2010, p. 33).

8.{11} 393 L 0041: Council Directive 93/41/EEC of 14 June 1993 repealing Directive 87/22/EEC on the

approximation of national measures relating to the placing on the market of high-technology medicinal

products, particularly those derived from biotechnology (OJ L 214, 24.8.1993, p. 40).

9. 389 L 0105: Council Directive 89/105/EEC of 21 December 1988 relating to the transparency of measures

regulating the pricing of medicinal products for human use and their inclusion in the scope of national health

insurance systems (OJ No L 40, 11.2.1989, p. 8).

10.{12} [ ]

11.{13} [ ]

{4} Text of point 1 (Council Directive 65/65/EEC), as amended, deleted by Decision No 82/2002 (OJ L 266, 3.10.2002, p. 32 and EEA

Supplement No 49, 3.10.2002, p. 22), e.i.f. 26.6.2002.

{5} Text of point 2 (Council Directive 75/318/EEC), as amended, deleted by Decision No 82/2002 (OJ L 266, 3.10.2002, p. 32 and EEA

Supplement No 49, 3.10.2002, p. 22), e.i.f. 26.6.2002.

{6} Text of point 3 (Second Council Directive 75/319/EEC) as amended, deleted by Decision No 82/2002 (OJ L 266, 3.10.2002, p. 32 and EEA

Supplement No 49, 3.10.2002, p. 22), e.i.f. 26.6.2002.

{7} Text of point 4 (Council Directive 78/25/EEC) replaced by Decision No 72/2011 (OJ L 262, 6.10.2011, p. 28 and EEA Supplement No 54,

6.10.2011, p. 38), e.i.f. 2.7.2011.

{8} Text of point 5 (Council Directive 81/851/EEC), as amended, deleted by Decision No 82/2002 (OJ L 266, 3.10.2002, p. 32 and EEA

Supplement No 49, 3.10.2002, p. 22), e.i.f. 26.6.2002.

{9} Text of point 6 (Council Directive 81/852/EEC), as amended, deleted by Decision No 82/2002 (OJ L 266, 3.10.2002, p. 32 and EEA

Supplement No 49, 3.10.2002, p. 22), e.i.f. 26.6.2002.

{10} Text of point 7 (Council Directive 86/609/EEC) replaced by Decision No 256/2014 (OJ L 311, 26.11.2015, p. 4 and EEA Supplement No 71,

26.11.2015, p. 4), e.i.f. 1.8.2016.

{11} Text of point 8 replaced by Decision 74/1999 (OJ L 284, 9.11.2000, p. 65 and EEA Supplement No 51, 9.11.2000, p. 76), e.i.f. 1.1.2000.

{12} Text of point 10 (Council Directive 89/342/EEC) deleted by Decision No 82/2002 (OJ L 266, 3.10.2002, p. 32 and EEA Supplement No 49,

3.10.2002, p. 22), e.i.f. 26.6.2002.

{13} Text of point 11 (Council Directive 89/343/EEC) deleted by Decision No 82/2002 (OJ L 266, 3.10.2002, p. 32 and EEA Supplement No 49,

3.10.2002, p. 22), e.i.f. 26.6.2002.

Page 4: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 130

12.{14} 32009 R 0470: Regulation (EC) No 470/2009 of the European Parliament and of the Council of 6 May 2009

laying down Community procedures for the establishment of residue limits of pharmacologically active

substances in foodstuffs of animal origin, repealing Council Regulation (EEC) No 2377/90 and amending

Directive 2001/82/EC of the European Parliament and of the Council and Regulation (EC) No 726/2004 of the

European Parliament and of the Council (OJ L 152, 16.6.2009, p. 11).

The provisions of the Regulation shall, for the purposes of this Agreement, be read with the following

adaptation:

(a) References to other acts in the Regulation shall be considered relevant to the extent and in the form that

those acts are incorporated into the Agreement.

(b) An EFTA State may request the Agency to issue an opinion according to Article 9(1), first paragraph of

Article 11, Article 15(1) and Article 27(2). Such a request shall, in the first place, be addressed to the

Commission which shall, where it considers that the request is of common interest, forward it to the

Agency for further processing.

12a.{15} 32017 R 0880: Commission Regulation (EU) 2017/880 of 23 May 2017 laying down rules on the use of a

maximum residue limit established for a pharmacologically active substance in a particular foodstuff for

another foodstuff derived from the same species and a maximum residue limit established for a

pharmacologically active substance in one or more species for other species, in accordance with Regulation

(EC) No 470/2009 of the European Parliament and of the Council (OJ L 135, 24.5.2017, p. 1).

12b.{16} 32017 R 0012: Commission Implementing Regulation (EU) 2017/12 of 6 January 2017 regarding the form and

content of the applications and requests for the establishment of maximum residue limits in accordance with

Regulation (EC) No 470/2009 of the European Parliament and of the Council (OJ L 4, 7.1.2017, p. 1).

12c.{17} 32018 R 0782: Commission Regulation (EU) 2018/782 of 29 May 2018 establishing the methodological

principles for the risk assessment and risk management recommendations referred to in Regulation (EC) No

470/2009 (OJ L 132, 30.5.2018, p. 5).

12d.{18} 32018 R 0470: Commission Implementing Regulation (EU) 2018/470 of 21 March 2018 on detailed rules on

the maximum residue limit to be considered for control purposes for foodstuffs derived from animals which

have been treated in the EU under Article 11 of Directive 2001/82/EC (OJ L 79, 22.3.2018, p. 16).

13.{19} 32010 R 0037: Commission Regulation (EU) No 37/2010 of 22 December 2009 on pharmacologically active

substances and their classification regarding maximum residue limits in foodstuffs of animal origin (OJ L 15,

20.1.2010, p. 1), as corrected by OJ L 293, 11.11.2010, p. 72, as amended by:

-{20} 32010 R 0890: Commission Regulation (EU) No 890/2010 of 8 October 2010 (OJ L 266, 9.10.2010,

p. 1),

-{21} 32010 R 0914: Commission Regulation (EU) No 914/2010 of 12 October 2010 (OJ L 269,

13.10.2010, p. 5),

-{22} 32010 R 0758: Commission Regulation (EU) No 758/2010 of 24 August 2010 (OJ L 223,

25.8.2010, p. 37),

{14} Text of point 12 (Council Directive 89/381/EEC) deleted by Decision No 82/2002 (OJ L 266, 3.10.2002, p. 32 and EEA Supplement No 49,

3.10.2002, p. 22), e.i.f. 26.6.2002 subsequently new point and adaptation text inserted by Decision No 83/2012 (OJ L 248, 13.9.2012, p. 19

and EEA Supplement No 50, 13.9.2012, p. 21), e.i.f. 1.5.2012.

{15} Point inserted by Decision No 167/2017 (OJ L 174, 27.6.2019, p. 28 and EEA Supplement No 52, 27.6.2019, p. 35), e.i.f. 23.9.2017.

{16} Point inserted by Decision No 223/2017 (OJ L 254, 3.10.2019, p. 29 and EEA Supplement No 80, 3.10.2019, p. 32), e.i.f. 16.12.2017.

{17} Point inserted by Decision No 236/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 6.12.2018.

{18} Point inserted by Decision No 61/2019 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 30.3.2019.

{19} Text of point 13 (Council Directive 90/677/EEC) deleted by Decision No 82/2002 (OJ L 266, 3.10.2002, p. 32 and EEA Supplement No 49,

3.10.2002, p. 22), e.i.f. 26.6.2002 subsequently new point inserted by Decision No 83/2012 (OJ L 248, 13.9.2012, p. 19 and EEA Supplement

No 50, 13.9.2012, p. 21), e.i.f. 1.5.2012.

{20} Indent and words “, as amended by:” added by Decision No 84/2012 (OJ L 248, 13.9.2012, p. 21 and EEA Supplement No 50, 13.9.2012, p.

23), e.i.f. 1.5.2012.

{21} Indent and words “, as amended by:” added by Decision No 84/2012 (OJ L 248, 13.9.2012, p. 21 and EEA Supplement No 50, 13.9.2012, p.

23), e.i.f. 1.5.2012.

{22} Indent added by Decision No 85/2012 (OJ L 248, 13.9.2012, p. 22 and EEA Supplement No 50, 13.9.2012, p. 25), e.i.f. 1.5.2012.

Page 5: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 131

-{23} 32010 R 0759: Commission Regulation (EU) No 759/2010 of 24 August 2010 (OJ L 223,

25.8.2010, p. 39),

-{24} 32010 R 0761: Commission Regulation (EU) No 761/2010 of 25 August 2010 (OJ L 224,

26.8.2010, p. 1),

-{25} 32011 R 0362: Commission Regulation (EU) No 362/2011 of 13 April 2011 (OJ L 100, 14.4.2011,

p. 26),

-{26} 32011 R 0363: Commission Regulation (EU) No 363/2011 of 13 April 2011 (OJ L 100, 14.4.2011,

p. 28),

-{27} 32012 R 0084: Commission Implementing Regulation (EU) No 84/2012 of 1 February 2012 (OJ

L 30, 2.2.2012, p. 1),

-{28} 32012 R 0085: Commission Implementing Regulation (EU) No 85/2012 of 1 February 2012 (OJ

L 30, 2.2.2012, p. 4),

-{29} 32012 R 0086: Commission Implementing Regulation (EU) No 86/2012 of 1 February 2012 (OJ

L 30, 2.2.2012, p. 6),

-{30} 32012 R 0107: Commission Implementing Regulation (EU) No 107/2012 of 8 February 2012 (OJ

L 36, 9.2.2012, p. 25),

-{31} 32012 R 0122: Commission Implementing Regulation (EU) No 122/2012 of 13 February 2012 (OJ

L 40, 14.2.2012, p. 2),

-{32} 32012 R 0123: Commission Implementing Regulation (EU) No 123/2012 of 13 February 2012 (OJ

L 40, 14.2.2012, p. 4),

-{33} 32012 R 0201: Commission Implementing Regulation (EU) No 201/2012 of 8 March 2012 (OJ L 71,

9.3.2012, p. 37),

-{34} 32012 R 0202: Commission Implementing Regulation (EU) No 202/2012 of 8 March 2012 (OJ L 71,

9.3.2012, p. 40),

-{35} 32012 R 0221: Commission Implementing Regulation (EU) No 221/2012 of 14 March 2012 (OJ

L 75, 15.3.2012, p. 7),

-{36} 32012 R 0222: Commission Implementing Regulation (EU) No 222/2012 of 14 March 2012 (OJ

L 75, 15.3.2012, p. 10),

-{37} 32012 R 0436: Commission Implementing Regulation (EU) No 436/2012 of 23 May 2012 (OJ

L 134, 24.5.2012, p. 10),

{23} Indent added by Decision No 85/2012 (OJ L 248, 13.9.2012, p. 22 and EEA Supplement No 50, 13.9.2012, p. 25), e.i.f. 1.5.2012.

{24} Indent added by Decision No 85/2012 (OJ L 248, 13.9.2012, p. 22 and EEA Supplement No 50, 13.9.2012, p. 25), e.i.f. 1.5.2012.

{25} Indent added by Decision No 86/2012 (OJ L 248, 13.9.2012, p. 23 and EEA Supplement No 50, 13.9.2012, p. 27), e.i.f. 1.5.2012.

{26} Indent added by Decision No 86/2012 (OJ L 248, 13.9.2012, p. 23and EEA Supplement No 50, 13.9.2012, p. 27), e.i.f. 1.5.2012.

{27} Indent added by Decision No 159/2012 (OJ L 341, 13.12.2012, p. 9 and EEA Supplement No 70, 13.12.2012, p. 11), e.i.f. 1.11.2012.

{28} Indent added by Decision No 159/2012 (OJ L 341, 13.12.2012, p. 9 and EEA Supplement No 70, 13.12.2012, p. 11), e.i.f. 1.11.2012.

{29} Indent added by Decision No 159/2012 (OJ L 341, 13.12.2012, p. 9 and EEA Supplement No 70, 13.12.2012, p. 11), e.i.f. 1.11.2012.

{30} Indent added by Decision No 159/2012 (OJ L 341, 13.12.2012, p. 9 and EEA Supplement No 70, 13.12.2012, p. 11), e.i.f. 1.11.2012.

{31} Indent added by Decision No 159/2012 (OJ L 341, 13.12.2012, p. 9 and EEA Supplement No 70, 13.12.2012, p. 11), e.i.f. 1.11.2012.

{32} Indent added by Decision No 159/2012 (OJ L 341, 13.12.2012, p. 9 and EEA Supplement No 70, 13.12.2012, p. 11), e.i.f. 1.11.2012.

{33} Indent added by Decision No 159/2012 (OJ L 341, 13.12.2012, p. 9 and EEA Supplement No 70, 13.12.2012, p. 11), e.i.f. 1.11.2012.

{34} Indent added by Decision No 159/2012 (OJ L 341, 13.12.2012, p. 9 and EEA Supplement No 70, 13.12.2012, p. 11), e.i.f. 1.11.2012.

{35} Indent added by Decision No 8/2013 (OJ L 144, 30.5.2013, p. 12 and EEA Supplement No 31, 30.5.2013, p.14), e.i.f. 2.2.2013.

{36} Indent added by Decision No 8/2013 (OJ L 144, 30.5.2013, p. 12 and EEA Supplement No 31, 30.5.2013, p.14), e.i.f. 2.2.2013.

{37} Indent added by Decision No 35/2013 (OJ L 231, 29.8.2013, p. 10 and EEA Supplement No 49, 29.8.2013, p. 12), e.i.f. 16.3.2013.

Page 6: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 132

-{38} 32012 R 0466: Commission Implementing Regulation (EU) No 466/2012 of 1 June 2012 (OJ L 143,

2.6.2012, p. 2),

-{39} 32012 R 1161: Commission Implementing Regulation (EU) No 1161/2012 of 7 December 2012 (OJ

L 336, 8.12.2012, p. 14),

-{40} 32012 R 1186: Commission Implementing Regulation (EU) No 1186/2012 of 11 December 2012

(OJ L 338, 12.12.2012, p. 20),

-{41} 32012 R 1191: Commission Implementing Regulation (EU) No 1191/2012 of 12 December 2012

(OJ L 340, 13.12.2012, p. 35),

-{42} 32013 R 0059: Commission Implementing Regulation (EU) No 59/2013 of 23 January 2013 (OJ

L 21, 24.1.2013, p. 21),

-{43} 32013 R 0115: Commission Implementing Regulation (EU) No 115/2013 of 8 February 2013 (OJ

L 38, 9.2.2013, p. 11),

-{44} 32013 R 0116: Commission Implementing Regulation (EU) No 116/2013 of 8 February 2013 (OJ

L 38, 9.2.2013, p. 14),

-{45} 32013 R 0394: Commission Implementing Regulation (EU) No 394/2013 of 29 April 2013 (OJ

L 118, 30.4.2013, p. 17),

-{46} 32013 R 0406: Commission Implementing Regulation (EU) No 406/2013 of 2 May 2013 (OJ L 121,

3.5.2013, p. 42),

-{47} 32013 R 0489: Commission Implementing Regulation (EU) No 489/2013 of 27 May 2013 (OJ

L 141, 28.5.2013, p. 4),

-{48} 32013 R 1056: Commission Implementing Regulation (EU) No 1056/2013 of 29 October 2013 (OJ

L 288, 30.10.2013, p. 60),

-{49} 32013 R 1057: Commission Implementing Regulation (EU) No 1057/2013 of 29 October 2013 (OJ

L 288, 30.10.2013, p. 63),

-{50} 32013 R 1235: Commission Implementing Regulation (EU) No 1235/2013 of 2 December 2013 (OJ

L 322, 3.12.2013, p. 21),

-{51} 32014 R 0019: Commission Implementing Regulation (EU) No 19/2014 of 10 January 2014 (OJ

L 8, 11.1.2014, p. 18),

-{52} 32014 R 0020: Commission Implementing Regulation (EU) No 20/2014 of 10 January 2014 (OJ

L 8, 11.1.2014, p. 20),

{38} Indent added by Decision No 35/2013 (OJ L 231, 29.8.2013, p. 10 and EEA Supplement No 49, 29.8.2013, p. 12), e.i.f. 16.3.2013.

{39} Indent added by Decision No 157/2013 (OJ L 58, 27.2.2014, p. 9 and EEA Supplement No 13, 27.2.2014, p. 9), e.i.f. 9.10.2013.

{40} Indent added by Decision No 157/2013 (OJ L 58, 27.2.2014, p. 9 and EEA Supplement No 13, 27.2.2014, p. 9), e.i.f. 9.10.2013.

{41} Indent added by Decision No 157/2013 (OJ L 58, 27.2.2014, p. 9 and EEA Supplement No 13, 27.2.2014, p. 9), e.i.f. 9.10.2013.

{42} Indent added by Decision No 189/2013 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 9.11.2013.

{43} Indent added by Decision No 189/2013 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 9.11.2013.

{44} Indent added by Decision No 189/2013 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 9.11.2013.

{45} Indent added by Decision No 190/2013 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 9.11.2013.

{46} Indent added by Decision No 190/2013 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 9.11.2013.

{47} Indent added by Decision No 39/2014 (OJ L 256, 28.8.2014, p. 12 and EEA Supplement No 49, 28.8.2014, p. 12), e.i.f. 9.4.2014.

{48} Indent added by Decision No 80/2014 (OJ L 310, 30.10.2014, p. 32 and EEA Supplement No 63, 30.10.2014, p. 24), e.i.f. 17.5.2014.

{49} Indent added by Decision No 80/2014 (OJ L 310, 30.10.2014, p. 32 and EEA Supplement No 63, 30.10.2014, p. 24), e.i.f. 17.5.2014.

{50} Indent added by Decision No 81/2014 (OJ L 310, 30.10.2014, p. 34 and EEA Supplement No 63, 30.10.2014, p. 25), e.i.f. 17.5.2014.

{51} Indent added by Decision No 177/2014 (OJ L 202, 30.7.2015, p. 27 and EEA Supplement No 43, 30.7.2015, p. 27), e.i.f. 26.9.2014.

{52} Indent added by Decision No 177/2014 (OJ L 202, 30.7.2015, p. 27 and EEA Supplement No 43, 30.7.2015, p. 27), e.i.f. 26.9.2014.

Page 7: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 133

-{53} 32014 R 0200: Commission Implementing Regulation (EU) No 200/2014 of 3 March 2014 (OJ

L 62, 4.3.2014, p. 8),

-{54} 32014 R 0201: Commission Implementing Regulation (EU) No 201/2014 of 3 March 2014 (OJ

L 62, 4.3.2014, p. 10),

-{55} 32014 R 0418: Commission Implementing Regulation (EU) No 418/2014 of 24 April 2014 (OJ

L 124, 25.4.2014, p. 19),

-{56} 32014 R 0676: Commission Implementing Regulation (EU) No 676/2014 of 19 June 2014 (OJ

L 180, 20.6.2014, p. 5),

-{57} 32014 R 0677: Commission Implementing Regulation (EU) No 677/2014 of 19 June 2014 (OJ

L 180, 20.6.2014, p. 8),

-{58} 32014 R 0681: Commission Implementing Regulation (EU) No 681/2014 of 20 June 2014 (OJ

L 182, 21.6.2014, p. 11),

-{59} 32014 R 0682: Commission Implementing Regulation (EU) No 682/2014 of 20 June 2014 (OJ

L 182, 21.6.2014, p. 14),

-{60} 32014 R 0683: Commission Implementing Regulation (EU) No 683/2014 of 20 June 2014 (OJ

L 182, 21.6.2014, p. 17),

-{61} 32014 R 0967: Commission Implementing Regulation (EU) No 967/2014 of 12 September 2014 (OJ

L 272, 13.9.2014, p. 3),

-{62} 32015 R 0149: Commission Implementing Regulation (EU) 2015/149 of 30 January 2015 (OJ L 26,

31.1.2015, p. 7),

-{63} 32015 R 0150: Commission Implementing Regulation (EU) 2015/150 of 30 January 2015 (OJ L 26,

31.1.2015, p. 10),

-{64} 32015 R 0151: Commission Implementing Regulation (EU) 2015/151 of 30 January 2015 (OJ L 26,

31.1.2015, p. 13),

-{65} 32015 R 0152: Commission Implementing Regulation (EU) 2015/152 of 30 January 2015 (OJ L 26,

31.1.2015, p. 16),

-{66} 32015 R 0394: Commission Implementing Regulation (EU) 2015/394 of 10 March 2015 (OJ L 66,

11.3.2015, p. 1),

-{67} 32015 R 0446: Commission Implementing Regulation (EU) 2015/446 of 17 March 2015 (OJ L 74,

18.3.2015, p. 18),

{53} Indent added by Decision No 261/2014 (OJ L 311, 26.11.2015, p. 11 and EEA Supplement No 71, 26.11.2015, p. 11), e.i.f. 13.12.2014.

{54} Indent added by Decision No 261/2014 (OJ L 311, 26.11.2015, p. 11 and EEA Supplement No 71, 26.11.2015, p. 11), e.i.f. 13.12.2014.

{55} Indent added by Decision No 262/2014 (OJ L 311, 26.11.2015, p. 12 and EEA Supplement No 71, 26.11.2015, p. 12), e.i.f. 13.12.2014 and

subsequently corrected before publication by Corrigendum of 20.3.2015.

{56} Indent added by Decision No 14/2015 (OJ L 93, 7.4.2016, p. 24 and EEA Supplement No 21, 7.4.2016, p. 21), e.i.f. 26.2.2015.

{57} Indent added by Decision No 14/2015 (OJ L 93, 7.4.2016, p. 24 and EEA Supplement No 21, 7.4.2016, p. 21), e.i.f. 26.2.2015.

{58} Indent added by Decision No 14/2015 (OJ L 93, 7.4.2016, p. 24 and EEA Supplement No 21, 7.4.2016, p. 21), e.i.f. 26.2.2015.

{59} Indent added by Decision No 14/2015 (OJ L 93, 7.4.2016, p. 24 and EEA Supplement No 21, 7.4.2016, p. 21), e.i.f. 26.2.2015.

{60} Indent added by Decision No 14/2015 (OJ L 93, 7.4.2016, p. 24 and EEA Supplement No 21, 7.4.2016, p. 21), e.i.f. 26.2.2015.

{61} Indent added by Decision No 50/2015 (OJ L 129, 19.5.2016, p. 31 and EEA Supplement No 29, 19.5.2016, p. 32), e.i.f. 21.3.2015.

{62} Indent added by Decision No 149/2015 (OJ L 341, 15.12.2016, p. 41 and EEA Supplement No 69, 15.12.2016, p. 42), e.i.f. 12.6.2015.

{63} Indent added by Decision No 149/2015 (OJ L 341, 15.12.2016, p. 41 and EEA Supplement No 69, 15.12.2016, p. 42), e.i.f. 12.6.2015.

{64} Indent added by Decision No 149/2015 (OJ L 341, 15.12.2016, p. 41 and EEA Supplement No 69, 15.12.2016, p. 42), e.i.f. 12.6.2015.

{65} Indent added by Decision No 149/2015 (OJ L 341, 15.12.2016, p. 41 and EEA Supplement No 69, 15.12.2016, p. 42), e.i.f. 12.6.2015.

{66} Indent added by Decision No 177/2015 (OJ L 8, 12.1.2017, p. 5 and EEA Supplement No 3, 12.1.2017, p. 5), e.i.f. 11.7.2015.

{67} Indent added by Decision No 211/2015 (OJ L 85, 30.3.2017, p. 28 and EEA Supplement No 19, 30.3.2017, p. 28), e.i.f. 26.9.2015.

Page 8: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 134

-{68} 32014 R 1277: Commission Implementing Regulation (EU) No 1277/2014 of 1 December 2014 (OJ

L 346, 2.12.2014, p. 23),

-{69} 32014 R 1359: Commission Implementing Regulation (EU) No 1359/2014 of 18 December 2014

(OJ L 365, 19.12.2014, p. 103),

-{70} 32014 R 1390: Commission Implementing Regulation (EU) No 1390/2014 of 19 December 2014

(OJ L 369, 24.12.2014, p. 65),

-{71} 32015 R 1078: Commission Implementing Regulation (EU) 2015/1078 of 3 July 2015 (OJ L 175,

4.7.2015, p. 5),

-{72} 32015 R 1079: Commission Implementing Regulation (EU) 2015/1079 of 3 July 2015 (OJ L 175,

4.7.2015, p. 8),

-{73} 32015 R 1080: Commission Implementing Regulation (EU) 2015/1080 of 3 July 2015 (OJ L 175,

4.7.2015, p. 11),

-{74} 32015 R 1308: Commission Implementing Regulation (EU) 2015/1308 of 29 July 2015 (OJ L 200,

30.7.2015, p. 11),

-{75} 32015 R 1491: Commission Implementing Regulation (EU) 2015/1491 of 3 September 2015 (OJ

L 231, 4.9.2015, p. 7),

-{76} 32015 R 1492: Commission Implementing Regulation (EU) 2015/1492 of 3 September 2015 (OJ

L 231, 4.9.2015, p. 10),

-{77} 32015 R 1820: Commission Implementing Regulation (EU) 2015/1820 of 9 October 2015 (OJ

L 265, 10.10.2015, p. 1),

-{78} 32015 R 2062: Commission Implementing Regulation (EU) 2015/2062 of 17 November 2015 (OJ

L 301, 18.11.2015, p. 7),

-{79} 32016 R 0129: Commission Implementing Regulation (EU) 2016/129 of 1 February 2016 (OJ L 25,

2.2.2016, p. 44),

-{80} 32016 R 0305: Commission Implementing Regulation (EU) 2016/305 of 3 March 2016 (OJ L 58,

4.3.2016, p. 35),

-{81} 32016 R 0312: Commission Implementing Regulation (EU) 2016/312 of 4 March 2016 (OJ L 60,

5.3.2016, p. 3),

-{82} 32016 R 0576: Commission Implementing Regulation (EU) 2016/576 of 14 April 2016 (OJ L 99,

15.4.2016, p. 1),

{68} Indent added by Decision No 253/2015 (OJ L 161, 22.6.2017, p. 33 and EEA Supplement No 38, 22.6.2017, p. 33), e.i.f. 1.11.2015.

{69} Indent added by Decision No 253/2015 (OJ L 161, 22.6.2017, p. 33 and EEA Supplement No 38, 22.6.2017, p. 33), e.i.f. 1.11.2015.

{70} Indent added by Decision No 253/2015 (OJ L 161, 22.6.2017, p. 33 and EEA Supplement No 38, 22.6.2017, p. 33), e.i.f. 1.11.2015.

{71} Indent added by Decision No 254/2015 (OJ L 161, 22.6.2017, p. 33 and EEA Supplement No 38, 22.6.2017, p. 35), e.i.f. 1.11.2015.

{72} Indent added by Decision No 254/2015 (OJ L 161, 22.6.2017, p. 35 and EEA Supplement No 38, 22.6.2017, p. 35), e.i.f. 1.11.2015.

{73} Indent added by Decision No 254/2015 (OJ L 161, 22.6.2017, p. 35 and EEA Supplement No 38, 22.6.2017, p. 35), e.i.f. 1.11.2015.

{74} Indent added by Decision No 255/2015 (OJ L 161, 22.6.2017, p. 37 and EEA Supplement No 38, 22.6.2017, p. 37), e.i.f. 1.11.2015.

{75} Indent added by Decision No 16/2016 (OJ L 189, 20.7.2017, p. 22 and EEA Supplement No 45, 20.7.2017, p. 24), e.i.f. 6.2.2016.

{76} Indent added by Decision No 16/2016 (OJ L 189, 20.7.2017, p. 22 and EEA Supplement No 45, 20.7.2017, p. 24), e.i.f. 6.2.2016.

{77} Indent added by Decision No 48/2016 (OJ L 270, 19.10.2017, p. 15 and EEA Supplement No 66, 19.10.2017, p. 15), e.i.f. 19.3.2016.

{78} Indent added by Decision No 81/2016 (OJ L 300, 16.11.2017, p. 25 and EEA Supplement No 73, 16.11.2017, p. 29), e.i.f. 30.4.2016.

{79} Indent added by Decision No 116/2016 (OJ L 308, 23.11.2017, p. 19 and EEA Supplement No 76, 23.11.2017, p. 24), e.i.f. 4.6.2016.

{80} Indent added by Decision No 145/2016 (OJ L 73, 15.3.2018, p. 18 and EEA Supplement No 16, 15.3.2018, p. 21), e.i.f. 9.7.2016.

{81} Indent added by Decision No 145/2016 (OJ L 73, 15.3.2018, p. 18 and EEA Supplement No 16, 15.3.2018, p. 21), e.i.f. 9.7.2016.

{82} Indent added by Decision No 22/2017 (OJ L 297, 22.11.2018, p. 28 and EEA Supplement No 78, 22.11.2018, p. 34), e.i.f. 4.2.2017.

Page 9: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 135

-{83} 32016 R 0710: Commission Implementing Regulation (EU) 2016/710 of 12 May 2016 (OJ L 125,

13.5.2016, p. 6),

-{84} 32016 R 0885: Commission Implementing Regulation (EU) 2016/885 of 3 June 2016 (OJ L 148,

4.6.2016, p. 1),

-{85} 32016 R 1444: Commission Implementing Regulation (EU) 2016/1444 of 31 August 2016 (OJ L

235, 1.9.2016, p. 8),

-{86} 32016 R 1834: Commission Implementing Regulation (EU) 2016/1834 of 17 October 2016 (OJ L

280, 18.10.2016, p. 22),

-{87} 32016 R 2045: Commission Implementing Regulation (EU) 2016/2045 of 23 November 2016 (OJ L

318, 24.11.2016, p. 3),

-{88} 32016 R 2074: Commission Implementing Regulation (EU) 2016/2074 of 25 November 2016 (OJ L

320, 26.11.2016, p. 29),

-{89} 32017 R 0201: Commission Implementing Regulation (EU) 2017/201 of 6 February 2017 (OJ L 32,

7.2.2017, p. 17),

-{90} 32017 R 1558: Commission Implementing Regulation (EU) 2017/1558 of 14 September 2017 (OJ L

237, 15.9.2017, p. 67),

-{91} 32017 R 1559: Commission Implementing Regulation (EU) 2017/1559 of 14 September 2017 (OJ L

237, 15.9.2017, p. 69),

-{92} 32018 R 0520: Commission Implementing Regulation (EU) 2018/520 of 28 March 2018 (OJ L 87,

3.4.2018, p. 9),

-{93} 32018 R 0523: Commission Implementing Regulation (EU) 2018/523 of 28 March 2018 (OJ L 88,

4.4.2018, p. 1),

-{94} 32018 R 0721: Commission Implementing Regulation (EU) 2018/721 of 16 May 2018 (OJ L 122,

17.5.2018, p. 5),

-{95} 32018 R 0722: Commission Implementing Regulation (EU) 2018/722 of 16 May 2018 (OJ L 122,

17.5.2018, p. 8),

-{96} 32018 R 1076: Commission Implementing Regulation (EU) 2018/1076 of 30 July 2018 (OJ L 194,

31.7.2018, p. 41).

-{97} 32018 R 1967: Commission Implementing Regulation (EU) 2018/1967 of 12 December 2018 (OJ L

316, 13.12.2018, p. 6),

{83} Indent added by Decision No 23/2017 (OJ L 297, 22.11.2018, p. 29 and EEA Supplement No 78, 22.11.2018, p. 35), e.i.f. 4.2.2017.

{84} Indent added by Decision No 23/2017 (OJ L 297, 22.11.2018, p. 29 and EEA Supplement No 78, 22.11.2018, p. 35), e.i.f. 4.2.2017.

{85} Indent added by Decision No 24/2017 (OJ L 297, 22.11.2018, p. 30 and EEA Supplement No 78, 22.11.2018, p. 36), e.i.f. 4.2.2017.

{86} Indent added by Decision No 52/2017 (OJ L 305, 29.11.2018, p. 17 and EEA Supplement No 81, 29.11.2018, p. 20), e.i.f. 18.3.2017.

{87} Indent added by Decision No 87/2017 (OJ L 36, 7.2.2019, p. 34 and EEA Supplement No 11, 7.2.2019, p. 39), e.i.f. 6.5.2017.

{88} Indent added by Decision No 87/2017 (OJ L 36, 7.2.2019, p. 34 and EEA Supplement No 11, 7.2.2019, p. 39), e.i.f. 6.5.2017.

{89} Indent added by Decision No 128/2017 (OJ L 128, 16.5.2019, p. 20 and EEA Supplement No 40, 16.5.2019, p. 21), e.i.f. 8.7.2017.

{90} Indent added by Decision No 13/2018 (OJ L 323, 12.12.2019, p. 26 and EEA Supplement No 98, 12.12.2019, p. 24), e.i.f. 10.2.2018.

{91} Indent added by Decision No 13/2018 (OJ L 323, 12.12.2019, p. 26 and EEA Supplement No 98, 12.12.2019, p. 24), e.i.f. 10.2.2018.

{92} Indent added by Decision No 237/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 6.12.2018.

{93} Indent added by Decision No 237/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 6.12.2018.

{94} Indent added by Decision No 62/2019 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 30.3.2019.

{95} Indent added by Decision No 62/2019 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 30.3.2019.

{96} Indent added by Decision No 63/2019 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 30.3.2019.

{97} Indent added by Decision No 115/2019 (OJ L [to be published] and EEA supplement No [to be published]), e.i.f. 1.6.2019.

Page 10: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 136

-{98} 32019 R 0238: Commission Implementing Regulation (EU) 2019/238 of 8 February 2019

(OJ L 39, 11.2.2019, p. 4).

14. [ ] {99}

15. [ ] {100}

15a.{101} 391 L 0412: Commission Directive 91/412/EEC of 23 July 1991 laying down the principles and guidelines of

good manufacturing practice for veterinary medicinal products (OJ No L 228, 17.8.1991, p. 70).

15b. [ ] {102}

15c. [ ] {103}

15d. [ ] {104}

15e. [ ] {105}

15f.{106} [ ]

15g.{107} [ ]

15h.{108} 395 R 0297: Council Regulation (EC) No 297/95 of 10 February 1995 on fees payable to the European

Agency for the Evaluation of Medicinal Products (OJ L 35, 15.2.1995, p. 1), as amended by:

-{109} 398 R 2743: Council Regulation (EC) No 2743/98 of 14 December 1998 (OJ L 345, 19.12.1998,

p. 3),

-{110} 32003 R 0494: Commission Regulation (EC) No 494/2003 of 18 March 2003 (OJ L 73, 19.3.2003,

p. 6),

{98} Indent added by Decision No 224/2019 (OJ L [to be published] and EEA supplement No [to be published]), e.i.f. 28.9.2019.

{99} Text of point 14 (Council Regulation (EEC) No 2377/90) deleted by Decision No 117/2016 (OJ L 308, 23.11.2017, p. 20 and EEA

Supplement No 76, 23.11.2017, p. 25), e.i.f. 4.6.2016.

{100} Text of point 15 deleted by Decision No 23/2004 (OJ L 127, 29.4.2004, p. 128 and EEA Supplement No 22, 29.4.2004, p. 10), e.i.f.

20.3.2004.

{101} Point inserted by Decision No 7/94 (OJ L 160, 28.6.1994, p. 1 and EEA Supplement No 17, 28.6.1994, p. 1), e.i.f. 1.7.1994.

{102} Text of point 15b (Council Directive 92/25/EEC) inserted by Decision No 7/94 (OJ L 160, 28.6.1994, p. 1 and EEA Supplement No 17,

28.6.1994, p. 1), e.i.f. 1.7.1994, and subsequently deleted by Decision No 82/2002 (OJ L 266, 3.10.2002, p. 32 and EEA Supplement No 49,

3.10.2002, p. 22), e.i.f. 26.6.2002.

{103} Text of point 15c (Council Directive 92/26/EEC) inserted by Decision No 7/94 (OJ L 160, 28.6.1994, p. 1 and EEA Supplement No 17,

28.6.1994, p. 1), e.i.f. 1.7.1994, and subsequently deleted by Decision No 82/2002 (OJ L 266, 3.10.2002, p. 32 and EEA Supplement No 49,

3.10.2002, p. 22), e.i.f. 26.6.2002.

{104} Text of point 15d (Council Directive 92/27/EEC) inserted by Decision No 7/94 (OJ L 160, 28.6.1994, p. 1 and EEA Supplement No 17,

28.6.1994, p. 1), e.i.f. 1.7.1994, and subsequently deleted by Decision No 82/2002 (OJ L 266, 3.10.2002, p. 32 and EEA Supplement No 49,

3.10.2002, p. 22), e.i.f. 26.6.2002.

{105} Text of point 15e (Council Directive 92/28/EEC) inserted by Decision No 7/94 (OJ L 160, 28.6.1994, p. 1 and EEA Supplement No 17,

28.6.1994, p. 1), e.i.f. 1.7.1994, and subsequently deleted by Decision No 82/2002 (OJ L 266, 3.10.2002, p. 32 and EEA Supplement No 49,

3.10.2002, p. 22), e.i.f. 26.6.2002.

{106} Text of point 15f (Council Directive 92/109/EEC) inserted by Decision No 7/94 (OJ L 160, 28.6.1994, p. 1 and EEA Supplement No 17,

28.6.1994, p. 1), e.i.f. 1.7.1994, and subsequently deleted by Decision No 131/2005 (OJ L 14, 19.1.2006, p. 18 and EEA Supplement No 4,

19.1.2006, p. 2), e.i.f. 22.10.2005.

{107} Point inserted by Decision 74/1999 (OJ L 284, 9.11.2000, p. 65 and EEA Supplement No 51, 9.11.2000, p. 76), e.i.f. 1.1.2000 and

subsequently deleted by Decision No 61/2009 (OJ L 232, 3.9.2009, p. 13 and EEA Supplement No 47, 3.9.2009, p. 14), e.i.f. 23.12.2009. For

Liechtenstein, Decision 61/2009 entered into force 1.12.2010 which is the day of entry into force of the Agreement between Liechtenstein

and Austria laying down the technical details for Liechtenstein’s recognition of Austrian marketing authorisations within the decentralized

procedure (DCP) and the mutual recognition procedure (MRP).

{108} Point inserted by Decision 74/1999 (OJ L 284, 9.11.2000, p. 65 and EEA Supplement No 51, 9.11.2000, p. 76), e.i.f. 1.1.2000.

{109} Indent and words “, as amended by:” above, added by Decision No 75/2000 (OJ L 284, 9.11.2000, p. 71 and EEA Supplement No 51,

9.11.2000, p. 144), e.i.f. 3.10.2000.

{110} Indent added by Decision No 108/2003 (OJ L 331, 18.12.2003, p. 20 and EEA Supplement No 64, 18.12.2003, p. 14), e.i.f. 27.9.2003.

Page 11: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 137

-{111} 32005 R 1905: Council Regulation (EC) No 1905/2005 of 14 November 2005 (OJ L 304,

23.11.2005, p. 1),

-{112} 32009 R 0249: Commission Regulation (EC) No 249/2009 of 23 March 2009 (OJ L 79, 25.3.2009,

p. 34),

-{113} 32011 R 0301: Commission Regulation (EU) No 301/2011 of 28 March 2011 (OJ L 81, 29.3.2011,

p. 5),

-{114} 32012 R 0273: Commission Regulation (EU) No 273/2012 of 27 March 2012 (OJ L 90, 28.3.2012,

p. 11),

-{115} 32013 R 0220: Commission Regulation (EU) No 220/2013 of 13 March 2013 (OJ L 70, 14.3.2013,

p. 1),

-{116} 32014 R 0272: Commission Regulation (EU) No 272/2014 of 17 March 2014 (OJ L 79, 18.3.2014,

p. 37),

-{117} 32015 R 0490: Commission Regulation (EU) 2015/490 of 23 March 2015 (OJ L 78, 24.3.2015,

p. 9),

-{118} 32016 R 0461: Commission Regulation (EU) 2016/461 of 30 March 2016 (OJ L 80, 31.3.2016, p.

25),

-{119} 32017 R 0612: Commission Regulation (EU) 2017/612 of 30 March 2017 (OJ L 86, 31.3.2017, p.

7).

-{120} 32018 R 0471: Commission Regulation (EU) 2018/471 of 21 March 2018 (OJ L 79,

22.3.2018, p. 19).

15i.{121} 395 R 0540: Commission Regulation (EC) No 540/95 of 10 March 1995 laying down the arrangements for

reporting suspected unexpected adverse reactions which are not serious, whether arising in the Community or

in a third country, to medicinal products for human or veterinary use authorised in accordance with the

provisions of Council Regulation (EEC) No 2309/93 (OJ L 55, 11.3.1995, p. 5).

15j. [ ] {122}

15k. [ ] {123}

15l.{124} 396 R 2141: Commission Regulation (EC) No 2141/96 of 7 November 1996 concerning the examination of an

application for the transfer of marketing authorisation for a medicinal product falling within the scope of

Council Regulation (EEC) No 2309/93 (OJ L 286, 8.11.1996, p. 6).

{111} Indent added by Decision No 62/2009 (OJ L 232, 3.9.2009, p. 18 and EEA Supplement No 47, 3.9.2009, p. 18), e.i.f. 1.3.2010.

{112} Indent added by Decision No 72/2011 (OJ L 262, 6.10.2011, p. 28 and EEA Supplement No 54, 6.10.2011, p. 38), e.i.f. 2.7.2011.

{113} Indent added by Decision No 10/2012 (OJ L 161, 21.6.2012, p. 16 and EEA Supplement No 34, 21.6.2012, p. 19), e.i.f. 11.2.2012.

{114} Indent added by Decision No 160/2012 (OJ L 341, 13.12.2012, p. 11 and EEA Supplement No 70, 13.12.2012, p. 13), e.i.f. 29.9.2012.

{115} Indent added by Decision No 41/2014 (OJ L 256, 28.8.2014, p. 14 and EEA Supplement No 49, 28.8.2014, p. 14), e.i.f. 9.4.2014.

{116} Indent added by Decision No 178/2014 (OJ L 202, 30.7.2015, p. 28 and EEA Supplement No 43, 30.7.2015, p. 28), e.i.f. 26.9.2014.

{117} Indent added by Decision No 178/2015 (OJ L 8, 12.1.2017, p. 6 and EEA Supplement No 3, 12.1.2017, p. 6), e.i.f. 11.7.2015.

{118} Indent added by Decision No 173/2016 (OJ L 80, 22.3.2018, p. 14 and EEA Supplement No 19, 22.3.2018, p. 19), e.i.f. 24.9.2016.

{119} Indent added by Decision No 224/2017 (OJ L 254, 3.10.2019, p. 30 and EEA Supplement No 80, 3.10.2019, p. 33), e.i.f. 16.12.2017.

{120} Indent added by Decision No 141/2018 (OJ L [to be published]and EEA Supplement No [to be published]), e.i.f. 7.7.2018.

{121} Point inserted by Decision 74/1999 (OJ L 284, 9.11.2000, p. 65 and EEA Supplement No 51, 9.11.2000, p. 76), e.i.f. 1.1.2000.

{122} Point inserted by Decision 74/1999 (OJ L 284, 9.11.2000, p. 65 and EEA Supplement No 51, 9.11.2000, p. 76), e.i.f. 1.1.2000, and

subsequently deleted by Decision 3/2004 (OJ L 116, 22.4.2004, p. 44 and EEA Supplement No 20, 22.4.2004, p. 5), e.i.f. 7.2.2004.

{123} Point inserted by Decision 74/1999 (OJ L 284, 9.11.2000, p. 65 and EEA Supplement No 51, 9.11.2000, p. 76), e.i.f. 1.1.2000, and

subsequently deleted by Decision 3/2004 (OJ L 116, 22.4.2004, p. 44 and EEA Supplement No 20, 22.4.2004, p. 5), e.i.f. 7.2.2004.

{124} Point inserted by Decision 74/1999 (OJ L 284, 9.11.2000, p. 65 and EEA Supplement No 51, 9.11.2000, p. 76), e.i.f. 1.1.2000.

Page 12: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 138

15m.{125} 32000 R 0141: Regulation (EC) No 141/2000 of the European Parliament and of the Council of 16 December

1999 on orphan medicinal products (OJ L 18, 22.1.2000, p. 1).

{126}The provisions of the Regulation shall, for the purposes of the present Agreement, be read with the

following adaptation:

The EFTA States shall be fully associated with the work of the Committee for Orphan Medicinal Products. The

detailed arrangements of participation for the representatives of EFTA States shall be in accordance with the

provisions of Article 4 of the Regulation. Such representatives will, however, not participate in the voting and

their positions shall be recorded separately. The position of Chairman shall be reserved for a member

nominated by a Member State of the Community. The internal rules of procedure of this committee shall be

amended in order to give full effect to the EFTA States' participation.

The EFTA States shall contribute financially to the work of the Committee in accordance with Article 82(1)(a)

of the Agreement.

15n.{127} 32000 R 0847: Commission Regulation (EC) No 847/2000 of 27 April 2000 laying down the provisions for

implementation of the criteria for designation of a medical product as an orphan medicinal product and

definitions of the concepts ‘similar medicinal product’ and ‘clinical superiority’ (OJ L 103, 28.4.2000, p. 5) , as amended by:

-{128} 32018 R 0781: Commission Regulation (EU) 2018/781 of 29 May 2018 (OJ L 132, 30.5.2018, p. 1).

15o. [ ] {129}

15p.{130} 32001 L 0082: Directive 2001/82/EC of the European Parliament and of the Council of 6 November 2001 on

the Community code relating to veterinary medicinal products (OJ L 311, 28.11.2001, p. 1), as amended by:

-{131} 32004 L 0028: Directive 2004/28/EC of the European Parliament and of the Council of 31 March

2004 (OJ L 136, 30.4.2004, p. 58),

-{132} 32009 L 0009: Commission Directive 2009/9/EC of 10 February 2009 (OJ L 44, 14.2.2009, p. 10),

-{133} 32009 L 0053: Directive 2009/53/EC of the European Parliament and of the Council of 18 June

2009 (OJ L 168, 30.6.2009, p. 33),

-{134} 32009 R 0470: Regulation (EC) No 470/2009 of the European Parliament and of the Council of 6

May 2009 (OJ L 152, 16.6.2009, p. 11).

{135}The transitional arrangements set out in the Annexes to the Act of Accession of 16 April 2003 for

Lithuania (Annex IX, Chapter 1, Point 1) and Poland (Annex XII, Chapter 1, Point 4), shall apply.

{125} Point inserted by Decision No 68/2001 (OJ L 238, 6.9.2001, p. 14 and EEA Supplement No 44, 6.9.2001, p. 12), e.i.f. 20.6.2001.

{126} Adaptation text added by Decision No 140/2002 (OJ L 19, 23.1.2003, p. 5 and EEA Supplement No 4, 23.1.2003, p. 5), e.i.f. 1.7.2003.

{127} Point inserted by Decision No 69/2001 (OJ L 238, 6.9.2001, p. 15 and EEA Supplement No 44, 6.9.2001, p. 13), e.i.f. 20.6.2001.

{128} Indent and words “, as amended by:” added by Decision No 238/2018 (OJ L [to be published] and EEA Supplement No [to be published]),

e.i.f. 6.12.2018.

{129} Point inserted by Decision No 33/2002 (OJ L 154, 13.6.2002, p. 14 and EEA Supplement No 29, 13.6.2002, p. 11), e.i.f. 20.4.2002. Text of

point 15o (Directive 2001/20/EC of the European Parliament and of the Council) shall be deleted with effect from six months after the

publication of the notice referred to in Article 82(3) of Regulation (EU) No 536/2014, but in any event no earlier than 28 May 2016, by

Decision No 213/2015 (OJ L 85, 30.3.2017, p. 31 and EEA Supplement No 19, 30.3.2017, p. 31), e.i.f. 1.8.2016.

{130} Point inserted by Decision No 82/2002 (OJ L 266, 3.10.2002, p. 32 and EEA Supplement No 49, 3.10.2002, p. 22), e.i.f. 26.6.2002.

{131} Indent and words “, as amended by:” inserted by Decision No 61/2009 (OJ L 232, 3.9.2009, p. 13 and EEA Supplement No 47, 3.9.2009, p.

14), e.i.f. 23.12.2009. For Liechtenstein, Decision 61/2009 entered into force 1.12.2010 which is the day of entry into force of the

Agreement between Liechtenstein and Austria laying down the technical details for Liechtenstein’s recognition of Austrian marketing

authorisations within the decentralized procedure (DCP) and the mutual recognition procedure (MRP).

{132} Indent added by Decision No 25/2010 (OJ L 143, 10.6.2010, p. 18 and EEA Supplement No 30, 10.6.2010, p. 23), e.i.f. 13.3.2010.

{133} Indent added by Decision No 72/2011 (OJ L 262, 6.10.2011, p. 28 and EEA Supplement No 54, 6.10.2011, p. 38), e.i.f. 2.7.2011.

{134} Indent added by Decision No 83/2012 (OJ L 248, 13.9.2012, p. 19 and EEA Supplement No 50, 13.9.2012, p. 21), e.i.f. 1.5.2012.

{135} Text added by the 2004 EEA Enlargement Agreement (OJ L 130, 29.4.2004, p. 3 and EEA Supplement No 23, 29.4.2004, p. 1), e.i.f.

1.5.2004.

Page 13: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 139

{136}The provisions of the Directive shall, for the purposes of this Agreement, be read with the following

adaptation:

Liechtenstein shall not be obliged to participate in the decentralised procedure (DCP) and in the mutual

recognition procedure (MRP) and shall, therefore, not be obliged to issue the corresponding marketing

authorisations. Instead, Austrian marketing authorisations within the DCP and the MRP shall be valid for

Liechtenstein upon request of a marketing authorisation applicant.

15q.{137} 32001 L 0083: Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on

the Community code relating to medicinal products for human use (OJ L 311, 28.11.2001, p. 67), as amended

by:

-{138} 32003 L 0063: Commission Directive 2003/63/EC of 25 June 2003 (OJ L 159, 27.6.2003, p. 46),

-{139} 32002 L 0098: Directive 2002/98/EC of the European Parliament and of the Council of 27 January

2003 (OJ L 33, 8.2.2003, p. 30),

-{140} 32004 L 0027: Directive 2004/27/EC of the European Parliament and of the Council of 31 March

2004 (OJ L 136, 30.4.2004, p. 34),

-{141} 32004 L 0024: Directive 2004/24/EC of the European Parliament and of the Council of 31 March

2004 (OJ L 136, 30.4.2004, p. 85),

-{142} 32007 R 1394: Regulation (EC) No 1394/2007 of the European Parliament and of the Council of 13

November 2007 (OJ L 324, 10.12.2007, p. 121), as corrected by OJ L 87, 31.3.2009, p. 174,

-{143} 32009 L 0053: Directive 2009/53/EC of the European Parliament and of the Council of 18 June 2009

(OJ L 168, 30.6.2009, p. 33),

-{144} 32009 L 0120: Commission Directive 2009/120/EC of 14 September 2009 (OJ L 242, 15.9.2009, p.

3),

-{145} 32010 L 0084: Directive 2010/84/EU of the European Parliament and of the Council of

15 December 2010 (OJ L 348, 31.12.2010, p. 74), as corrected by OJ L 21, 25.1.2011, p. 8 and OJ L

276, 21.10.2011, p. 63,

-{146} 32011 L 0062: Directive 2011/62/EU of the European Parliament and of the Council of 8 June 2011

(OJ L 174, 1.7.2011, p. 74),

{136} Text added by Decision No 61/2009 (OJ L 232, 3.9.2009, p. 13 and EEA Supplement No 47, 3.9.2009, p. 14), e.i.f. 23.12.2009. For

Liechtenstein, Decision 61/2009 entered into force 1.12.2010 which is the day of entry into force of the Agreement between Liechtenstein

and Austria laying down the technical details for Liechtenstein’s recognition of Austrian marketing authorisations within the decentralized

procedure (DCP) and the mutual recognition procedure (MRP).

{137} Point inserted by Decision No 82/2002 (OJ L 266, 3.10.2002, p. 32 and EEA Supplement No 49, 3.10.2002, p. 22), e.i.f. 26.6.2002.

{138} Indent, and words “, as amended by:” above, added by Decision No 3/2004 (OJ L 116, 22.4.2004, p. 44 and EEA Supplement No 20,

22.4.2004, p. 5), e.i.f. 7.2.2004.

{139} Indent added by Decision No 99/2004 (OJ L 376, 23.12.2004, p. 23 and EEA Supplement No 65, 23.12.2004, p. 17), e.i.f. 1.7.2005.

{140} Indent added by Decision No 61/2009 (OJ L 232, 3.9.2009, p. 13 and EEA Supplement No 47, 3.9.2009, p. 14), e.i.f. 23.12.2009. For

Liechtenstein, Decision 61/2009 entered into force 1.12.2010 which is the day of entry into force of the Agreement between Liechtenstein

and Austria laying down the technical details for Liechtenstein’s recognition of Austrian marketing authorisations within the decentralized

procedure (DCP) and the mutual recognition procedure (MRP).

{141} Indent added by Decision No 61/2009 (OJ L 232, 3.9.2009, p. 13 and EEA Supplement No 47, 3.9.2009, p. 14), e.i.f. 23.12.2009. For

Liechtenstein, Decision 61/2009 entered into force 1.12.2010 which is the day of entry into force of the Agreement between Liechtenstein

and Austria laying down the technical details for Liechtenstein’s recognition of Austrian marketing authorisations within the decentralized

procedure (DCP) and the mutual recognition procedure (MRP).

{142} Indent added by Decision No 128/2009 (OJ L 62, 11.3.2010, p. 16 and EEA Supplement No 12, 11.3.2010, p. 15), e.i.f. 23.12.2009.For

Liechtenstein, Decision 128/2009 entered into force 1.12.2010 which is the day of entry into force of the Agreement between Liechtenstein

and Austria laying down the technical details for Liechtenstein’s recognition of Austrian marketing authorisations within the decentralized

procedure (DCP) and the mutual recognition procedure (MRP).

{143} Indent added by Decision No 72/2011 (OJ L 262, 6.10.2011, p. 28 and EEA Supplement No 54, 6.10.2011, p. 38), e.i.f. 2.7.2011.

{144} Indent added by Decision No 72/2011 (OJ L 262, 6.10.2011, p. 28 and EEA Supplement No 54, 6.10.2011, p. 38), e.i.f. 2.7.2011.

{145} Indent added by Decision No 158/2013 (OJ L 58, 27.2.2014, p. 10 and EEA Supplement No 13, 27.2.2014, p. 11), e.i.f. 28.5.2014.

{146} Indent added by Decision No 159/2013 (OJ L 58, 27.2.2014, p. 12 and EEA Supplement No 13, 27.2.2014, p. 14), e.i.f. 1.6.2014.

Page 14: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 140

-{147} 32012 L 0026: Directive 2012/26/EU of the European Parliament and of the Council of 25 October

2012 (OJ L 299, 27.10.2012, p. 1),

-{148} 32006 R 1901: Regulation (EC) No 1901/2006 of the European Parliament and of the Council of 12

December 2006 (OJ L 378, 27.12.2006, p. 1),

-{149} 32017 R 0745: Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April

2017 (OJ L 117, 5.5.2017, p. 1), as corrected by OJ L 117, 3.5.2019, p. 9.

{150} The transitional arrangements set out in the Annexes to the Act of Accession of 16 April 2003 for

Cyprus (Annex VII, Chapter 1), Lithuania (Annex IX, Chapter 1, Point 2), Malta (Annex XI, Chapter

1, Point 2), Poland (Annex XII, Chapter 1, Point 5) and Slovenia (Annex XIII, Chapter 1), shall

apply.

{151} The transitional arrangements set out in the Annexes to the Act of Accession of 9 December 2011 for

Croatia (Annex V, Chapter 1) shall apply.

{152} The provisions of the Directive shall, for the purposes of this Agreement, be read with the following

adaptations:

(a) Liechtenstein shall not be obliged to participate in the decentralised procedure (DCP) and in

the mutual recognition procedure (MRP) and shall, therefore, not be obliged to issue the

corresponding marketing authorisations. Instead, Austrian marketing authorisations within

the DCP and the MRP shall be valid for Liechtenstein upon request of a marketing

authorisation applicant.

(b) The EFTA States may initiate the urgent Union procedure pursuant to Section 4 of Chapter 3

of Title IX of the Directive.

(c) With respect to Title IX, the obligations of Liechtenstein will be executed by Austria.

Liechtenstein will however, as far as applicable to Liechtenstein:

- operate a pharmacovigilance system in accordance with Article 101(1);

- perform a regular audit of its pharmacovigilance system in accordance with Article 101(2);

- designate a competent authority for the performance of its pharmacovigilance tasks in

accordance with Article 101(3),

- take all appropriate measures to encourage patients, doctors, pharmacists and other

healthcare professionals to report suspected adverse reactions to the national competent

authority in accordance with Article 102(a);

- facilitate patient reporting through the provision of alternative reporting formats in addition

to web-based formats in accordance with Article 102(b);

- impose an obligation on a marketing authorisation holder to operate a risk management

system, as referred to in Article 104(3)(c), if there are concerns about the risks affecting the

risk-benefit balance of an authorised medicinal product in accordance with Article 104a(2).

{147} Indent added by Decision No 160/2013 (OJ L 58, 27.2.2014, p. 13 and EEA Supplement No 13, 27.2.2014, p. 15), e.i.f. 1.6.2014.

{148} Indent added by Decision No 92/2017 (OJ L 36, 7.2.2019, p. 41 and EEA Supplement No 11, 7.2.2019, p. 49), e.i.f. 1.6.2018.

{149} Indent added by Decision No 288/2019 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. pending.

{150} Text added by the 2004 EEA Enlargement Agreement (OJ L 130, 29.4.2004, p. 3 and EEA Supplement No 23, 29.4.2004, p. 1), e.i.f.

1.5.2004.

{151} Sentence added by the 2014 EEA Enlargement Agreement (OJ L 170, 11.6.2014, p. 5 and EEA Supplement No 58, 9.10.2014, p. 1),

provisionally applicable as of 12.4.2014, e.i.f. pending.

{152} Text added by Decision No 61/2009 (OJ L 232, 3.9.2009, p. 13 and EEA Supplement No 47, 3.9.2009, p. 14), e.i.f. 23.12.2009 For

Liechtenstein, Decision 61/2009 entered into force 1.12.2010 which is the day of entry into force of the Agreement between Liechtenstein

and Austria laying down the technical details for Liechtenstein’s recognition of Austrian marketing authorisations within the decentralized

procedure (DCP) and the mutual recognition procedure (MRP) and subsequently the adaptation text is replaced by Decision No 158/2013

(OJ L 58, 27.2.2014, p. 10 and EEA Supplement No 13, 27.2.2014, p. 11), e.i.f. 28.5.2014.

Page 15: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 141

For the imposition of such obligation Liechtenstein will base itself on a corresponding

decision of the Austrian authorities;

- set up and maintain a national medicines web-portal which shall be linked to the European

medicines web-portal in accordance with Article 106;

- record all suspected adverse reactions that occur in its territory which are brought to its

attention from healthcare professionals and patients and ensure that reports of such

reactions may be submitted by means of the national medicines web-portals or by other

means in accordance with Article 107a(1), and

- submit reports in accordance with Article 107a(4).

(d) The following subparagraph shall be added to Article 107c(5):

“A Swiss marketing authorisation for a medicinal product taking effect in Liechtenstein by

virtue of Liechtenstein law on the basis of the Customs Union between the Principality of

Liechtenstein and the Swiss Confederation shall not be considered as a first authorisation to

place a product on the market for the purposes of this paragraph.”’

15qa.{153} 32013 D 0051: Commission Implementing Decision 2013/51/EU of 23 January 2013 on the assessment of a

third country’s regulatory framework applicable to active substances of medicinal products for human use

and of the respective control and enforcement activities pursuant to Article 111b of Directive 2001/83/EC of

the European Parliament and of the Council (OJ L 21, 24.1.2013, p. 36).

15qb.{154} 32012 D 0715: Commission Implementing Decision 2012/715/EU of 22 November 2012 establishing a list

of third countries with a regulatory framework applicable to active substances for medicinal products for

human use and the respective control and enforcement activities ensuring a level of protection of public

health equivalent to that in the Union, in accordance with Directive 2001/83/EC of the European Parliament

and of the Council (OJ L 325, 23.11.2012, p. 15), as amended by:

-{155} 32013 D 0262: Commission Implementing Decision 2013/262/EU of 4 June 2013 (OJ L 152,

5.6.2013, p. 52),

-{156} 32013 D 0301: Commission Implementing Decision 2013/301/EU of 11 June 2013 (OJ L 196,

21.6.2013, p. 71),

-{157} 32013 D 0196: Commission Implementing Decision 2013/196/EU of 24 April 2013 (OJ L 113,

25.4.2013, p. 22),

-{158} 32015 D 1057: Commission Implementing Decision (EU) 2015/1057 of 1 July 2015 (OJ L 171,

2.7.2015, p. 23).

15qc.{159} 32014 R 0357: Commission Delegated Regulation (EU) No 357/2014 of 3 February 2014 supplementing

Directive 2001/83/EC of the European Parliament and of the Council and Regulation (EC) No 726/2004 of the

European Parliament and of the Council as regards situations in which post-authorisation efficacy studies may

be required (OJ L 107, 10.4.2014, p. 1).

15qd.{160}32014 R 1252: Commission Delegated Regulation (EU) No 1252/2014 of 28 May 2014 supplementing

Directive 2001/83/EC of the European Parliament and of the Council with regard to principles and guidelines

of good manufacturing practice for active substances for medicinal products for human use (OJ L 337,

25.11.2014, p. 1).

{153} Point inserted by Decision No 161/2013 (OJ L 58, 27.2.2014, p. 14 and EEA Supplement No 13, 27.2.2014, p. 16), e.i.f. 9.10.2013.

{154} Point inserted by Decision No 162/2013 (OJ L 58, 27.2.2014, p. 15 and EEA Supplement No 13, 27.2.2014, p. 17), e.i.f. 9.10.2013.

{155} Indent and words “ , as amended by:”, inserted by Decision No 191/2013 (OJ L [to be published] and EEA Supplement No [to be

published]), e.i.f. 9.11.2013.

{156} Indent added by Decision No 40/2014 (OJ L 256, 28.8.2014, p. 13 and EEA Supplement No 49, 28.8.2014, p. 13), e.i.f. 9.4.2014.

{157} Indent added by Decision No 82/2014 (OJ L 310, 30.10.2014, p. 35 and EEA Supplement No 63, 30.10.2014, p. 26), e.i.f. 17.5.2014.

{158} Indent added by Decision No 256/2015 (OJ L 161, 22.6.2017, p. 38 and EEA Supplement No 38, 22.6.2017, p. 38), e.i.f. 1.11.2015.

{159} Point inserted by Decision No 263/2014 (OJ L 311, 26.11.2015, p. 13 and EEA Supplement No 71, 26.11.2015, p. 13), e.i.f. 13.12.2014.

{160} Point inserted by Decision No 88/2015 (OJ L 211, 4.8.2016, p. 25 and EEA Supplement No 42, 4.8.2016, p. 24), e.i.f. 1.5.2015.

Page 16: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 142

15qe.{161}32017 L 1572: Commission Directive (EU) 2017/1572 of 15 September 2017 supplementing Directive

2001/83/EC of the European Parliament and of the Council as regards the principles and guidelines of good

manufacturing practice for medicinal products for human use (OJ L 238, 16.9.2017, p. 44).

The provisions of the Directive shall, for the purposes of this Agreement, be read with the following

adaptation:

The inspections in Liechtenstein shall be performed by the Swiss inspectorate on behalf of Liechtenstein on the

basis of the agreement between Swissmedic and Amt für Gesundheit (Verwaltungsvereinbarung betreffend

Inspektionen).

15qf.{162}32016 R 0161: Commission Delegated Regulation (EU) 2016/161 of 2 October 2015 supplementing Directive

2001/83/EC of the European Parliament and of the Council by laying down detailed rules for the safety

features appearing on the packaging of medicinal products for human use (OJ L 32, 9.2.2016, p. 1).

15r. [ ] {163}

15s. [ ] {164}

15t.{165} 32003 L 0094: Commission Directive 2003/94/EC of 8 October 2003 laying down the principles and

guidelines of good manufacturing practice in respect of medicinal products for human use and investigational

medicinal products for human use (OJ L 262, 14.10.2003, p. 22).

15u.{166} 32002 L 0098: Directive 2002/98/EC of the European Parliament and of the Council of 27 January 2003

setting standards of quality and safety for the collection, testing, processing, storage and distribution of human

blood and blood components and amending Directive 2001/83/EC (OJ L 33, 8.2.2003, p. 30).

15v.{167} 32004 L 0033: Commission Directive 2004/33/EC of 22 March 2004 implementing Directive 2002/98/EC of

the European Parliament and of the Council as regards certain technical requirements for blood and blood

components (OJ L 91, 30.3.2004, p. 25), as amended by:

-{168} 32011 L 0038: Commission Implementing Directive 2011/38/EU of 11 April 2011 (OJ L 97,

12.4.2011, p. 28),

-{169} 32014 L 0110: Commission Directive 2014/110/EU of 17 December 2014 (OJ L 366, 20.12.2014,

p. 81).

15va.{170}32005 L 0061: Commission Directive 2005/61/EC of 30 September 2005 implementing Directive 2002/98/EC

of the European Parliament and of the Council as regards traceability requirements and notification of serious

adverse reactions and events (OJ L 256, 1.10.2005, p. 32).

{161} Point inserted by Decision No 48/2018 (OJ L 211 [to be published] and EEA Supplement No [to be published]), e.i.f. 1.12.2018.

{162} Point inserted by Decision No 116/2019 (OJ L [to be published] and EEA supplement No [to be published]), e.i.f. 1.6.2019.

{163} Point inserted by Decision No 3/2004 (OJ L 116, 22.4.2004, p. 44 and EEA Supplement No 20, 22.4.2004, p. 5), e.i.f. 7.2.2004 and

subsequently deleted by Decision No 128/2009 (OJ L 62, 11.3.2010, p. 16 and EEA Supplement No 12, 11.3.2010, p. 15), e.i.f. 23.12.2009.

For Liechtenstein, Decision 128/2009 entered into force 1.12.2010 which is the day of entry into force of the Agreement between

Liechtenstein and Austria laying down the technical details for Liechtenstein’s recognition of Austrian marketing authorisations within the

decentralized procedure (DCP) and the mutual recognition procedure (MRP).

{164} Point inserted by Decision No 3/2004 (OJ L 116, 22.4.2004, p. 44 and EEA Supplement No 20, 22.4.2004, p. 5), e.i.f. 7.2.2004 and

subsequently deleted by Decision No 128/2009 (OJ L 62, 11.3.2010, p. 16 and EEA Supplement No 12, 11.3.2010, p. 15), e.i.f. 23.12.2009.

For Liechtenstein, Decision 128/2009 entered into force 1.12.2010 which is the day of entry into force of the Agreement between

Liechtenstein and Austria laying down the technical details for Liechtenstein’s recognition of Austrian marketing authorisations within the

decentralized procedure (DCP) and the mutual recognition procedure (MRP).

{165} Point inserted by Decision No 23/2004 (OJ L 127, 29.4.2004, p. 128 and EEA Supplement No 22, 29.4.2004, p. 10), e.i.f. 20.3.2004.

{166} Point inserted by Decision No 99/2004 (OJ L 376, 23.12.2004, p. 23 and EEA Supplement No 65, 23.12.2004, p. 17), e.i.f. 1.7.2005.

{167} Point inserted by Decision No 32/2005 (OJ L 198, 28.7.2005, p. 22 and EEA Supplement No 38, 28.7.2005, p. 14), e.i.f. 1.8.2005.

{168} Indent and words “, as amended by:” added by Decision No 46/2012 (OJ L 207, 2.8.2012, p. 26 and EEA Supplement No 43, 2.8.2012,

p. 30) e.i.f. 1.5.2012.

{169} Indent added by Decision No 89/2015 (OJ L 211, 4.8.2016, p. 26 and EEA Supplement No 42, 4.8.2016, p. 25) e.i.f. 1.5.2015

{170} Point inserted by Decision No 81/2006 (OJ L 289, 19.10.2006, p. 12 and EEA Supplement No 52, 19.10.2006, p. 11), e.i.f. 1.2.2007.

Page 17: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 143

15vb.{171}32005 L 0062: Commission Directive 2005/62/EC of 30 September 2005 implementing Directive 2002/98/EC

of the European Parliament and of the Council as regards Community standards and specifications relating to a

quality system for blood establishments (OJ L 256, 1.10.2005, p. 41), as amended by:

-{172} 32016 L 1214: Commission Directive (EU) 2016/1214 of 25 July 2016 (OJ L 199, 26.7.2016, p. 14).

15w.{173} 32004 L 0023: Directive 2004/23/EC of the European Parliament and of the Council of 31 March 2004 on

setting standards of quality and safety for the donation, procurement, testing, processing, preservation, storage

and distribution of human tissues and cells (OJ L 102, 7.4.2004, p. 48).

15x.{174} 32004 R 0273: Regulation (EC) No 273/2004 of the European Parliament and of the Council of 11 February

2004 on drug precursors (OJ L 47, 18.2.2004, p. 1), as amended by:

-{175} 32013 R 1258: Regulation (EU) No 1258/2013 of the European Parliament and of the Council of

20 November 2013 (OJ L 330, 10.12.2013, p. 21),

-{176} 32016 R 1443: Commission Delegated Regulation (EU) 2016/1443 of 29 June 2016 (OJ L 235,

1.9.2016, p. 6),

-{177} 32018 R 0729: Commission Delegated Regulation (EU) 2018/729 of 26 February 2018 (OJ L 123,

18.5.2018, p. 4).

The provisions of the Regulation shall, for the purposes of this Agreement, be read with the following

adaptations:

(a) The text of Article 11 (2) shall not apply.

(b) In Article 14a a reference is made to the Committee set up by Article 30 of Council Regulation (EC)

No 111/2005. When that Committee deals with matters covered by this Regulation the EFTA States

shall participate fully in the work of the Committee, but shall not have the right to vote.

15xa.{178}32015 R 1011: Commission Delegated Regulation (EU) 2015/1011 of 24 April 2015 supplementing

Regulation (EC) No 273/2004 of the European Parliament and of the Council on drug precursors and Council

Regulation (EC) No 111/2005 laying down rules for the monitoring of trade between the Union and third

countries in drug precursors, and repealing Commission Regulation (EC) No 1277/2005 (OJ L 162, 27.6.2015,

p. 12), as corrected by OJ L 185, 14.7.2015, p. 31 and OJ L 125, 18.5.2017, p. 75.

The provisions of the Delegated Regulation shall, for the purposes of this Agreement, be read with the

following adaptation:

The Regulation shall only apply to the EEA EFTA States with regard to Regulation (EC) No 273/2004.

15xb.{179}32015 R 1013: Commission Implementing Regulation (EU) 2015/1013 of 25 June 2015 laying down rules in

respect of Regulation (EC) No 273/2004 of the European Parliament and of the Council on drug precursors

{171} Point inserted by Decision No 81/2006 (OJ L 289, 19.10.2006, p. 12 and EEA Supplement No 52, 19.10.2006, p. 11), e.i.f. 1.2.2007.

{172} Indent and words “, as amended by: “ added by Decision No 25/2017 (OJ L 297, 22.11.2018, p. 31 and EEA Supplement No 78, 22.11.2018,

p. 37), e.i.f. 4.2.2017

{173} Point inserted by Decision No 116/2005 (OJ L 339, 22.12.2005, p. 18 and EEA Supplement No 66, 22.12.2005, p. 10), e.i.f. 1.4.2006.

{174} Point and adaptation text inserted by Decision No 131/2005 (OJ L 14, 19.1.2006, p. 18 and EEA Supplement No 4, 19.1.2006, p. 2), e.i.f.

22.10.2005. In adaptation text (b) of point 15x (Regulation (EC) No 273/2004 of the European Parliament and of the Council), the words

“Article 15” are replaced by “Article 14a” and the reference to “Article 10 of Regulation (EEC) No 3677/90” is replaced by a reference to

“Article 30 of Council Regulation (EC) No 111/2005” by Decision No 49/2016 (OJ L 270, 19.10.2017, p. 16 and EEA Supplement No 66,

19.10.2017, p. 16), e.i.f. 19.3.2016.

{175} Indent and words “, as amended by:” added by Decision No 49/2016 (OJ L 270, 19.10.2017, p. 16 and EEA Supplement No 66, 19.10.2017,

p. 16) e.i.f. 19.3.2016.

{176} Indent added by Decision No 50/2018 (OJ L [to be published]and EEA Supplement No [to be published]), e.i.f. 24.3.2018.

{177} Indent added by Decision No 151/2019 (OJ L [to be published]and EEA Supplement No [to be published]), e.i.f. 15.6.2019.

{178} Point and adaptation text inserted by Decision No 49/2018 (OJ L [to be published]and EEA Supplement No [to be published]), e.i.f.

24.3.2018.

{179} Point and adaptation text inserted by Decision No 49/2018 (OJ L [to be published]and EEA Supplement No [to be published]), e.i.f.

24.3.2018.

Page 18: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 144

and of Council Regulation (EC) No 111/2005 laying down rules for the monitoring of trade between the Union

and third countries in drug precursors (OJ L 162, 27.6.2015, p. 33).

The provisions of the Implementing Regulation shall, for the purposes of this Agreement, be read with the

following adaptation:

The Regulation shall only apply to the EEA EFTA States with regard to Regulation (EC) No 273/2004.

15y.{180} 32006 L 0017: Commission Directive 2006/17/EC of 8 February 2006 implementing Directive 2004/23/EC of

the European Parliament and of the Council as regards certain technical requirements for the donation,

procurement and testing of human tissues and cells (OJ L 38, 9.2.2006, p. 40), as amended by:

-{181} 32012 L 0039: Commission Directive 2012/39/EU of 26 November 2012 (OJ L 327, 27.11.2012,

p. 24)

15z.{182} 32006 L 0086: Commission Directive 2006/86/EC of 24 October 2006 implementing Directive 2004/23/EC of

the European Parliament and of the Council as regards traceability requirements, notification of serious

adverse reactions and events and certain technical requirements for the coding, processing, preservation,

storage and distribution of human tissues and cells (OJ L 294, 25.10.2006, p. 32), as amended by:

-{183} 32015 L 0565: Commission Directive (EU) 2015/565 of 8 April 2015 (OJ L 93, 9.4.2015, p. 43).

15za.{184} 32006 R 1950: Commission Regulation (EC) No 1950/2006 of 13 December 2006 establishing, in accordance

with Directive 2001/82/EC of the European Parliament and of the Council on the Community code relating to

veterinary medicinal products, a list of substances essential for the treatment of equidae (OJ L 367,

22.12.2006, p. 33), as amended by:

-{185} 32013 R 0122: Commission Regulation (EU) No 122/2013 of 12 February 2013 (OJ L 42,

13.2.2013, p. 1).

15zb.{186}32004 R 0726: Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March

2004 laying down Community procedures for the authorisation and supervision of medicinal products for

human and veterinary use and establishing a European Medicines Agency (OJ L 136, 30.4.2004, p. 1), as

amended by:

-{187} 32007 R 1394: Regulation (EC) No 1394/2007 of the European Parliament and of the Council of 13

November 2007 (OJ L 324, 10.12.2007, p. 121), as corrected by OJ L 87, 31.3.2009, p. 174,

-{188} 32009 R 0470: Regulation (EC) No 470/2009 of the European Parliament and of the Council of 6

May 2009 (OJ L 152, 16.6.2009, p. 11),

-{189} 32010 R 1235: Regulation (EU) No 1235/2010 of the European Parliament and of the Council of

15 December 2010 (OJ L 348, 31.12.2010, p. 1), as corrected by OJ L 201, 27.7.2012, p. 138,

{180} Point inserted by Decision No 81/2007 (OJ L 328, 13.12.2007, p.21 and EEA Supplement No 60, 13.12.2007, p.15), e.i.f. 7.7.2007.

{181} Indent and words “, as amended by:” added by Decision No 138/2013 (OJ L 345, 19.12.2013, p. 6 and EEA Supplement No 72, 19.12.2013,

p. 10), e.i.f. 16.7.2013.

{182} Point inserted by Decision No 81/2007 (OJ L 328, 13.12.2007, p. 21 and EEA Supplement No 60, 13.12.2007, p.15), e.i.f. 7.7.2007.

{183} Indent and words “, as amended by:” added by Decision No 212/2015 (OJ L 85, 30.3.2017, p. 29 and EEA Supplement No 19, 30.3.2017, p.

29), e.i.f. 26.9.2015.

{184} Point inserted by Decision No 140/2007 (OJ L 100, 10.4.2008, p. 66 and EEA Supplement No 19, 10.4.2008, p. 68), e.i.f. 27.10.2007.

{185} Indent and words “,as amended by:” added by Decision No 14/2014 (OJ L 211, 17.7.2014, p. 21 and EEA Supplement No 42, 17.7.2014,

p. 19), e.i.f. 15.2.2014.

{186} Point and texts inserted by Decision No 61/2009 (OJ L 232, 3.9.2009, p. 13 and EEA Supplement No 47, 3.9.2009, p. 14), e.i.f. 23.12.2009.

For Liechtenstein, Decision 61/2009 entered into force 1.12.2010 which is the day of entry into force of the Agreement between

Liechtenstein and Austria laying down the technical details for Liechtenstein’s recognition of Austrian marketing authorisations within the

decentralized procedure (DCP) and the mutual recognition procedure (MRP). The adaptation text is replaced by Decision No 92/2017 (OJ

L 36, 7.2.2019, p. 41 and EEA Supplement No 11, 7.2.2019, p. 49), e.i.f. 1.6.2018.

{187} Indent and words “, as amended by:” added by Decision No 128/2009 (OJ L 62, 11.3.2010, p. 16 and EEA Supplement No12, 11.3.2010,

p. 15), e.i.f. 23.12.2009. For Liechtenstein, Decision 128/2009 entered into force 1.12.2010 which is the day of entry into force of the

Agreement between Liechtenstein and Austria laying down the technical details for Liechtenstein’s recognition of Austrian marketing

authorisations within the decentralized procedure (DCP) and the mutual recognition procedure (MRP).

{188} Indent added by Decision No 83/2012 (OJ L 248, 13.9.2012, p. 19 and EEA Supplement No 50, 13.9.2012, p. 21), e.i.f. 1.5.2012.

Page 19: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 145

-{190} 32012 R 1027: Regulation (EU) No 1027/2012 of the European Parliament and of the Council of 25

October 2012 (OJ L 316, 14.11.2012, p. 38),

-{191} 32006 R 1901: Regulation (EC) No 1901/2006 of the European Parliament and of the Council of 12

December 2006 (OJ L 378, 27.12.2006, p. 1),

-{192} 32018 R 1718: Regulation (EU) 2018/1718 of the European Parliament and of the Council of 14

November 2018 (OJ L 291, 16.11.2018, p. 3).

The provisions of the Regulation shall, for the purposes of this Agreement, be read with the following

adaptation:

The powers vested in the European Commission in relation to the infringement procedure foreseen in Article

84(3), including the power to impose financial penalties on the holders of marketing authorisations, shall, in

the cases where the marketing authorisation holder is established in an EFTA State, be carried out by the EFTA

Surveillance Authority in close cooperation with the Commission. Before the EFTA Surveillance Authority

takes a decision regarding financial penalties, the Commission shall provide it with its assessment and a

proposal on how to act.

15zc.{193}32005 R 2049: Commission Regulation (EC) No 2049/2005 of 15 December 2005 laying down, pursuant to

Regulation (EC) No 726/2004 of the European Parliament and of the Council, rules regarding the payment of

fees to, and the receipt of administrative assistance from, the European Medicines Agency by micro, small and

medium-sized enterprises (OJ L 329, 16.12.2005, p. 4).

15zd.{194} 32006 R 0507: Commission Regulation (EC) No 507/2006 of 29 March 2006 on the conditional marketing

authorisation for medicinal products for human use falling within the scope of Regulation (EC) No 726/2004

of the European Parliament and of the Council (OJ L 92, 30.3.2006, p. 6.).

15ze.{195} [ ]

15zf.{196} 32005 L 0028: Commission Directive 2005/28/EC of 8 April 2005 laying down principles and detailed

guidelines for good clinical practice as regards investigational medicinal products for human use, as well as the

requirements for authorisation of the manufacturing or importation of such products (OJ L 91, 9.4.2005, p.

13).

15zg.{197} 32006 L 0130: Commission Directive 2006/130/EC of 11 December 2006 implementing Directive

2001/82/EC of the European Parliament and of the Council as regards the establishment of criteria for

exempting certain veterinary medicinal products for food-producing animals from the requirement of a

veterinary prescription (OJ L 349, 12.12.2006, p. 15).

15zh. 32007 R 1394: Regulation (EC) No 1394/2007 of the European Parliament and of the Council of 13

November 2007 on advanced therapy medicinal products and amending Directive 2001/83/EC and Regulation

(EC) No 726/2004 (OJ L 324, 10.12.2007, p. 121), as corrected by OJ L 87, 31.3.2009, p. 174, as amended

by:

{189} Indent added by Decision No 158/2013 (OJ L 58, 27.2.2014, p. 10 and EEA Supplement No 13, 27.2.2014, p. 11), e.i.f. 28.5.2014.

{190} Indent added by Decision No 163/2013 (OJ L 58, 27.2.2014, p. 16 and EEA Supplement No 13, 27.2.2014, p. 18), e.i.f. 28.5.2014.

{191} Indent added by Decision No 92/2017 (OJ L 36, 7.2.2019, p. 41 and EEA Supplement No 11, 7.2.2019, p. 49), e.i.f. 1.6.2018.

{192} Indent added by Decision No 64/2019 (OJ L 192, 18.7.2019, p. 52 and EEA Supplement No 57, 18.7.2019, p. 19), e.i.f. 30.3.2019.

{193} Point inserted by by Decision No 61/2009 (OJ L 232, 3.9.2009, p. 13 and EEA Supplement No 47, 3.9.2009, p. 14), e.i.f. 23.12.2009. For

Liechtenstein, Decision 61/2009 entered into force 1.12.2010 which is the day of entry into force of the Agreement between Liechtenstein

and Austria laying down the technical details for Liechtenstein’s recognition of Austrian marketing authorisations within the decentralized

procedure (DCP) and the mutual recognition procedure (MRP).

{194} Point inserted by Decision No 61/2009 (OJ L 232, 3.9.2009, p. 13 and EEA Supplement No 47, 3.9.2009, p. 14), e.i.f. 23.12.2009. For

Liechtenstein, Decision 61/2009 entered into force 1.12.2010 which is the day of entry into force of the Agreement between Liechtenstein

and Austria laying down the technical details for Liechtenstein’s recognition of Austrian marketing authorisations within the decentralized

procedure (DCP) and the mutual recognition procedure (MRP).

{195} Point (Commission Regulation (EC) No 1277/2005) and texts inserted by Decision No 62/2009 (OJ L 232, 3.9.2009, p. 18 and EEA

Supplement No 47, 3.9.2009, p. 18), e.i.f. 1.3.2010 and subsequently deleted by Decision No 49/2018 (OJ L [to be published] and EEA

Supplement No [to be published]), e.i.f. 24.3.2018.

{196} Point inserted by Decision No 62/2009 (OJ L 232, 3.9.2009, p. 18 and EEA Supplement No 47, 3.9.2009, p. 18), e.i.f. 1.3.2010.

{197} Three points and text inserted by Decision No 128/2009 (OJ L 62, 11.3.2010, p. 16 and EEA Supplement No 12, 11.3.2010, p. 15), e.i.f.

23.12.2009. For Liechtenstein, Decision 128/2009 entered into force 1.12.2010 which is the day of entry into force of the Agreement

between Liechtenstein and Austria laying down the technical details for Liechtenstein’s recognition of Austrian marketing authorisations

within the decentralized procedure (DCP) and the mutual recognition procedure (MRP).

Page 20: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 146

-{198} 32010 R 1235: Regulation (EU) No 1235/2010 of the European Parliament and of the Council of

15 December 2010 (OJ L 348, 31.12.2010, p. 1), as corrected by OJ L 201, 27.7.2012, p. 138.

The provisions of the Regulation shall, for the purposes of this Agreement, be read with the following

adaptation:

The EFTA States shall be fully associated with the work of the Committee for Advanced Therapy, but without

the right to vote.

15zi. 32008 R 1234: Commission Regulation (EC) No 1234/2008 of 24 November 2008 concerning the

examination of variations to the terms of marketing authorisations for medicinal products for human use and

veterinary medicinal products (OJ L 334, 12.12.2008, p. 7), as amended by:

-{199} 32012 R 0712: Commission Regulation (EU) No 712/2012 of 3 August 2012 (OJ L 209, 4.8.2012,

p. 4).

15zj.{200} 32007 R 0658: Commission Regulation (EC) No 658/2007 of 14 June 2007 concerning financial penalties for

infringement of certain obligations in connection with marketing authorisations granted under Regulation (EC)

No 726/2004 of the European Parliament and of the Council (OJ L 155, 15.6.2007, p. 10), as amended by:

-{201} 32012 R 0488: Commission Regulation (EU) No 488/2012 of 8 June 2012 (OJ L 150, 9.6.2012, p.

68),as corrected by OJ L 338, 12.12.2012, p. 44.

The provisions of the Regulation shall, for the purposes of this Agreement, be read with the following

adaptation:

The powers vested in the European Commission in relation to the infringement procedure, including the power

to impose financial penalties on the holders of marketing authorisations, shall, in the cases where the marketing

authorisation holder is established in an EFTA State, be carried out by the EFTA Surveillance Authority in

close cooperation with the Commission. Before the EFTA Surveillance Authority takes a decision regarding

financial penalties, the Commission shall provide it with its assessment and a proposal on how to act.

15zk.{202} [ ]

15zl.{203} 32008 D 0911: Commission Decision 2008/911/EC of 21 November 2008 establishing of a list of herbal

substances, preparations and combinations thereof for use in traditional herbal medicinal products (OJ L 328,

6.12.2008, p. 42), as amended by:

- 32010 D 0028: Commission Decision 2010/28/EC of 28 July 2009 (OJ L 11, 16.1.2010,

p. 12),

- 32010 D 0030: Commission Decision 2010/30/EU of 9 December 2009 (OJ L 12, 19.1.2010,

p. 14),

- 32010 D 0180: Commission Decision 2010/180/EU of 25 March 2010 (OJ L 80, 26.3.2010,

p. 52),

{198} Indent and words “, as amended by:”added by Decision No 158/2013 (OJ L 58, 27.2.2014, p. 10 and EEA Supplement No 13, 27.2.2014, p.

11), e.i.f. 28.5.2014.

{199} Indent and words “, as amended by:” added by Decision No 65/2013 (OJ L 291, 31.10.2013, p. 21 and EEA Supplement No 61, 31.10.2013,

p. 24), e.i.f. 4.5.2013.

{200} Point 15zj (Commission regulation (EC) No 658/2007) and text inserted by Decision No 129/2009 (OJ L 62, 11.3.2010, p. 18 and EEA

Supplement No 12, 11.3.2010, p. 17), e.i.f. 1.8.2010. Text of point 15 zj and adaptation text replaced by Decision No 92/2017 (OJ L 36,

7.2.2019, p. 41 and EEA Supplement No 11, 7.2.2019, p. 49), e.i.f. 1.6.2018.

{201} Point 15zj (Commission regulation (EC) No 658/2007) and text inserted by Decision No 129/2009 (OJ L 62, 11.3.2010, p. 18 and EEA

Supplement No 12, 11.3.2010, p. 17), e.i.f. 1.8.2010. Text replaced by Decision No 92/2017 (OJ L 36, 7.2.2019, p. 41 and EEA Supplement

No 11, 7.2.2019, p. 49), e.i.f. 1.6.2018.

{202} Point 15zk inserted by Decision No 5/2010 (OJ L 101, 22.4.2010, p. 11 and EEA Supplement No 19, 22.4.2010, p. 11), e.i.f. 30.1.2010, and

sunsequently deleted by Decision No 223/2013 (OJ L 154, 22.5.2014, p. 20 and EEA Supplement No 29, 22.5.2014, p. 19), e.i.f. 14.12.2013.

{203} Point 15zl and 3 indents inserted by Decision No 10/2012 (OJ L 161, 21.6.2012, p. 16 and EEA Supplement No 34, 21.6.2012, p. 19), e.i.f.

11.2.2012.

Page 21: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 147

-{204} 32012 D 0067: Commission Implementing Decision 2012/67/EU of 3 February 2012 (OJ

L 34, 7.2.2012, p. 5),

-{205} 32012 D 0068: Commission Implementing Decision 2012/68/EU of 3 February 2012 (OJ

L 34, 7.2.2012, p. 8),

-{206} 32016 D 1658: Commission Implementing Decision (EU) 2016/1658 of 13 September 2016

(OJ L 247, 15.9.2016, p. 19),

-{207} 32016 D 1659: Commission Implementing Decision (EU) 2016/1659 of 13 September 2016

(OJ L 247, 15.9.2016, p. 22),

-{208} 32011 D 0785: Commission Implementing Decision 2011/785/EU of 28 November 2011 (OJ

L 319, 2.12.2011, p. 102),

-{209} 32018 D 0134: Commission Implementing Decision (EU) 2018/134 of 24 January 2018 (OJ

L 22, 26.1.2018, p. 41),

-{210} 32018 D 0133: Commission Implementing Decision (EU) 2018/133 of 24 January 2018 (OJ

L 22, 26.1.2018, p. 36), as corrected by OJ L 38, 10.2.2018, p. 42.

15zm.{211}32009 R 0668: Commission Regulation (EC) No 668/2009 of 24 July 2009 implementing Regulation (EC) No

1394/2007 of the European Parliament and of the Council with regard to the evaluation and certification of

quality and non-clinical data relating to advanced therapy medicinal products developed by micro, small and

medium-sized enterprises (OJ L 194, 25.7.2009, p. 7).

15zn.{212} 32010 L 0053: Directive 2010/53/EU of the European Parliament and of the Council of 7 July 2010 on

standards of quality and safety of human organs intended for transplantation (OJ L 207, 6.8.2010, p. 14), as

corrected by OJ L 243, 16.9.2010, p. 68.

The provisions of the Directive shall, for the purposes of this Agreement, be read with the following

adaptation:

This Directive shall not apply to Liechtenstein, with the exception of Articles 15 and 16. The definitions in

Article 3 and general provisions in Articles 17(2)(h) and 23 shall only apply to Liechtenstein as far as

necessary for transposing Articles 15 and 16 of the Directive.

15zna.{213}32012 L 0025: Commission Implementing Directive 2012/25/EU of 9 October 2012 laying down information

procedures for the exchange, between Member States, of human organs intended for transplantation (OJ L 275,

10.10.2012, p. 27).

The provisions of the Implementing Directive shall, for the purposes of this Agreement, be read with the

following adaptation:

This Implementing Directive shall not apply to Liechtenstein, with the exception of Article 7.

15zo.{214} 32013 R 0198: Commission Implementing Regulation (EU) No 198/2013 of 7 March 2013 on the selection of

a symbol for the purpose of identifying medicinal products for human use that are subject to additional

monitoring (OJ L 65, 8.3.2013, p. 17).

{204} Indent added by Decision No 146/2012 (OJ L 309, 8.11.2012, p. 31 and EEA Supplement No 63, 8.11.2012, p. 36), e.i.f. 14.7.2012.

{205} Indent added by Decision No 146/2012 (OJ L 309, 8.11.2012, p. 31 and EEA Supplement No 63, 8.11.2012, p. 36), e.i.f. 14.7.2012.

{206} Indent added by Decision No 88/2017 (OJ L 36, 7.2.2019, p. 35 and EEA Supplement No 11, 7.2.2019, p. 41), e.i.f. 6.5.2017.

{207} Indent added by Decision No 88/2017 (OJ L 36, 7.2.2019, p. 35 and EEA Supplement No 11, 7.2.2019, p. 41), e.i.f. 6.5.2017.

{208} Indent added by Decision No 14/2018 (OJ L 323, 12.12.2019, p. 28 and EEA Supplement No 98, 12.12.2019, p. 26), e.i.f. 10.2.2018.

{209} Indent added by Decision No 86/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 28.4.2018.

{210} Indent added by Decision No 107/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 1.6.2018.

{211} Point inserted by Decision No 47/2012 (OJ L 207, 2.8.2012, p. 27 and EEA Supplement No 43, 2.8.2012, p. 31), e.i.f. 31.3.2012.

{212} Point inserted by Decision No 164/2013 (OJ L 58, 27.2.2014, p. 17 and EEA Supplement No 13, 27.2.2014, p. 19), e.i.f. 1.7.2014.

{213} Point inserted by Decision No 179/2014 (OJ L 202, 30.7.2015, p. 29 and EEA Supplement No 43, 30.7.2015, p. 29), e.i.f. 1.6.2015.

Page 22: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 148

15zp.{215}32012 D 0707: Commission Implementing Decision 2012/707/EU of 14 November 2012 establishing a

common format for the submission of the information pursuant to Directive 2010/63/EU of the European

Parliament and of the Council on the protection of animals used for scientific purposes (OJ L 320, 17.11.2012,

p. 33) , as amended by:

-{216} 32014 D 0011: Commission Implementing Decision 2014/11/EU of 20 December 2013 (OJ L 10,

15.1.2014, p. 18).

15zq.{217} 32012 R 0520: Commission Implementing Regulation (EU) No 520/2012 of 19 June 2012 on the performance

of pharmacovigilance activities provided for in Regulation (EC) No 726/2004 of the European Parliament and

of the Council and Directive 2001/83/EC of the European Parliament and of the Council (OJ L 159, 20.6.2012,

p. 5).

15zr.{218} 32006 R 1901: Regulation (EC) No 1901/2006 of the European Parliament and of the Council of 12 December

2006 on medicinal products for paediatric use and amending Regulation (EEC) No 1768/92, Directive

2001/20/EC, Directive 2001/83/EC and Regulation (EC) No 726/2004 (OJ L 378, 27.12.2006, p. 1), as

amended by:

-{219} 32006 R 1902: Regulation (EC) No 1902/2006 of the European Parliament and of the Council of 20

December 2006 (OJ L 378, 27.12.2006, p. 20).

The provisions of the Regulation shall, for the purposes of this Agreement, be read with the following

adaptations:

(a) The application of Article 36(3) shall not be made dependent on an authorisation of the medicinal

product in Liechtenstein.

(b) The powers vested in the European Commission in relation to the infringement procedure foreseen in

Article 49(3), including the power to impose financial penalties on the holders of marketing

authorisations, shall, in the cases where the marketing authorisation holder is established in an EFTA

State, be carried out by the EFTA Surveillance Authority in close cooperation with the Commission.

Before the EFTA Surveillance Authority takes a decision regarding financial penalties, the

Commission shall provide it with its assessment and a proposal on how to act.

16.{220} 32014 R 0658: Regulation (EU) No 658/2014 of the European Parliament and of the Council of 15 May 2014

on fees payable to the European Medicines Agency for the conduct of pharmacovigilance activities in respect

of medicinal products for human use (OJ L 189, 27.6.2014, p. 112), as amended by:

-{221} 32018 R 0092: Commission Delegated Regulation (EU) 2018/92 of 18 October 2017 (OJ L 17,

23.1.2018, p. 2),

-{222} 32018 R 1298: Commission Delegated Regulation (EU) 2018/1298 of 11 July 2018 (OJ L 244,

28.9.2018, p. 1).

17.{223} 32015 L 0566: Commission Directive (EU) 2015/566 of 8 April 2015 implementing Directive 2004/23/EC as

regards the procedures for verifying the equivalent standards of quality and safety of imported tissues and cells

(OJ L 93, 9.4.2015, p. 56).

{214} Point inserted by Decision No 41/2014 (OJ L 256, 28.8.2014, p. 14 and EEA Supplement No 49, 28.8.2014, p. 14), e.i.f. 9.4.2014.

{215} Point inserted by Decision No 264/2014 (OJ L 311, 26.11.2015, p. 14 and EEA Supplement No 71, 26.11.2015, p. 14), e.i.f. pending.

{216} Indent and words “, as amended by:” added by Decision No 150/2015 (OJ L 341, 15.12.2016, p. 43 and EEA Supplement No 69,

15.12.2016, p. 44), e.i.f. pending.

{217} Point inserted by Decision No 15/2015 (OJ L 93, 7.4.2016, p. 26 and EEA Supplement No 21, 7.4.2016, p. 23), e.i.f. 1.1.2016.

{218} Point and adaptation text inserted by Decision No 92/2017 (OJ L 36, 7.2.2019, p. 41 and EEA Supplement No 11, 7.2.2019, p. 49), e.i.f.

1.6.2018.

{219} Indent added by Decision No 92/2017 (OJ L 36, 7.2.2019, p. 41 and EEA Supplement No 11, 7.2.2019, p. 49), e.i.f. 1.6.2018.

{220} Point inserted by Decision No 265/2014 (OJ L 311, 26.11.2015, p. 15 and EEA Supplement No 71, 26.11.2015, p. 15), e.i.f. 13.12.2014.

{221} Indent and words “, as amended by:” added by Decision No 87/2018 (OJ L [to be published] and EEA Supplement No [to be published]),

e.i.f. 28.4.2018.

{222} Indent added by Decision No 239/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 6.12.2018.

{223} Point inserted by Decision No 212/2015 (OJ L 85, 30.3.2017, p. 29 and EEA Supplement No 19, 30.3.2017, p. 29), e.i.f. 26.9.2015.

Page 23: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 149

18.{224} 32014 R 0536: Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014

on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC (OJ L 158,

27.5.2014, p. 1), as corrected by OJ L 311, 17.11.2016, p. 25.

18a.{225} 32017 R 1569: Commission Delegated Regulation (EU) 2017/1569 of 23 May 2017 supplementing Regulation

(EU) No 536/2014 of the European Parliament and of the Council by specifying principles of and guidelines

for good manufacturing practice for investigational medicinal products for human use and arrangements for

inspections (OJ L 238, 16.9.2017, p. 12).

The provisions of the Delegated Regulation shall, for the purposes of this Agreement, be read with the

following adaptation:

The inspections in Liechtenstein shall be carried out, on behalf of Liechtenstein, by the Swiss inspectorate.

19.{226} 32014 R 0699: Commission Implementing Regulation (EU) No 699/2014 of 24 June 2014 on the design of the

common logo to identify persons offering medicinal products for sale at a distance to the public and the

technical, electronic and cryptographic requirements for verification of its authenticity (OJ L 184, 25.6.2014, p.

5).

ACTS OF WHICH THE CONTRACTING PARTIES SHALL TAKE NOTE

The Contracting Parties take note of the content of the following acts:

1.{227} C/310/86/p. 7: Commission Communication on the compatibility with Article 30 of the Treaty of Measures

taken by Member States relating to price controls and reimbursement of medicinal products (OJ No C 310,

4.12.1986, p. 7).

2.{228} C/115/82/p. 5: Commission Communication on parallel imports of proprietary medicinal products for which

marketing authorisation have already been granted (OJ No C 115, 6.5.1982, p. 5).

3.{229} 32010 D 0453: Commission Decision 2010/453/EU of 3 August 2010 establishing guidelines concerning the

conditions of inspections and control measures, and on the training and qualification of officials, in the field of

human tissues and cells provided for in Directive 2004/23/EC of the European Parliament and of the Council

(OJ L 213, 13.8.2010, p. 48).

XIV. FERTILIZERS{230}

ACTS REFERRED TO

{224} Point inserted by Decision No 213/2015 (OJ L 85, 30.3.2017, p. 31 and EEA Supplement No 19, 30.3.2017, p. 31), e.i.f. 1.8.2016.

Corrigendum to the EU act subsequently taken note of by the EEA Joint Committee on 3.2.2017.

{225} Point inserted by Decision No 88/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 28.4.2018.

{226} Point inserted by Decision No 129/2017 (OJ L 128, 16.5.2019, p. 21 and EEA Supplement No 40, 16.5.2019, p. 22), e.i.f. 1.6.2018.

{227} Point 16 (Commission Communication 310/86) renumbered to point 1 by Decision No 223/2013 (OJ L 154, 22.5.2014, p. 20 and EEA

Supplement No 29, 22.5.2014, p. 19), e.i.f. 14.12.2013.

{228} Point 17 (Commission Communication 115/82) renumbered to point 2 by Decision No 223/2013 (OJ L 154, 22.5.2014, p. 20 and EEA

Supplement No 29, 22.5.2014, p. 19), e.i.f. 14.12.2013.

{229} Point 18 inserted by Decision No 71/2011 (OJ L 262, 6.10.2011, p. 27 and EEA Supplement No 54, 6.10.2011, p. 36), e.i.f. 2.7.2011, and

subsequently renumbered to point 3 by Decision No 223/2013 (OJ L 154, 22.5.2014, p. 20 and EEA Supplement No 29, 22.5.2014, p. 19),

e.i.f. 14.12.2013.

{230} Text of chapter XIV replaced by Decision No 8/2005 (OJ L 161, 23.6.2005, p. 17 and EEA Supplement No 32, 23.6.2005, p. 9), e.i.f.

9.2.2005.

Page 24: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 150

1. 32003 R 2003: Regulation (EC) No 2003/2003 of the European Parliament and of the Council of 13 October

2003 relating to fertilisers (OJ L 304, 21.11.2003, p. 1), as amended by:

-{231} 32004 R 2076: Commission Regulation (EC) No 2076/2004 of 3 December 2004 (OJ L 359,

4.12.2004, p. 25),

-{232} 32004 R 0885: Council Regulation (EC) No 885/2004 of 26 April 2004 (OJ L 168, 1.5.2004, p. 1),

-{233} 32007 R 0162: Commission Regulation (EC) No 162/2007 of 19 February 2007 (OJ L 51,

20.2.2007, p. 7),

-{234} 32006 R 1791: Council Regulation (EC) No 1791/2006 of 20 November 2006 (OJ L 363,

20.12.2006, p. 1),

-{235} 32008 R 1107: Commission Regulation (EC) No 1107/2008 of 7 November 2008 (OJ L 299,

8.11.2008, p. 13),

-{236} 32009 R 1020: Commission Regulation (EC) No 1020/2009 of 28 October 2009 (OJ L 282,

29.10.2009, p. 7),

-{237} 32011 R 0137: Commission Regulation (EU) No 137/2011 of 16 February 2011 (OJ L 43,

17.2.2011, p. 1),

-{238} 32012 R 0223: Commission Regulation (EU) No 223/2012 of 14 March 2012 (OJ L 75, 15.3.2012,

p. 12),

-{239} 32013 R 0463: Commission Regulation (EU) No 463/2013 of 17 May 2013 (OJ L 134, 18.5.2013, p.

1),

-{240} 32014 R 1257: Commission Regulation (EU) No 1257/2014 of 24 November 2014 (OJ L 337,

25.11.2014, p. 53),

-{241} 32016 R 1618: Commission Regulation (EU) 2016/1618 of 8 September 2016 (OJ L 242, 9.9.2016,

p. 24).

The provisions of the Regulation shall, for the purposes of the present Agreement, be read with the following

adaptations:

(a) The EFTA States will be free to limit access to their market according to the requirements of their

legislation existing at the date of entry into force of this Agreement concerning cadmium in

fertilizers. The Contracting Parties shall jointly review the situation in 2009.

(b) In Annex I, A.2, the following shall be added to the text in brackets of No. 1, column 6, third

paragraph:

“Iceland, Liechtenstein, Norway”.

{231} Indent and words “, as amended by:” above, added by Decision No 61/2005 (OJ L 239, 15.9.2005, p. 42 and EEA Supplement No 46,

15.9.2005, p. 26), e.i.f. 30.4.2005.

{232} Indent added by Decision No 107/2005 (OJ L 306, 24.11.2005, p. 45 and EEA Supplement No 60, 24.11..2005, p. 28), e.i.f. 9.7.2005.

{233} Indent added by Decision No 106/2007 (OJ L 047, 21.2.2008, p. 24 and EEA Supplement No 9, 21.2.2008, p. 20), e.i.f. 29.9.2007.

{234} Indent added by Decision No 132/2007 (OJ L 100, 10.4.2008, p. 1 and EEA Supplement No 19, 10.4.2008, p.1), e.i.f. 9.11.2011.

{235} Indent added by Decision No 45/2010 (OJ L 181, 15.7.2010, p. 13 and EEA Supplement No 37, 15.7.2010, p. 17), e.i.f. 1.5.2010.

{236} Indent added by Decision No 51/2011 (OJ L 196, 28.7.2011, p. 32 and EEA Supplement No 43, 28.7.2011, p. 10), e.i.f. 21.5.2011.

{237} Indent added by Decision No 11/2012 (OJ L 161, 21.6.2012, p. 17 and EEA Supplement No 34, 21.6.2012, p. 21), e.i.f. 11.2.2012.

{238} Indent added by Decision No 161/2012 (OJ L 341, 13.12.2012, p. 12 and EEA Supplement No 70, 13.12.2012, p. 14), e.i.f. 1.11.2012.

{239} Indent added by Decision No 42/2014 (OJ L 256, 28.8.2014, p. 16 and EEA Supplement No 49, 28.8.2014, p. 16), e.i.f. 9.4.2014.

{240} Indent added by Decision No 51/2015 (OJ L 129, 19.5.2016, p. 32 and EEA Supplement No 29, 19.5.2016, p. 33), e.i.f. 21.3.2015.

{241} Indent added by Decision No 26/2017 (OJ L 297, 22.11.2018, p. 32 and EEA Supplement No 78, 22.11.2018, p. 38), e.i.f. 4.2.2017.

Page 25: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 151

(c) In Annex I, B.1.1, B.2.1 and B.4, the following shall be added to the text in brackets after (6b) in

column 5, point 3, second paragraph first indent:

“Iceland, Liechtenstein, Norway”.

2.{242} 32006 D 0347: Commission Decision 2006/347/EC of 3 January 2006 on the national provisions notified by

the Kingdom of Sweden under Article 95(4) of the EC Treaty concerning the maximum admissible content of

cadmium in fertilisers (OJ L 129, 17.5.2006, p. 19).

3.{243} 32006 D 0348: Commission Decision 2006/348/EC of 3 January 2006 on the national provisions notified by

the Republic of Finland under Article 95(4) of the EC Treaty concerning the maximum admissible content of

cadmium in fertilisers (OJ L 129, 17.5.2006, p. 25).

4.{244} 32006 D 0349: Commission Decision 2006/349/EC of 3 January 2006 on the national provisions notified by

the Republic of Austria under Article 95(4) of the EC Treaty concerning the maximum admissible content of

cadmium in fertilisers (OJ L 129, 17.5.2006, p. 31).

5.{245} 32006 D 0390: Commission Decision 2006/390/EC of 24 May 2006 on the national provisions notified by

the Czech Republic under Article 95(4) of the EC Treaty concerning the maximum admissible content of

cadmium in fertilisers (OJ L 150, 3.6.2006, p. 17).

XV. DANGEROUS SUBSTANCES

ACTS REFERRED TO

1. [ ] {246}

2. [ ] {247}

3. [ ] {248}

4. [ ] {249}

5. [ ] {250}

6. [ ] {251}

7. [ ] {252}

{242} Point inserted by Decision No 149/2006 (OJ L 89, 29.3.2007, p. 19 and EEA Supplement No 15, 29.3.2007, p. 15), e.i.f. 9.12.2006.

{243} Point inserted by Decision No 149/2006 (OJ L 89, 29.3.2007, p. 19 and EEA Supplement No 15, 29.3.2007, p. 15), e.i.f. 9.12.2006.

{244} Point inserted by Decision No 149/2006 (OJ L 89, 29.3.2007, p. 19 and EEA Supplement No 15, 29.3.2007, p. 15), e.i.f. 9.12.2006.

{245} Point inserted by Decision No 149/2006 (OJ L 89, 29.3.2007, p. 19 and EEA Supplement No 15, 29.3.2007, p. 15), e.i.f. 9.12.2006.

{246} Text of point 1 (Council Directive 67/548/EEC) deleted with effect from 1 June 2015 by Decision No 106/2012 (OJ L 270, 4.10.2012, p. 6

and EEA Supplement No 56, 4.10.2012, p. 8), e.i.f. 1.2.2013.

{247} Text of point 2 (Council Directive 73/404/EEC) deleted by Decision No 144/2005 (OJ L 53, 23.2.2006, p. 40 and EEA Supplement No 10,

23.2.2005, p. 15), e.i.f. 3.12.2005.

{248} Text of point 3 (Council Directive 73/405/EEC) deleted by Decision No 144/2005 (OJ L 53, 23.2.2006, p. 40 and EEA Supplement No 10,

23.2.2005, p. 15), e.i.f. 3.12.2005.

{249} Text of point 4 (Council Directive 76/769/EEC) to be deleted with effect from 1.6.2009 by Decision No 25/2008 (OJ L 182, 10.7.2008, p. 11

and EEA Supplement No 42, 10.7.2008, p. 6), e.i.f. 5.6.2008.

{250} Text of point 5 (Council Directive 78/631/EEC) deleted by Decision No 59/2004 (OJ L 277, 26.8.2004, p. 30 and EEA Supplement No 43,

26.8.2004, p. 25), e.i.f. 27.4.2004.

{251} Text of point 6 (Council Directive 79/117/EEC) deleted by Decision No 203/2014 (OJ L 202, 30.7.2015, p. 57 and EEA Supplement No 43,

30.7.2015, p. 57), e.i.f. 1.6.2015.

Page 26: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 152

8. {253} 32004 L 0010: Directive 2004/10/EC of the European Parliament and of the Council of 11 February 2004 on

the harmonisation of laws, regulations and administrative provisions relating to the application of the

principles of good laboratory practice and the verification of their applications for tests on chemical substances

(OJ L 50, 20.2.2004, p. 44).

9. {254} 32004 L 0009: Directive 2004/9/EC of the European Parliament and of the Council of 11 February 2004 on

the inspection and verification of good laboratory practice (GLP)(OJ L 50, 20.2.2004, p. 28).

10. [ ]{255}

11. [ ] {256}

12. [ ]{257}

12a. [ ] {258}

12b. [ ] {259}

12c. [ ] {260}

12d. [ ] {261}

12e. [ ] {262}

12f. [ ] {263}

12g.{264} 394 D 0643: Commission Decision 94/643/EC of 12 September 1994 concerning the withdrawal of auth-

orizations for plant protection products containing cyhalothrin as active substance (OJ No L 249, 24.9.1994,

p.18).

{252} Text of point 7 (Council Directive 82/242/EEC) deleted by Decision No 144/2005 (OJ L 53, 23.2.2006, p. 40 and EEA Supplement No 10,

23.2.2005, p. 15), e.i.f. 3.12.2005.

{253} Text of point 8 (Council Directive 87/18/EEC) replaced by Decision No 34/2005 (OJ L 198, 28.7.2005, p. 26 and EEA Supplement No 38,

28.7.2005, p. 16), e.i.f. 12.3.2005.

{254} Text of point 9 (Council Directive 88/320/EEC) replaced by Decision No 34/2005 (OJ L 198, 28.7.2005, p. 26 and EEA Supplement No 38,

28.7.2005, p. 16), e.i.f. 12.3.2005.

{255} Text of point 10 (Council Directive 88/379/EEC) replaced by Decision No 59/2004 (91/155/EEC) (OJ L 277, 26.8.2004, p. 30 and EEA

Supplement No 43, 26.8.2004, p. 25), e.i.f. 27.4.2004 and subsequently deleted by Decision No 25/2008 (OJ L 182, 10.7.2008, p. 11 and EEA

Supplement No 42, 10.7.2008, p. 6), e.i.f. 5.6.2008.

{256} Text of Point 11 (Council Directive 91/157/EEC) deleted with effect from 26.9.2008 by Decision No 141/2007 (OJ L 100, 10.4.2008, p. 68

and EEA Supplement No 19, 10.4.2008, p. 69), e.i.f. 1.11.2010.

{257} Text of point 12 deleted by Decision No 57/96 (OJ L 160, 4.6.1998, p. 36 and EEA Supplement No 22, 4.6.1998, p. 1), e.i.f. 1.11.1996.

{258} Point inserted by Decision No 7/94 (OJ L 160, 28.6.1994, p. 1 and EEA Supplement No 17, 28.6.1994, p. 1), e.i.f. 1.7.1994. Text of point 12a

(Council Directive 91/414/EEC) deleted by Decision No 203/2014 (OJ L 202, 30.7.2015, p. 57 and EEA Supplement No 43, 30.7.2015,

p. 57), e.i.f. 1.6.2015.

{259} Point (Commission Directive 91/442/EEC) inserted by Decision No 7/94 (OJ L 160, 28.6.1994, p. 1 and EEA Supplement No 17, 28.6.1994,

p. 1), e.i.f. 1.7.1994, and subsequently deleted by Decision No 59/2004 (OJ L 277, 26.8.2004, p. 30 and EEA Supplement No 43, 26.8.2004,

p. 25), e.i.f. 27.4.2004.

{260} Point 12c (Council Regulation (EEC) No 2455/92 (OJ L 251, 29.8.1992, p. 13) inserted by Decision No 7/94 (OJ L 160, 28.6.1994, p. 1 and

EEA Supplement No 17, 28.6.1994, p. 1), e.i.f. 1.7.1994, and subsequently deleted by Decision 107/2007 (OJ L 47, 21.2.2008, p. 25 and

EEA Supplement No 9, 21.2.2008, p. 21), e.i.f. 29.9.2007.

{261} Point 12d (Commission Directive 93/67/EEC) inserted by Decision No 7/94 (OJ L 160, 28.6.1994, p. 1 and EEA Supplement No 17,

28.6.1994, p. 1), e.i.f. 1.7.1994, and subsequently deleted with effect from 1.8.2008 by Decision No 25/2008 (OJ L 182, 10.7.2008, p. 11 and

EEA Supplement No 42, 10.7.2008, p. 6), e.i.f. 5.6.2008.

{262} Point and adaptations (a) to (j) inserted by Decision No 12/94 (OJ L 292, 12.11.1994, p. 39 and EEA Supplement No 45, 12.11.1994, p. 1),

e.i.f. 1.2.1995, deleted with effect from 1.6.2008 by Decision No 25/2008 (OJ L 182, 10.7.2008, p. 11 and EEA Supplement No 42,

10.7.2008, p. 6), e.i.f. 5.6.2008.

{263} Point inserted by Decision No 15/95 (OJ L 83, 13.4.1995, p. 46 and EEA Supplement No 13, 13.4.1995, p. 19), e.i.f. 1.4.1995, deleted with

effect from 1.6.2008 by Decision No 25/2008 (OJ L 182, 10.7.2008, p. 11 and EEA Supplement No 42, 10.7.2008, p. 6), e.i.f. 5.6.2008.

Page 27: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 153

12h.{265} 397 R 0142: Commission Regulation (EC) No 142/97 of 27 January 1997 concerning delivery of information

about certain existing substances as foreseen under Council Regulation (EEC) No 793/93 (OJ No L 25,

28.1.1997, p. 11).

12i.{266} 399 R 2161: Commission Regulation (EC) No 2161/1999 of 12 October 1999 imposing further testing

requirements on the importers or manufacturers of a certain priority substance as foreseen under Council

Regulation (EEC) No 793/93 on the evaluation and control of the risks of existing substances (OJ L 265,

13.10.1999, p. 11).

12j. [ ] {267}

12k.{268} 32000 D 0166: Commission Decision 2000/166/EC of 23 February 2000 extending the possible time period

for provisional authorisations of the new active substance quinoxyfen (OJ L 52, 25.2.2000, p. 44).

12l.{269} 32000 D 0657: Commission Decision 2000/657/EC of 16 October 2000 adopting Community import

decisions for certain chemicals pursuant to Council Regulation (EEC) No 2455/92 concerning the export and

import of certain dangerous chemicals (OJ L 275, 27.10.2000, p. 44), as amended by:

-{270} 32004 R 0886: Commission Regulation (EC) No 886/2004 of 4 March 2004 (OJ L 168, 1.5.2004,

p. 14),

-{271} 32006 R 1792: Commission Regulation (EC) No 1792/2006 of 23 October 2006 (OJ L 362,

20.12.2006, p. 1),

-{272} 32013 R 0519: Commission Regulation (EU) No 519/2013 of 21 February 2013 (OJ L 158,

10.6.2013, p. 74).

12m.{273} 32001 R 2592: Commission Regulation (EC) No 2592/2001 of 28 December 2001 imposing further

information and testing requirements on the manufacturers or importers of certain priority substances in

accordance with Council Regulation (EEC) No 793/93 on the evaluation and control of the risk of existing

substances (OJ L 345, 29.12.2001, p. 25).

12n.{274} 32012 R 0528: Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012

concerning the making available on the market and use of biocidal products (OJ L 167, 27.6.2012, p. 1), as

amended by, as corrected by OJ L 280, 28.10.2017, p. 57:

- {275} 32013 R 0736: Commission Delegated Regulation (EU) No 736/2013 of 17 May 2013 (OJ L 204,

31.7.2013, p. 25),

{264} Point inserted by Decision No 16/95 (OJ L 83, 13.4.1995, p. 47 and EEA Supplement No 13, 13.4.1995, p. 30), e.i.f. 1.4.1995.

{265} Point inserted by Decision No 15/97 (OJ L 182, 10.7.1997, p. 47 and EEA Supplement No 29, 10.7.1997, p. 65), e.i.f. 1.4.1997.

{266} Point inserted by Decision No 77/2000 (OJ L 315, 14.12.2000, p. 16 and EEA Supplement No 59, 14.12.2000, p. 15), e.i.f. 3.10.2000.

{267} Point inserted by Decision No 78/2000 (OJ L 315, 14.12.2000, p. 18 and EEA Supplement No 59, 14.12.2000, p. 17), e.i.f. 3.10.2000 and

subsequently deleted by Decision No 180/2014 (OJ L 202, 30.7.2015, p. 30 and EEA Supplement No 43, 30.7.2015, p. 30), e.i.f. 26.9.2014.

{268} Point inserted by Decision No 109/2000 (OJ L 52, 22.2.2001 p. 33 and EEA Supplement No 9, 22.2.2001, p. 1), e.i.f. 23.12.2000.

{269} Point inserted by Decision No 154/2001 (OJ L 65, 7.3.2002, p. 30 and EEA Supplement No 13, 7.3.2002, p.18), e.i.f. 12.12.2001.

{270} Indent and words “, as amended by:” above, inserted by Decision No 107/2005 (OJ L 306, 24.11.2005, p. 45 and EEA Supplement No 60,

24.11..2005, p. 28), e.i.f. 9.7.2005.

{271} Indent added by Decision No 132/2007 (OJ L 100, 10.4.2008, p. 1 and EEA Supplement No 19, 10.4.2008, p.1), e.i.f. 9.11.2011.

{272} Indent added by Decision No 159/2014 (OJ L 15, 22.1.2015, p. 87 and EEA Supplement No 5, 22.1.2015, p. 10), e.i.f. pending; it shall apply

from 9.7.2014.

{273} Point inserted by Decision No 126/2002 (OJ L 336, 12.12.2002, p. 25 and EEA Supplement No 61, 12.12.2002, p. 19), e.i.f. 5.10.2002.

{274} Point 12n (Directive 98/8/EC) inserted by Decision No 32/2003 (OJ L 137, 5.6.2003, p. 33 and EEA Supplement No 29, p. 21), e.i.f.

1.3.2004, and subsequently replaced by Decision No 225/2013 (OJ L 154, 22.5.2014, p. 22 and EEA Supplement No 29, 22.5.2014, p. 21),

e.i.f. 1.6.2014. For Liechtenstein, this Decision shall enter into force on the same day or on the day of entry into force of the Agreement

between Liechtenstein and Switzerland laying down the cooperation in the field of authorisation procedures for biocidal products

according to Regulation (EU) No 528/2012, whichever is the later. Corrigendum to the EU act subsequently taken note of by the EEA Joint

Committee on 6.7.2018.

Page 28: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 154

-{276} 32013 R 0837: Commission Delegated Regulation (EU) No 837/2013 of 25 June 2013 (OJ L 234,

3.9.2013, p. 1),

-{277} 32014 R 0334: Regulation (EU) No 334/2014 of the European Parliament and of the Council of

11 March 2014 (OJ L 103, 5.4.2014, p. 22).

The provisions of the Regulation shall, for the purpose of this Agreement, be read with the following

adaptations:

(a) The EFTA States shall participate in the work of the European Chemicals Agency, hereinafter

referred to as ‘the Agency’, as set up by European Parliament and Council Regulation (EC) No

1907/2006.

(b) Notwithstanding the provisions of Protocol 1 to the Agreement, the term ‘Member State(s)’

contained in Regulation (EU) No 528/2012 shall be understood to include, in addition to its meaning

in that Regulation, the EFTA States.

(c) As regards the EFTA States, the Agency shall, as and when appropriate, assist the EFTA

Surveillance Authority or the Standing Committee, as the case may be, in the performance of their

respective tasks.

(d) The following paragraph shall be added in Article 35:

“4. The EFTA States shall be entitled to participate fully in the work of the coordination group

and shall within it have the same rights and obligations as EU Member States, except the

right to vote. The rules of procedures of the coordination Group shall give full effect to the

EFTA States’ participation.”

(e) The following subparagraph shall be added in Article 44(5):

“When the Commission grants a Union authorisation or decides that a Union authorisation has not

been granted, the EFTA States will simultaneously and within 30 days of the Commission act take

corresponding decisions. The EEA Joint Committee shall be informed and shall periodically publish

lists of such decisions in the EEA Supplement to the Official Journal.”

(f) The following paragraph shall be added in Article 48:

“4. If the Commission cancels or amends a Union authorisation, the EFTA States shall

cancel or amend the corresponding decision.”

(g) The following subparagraph shall be added in Article 49:

“If the Commission cancels a Union authorisation, the EFTA States shall cancel the corresponding

decision.”

(h) The following paragraph shall be added in Article 50:

“4. If the Commission amends a Union authorisation, the EFTA states shall amend the

corresponding decision.”

(i) The following paragraph shall be added in Article 75:

“5. The EFTA States shall be entitled to participate fully in the work of the Biocidal

Products Committee and shall within it have the same rights and obligations as EU

Member States, except the right to vote.”

{275} Indent and words “, as amended by:” added by Decision No 15/2014 (OJ L 211, 17.7.2014, p. 22 and EEA Supplement No 42, 17.7.2014, p.

20), e.i.f. 1.6.2014.

{276} Indent and words “, as amended by:” added by Decision No 43/2014 (OJ L 256, 28.8.2014, p. 17 and EEA Supplement No 49, 28.8.2014, p.

17), e.i.f. 1.6.2014.

{277} Indent added by Decision No 218/2014 (OJ L 230, 3.9.2015, p. 16 and EEA Supplement No 52, 3.9.2015, p. 16), e.i.f. 1.11.2014.

Page 29: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 155

(j) The following paragraph shall be added in Article 78:

“3. The EFTA States shall, as from the entry into force of this Decision participate in the

financing of the Agency. For this purpose the procedures laid down in Article 82(1)(a) and

Protocol 32 of the Agreement shall apply mutatis mutandis.”

(k) Should any disagreement between the Contracting Parties arise as to the administration of these

provisions, Part VII of the Agreement shall apply mutatis mutandis.

12na.{278} 32013 R 0945: Commission Implementing Regulation (EU) No 945/2013 of 2 October 2013 to approve

cypermethrin as an existing active substance for use in biocidal products for product-type 8 (OJ L 261,

3.10.2013, p. 23).

12nb.{279}32013 R 0955: Commission Implementing Regulation (EU) No 955/2013 of 4 October 2013 to approve

propiconazole as an existing active substance for use in biocidal products for product-type 9 (OJ L 263,

5.10.2013, p. 7).

12nc.{280} 32013 R 1032: Commission Implementing Regulation (EU) No 1032/2013 of 24 October 2013 approving

bromoacetic acid as an existing active substance for use in biocidal products for product-type 4 (OJ L 283,

25.10.2013, p. 22).

12nd.{281}32013 R 1033: Commission Implementing Regulation (EU) No 1033/2013 of 24 October 2013 approving

copper sulphate pentahydrate as an existing active substance for use in biocidal products for product-type 2 (OJ

L 283, 25.10.2013, p. 25).

12ne.{282} 32013 R 1034: Commission Implementing Regulation (EU) No 1034/2013 of 24 October 2013 approving

aluminium phosphide releasing phosphine as an active substance for use in biocidal products for product type

20 (OJ L 283, 25.10.2013, p. 28).

12nf.{283} 32013 R 1035: Commission Implementing Regulation (EU) No 1035/2013 of 24 October 2013 approving

benzoic acid as an existing active substance for use in biocidal products for product-types 3 and 4 (OJ L 283,

25.10.2013, p. 31).

12ng.{284}32013 R 1036: Commission Implementing Regulation (EU) No 1036/2013 of 24 October 2013 approving

etofenprox as an existing active substance for use in biocidal products for product-type 18 (OJ L 283,

25.10.2013, p. 35).

12nh.{285}32013 R 1037: Commission Implementing Regulation (EU) No 1037/2013 of 24 October 2013 approving

IPBC as an existing active substance for use in biocidal products for product-type 6 (OJ L 283, 25.10.2013, p.

38).

12ni.{286} 32013 R 1038: Commission Implementing Regulation (EU) No 1038/2013 of 24 October 2013 approving

tebuconazole as an existing active substance for use in biocidal products for product-types 7 and 10 (OJ L 283,

25.10.2013, p. 40).

12nj.{287} 32013 R 1039: Commission Implementing Regulation (EU) No 1039/2013 of 24 October 2013 modifying the

approval of nonanoic acid as an existing active substance for use in biocidal products for product-type 2 (OJ L

283, 25.10.2013, p. 43).

{278} Point inserted by Decision No 43/2014 (OJ L 256, 28.8.2014, p. 17 and EEA Supplement No 49, 28.8.2014, p. 17), e.i.f. 1.6.2014.

{279} Point inserted by Decision No 43/2014 (OJ L 256, 28.8.2014, p. 17 and EEA Supplement No 49, 28.8.2014, p. 17), e.i.f. 1.6.2014.

{280} Point inserted by Decision No 43/2014 (OJ L 256, 28.8.2014, p. 17 and EEA Supplement No 49, 28.8.2014, p. 17), e.i.f. 1.6.2014.

{281} Point inserted by Decision No 43/2014 (OJ L 256, 28.8.2014, p. 17 and EEA Supplement No 49, 28.8.2014, p. 17), e.i.f. 1.6.2014.

{282} Point inserted by Decision No 43/2014 (OJ L 256, 28.8.2014, p. 17 and EEA Supplement No 49, 28.8.2014, p. 17), e.i.f. 1.6.2014.

{283} Point inserted by Decision No 43/2014 (OJ L 256, 28.8.2014, p. 17 and EEA Supplement No 49, 28.8.2014, p. 17), e.i.f. 1.6.2014.

{284} Point inserted by Decision No 43/2014 (OJ L 256, 28.8.2014, p. 17 and EEA Supplement No 49, 28.8.2014, p. 17), e.i.f. 1.6.2014.

{285} Point inserted by Decision No 43/2014 (OJ L 256, 28.8.2014, p. 17 and EEA Supplement No 49, 28.8.2014, p. 17), e.i.f. 1.6.2014.

{286} Point inserted by Decision No 43/2014 (OJ L 256, 28.8.2014, p. 17 and EEA Supplement No 49, 28.8.2014, p. 17), e.i.f. 1.6.2014.

{287} Point inserted by Decision No 43/2014 (OJ L 256, 28.8.2014, p. 17 and EEA Supplement No 49, 28.8.2014, p. 17), e.i.f. 1.6.2014.

Page 30: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 156

12nk.{288}32013 R 0354: Commission Implementing Regulation (EU) No 354/2013 of 18 April 2013 on changes of

biocidal products authorized in accordance with Regulation (EU) No 528/2012 of the European Parliament and

of the Council (OJ L 109, 19.4.2013, p. 4).

12nl.{289} 32013 R 0564: Commission Implementing Regulation (EU) No 564/2013 of 18 June 2013 on the fees and

charges payable to the European Chemicals Agency pursuant to Regulation (EU) No 528/2012 of the European

Parliament and of the Council concerning the making available on the market and use of biocidal products (OJ

L 167, 19.6.2013, p.17).

12nm.{290}32014 R 0088: Commission Implementing Regulation (EU) No 88/2014 of 31 January 2014 specifying a

procedure for the amendment of Annex I to Regulation (EU) No 528/2012 of the European Parliament and of

the Council concerning the making available on the market and use of biocidal products (OJ L 32, 1.2.2014, p.

3).

12nn.{291}32014 R 0089: Commission Implementing Regulation (EU) No 89/2014 of 31 January 2014 approving bis(N-

cyclohexyl-diazenium-dioxy)-copper (Cu-HDO) as an existing active substance for use in biocidal products for

product-type 8 (OJ L 32, 1.2.2014, p. 6).

12no.{292}32014 R 0090: Commission Implementing Regulation (EU) No 90/2014 of 31 January 2014 approving

decanoic acid as an existing active substance for use in biocidal products for product-types 4, 18 and 19 (OJ L

32, 1.2.2014, p. 9).

12np.{293}32014 R 0091: Commission Implementing Regulation (EU) No 91/2014 of 31 January 2014 approving S-

methoprene as an existing active substance for use in biocidal products for product-type 18 (OJ L 32, 1.2.2014,

p. 13).

12nq.{294}32014 R 0092: Commission Implementing Regulation (EU) No 92/2014 of 31 January 2014 approving zineb

as an existing active substance for use in biocidal products for product-type 21 (OJ L 32, 1.2.2014, p. 16).

12nr.{295}32014 R 0093: Commission Implementing Regulation (EU) No 93/2014 of 31 January 2014 approving

octanoic acid as an existing active substance for use in biocidal products for product-types 4 and 18 (OJ L 32,

1.2.2014, p. 19).

12ns.{296}32014 R 0094: Commission Implementing Regulation (EU) No 94/2014 of 31 January 2014 approving iodine,

including polyvinylpyrrolidone iodine, as an existing active substance for use in biocidal products for product-

types 1, 3, 4 and 22 (OJ L 32, 1.2.2014, p. 23).

12nt.{297} 32014 R 0405: Commission Implementing Regulation (EU) No 405/2014 of 23 April 2014 approving lauric

acid as an existing active substance for use in biocidal products for product-type 19 (OJ L 121, 24.4.2014, p.

8).

12nu.{298}32014 R 0406: Commission Implementing Regulation (EU) No 406/2014 of 23 April 2014 to approve ethyl

butylacetylaminopropionate as an existing active substance for use in biocidal products for product-type 19 (OJ

L 121, 24.4.2014, p. 11).

12nv.{299}32014 R 0407: Commission Implementing Regulation (EU) No 407/2014 of 23 April 2014 approving

transfluthrin as an existing active substance for use in biocidal products for product-type 18 (OJ L 121,

24.4.2014, p. 14).

{288} Point inserted by Decision No 44/2014 (OJ L 256, 28.8.2014, p. 20 and EEA Supplement No 49, 28.8.2014, p. 20), e.i.f. 1.6.2014.

{289} Point inserted by Decision No 44/2014 (OJ L 256, 28.8.2014, p. 20 and EEA Supplement No 49, 28.8.2014, p. 20), e.i.f. 1.6.2014.

{290} Point inserted by Decision No 121/2014 (OJ L 342, 27.11.2014, p. 15 and EEA Supplement No 71, 27.11.2014, p. 15), e.i.f. 28.6.2014.

{291} Point inserted by Decision No 121/2014 (OJ L 342, 27.11.2014, p. 15 and EEA Supplement No 71, 27.11.2014, p. 15), e.i.f. 28.6.2014.

{292} Point inserted by Decision No 121/2014 (OJ L 342, 27.11.2014, p. 15 and EEA Supplement No 71, 27.11.2014, p. 15), e.i.f. 28.6.2014.

{293} Point inserted by Decision No 121/2014 (OJ L 342, 27.11.2014, p. 15 and EEA Supplement No 71, 27.11.2014, p. 15), e.i.f. 28.6.2014.

{294} Point inserted by Decision No 121/2014 (OJ L 342, 27.11.2014, p. 15 and EEA Supplement No 71, 27.11.2014, p. 15), e.i.f. 28.6.2014.

{295} Point inserted by Decision No 121/2014 (OJ L 342, 27.11.2014, p. 15 and EEA Supplement No 71, 27.11.2014, p. 15), e.i.f. 28.6.2014.

{296} Point inserted by Decision No 121/2014 (OJ L 342, 27.11.2014, p. 15 and EEA Supplement No 71, 27.11.2014, p. 15), e.i.f. 28.6.2014.

{297} Point inserted by Decision No 218/2014 (OJ L 230, 3.9.2015, p. 16 and EEA Supplement No 52, 3.9.2015, p. 16), e.i.f. 1.11.2014.

{298} Point inserted by Decision No 218/2014 (OJ L 230, 3.9.2015, p. 16 and EEA Supplement No 52, 3.9.2015, p. 16), e.i.f. 1.11.2014.

{299} Point inserted by Decision No 218/2014 (OJ L 230, 3.9.2015, p. 16 and EEA Supplement No 52, 3.9.2015, p. 16), e.i.f. 1.11.2014.

Page 31: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 157

12nw.{300}32014 R 0408: Commission Implementing Regulation (EU) No 408/2014 of 23 April 2014 approving

synthetic amorphous silicon dioxide as an existing active substance for use in biocidal products for product-

type 18 (OJ L 121, 24.4.2014, p. 17).

12nx.{301}32014 D 0227: Commission Implementing Decision 2014/227/EU of 24 April 2014 on the non-approval of

certain biocidal active substances pursuant to Regulation (EU) No 528/2012 of the European Parliament and of

the Council (OJ L 124, 25.4.2014, p. 27).

12ny.{302} 32014 R 0437: Commission Implementing Regulation (EU) No 437/2014 of 29 April 2014 approving 4,5-

Dichloro-2-octyl-2H-isothiazol-3-one as an existing active substance for use in biocidal products for product-

type 21 (OJ L 128, 30.4.2014, p. 64).

12nz.{303} 32014 R 0438: Commission Implementing Regulation (EU) No 438/2014 of 29 April 2014 approving

cyproconazole as an existing active substance for use in biocidal products for product-type 8 (OJ L 128,

30.4.2014, p. 68).

12nza.{304}32014 R 1062: Commission Delegated Regulation (EU) No 1062/2014 of 4 August 2014 on the work

programme for the systematic examination of all existing active substances contained in biocidal products

referred to in Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L 294,

10.10.2014, p. 1), as amended by:

-{305} 32017 R 0698: Commission Delegated Regulation (EU) 2017/698 of 3 February 2017 (OJ L 103,

19.4.2017, p. 1),

-{306} 32019 R 0157: Commission Delegated Regulation (EU) 2019/157 of 6 November 2018 (OJ L 31,

1.2.2019, p. 1),

-{307} 32019 R 0227: Commission Delegated Regulation (EU) 2019/227 of 28 November 2018 (OJ L 37,

8.2.2019, p. 1).

12nzb.{308}32014 R 1090: Commission Implementing Regulation (EU) No 1090/2014 of 16 October 2014 approving

permethrin as an existing active substance for use in biocidal products for product-types 8 and 18 (OJ L 299,

17.10.2014, p. 10).

12nzc.{309}32014 R 1091: Commission Implementing Regulation (EU) No 1091/2014 of 16 October 2014 approving

tralopyril as a new active substance for use in biocidal products for product-type 21 (OJ L 299, 17.10.2014,

p. 15).

12nna.{310}32014 R 0492: Commission Delegated Regulation (EU) No 492/2014 of 7 March 2014 supplementing

Regulation (EU) No 528/2012 of the European Parliament and of the Council as regards the rules for the

renewal of authorisations of biocidal products subject to mutual recognition (OJ L 139, 14.5.2014, p. 1).

12nnb.{311}32014 D 0397: Commission Implementing Decision 2014/397/EU of 25 June 2014 postponing the expiry

date of approval of difethialone and difenacoum for use in biocidal products for product-type 14 (OJ L 186,

26.6.2014, p. 111).

{300} Point inserted by Decision No 218/2014 (OJ L 230, 3.9.2015, p. 16 and EEA Supplement No 52, 3.9.2015, p. 16), e.i.f. 1.11.2014.

{301} Point inserted by Decision No 218/2014 (OJ L 230, 3.9.2015, p. 16 and EEA Supplement No 52, 3.9.2015, p. 16), e.i.f. 1.11.2014.

{302} Point inserted by Decision No 218/2014 (OJ L 230, 3.9.2015, p. 16 and EEA Supplement No 52, 3.9.2015, p. 16), e.i.f. 1.11.2014.

{303} Point inserted by Decision No 218/2014 (OJ L 230, 3.9.2015, p. 16 and EEA Supplement No 52, 3.9.2015, p. 16), e.i.f. 1.11.2014.

{304} Point inserted by Decision No 52/2015 (OJ L 129, 19.5.2016, p. 33 and EEA Supplement No 29, 19.5.2016, p. 34), e.i.f. 21.3.2015.

{305} Indent and words ”, as amended by: “ added by Decision No 169/2017 (OJ L 174, 27.6.2019, p. 31 and EEA Supplement No 52, 27.6.2019,

p. 39), e.i.f. 23.9.2017.

{306} Indent added by Decision No 117/2019 (OJ L [to be published] and EEA supplement No [to be published]), e.i.f. 1.6.2019.

{307} Indent added by Decision No 152/2019 (OJ L [to be published] and EEA supplement No [to be published]), e.i.f. 15.6.2019.

{308} Point inserted by Decision No 52/2015 (OJ L 129, 19.5.2016, p. 33 and EEA Supplement No 29, 19.5.2016, p. 34), e.i.f. 21.3.2015.

{309} Point inserted by Decision No 52/2015 (OJ L 129, 19.5.2016, p. 33 and EEA Supplement No 29, 19.5.2016, p. 34), e.i.f. 21.3.2015.

{310} Point inserted by Decision No 266/2014 (OJ L 311, 26.11.2015, p. 16 and EEA Supplement No 71, 26.11.2015, p. 16), e.i.f. 13.12.2014.

{311} Point inserted by Decision No 267/2014 (OJ L 311, 26.11.2015, p. 17 and EEA Supplement No 71, 26.11.2015, p. 17), e.i.f. 13.12.2014.

Page 32: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 158

12nnc.{312}32014 D 0402: Commission Implementing Decision 2014/402/EU of 25 June 2014 regarding restrictions of

authorisations of biocidal products containing IPBC notified by Germany in accordance with Directive

98/8/EC of the European Parliament and of the Council (OJ L 188, 27.6.2014, p. 85).

12nnd.{313}32015 D 0646: Commission Implementing Decision (EU) 2015/646 of 23 April 2015 pursuant to Article 3(3)

of Regulation (EU) No 528/2012 of the European Parliament and of the Council on bacterial cultures intended

to reduce organic solids and to be placed on the market for that purpose (OJ L 106, 24.4.2015, p. 79).

12nne.{314}32015 D 0655: Commission Implementing Decision (EU) 2015/655 of 23 April 2015 pursuant to Article 3(3)

of Regulation (EU) No 528/2012 of the European Parliament and of the Council on a polydimethylsiloxane-

based formulation placed on the market to control mosquitoes (OJ L 107, 25.4.2015, p. 75).

12nnf.{315}32015 R 1609: Commission Implementing Regulation (EU) 2015/1609 of 24 September 2015 approving

propiconazole as an existing active substance for use in biocidal products for product-type 7 (OJ L 249,

25.9.2015, p. 17).

12nng.{316}32015 R 1610: Commission Implementing Regulation (EU) 2015/1610 of 24 September 2015 approving

Pythium oligandrum strain M1 as an active substance for use in biocidal products for product-type 10 (OJ

L 249, 25.9.2015, p. 20).

12nnh.{317}32015 R 1726: Commission Implementing Regulation (EU) 2015/1726 of 28 September 2015 approving 2-

methylisothiazol-3(2H)-one as an existing active substance for use in biocidal products for product-type 13 (OJ

L 252, 29.9.2015, p. 14).

12nni.{318}32015 R 1727: Commission Implementing Regulation (EU) 2015/1727 of 28 September 2015 approving 5-

Chloro-2-(4-chlorophenoxy)phenol as an existing active substance for use in biocidal products for product-

types 1, 2 and 4 (OJ L 252, 29.9.2015, p. 17).

12nnj.{319}32015 R 1728: Commission Implementing Regulation (EU) 2015/1728 of 28 September 2015 approving

IPBC as an existing active substance for use in biocidal products for product-type 13 (OJ L 252, 29.9.2015,

p. 21).

12nnk.{320}32015 R 1729: Commission Implementing Regulation (EU) 2015/1729 of 28 September 2015 approving

potassium sorbate as an existing active substance for use in biocidal products for product-type 8 (OJ L 252,

29.9.2015, p. 24).

12nnl.{321}32015 R 1730: Commission Implementing Regulation (EU) 2015/1730 of 28 September 2015 approving

hydrogen peroxide as an existing active substance for use in biocidal products for product-types 1, 2, 3, 4, 5

and 6 (OJ L 252, 29.9.2015, p. 27).

12nnm.{322}32015 R 1731: Commission Implementing Regulation (EU) 2015/1731 of 28 September 2015 approving

medetomidine as an active substance for use in biocidal products for product-type 21 (OJ L 252, 29.9.2015,

p. 33).

12nnn.{323}32015 D 1736: Commission Implementing Decision (EU) 2015/1736 of 28 September 2015 not approving

triflumuron as an existing active substance for use in biocidal products for product-type 18 (OJ L 252,

29.9.2015, p. 56).

{312} Point inserted by Decision No 267/2014 (OJ L 311, 26.11.2015, p. 17 and EEA Supplement No 71, 26.11.2015, p. 17), e.i.f. 13.12.2014.

{313} Point inserted by Decision No 214/2015 (OJ L 85, 30.3.2017, p. 33 and EEA Supplement No 19, 30.3.2017, p. 32), e.i.f. 26.9.2015.

{314} Point inserted by Decision No 214/2015 (OJ L 85, 30.3.2017, p. 33 and EEA Supplement No 19, 30.3.2017, p. 32), e.i.f. 26.9.2015.

{315} Point inserted by Decision No 300/2015 (OJ L 263, 12.10.2017, p. 10 and EEA Supplement No 64, 12.10.2017, p. 11), e.i.f. 12.12.2015.

{316} Point inserted by Decision No 300/2015 (OJ L 263, 12.10.2017, p. 10 and EEA Supplement No 64, 12.10.2017, p. 11), e.i.f. 12.12.2015.

{317} Point inserted by Decision No 301/2015 (OJ L 263, 12.10.2017, p. 11 and EEA Supplement No 64, 12.10.2017, p. 13), e.i.f. 12.12.2015.

{318} Point inserted by Decision No 301/2015 ((OJ L 263, 12.10.2017, p. 11 and EEA Supplement No 64, 12.10.2017, p. 13), e.i.f. 12.12.2015.

{319} Point inserted by Decision No 301/2015 (OJ L 263, 12.10.2017, p. 11 and EEA Supplement No 64, 12.10.2017, p. 13), e.i.f. 12.12.2015.

{320} Point inserted by Decision No 301/2015 (OJ L 263, 12.10.2017, p. 11 and EEA Supplement No 64, 12.10.2017, p. 13), e.i.f. 12.12.2015.

{321} Point inserted by Decision No 301/2015 (OJ L 263, 12.10.2017, p. 11 and EEA Supplement No 64, 12.10.2017, p. 13), e.i.f. 12.12.2015.

{322} Point inserted by Decision No 301/2015 (OJ L 263, 12.10.2017, p. 11 and EEA Supplement No 64, 12.10.2017, p. 13), e.i.f. 12.12.2015.

{323} Point inserted by Decision No 301/2015 (OJ L 263, 12.10.2017, p. 11 and EEA Supplement No 64, 12.10.2017, p. 13), e.i.f. 12.12.2015.

Page 33: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 159

12nno.{324}32015 D 1737: Commission Implementing Decision (EU) 2015/1737 of 28 September 2015 postponing the

expiry date of approval of bromadiolone, chlorophacinone and coumatetralyl for use in biocidal products for

product-type 14 (OJ L 252, 29.9.2015, p. 58).

12nnp.{325}32015 D 1751: Commission Implementing Decision (EU) 2015/1751 of 29 September 2015 on the terms and

conditions of the authorisation of a biocidal product containing bromadiolone referred by the United Kingdom

in accordance with Article 36 of Regulation (EU) No 528/2012 of the European Parliament and of the Council

(OJ L 256, 1.10.2015, p. 15).

12nnq.{326}32015 R 1757: Commission Implementing Regulation (EU) 2015/1757 of 28 September 2015 approving

folpet as an active substance for use in biocidal products for product-type 6 (OJ L 257, 2.10.2015, p. 12).

12nnr.{327}32015 R 1758: Commission Implementing Regulation (EU) 2015/1758 of 28 September 2015 approving

folpet as an existing active substance for use in biocidal products for product-types 7 and 9 (OJ L 257,

2.10.2015, p. 15).

12nns.{328}32015 R 1759: Commission Implementing Regulation (EU) 2015/1759 of 28 September 2015 approving

glutaraldehyde as an existing active substance for use in biocidal products for product-types 2, 3, 4, 6, 11 and

12 (OJ L 257, 2.10.2015, p. 19).

12nnt.{329}32015 R 1981: Commission Implementing Regulation (EU) 2015/1981 of 4 November 2015 approving

Formaldehyde released from N,N-Methylenebismorpholine as an existing active substance for use in biocidal

products for product-types 6 and 13 (OJ L 289, 5.11.2015, p. 9).

12nnu.{330}32015 R 1982: Commission Implementing Regulation (EU) 2015/1982 of 4 November 2015 approving

hexaflumuron as an existing active substance for use in biocidal products for product-type 18 (OJ L 289,

5.11.2015, p. 13).

12nnv.{331}32015 D 1985: Commission Implementing Decision (EU) 2015/1985 of 4 November 2015 pursuant to

Article 3(3) of Regulation (EU) No 528/2012 of the European Parliament and of the Council on an anti-viral

tissue impregnated with citric acid (OJ L 289, 5.11.2015, p. 26).

12nnw.{332}32016 D 0903: Commission Implementing Decision (EU) 2016/903 of 8 June 2016 pursuant to Article 3(3)

of Regulation (EU) No 528/2012 of the European Parliament and of the Council on a horse rug impregnated

with permethrin used for the purpose of controlling nuisance insects in the environment of the horse (OJ L 152,

9.6.2016, p. 43).

12nnx.{333}32016 D 0904: Commission Implementing Decision (EU) 2016/904 of 8 June 2016 pursuant to Article 3(3)

of Regulation (EU) No 528/2012 of the European Parliament and of the Council on propan-2-ol containing

products used for hand disinfection (OJ L 152, 9.6.2016, p. 45).

12nny.{334}32016 D 1174: Commission Implementing Decision (EU) 2016/1174 of 15 July 2016 on the terms and

conditions of the authorisation of a biocidal product containing difenacoum referred by Spain in accordance

with Article 36 of Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L 193,

19.7.2016, p. 110).

12nnz.{335}32016 D 1175: Commission Implementing Decision (EU) 2016/1175 of 15 July 2016 on the terms and

conditions of the authorisation of a biocidal product containing spinosad referred by the United Kingdom in

{324} Point inserted by Decision No 301/2015 (OJ L 263, 12.10.2017, p. 11 and EEA Supplement No 64, 12.10.2017, p. 13), e.i.f. 12.12.2015.

{325} Point inserted by Decision No 302/2015 (OJ L 263, 12.10.2017, p. 13 and EEA Supplement No 64, 12.10.2017, p. 16), e.i.f. 12.12.2015.

{326} Point inserted by Decision No 17/2016 (OJ L 189, 20.7.2017, p. 23 and EEA Supplement No 45, 20.7.2017, p. 26), e.i.f. 6.2.2016.

{327} Point inserted by Decision No 17/2016 (OJ L 189, 20.7.2017, p. 23 and EEA Supplement No 45, 20.7.2017, p. 26), e.i.f. 6.2.2016.

{328} Point inserted by Decision No 17/2016 (OJ L 189, 20.7.2017, p. 23 and EEA Supplement No 45, 20.7.2017, p. 26), e.i.f. 6.2.2016.

{329} Point inserted by Decision No 18/2016 (OJ L 189, 20.7.2017, p. 25 and EEA Supplement No 45, 20.7.2017, p. 28), e.i.f. 6.2.2016.

{330} Point inserted by Decision No 18/2016 (OJ L 189, 20.7.2017, p. 25 and EEA Supplement No 45, 20.7.2017, p. 28), e.i.f. 6.2.2016.

{331} Point inserted by Decision No 18/2016 (OJ L 189, 20.7.2017, p. 25 and EEA Supplement No 45, 20.7.2017, p. 28), e.i.f. 6.2.2016.

{332} Point inserted by Decision No 174/2016 (OJ L 80, 22.3.2018, p. 15 and EEA Supplement No 19, 22.3.2018, p. 20), e.i.f. 24.9.2016.

{333} Point inserted by Decision No 174/2016 (OJ L 80, 22.3.2018, p. 15 and EEA Supplement No 19, 22.3.2018, p. 20), e.i.f. 24.9.2016.

{334} Point inserted by Decision No 234/2016 (OJ L 215, 23.8.2018, p. 30 and EEA Supplement No 56, 23.8.2018, p. 36), e.i.f. 3.12.2016.

{335} Point inserted by Decision No 234/2016 (OJ L 215, 23.8.2018, p. 30 and EEA Supplement No 56, 23.8.2018, p. 36), e.i.f. 3.12.2016.

Page 34: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 160

accordance with Article 36 of Regulation (EU) No 528/2012 of the European Parliament and of the Council

(OJ L 193, 19.7.2016, p. 113).

12o.{336} 32000 R 1896: Commission Regulation (EC) No 1896/2000 of 7 September 2000 on the first phase of the

programme referred to in Article 16(2) of Directive 98/8/EC of the European Parliament and of the Council on

biocidal products (OJ L 228, 8.9.2000, p. 6).

- [ ] {337}

The provisions of the Regulation shall, for the purposes of the present Agreement, be read with the following

adaptations, in addition to the adaptations to the Directive 98/8/EC:

(a) The EFTA States and their producers shall participate in the 10-year programme of work mentioned

in Article 16(2) of Directive 98/8/EC. The EFTA States may be designated under Article 7(5) as

responsible for the review of active substances under this programme.

(b) The Commission shall take into account information concerning active substances already on the

market in the EFTA States on 14 May 2000 submitted under Article 3 paragraph 1 before the entry

into force of the Joint Committee Decision integrating this Regulation into the Agreement.

(c) The Commission shall take into account notifications concerning active substances already on the

market in the EFTA States on 14 May 2000 submitted under Article 4 paragraph 1 before the entry

into force of the Joint Committee Decision integrating this Regulation into the Agreement.

12p.{338} 32002 R 1687: Commission Regulation (EC) No 1687/2002 of 25 September 2002 on an additional period for

notification of certain active substances already on the market for biocidal use as established in Article 4(1) of

Regulation (EC) No 1896/2000 (OJ L 258, 26.9.2002, p. 15).

12q.{339} 32011 L 0065: Directive 2011/65/EU of the European Parliament and of the Council of 8 June 2011 on the

restriction of the use of certain hazardous substances in electrical and electronic equipment (OJ L 174,

1.7.2011, p. 88.), as amended by:

-{340} 32012 L 0050: Commission Delegated Directive 2012/50/EU of 10 October 2012 (OJ L 348.

18.12.2012, p. 16),

-{341} 32012 L 0051: Commission Delegated Directive 2012/51/EU of 10 October 2012 (OJ L 348,

18.12.2013, p. 18),

-{342} 32014 L 0001: Commission Delegated Directive 2014/1/EU of 18 October 2013 (OJ L 4, 9.1.2014,

p. 45),

-{343} 32014 L 0002: Commission Delegated Directive 2014/2/EU of 18 October 2013 (OJ L 4, 9.1.2014,

p. 47),

-{344} 32014 L 0003: Commission Delegated Directive 2014/3/EU of 18 October 2013 (OJ L 4, 9.1.2014,

p. 49),

{336} Point inserted by Decision No 32/2003 (OJ L 137, 5.6.2003, p. 33 and EEA Supplement No 29, 5.6.2003, p. 21), e.i.f. 1.3.2004.

{337} Indent and words “, as amended by:”, inserted by Decision No 165/2004 (OJ L 133, 26.5.2005, p. 9 and EEA Supplement No 26, 26.5.2005,

p. 7), e.i.f. 4.12.2004 and subsequently deleted by Decision No 132/2009 ( OJ L 62, 11.3.2010, p. 22 and EEA Supplement No 12, 11.3.2010,

p. 21), e.i.f. 5.12.2009.

{338} Point inserted by Decision No 32/2003 (OJ L 137, 5.6.2003, p. 33 and EEA Supplement No 29, p. 21), e.i.f. 1.3.2004.

{339} Point 12q (Directive 2002/95/EC) inserted by Decision No 147/2003 (OJ L 41, 12.2.2004, p. 33 and EEA Supplement No 7, 12.2.2004,

p. 26), e.i.f. 8.11.2003 subsequently replaced by Decision No 67/2013 (OJ L 291, 31.10.2013, p. 24 and EEA Supplement No 61, 31.10.2013,

p. 27), e.i.f. 4.5.2013.

{340} Indent and words “, as amended by:”, added by Decision No 32/2003 (OJ L 137, 5.6.2003, p. 33 and EEA Supplement No 29, p. 21), e.i.f.

1.3.2004.

{341} Indent added by Decision No 32/2003 (OJ L 137, 5.6.2003, p. 33 and EEA Supplement No 29, p. 21), e.i.f. 1.3.2004.

{342} Indent added by Decision No 122/2014 (OJ L 342, 27.11.2014, p. 17 and EEA Supplement No 71, 27.11.2014, p. 17), e.i.f. 28.6.2014.

{343} Indent added by Decision No 122/2014 (OJ L 342, 27.11.2014, p. 17 and EEA Supplement No 71, 27.11.2014, p. 17), e.i.f. 28.6.2014.

{344} Indent added by Decision No 122/2014 (OJ L 342, 27.11.2014, p. 17 and EEA Supplement No 71, 27.11.2014, p. 17), e.i.f. 28.6.2014.

Page 35: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 161

-{345} 32014 L 0004: Commission Delegated Directive 2014/4/EU of 18 October 2013 (OJ L 4, 9.1.2014,

p. 51),

-{346} 32014 L 0005: Commission Delegated Directive 2014/5/EU of 18 October 2013 (OJ L 4, 9.1.2014,

p. 53),

-{347} 32014 L 0006: Commission Delegated Directive 2014/6/EU of 18 October 2013 (OJ L 4, 9.1.2014,

p. 55),

-{348} 32014 L 0007: Commission Delegated Directive 2014/7/EU of 18 October 2013 (OJ L 4, 9.1.2014,

p. 57),

-{349} 32014 L 0008: Commission Delegated Directive 2014/8/EU of 18 October 2013 (OJ L 4, 9.1.2014,

p. 59),

-{350} 32014 L 0009: Commission Delegated Directive 2014/9/EU of 18 October 2013 (OJ L 4, 9.1.2014,

p. 61),

-{351} 32014 L 0010: Commission Delegated Directive 2014/10/EU of 18 October 2013 (OJ L 4, 9.1.2014,

p. 63),

-{352} 32014 L 0011: Commission Delegated Directive 2014/11/EU of 18 October 2013 (OJ L 4, 9.1.2014,

p. 65),

-{353} 32014 L 0012: Commission Delegated Directive 2014/12/EU of 18 October 2013 (OJ L 4, 9.1.2014,

p. 67),

-{354} 32014 L 0013: Commission Delegated Directive 2014/13/EU of 18 October 2013 (OJ L 4, 9.1.2014,

p. 69),

-{355} 32014 L 0014: Commission Delegated Directive 2014/14/EU of 18 October 2013 (OJ L 4, 9.1.2014,

p. 71),

-{356} 32014 L 0015: Commission Delegated Directive 2014/15/EU of 18 October 2013 (OJ L 4, 9.1.2014,

p. 73),

-{357} 32014 L 0016: Commission Delegated Directive 2014/16/EU of 18 October 2013 (OJ L 4, 9.1.2014,

p. 75),

-{358} 32014 L 0069: Commission Delegated Directive 2014/69/EU of 13 March 2014 (OJ L 148,

20.5.2014, p. 72),

{345} Indent added by Decision No 122/2014 (OJ L 342, 27.11.2014, p. 17 and EEA Supplement No 71, 27.11.2014, p. 17), e.i.f. 28.6.2014.

{346} Indent added by Decision No 122/2014 (OJ L 342, 27.11.2014, p. 17 and EEA Supplement No 71, 27.11.2014, p. 17), e.i.f. 28.6.2014.

{347} Indent added by Decision No 122/2014 (OJ L 342, 27.11.2014, p. 17 and EEA Supplement No 71, 27.11.2014, p. 17), e.i.f. 28.6.2014.

{348} Indent added by Decision No 122/2014 (OJ L 342, 27.11.2014, p. 17 and EEA Supplement No 71, 27.11.2014, p. 17), e.i.f. 28.6.2014.

{349} Indent added by Decision No 122/2014 (OJ L 342, 27.11.2014, p. 17 and EEA Supplement No 71, 27.11.2014, p. 17), e.i.f. 28.6.2014.

{350} Indent added by Decision No 122/2014 (OJ L 342, 27.11.2014, p. 17 and EEA Supplement No 71, 27.11.2014, p. 17), e.i.f. 28.6.2014.

{351} Indent added by Decision No 122/2014 (OJ L 342, 27.11.2014, p. 17 and EEA Supplement No 71, 27.11.2014, p. 17), e.i.f. 28.6.2014.

{352} Indent added by Decision No 122/2014 (OJ L 342, 27.11.2014, p. 17 and EEA Supplement No 71, 27.11.2014, p. 17), e.i.f. 28.6.2014.

{353} Indent added by Decision No 122/2014 (OJ L 342, 27.11.2014, p. 17 and EEA Supplement No 71, 27.11.2014, p. 17), e.i.f. 28.6.2014.

{354} Indent added by Decision No 122/2014 (OJ L 342, 27.11.2014, p. 17 and EEA Supplement No 71, 27.11.2014, p. 17), e.i.f. 28.6.2014.

{355} Indent added by Decision No 122/2014 (OJ L 342, 27.11.2014, p. 17 and EEA Supplement No 71, 27.11.2014, p. 17), e.i.f. 28.6.2014.

{356} Indent added by Decision No 122/2014 (OJ L 342, 27.11.2014, p. 17 and EEA Supplement No 71, 27.11.2014, p. 17), e.i.f. 28.6.2014.

{357} Indent added by Decision No 122/2014 (OJ L 342, 27.11.2014, p. 17 and EEA Supplement No 71, 27.11.2014, p. 17), e.i.f. 28.6.2014.

{358} Indent added by Decision No 181/2014 (OJ L 202, 30.7.2015, p. 31 and EEA Supplement No 43, 30.7.2015, p. 31), e.i.f. 26.9.2014.

Page 36: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 162

-{359} 32014 L 0070: Commission Delegated Directive 2014/70/EU of 13 March 2014 (OJ L 148,

20.5.2014, p. 74),

-{360} 32014 L 0071: Commission Delegated Directive 2014/71/EU of 13 March 2014 (OJ L 148,

20.5.2014, p. 76),

-{361} 32014 L 0072: Commission Delegated Directive 2014/72/EU of 13 March 2014 (OJ L 148,

20.5.2014, p. 78),

-{362} 32014 L 0073: Commission Delegated Directive 2014/73/EU of 13 March 2014 (OJ L 148,

20.5.2014, p. 80),

-{363} 32014 L 0074: Commission Delegated Directive 2014/74/EU of 13 March 2014 (OJ L 148,

20.5.2014, p. 82),

-{364} 32014 L 0075: Commission Delegated Directive 2014/75/EU of 13 March 2014 (OJ L 148,

20.5.2014, p. 84),

-{365} 32014 L 0076: Commission Delegated Directive 2014/76/EU of 13 March 2014 (OJ L 148,

20.5.2014, p. 86),

-{366} 32015 L 0573: Commission Delegated Directive (EU) 2015/573 of 30 January 2015 (OJ L 94,

10.4.2015, p. 4),

-{367} 32015 L 0574: Commission Delegated Directive (EU) 2015/574 of 30 January 2015 (OJ L 94,

10.4.2015, p. 6),

-{368} 32015 L 0863: Commission Delegated Directive (EU) 2015/863 of 31 March 2015 (OJ L 137,

4.6.2015, p. 10),

-{369} 32016 L 0585: Commission Delegated Directive (EU) 2016/585 of 12 February 2016 (OJ L 101,

16.4.2016, p. 12),

-{370} 32016 L 1028: Commission Delegated Directive (EU) 2016/1028 of 19 April 2016 (OJ L 168,

25.6.2016, p. 13),

-{371} 32016 L 1029: Commission Delegated Directive (EU) 2016/1029 of 19 April 2016 (OJ L 168,

25.6.2016, p. 15),

-{372} 32017 L 1009: Commission Delegated Directive (EU) 2017/1009 of 13 March 2017 (OJ L 153,

16.6.2017, p. 21),

-{373} 32017 L 1010: Commission Delegated Directive (EU) 2017/1010 of 13 March 2017 (OJ L 153,

16.6.2017, p. 23),

{359} Indent added by Decision No 181/2014 (OJ L 202, 30.7.2015, p. 31 and EEA Supplement No 43, 30.7.2015, p. 31), e.i.f. 26.9.2014.

{360} Indent added by Decision No 181/2014 (OJ L 202, 30.7.2015, p. 31 and EEA Supplement No 43, 30.7.2015, p. 31), e.i.f. 26.9.2014.

{361} Indent added by Decision No 181/2014 (OJ L 202, 30.7.2015, p. 31 and EEA Supplement No 43, 30.7.2015, p. 31), e.i.f. 26.9.2014.

{362} Indent added by Decision No 181/2014 (OJ L 202, 30.7.2015, p. 31 and EEA Supplement No 43, 30.7.2015, p. 31), e.i.f. 26.9.2014.

{363} Indent added by Decision No 181/2014 (OJ L 202, 30.7.2015, p. 31 and EEA Supplement No 43, 30.7.2015, p. 31), e.i.f. 26.9.2014.

{364} Indent added by Decision No 181/2014 (OJ L 202, 30.7.2015, p. 31 and EEA Supplement No 43, 30.7.2015, p. 31), e.i.f. 26.9.2014.

{365} Indent added by Decision No 181/2014 (OJ L 202, 30.7.2015, p. 31 and EEA Supplement No 43, 30.7.2015, p. 31), e.i.f. 26.9.2014.

{366} Indent added by Decision No 179/2015 (OJ L 8, 12.1.2017, p. 7 and EEA Supplement No 3, 12.1.2017, p. 7), e.i.f. 11.7.2015.

{367} Indent added by Decision No 179/2015 (OJ L 8, 12.1.2017, p. 7 and EEA Supplement No 3, 12.1.2017, p. 7), e.i.f. 11.7.2015.

{368} Indent added by Decision No 215/2015 (OJ L 85, 30.3.2017, p. 35 and EEA Supplement No 19, 30.3.2017, p. 34), e.i.f. 26.9.2015.

{369} Indent added by Decision No 146/2016 (OJ L 73, 15.3.2018, p. 19 and EEA Supplement No 16, 15.3.2018, p. 22), e.i.f. 9.7.2016.

{370} Indent added by Decision No 175/2016 (OJ L 80, 22.3.2018, p. 17 and EEA Supplement No 19, 22.3.2018, p. 22), e.i.f. 24.9.2016.

{371} Indent added by Decision No 175/2016 (OJ L 80, 22.3.2018, p. 17 and EEA Supplement No 19, 22.3.2018, p. 22), e.i.f. 24.9.2016.

{372} Indent added by Decision No 168/2017 (OJ L 174, 27.6.2019, p. 29 and EEA Supplement No 52, 27.6.2019, p. 37), e.i.f. 23.9.2017.

{373} Indent added by Decision No 168/2017 (OJ L 174, 27.6.2019, p. 29 and EEA Supplement No 52, 27.6.2019, p. 37), e.i.f. 23.9.2017.

Page 37: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 163

-{374} 32017 L 1011: Commission Delegated Directive (EU) 2017/1011 of 15 March 2017 (OJ L 153,

16.6.2017, p. 25),

-{375} 32017 L 1975: Commission Delegated Directive (EU) 2017/1975 of 7 August 2017 (OJ L 281,

31.10.2017, p. 29), as corrected by OJ L 285, 1.11.2017, p. 32,

-{376} 32017 L 2102: Directive (EU) 2017/2102 of the European Parliament and of the Council of 15

November 2017 (OJ L 305, 21.11.2017, p. 8),

-{377} 32018 L 0736: Commission Delegated Directive (EU) 2018/736 of 27 February 2018 (OJ L 123,

18.5.2018, p. 94),

-{378} 32018 L 0737: Commission Delegated Directive (EU) 2018/737 of 27 February 2018 (OJ L 123,

18.5.2018, p. 97),

-{379} 32018 L 0738: Commission Delegated Directive (EU) 2018/738 of 27 February 2018 (OJ L 123,

18.5.2018, p. 100),

-{380} 32018 L 0739: Commission Delegated Directive (EU) 2018/739 of 1 March 2018 (OJ L 123,

18.5.2018, p. 103),

-{381} 32018 L 0740: Commission Delegated Directive (EU) 2018/740 of 1 March 2018 (OJ L 123,

18.5.2018, p. 106),

-{382} 32018 L 0741: Commission Delegated Directive (EU) 2018/741 of 1 March 2018 (OJ L 123,

18.5.2018, p. 109),

-{383} 32018 L 0742: Commission Delegated Directive (EU) 2018/742 of 1 March 2018 (OJ L 123,

18.5.2018, p. 112),

-{384} 32019 L 0169: Commission Delegated Directive (EU) 2019/169 of 16 November 2018 (OJ L 33,

5.2.2019, p. 5),

-{385} 32019 L 0170: Commission Delegated Directive (EU) 2019/170 of 16 November 2018 (OJ L 33,

5.2.2019, p. 8),

-{386} 32019 L 0171: Commission Delegated Directive (EU) 2019/171 of 16 November 2018 (OJ L 33,

5.2.2019, p. 11),

-{387} 32019 L 0172: Commission Delegated Directive (EU) 2019/172 of 16 November 2018 (OJ L 33,

5.2.2019, p. 14),

-{388} 32019 L 0173: Commission Delegated Directive (EU) 2019/173 of 16 November 2018 (OJ L 33,

5.2.2019, p. 17),

-{389} 32019 L 0174: Commission Delegated Directive (EU) 2019/174 of 16 November 2018 (OJ L 33,

5.2.2019, p. 20),

{374} Indent added by Decision No 168/2017 (OJ L 174, 27.6.2019, p. 29 and EEA Supplement No 52, 27.6.2019, p. 37), e.i.f. 23.9.2017.

{375} Indent added by Decision No 15/2018 (OJ L 323, 12.12.2019, p. 29 and EEA Supplement No 98, 12.12.2019, p. 27), e.i.f. 10.2.2018.

{376} Indent added by Decision No 51/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 24.3.2018.

{377} Indent added by Decision No 210/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 27.10.2018.

{378} Indent added by Decision No 210/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 27.10.2018.

{379} Indent added by Decision No 210/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 27.10.2018.

{380} Indent added by Decision No 210/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 27.10.2018.

{381} Indent added by Decision No 210/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 27.10.2018.

{382} Indent added by Decision No 210/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 27.10.2018.

{383} Indent added by Decision No 210/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 27.10.2018.

{384} Indent added by Decision No 153/2019 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 15.6.2019.

{385} Indent added by Decision No 153/2019 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 15.6.2019.

{386} Indent added by Decision No 153/2019 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 15.6.2019.

{387} Indent added by Decision No 153/2019 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 15.6.2019.

{388} Indent added by Decision No 153/2019 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 15.6.2019.

Page 38: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 164

-{390} 32019 L 0175: Commission Delegated Directive (EU) 2019/175 of 16 November 2018 (OJ L 33,

5.2.2019, p. 23),

-{391} 32019 L 0176: Commission Delegated Directive (EU) 2019/176 of 16 November (OJ L 33,

5.2.2019, p. 26),

-{392} 32019 L 0177: Commission Delegated Directive (EU) 2019/177 of 16 November (OJ L 33,

5.2.2019, p. 29),

-{393} 32019 L 0178: Commission Delegated Directive (EU) 2019/178 of 16 November (OJ L 33,

5.2.2019, p. 32).

12r. [ ] {394}

12s. [ ] {395}

12t.{396} 32005 R 0642: Commission Regulation (EC) No 642/2005 of 27 April 2005 imposing testing and information

requirements on the importers or manufacturers of certain priority substances in accordance with Council

Regulation (EEC) No 793/93 on the evaluation and control of the risks of existing substances (OJ L 107,

28.4.2005, p. 14).

12u.{397} 32004 R 0648: Regulation (EC) No 648/2004 of the European Parliament and of the Council of 31 March

2004 on detergents (OJ L 104, 8.4.2004, p. 1), as amended by:

-{398} 32006 R 0907: Commission Regulation (EC) No 907/2006 of 20 June 2006 (OJ L 168, 21.6.2006,

p. 5),

-{399} 32009 R 0551: Commission Regulation (EC) No 551/2009 of 25 June 2009 (OJ L 164, 26.6.2009,

p. 3),

-{400} 32008 R 1336: Regulation (EC) No 1336/2008 of the European Parliament and of the Council of 16

December 2008 (OJ L 354, 31.12.2008, p. 60),

-{401} 32012 R 0259: Regulation (EU) No 259/2012 of the European Parliament and of the Council of 14

March 2012 (OJ L 94, 30.3.2012, p. 16).

12v.{402} 32006 R 0565: Commission Regulation (EC) No 565/2006 of 6 April 2006 imposing testing and information

requirements on the importers or manufacturers of certain priority substances in accordance with Council

{389} Indent added by Decision No 153/2019 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 15.6.2019.

{390} Indent added by Decision No 153/2019 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 15.6.2019.

{391} Indent added by Decision No 153/2019 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 15.6.2019.

{392} Indent added by Decision No 153/2019 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 15.6.2019.

{393} Indent added by Decision No 153/2019 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 15.6.2019.

{394} Point 12r (Directive 1999/45/EC) inserted by Decision No 59/2004 (OJ L 277, 26.8.2004, p. 30 and EEA Supplement No 43, 26.8.2004, p.

25), e.i.f. 27.4.2004 and subsequently deleted with effect from 1 June 2015 by Decision No 106/2012 (OJ L 270, 4.10.2012, p. 6 and EEA

Supplement No 56, 4.10.2012, p. 8), e.i.f. 1.2.2013.

{395} Point inserted by Decision No 165/2004 (OJ L 133, 26.5.2005, p. 9 and EEA Suppl. No 26, 26.5.2005, p. 7), e.i.f. 4.12.2004 and subsequently

deleted by Decision No 132/2009 (OJ L 62, 11.3.2010, p. 22 and EEA Supplement No 12, 11.3.2010, p. 21), e.i.f. 5.12.2009.

{396} Point inserted by Decision No 133/2005 (OJ L 14, 19.1.2006, p. 21 and EEA Supplement No 4, 19.1.2006, p. 4), e.i.f. 22.10.2005.

{397} Point inserted by Decision No 144/2005 (OJ L 53, 23.2.2006, p. 40 and EEA Supplement No 10, 23.2.2005, p. 15), e.i.f. 3.12.2005.

{398} Indent and words “, as amended by:” above, inserted by Decision No 15/2007 (OJ L 209, 9.8.2007, p. 26 and EEA Supplement No 38,

9.8.2007, p. 20), e.i.f. 1.8.2008.

{399} Indent added by Decision No 66/2010 (OJ L 244, 16.9.2010, p. 17 and EEA Supplement No 49, 16.9.2010, p. 16), e.i.f. 12.6.2010.

{400} Indent added by Decision No 106/2012 (OJ L 270, 4.10.2012, p. 6 and EEA Supplement No 56, 4.10.2012, p. 8), e.i.f. 1.2.2013.

{401} Indent added by Decision No 140/2013 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 16.7.2013.

{402} Point inserted by Decision No 16/2007 (OJ L 209, 9.8.2007, p. 28 and EEA Supplement No 38, 9.8.2007, p. 21), e.i.f. 28.4.2007.

Page 39: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 165

Regulation (EEC) No 793/93 on the evaluation and control of the risks of existing substances (OJ L 99,

7.4.2006, p. 3).

12w.{403} 32004 R 0850: Regulation (EC) No 850/2004 of the European Parliament and of the Council of 29 April 2004

on persistent organic pollutants and amending Directive 79/117/EEC (OJ L 158, 30.4.2004, p. 7), as corrected

by OJ L 229, 29.6.2004, p. 5, as amended by:

- 32006 R 1195: Council Regulation (EC) No 1195/2006 of 18 July 2006 (OJ L 217, 8.8.2006, p. 1),

- 32007 R 0172: Council Regulation (EC) No 172/2007 of 16 February 2007 (OJ L 55, 23.2.2007,

p. 1),

- 32007 R 0323: Commission Regulation (EC) No 323/2007 of 26 March 2007 (OJ L 85, 27.3.2007,

p. 3),

-{404} 32009 R 0304: Commission Regulation (EC) No 304/2009 of 14 April 2009 (OJ L 96, 15.4.2009,

p. 33),

-{405} 32010 R 0756: Commission Regulation (EU) No 756/2010 of 24 August 2010 (OJ L 223, 25.8.2010,

p. 20),

-{406} 32010 R 0757: Commission Regulation (EU) No 757/2010 of 24 August 2010 (OJ L 223, 25.8.2010,

p. 29),

-{407} 32012 R 0519: Commission Regulation (EU) No 519/2012 of 19 June 2012 (OJ L 159, 20.6.2012,

p. 1),

-{408} 32014 R 1342: Commission Regulation (EU) No 1342/2014 of 17 December 2014 (OJ L 363,

18.12.2014, p. 67),

-{409} 32015 R 2030: Commission Regulation (EU) 2015/2030 of 13 November 2015 (OJ L 298,

14.11.2015, p. 1),

-{410} 32016 R 0460: Commission Regulation (EU) 2016/460 of 30 March 2016 (OJ L 80, 31.3.2016,

p. 17),

-{411} 32016 R 0293: Commission Regulation (EU) 2016/293 of 1 March 2016 (OJ L 55, 2.3.2016, p. 4),

-{412} 32019 R 0636: Commission Regulation (EU) 2019/636 of 23 April 2019 (OJ L 109, 24.4.2019,

p. 6).

The provisions of the Regulation shall, for the purposes of this Agreement, be read with the following

adaptation:

Notwithstanding the provisions of Protocol 1 to the Agreement, the term ‘customs territory of the Community’

contained in Article 2 shall be understood to include the territory of the EFTA States.

{403} Point inserted by Decision No 107/2007 (OJ L 47, 21.2.2008, p. 25 and EEA Supplement No 9, 21.2.2008, p. 21), e.i.f. 29.9.2007.

{404} Indent added by Decision No 67/2010 (OJ L 244, 16.9.2010, p. 19 and EEA Supplement No 49, 16.9.2010, p. 18), e.i.f. 12.6.2010.

{405} Indent added by Decision No 211/2012 (OJ L 81, 21.3.2013, p. 11 and EEA Supplement No 18, 21.3.2013, p. 13), e.i.f. 8.12.2012.

{406} Indent added by Decision No 212/2012 (OJ L 81, 21.3.2013, p. 12 and EEA Supplement No 18, 21.3.2013, p. 14), e.i.f. 8.12.2012.

{407} Indent added by Decision No 69/2013 (OJ L 291, 31.10.2013, p. 26 and EEA Supplement No 61, 31.10.2013, p. 30), e.i.f. 4.5.2013.

{408} Indent added by Decision No 90/2015 (OJ L 211, 4.8.2016, p. 27 and EEA Supplement No 42, 4.8.2016, p. 26), e.i.f. 1.5.2015.

{409} Indent added by Decision No 19/2016 (OJ L 189, 20.7.2017, p. 27 and EEA Supplement No 45, 20.7.2017, p. 30), e.i.f. 6.2.2016.

{410} Indent added by Decision No 118/2016 (OJ L 308, 23.11.2017, p. 21 and EEA Supplement No 76, 23.11.2017, p. 26), e.i.f. 4.6.2016.

{411} Indent added by Decision No 147/2016 (OJ L 73, 15.3.2018, p. 20 and EEA Supplement No 16, 15.3.2018, p. 23), e.i.f. 9.7.2016.

{412} Indent added by Decision No 225/2019 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 28.9.2019.

Page 40: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 166

12x.{413} 32006 L 0066: Directive 2006/66/EC of the European Parliament and of the Council of 6 September 2006 on

batteries and accumulators and waste batteries and accumulators and repealing Directive 91/157/EEC (OJ

L 266, 29.9.2006, p. 1), as corrected by OJ L 311, 10.11.2006, p. 58, as amended by:

-{414} 32008 L 0103: Directive 2008/103/EC of the European Parliament and of the Council of 19

November 2008 (OJ L 327, 5.12.2008, p. 7),

-{415} 32013 L 0056: Directive 2013/56/EU of the European Parliament and of the Council of

20 November 2013 (OJ L 329, 10.12.2013, p. 5).

The provisions of the Directive shall, for the purposes of this Agreement, be read with the following

adaptation:

Article 17 shall not apply to Liechtenstein.

12y.{416} 32007 D 0395: Commission Decision 2007/395/EC of 7 June 2007 concerning national provisions on the use

of short-chain chlorinated paraffins notified by the Kingdom of the Netherlands under Article 95(4) of the EC

Treaty (OJ L 148, 9.6.2007, p. 17).

12z.{417} 32007 D 0597: Commission Decision 2007/597/EC of 27 August 2007 concerning the non-inclusion of

guazatine triacetate in Annex I, IA or IB to Directive 98/8/EC of the European Parliament and of the Council

concerning the placing of biocidal products on the market (OJ L 230, 1.9.2007, p. 18).

12za.{418} 32007 D 0639: Commission Decision 2007/639/EC of 2 October 2007 establishing a common format for the

submission of data and information pursuant to Regulation (EC) No 850/2004 of the European Parliament and

of the Council concerning persistent organic pollutants (OJ L 258, 4.10.2007, p. 39).

12zb.{419} 32007 D 0565: Commission Decision 2007/565/EC of 14 August 2007 concerning the non-inclusion in Annex

I, IA or IB to Directive 98/8/EC of the European Parliament and of the Council concerning the placing of

biocidal products on the market of certain substances to be examined under the 10-year work programme

referred to in Article 16(2) thereof (OJ L 216, 21.8.2007, p. 17).

12zc.{420} 32006 R 1907: Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18

December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals

(REACH), establishing a European Chemicals Agency, amending Directive 1999/45/EC and repealing Council

Regulation (EEC) No 793/93 and Commission Regulation (EC) No 1488/94 as well as Council Directive

76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC (OJ L 396,

30.12.2006, p. 1), as corrected by OJ L 136, 29.5.2007, p. 3, as corrected by OJ L 141, 31.5.2008, p. 22, as

amended by:

-{421} 32007 R 1354: Council Regulation (EC) No 1354/2007 of 15 November 2007 (OJ L 304,

22.11.2007, p. 1),

-{422} 32009 R 0134: Commission Regulation (EC) No 134/2009 of 16 February 2009 (OJ L 46,

17.2.2009, p. 3),

{413} Point inserted by Decision No 141/2007 (OJ L 100, 10.4.2008, p. 68 and EEA Supplement No 19, 10.4.2008, p. 69), e.i.f. 1.11.2010.

{414} Indent and words “, as amended by:” added by Decision No 7/2010 (OJ L 101, 22.4.2010, p. 14 and EEA Supplement No 19, 22.4.2010,

p. 14), e.i.f. 1.11.2010.

{415} Indent added by Decision No 216/2015 (OJ L 85, 30.3.2017, p. 36 and EEA Supplement No 19, 30.3.2017, p. 35), e.i.f. 1.11.2015.

{416} Point inserted by Decision No 156/2007 (OJ L 124, 8.5.2008, p. 18 and EEA Supplement No 26, 8.5.2008, p. 15), e.i.f. 8.12.2007.

{417} Point inserted by Decision No 8/2008 (OJ L 154, 12.6.2008, p. 15 and EEA Supplement No 33, 12.6.2008, p. 13), e.i.f. 2.2.2008.

{418} Point inserted by Decision No 8/2008 (OJ L 154, 12.6.2008, p. 15 and EEA Supplement No 33, 12.6.2008, p. 13), e.i.f. 2.2.2008.

{419} Point inserted by Decision No 24/2008 (OJ L 182, 10.7.2008, p. 7 and EEA Supplement No 42, 10.7.2008, p. 4), e.i.f. 15.3.2008.

{420} Point inserted by Decision No 25/2008 (OJ L 182, 10.7.2008, p. 11 and EEA Supplement No 42, 10.7.2008, p. 6), e.i.f. 5.6.2008, text of the

Act subsequently corrected by Corrigendum noted in the EEA Joint Committee Meeting on 26.9.2008.

{421} Indent and words “, as amended by:” added by Decision No 100/2008 (OJ L 309, 20.11.2008, p. 22 and EEA Supplement No 70,

20.11.2008, p. 10), e.i.f. 27.9.2008.

{422} Indent added by Decision No 8/2010 (OJ L 19, 22.4.2010, p. 16 and EEA Supplement No19, 22.4.2010, p. 16).e.i.f. 30.1.2010.

Page 41: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 167

-{423} 32008 R 0987: Commission Regulation (EC) No 987/2008 of 8 October 2008 (OJ L 268, 9.10.2008,

p. 14),

-{424} 32009 R 0552: Commission Regulation (EC) No 552/2009 of 22 June 2009 (OJ L 164, 26.6.2009,

p. 7),

-{425} 32010 R 0276: Commission Regulation (EU) No 276/2010 of 31 March 2010 (OJ L 86, 1.4.2010,

p. 7),

-{426} 32011 R 0143: Commission Regulation (EU) No 143/2011 of 17 February 2011 (OJ L 44,

18.2.2011, p. 2), as corrected by OJ L 49, 24.2.2011, p. 52,

-{427} 32011 R 0207: Commission Regulation (EU) No 207/2011 of 2 March 2011 (OJ L 58, 3.3.2011,

p. 27),

-{428} 32011 R 0253: Commission Regulation (EU) No 253/2011 of 15 March 2011 (OJ L 69, 16.3.2011,

p. 7),

-{429} 32008 R 1272: Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16

December 2008 (OJ L 353, 31.12.2008, p. 1),

-{430} 32010 R 0453: Commission Regulation (EU) No 453/2010 of 20 May 2010 (OJ L 133, 31.5.2010, p.

1),

-{431} 32011 R 0252: Commission Regulation (EU) No 252/2011 of 15 March 2011 (OJ L 69, 16.3.2011,

p. 3),

-{432} 32011 R 0366: Commission Regulation (EU) No 366/2011 of 14 April 2011 (OJ L 101, 15.4.2011,

p. 12),

-{433} 32012 R 0109: Commission Regulation (EU) No 109/2012 of 9 February 2012 (OJ L 37, 10.2.2012,

p. 1),

-{434} 32012 R 0125: Commission Regulation (EU) No 125/2012 of 14 February 2012 (OJ L 41,

15.2.2012, p. 1),

-{435} 32012 R 0412: Commission Regulation (EU) No 412/2012 of 15 May 2012 (OJ L 128, 16.5.2012, p.

1),

-{436} 32011 R 0494: Commission Regulation (EU) No 494/2011 of 20 May 2011 (OJ L 134, 21.5.2011, p.

2), as corrected by OJ L 136, 24.5.2011, p. 105,

-{437} 32012 R 0835: Commission Regulation (EU) No 835/2012 of 18 September 2012 (OJ L 252,

19.9.2012, p. 1),

-{438} 32012 R 0836: Commission Regulation (EU) No 836/2012 of 18 September 2012 (OJ L 252,

19.9.2012, p. 4),

-{439} 32013 R 0126: Commission Regulation (EU) No 126/2013 of 13 February 2013 (OJ L 43,

14.2.2013, p. 24),

{423} Indent added by Decision No 26/2010 (OJ L 143, 10.6.2010, p. 19 and EEA Supplement No 30, 10.6.2010, p. 24).e.i.f. 13.3.2010.

{424} Indent added by Decision No 74/2011 (OJ L 262, 6.10.2011, p. 31 and EEA Supplement No 54, 6.10.2011, p. 42), e.i.f. 2.7.2011.

{425} Indent added by Decision No 74/2011 (OJ L 262, 6.10.2011, p. 31 and EEA Supplement No 54, 6.10.2011, p. 42).e.i.f. 2.7.2011.

{426} Indent added by Decision No 116/2011 (OJ L 341, 22.12.2011, p. 80 and EEA Supplement No 70, 22.12.2011, p. 15).e.i.f. 1.11.2011.

{427} Indent added by Decision No 116/2011 (OJ L 341, 22.12.2011, p. 80 and EEA Supplement No 70, 22.12.2011, p. 15).e.i.f. 1.11.2011.

{428} Indent added by Decision No 130/2011 (OJ L 76, 15.3.2012, p. 14 and EEA Supplement No 15, 15.3.2012, p. 16 ).e.i.f. 3.12.2011.

{429} Indent added by Decision No 106/2012 (OJ L 270, 4.10.2012, p. 6 and EEA Supplement No 56, 4.10.2012, p. 8).e.i.f. 1.2.2013.

{430} Indent added by Decision No 106/2012 (OJ L 270, 4.10.2012, p. 6 and EEA Supplement No 56, 4.10.2012, p. 8).e.i.f. 1.2.2013.

{431} Indent added by Decision No 107/2012 (OJ L 270, 4.10.2012, p. 29 and EEA Supplement No 56, 4.10.2012, p. 28).e.i.f. 1.2.2013.

{432} Indent added by Decision No 125/2012 (OJ L 309, 8.11.2012, p. 3 and EEA Supplement No 63, 8.11.2012, p. 4).e.i.f. 14.7.2012.

{433} Indent added by Decision No 163/2012 (OJ L 341, 13.12.2012, p. 14 and EEA Supplement No 70, 13.12.2012, p. 17).e.i.f. 1.11.2012.

{434} Indent added by Decision No 163/2012 (OJ L 341, 13.12.2012, p. 14 and EEA Supplement No 70, 13.12.2012, p. 17).e.i.f. 1.11.2012.

{435} Indent added by Decision No 195/2012 (OJ L 21, 24.1.2013, p. 43 and EEA Supplement No 6, 24.1.2013, p. 9).e.i.f. 1.11.2012.

{436} Indent added by Decision No 70/2013 (OJ L 291, 31.10.2013, p. 27 and EEA Supplement No 61, 31.10.2013, p. 31), e.i.f. 4.5.2013.

{437} Indent added by Decision No 71/2013 (OJ L 291, 31.10.2013, p. 28 and EEA Supplement No 61, 31.10.2013, p. 32), e.i.f. 4.5.2013.

{438} Indent added by Decision No 72/2013 (OJ L 291, 31.10.2013, p. 29 and EEA Supplement No 61, 31.10.2013, p. 33), e.i.f. 4.5.2013.

{439} Indent added by Decision No 166/2013 (OJ L 58, 27.2.2014, p. 20 and EEA Supplement No 13, 27.2.2014, p. 22), e.i.f. 9.10.2013.

Page 42: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 168

-{440} 32013 R 0348: Commission Regulation (EU) No 348/2013 of 17 April 2013 (OJ L 108, 18.4.2013,

p. 1),

-{441} 32012 R 0847: Commission Regulation (EU) No 847/2012 of 19 September 2012 (OJ L 253,

20.9.2012, p. 1),

-{442} 32013 R 1272: Commission Regulation (EU) No 1272/2013 of 6 December 2013 (OJ L 328,

7.12.2013, p. 69),

-{443} 32012 R 0848: Commission Regulation (EU) No 848/2012 of 19 September 2012 (OJ L 253,

20.9.2012, p. 5),

-{444} 32013 R 0517: Council Regulation (EU) No 517/2013 of 13 May 2013 (OJ L 158, 10.6.2013,

p. 1),

-{445} 32014 R 0301: Commission Regulation (EU) No 301/2014 of 25 March 2014 (OJ L 90, 26.3.2014,

p. 1),

-{446} 32014 R 0474: Commission Regulation (EU) No 474/2014 of 8 May 2014 (OJ L 136, 9.5.2014,

p. 19),

-{447} 32014 R 0895: Commission Regulation (EU) No 895/2014 of 14 August 2014 (OJ L 244, 19.8.2014,

p. 6),

-{448} 32015 R 0282: Commission Regulation (EU) 2015/282 of 20 February 2015 (OJ L 50, 21.2.2015,

p. 1),

-{449} 32014 R 0317: Commission Regulation (EU) No 317/2014 of 27 March 2014 (OJ L 93, 28.3.2014,

p. 24),

-{450} 32015 R 0628: Commission Regulation (EU) 2015/628 of 22 April 2015 (OJ L 104, 23.4.2015,

p. 2),

-{451} 32015 R 0326: Commission Regulation (EU) 2015/326 of 2 March 2015 (OJ L 58, 3.3.2015, p. 43),

-{452} 32015 R 1494: Commission Regulation (EU) 2015/1494 of 4 September 2015 (OJ L 233, 5.9.2015,

p. 2),

-{453} 32015 R 0830: Commission Regulation (EU) 2015/830 of 28 May 2015 (OJ L 132, 29.5.2015, p. 8),

-{454} 32016 R 0026: Commission Regulation (EU) 2016/26 of 13 January 2016 (OJ L 9, 14.1.2016, p. 1),

-{455} 32016 R 0217: Commission Regulation (EU) 2016/217 of 16 February 2016 (OJ L 40, 17.2.2016,

p . 5),

{440} Indent added by Decision No 192/2013 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 9.11.2013.

{441} Indent added by Decision No 193/2013 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 9.11.2013.

{442} Indent added by Decision No 83/2014 (OJ L 310, 30.10.2014, p. 36 and EEA Supplement No 63, 30.10.2014, p. 27), e.i.f. 17.5.2014.

{443} Indent added by Decision No 123/2014 (OJ L 342, 27.11.2014, p. 21 and EEA Supplement No 71, 27.11.2014, p. 21), e.i.f. 28.6.2014.

{444} Indent added by Decision No 159/2014 (OJ L 15, 22.1.2015, p. 87 and EEA Supplement No 5, 22.1.2015, p. 10), e.i.f. pending; it shall apply

from 9.7.2014.

{445} Indent added by Decision No 182/2014 (OJ L 202, 30.7.2015, p. 33 and EEA Supplement No 43, 30.7.2015, p. 33), e.i.f. 26.9.2014.

{446} Indent added by Decision No 219/2014 (OJ L 230, 3.9.2015, p. 18 and EEA Supplement No 52, 3.9.2015, p. 18), e.i.f. 1.11.2014.

{447} Indent added by Decision No 268/2014 (OJ L 311, 26.11.2015, p. 19 and EEA Supplement No 71, 26.11.2015, p. 18), e.i.f. 13.12.2014.

{448} Indent added by Decision No 151/2015 (OJ L 341, 15.12.2016, p. 44 and EEA Supplement No 69, 15.12.2016, p. 45), e.i.f. 12.6.2015.

{449} Indent added by Decision No 180/2015 (OJ L 8, 12.1.2017, p. 9 and EEA Supplement No 3, 12.1.2017, p. 8), e.i.f. 11.7.2015.

{450} Indent added by Decision No 181/2015 (OJ L 8, 12.1.2017, p. 10 and EEA Supplement No 3, 12.1.2017, p. 9), e.i.f. 11.7.2015.

{451} Indent added by Decision No 182/2015 (OJ L 8, 12.1.2017, p. 11 and EEA Supplement No 3, 12.1.2017, p. 10), e.i.f. 11.7.2015.

{452} Indent added by Decision No 257/2015 (OJ L 161, 22.6.2017, p. 39 and EEA Supplement No 38, 22.6.2017, p. 39), e.i.f. 1.11.2015.

{453} Indent added by Decision No 258/2015 (OJ L 161, 22.6.2017, p. 40 and EEA Supplement No 38, 22.6.2017, p. 40), e.i.f. 1.11.2015.

{454} Indent added by Decision No 82/2016 (OJ L 300, 16.11.2017, p. 26 and EEA Supplement No 73, 16.11.2017, p. 30), e.i.f. 30.4.2016.

{455} Indent added by Decision No 83/2016 (OJ L 300, 16.11.2017, p. 27 and EEA Supplement No 73, 16.11.2017, p. 31), e.i.f. 30.4.2016.

Page 43: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 169

-{456} 32016 R 0863: Commission Regulation (EU) 2016/863 of 31 May 2016 (OJ L 144, 1.6.2016, p. 27),

-{457} 32016 R 1005: Commission Regulation (EU) 2016/1005 of 22 June 2016 (OJ L 165, 23.6.2016, p.

4),

-{458} 32016 R 1017: Commission Regulation (EU) 2016/1017 of 23 June 2016 (OJ L 166, 24.6.2016,

p. 1),

- [ ] {459}

-{460} 32016 R 2235: Commission Regulation (EU) 2016/2235 of 12 December 2016 (OJ L 337,

13.12.2016, p. 3),

-{461} 32017 R 0227: Commission Regulation (EU) 2017/227 of 9 February 2017 (OJ L 35, 10.2.2017,

p. 6), as corrected by OJ L 249, 4.10.2018, p. 18.

-{462} 32017 R 0706: Commission Regulation (EU) 2017/706 of 19 April 2017 (OJ L 104, 20.4.2017, p 8),

-{463} 32017 R 0999: Commission Regulation (EU) 2017/999 of 13 June 2017 (OJ L 150, 14.6.2017, p. 7),

-{464} 32017 R 1000: Commission Regulation (EU) 2017/1000 of 13 June 2017 (OJ L 150, 14.6.2017, p.

14),

-{465} 32017 R 1510: Commission Regulation (EU) 2017/1510 of 30 August 2017 (OJ L 224, 31.8.2017,

p. 110),

-{466} 32018 R 0035: Commission Regulation (EU) 2018/35 of 10 January 2018 (OJ L 6, 11.1.2018, p.

45),

-{467} 32018 R 0588: Commission Regulation (EU) 2018/588 of 18 April 2018 (OJ L 99, 19.4.2018, p. 3),

-{468} 32018 R 0589: Commission Regulation (EU) 2018/589 of 18 April 2018 (OJ L 99, 19.4.2018, p. 7),

as corrected by OJ L 102, 23.4.2018, p. 99,

-{469} 32018 R 0675: Commission Regulation (EU) 2018/675 of 2 May 2018 (OJ L 114, 4.5.2018, p. 4),

-{470} 32018 R 1513: Commission Regulation (EU) 2018/1513 of 10 October 2018 (OJ L 256, 12.10.2018,

p. 1),

-{471} 32018 R 1881: Commission Regulation (EU) 2018/1881 of 3 December 2018 (OJ L 308, 4.12.2018,

p. 1),

{456} Indent added by Decision No 176/2016 (OJ L 80, 22.3.2018, p. 18 and EEA Supplement No 19, 22.3.2018, p. 24), e.i.f. 24.9.2016.

{457} Indent added by Decision No 177/2016 (OJ L 80, 22.3.2018, p. 19 and EEA Supplement No 19, 22.3.2018, p. 25), e.i.f. 24.9.2016.

{458} Indent added by Decision No 177/2016 (OJ L 80, 22.3.2018, p. 19 and EEA Supplement No 19, 22.3.2018, p. 25), e.i.f. 24.9.2016.

{459} Indent added by Decision No 235/2016 (OJ L 215, 23.8.2018, p. 32 and EEA Supplement No 56, 23.8.2018, p. 38), e.i.f. 3.12.2016 and

subsequently deleted by Decision No 130/2017 (OJ L 128, 16.5.2019, p. 22 and EEA Supplement No 40, 16.5.2019, p. 23), e.i.f. 8.7.2017.

{460} Indent added by Decision No 27/2017 (OJ L 297, 22.11.2018, p. 33 and EEA Supplement No 78, 22.11.2018, p. 39), e.i.f. 4.2.2017.

{461} Indent added by Decision No 89/2017 (OJ L 36, 7.2.2019, p. 36 and EEA Supplement No 11, 7.2.2019, p. 43), e.i.f. 6.5.2017. Corrigedum to

the EU act subsequently taken note of by the EEA Joint Committee on 5.12.2018.

{462} Indent added by Decision No 130/2017 (OJ L 128, 16.5.2019, p. 22 and EEA Supplement No 40, 16.5.2019, p. 23), e.i.f. 8.7.2017.

{463} Indent added by Decision No 170/2017 (OJ L 174, 27.6.2019, p. 32 and EEA Supplement No 52, 27.6.2019, p. 40), e.i.f. 23.9.2017.

{464} Indent added by Decision No 170/2017 (OJ L 174, 27.6.2019, p. 32 and EEA Supplement No 52, 27.6.2019, p. 40), e.i.f. 23.9.2017.

{465} Indent added by Decision No 225/2017 (OJ L 254, 3.10.2019, p. 31 and EEA Supplement No 80, 3.10.2019, p. 34), e.i.f. 16.12.2017.

{466} Indent added by Decision No 52/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 24.3.2018.

{467} Indent added by Decision No 142/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 7.7.2018

{468} Indent added by Decision No 142/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 7.7.2018.

{469} Indent added by Decision No 143/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 7.7.2018.

{470} Indent added by Decision No 11/2019 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 9.2.2019.

{471} Indent added by Decision No 65/2019 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 30.3.2019.

Page 44: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 170

-{472} 32018 R 2005: Commission Regulation (EU) 2018/2005 of 17 December 2018 (OJ L 322,

18.12.2018, p. 14),

-{473} 32019 R 0957: Commission Regulation (EU) 2019/957 of 11 June 2019 (OJ L 154, 12.6.2019, p.

37).

{474}The transitional arrangements set out in the Annexes to the Act of Accession of 9 December 2011 for

Croatia (Annex V, Chapter 10, Section VI) shall apply.

The Provisions of the Regulation shall, for the purpose of this Agreement, be read with the following

adaptations:

(a) The EFTA States shall participate in the work of the European Chemicals Agency, hereinafter

referred to as ‘the Agency’, as set up by European Parliament and Council Regulation (EC) No

1907/2006.

(b) Notwithstanding the provisions of Protocol 1 to the Agreement, the term ‘Member State(s)’

contained in the Regulation shall be understood to include, in addition to its meaning in the

Regulation, the EFTA States.

(c) As regards the EFTA States, the Agency shall, as and when appropriate, assist the EFTA

Surveillance Authority or the Standing Committee, as the case may be, in the performance of their

respective tasks.

(d) For products covered by Council Directive 91/414/EEC, the EFTA States will be free to limit access

to their markets according to the requirements of their legislation existing at the date of entry into

force of this Agreement. New EC rules will be dealt with according to the procedures laid down in

Articles 97 to 104 of the Agreement.

(e) Should any disagreement between the contracting parties arise as to the administration of these

provisions, Part VII of the Agreement shall apply mutatis mutandis.

(f) In Article 3, paragraph 10, the following shall be added at the end: “or into the territory of the EFTA

States”.

(g) Article 64 (8) shall be read with the following adaptation:

“When the Commission takes authorisation decisions, the EFTA States will simultaneously and

within 30 days of the Community Decision, take corresponding decisions. The EEA Joint Committee

shall be informed and shall periodically publish lists of such decisions in the EEA Supplement to the

Official Journal.”

(h) The following paragraph shall be added in Article 79:

“4. The EFTA States shall participate fully in the Management Board and shall within it have the

same rights and obligations as EC Member States, except for the right to vote. The internal

rules of procedure of the Board shall give full effect to the EFTA States’ participation.”

(i) The following paragraph shall be added in Article 85:

“10. The EFTA States shall participate fully in the Member State Committee, in the Committee for

Risk Assessment and the Committee for Socio-economic Analysis, and shall have the same

rights and obligations as EC Member States, except for the right to vote. The internal rules of

procedure of these committees shall give full effect to the EFTA States’ participation.”

{472} Indent added by Decision No 66/2019 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 30.3.2019.

{473} Indent added by Decision No 296/2019 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 14.12.2019.

{474} Sentence added by the 2014 EEA Enlargement Agreement (OJ L 170, 11.6.2014, p. 5 and EEA Supplement No 58, 9.10.2014, p. 1),

provisionally applicable as of 12.4.2014, e.i.f. pending.

Page 45: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 171

(j) The following paragraph shall be added in Article 86:

“5. EFTA States shall participate in the Forum for Exchange of Information on Enforcement. The

internal rules of procedure of this Forum shall give full effect to the EFTA States’

participation.’

(k) The following paragraph shall be added in Article 89:

“Nationals of the EFTA States shall be eligible as members, or as alternates, of the Board of

Appeal.”

(l) The following paragraph shall be added in Article 96:

“12. The EFTA States shall, as from the entry into force of this Decision, participate in the

financing of the Agency. For this purpose the procedures laid down in Article 82(1)(a) and

Protocol 32 of the Agreement shall apply mutatis mutandis.”

(m) The following shall be added in Article 102:

“The EFTA States shall grant privileges and immunities to the Agency equivalent to those contained

in the Protocol on privileges and immunities of the European Communities.”

(n) The following paragraph shall be added to Article 103:

“By way of derogation from Article 12(2)(a) of the Conditions of employment of other servants of

the European Communities, nationals of the EFTA States enjoying their full rights as citizens may be

engaged under contract by the Executive Director of the Agency.”

(o) The following paragraph shall be added in Article 118:

“5. Regulation (EC) No 1049/2001 of the European Parliament and the Council of 30 May 2001

regarding public access to European Parliament, Council and Commission documents shall,

for the application of Regulation (EC) No 1907/2006, apply to any documents of the Agency

regarding the EFTA States as well.”

(p) The following paragraph shall be added in Article 124:

“Liechtenstein shall not be obliged to establish a national helpdesk. Instead, Liechtenstein will

publish a link to the helpdesk of the German Federal Institute for Occupational Safety and Health on

the homepage of the competent Liechtenstein authority for chemicals, the Office for Environmental

Protection.”

12zca.{475}32007 R 1238: Commission Regulation (EC) No 1238/2007 of 23 October 2007 on laying down rules on the

qualifications of the members of the Board of Appeal of the European Chemicals Agency (OJ L 280,

24.10.2007, p. 10).

12zd.{476} 32007 D 0794: Commission Decision 2007/794/EC of 29 November 2007 setting a new deadline for the

submission of dossiers for certain substances to be examined under the 10-year work programme referred to in

Article 16(2) of Directive 98/8/EC (OJ L 320, 6.12.2007, p. 35).

12ze. [ ] {477}

{475} Point inserted by Decision No 100/2008 (OJ L 309, 20.11.2008, p. 22 and EEA Supplement No 70, 20.11.2008, p. 10), e.i.f. 27.9.2008.

{476} Point inserted by Decision No 48/2008 (OJ L 223, 21.8.2008, p. 43 and EEA Supplement No 52, 21.8.2008, p.16), e.i.f. 26.4.2008.

{477} Point inserted by Decision No 132/2009 (OJ L 62, 11.3.2010, p. 22 and EEA Supplement No 12, 11.3.2010, p. 21), e.i.f. 5.12.2009. Text of

point 12ze (Commission Regulation (EC) No 1451/2007) deleted by Decision No 52/2015 (OJ L 129, 19.5.2016, p. 33 and EEA Supplement

No 29, 19.5.2016, p. 34), e.i.f. 21.3.2015.

Page 46: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 172

12zf.{478} 32008 R 0340: Commission Regulation (EC) No 340/2008 of 16 April 2008 on the fees and charges payable to

the European Chemicals Agency pursuant to Regulation (EC) No 1907/2006 of the European Parliament and

of the Council on the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) (OJ

L 107, 17.4.2008, p. 6), as amended by:

-{479} 32013 R 0254: Commission Implementing Regulation (EU) No 254/2013 of 20 March 2013 (OJ

L 79, 21.3.2013, p. 7),

-{480} 32015 R 0864: Commission Implementing Regulation (EU) 2015/864 of 4 June 2015 (OJ L 139,

5.6.2015, p. 1),

-{481} 32018 R 0895: Commission Implementing Regulation (EU) 2018/895 of 22 June 2018 (OJ L 160,

25.6.2018, p. 1).

12zg.{482} 32008 D 0423: Commission Decision 2008/423/EC of 8 May 2008 setting a new deadline for the submission

of dossiers for certain substances to be examined under the 10-year work programme referred to in Article

16(2) of Directive 98/8/EC of the European Parliament and of the Council (OJ L 149, 7.6.2008, p. 79).

12zh.{483} 32008 D 0763: Commission Decision 2008/763/EC of 29 September 2008 establishing, pursuant to Directive

2006/66/EC of the European Parliament and of the Council, a common methodology for the calculation of

annual sales of portable batteries and accumulators to end-users (OJ L 262, 1.10.2008, p. 39).

12zi.{484} 32008 D 0809: Commission Decision 2008/809/EC of 14 October 2008 concerning the non-inclusion of

certain substances in Annex I, IA or IB to Directive 98/8/EC of the European Parliament and of the Council

concerning the placing of biocidal products on the market (OJ L 281, 24.10.2008, p. 16).

12zj. 32008 D 0831: Commission Decision 2008/831/EC of 31 October 2008 setting a new deadline for the

submission of dossiers for certain substances to be examined under the 10-year work programme referred to in

Article 16(2) of Directive 98/8/EC (OJ L 295, 4.11.2008, p. 50).

12zk.{485}32008 D 0681: Commission Decision 2008/681/EC of 28 July 2008 concerning the non-inclusion of certain

substances in Annexes I, IA or IB to Directive 98/8/EC of the European Parliament and of the Council

concerning the placing of biocidal products on the market (OJ L 222, 20.8.2008, p. 7).

12zl.{486} 32007 R 0506: Commission Regulation (EC) No 506/2007 of 8 May 2007 imposing testing and information

requirements on the importers or manufacturers of certain priority substances in accordance with Council

Regulation (EEC) No 793/93 on the evaluation and control of the risks of existing substances (OJ L 119,

9.5.2007, p. 24).

12zm. 32008 R 0465: Commission Regulation (EC) No 465/2008 of 28 May 2008 imposing, pursuant to Council

Regulation (EEC) No 793/93, testing and information requirements on importers and manufacturers of certain

substances that may be persistent, bioaccumulating and toxic and are listed in the European Inventory of

Existing Commercial Chemical Substances (OJ L 139, 29.5.2008, p. 8).

12zn. 32008 R 0466: Commission Regulation (EC) No 466/2008 of 28 May 2008 imposing testing and information

requirements on the importers and manufacturers of certain priority substances in accordance with Council

Regulation (EEC) No 793/93 on the evaluation and control of the risks of existing substances (OJ L 139,

29.5.2008, p. 10

{478} Point inserted by Decision No 133/2009 (OJ L 62, 11.3.2010, p. 24 and EEA Supplement No 12, 11.3.2010, p. 23), e.i.f. 5.12.2009.

{479} Indent and words “, as amended by:” added by Decision No 123/2014 (OJ L 342, 27.11.2014, p. 21 and EEA Supplement No 71,

27.11.2014, p. 21), e.i.f. 28.6.2014.

{480} Indent added by Decision No 259/2015 (OJ L 161, 22.6.2017, p. 41 and EEA Supplement No 38, 22.6.2017, p. 41), e.i.f. 1.11.2015.

{481} Indent added by Decision No 240/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 6.12.2018.

{482} Point inserted by Decision No 134/2009 (OJ L 62, 11.3.2010, p.25 and EEA Supplement No 12, 11.3.2010, p. 24), e.i.f. 5.12.2009.

{483} Point inserted by Decision No 135/2009 (OJ L 62, 11.3.2010, p. 26 and EEA Supplement No 12, 11.3.2010, p. 25), e.i.f. 5.12.2009.

{484} Two points inserted by Decision No 136/2009 (OJ L 62, 11.3.2010, p. 28 and EEA Supplement No 12, 11.3.2010, p. 27), e.i.f. 5.12.2009.

{485} Point inserted by Decision No 137/2009 (OJ L 62, 11.3.2010, p. 30 and EEA Supplement No 12, 11.3.2010, p. 29), e.i.f. 5.12.2009.

{486} 3 points inserted by Decision No 7/2010 (OJ L 101, 22.4.2010, p. 14 and EEA Supplement No 19, 22.4.2010, p. 14), e.i.f. 1.11.2010.

Page 47: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 173

12zo.{487}32009 D 0063: Commission Decision 2009/63/EC of 20 November 2008 defining a format for the submission

of the information by Member States in accordance with Article 7(4)(b)(iii) of the Regulation (EC) No

850/2004 of the European Parliament and of the Council (OJ L 23, 27.1.2009, p. 30).

12zp. 32009 D 0321: Commission Decision 2009/321/EC of 8 April 2009 setting a new deadline for the submission

of dossiers for certain substances to be examined under the 10-year work programme referred to in Article

16(2) of Directive 98/8/EC of the European Parliament and of the Council (OJ L 95, 9.4.2009, p. 42).

12zq. 32009 D 0322: Commission Decision 2009/322/EC of 8 April 2009 concerning the non-inclusion of certain

substances in Annexes I, IA or IB to Directive 98/8/EC of the European Parliament and of the Council

concerning the placing of biocidal products on the market (OJ L 95, 9.4.2009, p. 44).

12zr. 32009 D 0324: Commission Decision 2009/324/EC of 14 April 2009 concerning the non-inclusion of certain

substances in Annex I, IA or IB to Directive 98/8/EC of the European Parliament and of the Council

concerning the placing of biocidal products on the market (OJ L 96, 15.4.2009, p. 37).

12zs.{488} 32008 R 0771: Commission Regulation (EC) No 771/2008 of 1 August 2008 laying down the rules of

organisation and procedure of the Board of Appeal of the European Chemicals Agency (OJ L 206, 2.8.2008,

p. 5), as amended by:

-{489} 32016 R 0823: Commission Implementing Regulation (EU) 2016/823 of 25 May 2016 (OJ L 137,

26.5.2016, p. 4).

12zt. [ ] {490}

12zu.{491} 32010 D 0071: Commission Decision 2010/71/EU of 8 February 2010 concerning the non-inclusion of

diazinon in Annex I, IA or IB to Directive 98/8/EC of the European Parliament and of the Council concerning

the placing of biocidal products on the market (OJ L 36, 9.2.2010, p. 34).

12zv.{492} 32010 D 0072: Commission Decision 2010/72/EU of 8 February 2010 concerning the non-inclusion of certain

substances in Annex I, IA or IB to Directive 98/8/EC of the European Parliament and of the Council

concerning the placing of biocidal products on the market (OJ L 36, 9.2.2010, p. 36).

12zw.{493}32010 D 0084: Commission Decision 2010/84/EU of 9 February 2010 setting a new deadline for the

submission of dossiers for certain substances to be examined under the 10-year work programme referred to in

Article 16(2) of Directive 98/8/EC of the European Parliament and of the Council (OJ L 38, 11.2.2010, p. 15).

12zx.{494} 32010 D 0226: Commission Decision 2010/226/EU of 20 April 2010 on the re-examination of the restriction

concerning short-chain chlorinated paraffins (SCCPs) listed in Annex XVII to Regulation (EC) No 1907/2006

of the European Parliament and of the Council. (OJ L 100, 22.4.2010, p. 15).

12zy.{495} 32010 D 0675: Commission Decision 2010/675/EU of 8 November 2010 concerning the non-inclusion of

certain substances in Annex I, IA or IB to Directive 98/8/EC of the European Parliament and of the Council

concerning the placing of biocidal products on the market (OJ L 291, 9.11.2010, p. 47).

12zz.{496} 32010 D 0296: Commission Decision 2010/296/EU of 21 May 2010 on the establishment of a Register for

Biocidal Products (OJ L 126, 22.5.2010, p. 26).

{487} 4 points inserted by Decision No 8/2010 (OJ L 101, 22.4.2010, p. 16 and EEA Supplement No 19, 22.4.2010, p. 16), e.i.f. 30.1.2010.

{488} Point inserted by Decision No 26/2010 (OJ L 143, 10.6.2010, p. 19 and EEA Supplement No 30, 10.6.2010, p. 24), e.i.f. 13.3.2010.

{489} Indent and words “, as amended by” above added by Decision No 178/2016 (OJ L 80, 22.3.2018, p. 20 and EEA Supplement No 19,

22.3.2018, p. 27), e.i.f. 24.9.2016.

{490} Point inserted by Decision No 46/2010 (OJ L 181, 15.7.2010, p. 14 and EEA Supplement No 37, 15.7.2010, p. 18), e.i.f. 1.11.2011. Text of

point 12zt (Commission Decision 2009/603/EC) shall be deleted by Decision No 216/2015 (OJ L 85, 30.3.2017, p. 36 and EEA Supplement

No 19, 30.3.2017, p. 35), e.i.f. 1.11.2015.

{491} Point inserted by Decision No 128/2010 (OJ L 85, 31.3.2011, p. 11 and EEA Supplement No 17, 31.3.2011, p. 1), e.i.f. 11.12.2010.

{492} Point inserted by Decision No 128/2010 (OJ L 85, 31.3.2011, p. 11 and EEA Supplement No 17, 31.3.2011, p. 1), e.i.f. 11.12.2010.

{493} Point inserted by Decision No 128/2010 (OJ L 85, 31.3.2011, p. 11 and EEA Supplement No 17, 31.3.2011, p. 1), e.i.f. 11.12.2010.

{494} Point inserted by Decision No 31/2011 (OJ L 171, 30.6.2011, p. 31 and EEA Supplement No 37, 30.6.2011, p. 37), e.i.f. 2.4.2011.

{495} Point inserted by Decision No 73/2011 (OJ L 262, 6.10.2011, p. 30 and EEA Supplement No 54, 6.10.2011, p. 40), e.i.f. 2.7.2011.

Page 48: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 174

12zza.{497} 32008 R 0440: Council Regulation (EC) No 440/2008 of 30 May 2008 laying down test methods pursuant to

Regulation (EC) No 1907/2006 of the European Parliament and of the Council on the Registration,

Evaluation, Authorisation and Restriction of Chemicals (REACH) (OJ L 142, 31.5.2008, p. 1), as corrected

by OJ L 143, 3.6.2008, p. 55, as amended by:

- 32009 R 0761: Commission Regulation (EC) No 761/2009 of 23 July 2009 (OJ L 220, 24.8.2009,

p. 1),

-{498} 32010 R 1152: Commission Regulation (EU) No 1152/2010 of 8 December 2010 (OJ L 234,

9.12.2010, p. 13),

-{499} 32012 R 0640: Commission Regulation (EU) No 640/2012 of 6 July 2012 (OJ L 193, 20.7.2012,

p. 1),

-{500} 32014 R 0260: Commission Regulation (EU) No 260/2014 of 24 January 2014 (OJ L 81, 19.3.2014,

p. 1),

-{501} 32014 R 0900: Commission Regulation (EU) No 900/2014 of 15 July 2014 (OJ L 247, 21.8.2014,

p. 1),

-{502} 32016 R 0266: Commission Regulation (EU) 2016/266 of 7 December 2015 (OJ L 54, 1.3.2016, p.

1),

-{503} 32017 R 0735: Commission Regulation (EU) 2017/735 of 14 February 2017 (OJ L 112, 28.4.2017,

p. 1).

12zzb.{504} 32009 D 0851: Commission Decision 2009/851/EC of 25 November 2009 establishing a questionnaire for

Member States reports on the implementation of Directive 2006/66/EC of the European Parliament and of

the Council on batteries and accumulators and waste batteries and accumulators (OJ L 312, 27.11.2009,

p. 56).

12zzc.{505} 32011 D 0391: Commission Decision 2011/391/EU of 1 July 2011 concerning the non-inclusion of certain

substances in Annex I, IA or IB to Directive 98/8/EC of the European Parliament and of the Council

concerning the placing of biocidal products on the market (OJ L 175, 2.7.2011, p. 28).

12zzd.{506} 32010 R 1103: Commission Regulation (EU) No 1103/2010 of 29 November 2010 establishing, pursuant to

Directive 2006/66/EC of the European Parliament and of the Council, rules as regards capacity labelling of

portable secondary (rechargeable) and automotive batteries and accumulators (OJ L 313, 30.11.2010, p. 3).

12zze.{507} 32008 R 1272: Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16

December 2008 on classification, labelling and packaging of substances and mixtures, amending and

repealing Directives 67/548/EEC and 1999/45/EC, and amending Regulation (EC) No 1907/2006 (OJ L 353,

31.12.2008, p. 1), as corrected by OJ L 349, 21.12.2016, p. 1, as amended by:

{496} Point inserted by Decision No 130/2011 (OJ L 76, 15.3.2012, p. 14 and EEA Supplement No 15, 15.3.2012, p. 16), e.i.f. 3.12.2011.

{497} Point and indent inserted by Decision No 12/2012 (OJ L 161, 21.6.2012, p.18 and EEA Supplement No 34, 21.6.2012, p. 22), e.i.f. 11.2.2012

and subsequently corrected [before publication] by Corrigendum of 5.5.2017.

{498} Indent added by Decision No 13/2012 (OJ L 161, 21.6.2012, p.19 and EEA Supplement No 34, 21.6.2012, p. 24), e.i.f. 11.2.2012.

{499} Indent added by Decision No 69/2013 (OJ L 291, 31.10.2013, p. 26 and EEA Supplement No 61, 31.10.2013, p. 30), e.i.f. 4.5.2013.

{500} Indent added by Decision No 183/2014 (OJ L 202, 30.7.2015, p. 34 and EEA Supplement No 43, 30.7.2015, p. 34), e.i.f. 26.9.2014.

{501} Indent added by Decision No 16/2015 (OJ L 93, 7.4.2016, p. 28 and EEA Supplement No 21, 7.4.2016, p. 24), e.i.f. 26.2.2015.

{502} Indent added by Decision No 148/2016 (OJ L 73, 15.3.2018, p. 21 and EEA Supplement No 16, 15.3.2018, p. 24), e.i.f. 9.7.2016.

{503} Indent added by Decision No 171/2017 (OJ L 174, 27.6.2019, p. 33 and EEA Supplement No 52, 27.6.2019, p. 42), e.i.f. 23.9.2017.

{504} Point inserted by Decision No 12/2012 (OJ L 161, 21.6.2012, p.18 and EEA Supplement No 34, 21.6.2012, p. 22), e.i.f. 11.2.2012.

{505} Point inserted by Decision No 14/2012 (OJ L 161, 21.6.2012, p. 20 and EEA Supplement No 34, 21.6.2012, p. 25), e.i.f. 11.2.2012.

{506} Point inserted by Decision No 88/2012 (OJ L 248, 13.9.2012, p. 25 and EEA Supplement No 50, 13.9.2012, p. 30), e.i.f. 1.5.2012.

{507} Point and adaptation text inserted by Decision No 106/2012 (OJ L 270, 4.10.2012, p. 6 and EEA Supplement No 56, 4.10.2012, p. 8), e.i.f.

1.2.2013. Corrigendum to the EU act subsequently taken note of by the EEA Joint Committee on 3.2.2017.

Page 49: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 175

-{508} 32009 R 0790: Commission Regulation (EC) No 790/2009 of 10 August 2009 (OJ L 235, 5.9.2009,

p. 1),

-{509} 32011 R 0286: Commission Regulation (EU) No 286/2011 of 10 March 2011 (OJ L 83, 30.3.2011,

p. 1), as corrected by OJ L 138, 26.5.2011, p. 66,

-{510} 32012 R 0618: Commission Regulation (EU) No 618/2012 of 10 July 2012 (OJ L 179, 11.7.2012,

p. 3),

-{511} 32013 R 0758: Commission Regulation (EU) No 758/2013 of 7 August 2013 (OJ L 216, 10.8.2013,

p. 1),

-{512} 32013 R 0944: Commission Regulation (EU) No 944/2013 of 2 October 2013 (OJ L 261, 3.10.2013,

p. 5),

-{513} 32013 R 0487: Commission Regulation (EU) No 487/2013 of 8 May 2013 (OJ L 149, 1.6.2013,

p. 1),

-{514} 32013 R 0517: Council Regulation (EU) No 517/2013 of 13 May 2013 (OJ L 158, 10.6.2013, p. 1),

-{515} 32013 R 0519: Commission Regulation (EU) No 519/2013 of 21 February 2013 (OJ L 158,

10.6.2013, p. 74),

-{516} 32014 R 0605: Commission Regulation (EU) No 605/2014 of 5 June 2014 (OJ L 167, 6.6.2014,

p. 36),

-{517} 32014 R 1297: Commission Regulation (EU) No 1297/2014 of 5 December 2014 (OJ L 350,

6.12.2014, p. 1),

-{518} 32015 R 0491: Commission Regulation (EU) 2015/491 of 23 March 2015 (OJ L 78, 24.3.2015,

p. 12),

-{519} 32015 R 1221: Commission Regulation (EU) 2015/1221 of 24 July 2015 (OJ L 197, 25.7.2015,

p. 10),

-{520} 32016 R 1179: Commission Regulation (EU) 2016/1179 of 19 July 2016 (OJ L 195, 20.7.2016, p.

11),

-{521} 32016 R 0918: Commission Regulation (EU) 2016/918 of 19 May 2016 (OJ L 156, 14.6.2016, p. 1),

-{522} 32017 R 0542: Commission Regulation (EU) 2017/542 of 22 March 2017 (OJ L 78, 23.3.2017, p.

1),

{508} Indent and words “, as amended by:” added by Decision No 107/2012 (OJ L 270, 4.10.2012, p. 29 and EEA Supplement No 56, 4.10.2012,

p. 28), e.i.f. 1.2.2013.

{509} Indent and words “, as amended by:” added by Decision No 107/2012 (OJ L 270, 4.10.2012, p. 29 and EEA Supplement No 56, 4.10.2012,

p. 28), e.i.f. 1.2.2013.

{510} Indent added by Decision No 9/2013 (OJ L 144, 30.5.2013, p. 13 and EEA Supplement No 31, 30.5.2013, p.15), e.i.f. 2.2.2013.

{511} Indent added by Decision No 45/2014 (OJ L 256, 28.8.2014, p. 22 and EEA Supplement No 49, 28.8.2014, p. 21), e.i.f. 9.4.2014.

{512} Indent added by Decision No 45/2014 (OJ L 256, 28.8.2014, p. 22 and EEA Supplement No 49, 28.8.2014, p. 21), e.i.f. 9.4.2014.

{513} Indent added by Decision No 124/2014 (OJ L 342, 27.11.2014, p. 23 and EEA Supplement No 71, 27.11.2014, p. 23), e.i.f. 28.6.2014.

{514} Indent added by Decision No 159/2014 (OJ L 15, 22.1.2015, p. 87 and EEA Supplement No 5, 22.1.2015, p. 10), e.i.f. pending; it shall apply

from 9.7.2014.

{515} Indent added by Decision No 159/2014 (OJ L 15, 22.1.2015, p. 87 and EEA Supplement No 5, 22.1.2015, p. 10), e.i.f. pending; it shall apply

from 9.7.2014.

{516} Indent added by Decision No 17/2015 (OJ L 93, 7.4.2016, p. 29 and EEA Supplement No 21, 7.4.2016, p. 25), e.i.f. 26.2.2015.

{517} Indent added by Decision No 53/2015 (OJ L 129, 19.5.2016, p. 35 and EEA Supplement No 29, 19.5.2016, p. 36), e.i.f. 21.3.2015.

{518} Indent added by Decision No 152/2015 (OJ L 341, 15.12.2016, p. 45 and EEA Supplement No 69, 15.12.2016, p. 46), e.i.f. 12.6.2015.

{519} Indent added by Decision No 303/2015 (OJ L 263, 12.10.2017, p. 14 and EEA Supplement No 64, 12.10.2017, p. 17), e.i.f. 12.12.2015.

{520} Indent added by Decision No 179/2016 (OJ L 80, 22.3.2018, p. 21 and EEA Supplement No 19, 22.3.2018, p. 28), e.i.f. 24.9.2016.

{521} Indent added by Decision No 209/2016 (OJ L 89, 5.4.2018, p. 12 and EEA Supplement No 22, 5.4.2018, p. 4), e.i.f. 29.10.2016.

{522} Indent added by Decision No 131/2017 (OJ L 128, 16.5.2019, p. 23 and EEA Supplement No 40, 16.5.2019, p. 24), e.i.f. 8.7.2017.

Page 50: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 176

-{523} 32017 R 0776: Commission Regulation (EU) 2017/776 of 4 May 2017 (OJ L 116, 5.5.2017, p. 1), as

amended by:

-{524} 32018 R 1480: Commission Regulation (EU) 2018/1480 of 4 October 2018 (OJ L 251,

5.10.2018, p. 1).

-{525} 32018 R 0669: Commission Regulation (EU) 2018/669 of 16 April 2018 (OJ L 115, 4.5.2018, p. 1),

-{526} 32018 R 1480: Commission Regulation (EU) 2018/1480 of 4 October 2018 (OJ L 251, 5.10.2018,

p.1),

-{527} 32019 R 0521: Commission Regulation (EU) 2019/521 of 27 March 2019 (OJ L 86, 28.3.2019,

p. 1).

The Provisions of Regulation (EC) No 1272/2008 shall, for the purpose of this Agreement, be read with the

following adaptations:

(a) Liechtenstein shall not be obliged to establish a national helpdesk in the meaning of Article 44 of

Regulation (EC) No 1272/2008. Instead, Liechtenstein will publish a link to the helpdesk of the

German Federal Institute for Occupational Safety and Health on the homepage of the competent

Liechtenstein authority for chemicals, the Office of Environmental Protection.

(b) The following provisions shall not apply to Norway:

(i) Article 51, in conjunction with Articles 4 and 46(1), with respect to the requirements for the

classification, labelling and/or specific concentration limits for the substances or groups of

substances listed in Part 3 of Annex VI to the Regulation (EC) No 1272/2008 and shown in

the following list. Norway may require the use of different classification, labelling and/or

specific concentration limits for this substance;

Name CAS No Index No EINECS

acrylamide 79-06-1 616-003-00-0 201-173-7

(ii) Article 51, in conjunction with Articles 4 and 46(1), with respect to the requirements for the

classification, labelling and/or specific concentration limits for the substances or group of

substances not listed in Part 3 of Annex VI to the Regulation (EC) No 1272/2008 shown in

the following list. Norway may require the use of different classification, labelling and/or

specific concentration limits for these substances;

Name CAS No Index No ELINCS

methyl acrylamidoglycolate

(containing 0,01% ≤ acrylamide < 0,1%)

77402-05-2 [NOR-UNN-02-

91]

403-230-3

methyl acrylamidomethoxyacetate

(containing 0,01% ≤ acrylamide < 0,1%)

77402-03-0 [NOR-UNN-03-

01]

401-890-7

(iii) Article 51, in conjunction with Articles 4, 9 and 46(1), with respect to mixtures containing

substances as defined in adaptation text (i) and (ii) above.

(iv) These derogations shall elapse as from 1 June 2012 if by that date Norway does not pursue,

in accordance with Article 37(1) of Regulation (EC) No 1272/2008, with the proposals for

harmonised classification and labelling that were submitted to the European Chemical

Agency on 1 June 2009 to support the more stringent classification and labelling.

If the procedure for harmonisation of classification and labelling foreseen in Article 37 of

Regulation (EC) No 1272/2008 is pursued, a review of the derogations shall take place before

31 December 2013. If the derogations are supported by the outcome of that procedure, the

{523} Indent added by Decision No 172/2017 (OJ L 174, 27.6.2019, p. 34 and EEA Supplement No 52, 27.6.2019, p. 43), e.i.f. 23.9.2017.

{524} Indent and words “as amended by,” added by Decision No 67/2019 (OJ L [to be published] and EEA Supplement No [to be published]),

e.i.f. 30.3.2019.

{525} Indent added by Decision No 180/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 22.9.2018.

{526} Indent added by Decision No 67/2019 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 30.3.2019.

{527} Indent added by Decision No 226/2019 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 28.9.2019.

Page 51: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 177

derogations may be maintained by a Decision of the EEA Joint Committee. In the absence of

such a Decision before 1 July 2014, the derogations shall elapse on that date.

(c) The Icelandic and Norwegian versions of the statements referred to in Articles 21 and 22 are set out

in Appendices 5 and 6, respectively.

12zzf. {528} 32010 R 0440: Commission Regulation (EU) No 440/2010 of 21 May 2010 on the fees payable to the

European Chemicals Agency pursuant to Regulation (EC) No 1272/2008 of the European Parliament and of

the Council on classification, labelling and packaging of substances and mixtures (OJ L 126, 22.5.2010,

p. 1).

12zzg.{529} 32012 D 0077: Commission Decision 2012/77/EU of 9 February 2012 concerning the non-inclusion of

flufenoxuron for product type 18 in Annex I, IA or IB to Directive 98/8/EC of the European Parliament and

of the Council concerning the placing of biocidal products on the market (OJ L 38, 11.2.2012, p. 47).

12zzh.{530} 32012 D 0078: Commission Decision 2012/78/EU of 9 February 2012 concerning the non-inclusion of

certain substances in Annex I, IA or IB to Directive 98/8/EC of the European Parliament and of the Council

concerning the placing of biocidal products on the market (OJ L 38, 11.2.2012, p. 48).

12zzi.{531} 32012 R 0493: Commission Regulation (EU) No 493/2012 of 11 June 2012 laying down, pursuant to

Directive 2006/66/EC of the European Parliament and of the Council, detailed rules regarding the calculation

of recycling efficiencies of the recycling processes of waste batteries and accumulators (OJ L 151, 12.6.2012,

p. 9).

12zzj.{532} 32012 D 0254: Commission Decision 2012/254/EU of 10 May 2012 concerning the non-inclusion of

dichlorvos for product type 18 in Annex I, IA or IB to Directive 98/8/EC of the European Parliament and of

the Council concerning the placing of biocidal products on the market (OJ L 125, 12.5.2012, p. 53).

12zzk.{533} 32012 D 0257: Commission Decision 2012/257/EU of 11 May 2012 concerning the non-inclusion of naled

for product type 18 in Annex I, IA or IB to Directive 98/8/EC of the European Parliament and of the Council

concerning the placing of biocidal products on the market (OJ L 126, 15.5.2012, p. 12).

12zzl.{534} 32012 D 0483: Commission Decision 2012/483/EU of 20 August 2012 setting a new deadline for the

submission of dossiers for certain substances to be examined under the 14-year work programme referred to

in Article 16(2) of Directive 98/8/EC of the European Parliament and of the Council (OJ L 226, 22.8.2012,

p. 6).

12zzm.{535}32012 D 0728: Commission Decision 2012/728/EU of 23 November 2012 concerning the non-inclusion of

bifenthrin for product type 18 in Annex I, IA or IB to Directive 98/8/EC of the European Parliament and of

the Council concerning the placing of biocidal products on the market (OJ L 327, 27.11.2012, p. 55).

12zzn.{536} 32013 D 0085: Commission Decision 2013/85/EU of 14 February 2013 concerning the non-inclusion of

certain substances in Annex I, IA or IB to Directive 98/8/EC of the European Parliament and of the Council

concerning the placing of biocidal products on the market (OJ L 45, 16.2.2013, p. 30).

12zzo.{537} 32013 D 0204: Commission Decision 2013/204/EU of 25 April 2013 concerning the non-inclusion of

formaldehyde for product-type 20 in Annex I, IA or IB to Directive 98/8/EC of the European Parliament and

of the Council concerning the placing of biocidal products on the market (OJ L 117, 27.4.2013, p. 18).

12zzp.{538} 32013 R 0414: Commission Implementing Regulation (EU) No 414/2013 of 6 May 2013 specifying a

procedure for the authorisation of same biocidal products in accordance with Regulation (EU) No 528/2012

of the European Parliament and of the Council (OJ L 125, 7.5.2013, p. 4), as amended by:

{528} Point inserted by Decision No 106/2012 (OJ L 270, 4.10.2012, p. 6 and EEA Supplement No 56, 4.10.2012, p. 8), e.i.f. 1.2.2013.

{529} Point inserted by Decision No 162/2012 (OJ L 341, 13.12.2012, p. 13 and EEA Supplement No 70, 13.12.2012, p. 15), e.i.f. 29.9.2012.

{530} Point inserted by Decision No 162/2012 (OJ L 341, 13.12.2012, p. 13 and EEA Supplement No 70, 13.12.2012, p. 15), e.i.f. 29.9.2012.

{531} Point inserted by Decision No 213/2012 (OJ L 81, 21.3.2013, p. 13 and EEA Supplement No 18, 21.3.2013, p. 15), e.i.f. 8.12.2012.

{532} Point inserted by Decision No 66/2013 (OJ L 291, 31.10.2013, p. 22 and EEA Supplement No 61, 31.10.2013, p. 25), e.i.f. 4.5.2013.

{533} Point inserted by Decision No 66/2013 (OJ L 291, 31.10.2013, p. 22 and EEA Supplement No 61, 31.10.2013, p. 25), e.i.f. 4.5.2013.

{534} Point inserted by Decision No 66/2013 (OJ L 291, 31.10.2013, p. 22 and EEA Supplement No 61, 31.10.2013, p. 25), e.i.f. 4.5.2013.

{535} Point inserted by Decision No 139/2013 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 16.7.2013.

{536} Point inserted by Decision No 139/2013 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 16.7.2013.

{537} Point inserted by Decision No 194/2013 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 9.11.2013.

Page 52: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 178

-{539} 32016 R 1802: Commission Implementing Regulation (EU) 2016/1802 of 11 October 2016 (OJ L

275, 12.10.2016, p. 34).

12zzq.{540} 32013 R 0098: Regulation (EU) No 98/2013 of the European Parliament and of the Council of 15 January

2013 on the marketing and use of explosives precursors (OJ L 39, 9.2.2013, p. 1), as amended by, as

corrected by OJ L 315, 30.11.2017, p. 78.

:

-{541} 32017 R 0214: Commission Delegated Regulation (EU) 2017/214 of 30 November 2016 (OJ L 34,

9.2.2017, p. 1),

-{542} 32017 R 0215: Commission Delegated Regulation (EU) 2017/215 of 30 November 2016 (OJ L 34,

9.2.2017, p. 3),

-{543} 32017 R 0216: Commission Delegated Regulation (EU) 2017/216 of 30 November 2016 (OJ L 34,

9.2.2017, p. 5).

12zzr.{544} 32015 R 0292: Commission Implementing Regulation (EU) 2015/292 of 24 February 2015 approving

carbon dioxide as an active substance for use in biocidal products for product-type 15 (OJ L 53, 25.2.2015,

p. 3).

12zzs.{545} 32015 R 0405: Commission Implementing Regulation (EU) 2015/405 of 11 March 2015 approving alpha-

cypermethrin as an active substance for use in biocidal products for product-type 18 (OJ L 67, 12.3.2015,

p. 9).

12zzt.{546} 32015 R 0406: Commission Implementing Regulation (EU) 2015/406 of 11 March 2015 approving Bacillus

thuringiensis subsp. israelensis serotype H14, strain SA3A as an active substance for use in biocidal

products for product-type 18 (OJ L 67, 12.3.2015, p. 12).

12zzu.{547} 32015 R 0407: Commission Implementing Regulation (EU) 2015/407 of 11 March 2015 approving propan-

2-ol as an active substance for use in biocidal products for product-types 1, 2 and 4 (OJ L 67, 12.3.2015,

p. 15).

12zzv.{548} 32015 D 0411: Commission Implementing Decision (EU) 2015/411 of 11 March 2015 pursuant to Article

3(3) of Regulation (EU) No 528/2012 of the European Parliament and of the Council on cationic polymeric

binders with quaternary ammonium compounds incorporated in paints and coatings (OJ L 67, 12.3.2015,

p. 30).

12zzw.{549} 32015 R 0416: Commission Implementing Regulation (EU) 2015/416 of 12 March 2015 approving

dinotefuran as an active substance for use in biocidal products for product-type 18 (OJ L 68, 13.3.2015,

p. 30).

12zzx.{550} 32015 R 0417: Commission Implementing Regulation (EU) 2015/417 of 12 March 2015 approving Bacillus

sphaericus 2362 serotype H5a5b, strain ABTS1743 as an active substance for use in biocidal products for

product-type 18 (OJ L 68, 13.3.2015, p. 33).

{538} Point inserted by Decision No 15/2014 (OJ L 211, 17.7.2014, p. 22 and EEA Supplement No 42, 17.7.2014, p. 20), e.i.f. 1.6.2014.

{539} Indent and words “ , as amended by” added by Decision No 28/2017 (OJ L 297, 22.11.2018, p. 34 and EEA Supplement No 78, 22.11.2018,

p. 40), e.i.f. 4.2.2017.

{540} Point inserted by Decision No 269/2014 (OJ L 311, 26.11.2015, p. 20 and EEA Supplement No 71, 26.11.2015, p. 19), e.i.f. 1.8.2015.

Corrigendum to the EU act subsequently taken note of by the EEA Joint Committee on 6.7.2018. {541} Indent and words “, as amended by” added by Decision No 109/2018 (OJ L [to be published] and EEA Supplement No [to be published]),

e.i.f. 1.6.2018.

{542} Indent added by Decision No 109/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 1.6.2018.

{543} Indent added by Decision No 109/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 1.6.2018.

{544} Point inserted by Decision No 91/2015 (OJ L 211, 4.8.2016, p. 28 and EEA Supplement No 42, 4.8.2016, p. 27), e.i.f. 1.5.2015.

{545} Point inserted by Decision No 92/2015 (OJ L 211, 4.8.2016, p. 29 and EEA Supplement No 42, 4.8.2016, p. 28), e.i.f. 1.5.2015.

{546} Point inserted by Decision No 92/2015 (OJ L 211, 4.8.2016, p. 29 and EEA Supplement No 42, 4.8.2016, p. 28), e.i.f. 1.5.2015.

{547} Point inserted by Decision No 92/2015 (OJ L 211, 4.8.2016, p. 29 and EEA Supplement No 42, 4.8.2016, p. 28), e.i.f. 1.5.2015.

{548} Point inserted by Decision No 153/2015 (OJ L 341, 15.12.2016, p. 46 and EEA Supplement No 69, 15.12.2016, p. 47), e.i.f. 12.6.2015.

{549} Point inserted by Decision No 153/2015 (OJ L 341, 15.12.2016, p. 46 and EEA Supplement No 69, 15.12.2016, p. 47), e.i.f. 12.6.2015.

{550} Point inserted by Decision No 153/2015 (OJ L 341, 15.12.2016, p. 46 and EEA Supplement No 69, 15.12.2016, p. 47), e.i.f. 12.6.2015.

Page 53: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 179

12zzy.{551} 32015 R 0419: Commission Implementing Regulation (EU) 2015/419 of 12 March 2015 approving

tolylfluanid as an active substance for use in biocidal products for product-type 21 (OJ L 68, 13.3.2015,

p. 39).

12zzz.{552} 32015 D 0744: Commission Implementing Decision (EU) 2015/744 of 8 May 2015 authorising the

provisional measure taken by the Netherlands in accordance with Article 52 of Regulation (EC) No

1272/2008 of the European Parliament and of the Council as regards additional packaging and labelling

requirements for electronic cigarettes containing nicotine and refill containers (OJ L 118, 9.5.2015, p. 8).

12zzza.{553}32015 R 0984: Commission Implementing Regulation (EU) 2015/984 of 24 June 2015 approving copper

pyrithione as an existing active substance for use in biocidal products for product-type 21 (OJ L 159,

25.6.2015, p. 43).

12zzzb.{554}32015 R 0985: Commission Implementing Regulation (EU) 2015/985 of 24 June 2015 approving

clothianidin as an existing active substance for use in biocidal products for product-type 18 (OJ L 159,

25.6.2015, p. 46).

12zzzc.{555}32016 R 0105: Commission Implementing Regulation (EU) 2016/105 of 27 January 2016 approving

biphenyl-2-ol as an existing active substance for use in biocidal products for product-types 1, 2, 4, 6 and 13

(OJ L 21, 28.1.2016, p. 74).

12zzzd.{556}32016 D 0107: Commission Implementing Decision (EU) 2016/107 of 27 January 2016 not approving

cybutryne as an existing active substance for use in biocidal products for product-type 21 (OJ L 21,

28.1.2016, p. 81).

12zzze.{557}32016 D 0108: Commission Implementing Decision (EU) 2016/108 of 27 January 2016 not approving 2-

Butanone, peroxide as an existing active substance for use in biocidal products for product-types 1 and 2 (OJ

L 21, 28.1.2016, p. 83).

12zzzf.{558} 32016 D 0109: Commission Implementing Decision (EU) 2016/109 of 27 January 2016 not to approve

PHMB (1600; 1.8) as an existing active substance for use in biocidal products for product-types 1, 6 and 9

(OJ L 21, 28.1.2016, p. 84).

12zzzg.{559}32016 D 0110: Commission Implementing Decision (EU) 2016/110 of 27 January 2016 not approving

triclosan as an existing active substance for use in biocidal products for product-type 1 (OJ L 21, 28.1.2016,

p. 86).

12zzzh.{560}32016 R 0124: Commission Implementing Regulation (EU) 2016/124 of 29 January 2016 approving PHMB

(1600; 1.8) as an existing active substance for use in biocidal products for product-type 4 (OJ L 24,

30.1.2016, p. 1).

12zzzi.{561} 32016 R 0125: Commission Implementing Regulation (EU) 2016/125 of 29 January 2016 approving PHMB

(1600; 1.8) as an existing active substance for use in biocidal products for product-types 2, 3, 11 (OJ L 24,

30.1.2016, p. 6).

12zzzj.{562} 32016 R 0131: Commission Implementing Regulation (EU) 2016/131 of 1 February 2016 approving

C(M)IT/MIT (3:1) as an existing active substance for use in biocidal products for product-types 2, 4, 6, 11,

12 and 13 (OJ L 25, 2.2.2016, p. 48).

{551} Point inserted by Decision No 153/2015 (OJ L 341, 15.12.2016, p. 46 and EEA Supplement No 69, 15.12.2016, p. 47), e.i.f. 12.6.2015.

{552} Point inserted by Decision No 260/2015 (OJ L 161, 22.6.2017, p. 42 and EEA Supplement No 38, 22.6.2017, p. 42), e.i.f. 1.11.2015.

{553} Point inserted by Decision No 261/2015 (OJ L 161, 22.6.2017, p. 43 and EEA Supplement No 38, 22.6.2017, p. 43), e.i.f. 1.11.2015.

{554} Point inserted by Decision No 261/2015 (OJ L 161, 22.6.2017, p. 43 and EEA Supplement No 38, 22.6.2017, p. 43), e.i.f. 1.11.2015.

{555} Point inserted by Decision No 84/2016 (OJ L 300, 16.11.2017, p. 28 and EEA Supplement No 73, 16.11.2017, p. 32), e.i.f. 30.4.2016 and

subsequently corrected [before publication] by Corrigendum of 28.10.2016.

{556} Point inserted by Decision No 84/2016 (OJ L 300, 16.11.2017, p. 28 and EEA Supplement No 73, 16.11.2017, p. 32), e.i.f. 30.4.2016.

{557} Point inserted by Decision No 84/2016 (OJ L 300, 16.11.2017, p. 28 and EEA Supplement No 73, 16.11.2017, p. 32), e.i.f. 30.4.2016.

{558} Point inserted by Decision No 84/2016 (OJ L 300, 16.11.2017, p. 28 and EEA Supplement No 73, 16.11.2017, p. 32), e.i.f. 30.4.2016.

{559} Point inserted by Decision No 84/2016 (OJ L 300, 16.11.2017, p. 28 and EEA Supplement No 73, 16.11.2017, p. 32), e.i.f. 30.4.2016.

{560} Point inserted by Decision No 84/2016 (OJ L 300, 16.11.2017, p. 28 and EEA Supplement No 73, 16.11.2017, p. 32), e.i.f. 30.4.2016.

{561} Point inserted by Decision No 84/2016 (OJ L 300, 16.11.2017, p. 28 and EEA Supplement No 73, 16.11.2017, p. 32), e.i.f. 30.4.2016.

{562} Point inserted by Decision No 84/2016 (OJ L 300, 16.11.2017, p. 28 and EEA Supplement No 73, 16.11.2017, p. 32), e.i.f. 30.4.2016.

Page 54: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 180

12zzzk.{563}32016 D 0135: Commission Implementing Decision (EU) 2016/135 of 29 January 2016 postponing the

expiry date of approval of flocoumafen, brodifacoum and warfarin for use in biocidal products for product-

type 14 (OJ L 25, 2.2.2016, p. 65).

12zzzl.{564}32016 R 1068: Commission Implementing Regulation (EU) 2016/1068 of 1 July 2016 approving N-

cyclopropyl-1,3,5-triazine-2,4,6-triamine (cyromazine) as an existing active substance for use in biocidal

products of product-type 18 (OJ L 178, 2.7.2016, p. 13).

12zzzm.{565}32016 R 1083: Commission Implementing Regulation (EU) 2016/1083 of 5 July 2016 approving amines,

N-C10–16-alkyltrimethylenedi-, reaction products with chloroacetic acid as an existing active substance for

use in biocidal products of product-types 2, 3 and 4 (OJ L 180, 6.7.2016, p. 4).

12zzzn.{566}32016 R 1084: Commission Implementing Regulation (EU) 2016/1084 of 5 July 2016 approving biphenyl-

2-ol as an existing active substance for use in biocidal products of product-type 3 (OJ L 180, 6.7.2016, p. 9).

12zzzo.{567}32016 R 1085: Commission Implementing Regulation (EU) 2016/1085 of 5 July 2016 approving Bacillus

amyloliquefaciens strain ISB06 as an existing active substance for use in biocidal products of product-type 3

(OJ L 180, 6.7.2016, p. 12).

12zzzp.{568}32016 R 1086: Commission Implementing Regulation (EU) 2016/1086 of 5 July 2016 approving 2-bromo-

2-(bromomethyl)pentanedinitrile (DBDCB) as an existing active substance for use in biocidal products of

product-type 6 (OJ L 180, 6.7.2016, p. 15).

12zzzq.{569}32016 R 1087: Commission Implementing Regulation (EU) 2016/1087 of 5 July 2016 approving

tolylfluanid as an existing active substance for use in biocidal products of product-type 7 (OJ L 180,

6.7.2016, p. 18).

12zzzr.{570}32016 R 1088: Commission Implementing Regulation (EU) 2016/1088 of 5 July 2016 approving copper

flakes (coated with aliphatic acid) as an existing active substance for use in biocidal products of product-type

21 (OJ L 180, 6.7.2016, p. 21).

12zzzs.{571}32016 R 1089: Commission Implementing Regulation (EU) 2016/1089 of 5 July 2016 approving dicopper

oxide as an existing active substance for use in biocidal products of product-type 21 (OJ L 180, 6.7.2016, p.

25).

12zzzt.{572}32016 R 1090: Commission Implementing Regulation (EU) 2016/1090 of 5 July 2016 approving copper

thiocyanate as an existing active substance for use in biocidal products of product-type 21 (OJ L 180,

6.7.2016, p. 29).

12zzzu.{573}32016 R 1093: Commission Implementing Regulation (EU) 2016/1093 of 6 July 2016 approving

didecylmethylpoly(oxyethyl)ammonium propionate as an existing active substance for use in biocidal

products of product-type 8 (OJ L 182, 7.7.2016, p. 1).

12zzzv.{574}32016 R 1094: Commission Implementing Regulation (EU) 2016/1094 of 6 July 2016 approving copper,

granulated, as an active substance for use in biocidal products of product-type 8 (OJ L 182, 7.7.2016, p. 4).

12zzzw.{575}32016 R 1929: Commission Implementing Regulation (EU) 2016/1929 of 4 November 2016 approving

Bacillus thuringiensis subsp. kurstaki, serotype 3a3b, strain ABTS-351, as an active substance for use in

biocidal products of product-type 18 (OJ L 299, 5.11.2016, p. 26).

{563} Point inserted by Decision No 84/2016 (OJ L 300, 16.11.2017, p. 28 and EEA Supplement No 73, 16.11.2017, p. 32), e.i.f. 30.4.2016..

{564} Point inserted by Decision No 180/2016 (OJ L 80, 22.3.2018, p. 22 and EEA Supplement No 19, 22.3.2018, p. 29), e.i.f. 24.9.2016.

{565} Point inserted by Decision No 180/2016 (OJ L 80, 22.3.2018, p. 22 and EEA Supplement No 19, 22.3.2018, p. 29), e.i.f. 24.9.2016.

{566} Point inserted by Decision No 180/2016 (OJ L 80, 22.3.2018, p. 22 and EEA Supplement No 19, 22.3.2018, p. 29), e.i.f. 24.9.2016.

{567} Point inserted by Decision No 180/2016 (OJ L 80, 22.3.2018, p. 22 and EEA Supplement No 19, 22.3.2018, p. 29), e.i.f. 24.9.2016.

{568} Point inserted by Decision No 180/2016 (OJ L 80, 22.3.2018, p. 22 and EEA Supplement No 19, 22.3.2018, p. 29), e.i.f. 24.9.2016.

{569} Point inserted by Decision No 180/2016 (OJ L 80, 22.3.2018, p. 22 and EEA Supplement No 19, 22.3.2018, p. 29), e.i.f. 24.9.2016.

{570} Point inserted by Decision No 180/2016 (OJ L 80, 22.3.2018, p. 22 and EEA Supplement No 19, 22.3.2018, p. 29), e.i.f. 24.9.2016.

{571} Point inserted by Decision No 180/2016 (OJ L 80, 22.3.2018, p. 22 and EEA Supplement No 19, 22.3.2018, p. 29), e.i.f. 24.9.2016.

{572} Point inserted by Decision No 180/2016 (OJ L 80, 22.3.2018, p. 22 and EEA Supplement No 19, 22.3.2018, p. 29), e.i.f. 24.9.2016.

{573} Point inserted by Decision No 180/2016 (OJ L 80, 22.3.2018, p. 22 and EEA Supplement No 19, 22.3.2018, p. 29), e.i.f. 24.9.2016.

{574} Point inserted by Decision No 180/2016 (OJ L 80, 22.3.2018, p. 22 and EEA Supplement No 19, 22.3.2018, p. 29), e.i.f. 24.9.2016.

Page 55: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 181

12zzzx.{576}32016 R 1930: Commission Implementing Regulation (EU) 2016/1930 of 4 November 2016 approving

chlorocresol as an existing active substance for use in biocidal products of product-types 1, 2, 3, 6 and 9 (OJ

L 299, 5.11.2016, p. 29).

12zzzy.{577}32016 R 1931: Commission Implementing Regulation (EU) 2016/1931 of 4 November 2016 approving

chlorocresol as an existing active substance for use in biocidal products of product-type 13 (OJ L 299,

5.11.2016, p. 33).

12zzzz.{578}32016 R 1932: Commission Implementing Regulation (EU) 2016/1932 of 4 November 2016 approving

calcium magnesium oxide (burnt dolomitic lime) as an existing active substance for use in biocidal products

of product-types 2 and 3 (OJ L 299, 5.11.2016, p. 36).

12zzzza.{579}32016 R 1933: Commission Implementing Regulation (EU) 2016/1933 of 4 November 2016 approving

calcium magnesium tetrahydroxide (hydrated dolomitic lime) as an existing active substance for use in

biocidal products of product-types 2 and 3 (OJ L 299, 5.11.2016, p. 39).

12zzzzb.{580}32016 R 1934: Commission Implementing Regulation (EU) 2016/1934 of 4 November 2016 approving

coco alkyltrimethylammonium chloride (ATMAC/TMAC) as an existing active substance for use in biocidal

products of product-type 8 (OJ L 299, 5.11.2016, p. 42).

12zzzzc.{581}32016 R 1935: Commission Implementing Regulation (EU) 2016/1935 of 4 November 2016 approving

calcium dihydroxide (hydrated lime) as an existing active substance for use in biocidal products of product-

types 2 and 3 (OJ L 299, 5.11.2016, p. 45).

12zzzzd.{582}32016 R 1937: Commission Implementing Regulation (EU) 2016/1937 of 4 November 2016 approving

cyfluthrin as an existing active substance for use in biocidal products of product-type 18 (OJ L 299,

5.11.2016, p. 51).

12zzzze.{583}32016 R 1938: Commission Implementing Regulation (EU) 2016/1938 of 4 November 2016 approving

citric acid as an existing active substance for use in biocidal products of product-type 2 (OJ L 299,

5.11.2016, p. 54).

12zzzzf.{584}32016 D 1943: Commission Implementing Decision (EU) 2016/1943 of 4 November 2016 pursuant to

Article 3(3) of Regulation (EU) No 528/2012 of the European Parliament and of the Council on the use of

paraffin oil for coating eggs to control the population size of nesting birds (OJ L 299, 5.11.2016, p. 90).

12zzzzg.{585}32016 D 1950: Commission Implementing Decision (EU) 2016/1950 of 4 November 2016 on the non-

approval of certain biocidal active substances pursuant to Regulation (EU) No 528/2012 of the European

Parliament and of the Council (OJ L 300, 8.11.2016, p. 14).

12zzzzh.{586}32016 R 1936: Commission Implementing Regulation (EU) 2016/1936 of 4 November 2016 approving

calcium oxide (burnt lime) as an existing active substance for use in biocidal products of product-types 2 and

3 (OJ L 299, 5.11.2016, p. 48).

12zzzzi.{587}32016 R 2288: Commission Implementing Regulation (EU) 2016/2288 of 16 December 2016 approving

piperonyl butoxide as an existing active substance for use in biocidal products of product-type 18 (OJ L 344,

17.12.2016, p. 65).

{575} Point inserted by Decision No 29/2017 (OJ L 297, 22.11.2018, p. 35 and EEA Supplement No 78, 22.11.2018, p. 41), e.i.f. 4.2.2017 and

subsequently corrected [before publication] by Corrigendum of 5.5.2017.

{576} Point inserted by Decision No 29/2017 (OJ L 297, 22.11.2018, p. 35 and EEA Supplement No 78, 22.11.2018, p. 41), e.i.f. 4.2.2017.

{577} Point inserted by Decision No 29/2017 (OJ L 297, 22.11.2018, p. 35 and EEA Supplement No 78, 22.11.2018, p. 41), e.i.f. 4.2.2017.

{578} Point inserted by Decision No 29/2017 (OJ L 297, 22.11.2018, p. 35 and EEA Supplement No 78, 22.11.2018, p. 41), e.i.f. 4.2.2017.

{579} Point inserted by Decision No 29/2017 (OJ L 297, 22.11.2018, p. 35 and EEA Supplement No 78, 22.11.2018, p. 41), e.i.f. 4.2.2017.

{580} Point inserted by Decision No 29/2017 (OJ L 297, 22.11.2018, p. 35 and EEA Supplement No 78, 22.11.2018, p. 41), e.i.f. 4.2.2017.

{581} Point inserted by Decision No 29/2017 (OJ L 297, 22.11.2018, p. 35 and EEA Supplement No 78, 22.11.2018, p. 41), e.i.f. 4.2.2017.

{582} Point inserted by Decision No 29/2017 (OJ L 297, 22.11.2018, p. 35 and EEA Supplement No 78, 22.11.2018, p. 41), e.i.f. 4.2.2017.

{583} Point inserted by Decision No 29/2017 (OJ L 297, 22.11.2018, p. 35 and EEA Supplement No 78, 22.11.2018, p. 41), e.i.f. 4.2.2017.

{584} Point inserted by Decision No 29/2017 (OJ L 297, 22.11.2018, p. 35 and EEA Supplement No 78, 22.11.2018, p. 41), e.i.f. 4.2.2017.

{585} Point inserted by Decision No 29/2017 (OJ L 297, 22.11.2018, p. 35 and EEA Supplement No 78, 22.11.2018, p. 41), e.i.f. 4.2.2017.

{586} Point inserted by Decision No 53/2017 (OJ L 305, 29.11.2018, p. 18 and EEA Supplement No 81, 29.11.2018, p. 21), e.i.f. 18.3.2017.

Page 56: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 182

12zzzzj.{588}32016 R 2289: Commission Implementing Regulation (EU) 2016/2289 of 16 December 2016 approving

epsilon-Momfluorothrin as an active substance for use in biocidal products of product-type 18 (OJ L 344,

17.12.2016, p. 68).

12zzzzk.{589}32016 R 2290: Commission Implementing Regulation (EU) 2016/2290 of 16 December 2016 approving

peracetic acid as an existing active substance for use in biocidal products of product-types 11 and 12 (OJ L

344, 17.12.2016, p. 71).

12zzzzl.{590}32016 R 2291: Commission Implementing Regulation (EU) 2016/2291 of 16 December 2016 approving

L(+) Lactic acid as an active substance for use in biocidal products of product-type 1 (OJ L 344, 17.12.2016,

p. 74).

12zzzzm.{591}32017 R 0794: Commission Implementing Regulation (EU) 2017/794 of 10 May 2017 approving silicon

dioxide Kieselguhr as an existing active substance for use in biocidal products of product-type 18 (OJ L 120,

11.5.2017, p. 7).

12zzzzn.{592}32017 R 0795: Commission Implementing Regulation (EU) 2017/795 of 10 May 2017 approving

pyrogenic, synthetic amorphous, nano, surface treated silicon dioxide as an existing active substance for use

in biocidal products of product-type 18 (OJ L 120, 11.5.2017, p. 10).

12zzzzo.{593}32017 R 0796: Commission Implementing Regulation (EU) 2017/796 of 10 May 2017 approving

dichlofluanid as an existing active substance for use in biocidal products of product-type 21 (OJ L 120,

11.5.2017, p. 13).

12zzzzp.{594}32017 D 0802: Commission Implementing Decision (EU) 2017/802 of 10 May 2017 not approving PHMB

(1600; 1.8) as an existing active substance for use in biocidal products for product-type 5 (OJ L 120,

11.5.2017, p. 29).

12zzzzq.{595}32017 R 1273: Commission Implementing Regulation (EU) 2017/1273 of 14 July 2017 approving active

chlorine released from sodium hypochlorite as an existing active substance for use in biocidal products of

product-types 1, 2, 3, 4 and 5 (OJ L 184, 15.7.2017, p. 13).

12zzzzr.{596}32017 R 1274: Commission Implementing Regulation (EU) 2017/1274 of 14 July 2017 approving active

chlorine released from calcium hypochlorite as an existing active substance for use in biocidal products of

product-types 2, 3, 4 and 5 (OJ L 184, 15.7.2017, p. 17).

12zzzzs.{597}32017 R 1275: Commission Implementing Regulation (EU) 2017/1275 of 14 July 2017 approving active

chlorine released from chlorine as an existing active substance for use in biocidal products of product-types 2

and 5 (OJ L 184, 15.7.2017, p. 21).

12zzzzt. {598}32017 R 1276: Commission Implementing Regulation (EU) 2017/1276 of 14 July 2017 approving

peracetic acid generated from tetraacetylethylenediamine and sodium percarbonate as an existing active

substance for use in biocidal products of product-types 2, 3 and 4 (OJ L 184, 15.7.2017, p. 24).

12zzzzu.{599}32017 R 1277: Commission Implementing Regulation (EU) 2017/1277 of 14 July 2017 approving 2-octyl-

isothiazol-3(2H)-one as an active substance for use in biocidal products of product-type 8 (OJ L 184,

15.7.2017, p. 27).

{587} Point inserted by Decision No 54/2017 (OJ L 305, 29.11.2018, p. 19 and EEA Supplement No 81, 29.11.2018, p. 22), e.i.f. 18.3.2017.

{588} Point inserted by Decision No 54/2017 (OJ L 305, 29.11.2018, p. 19 and EEA Supplement No 81, 29.11.2018, p. 22), e.i.f. 18.3.2017.

{589} Point inserted by Decision No 54/2017 (OJ L 305, 29.11.2018, p. 19 and EEA Supplement No 81, 29.11.2018, p. 22), e.i.f. 18.3.2017.

{590} Point inserted by Decision No 54/2017 (OJ L 305, 29.11.2018, p. 19 and EEA Supplement No 81, 29.11.2018, p. 22), e.i.f. 18.3.2017.

{591} Point inserted by Decision No 173/2017 (OJ L 174, 27.6.2019, p. 35 and EEA Supplement No 52, 27.6.2019, p. 44), e.i.f. 23.9.2017.

{592} Point inserted by Decision No 173/2017 (OJ L 174, 27.6.2019, p. 35 and EEA Supplement No 52, 27.6.2019, p. 44), e.i.f. 23.9.2017.

{593} Point inserted by Decision No 173/2017 (OJ L 174, 27.6.2019, p. 35 and EEA Supplement No 52, 27.6.2019, p. 44), e.i.f. 23.9.2017.

{594} Point inserted by Decision No 173/2017 (OJ L 174, 27.6.2019, p. 35 and EEA Supplement No 52, 27.6.2019, p. 44), e.i.f. 23.9.2017.

{595} Point inserted by Decision No 226/2017 (OJ L 254, 3.10.2019, p. 32 and EEA Supplement No 80, 3.10.2019, p. 35), e.i.f. 16.12.2017.

{596} Point inserted by Decision No 226/2017 (OJ L 254, 3.10.2019, p. 32 and EEA Supplement No 80, 3.10.2019, p. 35), e.i.f. 16.12.2017.

{597} Point inserted by Decision No 226/2017 (OJ L 254, 3.10.2019, p. 32 and EEA Supplement No 80, 3.10.2019, p. 35), e.i.f. 16.12.2017.

{598} Point inserted by Decision No 226/2017 (OJ L 254, 3.10.2019, p. 32 and EEA Supplement No 80, 3.10.2019, p. 35), e.i.f. 16.12.2017.

{599} Point inserted by Decision No 226/2017 (OJ L 254, 3.10.2019, p. 32 and EEA Supplement No 80, 3.10.2019, p. 35), e.i.f. 16.12.2017.

Page 57: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 183

12zzzzv.{600}32017 R 1278: Commission Implementing Regulation (EU) 2017/1278 of 14 July 2017 approving 2-

methylisothiazol-3(2H)-one as an existing active substance for use in biocidal products of product-type 11

(OJ L 184, 15.7.2017, p. 30).

12zzzzw.{601}32017 D 1282: Commission Implementing Decision (EU) 2017/1282 of 14 July 2017 not approving 2-

methyl-1,2-benzisothiazol-3(2H)-one as an active substance for use in biocidal products of product-type 13

(OJ L 184, 15.7.2017, p. 69).

12zzzzx.{602}32017 R 1376: Commission Implementing Regulation (EU) 2017/1376 of 25 July 2017 renewing the

approval of warfarin as an active substance for use in biocidal products of product-type 14 (OJ L 194,

26.7.2017, p. 9).

12zzzzy.{603}32017 R 1377: Commission Implementing Regulation (EU) 2017/1377 of 25 July 2017 renewing the

approval of chlorophacinone as an active substance for use in biocidal products of product-type 14 (OJ L

194, 26.7.2017, p. 15).

12zzzzz.{604}32017 R 1378: Commission Implementing Regulation (EU) 2017/1378 of 25 July 2017 renewing the

approval of coumatetralyl as an active substance for use in biocidal products of product-type 14 (OJ L 194,

26.7.2017, p. 21).

12zzzzza.{605}32017 R 1379: Commission Implementing Regulation (EU) 2017/1379 of 25 July 2017 renewing the

approval of difenacoum as an active substance for use in biocidal products of product-type 14 (OJ L 194,

26.7.2017, p. 27).

12zzzzzb.{606}32017 R 1380: Commission Implementing Regulation (EU) 2017/1380 of 25 July 2017 renewing the

approval of bromadiolone as an active substance for use in biocidal products of product-type 14 (OJ L 194,

26.7.2017, p. 33).

12zzzzzc.{607}32017 R 1381: Commission Implementing Regulation (EU) 2017/1381 of 25 July 2017 renewing the

approval of brodifacoum as an active substance for use in biocidal products of product-type 14 (OJ L 194,

26.7.2017, p. 39).

12zzzzzd.{608}32017 R 1382: Commission Implementing Regulation (EU) 2017/1382 of 25 July 2017 renewing the

approval of difethialone as an active substance for use in biocidal products of product-type 14 (OJ L 194,

26.7.2017, p. 45).

12zzzzze.{609}32017 R 1383: Commission Implementing Regulation (EU) 2017/1383 of 25 July 2017 renewing the

approval of flocoumafen as an active substance for use in biocidal products of product-type 14 (OJ L 194,

26.7.2017, p. 51).’

12zzzzzf.{610}32017 R 2326: Commission Implementing Regulation (EU) 2017/2326 of 14 December 2017 approving

imiprothrin as an existing active substance for use in biocidal products of product-type 18 (OJ L 333,

15.12.2017, p. 22).

12zzzzzg.{611}32017 R 2327: Commission Implementing Regulation (EU) 2017/2327 of 14 December 2017 approving

2-methyl-1,2-benzisothiazol-3(2H)-one as an active substance for use in biocidal products of product-type 6

(OJ L 333, 15.12.2017, p. 25).

{600} Point inserted by Decision No 226/2017 (OJ L 254, 3.10.2019, p. 32 and EEA Supplement No 80, 3.10.2019, p. 35), e.i.f. 16.12.2017.

{601} Point inserted by Decision No 226/2017 (OJ L 254, 3.10.2019, p. 32 and EEA Supplement No 80, 3.10.2019, p. 35), e.i.f. 16.12.2017.

{602} Point inserted by Decision No 227/2017 (OJ L 254, 3.10.2019, p. 34 and EEA Supplement No 80, 3.10.2019, p. 37), e.i.f. 16.12.2017.

{603} Point inserted by Decision No 227/2017 (OJ L 254, 3.10.2019, p. 34 and EEA Supplement No 80, 3.10.2019, p. 37), e.i.f. 16.12.2017.

{604} Point inserted by Decision No 227/2017 (OJ L 254, 3.10.2019, p. 34 and EEA Supplement No 80, 3.10.2019, p. 37), e.i.f. 16.12.2017.

{605} Point inserted by Decision No 227/2017 (OJ L 254, 3.10.2019, p. 34 and EEA Supplement No 80, 3.10.2019, p. 37), e.i.f. 16.12.2017.

{606} Point inserted by Decision No 227/2017 (OJ L 254, 3.10.2019, p. 34 and EEA Supplement No 80, 3.10.2019, p. 37), e.i.f. 16.12.2017.

{607} Point inserted by Decision No 227/2017 (OJ L 254, 3.10.2019, p. 34 and EEA Supplement No 80, 3.10.2019, p. 37), e.i.f. 16.12.2017.

{608} Point inserted by Decision No 227/2017 (OJ L 254, 3.10.2019, p. 34 and EEA Supplement No 80, 3.10.2019, p. 37), e.i.f. 16.12.2017.

{609} Point inserted by Decision No 227/2017 (OJ L 254, 3.10.2019, p. 34 and EEA Supplement No 80, 3.10.2019, p. 37), e.i.f. 16.12.2017.

{610} Point inserted by Decision No 53/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 24.3.2018.

{611} Point inserted by Decision No 53/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 24.3.2018.

Page 58: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 184

12zzzzzh.{612}32017 D 2334: Commission Implementing Decision (EU) 2017/2334 of 14 December 2017 postponing

the expiry date of approval of creosote for use in biocidal products of product-type 8 (OJ L 333, 15.12.2017,

p. 64).

12zzzzzi.{613} 32018 D 0622: Commission Implementing Decision (EU) 2018/622 of 20 April 2018 not approving

chlorophene as an existing active substance for use in biocidal products of product-type 3 (OJ L 102,

23.4.2018, p. 80).

12zzzzzj.{614} 32018 R 0613: Commission Implementing Regulation (EU) 2018/613 of 20 April 2018 approving PHMB

(1415; 4.7) as an existing active substance for use in biocidal products of product-types 2 and 4 (OJ L 102,

23.4.2018, p. 1).

12zzzzzk.{615} 32018 R 0614: Commission Implementing Regulation (EU) 2018/614 of 20 April 2018 approving

azoxystrobin as an active substance for use in biocidal products of product-types 7, 9 and 10 (OJ L 102,

23.4.2018, p. 5).

12zzzzzl.{616} 32018 D 0619: Commission Implementing Decision (EU) 2018/619 of 20 April 2018 not approving

PHMB (1415; 4.7) as an existing active substance for use in biocidal products of product-types 1, 5 and 6

(OJ L 102, 23.4.2018, p. 21).

12zzzzzm.{617} 32018 R 1129: Commission Implementing Regulation (EU) 2018/1129 of 13 August 2018 approving

acetamiprid as an existing active substance for use in biocidal products of product-type 18 (OJ L 205,

14.8.2018, p. 4).

12zzzzzn.{618} 32018 R 1130: Commission Implementing Regulation (EU) 2018/1130 of 13 August 2018 approving

cypermethrin as an existing active substance for use in biocidal products of product-type 18 (OJ L 205,

14.8.2018, p. 8).

12zzzzzo.{619} 32018 R 1131: Commission Implementing Regulation (EU) 2018/1131 of 13 August 2018 approving

penflufen as an active substance for use in biocidal products of product-type 8 (OJ L 205, 14.8.2018, p. 12).

12zzzzzp.{620} 32018 D 1477: Commission Implementing Decision (EU) 2018/1477 of 2 October 2018 on the terms and

conditions of the authorisations of biocidal products containing ethyl butylacetylaminopropionate referred by

Belgium in accordance with Article 36 of Regulation (EU) No 528/2012 of the European Parliament and of

the Council (OJ L 249, 4.10.2018, p. 3).

12zzzzzq.{621} 32018 D 1479: Commission Implementing Decision (EU) 2018/1479 of 3 October 2018 postponing the

expiry date of approval of sulfuryl fluoride for use in biocidal products of product-type 8 (OJ L 249,

4.10.2018, p. 16).

12zzzzzr.{622}32018 D 1622: Commission Implementing Decision (EU) 2018/1622 of 29 October 2018 on the non-

approval of certain active substances in biocidal products pursuant to Regulation (EU) No 528/2012 of the

European Parliament and of the Council (OJ L 271, 30.10.2018, p. 26), as corrected by OJ L 34, 6.2.2019, p.

10.

12zzzzzs.{623}32018 D 1623: Commission Implementing Decision (EU) 2018/1623 of 29 October 2018 pursuant to

Article 3(3) of Regulation (EU) No 528/2012 of the European Parliament and of the Council on mosquitoes

non-naturally infected with Wolbachia used for vector control purposes (OJ L 271, 30.10.2018, p. 30).

{612} Point inserted by Decision No 53/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 24.3.2018.

{613} Point inserted by Decision No 181/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 22.9.2018.

{614} Point inserted by Decision No 182/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 22.9.2018.

{615} Point inserted by Decision No 182/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 22.9.2018.

{616} Point inserted by Decision No 182/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 22.9.2018.

{617} Point inserted by Decision No 241/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 6.12.2018.

{618} Point inserted by Decision No 241/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 6.12.2018.

{619} Point inserted by Decision No 241/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 6.12.2018.

{620} Point inserted by Decision No 12/2019 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 9.2.2019.

{621} Point inserted by Decision No 12/2019 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 9.2.2019.

{622} Point inserted by Decision No 13/2019 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 9.2.2019. Corrigendum to

the EU act subsequently taken note of by the EEA Joint Committee on 13.6.2019.

{623} Point inserted by Decision No 13/2019 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 9.2.2019.

Page 59: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 185

12zzzzzt.{624} 32018 R 1292: Commission Implementing Regulation (EU) 2018/1292 of 25 September 2018 approving

cyphenothrin as an existing active substance for use in biocidal products of product-type 18 (OJ L 241,

26.9.2018, p. 11).

12zzzzzu.{625}32018 D 1305: Commission Implementing Decision (EU) 2018/1305 of 26 September 2018 on the terms

and conditions of the authorisation of a biocidal product family containing deltamethrin referred by

Sweden in accordance with Article 36 of Regulation (EU) No 528/2012 of the European Parliament and of

the Council (OJ L 244, 28.9.2018, p. 109).

12zzzzzv.{626}32018 D 1985: Commission Implementing Decision (EU) 2018/1985 of 13 December 2018 not approving

Willaertia magna c2c maky as an active substance for use in biocidal products of product-type 11 (OJ L

317, 14.12.2018, p. 27).

12zzzzzw.{627}32018 D 1251: Commission Implementing Decision (EU) 2018/1251 of 18 September 2018 not

approving empenthrin as an existing active substance for use in biocidal products of product-type 18 (OJ L

235, 19.9.2018, p. 24).

12zzzzzx.{628}32019 R 0637: Commission Implementing Regulation (EU) 2019/637 of 23 April 2019 approving

cholecalciferol as an active substance for use in biocidal products of product-type 14 (OJ L 109, 24.4.2019,

p. 13).

12zzzzzy.{629}32019 D 0641: Commission Implementing Decision (EU) 2019/641 of 17 April 2019 on the terms and

conditions of the authorisation of a biocidal product family containing 1R-trans phenothrin referred by

Ireland in accordance with Article 36 of Regulation (EU) No 528/2012 of the European Parliament and of

the Council (OJ L 109, 24.4.2019, p. 26).

12zzzzzz.{630}32019 D 0994: Commission Implementing Decision (EU) 2019/994 of 17 June 2019 postponing the

expiry date of approval of etofenprox for use in biocidal products of product-type 8 (OJ L 160, 18.6.2019,

p. 26).

12zzzzzza.{631}32019 D 1030: Commission Implementing Decision 2019/1030 of 21 June 2019 postponing the expiry

date of approval of indoxacarb for use in biocidal products of product-type 18 (OJ L 167, 24.6.2019, p.

32).

12zzzzzzb.{632}32019 D 1331: Commission Implementing Decision (EU) 2019/1331 of 5 August 2019 on the terms and

conditions of the authorisation of a biocidal product containing peppermint oil and citronellal referred by

the United Kingdom in accordance with Article 36(1) of Regulation (EU) No 528/2012 of the European

Parliament and of the Council (OJ L 207, 7.8.2019, p. 37).

13.{633} 32009 R 1107: Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October

2009 concerning the placing of plant protection products on the market and repealing Council Directives

79/117/EEC and 91/414/EEC (OJ L 309, 24.11.2009, p. 1), as amended by:

-{634} 32013 R 0518: Council Regulation (EU) No 518/2013 of 13 May 2013 (OJ L 158, 10.6.2013, p. 72),

-{635} 32017 R 1432: Commission Regulation (EU) 2017/1432 of 7 August 2017 (OJ L 205, 8.8.2017,

p. 59),

{624} Point inserted by Decision No 68/2019 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 30.3.2019.

{625} Point inserted by Decision No 68/2019 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 30.3.2019.

{626} Point inserted by Decision No 118/2019 (OJ L [to be published] and EEA supplement No [to be published]), e.i.f. 1.6.2019.

{627} Point inserted by Decision No 154/2019 (OJ L [to be published] and EEA supplement No [to be published]), e.i.f. 15.6.2019.

{628} Point inserted by Decision No 227/2019 (OJ L [to be published] and EEA supplement No [to be published]), e.i.f. 28.9.2019.

{629} Point inserted by Decision No 227/2019 (OJ L [to be published] and EEA supplement No [to be published]), e.i.f. 28.9.2019.

{630} Point inserted by Decision No 228/2019 (OJ L [to be published] and EEA supplement No [to be published]), e.i.f. 28.9.2019.

{631} Point inserted by Decision No 228/2019 (OJ L [to be published] and EEA supplement No [to be published]), e.i.f. 28.9.2019.

{632} Point inserted by Decision No 295/2019 (OJ L [to be published] and EEA supplement No [to be published]), e.i.f. 14.12.2019.

{633} Point inserted by Decision No 203/2014 (OJ L 202, 30.7.2015, p. 57 and EEA Supplement No 43, 30.7.2015, p. 57), e.i.f. 1.6.2015.

{634} Indent and words “, as amended by:” added by Decision No 18/2015 (OJ L 93, 7.4.2016, p. 30 and EEA Supplement No 21, 7.4.2016,

p. 26), e.i.f. pending.

{635} Indent added by Decision No 195/2017 (OJ L 219, 22.8.2019, p. 5 and EEA Supplement No 68, 22.8.2019, p. 5), e.i.f. 28.10.2017.

Page 60: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 186

-{636} 32018 R 0605: Commission Regulation (EU) 2018/605 of 19 April 2018 (OJ L 101, 20.4.2018,

p. 33), as corrected by OJ L 111, 2.5.2018, p. 10,

-{637} 32017 R 0625: Regulation (EU) 2017/625 of the European Parliament and of the Council of 15

March 2017 (OJ L 95, 7.4.2017, p. 1).

The provisions of the Regulation shall, for the purposes of this Agreement, be read with the

following adaptations:

(a) The EFTA States shall be free to limit access to their markets of plant protection products

containing active substances approved in accordance with Council Directive 91/414/EEC or

the Transitional measures in Article 80 of Regulation (EC) No 1107/2009.

(b) The EFTA States, with the exception of Liechtenstein, may be ‘rapporteur Member State’ and

‘co-rapporteur’.

(c) The following shall be added to Article 18:

“The allocation of evaluation of active substances to an EFTA State according to Article

18(f) is subject to consent from that State.”

(d) The following shall be added to Articles 37(4) and 42(2):

“For the EFTA States the time limit of 120 days shall at the earliest run from the date when

the Act of approval of the active substances contained in the plant protection product is

incorporated into the present Agreement.”

(e) The following shall be added to Article 47(3):

“For the EFTA States the time limit of 120 days shall at the earliest run from the date when

the Act of approval of the active substances contained in the low-risk plant protection

product is incorporated into the present Agreement.”

(f) The following shall be added to Article 48:

“The EFTA States may limit access to their markets of plant protection products containing

genetically modified organisms, when measures to restrict or prohibit those organisms have

been taken according to Article 23 of Directive 2001/18/EC, as adapted by this Agreement.”

(g) Article 49 shall not apply to Liechtenstein.

(h) Article 80(6) shall be replaced by the following:

“Plant protection products authorized in accordance with national provisions applicable at the

time of authorization may continue to be placed on the market until the plant protection

product has been risk assessed according to Regulation (EU) No 1107/2009.”

(i) The following shall be added to “Zone A – North” in Annex I:

“Iceland, Norway”

(j) The following shall be added to “Zone B – Centre” in Annex I:

“Liechtenstein”

13a.{638} 32011 R 0540: Commission Implementing Regulation (EU) No 540/2011 of 25 May 2011 implementing

Regulation (EC) No 1107/2009 of the European Parliament and of the Council as regards the list of approved

active substances (OJ L 153, 11.6.2011, p. 1), as corrected by OJ L 26, 28.1.2012, p. 38, as amended by:

{636} Indent added by Decision No 183/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 22.9.2018.

{637} Indent added by Decision No 210/2019 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. pending.

Page 61: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 187

- 32011 R 0541: Commission Implementing Regulation (EU) No 541/2011 of 1 June 2011 (OJ

L 153, 11.6.2011, p. 187),

-{639} 32011 R 0542: Commission Implementing Regulation (EU) No 542/2011 of 1 June 2011 (OJ

L 153, 11.6.2011, p. 189),

-{640} 32011 R 0702: Commission Implementing Regulation (EU) No 702/2011 of 20 July 2011

(OJ L 190, 21.7.2011, p. 28),

-{641} 32011 R 0703: Commission Implementing Regulation (EU) No 703/2011 of 20 July 2011

(OJ L 190, 21.7.2011, p. 33),

-{642} 32011 R 0704: Commission Implementing Regulation (EU) No 704/2011 of 20 July 2011

(OJ L 190, 21.7.2011, p. 38),

-{643} 32011 R 0705: Commission Implementing Regulation (EU) No 705/2011 of 20 July 2011

(OJ L 190, 21.7.2011, p. 43),

-{644} 32011 R 0706: Commission Implementing Regulation (EU) No 706/2011 of 20 July 2011

(OJ L 190, 21.7.2011, p. 50),

-{645} 32011 R 0736: Commission Implementing Regulation (EU) No 736/2011 of 26 July 2011

(OJ L 195, 27.7.2011, p. 37),

-{646} 32011 R 0740: Commission Implementing Regulation (EU) No 740/2011 of 27 July 2011

(OJ L 196, 28.7.2011, p. 6),

-{647} 32011 R 0786: (Commission Implementing Regulation (EU) No 786/2011 of 5 August 2011

(OJ L 203, 6.8.2011, p. 11),

-{648} 32011 R 0787: Commission Implementing Regulation (EU) No 787/2011 of 5 August 2011

(OJ L 203, 6.8.2011, p. 16),

-{649} 32011 R 0788: Commission Implementing Regulation (EU) No 788/2011 of 5 August 2011

(OJ L 203, 6.8.2011, p. 21),

-{650} 32011 R 0797: Commission Implementing Regulation (EU) No 797/2011 of 9 August 2011

(OJ L 205, 10.8.2011, p. 3),

-{651} 32011 R 0798: Commission Implementing Regulation (EU) No 798/2011 of 9 August 2011

(OJ L 205, 10.8.2011, p. 9),

-{652} 32011 R 0800: Commission Implementing Regulation (EU) No 800/2011 of 9 August 2011

(OJ L 205, 10.8.2011, p. 22),

{638} Point and indent inserted by Decision No 203/2014 (OJ L 202, 30.7.2015, p. 57 and EEA Supplement No 43, 30.7.2015, p. 57), e.i.f.

1.6.2015.

{639} Indent added by Decision No 204/2014 (OJ L 202, 30.7.2015, p. 64 and EEA Supplement No 43, 30.7.2015, p. 63), e.i.f. 1.6.2015.

{640} Indent added by Decision No 204/2014 (OJ L 202, 30.7.2015, p. 64 and EEA Supplement No 43, 30.7.2015, p. 63), e.i.f. 1.6.2015.

{641} Indent added by Decision No 204/2014 (OJ L 202, 30.7.2015, p. 64 and EEA Supplement No 43, 30.7.2015, p. 63), e.i.f. 1.6.2015.

{642} Indent added by Decision No 204/2014 (OJ L 202, 30.7.2015, p. 64 and EEA Supplement No 43, 30.7.2015, p. 63), e.i.f. 1.6.2015.

{643} Indent added by Decision No 204/2014 (OJ L 202, 30.7.2015, p. 64 and EEA Supplement No 43, 30.7.2015, p. 63), e.i.f. 1.6.2015.

{644} Indent added by Decision No 204/2014 (OJ L 202, 30.7.2015, p. 64 and EEA Supplement No 43, 30.7.2015, p. 63), e.i.f. 1.6.2015.

{645} Indent added by Decision No 204/2014 (OJ L 202, 30.7.2015, p. 64 and EEA Supplement No 43, 30.7.2015, p. 63), e.i.f. 1.6.2015.

{646} Indent added by Decision No 204/2014 (OJ L 202, 30.7.2015, p. 64 and EEA Supplement No 43, 30.7.2015, p. 63), e.i.f. 1.6.2015.

{647} Indent added by Decision No 204/2014 (OJ L 202, 30.7.2015, p. 64 and EEA Supplement No 43, 30.7.2015, p. 63), e.i.f. 1.6.2015.

{648} Indent added by Decision No 204/2014 (OJ L 202, 30.7.2015, p. 64 and EEA Supplement No 43, 30.7.2015, p. 63), e.i.f. 1.6.2015.

{649} Indent added by Decision No 204/2014 (OJ L 202, 30.7.2015, p. 64 and EEA Supplement No 43, 30.7.2015, p. 63), e.i.f. 1.6.2015.

{650} Indent added by Decision No 204/2014 (OJ L 202, 30.7.2015, p. 64 and EEA Supplement No 43, 30.7.2015, p. 63), e.i.f. 1.6.2015.

{651} Indent added by Decision No 204/2014 (OJ L 202, 30.7.2015, p. 64 and EEA Supplement No 43, 30.7.2015, p. 63), e.i.f. 1.6.2015.

{652} Indent added by Decision No 204/2014 (OJ L 202, 30.7.2015, p. 64 and EEA Supplement No 43, 30.7.2015, p. 63), e.i.f. 1.6.2015.

Page 62: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 188

-{653} 32011 R 0806: Commission Implementing Regulation (EU) No 806/2011 of 10 August 2011

(OJ L 206, 11.8.2011, p. 39),

-{654} 32011 R 0807: Commission Implementing Regulation (EU) No 807/2011 of 10 August 2011

(OJ L 206, 11.8.2011, p. 44),

-{655} 32011 R 0810: Commission Implementing Regulation (EU) No 810/2011 of 11 August 2011

(OJ L 207, 12.8.2011, p. 7),

-{656} 32011 R 0820: Commission Implementing Regulation (EU) No 820/2011 of 16 August 2011

(OJ L 209, 17.8.2011, p. 18),

-{657} 32011 R 0974: Commission Implementing Regulation (EU) No 974/2011 of 29 September

2011 (OJ L 255, 1.10.2011, p. 1),

-{658} 32011 R 0993: Commission Implementing Regulation (EU) No 993/2011 of 6 October 2011

(OJ L 263, 7.10.2011, p. 1),

-{659} 32011 R 1022: Commission Implementing Regulation (EU) No 1022/2011 of 14 October

2011 (OJ L 270, 15.10.2011, p. 20),

-{660} 32011 R 1100: Commission Implementing Regulation (EU) No 1100/2011 of 31 October

2011 (OJ L 285, 1.11.2011, p. 10),

-{661} 32011 R 1134: Commission Implementing Regulation (EU) No 1134/2011 of 9 November

2011 (OJ L 292, 10.11.2011, p. 1),

-{662} 32011 R 1143: Commission Implementing Regulation (EU) No 1143/2011 of 10 November

2011 (OJ L 293, 11.11.2011, p. 26),

-{663} 32012 R 0735: Commission Implementing Regulation (EU) No 735/2012 of 14 August 2012

(OJ L 218, 15.8.2012, p. 3),

-{664} 32012 R 0746: Commission Implementing Regulation (EU) No 746/2012 of 16 August 2012

(OJ L 219, 17.8.2012, p. 15),

-{665} 32012 R 0087: Commission Implementing Regulation (EU) No 87/2012 of 1 February 2012

(OJ L 30, 2.2.2012, p. 8),

-{666} 32012 R 0127: Commission Implementing Regulation (EU) No 127/2012 of 14 February

2012 (OJ L 41, 15.2.2012, p. 12),

-{667} 32012 R 0287: Commission Implementing Regulation (EU) No 287/2012 of 30 March 2012

(OJ L 95, 31.3.2012, p. 7),

{653} Indent added by Decision No 204/2014 (OJ L 202, 30.7.2015, p. 64 and EEA Supplement No 43, 30.7.2015, p. 63), e.i.f. 1.6.2015.

{654} Indent added by Decision No 204/2014 (OJ L 202, 30.7.2015, p. 64 and EEA Supplement No 43, 30.7.2015, p. 63), e.i.f. 1.6.2015.

{655} Indent added by Decision No 204/2014 (OJ L 202, 30.7.2015, p. 64 and EEA Supplement No 43, 30.7.2015, p. 63), e.i.f. 1.6.2015.

{656} Indent added by Decision No 204/2014 (OJ L 202, 30.7.2015, p. 64 and EEA Supplement No 43, 30.7.2015, p. 63), e.i.f. 1.6.2015.

{657} Indent added by Decision No 204/2014 (OJ L 202, 30.7.2015, p. 64 and EEA Supplement No 43, 30.7.2015, p. 63), e.i.f. 1.6.2015.

{658} Indent added by Decision No 204/2014 (OJ L 202, 30.7.2015, p. 64 and EEA Supplement No 43, 30.7.2015, p. 63), e.i.f. 1.6.2015.

{659} Indent added by Decision No 204/2014 (OJ L 202, 30.7.2015, p. 64 and EEA Supplement No 43, 30.7.2015, p. 63), e.i.f. 1.6.2015.

{660} Indent added by Decision No 204/2014 (OJ L 202, 30.7.2015, p. 64 and EEA Supplement No 43, 30.7.2015, p. 63), e.i.f. 1.6.2015.

{661} Indent added by Decision No 204/2014 (OJ L 202, 30.7.2015, p. 64 and EEA Supplement No 43, 30.7.2015, p. 63), e.i.f. 1.6.2015.

{662} Indent added by Decision No 204/2014 (OJ L 202, 30.7.2015, p. 64 and EEA Supplement No 43, 30.7.2015, p. 63), e.i.f. 1.6.2015.

{663} Indent added by Decision No 204/2014 (OJ L 202, 30.7.2015, p. 64 and EEA Supplement No 43, 30.7.2015, p. 63), e.i.f. 1.6.2015.

{664} Indent added by Decision No 204/2014 (OJ L 202, 30.7.2015, p. 64 and EEA Supplement No 43, 30.7.2015, p. 63), e.i.f. 1.6.2015 and

subsequently corrected before publication by Corrigendum of 20.3.2015.

{665} Indent added by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{666} Indent added by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{667} Indent added by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

Page 63: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 189

-{668} 32012 R 0359: Commission Implementing Regulation (EU) No 359/2012 of 25 April 2012

(OJ L 114, 26.4.2012, p. 1),

-{669} 32012 R 0369: Commission Implementing Regulation (EU) No 369/2012 of 27 April 2012

(OJ L 116, 28.4.2012, p. 19),

-{670} 32012 R 0571: Commission Implementing Regulation (EU) No 571/2012 of 28 June 2012

(OJ L 169, 29.6.2012, p. 46),

-{671} 32012 R 0582: Commission Implementing Regulation (EU) No 582/2012 of 2 July 2012 (OJ

L 173, 3.7.2012, p. 3),

-{672} 32012 R 0589: Commission Implementing Regulation (EU) No 589/2012 of 4 July 2012 (OJ

L 175, 5.7.2012, p. 7),

-{673} 32012 R 0595: Commission Implementing Regulation (EU) No 595/2012 of 5 July 2012 (OJ

L 176, 6.7.2012, p. 46),

-{674} 32012 R 0597: Commission Implementing Regulation (EU) No 597/2012 of 5 July 2012 (OJ

L 176, 6.7.2012, p. 54),

-{675} 32012 R 0608: Commission Implementing Regulation (EU) No 608/2012 of 6 July 2012 (OJ

L 177, 7.7.2012, p. 19),

-{676} 32012 R 0637: Commission Implementing Regulation (EU) No 637/2012 of 13 July 2012

(OJ L 186, 14.7.2012, p. 20),

-{677} 32012 R 1037: Commission Implementing Regulation (EU) No 1037/2012 of 7 November

2012 (OJ L 308, 8.11.2012, p. 15),

-{678} 32012 R 1043: Commission Implementing Regulation (EU) No 1043/2012 of 8 November

2012 (OJ L 310, 9.11.2012, p. 24),

-{679} 32012 R 1197: Commission Implementing Regulation (EU) No 1197/2012 of 13 December

2012 (OJ L 342, 14.12.2012, p. 27),

-{680} 32012 R 1237: Commission Implementing Regulation (EU) No 1237/2012 of 19 December

2012 (OJ L 350, 20.12.2012, p. 55),

-{681} 32012 R 1238: Commission Implementing Regulation (EU) No 1238/2012 of 19 December

2012 (OJ L 350, 20.12.2012, p. 59),

-{682} 32013 R 0017: Commission Implementing Regulation (EU) No 17/2013 of 14 January 2013

(OJ L 9, 15.1.2013, p. 5),

{668} Indent added by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{669} Indent added by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{670} Indent added by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{671} Indent added by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{672} Indent added by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{673} Indent added by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{674} Indent added by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{675} Indent added by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{676} Indent added by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{677} Indent added by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{678} Indent added by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{679} Indent added by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{680} Indent added by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{681} Indent added by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{682} Indent added by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

Page 64: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 190

-{683} 32013 R 0022: Commission Implementing Regulation (EU) No 22/2013 of 15 January 2013

(OJ L 11, 16.1.2013, p. 8),

-{684} 32013 R 0175: Commission Implementing Regulation (EU) No 175/2013 of 27 February

2013 (OJ L 56, 28.2.2013, p. 4),

-{685} 32013 R 0188: Commission Implementing Regulation (EU) No 188/2013 of 5 March 2013

(OJ L 62, 6.3.2013, p. 13),

-{686} 32013 R 0200: Commission Implementing Regulation (EU) No 200/2013 of 8 March 2013

(OJ L 67, 9.3.2013, p. 1), as corrected by OJ L 235, 4.9.2013, p. 12,

-{687} 32013 R 0201: Commission Implementing Regulation (EU) No 201/2013 of 8 March 2013

(OJ L 67, 9.3.2013, p. 6),

-{688} 32013 R 0350: Commission Implementing Regulation (EU) No 350/2013 of 17 April 2013

(OJ L 108, 18.4.2013, p. 9),

-{689} 32013 R 0355: Commission Implementing Regulation (EU) No 355/2013 of 18 April 2013

(OJ L 109, 19.4.2013, p. 14),

-{690} 32013 R 0356: Commission Implementing Regulation (EU) No 356/2013 of 18 April 2013

(OJ L 109, 19.4.2013, p. 18),

-{691} 32013 R 0366: Commission Implementing Regulation (EU) No 366/2013 of 22 April 2013

(OJ L 111, 23.4.2013, p. 30),

-{692} 32013 R 0367: Commission Implementing Regulation (EU) No 367/2013 of 22 April 2013

(OJ L 111, 23.4.2013, p. 33),

-{693} 32013 R 0368: Commission Implementing Regulation (EU) No 368/2013 of 22 April 2013

(OJ L 111, 23.4.2013, p. 36),

-{694} 32013 R 0373: Commission Implementing Regulation (EU) No 373/2013 of 23 April 2013

(OJ L 112, 24.4.2013, p. 10),

-{695} 32013 R 0375: Commission Implementing Regulation (EU) No 375/2013 of 23 April 2013

(OJ L 112, 24.4.2013, p. 15),

-{696} 32013 R 0378: Commission Implementing Regulation (EU) No 378/2013 of 24 April 2013

(OJ L 113, 25.4.2013, p. 5),

-{697} 32013 R 0533: Commission Implementing Regulation (EU) No 533/2013 of 10 June 2013

(OJ L 159, 11.6.2013, p. 9),

{683} Indent added by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{684} Indent added by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{685} Indent added by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{686} Indent added by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{687} Indent added by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{688} Indent added by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{689} Indent added by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{690} Indent added by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{691} Indent added by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{692} Indent added by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{693} Indent added by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{694} Indent added by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{695} Indent added by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{696} Indent added by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{697} Indent added by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

Page 65: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 191

-{698} 32013 R 0546: Commission Implementing Regulation (EU) No 546/2013 of 14 June 2013

(OJ L 163, 15.6.2013, p. 17),

-{699} 32013 R 0568: Commission Implementing Regulation (EU) No 568/2013 of 18 June 2013

(OJ L 167, 19.6.2013, p. 33),

-{700} 32013 R 0570: Commission Implementing Regulation (EU) No 570/2013 of 17 June 2013

(OJ L 168, 20.6.2013, p. 18),

-{701} 32013 R 0762: Commission Implementing Regulation (EU) No 762/2013 of 7 August 2013

(OJ L 213, 8.8.2013, p. 14),

-{702} 32013 R 0767: Commission Implementing Regulation (EU) No 767/2013 of 8 August 2013

(OJ L 214, 9.8.2013, p. 5),

-{703} 32013 R 0802: Commission Implementing Regulation (EU) No 802/2013 of 22 August 2013

(OJ L 225, 23.8.2013, p. 13),

-{704} 32013 R 0826: Commission Implementing Regulation (EU) No 826/2013 of 29 August 2013

(OJ L 232, 30.8.2013, p. 13),

-{705} 32013 R 0827: Commission Implementing Regulation (EU) No 827/2013 of 29 August 2013

(OJ L 232, 30.8.2013, p. 18),

-{706} 32013 R 0828: Commission Implementing Regulation (EU) No 828/2013 of 29 August 2013

(OJ L 232, 30.8.2013, p. 23),

-{707} 32013 R 0829: Commission Implementing Regulation (EU) No 829/2013 of 29 August 2013

(OJ L 232, 30.8.2013, p. 29),

-{708} 32013 R 0832: Commission Implementing Regulation (EU) No 832/2013 of 30 August 2013

(OJ L 233, 31.8.2013, p. 3),

-{709} 32013 R 0833: Commission Implementing Regulation (EU) No 833/2013 of 30 August 2013

(OJ L 233, 31.8.2013, p. 7),

-{710} 32013 R 1031: Commission Implementing Regulation (EU) No 1031/2013 of 24 October

2013 (OJ L 283, 25.10.2013, p. 17),

-{711} 32013 R 1136: Commission Implementing Regulation (EU) No 1136/2013 of 12 November

2013 (OJ L 302, 13.11.2013, p. 34),

-{712} 32013 R 1175: Commission Implementing Regulation (EU) No 1175/2013 of 20 November

2013 (OJ L 312, 21.11.2013, p. 18),

{698} Indent added by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{699} Indent added by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{700} Indent added by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{701} Indent added by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{702} Indent added by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{703} Indent added by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{704} Indent added by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{705} Indent added by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{706} Indent added by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{707} Indent added by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{708} Indent added by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{709} Indent added by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{710} Indent added by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{711} Indent added by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{712} Indent added by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

Page 66: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 192

-{713} 32013 R 1176: Commission Implementing Regulation (EU) No 1176/2013 of 20 November

2013 (OJ L 312, 21.11.2013, p. 23),

-{714} 32013 R 1177: Commission Implementing Regulation (EU) No 1177/2013 of 20 November

2013 (OJ L 312, 21.11.2013, p. 28),

-{715} 32013 R 1187: Commission Implementing Regulation (EU) No 1187/2013 of 21 November

2013 (OJ L 313, 22.11.2013, p. 42),

-{716} 32013 R 1192: Commission Implementing Regulation (EU) No 1192/2013 of 22 November

2013 (OJ L 314, 23.11.2013, p. 6),

-{717} 32013 R 1195: Commission Implementing Regulation (EU) No 1195/2013 of 22 November

2013 (OJ L 315, 26.11.2013, p. 27),

-{718} 32013 R 1199: Commission Implementing Regulation (EU) No 1199/2013 of 25 November

2013 (OJ L 315, 26.11.2013, p. 69),

-{719} 32013 R 0187: Commission Implementing Regulation (EU) No 187/2013 of 5 March 2013

(OJ L 65, 6.3.2013, p.10),

-{720} 32013 R 0190: Commission Implementing Regulation (EU) No 190/2013 of 5 March 2013

(OJ L 62, 6.3.2013, p. 19),

-{721} 32013 R 0365: Commission Implementing Regulation (EU) No 365/2013 of 22 April 2013

(OJ L 111, 23.4.2013, p. 27),

-{722} 32013 R 0369: Commission Implementing Regulation (EU) No 369/2013 of 22 April 2013

(OJ L 111, 23.4.2013, p. 39),

-{723} 32013 R 0485: Commission Implementing Regulation (EU) No 485/2013 of 24 May 2013

(OJ L 139, 25.5.2013, p. 12),

-{724} 32013 R 0532: Commission Implementing Regulation (EU) No 532/2013 of 10 June 2013

(OJ L 159, 11.6.2013, p. 6),

-{725} 32013 R 0781: Commission Implementing Regulation (EU) No 781/2013 of 14 August 2013

(OJ L 219, 15.8.2013, p. 22),

-{726} 32013 R 0790: Commission Implementing Regulation (EU) No 790/2013 of 19 August 2013

(OJ L 222, 20.8.2013, p. 6),

-{727} 32013 R 0798: Commission Implementing Regulation (EU) No 798/2013 of 21 August 2013

(OJ L 224, 22.8.2013, p. 9),

{713} Indent added by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{714} Indent added by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{715} Indent added by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{716} Indent added by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{717} Indent added by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{718} Indent added by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{719} Indent added by Decision No 206/2014 (OJ L 202, 30.7.2015, p. 87 and EEA Supplement No 43, 30.7.2015, p. 86), e.i.f. 1.6.2015.

{720} Indent added by Decision No 206/2014 (OJ L 202, 30.7.2015, p. 87 and EEA Supplement No 43, 30.7.2015, p. 86), e.i.f. 1.6.2015.

{721} Indent added by Decision No 206/2014 (OJ L 202, 30.7.2015, p. 87 and EEA Supplement No 43, 30.7.2015, p. 86), e.i.f. 1.6.2015.

{722} Indent added by Decision No 206/2014 (OJ L 202, 30.7.2015, p. 87 and EEA Supplement No 43, 30.7.2015, p. 86), e.i.f. 1.6.2015.

{723} Indent added by Decision No 206/2014 (OJ L 202, 30.7.2015, p. 87 and EEA Supplement No 43, 30.7.2015, p. 86), e.i.f. 1.6.2015.

{724} Indent added by Decision No 206/2014 (OJ L 202, 30.7.2015, p. 87 and EEA Supplement No 43, 30.7.2015, p. 86), e.i.f. 1.6.2015.

{725} Indent added by Decision No 206/2014 (OJ L 202, 30.7.2015, p. 87 and EEA Supplement No 43, 30.7.2015, p. 86), e.i.f. 1.6.2015.

{726} Indent added by Decision No 206/2014 (OJ L 202, 30.7.2015, p. 87 and EEA Supplement No 43, 30.7.2015, p. 86), e.i.f. 1.6.2015.

{727} Indent added by Decision No 206/2014 (OJ L 202, 30.7.2015, p. 87 and EEA Supplement No 43, 30.7.2015, p. 86), e.i.f. 1.6.2015.

Page 67: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 193

-{728} 32013 R 1089: Commission Implementing Regulation (EU) No 1089/2013 of 4 November

2013 (OJ L 293, 5.11.2013, p. 31),

-{729} 32013 R 1124: Commission Implementing Regulation (EU) No 1124/2013 of 8 November

2013 (OJ L 299, 9.11.2013, p. 34),

-{730} 32013 R 1150: Commission Implementing Regulation (EU) No 1150/2013 of 14 November

2013 (OJ L 305, 15.11.2013, p. 13),

-{731} 32013 R 1165: Commission Implementing Regulation (EU) No 1165/2013 of 18 November

2013 (OJ L 309, 19.11.2013, p. 17),

-{732} 32013 R 1166: Commission Implementing Regulation (EU) No 1166/2013 of 18 November

2013 (OJ L 309, 19.11.2013, p. 22),

-{733} 32013 R 1178: Commission Implementing Regulation (EU) No 1178/2013 of 20 November

2013 (OJ L 312, 21.11.2013, p. 33),

-{734} 32014 R 0085: Commission Implementing Regulation (EU) No 85/2014 of 30 January 2014

(OJ L 28, 31.1.2014, p. 34),

-{735} 32014 R 0140: Commission Implementing Regulation (EU) No 140/2014 of 13 February

2014 (OJ L 44, 14.2.2014, p. 35), as corrected by OJ L 277, 22.10.2015, p. 60,

-{736} 32014 R 0141: Commission Implementing Regulation (EU) No 141/2014 of 13 February

2014 (OJ L 44, 14.2.2014, p. 40),

-{737} 32014 R 0143: Commission Implementing Regulation (EU) No 143/2014 of 14 February 2014

(OJ L 45, 15.2.2014, p. 1),

-{738} 32014 R 0144: Commission Implementing Regulation (EU) No 144/2014 of 14 February

2014 (OJ L 45, 15.2.2014, p. 7),

-{739} 32014 R 0145: Commission Implementing Regulation (EU) No 145/2014 of 14 February

2014 (OJ L 45, 15.2.2014, p. 12),

-{740} 32014 R 0149: Commission Implementing Regulation (EU) No 149/2014 of 17 February

2014 (OJ L 46, 18.2.2014, p. 3),

-{741} 32014 R 0151: Commission Implementing Regulation (EU) No 151/2014 of 18 February

2014 (OJ L 48, 19.2.2014, p. 1),

-{742} 32014 R 0154: Commission Implementing Regulation (EU) No 154/2014 of 19 February

2014 (OJ L 50, 20.2.2014, p. 7),

{728} Indent added by Decision No 206/2014 (OJ L 202, 30.7.2015, p. 87 and EEA Supplement No 43, 30.7.2015, p. 86), e.i.f. 1.6.2015.

{729} Indent added by Decision No 206/2014 (OJ L 202, 30.7.2015, p. 87 and EEA Supplement No 43, 30.7.2015, p. 86), e.i.f. 1.6.2015.

{730} Indent added by Decision No 206/2014 (OJ L 202, 30.7.2015, p. 87 and EEA Supplement No 43, 30.7.2015, p. 86), e.i.f. 1.6.2015.

{731} Indent added by Decision No 206/2014 (OJ L 202, 30.7.2015, p. 87 and EEA Supplement No 43, 30.7.2015, p. 86), e.i.f. 1.6.2015.

{732} Indent added by Decision No 206/2014 (OJ L 202, 30.7.2015, p. 87 and EEA Supplement No 43, 30.7.2015, p. 86), e.i.f. 1.6.2015.

{733} Indent added by Decision No 206/2014 (OJ L 202, 30.7.2015, p. 87 and EEA Supplement No 43, 30.7.2015, p. 86), e.i.f. 1.6.2015.

{734} Indent added by Decision No 207/2014 (OJ L 202, 30.7.2015, p. 92 and EEA Supplement No 43, 30.7.2015, p. 91), e.i.f. 1.6.2015.

{735} Indent added by Decision No 207/2014 (OJ L 202, 30.7.2015, p. 92 and EEA Supplement No 43, 30.7.2015, p. 91), e.i.f. 1.6.2015.

Corrigendum to the EU act subsequently taken note of by the EEA Joint Committee on 11.12.2015.

{736} Indent added by Decision No 207/2014 (OJ L 202, 30.7.2015, p. 92 and EEA Supplement No 43, 30.7.2015, p. 91), e.i.f. 1.6.2015.

{737} Indent added by Decision No 207/2014 (OJ L 202, 30.7.2015, p. 92 and EEA Supplement No 43, 30.7.2015, p. 91), e.i.f. 1.6.2015.

{738} Indent added by Decision No 207/2014 (OJ L 202, 30.7.2015, p. 92 and EEA Supplement No 43, 30.7.2015, p. 91), e.i.f. 1.6.2015.

{739} Indent added by Decision No 207/2014 (OJ L 202, 30.7.2015, p. 92 and EEA Supplement No 43, 30.7.2015, p. 91), e.i.f. 1.6.2015.

{740} Indent added by Decision No 207/2014 (OJ L 202, 30.7.2015, p. 92 and EEA Supplement No 43, 30.7.2015, p. 91), e.i.f. 1.6.2015.

{741} Indent added by Decision No 207/2014 (OJ L 202, 30.7.2015, p. 92 and EEA Supplement No 43, 30.7.2015, p. 91), e.i.f. 1.6.2015.

{742} Indent added by Decision No 207/2014 (OJ L 202, 30.7.2015, p. 92 and EEA Supplement No 43, 30.7.2015, p. 91), e.i.f. 1.6.2015.

Page 68: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 194

-{743} 32014 R 0192: Commission Implementing Regulation (EU) No 192/2014 of 27 February

2014 (OJ L 59, 28.2.2014, p. 20),

-{744} 32014 R 0193: Commission Implementing Regulation (EU) No 193/2014 of 27 February

2014 (OJ L 59, 28.2.2014, p. 25),

-{745} 32014 R 0187: Commission Implementing Regulation (EU) No 187/2014 of 26 February

2014 (OJ L 57, 27.2.2014, p. 24),

-{746} 32014 R 0462: Commission Implementing Regulation (EU) No 462/2014 of 5 May 2014 (OJ

L 134, 7.5.2014, p. 28),

-{747} 32014 R 0485: Commission Implementing Regulation (EU) No 485/2014 of 12 May 2014

(OJ L 138, 13.5.2014, p. 65),

-{748} 32014 R 0486: Commission Implementing Regulation (EU) No 486/2014 of 12 May 2014

(OJ L 138, 13.5.2014, p. 70),

-{749} 32014 R 0487: Commission Implementing Regulation (EU) No 487/2014 of 12 May 2014

(OJ L 138, 13.5.2014, p. 72),

-{750} 32014 R 0496: Commission Implementing Regulation (EU) No 496/2014 of 14 May 2014

(OJ L 143, 15.5.2014, p. 1),

-{751} 32014 R 0504: Commission Implementing Regulation (EU) No 504/2014 of 15 May 2014

(OJ L 145, 16.5.2014, p. 28),

-{752} 32014 R 0563: Commission Implementing Regulation (EU) No 563/2014 of 23 May 2014

(OJ L 156, 24.5.2014, p. 5),

-{753} 32014 R 0571: Commission Implementing Regulation (EU) No 571/2014 of 26 May 2014

(OJ L 157, 27.5.2014, p. 96),

-{754} 32014 R 0629: Commission Implementing Regulation (EU) No 629/2014 of 12 June 2014

(OJ L 174, 13.6.2014, p. 33),

-{755} 32014 R 0632: Commission Implementing Regulation (EU) No 632/2014 of 13 May 2014

(OJ L 175, 14.6.2014, p. 1),

-{756} 32014 R 0678: Commission Implementing Regulation (EU) No 678/2014 of 19 June 2014

(OJ L 180, 20.6.2014, p. 11),

-{757} 32014 R 0878: Commission Implementing Regulation (EU) No 878/2014 of 12 August 2014

(OJ L 240, 13.8.2014, p. 18),

{743} Indent added by Decision No 207/2014 (OJ L 202, 30.7.2015, p. 92 and EEA Supplement No 43, 30.7.2015, p. 91), e.i.f. 1.6.2015.

{744} Indent added by Decision No 207/2014 (OJ L 202, 30.7.2015, p. 92 and EEA Supplement No 43, 30.7.2015, p. 91), e.i.f. 1.6.2015.

{745} Indent added by Decision No 220/2014 (OJ L 230, 3.9.2015, p. 19 and EEA Supplement No 52, 3.9.2015, p. 19), e.i.f. 1.6.2015.

{746} Indent added by Decision No 220/2014 (OJ L 230, 3.9.2015, p. 19 and EEA Supplement No 52, 3.9.2015, p. 19), e.i.f. 1.6.2015.

{747} Indent added by Decision No 220/2014 (OJ L 230, 3.9.2015, p. 19 and EEA Supplement No 52, 3.9.2015, p. 19), e.i.f. 1.6.2015.

{748} Indent added by Decision No 220/2014 (OJ L 230, 3.9.2015, p. 19 and EEA Supplement No 52, 3.9.2015, p. 19), e.i.f. 1.6.2015.

{749} Indent added by Decision No 220/2014 (OJ L 230, 3.9.2015, p. 19 and EEA Supplement No 52, 3.9.2015, p. 19), e.i.f. 1.6.2015.

{750} Indent added by Decision No 220/2014 (OJ L 230, 3.9.2015, p. 19 and EEA Supplement No 52, 3.9.2015, p. 19), e.i.f. 1.6.2015.

{751} Indent added by Decision No 220/2014 (OJ L 230, 3.9.2015, p. 19 and EEA Supplement No 52, 3.9.2015, p. 19), e.i.f. 1.6.2015.

{752} Indent added by Decision No 221/2014 (OJ L 230, 3.9.2015, p. 22 and EEA Supplement No 52, 3.9.2015, p. 22), e.i.f. 1.6.2015.

{753} Indent added by Decision No 221/2014 (OJ L 230, 3.9.2015, p. 22 and EEA Supplement No 52, 3.9.2015, p. 22), e.i.f. 1.6.2015.

{754} Indent added by Decision No 221/2014 (OJ L 230, 3.9.2015, p. 22 and EEA Supplement No 52, 3.9.2015, p. 22), e.i.f. 1.6.2015.

{755} Indent added by Decision No 221/2014 (OJ L 230, 3.9.2015, p. 22 and EEA Supplement No 52, 3.9.2015, p. 22), e.i.f. 1.6.2015.

{756} Indent added by Decision No 221/2014 (OJ L 230, 3.9.2015, p. 22 and EEA Supplement No 52, 3.9.2015, p. 22), e.i.f. 1.6.2015.

{757} Indent added by Decision No 270/2014 (OJ L 311, 26.11.2015, p. 21 and EEA Supplement No 71, 26.11.2015, p. 20), e.i.f. 1.6.2015.

Page 69: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 195

-{758} 32014 R 0880: Commission Implementing Regulation (EU) No 880/2014 of 12 August 2014

(OJ L 240, 13.8.2014, p. 22),

-{759} 32014 R 0890: Commission Implementing Regulation (EU) No 890/2014 of 14 August 2014

(OJ L 243, 15.8.2014, p. 42),

-{760} 32014 R 0891: Commission Implementing Regulation (EU) No 891/2014 of 14 August 2014

(OJ L 243, 15.8.2014, p. 47),

-{761} 32014 R 0916: Commission Implementing Regulation (EU) No 916/2014 of 22 August 2014

(OJ L 251, 23.8.2014, p. 16),

-{762} 32014 R 0917: Commission Implementing Regulation (EU) No 917/2014 of 22 August 2014

(OJ L 251, 23.8.2014, p. 19),

-{763} 32014 R 0918: Commission Implementing Regulation (EU) No 918/2014 of 22 August 2014

(OJ L 251, 23.8.2014, p. 24),

-{764} 32014 R 0921: Commission Implementing Regulation (EU) No 921/2014 of 25 August 2014

(OJ L 252, 26.8.2014, p. 3),

-{765} 32014 R 0922: Commission Implementing Regulation (EU) No 922/2014 of 25 August 2014

(OJ L 252, 26.8.2014, p. 6),

-{766} 32015 R 0415: Commission Implementing Regulation (EU) 2015/415 of 12 March 2015 (OJ

L 68, 13.3.2015, p. 28),

-{767} 32015 R 0232: Commission Implementing Regulation (EU) 2015/232 of 13 February 2015

(OJ L 39, 14.2.2015, p. 7),

-{768} 32014 R 1316: Commission Implementing Regulation (EU) No 1316/2014 of 11 December

2014 (OJ L 355, 12.12.2014, p. 1),

-{769} 32014 R 1330: Commission Implementing Regulation (EU) No 1330/2014 of 15 December

2014 (OJ L 359, 16.12.2014, p. 85),

-{770} 32014 R 1334: Commission Implementing Regulation (EU) No 1334/2014 of 16 December

2014 (OJ L 360, 17.12.2014, p. 1),

-{771} 32015 R 0051: Commission Implementing Regulation (EU) 2015/51 of 14 January 2015 (OJ

L 9, 15.1.2015, p. 22),

-{772} 32015 R 0058: Commission Implementing Regulation (EU) 2015/58 of 15 January 2015 (OJ

L 10, 16.1.2015, p. 25),

{758} Indent added by Decision No 270/2014 (OJ L 311, 26.11.2015, p. 21 and EEA Supplement No 71, 26.11.2015, p. 20), e.i.f. 1.6.2015.

{759} Indent added by Decision No 271/2014 (OJ L 311, 26.11.2015, p. 22 and EEA Supplement No 71, 26.11.2015, p. 21), e.i.f. 1.6.2015.

{760} Indent added by Decision No 271/2014 (OJ L 311, 26.11.2015, p. 22 and EEA Supplement No 71, 26.11.2015, p. 21), e.i.f. 1.6.2015.

{761} Indent added by Decision No 271/2014 (OJ L 311, 26.11.2015, p. 22 and EEA Supplement No 71, 26.11.2015, p. 21), e.i.f. 1.6.2015.

{762} Indent added by Decision No 271/2014 (OJ L 311, 26.11.2015, p. 22 and EEA Supplement No 71, 26.11.2015, p. 21), e.i.f. 1.6.2015.

{763} Indent added by Decision No 271/2014 (OJ L 311, 26.11.2015, p. 22 and EEA Supplement No 71, 26.11.2015, p. 21), e.i.f. 1.6.2015.

{764} Indent added by Decision No 271/2014 (OJ L 311, 26.11.2015, p. 22 and EEA Supplement No 71, 26.11.2015, p. 21), e.i.f. 1.6.2015.

{765} Indent added by Decision No 271/2014 (OJ L 311, 26.11.2015, p. 22 and EEA Supplement No 71, 26.11.2015, p. 21), e.i.f. 1.6.2015.

{766} Indent added by Decision No 93/2015 (OJ L 211, 4.8.2016, p. 31 and EEA Supplement No 42, 4.8.2016, p. 30), e.i.f. 1.6.2015.

{767} Indent added by Decision No 94/2015 (OJ L 211, 4.8.2016, p. 32 and EEA Supplement No 42, 4.8.2016, p. 31), e.i.f. 1.6.2015.

{768} Indent added by Decision No 95/2015 (OJ L 211, 4.8.2016, p. 33 and EEA Supplement No 42, 4.8.2016, p. 32), e.i.f. 1.6.2015.

{769} Indent added by Decision No 95/2015 (OJ L 211, 4.8.2016, p. 33 and EEA Supplement No 42, 4.8.2016, p. 32), e.i.f. 1.6.2015.

{770} Indent added by Decision No 95/2015 (OJ L 211, 4.8.2016, p. 33 and EEA Supplement No 42, 4.8.2016, p. 32), e.i.f. 1.6.2015.

{771} Indent added by Decision No 95/2015 (OJ L 211, 4.8.2016, p. 33 and EEA Supplement No 42, 4.8.2016, p. 32), e.i.f. 1.6.2015.

{772} Indent added by Decision No 95/2015 (OJ L 211, 4.8.2016, p. 33 and EEA Supplement No 42, 4.8.2016, p. 32), e.i.f. 1.6.2015.

Page 70: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 196

-{773} 32015 R 0306: Commission Implementing Regulation (EU) 2015/306 of 26 February 2015

(OJ L 56, 27.2.2015, p. 1),

-{774} 32015 R 0307: Commission Implementing Regulation (EU) 2015/307 of 26 February 2015

(OJ L 56, 27.2.2015, p. 6),

-{775} 32015 R 0308: Commission Implementing Regulation (EU) 2015/308 of 26 February 2015

(OJ L 56, 27.2.2015, p. 9),

-{776} 32015 R 0404: Commission Implementing Regulation (EU) 2015/404 of 11 March 2015 (OJ

L 67, 12.3.2015, p. 6),

-{777} 32015 R 0418: Commission Implementing Regulation (EU) 2015/418 of 12 March 2015 (OJ

L 68, 13.3.2015, p. 36),

-{778} 32015 R 0543: Commission Implementing Regulation (EU) 2015/543 of 1 April 2015 (OJ

L 90, 2.4.2015, p. 1),

-{779} 32015 R 0553: Commission Implementing Regulation (EU) 2015/553 of 7 April 2015 (OJ

L 92, 8.4.2015, p. 86),

-{780} 32015 R 0762: Commission Implementing Regulation (EU) 2015/762 of 12 May 2015 (OJ

L 120, 13.5.2015, p. 6),

-{781} 32015 R 1106: Commission Implementing Regulation (EU) 2015/1106 of 8 July 2015 (OJ

L 181, 9.7.2015, p. 70),

-{782} 32015 R 1115: Commission Implementing Regulation (EU) 2015/1115 of 9 July 2015 (OJ L

182, 10.7.2015, p. 22),

-{783} 32015 R 1154: Commission Implementing Regulation (EU) 2015/1154 of 14 July 2015 (OJ

L 187, 15.7.2015, p. 18),

-{784} 32015 R 1166: Commission Implementing Regulation (EU) 2015/1166 of 15 July 2015 (OJ

L 188, 16.7.2015, p. 34),

-{785} 32015 R 1201: Commission Implementing Regulation (EU) 2015/1201 of 22 July 2015 (OJ

L 195, 23.7.2015, p. 37),

-{786} 32015 R 1107: Commission Implementing Regulation (EU) 2015/1107 of 8 July 2015 (OJ L

181, 9.7.2015, p. 72),

-{787} 32015 R 1108: Commission Implementing Regulation (EU) 2015/1108 of 8 July 2015 (OJ L

181, 9.7.2015, p. 75),

{773} Indent added by Decision No 154/2015 (OJ L 341, 15.12.2016, p. 48 and EEA Supplement No 69, 15.12.2016, p. 49), e.i.f. 12.6.2015.

{774} Indent added by Decision No 154/2015 (OJ L 341, 15.12.2016, p. 48 and EEA Supplement No 69, 15.12.2016, p. 49), e.i.f. 12.6.2015.

{775} Indent added by Decision No 154/2015 (OJ L 341, 15.12.2016, p. 48 and EEA Supplement No 69, 15.12.2016, p. 49), e.i.f. 12.6.2015.

{776} Indent added by Decision No 155/2015 (OJ L 341, 15.12.2016, p. 50 and EEA Supplement No 69, 15.12.2016, p. 51), e.i.f. 12.6.2015.

{777} Indent added by Decision No 155/2015 (OJ L 341, 15.12.2016, p. 50 and EEA Supplement No 69, 15.12.2016, p. 51), e.i.f. 12.6.2015 and

subsequently corrected before publication by Corrigendum of 18.3.2016.

{778} Indent added by Decision No 183/2015 (OJ L 8, 12.1.2017, p. 12 and EEA Supplement No 3, 12.1.2017, p. 11), e.i.f. 11.7.2015.

{779} Indent added by Decision No 183/2015 (OJ L 8, 12.1.2017, p. 12 and EEA Supplement No 3, 12.1.2017, p. 11), e.i.f. 11.7.2015.

{780} Indent added by Decision No 263/2015 (OJ L 161, 22.6.2017, p. 45 and EEA Supplement No 38, 22.6.2017, p. 45), e.i.f. 1.11.2015.

{781} Indent added by Decision No 264/2015 (OJ L 161, 22.6.2017, p. 46 and EEA Supplement No 38, 22.6.2017, p. 47), e.i.f. 1.11.2015.

{782} Indent added by Decision No 264/2015 (OJ L 161, 22.6.2017, p. 46 and EEA Supplement No 38, 22.6.2017, p. 47), e.i.f. 1.11.2015.

{783} Indent added by Decision No 264/2015 (OJ L 161, 22.6.2017, p. 46 and EEA Supplement No 38, 22.6.2017, p. 47), e.i.f. 1.11.2015.

{784} Indent added by Decision No 264/2015 (OJ L 161, 22.6.2017, p. 46 and EEA Supplement No 38, 22.6.2017, p. 47), e.i.f. 1.11.2015.

{785} Indent added by Decision No 264/2015 (OJ L 161, 22.6.2017, p. 46 and EEA Supplement No 38, 22.6.2017, p. 47), e.i.f. 1.11.2015.

{786} Indent added by Decision No 265/2015 (OJ L 161, 22.6.2017, p. 48 and EEA Supplement No 38, 22.6.2017, p. 50), e.i.f. 1.11.2015.

{787} Indent added by Decision No 265/2015 (OJ L 161, 22.6.2017, p. 48 and EEA Supplement No 38, 22.6.2017, p. 50), e.i.f. 1.11.2015.

Page 71: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 197

-{788} 32015 R 1116: Commission Implementing Regulation (EU) 2015/1116 of 9 July 2015 (OJ L 182,

10.7.2015, p. 26),

-{789} 32015 R 1165: Commission Implementing Regulation (EU) 2015/1165 of 15 July 2015 (OJ L 188,

16.7.2015, p. 30),

-{790} 32015 R 1176: Commission Implementing Regulation (EU) 2015/1176 of 17 July 2015 (OJ L 192,

18.7.2015, p. 1),

-{791} 32015 R 1192: Commission Implementing Regulation (EU) 2015/1192 of 20 July 2015 (OJ L 193,

21.7.2015, p. 124),

-{792} 32015 R 1295: Commission Implementing Regulation (EU) 2015/1295 of 27 July 2015 (OJ L 199,

29.7.2015, p. 8),

-{793} 32015 R 1392: Commission Implementing Regulation (EU) 2015/1392 of 13 August 2015 (OJ

L 215, 14.8.2015, p. 34),

-{794} 32015 R 1396: Commission Implementing Regulation (EU) 2015/1396 of 14 August 2015 (OJ

L 216, 15.8.2015, p. 1),

-{795} 32015 R 1397: Commission Implementing Regulation (EU) 2015/1397 of 14 August 2015 (OJ

L 216, 15.8.2015, p. 3),

-{796} 32015 R 2069: Commission Implementing Regulation (EU) 2015/2069 of 17 November 2015 (OJ

L 301, 18.11.2015, p. 42),

-{797} 32015 R 2085: Commission Implementing Regulation (EU) 2015/2085 of 18 November 2015 (OJ

L 302, 19.11.2015, p. 93),

-{798} 32015 R 2233: Commission Implementing Regulation (EU) 2015/2233 of 2 December 2015 (OJ

L 317, 3.12.2015, p. 26),

-{799} 32015 R 1885: Commission Implementing Regulation (EU) 2015/1885 of 20 October 2015 (OJ

L 276, 21.10.2015, p. 48),

-{800} 32015 R 2033: Commission Implementing Regulation (EU) 2015/2033 of 13 November 2015 (OJ

L 298, 14.11.2015, p. 8),

-{801} 32015 R 2047: Commission Implementing Regulation (EU) 2015/2047 of 16 November 2015 (OJ

L 300, 17.11.2015, p. 8),

-{802} 32015 R 2084: Commission Implementing Regulation (EU) 2015/2084 of 18 November 2015 (OJ

L 302, 19.11.2015, p. 89),

{788} Indent added by Decision No 265/2015 (OJ L 161, 22.6.2017, p. 48 and EEA Supplement No 38, 22.6.2017, p. 50), e.i.f. 1.11.2015.

{789} Indent added by Decision No 265/2015 (OJ L 161, 22.6.2017, p. 48 and EEA Supplement No 38, 22.6.2017, p. 50), e.i.f. 1.11.2015.

{790} Indent added by Decision No 265/2015 (OJ L 161, 22.6.2017, p. 48 and EEA Supplement No 38, 22.6.2017, p. 50), e.i.f. 1.11.2015.

{791} Indent added by Decision No 265/2015 (OJ L 161, 22.6.2017, p. 48 and EEA Supplement No 38, 22.6.2017, p. 50), e.i.f. 1.11.2015.

{792} Indent added by Decision No 265/2015 (OJ L 161, 22.6.2017, p. 48 and EEA Supplement No 38, 22.6.2017, p. 50), e.i.f. 1.11.2015.

{793} Indent added by Decision No 304/2015 (OJ L 263, 12.10.2017, p. 15 and EEA Supplement No 64, 12.10.2017, p. 18), e.i.f. 12.12.2015.

{794} Indent added by Decision No 305/2015 (OJ L 263, 12.10.2017, p. 16 and EEA Supplement No 64, 12.10.2017, p. 20), e.i.f. 12.12.2015.

{795} Indent added by Decision No 305/2015 (OJ L 263, 12.10.2017, p. 16 and EEA Supplement No 64, 12.10.2017, p. 20), e.i.f. 12.12.2015.

{796} Indent added by Decision No 50/2016 (OJ L 270, 19.10.2017, p. 17 and EEA Supplement No 66, 19.10.2017, p. 17), e.i.f. 19.3.2016.

{797} Indent added by Decision No 50/2016 (OJ L 270, 19.10.2017, p. 17 and EEA Supplement No 66, 19.10.2017, p. 17), e.i.f. 19.3.2016.

{798} Indent added by Decision No 50/2016 (OJ L 270, 19.10.2017, p. 17 and EEA Supplement No 66, 19.10.2017, p. 17), e.i.f. 19.3.2016.

{799} Indent added by Decision No 85/2016 (OJ L 300, 16.11.2017, p. 31 and EEA Supplement No 73, 16.11.2017, p. 35), e.i.f. 30.4.2016.

{800} Indent added by Decision No 86/2016 (OJ L 300, 16.11.2017, p. 32 and EEA Supplement No 73, 16.11.2017, p. 36), e.i.f. 30.4.2016.

{801} Indent added by Decision No 86/2016 (OJ L 300, 16.11.2017, p. 32 and EEA Supplement No 73, 16.11.2017, p. 36), e.i.f. 30.4.2016.

{802} Indent added by Decision No 86/2016 (OJ L 300, 16.11.2017, p. 32 and EEA Supplement No 73, 16.11.2017, p. 36), e.i.f. 30.4.2016.

Page 72: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 198

-{803} 32015 R 2105: Commission Implementing Regulation (EU) 2015/2105 of 20 November 2015 (OJ

L 305, 21.11.2015, p. 31),

-{804} 32015 R 2198: Commission Implementing Regulation (EU) 2015/2198 of 27 November 2015 (OJ

L 313, 28.11.2015, p. 35),

-{805} 32016 R 0138: Commission Implementing Regulation (EU) 2016/138 of 2 February 2016 (OJ L 27,

3.2.2016, p. 5),

-{806} 32016 R 0139: Commission Implementing Regulation (EU) 2016/139 of 2 February 2016 (OJ L 27,

3.2.2016, p. 7),

-{807} 32016 R 0146: Commission Implementing Regulation (EU) 2016/146 of 4 February 2016 (OJ L 30,

5.2.2016, p. 7),

-{808} 32016 R 0147: Commission Implementing Regulation (EU) 2016/147 of 4 February 2016 (OJ L 30,

5.2.2016, p. 12),

-{809} 32016 R 0177: Commission Implementing Regulation (EU) 2016/177 of 10 February 2016 (OJ L 35,

11.2.2016, p. 1),

-{810} 32016 R 0182: Commission Implementing Regulation (EU) 2016/182 of 11 February 2016 (OJ L 37,

12.2.2016, p. 40),

-{811} 32016 R 0370: Commission Implementing Regulation (EU) 2016/370 of 15 March 2016 (OJ L 70,

16.3.2016, p. 7),

-{812} 32016 R 0389: Commission Implementing Regulation (EU) 2016/389 of 17 March 2016 (OJ L 73,

18.3.2016, p. 77),

-{813} 32016 R 0636: Commission Implementing Regulation (EU) 2016/636 of 22 April 2016 (OJ L 108,

23.4.2016, p. 22),

-{814} 32016 R 0638: Commission Implementing Regulation (EU) 2016/638 of 22 April 2016 (OJ L 108,

23.4.2016, p. 28),

-{815} 32016 R 0548: Commission Implementing Regulation (EU) 2016/548 of 8 April 2016 (OJ L 95,

9.4.2016, p. 1),

-{816} 32016 R 0549: Commission Implementing Regulation (EU) 2016/549 of 8 April 2016 (OJ L 95,

9.4.2016, p. 4),

-{817} 32016 R 0560: Commission Implementing Regulation (EU) 2016/560 of 11 April 2016 (OJ L 96,

12.4.2016, p. 23),

{803} Indent added by Decision No 86/2016 (OJ L 300, 16.11.2017, p. 32 and EEA Supplement No 73, 16.11.2017, p. 36), e.i.f. 30.4.2016.

{804} Indent added by Decision No 87/2016 (OJ L 300, 16.11.2017, p. 34 and EEA Supplement No 73, 16.11.2017, p. 38), e.i.f. 30.4.2016.

{805} Indent added by Decision No 149/2016 (OJ L 73, 15.3.2018, p. 22 and EEA Supplement No 16, 15.3.2018, p. 25), e.i.f. 9.7.2016.

{806} Indent added by Decision No 149/2016 (OJ L 73, 15.3.2018, p. 22 and EEA Supplement No 16, 15.3.2018, p. 25), e.i.f. 9.7.2016.

{807} Indent added by Decision No 149/2016 (OJ L 73, 15.3.2018, p. 22 and EEA Supplement No 16, 15.3.2018, p. 25), e.i.f. 9.7.2016.

{808} Indent added by Decision No 149/2016 (OJ L 73, 15.3.2018, p. 22 and EEA Supplement No 16, 15.3.2018, p. 25), e.i.f. 9.7.2016.

{809} Indent added by Decision No 149/2016 (OJ L 73, 15.3.2018, p. 22 and EEA Supplement No 16, 15.3.2018, p. 25), e.i.f. 9.7.2016.

{810} Indent added by Decision No 149/2016 (OJ L 73, 15.3.2018, p. 22 and EEA Supplement No 16, 15.3.2018, p. 25), e.i.f. 9.7.2016.

{811} Indent added by Decision No 181/2016 (OJ L 80, 22.3.2018, p. 25 and EEA Supplement No 19, 22.3.2018, p. 32), e.i.f. 24.9.2016.

{812} Indent added by Decision No 182/2016 (OJ L 80, 22.3.2018, p. 26 and EEA Supplement No 19, 22.3.2018, p. 34), e.i.f. 24.9.2016.

{813} Indent added by Decision No 183/2016 (OJ L 80, 22.3.2018, p. 27 and EEA Supplement No 19, 22.3.2018, p. 36), e.i.f. 24.9.2016.

{814} Indent added by Decision No 183/2016 (OJ L 80, 22.3.2018, p. 27 and EEA Supplement No 19, 22.3.2018, p. 36), e.i.f. 24.9.2016.

{815} Indent added by Decision No 236/2016 (OJ L 215, 23.8.2018, p. 33 and EEA Supplement No 56, 23.8.2018, p. 39), e.i.f. 3.12.2016.

{816} Indent added by Decision No 236/2016 (OJ L 215, 23.8.2018, p. 33 and EEA Supplement No 56, 23.8.2018, p. 39), e.i.f. 3.12.2016.

{817} Indent added by Decision No 236/2016 (OJ L 215, 23.8.2018, p. 33 and EEA Supplement No 56, 23.8.2018, p. 39), e.i.f. 3.12.2016.

Page 73: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 199

-{818} 32016 R 0864: Commission Implementing Regulation (EU) 2016/864 of 31 May 2016 (OJ L 144,

1.6.2016, p. 32),

-{819} 32016 R 0871: Commission Implementing Regulation (EU) 2016/871 of 1 June 2016 (OJ L 145,

2.6.2016, p. 4),

-{820} 32016 R 0872: Commission Implementing Regulation (EU) 2016/872 of 1 June 2016 (OJ L 145,

2.6.2016, p. 7),

-{821} 32016 R 0951: Commission Implementing Regulation (EU) 2016/951 of 15 June 2016 (OJ L 159,

16.6.2016, p. 6),

-{822} 32016 R 1056: Commission Implementing Regulation (EU) 2016/1056 of 29 June 2016 (OJ L 173,

30.6.2016, p. 52),

-{823} 32016 R 1313: Commission Implementing Regulation (EU) 2016/1313 of 1 August 2016 (OJ L 208,

2.8.2016, p. 1),

-{824} 32016 R 1414: Commission Implementing Regulation (EU) 2016/1414 of 24 August 2016 (OJ L

230, 25.8.2016, p. 16),

-{825} 32016 R 1423: Commission Implementing Regulation (EU) 2016/1423 of 25 August 2016 (OJ L

231, 26.8.2016, p. 20),

-{826} 32016 R 1425: Commission Implementing Regulation (EU) 2016/1425 of 25 August 2016 (OJ L

231, 26.8.2016, p. 30),

-{827} 32016 R 1426: Commission Implementing Regulation (EU) 2016/1426 of 25 August 2016 (OJ L

231, 26.8.2016, p. 34),

-{828} 32016 R 0950: Commission Implementing Regulation (EU) 2016/950 of 15 June 2016 (OJ L 159,

16.6.2016, p. 3),

-{829} 32016 R 0952: Commission Implementing Regulation (EU) 2016/952 of 15 June 2016 (OJ L 159,

16.6.2016, p. 10),

-{830} 32016 R 1424: Commission Implementing Regulation (EU) 2016/1424 of 25 August 2016 (OJ L

231, 26.8.2016, p. 25),

-{831} 32016 R 1429: Commission Implementing Regulation (EU) 2016/1429 of 26 August 2016 (OJ L

232, 27.8.2016, p. 1),

- {832} 32016 R 1978: Commission Implementing Regulation (EU) 2016/1978 of 11 November 2016 (OJ L

305, 12.11.2016, p. 23),

{818} Indent added by Decision No 237/2016 (OJ L 215, 23.8.2018, p. 35 and EEA Supplement No 56, 23.8.2018, p. 41), e.i.f. 3.12.2016.

{819} Indent added by Decision No 237/2016 (OJ L 215, 23.8.2018, p. 35 and EEA Supplement No 56, 23.8.2018, p. 41), e.i.f. 3.12.2016.

{820} Indent added by Decision No 237/2016 (OJ L 215, 23.8.2018, p. 35 and EEA Supplement No 56, 23.8.2018, p. 41), e.i.f. 3.12.2016.

{821} Indent added by Decision No 238/2016 (OJ L 215, 23.8.2018, p. 37 and EEA Supplement No 56, 23.8.2018, p. 43), e.i.f. 3.12.2016.

{822} Indent added by Decision No 30/2017 (OJ L 297, 22.11.2018, p. 38 and EEA Supplement No 78, 22.11.2018, p. 44), e.i.f. 4.2.2017.

{823} Indent added by Decision No 30/2017 (OJ L 297, 22.11.2018, p. 38 and EEA Supplement No 78, 22.11.2018, p. 44), e.i.f. 4.2.2017.

{824} Indent added by Decision No 30/2017 (OJ L 297, 22.11.2018, p. 38 and EEA Supplement No 78, 22.11.2018, p. 44), e.i.f. 4.2.2017.

{825} Indent added by Decision No 30/2017 (OJ L 297, 22.11.2018, p. 38 and EEA Supplement No 78, 22.11.2018, p. 44), e.i.f. 4.2.2017.

{826} Indent added by Decision No 30/2017 (OJ L 297, 22.11.2018, p. 38 and EEA Supplement No 78, 22.11.2018, p. 44), e.i.f. 4.2.2017.

{827} Indent added by Decision No 30/2017 (OJ L 297, 22.11.2018, p. 38 and EEA Supplement No 78, 22.11.2018, p. 44), e.i.f. 4.2.2017.

{828} Indent added by Decision No 55/2017 (OJ L 305, 29.11.2018, p. 21 and EEA Supplement No 81, 29.11.2018, p. 24), e.i.f. 18.3.2017.

{829} Indent added by Decision No 55/2017 (OJ L 305, 29.11.2018, p. 21 and EEA Supplement No 81, 29.11.2018, p. 24), e.i.f. 18.3.2017.

{830} Indent added by Decision No 55/2017 (OJ L 305, 29.11.2018, p. 21 and EEA Supplement No 81, 29.11.2018, p. 24), e.i.f. 18.3.2017.

{831} Indent added by Decision No 55/2017 (OJ L 305, 29.11.2018, p. 21 and EEA Supplement No 81, 29.11.2018, p. 24), e.i.f. 18.3.2017.

{832} Indent added by Decision No 56/2017 (OJ L 305, 29.11.2018, p. 23 and EEA Supplement No 81, 29.11.2018, p. 26), e.i.f. 18.3.2017.

Page 74: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 200

-{833} 32016 R 2016: Commission Implementing Regulation (EU) 2016/2016 of 17 November 2016 (OJ L

312, 18.11.2016, p. 21),

-{834} 32016 R 2035: Commission Implementing Regulation (EU) 2016/2035 of 21 November 2016 (OJ L

314, 22.11.2016, p. 7),

-{835} 32017 R 0157: Commission Implementing Regulation (EU) 2017/157 of 30 January 2017 (OJ L 25,

31.1.2017, p. 5),

-{836} 32017 R 0239: Commission Implementing Regulation (EU) 2017/239 of 10 February 2017 (OJ L 36,

11.2.2017, p. 39),

-{837} 32017 R 0244: Commission Implementing Regulation (EU) 2017/244 of 10 February 2017 (OJ L 36,

11.2.2017, p. 54),

-{838} 32017 R 0195: Commission Implementing Regulation (EU) 2017/195 of 3 February 2017 (OJ L 31,

4.2.2017, p. 21),

-{839} 32017 R 0407: Commission Implementing Regulation (EU) 2017/407 of 8 March 2017 (OJ L 63,

9.3.2017, p. 87),

-{840} 32017 R 0270: Commission Implementing Regulation (EU) 2017/270 of 16 February 2017 (OJ L 40,

17.2.2017, p. 48),

-{841} 32017 R 0359: Commission Implementing Regulation (EU) 2017/359 of 28 February 2017 (OJ L 54,

1.3.2017, p. 8),

-{842} 32017 R 0360: Commission Implementing Regulation (EU) 2017/360 of 28 February 2017 (OJ L 54,

1.3.2017, p. 11),

-{843} 32017 R 0375: Commission Implementing Regulation (EU) 2017/375 of 2 March 2017 (OJ L 58,

4.3.2017, p. 3),

-{844} 32017 R 0406: Commission Implementing Regulation (EU) 2017/406 of 8 March 2017 (OJ L 63,

9.3.2017, p. 83),

-{845} 32017 R 0408: Commission Implementing Regulation (EU) 2017/408 of 8 March 2017 (OJ L 63,

9.3.2017, p. 91),

-{846} 32017 R 0409: Commission Implementing Regulation (EU) 2017/409 of 8 March 2017 (OJ L 63,

9.3.2017, p. 95),

-{847} 32017 R 0419: Commission Implementing Regulation (EU) 2017/419 of 9 March 2017 (OJ L 64,

10.3.2017, p. 4),

{833} Indent added by Decision No 132/2017 (OJ L 128, 16.5.2019, p. 24 and EEA Supplement No 40, 16.5.2019, p. 25), e.i.f. 8.7.2017.

{834} Indent added by Decision No 132/2017 (OJ L 128, 16.5.2019, p. 24 and EEA Supplement No 40, 16.5.2019, p. 25), e.i.f. 8.7.2017.

{835} Indent added by Decision No 133/2017 (OJ L 128, 16.5.2019, p. 26 and EEA Supplement No 40, 16.5.2019, p. 27), e.i.f. 8.7.2017.

{836} Indent added by Decision No 133/2017 (OJ L 128, 16.5.2019, p. 26 and EEA Supplement No 40, 16.5.2019, p. 27), e.i.f. 8.7.2017.

{837} Indent added by Decision No 133/2017 (OJ L 128, 16.5.2019, p. 26 and EEA Supplement No 40, 16.5.2019, p. 27), e.i.f. 8.7.2017.

{838} Indent added by Decision No 134/2017 (OJ L 128, 16.5.2019, p. 28 and EEA Supplement No 40, 16.5.2019, p. 29), e.i.f. 8.7.2017.

{839} Indent added by Decision No 134/2017 (OJ L 128, 16.5.2019, p. 28 and EEA Supplement No 40, 16.5.2019, p. 29), e.i.f. 8.7.2017.

{840} Indent added by Decision No 174/2017 (OJ L 174, 27.6.2019, p. 37 and EEA Supplement No 52, 27.6.2019, p. 46), e.i.f. 23.9.2017.

{841} Indent added by Decision No 174/2017 (OJ L 174, 27.6.2019, p. 37 and EEA Supplement No 52, 27.6.2019, p. 46), e.i.f. 23.9.2017.

{842} Indent added by Decision No 174/2017 (OJ L 174, 27.6.2019, p. 37 and EEA Supplement No 52, 27.6.2019, p. 46), e.i.f. 23.9.2017.

{843} Indent added by Decision No 174/2017 (OJ L 174, 27.6.2019, p. 37 and EEA Supplement No 52, 27.6.2019, p. 46), e.i.f. 23.9.2017.

{844} Indent added by Decision No 174/2017 (OJ L 174, 27.6.2019, p. 37 and EEA Supplement No 52, 27.6.2019, p. 46), e.i.f. 23.9.2017.

{845} Indent added by Decision No 174/2017 (OJ L 174, 27.6.2019, p. 37 and EEA Supplement No 52, 27.6.2019, p. 46), e.i.f. 23.9.2017.

{846} Indent added by Decision No 174/2017 (OJ L 174, 27.6.2019, p. 37 and EEA Supplement No 52, 27.6.2019, p. 46), e.i.f. 23.9.2017.

{847} Indent added by Decision No 174/2017 (OJ L 174, 27.6.2019, p. 37 and EEA Supplement No 52, 27.6.2019, p. 46), e.i.f. 23.9.2017.

Page 75: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 201

-{848} 32017 R 0428: Commission Implementing Regulation (EU) 2017/428 of 10 March 2017 (OJ L 66,

11.3.2017, p. 1),

-{849} 32017 R 0438: Commission Implementing Regulation (EU) 2017/438 of 13 March 2017 (OJ L 67,

14.3.2017, p. 67),

-{850} 32017 R 0555: Commission Implementing Regulation (EU) 2017/555 of 24 March 2017 (OJ L 80,

25.3.2017, p. 1),

-{851} 32017 R 0725: Commission Implementing Regulation (EU) 2017/725 of 24 April 2017 (OJ L 107,

25.4.2017, p. 24),

-{852} 32017 R 0753: Commission Implementing Regulation (EU) 2017/753 of 28 April 2017 (OJ L 113,

29.4.2017, p. 24),

-{853} 32017 R 0755: Commission Implementing Regulation (EU) 2017/755 of 28 April 2017 (OJ L 113,

29.4.2017, p. 35),

-{854} 32017 R 0781: Commission Implementing Regulation (EU) 2017/781 of 5 May 2017 (OJ L 118,

6.5.2017, p. 1),

-{855} 32017 R 0805: Commission Implementing Regulation (EU) 2017/805 of 11 May 2017 (OJ L 121,

12.5.2017, p. 26),

-{856} 32017 R 0806: Commission Implementing Regulation (EU) 2017/806 of 11 May 2017 (OJ L 121,

12.5.2017, p. 31),

-{857} 32017 R 0831: Commission Implementing Regulation (EU) 2017/831 of 16 May 2017 (OJ L 124,

17.5.2017, p. 27),

-{858} 32017 R 0841: Commission Implementing Regulation (EU) 2017/841 of 17 May 2017 (OJ L 125,

18.5.2017, p. 12), as corrected by OJ L 2, 5.1.2018, p. 14.

-{859} 32017 R 0842: Commission Implementing Regulation (EU) 2017/842 of 17 May 2017 (OJ L 125,

18.5.2017, p. 16), as corrected by OJ L 2, 5.1.2018, p. 15.

-{860} 32017 R 0843: Commission Implementing Regulation (EU) 2017/843 of 17 May 2017 (OJ L 125,

18.5.2017, p. 21),

-{861} 32017 R 0855: Commission Implementing Regulation (EU) 2017/855 of 18 May 2017 (OJ L 128,

19.5.2017, p. 10),

-{862} 32017 R 0856: Commission Implementing Regulation (EU) 2017/856 of 18 May 2017 (OJ L 128,

19.5.2017, p. 14),

{848} Indent added by Decision No 174/2017 (OJ L 174, 27.6.2019, p. 37 and EEA Supplement No 52, 27.6.2019, p. 46), e.i.f. 23.9.2017.

{849} Indent added by Decision No 174/2017 (OJ L 174, 27.6.2019, p. 37 and EEA Supplement No 52, 27.6.2019, p. 46), e.i.f. 23.9.2017.

{850} Indent added by Decision No 174/2017 (OJ L 174, 27.6.2019, p. 37 and EEA Supplement No 52, 27.6.2019, p. 46), e.i.f. 23.9.2017.

{851} Indent added by Decision No 175/2017 (OJ L 174, 27.6.2019, p. 41 and EEA Supplement No 52, 27.6.2019, p. 50), e.i.f. 23.9.2017.

{852} Indent added by Decision No 175/2017 (OJ L 174, 27.6.2019, p. 41 and EEA Supplement No 52, 27.6.2019, p. 50), e.i.f. 23.9.2017.

{853} Indent added by Decision No 175/2017 (OJ L 174, 27.6.2019, p. 41 and EEA Supplement No 52, 27.6.2019, p. 50), e.i.f. 23.9.2017.

{854} Indent added by Decision No 175/2017 (OJ L 174, 27.6.2019, p. 41 and EEA Supplement No 52, 27.6.2019, p. 50), e.i.f. 23.9.2017.

{855} Indent added by Decision No 175/2017 (OJ L 174, 27.6.2019, p. 41 and EEA Supplement No 52, 27.6.2019, p. 50), e.i.f. 23.9.2017.

{856} Indent added by Decision No 175/2017 (OJ L 174, 27.6.2019, p. 41 and EEA Supplement No 52, 27.6.2019, p. 50), e.i.f. 23.9.2017.

{857} Indent added by Decision No 175/2017 (OJ L 174, 27.6.2019, p. 41 and EEA Supplement No 52, 27.6.2019, p. 50), e.i.f. 23.9.2017.

{858} Indent added by Decision No 175/2017 (OJ L 174, 27.6.2019, p. 41 and EEA Supplement No 52, 27.6.2019, p. 50), e.i.f. 23.9.2017.

Corrigendum to the EU act subsequently taken note of by the EEA Joint Committee on 6.7.2018.

{859} Indent added by Decision No 175/2017 (OJ L 174, 27.6.2019, p. 41 and EEA Supplement No 52, 27.6.2019, p. 50), e.i.f. 23.9.2017.

Corrigendum to the EU act subsequently taken note of by the EEA Joint Committee on 6.7.2018.

{860} Indent added by Decision No 175/2017 (OJ L 174, 27.6.2019, p. 41 and EEA Supplement No 52, 27.6.2019, p. 50), e.i.f. 23.9.2017.

{861} Indent added by Decision No 195/2017 (OJ L 219, 22.8.2019, p. 5 and EEA Supplement No 68, 22.8.2019, p. 5), e.i.f. 28.10.2017.

Page 76: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 202

-{863} 32017 R 1113: Commission Implementing Regulation (EU) 2017/1113 of 22 June 2017 (OJ L 162,

23.6.2017, p. 27),

-{864} 32017 R 1114: Commission Implementing Regulation (EU) 2017/1114 of 22 June 2017 (OJ L 162,

23.6.2017, p. 32),

-{865} 32017 R 1115: Commission Implementing Regulation (EU) 2017/1115 of 22 June 2017 (OJ L 162,

23.6.2017, p. 38),

-{866} 32017 R 1125: Commission Implementing Regulation (EU) 2017/1125 of 22 June 2017 (OJ L 132,

24.6.2017, p. 10),

-{867} 32017 R 1186: Commission Implementing Regulation (EU) 2017/1186 of 3 July 2017 (OJ L 171,

4.7.2017, p. 131),

-{868} 32017 R 1491: Commission Implementing Regulation (EU) 2017/1491 of 21 August 2017 (OJ L

216, 22.8.2017, p. 15),

-{869} 32017 R 1506: Commission Implementing Regulation (EU) 2017/1506 of 28 August 2017 (OJ L

222, 29.8.2017, p. 21),

-{870} 32017 R 1455: Commission Implementing Regulation (EU) 2017/1455 of 10 August 2017 (OJ L

208, 11.8.2017, p. 28),

-{871} 32017 R 1496: Commission Implementing Regulation (EU) 2017/1496 of 23 August 2017 (OJ L

218, 24.8.2017, p. 7),

-{872} 32017 R 1511: Commission Implementing Regulation (EU) 2017/1511 of 30 August 2017 (OJ L

224, 31.8.2017, p. 115),

-{873} 32017 R 1527: Commission Implementing Regulation (EU) 2017/1527 of 6 September 2017 (OJ L

231, 7.9.2017, p. 3),

-{874} 32017 R 1529: Commission Implementing Regulation (EU) 2017/1529 of 7 September 2017 (OJ L

232, 8.9.2017, p. 1),

-{875} 32017 R 1530: Commission Implementing Regulation (EU) 2017/1530 of 7 September 2017 (OJ L

232, 8.9.2017, p. 4),

-{876} 32017 R 1531: Commission Implementing Regulation (EU) 2017/1531 of 7 September 2017 (OJ L

232, 8.9.2017, p. 6),

-{877} 32017 R 2066: Commission Implementing Regulation (EU) 2017/2066 of 13 November 2017 (OJ L

295, 14.11.2017, p. 43),

{862} Indent added by Decision No 195/2017 (OJ L 219, 22.8.2019, p. 5 and EEA Supplement No 68, 22.8.2019, p. 5), e.i.f. 28.10.2017.

{863} Indent added by Decision No 228/2017 (OJ L 254, 3.10.2019, p. 37 and EEA Supplement No 80, 3.10.2019, p. 39), e.i.f. 16.12.2017.

{864} Indent added by Decision No 228/2017 (OJ L 254, 3.10.2019, p. 37 and EEA Supplement No 80, 3.10.2019, p. 39), e.i.f. 16.12.2017.

{865} Indent added by Decision No 228/2017 (OJ L 254, 3.10.2019, p. 37 and EEA Supplement No 80, 3.10.2019, p. 39), e.i.f. 16.12.2017.

{866} Indent added by Decision No 228/2017 (OJ L 254, 3.10.2019, p. 37 and EEA Supplement No 80, 3.10.2019, p. 39), e.i.f. 16.12.2017.

{867} Indent added by Decision No 228/2017 (OJ L 254, 3.10.2019, p. 37 and EEA Supplement No 80, 3.10.2019, p. 39), e.i.f. 16.12.2017.

{868} Indent added by Decision No 16/2018 (OJ L 323, 12.12.2019, p. 31 and EEA Supplement No 98, 12.12.2019, p. 28), e.i.f. 10.2.2018.

{869} Indent added by Decision No 16/2018 (OJ L 323, 12.12.2019, p. 31 and EEA Supplement No 98, 12.12.2019, p. 28), e.i.f. 10.2.2018.

{870} Indent added by Decision No 54/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 24.3.2018.

{871} Indent added by Decision No 54/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 24.3.2018.

{872} Indent added by Decision No 54/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 24.3.2018.

{873} Indent added by Decision No 54/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 24.3.2018.

{874} Indent added by Decision No 54/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 24.3.2018.

{875} Indent added by Decision No 54/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 24.3.2018.

{876} Indent added by Decision No 54/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 24.3.2018.

Page 77: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 203

-{878} 32017 R 2069: Commission Implementing Regulation (EU) 2017/2069 of 13 November 2017 (OJ L

295, 14.11.2017, p. 51),

-{879} 32017 R 2090: Commission Implementing Regulation (EU) 2017/2090 of 14 November 2017 (OJ L

297, 15.11.2017, p. 22),

-{880} 32017 R 2091: Commission Implementing Regulation (EU) 2017/2091 of 14 November 2017 (OJ L

297, 15.11.2017, p. 25),

-{881} 32017 R 2324: Commission Implementing Regulation (EU) 2017/2324 of 12 December 2017 (OJ L

333, 15.12.2017, p. 10),

-{882} 32018 R 0084: Commission Implementing Regulation (EU) 2018/84 of 19 January 2018 (OJ L 16,

20.1.2018, p. 8),

-{883} 32018 R 0112: Commission Implementing Regulation (EU) 2018/112 of 24 January 2018 (OJ L 20,

25.1.2018, p. 3),

-{884} 32018 R 0113: Commission Implementing Regulation (EU) 2018/113 of 24 January 2018 (OJ L 20,

25.1.2018, p. 7),

-{885} 32018 R 0184: Commission Implementing Regulation (EU) 2018/184 of 7 February 2018 (OJ L 34,

8.2.2018, p. 10),

-{886} 32018 R 0185: Commission Implementing Regulation (EU) 2018/185 of 7 February 2018 (OJ L 34,

8.2.2018, p. 13),

-{887} 32018 R 0291: Commission Implementing Regulation (EU) 2018/291 of 26 February 2018 (OJ L 55,

27.2.2018, p. 30),

-{888} 32018 R 0309: Commission Implementing Regulation (EU) 2018/309 of 1 March 2018 (OJ L 60,

2.3.2018, p. 16),

-{889} 32018 R 0524: Commission Implementing Regulation (EU) 2018/524 of 28 March 2018 (OJ L 88,

4.4.2018, p. 4),

-{890} 32018 R 0660: Commission Implementing Regulation (EU) 2018/660 of 26 April 2018 (OJ L 110,

30.4.2018, p. 122),

-{891} 32018 R 0670: Commission Implementing Regulation (EU) 2018/670 of 30 April 2018 (OJ L 113,

3.5.2018, p. 1),

-{892} 32018 R 0679: Commission Implementing Regulation (EU) 2018/679 of 3 May 2018 (OJ L 114,

4.5.2018, p. 18),

{877} Indent added by Decision No 89/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 28.4.2018.

{878} Indent added by Decision No 89/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 28.4.2018.

{879} Indent added by Decision No 89/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 28.4.2018.

{880} Indent added by Decision No 90/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 28.4.2018.

{881} Indent added by Decision No 108/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 1.6.2018.

{882} Indent added by Decision No 144/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 7.7.2018.

{883} Indent added by Decision No 144/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 7.7.2018.

{884} Indent added by Decision No 144/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 7.7.2018.

{885} Indent added by Decision No 144/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 7.7.2018.

{886} Indent added by Decision No 144/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 7.7.2018.

{887} Indent added by Decision No 184/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 22.9.2018.

{888} Indent added by Decision No 184/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 22.9.2018.

{889} Indent added by Decision No 185/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 22.9.2018.

{890} Indent added by Decision No 14/2019 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 9.2.2019.

{891} Indent added by Decision No 14/2019 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 9.2.2019.

Page 78: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 204

-{893} 32018 R 0690: Commission Implementing Regulation (EU) 2018/690 of 7 May 2018 (OJ L 117,

8.5.2018, p. 3),

-{894} 32018 R 0691: Commission Implementing Regulation (EU) 2018/691 of 7 May 2018 (OJ L 117,

8.5.2018, p. 6),

-{895} 32018 R 0692: Commission Implementing Regulation (EU) 2018/692 of 7 May 2018 (OJ L 117,

8.5.2018, p. 9),

-{896} 32018 R 0710: Commission Implementing Regulation (EU) 2018/710 of 14 May 2018 (OJ L 119,

15.5.2018, p. 31),

-{897} 32018 R 0755: Commission Implementing Regulation (EU) 2018/755 of 23 May 2018 (OJ L 128,

24.5.2018, p. 4),

-{898} 32018 R 0783: Commission Implementing Regulation (EU) 2018/783 of 29 May 2018 (OJ L 132,

30.5.2018, p. 31),

-{899} 32018 R 0785: Commission Implementing Regulation (EU) 2018/785 of 29 May 2018 (OJ L 132,

30.5.2018, p. 40),

-{900} 32018 R 1060: Commission Implementing Regulation (EU) 2018/1060 of 26 July 2018 (OJ L 190,

27.7.2018, p. 3),

-{901} 32018 R 0917: Commission Implementing Regulation (EU) 2018/917 of 27 June 2018 (OJ L 163,

28.6.2018, p. 13),

-{902} 32018 R 1019: Commission Implementing Regulation (EU) 2018/1019 of 18 July 2018 (OJ L 183,

19.7.2018, p. 14),

-{903} 32018 R 1043: Commission Implementing Regulation (EU) 2018/1043 of 24 July 2018 (OJ L 188,

25.7.2018, p. 9),

-{904} 32018 R 1061: Commission Implementing Regulation (EU) 2018/1061 of 26 July 2018 (OJ L 190,

27.7.2018, p. 8),

-{905} 32018 R 1075: Commission Implementing Regulation (EU) 2018/1075 of 27 July 2018 (OJ L 194,

31.7.2018, p. 36),

-{906} 32018 R 1260: Commission Implementing Regulation (EU) 2018/1260 of 20 September 2018 (OJ L

238, 21.9.2018, p. 30),

-{907} 32018 R 1278: Commission Implementing Regulation (EU) 2018/1278 of 21 September 2018 (OJ L

239, 24.9.2018, p. 4),

{892} Indent added by Decision No 14/2019 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 9.2.2019.

{893} Indent added by Decision No 14/2019 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 9.2.2019.

{894} Indent added by Decision No 14/2019 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 9.2.2019.

{895} Indent added by Decision No 14/2019 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 9.2.2019.

{896} Indent added by Decision No 14/2019 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 9.2.2019.

{897} Indent added by Decision No 14/2019 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 9.2.2019.

{898} Indent added by Decision No 14/2019 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 9.2.2019.

{899} Indent added by Decision No 14/2019 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 9.2.2019.

{900} Indent added by Decision No 15/2019 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 9.2.2019.

{901} Indent added by Decision No 69/2019 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 30.3.2019.

{902} Indent added by Decision No 69/2019 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 30.3.2019.

{903} Indent added by Decision No 69/2019 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 30.3.2019.

{904} Indent added by Decision No 69/2019 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 30.3.2019.

{905} Indent added by Decision No 69/2019 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 30.3.2019.

{906} Indent added by Decision No 69/2019 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 30.3.2019.

Page 79: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 205

-{908} 32018 R 0784: Commission Implementing Regulation (EU) 2018/784 of 29 May 2018 (OJ L 132,

30.5.2018, p. 35).

-{909} 32018 R 1262: Commission Implementing Regulation (EU) 2018/1262 of 20 September 2018 (OJ L

238, 21.9.2018, p. 62),

-{910} 32018 R 1264: Commission Implementing Regulation (EU) 2018/1264 of 20 September 2018 (OJ L

238, 21.9.2018, p. 71),

-{911} 32018 R 1265: Commission Implementing Regulation (EU) 2018/1265 of 20 September 2018 (OJ L

238, 21.9.2018, p. 77),

-{912} 32018 R 1266: Commission Implementing Regulation (EU) 2018/1266 of 20 September 2018 (OJ L

238, 21.9.2018, p. 81),

-{913} 32018 R 1295: Commission Implementing Regulation (EU) 2018/1295 of 26 September 2018 (OJ L

243, 27.9.2018, p. 7),

-{914} 32018 R 1495: Commission Implementing Regulation (EU) 2018/1495 of 8 October 2018 (OJ L

253, 9.10.2018, p. 1),

-{915} 32018 R 1500: Commission Implementing Regulation (EU) 2018/1500 of 9 October 2018 (OJ L

254, 10.10.2018, p. 1),

-{916} 32018 R 1501: Commission Implementing Regulation (EU) 2018/1501 of 9 October 2018 (OJ L

254, 10.10.2018, p. 4),

-{917} 32018 R 1532: Commission Implementing Regulation (EU) 2018/1532 of 12 October 2018 (OJ L

257, 15.10.2018, p. 10),

-{918} 32018 R 1796: Commission Implementing Regulation (EU) 2018/1796 of 20 November 2018 (OJ L

294, 21.11.2018, p. 15),

-{919} 32018 R 1913: Commission Implementing Regulation (EU) 2018/1913 of 6 December 2018 (OJ L

311, 7.12.2018, p. 13),

-{920} 32018 R 1914: Commission Implementing Regulation (EU) 2018/1914 of 6 December 2018 (OJ L

311, 7.12.2018, p. 17),

-{921} 32018 R 1915: Commission Implementing Regulation (EU) 2018/1915 of 6 December 2018 (OJ L

311, 7.12.2018, p. 20),

-{922} 32018 R 1916: Commission Implementing Regulation (EU) 2018/1916 of 6 December 2018 (OJ L

311, 7.12.2018, p. 24),

{907} Indent added by Decision No 69/2019 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 30.3.2019.

{908} Indent added by Decision No 119/2019 (OJ L [to be published] and EEA supplement No [to be published]), e.i.f. 1.6.2019.

{909} Indent added by Decision No 120/2019 (OJ L [to be published] and EEA supplement No [to be published]), e.i.f. 1.6.2019.

{910} Indent added by Decision No 120/2019 (OJ L [to be published] and EEA supplement No [to be published]), e.i.f. 1.6.2019.

{911} Indent added by Decision No 120/2019 (OJ L [to be published] and EEA supplement No [to be published]), e.i.f. 1.6.2019.

{912} Indent added by Decision No 120/2019 (OJ L [to be published] and EEA supplement No [to be published]), e.i.f. 1.6.2019.

{913} Indent added by Decision No 120/2019 (OJ L [to be published] and EEA supplement No [to be published]), e.i.f. 1.6.2019.

{914} Indent added by Decision No 120/2019 (OJ L [to be published] and EEA supplement No [to be published]), e.i.f. 1.6.2019.

{915} Indent added by Decision No 120/2019 (OJ L [to be published] and EEA supplement No [to be published]), e.i.f. 1.6.2019.

{916} Indent added by Decision No 120/2019 (OJ L [to be published] and EEA supplement No [to be published]), e.i.f. 1.6.2019.

{917} Indent added by Decision No 120/2019 (OJ L [to be published] and EEA supplement No [to be published]), e.i.f. 1.6.2019.

{918} Indent added by Decision No 121/2019 (OJ L [to be published] and EEA supplement No [to be published]), e.i.f. 1.6.2019.

{919} Indent added by Decision No 121/2019 (OJ L [to be published] and EEA supplement No [to be published]), e.i.f. 1.6.2019.

{920} Indent added by Decision No 121/2019 (OJ L [to be published] and EEA supplement No [to be published]), e.i.f. 1.6.2019.

{921} Indent added by Decision No 121/2019 (OJ L [to be published] and EEA supplement No [to be published]), e.i.f. 1.6.2019.

Page 80: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 206

-{923} 32018 R 1917: Commission Implementing Regulation (EU) 2018/1917 of 6 December 2018 (OJ L

311, 7.12.2018, p. 27),

-{924} 32018 R 1865: Commission Implementing Regulation (EU) 2018/1865 of 28 November 2018 (OJ L

304, 29.11.2018, p. 6),

-{925} 32018 R 1981: Commission Implementing Regulation (EU) 2018/1981 of 13 December 2018 (OJ L

317, 14.12.2018, p. 16),

-{926} 32019 R 0139: Commission Implementing Regulation (EU) 2019/139 of 29 January 2019 (OJ L 26,

30.1.2019, p. 4),

-{927} 32019 R 0147: Commission Implementing Regulation (EU) 2019/147 of 30 January 2019 (OJ L 27,

31.1.2019, p. 14),

-{928} 32019 R 0149: Commission Implementing Regulation (EU) 2019/149 of 30 January 2019 (OJ L 27,

31.1.2019, p. 20),

-{929} 32019 R 0151: Commission Implementing Regulation (EU) 2019/151 of 30 January 2019 (OJ L 27,

31.1.2019, p. 26),

-{930} 32019 R 0158: Commission Implementing Regulation (EU) 2019/158 of 31 January 2019 (OJ L 31,

1.2.2019, p. 21),

-{931} 32019 R 0168: Commission Implementing Regulation (EU) 2019/168 of 31 January 2019 (OJ L 33,

5.2.2019, p. 1),

-{932} 32019 R 0291: Commission Implementing Regulation (EU) 2019/291 of 19 February 2019 (OJ L 48,

20.2.2019, p. 17),

-{933} 32019 R 0324: Commission Implementing Regulation (EU) 2019/324 of 25 February 2019 (OJ L 57,

26.2.2019, p. 1),

-{934} 32019 R 0337: Commission Implementing Regulation (EU) 2019/337 of 27 February 2019 (OJ L 60,

28.2.2019, p. 12),

-{935} 32019 R 0344: Commission Implementing Regulation (EU) 2019/344 of 28 February 2019 (OJ L 62,

1.3.2019, p. 7),

-{936} 32019 R 0481: Commission Implementing Regulation (EU) 2019/481 of 22 March 2019 (OJ L 82,

25.3.2019, p. 19).

-{937} 32019 R 0677: Commission Implementing Regulation (EU) 2019/677 of 29 April 2019 (OJ L 114,

30.4.2019, p. 15),

{922} Indent added by Decision No 121/2019 (OJ L [to be published] and EEA supplement No [to be published]), e.i.f. 1.6.2019.

{923} Indent added by Decision No 121/2019 (OJ L [to be published] and EEA supplement No [to be published]), e.i.f. 1.6.2019.

{924} Indent added by Decision No 122/2019 (OJ L [to be published] and EEA supplement No [to be published]), e.i.f. 1.6.2019.

{925} Indent added by Decision No 155/2019 (OJ L [to be published] and EEA supplement No [to be published]), e.i.f. 15.6.2019.

{926} Indent added by Decision No 229/2019 (OJ L [to be published] and EEA supplement No [to be published]), e.i.f. 28.9.2019.

{927} Indent added by Decision No 229/2019 (OJ L [to be published] and EEA supplement No [to be published]), e.i.f. 28.9.2019.

{928} Indent added by Decision No 229/2019 (OJ L [to be published] and EEA supplement No [to be published]), e.i.f. 28.9.2019.

{929} Indent added by Decision No 229/2019 (OJ L [to be published] and EEA supplement No [to be published]), e.i.f. 28.9.2019.

{930} Indent added by Decision No 229/2019 (OJ L [to be published] and EEA supplement No [to be published]), e.i.f. 28.9.2019.

{931} Indent added by Decision No 229/2019 (OJ L [to be published] and EEA supplement No [to be published]), e.i.f. 28.9.2019.

{932} Indent added by Decision No 297/2019 (OJ L [to be published] and EEA supplement No [to be published]), e.i.f. 14.12.2019.

{933} Indent added by Decision No 297/2019 (OJ L [to be published] and EEA supplement No [to be published]), e.i.f. 14.12.2019.

{934} Indent added by Decision No 297/2019 (OJ L [to be published] and EEA supplement No [to be published]), e.i.f. 14.12.2019.

{935} Indent added by Decision No 297/2019 (OJ L [to be published] and EEA supplement No [to be published]), e.i.f. 14.12.2019.

{936} Indent added by Decision No 297/2019 (OJ L [to be published] and EEA supplement No [to be published]), e.i.f. 14.12.2019.

Page 81: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 207

-{938} 32019 R 0706: Commission Implementing Regulation (EU) 2019/706 of 7 May 2019 (OJ L 120,

8.5.2019, p. 11),

-{939} 32019 R 0707: Commission Implementing Regulation (EU) 2019/707 of 7 May 2019 (OJ L 120,

8.5.2019, p. 16),

-{940} 32019 R 0717: Commission Implementing Regulation (EU) 2019/717 of 8 May 2019 (OJ L 122,

10.5.2019, p. 44).

The provisions of the Regulation shall, for the purposes of this Agreement, be read with the following

adaptation:

The EFTA States shall be free to limit access to their markets of plant protection products containing active

substances approved in accordance with Council Directive 91/414/EEC or the Transitional measures in

Regulation (EC) No 1107/2009 Article 80.

13aa.{941} 32012 R 0823: Commission Regulation (EU) No 823/2012 of 14 September 2012 derogating from

Implementing Regulation (EU) No 540/2011 as regards the expiry dates of the approval of the active

substances 2,4-DB, benzoic acid, beta-cyfluthrin, carfentrazone ethyl, Coniothyrium minitans Strain

CON/M/91-08 (DSM 9660), cyazofamid, cyfluthrin, deltamethrin, dimethenamid-P, ethofumesate,

ethoxysulfuron, fenamidone, flazasulfuron, flufenacet, flurtamone, foramsulfuron, fosthiazate, imazamox,

iodosulfuron, iprodione, isoxaflutole, linuron, maleic hydrazide, mecoprop, mecoprop-P, mesosulfuron,

mesotrione, oxadiargyl, oxasulfuron, pendimethalin, picoxystrobin, propiconazole, propineb,

propoxycarbazone, propyzamide, pyraclostrobin, silthiofam, trifloxystrobin, warfarin and zoxamide (OJ

L 250, 15.9.2012, p. 13), as amended by:

-{942} 32014 R 0460: Commission Regulation (EU) No 460/2014 of 5 May 2014 (OJ L 133, 6.5.2014,

p. 51),

-{943} 32014 R 0186: Commission Regulation (EU) No 186/2014 of 26 February 2014 (OJ L 57,

27.2.2014, p. 22).

13b.{944} 32013 R 0283: Commission Regulation (EU) No 283/2013 of 1 March 2013 setting out the data

requirements for active substances, in accordance with Regulation (EC) No 1107/2009 of the European

Parliament and of the Council concerning the placing of plant protection products on the market (OJ L 93,

3.4.2013, p. 1) , as amended by:

-{945} 32014 R 1136: Commission Regulation (EU) No 1136/2014 of 24 October 2014 (OJ L 307,

28.10.2014, p. 26).

13c.{946} 32013 R 0284: Commission Regulation (EU) No 284/2013 of 1 March 2013 setting out the data

requirements for plant protection products, in accordance with Regulation (EC) No 1107/2009 of the

European Parliament and of the Council concerning the placing of plant protection products on the market

(OJ L 93, 3.4.2013, p. 85), as amended by:

{937} Indent added by Decision No 298/2019 (OJ L [to be published] and EEA supplement No [to be published]), e.i.f. 14.12.2019.

{938} Indent added by Decision No 298/2019 (OJ L [to be published] and EEA supplement No [to be published]), e.i.f. 14.12.2019.

{939} Indent added by Decision No 298/2019 (OJ L [to be published] and EEA supplement No [to be published]), e.i.f. 14.12.2019.

{940} Indent added by Decision No 298/2019 (OJ L [to be published] and EEA supplement No [to be published]), e.i.f. 14.12.2019.

{941} Point inserted by Decision No 204/2014 (OJ L 202, 30.7.2015, p. 64 and EEA Supplement No 43, 30.7.2015, p. 63), e.i.f. 1.6.2015.

{942} Indent and words “, as amended by:” added by Decision No 220/2014 (OJ L 230, 3.9.2015, p. 19 and EEA Supplement No 52, 3.9.2015,

p. 19), e.i.f. 1.6.2015.

{943} Indent added by Decision No 272/2014 (OJ L 311, 26.11.2015, p. 25 and EEA Supplement No 71, 26.11.2015, p. 24), e.i.f. 1.6.2015.

{944} Point inserted by Decision No 203/2014 (OJ L 202, 30.7.2015, p. 57 and EEA Supplement No 43, 30.7.2015, p. 57), e.i.f. 1.6.2015. Text of

point 13b (Commission Regulation (EU) No 544/2011) subsequently replaced by Decision No 203/2014 (OJ L 202, 30.7.2015, p. 57 and

EEA Supplement No 43, 30.7.2015, p. 57), e.i.f. 1.6.2015.

{945} Indent and words “, as amended by:” added by Decision No 96/2015 (OJ L 211, 4.8.2016, p. 36 and EEA Supplement No 42, 4.8.2016, p.

35), e.i.f. 1.6.2015.

{946} Point inserted by Decision No 203/2014 (OJ L 202, 30.7.2015, p. 57 and EEA Supplement No 43, 30.7.2015, p. 57), e.i.f. 1.6.2015. Text of

point 13c (Commission Regulation (EU) No 545/2011) subsequently replaced by Decision No 203/2014 (OJ L 202, 30.7.2015, p. 57 and

EEA Supplement No 43, 30.7.2015, p. 57), e.i.f. 1.6.2015.

Page 82: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 208

-{947} 32015 R 1475: Commission Regulation (EU) 2015/1475 of 27 August 2015 (OJ L 225, 28.8.2015,

p. 10).

13d.{948} 32011 R 0546: Commission Regulation (EU) No 546/2011 of 10 June 2011 implementing Regulation (EC)

No 1107/2009 of the European Parliament and of the Council as regards uniform principles for evaluation

and authorisation of plant protection products (OJ L 155, 11.6.2011, p. 127), as amended by:

-{949} 32018 R 0676: Commission Regulation (EU) 2018/676 of 3 May 2018 (OJ L 114, 4.5.2018, p. 8).

13e.{950} 32011 R 0547: Commission Regulation (EU) No 547/2011 of 8 June 2011 implementing Regulation (EC) No

1107/2009 of the European Parliament and of the Council as regards labeling requirements for plant protection

products (OJ L 155, 11.6.2011, p. 176).

The provisions of the Regulation shall, for the purposes of this Agreement, be read with the following

adaptations:

(a) The following shall be added to the list under the title “RSh 1” in point 1.1. of Annex II:

“IS: Eitrað í snertingu við augu.

NO: Giftig ved øyekontakt.”

(b) The following shall be added to the list under the title “RSh 2” in point 1.1. of Annex II:

“IS: Getur valdið ljósnæmingu.

NO: Kan gi overfølsomhet for sollys/UV-stråling.”

(c) The following shall be added to the list under the title “RSh 3” in point 1.1. of Annex II:

“IS: Efnið brennir húð og augu í snertingu við gufu og veldur kali í snertingu við vökva.

NO: Kontakt med damp virker etsende på hud og øyne, og kontakt med væske gir frostskade.”

(d) The following shall be added to the list in point 1 of Annex III:

“IS: Mengið ekki vatn með efninu eða íláti þess. (Hreinsið ekki búnað nálægt yfirborðsvatni/Koma

skal í veg fyrir að mengun verði með afrennsli frá bæjarhlöðum og vegum.)

NO: Unngå forurensning av vannmiljøet med produktet eller emballasjen. (Ikke rengjør spredeutstyr

nær overflatevann/unngå forurensning via avrenning fra gårdsplasser og veier).“

(e) The following shall be added to the list under the title “SPo 1” under the title “Specific Provisions”

in point 2.1 of Annex III:

“IS: Ef efnið kemst í snertingu við húð skal fyrst hreinsa það af með þurrum klút og skola síðan

húðina með miklu vatni.

NO: Etter kontakt med huden, fjern først produktet med en tørr klut, og vask deretter med mye vann.”

(f) The following shall be added to the list under the title “SPo 2” under the title “Specific Provisions”

in point 2.1 of Annex III:

“IS: Þvoið allan hlífðarfatnað að lokinni notkun.

{947} Indent and words “, as amended by:” added by Decision No 266/(OJ L 161, 22.6.2017, p. 51 and EEA Supplement No 38, 22.6.2017, p. 53),

e.i.f. 1.11.2015.

{948} Point inserted by Decision No 203/2014 (OJ L 202, 30.7.2015, p. 57 and EEA Supplement No 43, 30.7.2015, p. 57), e.i.f. 1.6.2015.

{949} Indent and words “, as amended by:” added by Decision No 186/2018 (OJ L [to be published] and EEA Supplement No [to be published]),

e.i.f. 22.9.2018.

{950} Point and adaptation text inserted by Decision No 203/2014 (OJ L 202, 30.7.2015, p. 57 and EEA Supplement No 43, 30.7.2015, p. 57), e.i.f.

1.6.2015.

Page 83: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 209

NO: Vask alt personlig verneutstyr etter bruk.”

(g) The following shall be added to the list under the title “SPo 3” under the title “Specific Provisions”

in point 2.1 of Annex III:

“IS: Forðist innöndun reyks eftir að kveikt hefur verið í efninu og yfirgefið þegar í stað svæðið sem

er til meðhöndlunar.

NO: Pust ikke inn røyken etter at produktet har antent, og forlat det behandlede området

øyeblikkelig.”

(h) The following shall be added to the list under the title “SPo 4” under the title “Specific Provisions”

in point 2.1 of Annex III:

“IS: Opna skal ílátið utanhús og við þurr skilyrði.

NO: Beholderen skal åpnes utendørs og under tørre forhold.”

(i) The following shall be added to the list under the title “SPo 5” under the title “Specific Provisions”

in point 2.1 of Annex III:

“IS: Loftræsta skal úðuð svæði/gróðurhús (vandlega/eða í tilgreindan tíma/þar til úðinn hefur

þornað) áður en farið er þangað inn aftur.

NO: De behandlede områder/veksthus ventileres (grundig/eller angivelse av tid/inntil produktet har

tørket) før man oppholder seg der igjen.”

(j) The following shall be added to the list under the title “SPe 1” in point 2.2 of Annex III:

“IS: Til að vernda grunnvatn/jarðvegslífverur skal ekki nota þetta eða annað efni sem inniheldur

(tilgreinið virkt efni eða flokk virkra efna eftir því sem við á) lengur eða oftar en (tilgreinið hversu

lengi eða oft má nota efnið).

NO: For å beskytte (grunnvannet/jordlevende organismer) må dette produktet eller andre produkter

som inneholder (angi navnet på virksomt stoff eller gruppe av virksomme stoffer) kun brukes/ikke

brukes mer enn (angi tidsperiode eller antall behandlinger).”

(k) The following shall be added to the list under the title “SPe 2” in point 2.2 of Annex III:

“IS: Til að vernda grunnvatn/vatnalífverur skal ekki nota þetta efni (á tilgreinda jarðvegsgerð eða við

tilgreindar aðstæður).

NO: For å beskytte (grunnvannet/vannlevende organismer) må dette produktet ikke brukes (på

beskrevet jordtype eller under beskrevne forhold).”

(l) The following shall be added to the list under the title “SPe 3” in point 2.2 of Annex III:

“IS: Til að vernda vatnalífverur/plöntur utan markhóps/liðdýr utan markhóps/skordýr má ekki nota

efnið nær óræktuðu landi/yfirborðsvatni en (tilgreind breidd svæðis sem er óheimilt að úða).

NO: For å beskytte (vannlevende organismer/viltlevende planter/insekter/leddyr) må dette produktet

ikke brukes nærmere enn (angi avstand) fra (overflatevann/kantvegetasjon).”

(m) The following shall be added to the list under the title “SPe 4” in point 2.2 of Annex III:

“IS: Til að vernda vatnalífverur/plöntur utan markhóps má ekki nota efnið á malbikað, steinsteypt,

hellulagðt eða malarborið yfirborð eða vegi (járnbrautarspor) eða önnur svæði þar sem hætt er við

afrennsli út í umhverfið.

NO: For å beskytte (vannlevende organismer/viltlevende planter) må dette produktet ikke brukes på

harde overflater som asfalterte, betong- brostein- eller gruslagte områder og veier/jernbane, eller på

andre områder med stor risiko for avrenning.”

Page 84: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 210

(n) The following shall be added to the list under the title “SPe 5” in point 2.2 of Annex III:

“IS: Til að vernda fugla/villt spendýr verður að gæta þess vandlega að efnið sé algerlega hulið

jarðvegi; gætið þess sérstaklega að efnið sé hulið í endum raða.

NO: For å beskytte (fugler/ville pattedyr) skal produktet innblandes i jorden. Sørg også for at

produktet er helt innblandet i enden av radene.”

(o) The following shall be added to the list under the title “SPe 6” in point 2.2 of Annex III:

“IS: Hreinsið upp allt efni, sem hefur farið til spillis, til að vernda fugla/villt spendýr.

NO: For å beskytte (fugler/ville pattedyr) skal alt søl fjernes.”

(p) The following shall be added to the list under the title “SPe 7” in point 2.2 of Annex III:

“IS: Óheimilt er að nota efnið á varptíma fugla.

NO: Må ikke brukes i fuglenes hekketid.”

(q) The following shall be added to the list under the title “SPe 8” in point 2.2 of Annex III:

“IS: Hættulegt frævandi skordýrum/Til að vernda býflugur og önnur frævandi skordýr er óheimilt að

nota efnið á blómstrandi nytjaplöntur/Óheimilt er að nota efnið þar sem býflugur eru í

fæðuleit/Fjarlægið býkúpur meðan meðhöndlun með efninu fer fram eða hyljið þær á meðan og í

(tilgreinið tíma) að lokinni meðhöndlun/Óheimilt er að nota efnið ef blómstrandi illgresi er til

staðar/Eyða skal illgresi áður en það blómgast/Óheimilt er að nota efnið fyrir (tilgreinið tíma).

NO: Farlig for bier./For å beskytte bier og andre pollinerende insekter må dette produkt ikke brukes

mens kulturen blomstrer./Må ikke brukes der biene søker næring./Dekk til eller flytt bikuber i

behandlingsperioden og i (nevn antall timer/dager) etter behandlingen./Må ikke brukes i nærheten av

blomstrende ugress./Fjern ugresset før det blomstrer./Må ikke brukes før (tidspunkt).”

(r) The following shall be added to the list in point 2.3 of Annex III:

“IS: Til að koma í veg fyrir þolmyndun skal ekki nota þetta eða annað varnarefni sem inniheldur

(tilgreinið virkt efni eða flokk virkra efna eftir því sem við á) oftar eða lengur en (tilgreinið hversu oft

eða lengi má nota efnið).

NO: For å unngå utvikling av resistens må dette produkt eller andre produkter som inneholder (angi

virksomt stoff eller gruppe av virksomme stoffer) kun brukes/ikke brukes mer enn (i tidsperioden

eller antall ganger).”

(s) The following shall be added to the list under the title “SPr 1” in point 2.4 of Annex III:

“IS: Beitu skal komið fyrir þannig að ekki sé hætta á að önnur dýr komist í hana. Festa skal beituna

tryggilega þannig að nagdýr geti ekki dregið hana í burtu.

NO: Produktet skal plasseres på en slik måte at risikoen for at andre dyr kan innta produktet

minimeres. Pass på at produkt i blokkform ikke kan flyttes vekk av de gnagere som skal bekjempes.”

(t) The following shall be added to the list under the title “SPr 2” in point 2.4 of Annex III:

“IS: Auðkennið svæðið, sem meðhöndla á, meðan á meðhöndlun stendur. Varað skal við hættunni á

að verða fyrir eitrun (beinni eða óbeinni) af völdum storkuvarans og tilgreina skal móteitrið við

honum.

NO: Det behandlede området skal merkes i behandlingsperioden. Faren for forgiftning (primær eller

sekundær) ved inntak av antikoaguleringsmidler, samt motgift, skal angis på oppslag.”

(u) The following shall be added to the list under the title “SPr 3” in point 2.4 of Annex III:

Page 85: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 211

“IS: Hræ nagdýra skulu fjarlægð daglega af meðhöndlaða svæðinu meðan meðhöndlun stendur yfir.

Ekki má setja hræin í opin sorpílát.

NO: Døde gnagere skal fjernes fra behandlingsområdet hver dag. Døde gnagere må ikke plasseres i

åpne avfallsbeholdere.”

13f.{951} 32012 R 0844: Commission Implementing Regulation (EU) No 844/2012 of 18 September 2012 setting out

the provisions necessary for the implementation of the renewal procedure for active substances, as provided for

in Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of

plant protection products on the market (OJ L 252, 19.9.2012, p. 26), as amended by:

-{952} 32018 R 1659: Commission Implementing Regulation (EU) 2018/1659 of 7 November 2018 (OJ L

278, 8.11.2018, p. 3),

-{953} 32019 R 0724: Commission Implementing Regulation (EU) 2019/724 of 10 May 2019 (OJ L 124,

13.5.2019, p. 32).

13g.{954} 32011 R 0702: Commission Implementing Regulation (EU) No 702/2011 of 20 July 2011 approving the active

substance prohexadione, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of

the Council concerning the placing of plant protection products on the market, and amending the Annex to

Commission Implementing Regulation (EU) No 540/2011 (OJ L 190, 21.7.2011, p. 28).

13h.{955} 32011 R 0703: Commission Implementing Regulation (EU) No 703/2011 of 20 July 2011 approving the active

substance azoxystrobin, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of

the Council concerning the placing of plant protection products on the market, and amending the Annex to

Commission Implementing Regulation (EU) No 540/2011 (OJ L 190, 21.7.2011, p. 33).

13i.{956} 32011 R 0704: Commission Implementing Regulation (EU) No 704/2011 of 20 July 2011 approving the active

substance azimsulfuron, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of

the Council concerning the placing of plant protection products on the market, and amending the Annex to

Commission Implementing Regulation (EU) No 540/2011 (OJ L 190, 21.7.2011, p. 38).

13j.{957} 32011 R 0705: Commission Implementing Regulation (EU) No 705/2011 of 20 July 2011 approving the active

substance imazalil, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the

Council concerning the placing of plant protection products on the market, and amending the Annex to

Commission Implementing Regulation (EU) No 540/2011 (OJ L 190, 21.7.2011, p. 43).

13k.{958} 32011 R 0706: Commission Implementing Regulation (EU) No 706/2011 of 20 July 2011 approving the active

substance profoxydim, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of

the Council concerning the placing of plant protection products on the market, and amending the Annex to

Commission Implementing Regulation (EU) No 540/2011 (OJ L 190, 21.7.2011, p. 50).

13l.{959} 32011 R 0736: Commission Implementing Regulation (EU) No 736/2011 of 26 July 2011 approving the active

substance fluroxypyr, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of

the Council concerning the placing of plant protection products on the market, and amending the Annex to

Commission Implementing Regulation (EU) No 540/2011 (OJ L 195, 27.7.2011, p. 37).

13m.{960}32011 R 0740: Commission Implementing Regulation (EU) No 740/2011 of 27 July 2011 approving the active

substance bispyribac, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of

{951} Point inserted by Decision No 203/2014 (OJ L 202, 30.7.2015, p. 57 and EEA Supplement No 43, 30.7.2015, p. 57), e.i.f. 1.6.2015.

{952} Indent and words”, as amended by:” added by Decision No 121/2019 (OJ L [to be published] and EEA Supplement No [to be published]),

e.i.f. 1.6.2019.

{953} Indent added by Decision No 298/2019 (OJ L [to be published] and EEA supplement No [to be published]), e.i.f. 14.12.2019.

{954} Point inserted by Decision No 204/2014 (OJ L 202, 30.7.2015, p. 64 and EEA Supplement No 43, 30.7.2015, p. 63), e.i.f. 1.6.2015.

{955} Point inserted by Decision No 204/2014 (OJ L 202, 30.7.2015, p. 64 and EEA Supplement No 43, 30.7.2015, p. 63), e.i.f. 1.6.2015.

{956} Point inserted by Decision No 204/2014 (OJ L 202, 30.7.2015, p. 64 and EEA Supplement No 43, 30.7.2015, p. 63), e.i.f. 1.6.2015.

{957} Point inserted by Decision No 204/2014 (OJ L 202, 30.7.2015, p. 64 and EEA Supplement No 43, 30.7.2015, p. 63), e.i.f. 1.6.2015.

{958} Point inserted by Decision No 204/2014 (OJ L 202, 30.7.2015, p. 64 and EEA Supplement No 43, 30.7.2015, p. 63), e.i.f. 1.6.2015.

{959} Point inserted by Decision No 204/2014 (OJ L 202, 30.7.2015, p. 64 and EEA Supplement No 43, 30.7.2015, p. 63), e.i.f. 1.6.2015.

{960} Point inserted by Decision No 204/2014 (OJ L 202, 30.7.2015, p. 64 and EEA Supplement No 43, 30.7.2015, p. 63), e.i.f. 1.6.2015.

Page 86: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 212

the Council concerning the placing of plant protection products on the market, and amending the Annex to

Commission Implementing Regulation (EU) No 540/2011 (OJ L 196, 28.7.2011, p. 6).

13n.{961} 32011 R 0786: (Commission Implementing Regulation (EU) No 786/2011 of 5 August 2011 approving the

active substance 1-naphthylacetamide, in accordance with Regulation (EC) No 1107/2009 of the European

Parliament and of the Council concerning the placing of plant protection products on the market, and amending

the Annex to Commission Implementing Regulation (EU) No 540/2011 and Commission Decision

2008/941/EC (OJ L 203, 6.8.2011, p. 11).

13o.{962} 32011 R 0787: Commission Implementing Regulation (EU) No 787/2011 of 5 August 2011 approving the

active substance 1-naphthylacetic acid, in accordance with Regulation (EC) No 1107/2009 of the European

Parliament and of the Council concerning the placing of plant protection products on the market, and amending

the Annex to Commission Implementing Regulation (EU) No 540/2011 and Commission Decision

2008/941/EC (OJ L 203, 6.8.2011, p. 16).

13p.{963} 32011 R 0788: Commission Implementing Regulation (EU) No 788/2011 of 5 August 2011 approving the

active substance fluazifop-P, in accordance with Regulation (EC) No 1107/2009 of the European Parliament

and of the Council concerning the placing of plant protection products on the market, and amending the Annex

to Commission Implementing Regulation (EU) No 540/2011 and Commission Decision 2008/934/EC (OJ L

203, 6.8.2011, p. 21), as amended by:

-{964} 32013 R 0201: Commission Implementing Regulation (EU) No 201/2013 of 8 March 2013 (OJ L

67, 9.3.2013, p. 6).

13q.{965} 32011 R 0797: Commission Implementing Regulation (EU) No 797/2011 of 9 August 2011 approving the

active substance spiroxamine, in accordance with Regulation (EC) No 1107/2009 of the European Parliament

and of the Council concerning the placing of plant protection products on the market, and amending the Annex

to Commission Implementing Regulation (EU) No 540/2011 (OJ L 205, 10.8.2011, p. 3).

13r.{966} 32011 R 0798: Commission Implementing Regulation (EU) No 798/2011 of 9 August 2011 approving the

active substance oxyfluorfen, in accordance with Regulation (EC) No 1107/2009 of the European Parliament

and of the Council concerning the placing of plant protection products on the market, and amending the Annex

to Commission Implementing Regulation (EU) No 540/2011 and Commission Decision 2008/934/EC (OJ L

205, 10.8.2011, p. 9).

13s.{967} 32011 R 0800: Commission Implementing Regulation (EU) No 800/2011 of 9 August 2011 approving the

active substance tefluthrin, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and

of the Council concerning the placing of plant protection products on the market, and amending the Annex to

Commission Implementing Regulation (EU) No 540/2011 and amending Commission Decision 2008/934/EC

(OJ L 205, 10.8.2011, p. 22).

13t.{968} 32011 R 0806: Commission Implementing Regulation (EU) No 806/2011 of 10 August 2011 approving the

active substance fluquinconazole, in accordance with Regulation (EC) No 1107/2009 of the European

Parliament and of the Council concerning the placing of plant protection products on the market, and amending

the Annex to Commission Implementing Regulation (EU) No 540/2011 and Commission Decision

2008/934/EC (OJ L 206, 11.8.2011, p. 39).

13u.{969} 32011 R 0807: Commission Implementing Regulation (EU) No 807/2011 of 10 August 2011 approving the

active substance triazoxide, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and

of the Council concerning the placing of plant protection products on the market, and amending the Annex to

Commission Implementing Regulation (EU) No 540/2011 (OJ L 206, 11.8.2011, p. 44).

{961} Point inserted by Decision No 204/2014 (OJ L 202, 30.7.2015, p. 64 and EEA Supplement No 43, 30.7.2015, p. 63), e.i.f. 1.6.2015.

{962} Point inserted by Decision No 204/2014 (OJ L 202, 30.7.2015, p. 64 and EEA Supplement No 43, 30.7.2015, p. 63), e.i.f. 1.6.2015.

{963} Point inserted by Decision No 204/2014 (OJ L 202, 30.7.2015, p. 64 and EEA Supplement No 43, 30.7.2015, p. 63), e.i.f. 1.6.2015.

{964} Indent and words “, as amended by:” added by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015,

p. 72), e.i.f. 1.6.2015.

{965} Point inserted by Decision No 204/2014 (OJ L 202, 30.7.2015, p. 64 and EEA Supplement No 43, 30.7.2015, p. 63), e.i.f. 1.6.2015.

{966} Point inserted by Decision No 204/2014 (OJ L 202, 30.7.2015, p. 64 and EEA Supplement No 43, 30.7.2015, p. 63), e.i.f. 1.6.2015.

{967} Point inserted by Decision No 204/2014 (OJ L 202, 30.7.2015, p. 64 and EEA Supplement No 43, 30.7.2015, p. 63), e.i.f. 1.6.2015.

{968} Point inserted by Decision No 204/2014 (OJ L 202, 30.7.2015, p. 64 and EEA Supplement No 43, 30.7.2015, p. 63), e.i.f. 1.6.2015.

{969} Point inserted by Decision No 204/2014 (OJ L 202, 30.7.2015, p. 64 and EEA Supplement No 43, 30.7.2015, p. 63), e.i.f. 1.6.2015.

Page 87: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 213

13v.{970} 32011 R 0810: Commission Implementing Regulation (EU) No 810/2011 of 11 August 2011 approving the

active substance kresoxim-methyl, in accordance with Regulation (EC) No 1107/2009 of the European

Parliament and of the Council concerning the placing of plant protection products on the market, and amending

the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L 207, 12.8.2011, p. 7).

13w.{971} 32011 R 0820: Commission Implementing Regulation (EU) No 820/2011 of 16 August 2011 approving the

active substance terbuthylazine, in accordance with Regulation (EC) No 1107/2009 of the European Parliament

and of the Council concerning the placing of plant protection products on the market, and amending the Annex

to Commission Implementing Regulation (EU) No 540/2011 and Commission Decision 2008/934/EC (OJ L

209, 17.8.2011, p. 18).

13x.{972} 32011 R 0942: Commission Implementing Regulation (EU) No 942/2011 of 22 September 2011 concerning

the non-approval of the active substance flufenoxuron, in accordance with Regulation (EC) No 1107/2009 of

the European Parliament and of the Council concerning the placing of plant protection products on the market,

and amending Commission Decision 2008/934/EC (OJ L 246, 23.9.2011, p. 13).

13y.{973} 32011 R 0943: Commission Implementing Regulation (EU) No 943/2011 of 22 September 2011 concerning

the non-approval of the active substance propargite, in accordance with Regulation (EC) No 1107/2009 of the

European Parliament and of the Council concerning the placing of plant protection products on the market, and

amending Commission Decision 2008/934/EC (OJ L 246, 23.9.2011, p. 16).

13z.{974} 32011 R 0974: Commission Implementing Regulation (EU) No 974/2011 of 29 September 2011 approving the

active substance acrinathrin, in accordance with Regulation (EC) No 1107/2009 of the European Parliament

and of the Council concerning the placing of plant protection products on the market, and amending the Annex

to Commission Implementing Regulation (EU) No 540/2011 and Commission Decision 2008/934/EC (OJ L

255, 1.10.2011, p. 1).

13za.{975}32011 R 0993: Commission Implementing Regulation (EU) No 993/2011 of 6 October 2011 approving the

active substance 8-hydroxyquinoline, in accordance with Regulation (EC) No 1107/2009 of the European

Parliament and of the Council concerning the placing of plant protection products on the market, and amending

the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L 263, 7.10.2011, p. 1).

13zb.{976}32011 R 1022: Commission Implementing Regulation (EU) No 1022/2011 of 14 October 2011 concerning the

non-renewal of the approval of the active substance cyclanilide in accordance with Regulation (EC) No

1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products

on the market, and amending Commission Implementing Regulation (EU) No 540/2011 (OJ L 270,

15.10.2011, p. 20).

13zc.{977} 32011 R 1045: Commission Implementing Regulation (EU) No 1045/2011 of 19 October 2011 concerning the

non-approval of the active substance asulam, in accordance with Regulation (EC) No 1107/2009 of the

European Parliament and of the Council concerning the placing of plant protection products on the market, and

amending Commission Decision 2008/934/EC (OJ L 275, 20.10.2011, p. 23).

13zd.{978} 32011 R 1078: Commission Implementing Regulation (EU) No 1078/2011 of 25 October 2011 concerning the

non-approval of the active substance propanil, in accordance with Regulation (EC) No 1107/2009 of the

European Parliament and of the Council concerning the placing of plant protection products on the market (OJ

L 279, 26.10.2011, p. 1).

13ze.{979} 32011 R 1127: Commission Implementing Regulation (EU) No 1127/2011 of 7 November 2011 concerning

the non-approval of the active substance 2-naphthyloxyacetic acid, in accordance with Regulation (EC) No

{970} Point inserted by Decision No 204/2014 (OJ L 202, 30.7.2015, p. 64 and EEA Supplement No 43, 30.7.2015, p. 63), e.i.f. 1.6.2015.

{971} Point inserted by Decision No 204/2014 (OJ L 202, 30.7.2015, p. 64 and EEA Supplement No 43, 30.7.2015, p. 63), e.i.f. 1.6.2015.

{972} Point inserted by Decision No 204/2014 (OJ L 202, 30.7.2015, p. 64 and EEA Supplement No 43, 30.7.2015, p. 63), e.i.f. 1.6.2015.

{973} Point inserted by Decision No 204/2014 (OJ L 202, 30.7.2015, p. 64 and EEA Supplement No 43, 30.7.2015, p. 63), e.i.f. 1.6.2015.

{974} Point inserted by Decision No 204/2014 (OJ L 202, 30.7.2015, p. 64 and EEA Supplement No 43, 30.7.2015, p. 63), e.i.f. 1.6.2015.

{975} Point inserted by Decision No 204/2014 (OJ L 202, 30.7.2015, p. 64 and EEA Supplement No 43, 30.7.2015, p. 63), e.i.f. 1.6.2015.

{976} Point inserted by Decision No 204/2014 (OJ L 202, 30.7.2015, p. 64 and EEA Supplement No 43, 30.7.2015, p. 63), e.i.f. 1.6.2015.

{977} Point inserted by Decision No 204/2014 (OJ L 202, 30.7.2015, p. 64 and EEA Supplement No 43, 30.7.2015, p. 63), e.i.f. 1.6.2015.

{978} Point inserted by Decision No 204/2014 (OJ L 202, 30.7.2015, p. 64 and EEA Supplement No 43, 30.7.2015, p. 63), e.i.f. 1.6.2015.

{979} Point inserted by Decision No 204/2014 (OJ L 202, 30.7.2015, p. 64 and EEA Supplement No 43, 30.7.2015, p. 63), e.i.f. 1.6.2015.

Page 88: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 214

1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products

on the market (OJ L 289, 8.11.2011, p. 26).

13zf.{980} 32011 R 1134: Commission Implementing Regulation (EU) No 1134/2011 of 9 November 2011 concerning

the non-renewal of the approval of the active substance cinidon-ethyl, in accordance with Regulation (EC) No

1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products

on the market, and amending Commission Implementing Regulation (EU) No 540/2011 (OJ L 292,

10.11.2011, p. 1).

13zg.{981} 32011 R 1143: Commission Implementing Regulation (EU) No 1143/2011 of 10 November 2011 approving

the active substance prochloraz, in accordance with Regulation (EC) No 1107/2009 of the European

Parliament and of the Council concerning the placing of plant protection products on the market, and amending

the Annex to Commission Implementing Regulation (EU) No 540/2011 and Commission Decision

2008/934/EC (OJ L 293, 11.11.2011, p. 26).

13zh.{982} 32011 R 1372: Commission Implementing Regulation (EU) No 1372/2011 of 21 December 2011 concerning

the non-approval of the active substance acetochlor, in accordance with Regulation (EC) No 1107/2009 of the

European Parliament and of the Council concerning the placing of plant protection products on the market, and

amending Commission Decision 2008/934/EC (OJ L 341, 22.12.2011, p. 45).

13zi.{983} 32011 R 1381: Commission Implementing Regulation (EU) No 1381/2011 of 22 December 2011 concerning

the non-approval of the active substance chloropicrin, in accordance with Regulation (EC) No 1107/2009 of

the European Parliament and of the Council concerning the placing of plant protection products on the market,

and amending Decision 2008/934/EC (OJ L 343, 23.12.2011, p. 26).

13zj.{984} 32012 R 0746: Commission Implementing Regulation (EU) No 746/2012 of 16 August 2012 approving the

active substance Adoxophyes orana granulovirus, in accordance with Regulation (EC) No 1107/2009 of the

European Parliament and of the Council concerning the placing of plant protection products on the market, and

amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L 219, 17.8.2012,

p. 15).

13zk.{985}32012 R 0359: Commission Implementing Regulation (EU) No 359/2012 of 25 April 2012 approving the

active substance metam, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of

the Council concerning the placing of plant protection products on the market, and amending the Annex to

Commission Implementing Regulation (EU) No 540/2011 (OJ L 114, 26.4.2012, p. 1).

13zl.{986} 32012 R 0578: Commission Implementing Regulation (EU) No 578/2012 of 29 June 2012 concerning the non

approval of the active substance diphenylamine, in accordance with Regulation (EC) No 1107/2009 of the

European Parliament and of the Council concerning the placing of plant protection products on the market (OJ

L 171, 30.6.2012, p. 2).

13zm.{987}32012 R 0582: Commission Implementing Regulation (EU) No 582/2012 of 2 July 2012 approving the active

substance bifenthrin, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the

Council concerning the placing of plant protection products on the market, and amending the Annex to

Commission Implementing Regulation (EU) No 540/2011 (OJ L 173, 3.7.2012, p. 3).

13zn.{988} 32012 R 0589: Commission Implementing Regulation (EU) No 589/2012 of 4 July 2012 approving the active

substance fluxapyroxad, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of

the Council concerning the placing of plant protection products on the market, and amending the Annex to

Commission Implementing Regulation (EU) No 540/2011 (OJ L 175, 5.7.2012, p. 7).

{980} Point inserted by Decision No 204/2014 (OJ L 202, 30.7.2015, p. 64 and EEA Supplement No 43, 30.7.2015, p. 63), e.i.f. 1.6.2015.

{981} Point inserted by Decision No 204/2014 (OJ L 202, 30.7.2015, p. 64 and EEA Supplement No 43, 30.7.2015, p. 63), e.i.f. 1.6.2015.

{982} Point inserted by Decision No 204/2014 (OJ L 202, 30.7.2015, p. 64 and EEA Supplement No 43, 30.7.2015, p. 63), e.i.f. 1.6.2015.

{983} Point inserted by Decision No 204/2014 (OJ L 202, 30.7.2015, p. 64 and EEA Supplement No 43, 30.7.2015, p. 63), e.i.f. 1.6.2015.

{984} Point inserted by Decision No 204/2014 (OJ L 202, 30.7.2015, p. 64 and EEA Supplement No 43, 30.7.2015, p. 63), e.i.f. 1.6.2015 and

subsequently corrected before publication by Corrigendum of 20.3.2015, subsequently corrected before publication by Corrigendum of

10.7.2015.

{985} Point inserted by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{986} Point inserted by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{987} Point inserted by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{988} Point inserted by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

Page 89: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 215

13zo.{989} 32012 R 0595: Commission Implementing Regulation (EU) No 595/2012 of 5 July 2012 approving the active

substance fenpyrazamine, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and

of the Council concerning the placing of plant protection products on the market, and amending the Annex to

Commission Implementing Regulation (EU) No 540/2011 (OJ L 176, 6.7.2012, p. 46).

13zq.{990}32012 D 0480: Commission Implementing Decision 2012/480/EU of 16 August 2012 allowing Member States

to extend provisional authorisations granted for the new active substance Aureobasidium pullulans (OJ L 222,

18.8.2012, p. 13).

13zr.{991} 32012 D 0677: Commission Implementing Decision 2012/677/EU of 30 October 2012 allowing Member

States to extend provisional authorisations granted for the new active substances ametoctradin (initially applied

for under the development code BAS 650 F) and disodium phosphonate (OJ L 305, 1.11.2012, p. 27).

13zs. {992}32012 R 1037: Commission Implementing Regulation (EU) No 1037/2012 of 7 November 2012 approving the

active substance isopyrazam, in accordance with Regulation (EC) No 1107/2009 of the European Parliament

and of the Council concerning the placing of plant protection products on the market, and amending the Annex

to Commission Implementing Regulation (EU) No 540/2011 (OJ L 308, 8.11.2012, p. 15) as amended by:

-{993} 32015 R 1106: Commission Implementing Regulation (EU) 2015/1106 of 8 July 2015 (OJ L 181,

9.7.2015, p. 70).

13zt.{994} 32012 R 1043: Commission Implementing Regulation (EU) No 1043/2012 of 8 November 2012 approving the

active substance phosphane, in accordance with Regulation (EC) No 1107/2009 of the European Parliament

and of the Council concerning the placing of plant protection products on the market, and amending the Annex

to Commission Implementing Regulation (EU) No 540/2011 (OJ L 310, 9.11.2012, p. 24).

13zu.{995} 32012 R 1237: Commission Implementing Regulation (EU) No 1237/2012 of 19 December 2012 approving

the active substance Zucchini Yellow Mosaic Virus — weak strain, in accordance with Regulation (EC) No

1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products

on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ

L 350, 20.12.2012, p. 55).

13zv.{996} 32012 R 1238: Commission Implementing Regulation (EU) No 1238/2012 of 19 December 2012 approving

the active substance Trichoderma asperellum (strain T34), in accordance with Regulation (EC) No 1107/2009

of the European Parliament and of the Council concerning the placing of plant protection products on the

market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L 350,

20.12.2012, p. 59).

13zw.{997}32013 R 0017: Commission Implementing Regulation (EU) No 17/2013 of 14 January 2013 approving the

active substance Trichoderma atroviride strain I-1237, in accordance with Regulation (EC) No 1107/2009 of

the European Parliament and of the Council concerning the placing of plant protection products on the market,

and amending the Annex to Implementing Regulation (EU) No 540/2011 (OJ L 9, 15.1.2013, p. 5).

13zx.{998} 32013 R 0022: Commission Implementing Regulation (EU) No 22/2013 of 15 January 2013 approving the

active substance cyflumetofen, in accordance with Regulation (EC) No 1107/2009 of the European Parliament

and of the Council concerning the placing of plant protection products on the market, and amending the Annex

to Commission Implementing Regulation (EU) No 540/2011 (OJ L 11, 16.1.2013, p. 8).

13zy.{999}32013 R 0188: Commission Implementing Regulation (EU) No 188/2013 of 5 March 2013 approving the

active substance mandipropamid, in accordance with Regulation (EC) No 1107/2009 of the European

{989} Point inserted by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{990} Point inserted by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{991} Point inserted by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{992} Point inserted by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{993} Indent and words “, as amended by:” added by Decision No 264/2015 (OJ L [to be published] and EEA Supplement No [to be published]),

e.i.f. 1.11.2015.

{994} Point inserted by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{995} Point inserted by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{996} Point inserted by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{997} Point inserted by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{998} Point inserted by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{999} Point inserted by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

Page 90: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 216

Parliament and of the Council concerning the placing of plant protection products on the market, and amending

the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L 62, 6.3.2013, p. 13).

13zz.{1000} 32013 R 0200: Commission Implementing Regulation (EU) No 200/2013 of 8 March 2013

approving the active substance ametoctradin, in accordance with Regulation (EC) No 1107/2009 of the

European Parliament and of the Council concerning the placing of plant protection products on the market, and

amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L 67, 9.3.2013, p. 1), as

corrected by OJ L 235, 4.9.2013, p. 12.

13zza.{1001}32013 R 0350: Commission Implementing Regulation (EU) No 350/2013 of 17 April 2013 approving the

active substance bixafen, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and

of the Council concerning the placing of plant protection products on the market, and amending the Annex to

Commission Implementing Regulation (EU) No 540/2011 (OJ L 108, 18.4.2013, p. 9).

13zzb.{1002}32013 R 0355: Commission Implementing Regulation (EU) No 355/2013 of 18 April 2013 approving the

active substance maltodextrin, in accordance with Regulation (EC) No 1107/2009 of the European Parliament

and of the Council concerning the placing of plant protection products on the market, and amending the Annex

to Commission Implementing Regulation (EU) No 540/2011 (OJ L 109, 19.4.2013, p. 14).

13zzc.{1003}32013 R 0356: Commission Implementing Regulation (EU) No 356/2013 of 18 April 2013 approving the

active substance halosulfuron-methyl, in accordance with Regulation (EC) No 1107/2009 of the European

Parliament and of the Council concerning the placing of plant protection products on the market, and amending

the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L 109, 19.4.2013, p. 18).

13zzd.{1004}32013 R 0366: Commission Implementing Regulation (EU) No 366/2013 of 22 April 2013 approving the

active substance Bacillus firmus I-1582, in accordance with Regulation (EC) No 1107/2009 of the European

Parliament and of the Council concerning the placing of plant protection products on the market, and amending

the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L 111, 23.4.2013, p. 30).

13zze.{1005}32013 R 0367: Commission Implementing Regulation (EU) No 367/2013 of 22 April 2013 approving the

active substance Spodoptera littoralis nucleopolyhedrovirus, in accordance with Regulation (EC) No

1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products

on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ

L 111, 23.4.2013, p. 33).

13zzf.{1006}32013 R 0368: Commission Implementing Regulation (EU) No 368/2013 of 22 April 2013 approving the

active substance Helicoverpa armigera nucleopolyhedrovirus, in accordance with Regulation (EC) No

1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products

on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L

111, 23.4.2013, p. 36).

13zzg.{1007}32013 R 0373: Commission Implementing Regulation (EU) No 373/2013 of 23 April 2013 approving the

active substance Candida oleophila strain O, in accordance with Regulation (EC) No 1107/2009 of the

European Parliament and of the Council concerning the placing of plant protection products on the market, and

amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L 112, 24.4.2013, p.

10).

13zzh.{1008}32013 R 0375: Commission Implementing Regulation (EU) No 375/2013 of 23 April 2013 approving the

active substance spiromesifen, in accordance with Regulation (EC) No 1107/2009 of the European Parliament

and of the Council concerning the placing of plant protection products on the market, and amending the Annex

to Commission Implementing Regulation (EU) No 540/2011 (OJ L 112, 24.4.2013, p. 15).

{1000} Point inserted by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{1001} Point inserted by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{1002} Point inserted by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{1003} Point inserted by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{1004} Point inserted by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{1005} Point inserted by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{1006} Point inserted by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{1007} Point inserted by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{1008} Point inserted by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

Page 91: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 217

13zzi.{1009}32013 R 0378: Commission Implementing Regulation (EU) No 378/2013 of 24 April 2013 approving the

active substance Paecilomyces fumosoroseus strain FE 9901, in accordance with Regulation (EC) No

1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products

on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L

113, 25.4.2013, p. 5).

13zzj.{1010}32013 R 0546: Commission Implementing Regulation (EU) No 546/2013 of 14 June 2013 approving the

active substance eugenol, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and

of the Council concerning the placing of plant protection products on the market, and amending the Annex to

Commission Implementing Regulation (EU) No 540/2011 (OJ L 163, 15.6.2013, p. 17).

13zzk.{1011}32013 R 0568: Commission Implementing Regulation (EU) No 568/2013 of 18 June 2013 approving the

active substance thymol, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of

the Council concerning the placing of plant protection products on the market, and amending the Annex to

Commission Implementing Regulation (EU) No 540/2011 (OJ L 167, 19.6.2013, p. 33).

13zzl.{1012}32013 R 0570: Commission Implementing Regulation (EU) No 570/2013 of 17 June 2013 approving the

active substance geraniol, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and

of the Council concerning the placing of plant protection products on the market, and amending the Annex to

Implementing Regulation (EU) No 540/2011 (OJ L 168, 20.6.2013, p. 18).

13zzm.{1013}32013 R 0767: Commission Implementing Regulation (EU) No 767/2013 of 8 August 2013 withdrawing the

approval of the active substance bitertanol, in accordance with Regulation (EC) No 1107/2009 of the European

Parliament and of the Council concerning the placing of plant protection products on the market, and amending

Commission Implementing Regulation (EU) No 540/2011 (OJ L 214, 9.8.2013, p. 5).

13zzn.{1014}32013 R 0802: Commission Implementing Regulation (EU) No 802/2013 of 22 August 2013 approving the

active substance fluopyram, in accordance with Regulation (EC) No 1107/2009 of the European Parliament

and of the Council concerning the placing of plant protection products on the market, and amending the Annex

to Commission Implementing Regulation (EU) No 540/2011 (OJ L 225, 23.8.2013, p. 13).

13zzo.{1015}32013 R 0826: Commission Implementing Regulation (EU) No 826/2013 of 29 August 2013 approving the

active substance sedaxane, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and

of the Council concerning the placing of plant protection products on the market, and amending the Annex to

Implementing Regulation (EU) No 540/2011 (OJ L 232, 30.8.2013, p. 13).

13zzp.{1016}32013 R 0827: Commission Implementing Regulation (EU) No 827/2013 of 29 August 2013 approving the

active substance Aureobasidium pullulans (strains DSM 14940 and DSM 14941), in accordance with

Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant

protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No

540/2011 (OJ L 232, 30.8.2013, p. 18).

13zzq.{1017}32013 R 0828: Commission Implementing Regulation (EU) No 828/2013 of 29 August 2013 approving the

active substance emamectin, in accordance with Regulation (EC) No 1107/2009 of the European Parliament

and of the Council concerning the placing of plant protection products on the market, and amending the Annex

to Commission Implementing Regulation (EU) No 540/2011 (OJ L 232, 30.8.2013, p. 23).

13zzr.{1018}32013 R 0829: Commission Implementing Regulation (EU) No 829/2013 of 29 August 2013 approving the

active substance Pseudomonas sp. strain DSMZ 13134, in accordance with Regulation (EC) No 1107/2009 of

the European Parliament and of the Council concerning the placing of plant protection products on the market,

{1009} Point inserted by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{1010} Point inserted by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{1011} Point inserted by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{1012} Point inserted by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{1013} Point inserted by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{1014} Point inserted by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{1015} Point inserted by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{1016} Point inserted by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{1017} Point inserted by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{1018} Point inserted by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

Page 92: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 218

and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L 232, 30.8.2013,

p. 29).

13zzs.{1019}32013 R 0832: Commission Implementing Regulation (EU) No 832/2013 of 30 August 2013 approving the

active substance disodium phosphonate, in accordance with Regulation (EC) No 1107/2009 of the European

Parliament and of the Council concerning the placing of plant protection products on the market, and amending

the Annex to Implementing Regulation (EU) No 540/2011 (OJ L 233, 31.8.2013, p. 3).

13zzt.{1020}32013 R 0833: Commission Implementing Regulation (EU) No 833/2013 of 30 August 2013 approving the

active substance pyriofenone, in accordance with Regulation (EC) No 1107/2009 of the European Parliament

and of the Council concerning the placing of plant protection products on the market, and amending the Annex

to Implementing Regulation (EU) No 540/2011 (OJ L 233, 31.8.2013, p. 7).

13zzu.{1021}32013 R 1031: Commission Implementing Regulation (EU) No 1031/2013 of 24 October 2013 approving

the active substance penflufen, in accordance with Regulation (EC) No 1107/2009 of the European Parliament

and of the Council concerning the placing of plant protection products on the market, and amending the Annex

to Commission Implementing Regulation (EU) No 540/2011 (OJ L 283, 25.10.2013, p. 17).

13zzv.{1022}32013 R 1175: Commission Implementing Regulation (EU) No 1175/2013 of 20 November 2013 approving

the active substance benalaxyl-M, in accordance with Regulation (EC) No 1107/2009 of the European

Parliament and of the Council concerning the placing of plant protection products on the market, and amending

the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L 312, 21.11.2013, p. 18).

13zzw.{1023}32013 R 1176: Commission Implementing Regulation (EU) No 1176/2013 of 20 November 2013 approving

the active substance pyroxsulam, in accordance with Regulation (EC) No 1107/2009 of the European

Parliament and of the Council concerning the placing of plant protection products on the market, and amending

the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L 312, 21.11.2013, p. 23).

13zzx.{1024}32013 R 1177: Commission Implementing Regulation (EU) No 1177/2013 of 20 November 2013 approving

the active substance spirotetramat, in accordance with Regulation (EC) No 1107/2009 of the European

Parliament and of the Council concerning the placing of plant protection products on the market, and amending

the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L 312, 21.11.2013, p. 28).

13zzy.{1025}32013 R 1187: Commission Implementing Regulation (EU) No 1187/2013 of 21 November 2013 approving

the active substance penthiopyrad, in accordance with Regulation (EC) No 1107/2009 of the European

Parliament and of the Council concerning the placing of plant protection products on the market, and amending

the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L 313, 22.11.2013, p. 42).

13zzz.{1026}32013 R 1192: Commission Implementing Regulation (EU) No 1192/2013 of 22 November 2013 approving

the active substance tembotrione, in accordance with Regulation (EC) No 1107/2009 of the European

Parliament and of the Council concerning the placing of plant protection products on the market, and amending

the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L 314, 23.11.2013, p. 6).

13zzza.{1027}32013 R 1195: Commission Implementing Regulation (EU) No 1195/2013 of 22 November 2013 approving

the active substance sodium silver thiosulfate, in accordance with Regulation (EC) No 1107/2009 of the

European Parliament and of the Council concerning the placing of plant protection products on the market, and

amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L 315, 26.11.2013, p.

27).

13zzzb.{1028}32013 R 1199: Commission Implementing Regulation (EU) No 1199/2013 of 25 November 2013

approving the active substance chlorantraniliprole, in accordance with Regulation (EC) No 1107/2009 of the

{1019} Point inserted by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{1020} Point inserted by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{1021} Point inserted by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{1022} Point inserted by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{1023} Point inserted by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{1024} Point inserted by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{1025} Point inserted by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{1026} Point inserted by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{1027} Point inserted by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

{1028} Point inserted by Decision No 205/2014 (OJ L 202, 30.7.2015, p. 73 and EEA Supplement No 43, 30.7.2015, p. 72), e.i.f. 1.6.2015.

Page 93: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 219

European Parliament and of the Council concerning the placing of plant protection products on the market, and

amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L 315, 26.11.2013, p.

69).

13zzzc.{1029}32012 D 0191: Commission Implementing Decision 2012/191/EU of 10 April 2012 allowing Member

States to extend provisional authorisations granted for the new active substances amisulbrom,

chlorantraniliprole, meptyldinocap, pinoxaden, silver thiosulphate and tembotrione (OJ L 102, 12.4.2012, p.

15).

13zzzd.{1030}32012 D 0363: Commission Implementing Decision 2012/363/EU of 4 July 2012 allowing Member States

to extend provisional authorisations granted for the new active substances bixafen, Candida oleophila strain O,

fluopyram, halosulfuron, potassium iodide, potassium thiocyanate and spirotetramat (OJ L 176, 6.7.2012, p.

70).

13zzze.{1031}32012 R 0686: Commission Implementing Regulation (EU) No 686/2012 of 26 July 2012 allocating to

Member States, for the purposes of the renewal procedure, the evaluation of the active substances whose

approval expires by 31 December 2018 at the latest (OJ L 200, 27.7.2012, p. 5), as amended by:

-{1032} 32014 R 0700: Commission Implementing Regulation (EU) No 700/2014 of 24 June 2014 (OJ

L 184, 25.6.2014, p. 8),

-{1033} 32015 R 0052: Commission Implementing Regulation (EU) 2015/52 of 14 January 2015 (OJ L 9,

15.1.2015, p. 27),

-{1034} 32016 R 0138: Commission Implementing Regulation (EU) 2016/138 of 2 February 2016 (OJ L 27,

3.2.2016, p. 5),

-{1035} 32017 R 0243: Commission Implementing Regulation (EU) 2017/243 of 10 February 2017 (OJ L

36, 11.2.2017, p. 53),

-{1036} 32018 R 0155: Commission Implementing Regulation (EU) 2018/155 of 31 January 2018 (OJ L 29,

1.2.2018, p. 8),

-{1037} 32019 R 0150: Commission Implementing Regulation (EU) 2019/150 of 30 January 2019 (OJ L 27,

31.1.2019, p. 23),

-{1038} 32019 R 0336: Commission Implementing Regulation (EU) 2019/336 of 27 February 2019 (OJ L

60, 28.2.2019, p. 8),

-{1039} 32019 R 0724: Commission Implementing Regulation (EU) 2019/724 of 10 May 2019 (OJ L 124,

13.5.2019, p. 32).

13zzzf.{1040}32013 D 0038: Commission Implementing Decision 2013/38/EU of 18 January 2013 allowing Member

States to extend provisional authorisations granted for the new active substances emamectin and maltodextrin

(OJ L 18, 22.1.2013, p. 17).

13zzzg.{1041}32013 R 0369: Commission Implementing Regulation (EU) No 369/2013 of 22 April 2013 approving the

active substance potassium phosphonates, in accordance with Regulation (EC) No 1107/2009 of the European

{1029} Point inserted by Decision No 206/2014 (OJ L 202, 30.7.2015, p. 87 and EEA Supplement No 43, 30.7.2015, p. 86), e.i.f. 1.6.2015.

{1030} Point inserted by Decision No 206/2014 (OJ L 202, 30.7.2015, p. 87 and EEA Supplement No 43, 30.7.2015, p. 86), e.i.f. 1.6.2015.

{1031} Point inserted by Decision No 206/2014 (OJ L 202, 30.7.2015, p. 87 and EEA Supplement No 43, 30.7.2015, p. 86), e.i.f. 1.6.2015.

{1032} Indent and words “, as amended by:” added by Decision No 273/2014 (OJ L 311, 26.11.2015, p. 26 and EEA Supplement No 71,

26.11.2015, p. 25), e.i.f. 1.6.2015.

{1033} Indent added by Decision No 95/2015 (OJ L 211, 4.8.2016, p. 33 and EEA Supplement No 42, 4.8.2016, p. 32), e.i.f. 1.6.2015.

{1034} Indent added by Decision No 149/2016 (OJ L 73, 15.3.2018, p. 22 and EEA Supplement No 16, 15.3.2018, p. 25), e.i.f. 9.7.2016.

{1035} Indent added by Decision No 133/2017 (OJ L 128, 16.5.2019, p. 26 and EEA Supplement No 40, 16.5.2019, p. 27), e.i.f. 8.7.2017.

{1036} Indent added by Decision No 144/2017 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 7.7.2018.

{1037} Indent added by Decision No 229/2019 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 28.9.2019

{1038} Indent added by Decision No 297/2019 (OJ L [to be published] and EEA supplement No [to be published]), e.i.f. 14.12.2019.

{1039} Indent added by Decision No 298/2019 (OJ L [to be published] and EEA supplement No [to be published]), e.i.f. 14.12.2019.

{1040} Point inserted by Decision No 206/2014 (OJ L 202, 30.7.2015, p. 87 and EEA Supplement No 43, 30.7.2015, p. 86), e.i.f. 1.6.2015.

Page 94: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 220

Parliament and of the Council concerning the placing of plant protection products on the market, and amending

the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L 111, 23.4.2013, p. 39).

13zzzh.{1042}32013 D 0205: Commission Implementing Decision 2013/205/EU of 25 April 2013 allowing Member

States to extend provisional authorisations granted for the new active substances acequinocyl, aminopyralid,

ascorbic acid, flubendiamide, gamma-cyhalothrin, ipconazole, metaflumizone, orthosulfamuron, Pseudomonas

sp. strain DSMZ 13134, pyridalil, pyroxsulam, spiromesifen, thiencarbazone and topramezone (OJ L 117,

27.4.2013, p. 20).

13zzzi.{1043}32013 R 0485: Commission Implementing Regulation (EU) No 485/2013 of 24 May 2013 amending

Implementing Regulation (EU) No 540/2011, as regards the conditions of approval of the active substances

clothianidin, thiamethoxam and imidacloprid, and prohibiting the use and sale of seeds treated with plant

protection products containing those active substances (OJ L 139, 25.5.2013, p. 12), as amended by:

-{1044} 32018 R 0783: Commission Implementing Regulation (EU) 2018/783 of 29 May 2018 (OJ L 132,

30.5.2018, p. 31),

-{1045} 32018 R 0784: Commission Implementing Regulation (EU) 2018/784 of 29 May 2018 (OJ L 132,

30.5.2018, p. 35),

-{1046} 32018 R 0785: Commission Implementing Regulation (EU) 2018/785 of 29 May 2018 (OJ L 132,

30.5.2018, p. 40).

13zzzj.{1047}32013 D 0431: Commission Implementing Decision 2013/431/EU of 12 August 2013 allowing Member

States to extend provisional authorisations granted for the active substances benalaxyl-M and valifenalate (OJ

L 218, 14.8.2013, p. 28).

13zzzk.{1048}32013 R 0781: Commission Implementing Regulation (EU) No 781/2013 of 14 August 2013 amending

Implementing Regulation (EU) No 540/2011, as regards the conditions of approval of the active substance

fipronil, and prohibiting the use and sale of seeds treated with plant protection products containing this active

substance (OJ L 219, 15.8.2013, p. 22).

13zzzl.{1049}32013 R 1165: Commission Implementing Regulation (EU) No 1165/2013 of 18 November 2013 approving

the active substance orange oil, in accordance with Regulation (EC) No 1107/2009 of the European Parliament

and of the Council concerning the placing of plant protection products on the market, and amending the Annex

to Commission Implementing Regulation (EU) No 540/2011 (OJ L 309, 19.11.2013, p. 17).

13zzzm.{1050}32014 R 0108: Commission Implementing Regulation (EU) No 108/2014 of 5 February 2014 concerning

the non-approval of the active substance potassium thiocyanate, in accordance with Regulation (EC) No

1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products

on the market (OJ L 36, 6.2.2014, p. 9).

13zzzn.{1051}32014 R 0116: Commission Implementing Regulation (EU) No 116/2014 of 6 February 2014 concerning

the non-approval of the active substance potassium iodide, in accordance with Regulation (EC) No 1107/2009

of the European Parliament and of the Council concerning the placing of plant protection products on the

market (OJ L 38, 7.2.2014, p. 26).

{1041} Point inserted by Decision No 206/2014 (OJ L 202, 30.7.2015, p. 87 and EEA Supplement No 43, 30.7.2015, p. 86), e.i.f. 1.6.2015.

{1042} Point inserted by Decision No 206/2014 (OJ L 202, 30.7.2015, p. 87 and EEA Supplement No 43, 30.7.2015, p. 86), e.i.f. 1.6.2015.

{1043} Point inserted by Decision No 206/2014 (OJ L 202, 30.7.2015, p. 87 and EEA Supplement No 43, 30.7.2015, p. 86), e.i.f. 1.6.2015.

{1044} Indent and words “, as amended by:” inserted by Decision No 119/2019 (OJ L [to be published] and EEA supplement No [to be

published]), e.i.f. 1.6.2019.

{1045} Indent added by Decision No 119/2019 (OJ L [to be published] and EEA supplement No [to be published]), e.i.f. 1.6.2019.

{1046} Indent added by Decision No 119/2019 (OJ L [to be published] and EEA supplement No [to be published]), e.i.f. 1.6.2019.

{1047} Point inserted by Decision No 206/2014 (OJ L 202, 30.7.2015, p. 87 and EEA Supplement No 43, 30.7.2015, p. 86), e.i.f. 1.6.2015.

{1048} Point inserted by Decision No 206/2014 (OJ L 202, 30.7.2015, p. 87 and EEA Supplement No 43, 30.7.2015, p. 86), e.i.f. 1.6.2015.

{1049} Point inserted by Decision No 206/2014 (OJ L 202, 30.7.2015, p. 87 and EEA Supplement No 43, 30.7.2015, p. 86), e.i.f. 1.6.2015.

{1050} Point inserted by Decision No 207/2014 (OJ L 202, 30.7.2015, p. 92 and EEA Supplement No 43, 30.7.2015, p. 91), e.i.f. 1.6.2015.

{1051} Point inserted by Decision No 207/2014 (OJ L 202, 30.7.2015, p. 92 and EEA Supplement No 43, 30.7.2015, p. 91), e.i.f. 1.6.2015.

Page 95: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 221

13zzzo.{1052}32014 R 0140: Commission Implementing Regulation (EU) No 140/2014 of 13 February 2014 approving

the active substance spinetoram, in accordance with Regulation (EC) No 1107/2009 of the European

Parliament and of the Council concerning the placing of plant protection products on the market, and amending

the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L 44, 14.2.2014, p. 35), as

corrected by OJ L 277, 22.10, 2015, p. 60.

13zzzp.{1053}32014 R 0143: Commission Implementing Regulation (EU) No 143/2014 of 14 February 2014 approving

the active substance pyridalyl, in accordance with Regulation (EC) No 1107/2009 of the European Parliament

and of the Council concerning the placing of plant protection products on the market, and amending the Annex

to Commission Implementing Regulation (EU) No 540/2011 (OJ L 45, 15.2.2014, p. 1).

13zzzq.{1054}32014 R 0144: Commission Implementing Regulation (EU) No 144/2014 of 14 February 2014 approving

the active substance valifenalate, in accordance with Regulation (EC) No 1107/2009 of the European

Parliament and of the Council concerning the placing of plant protection products on the market, and amending

the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L 45, 15.2.2014, p. 7).

13zzzr.{1055}32014 R 0145: Commission Implementing Regulation (EU) No 145/2014 of 14 February 2014 approving

the active substance thiencarbazone, in accordance with Regulation (EC) No 1107/2009 of the European

Parliament and of the Council concerning the placing of plant protection products on the market, and amending

the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L 45, 15.2.2014, p. 12).

13zzzs.{1056}32014 R 0149: Commission Implementing Regulation (EU) No 149/2014 of 17 February 2014 approving

the active substance L-ascorbic acid, in accordance with Regulation (EC) No 1107/2009 of the European

Parliament and of the Council concerning the placing of plant protection products on the market, and amending

the Annex to Implementing Regulation (EU) No 540/2011 (OJ L 46, 18.2.2014, p. 3).

13zzzt.{1057}32014 R 0151: Commission Implementing Regulation (EU) No 151/2014 of 18 February 2014 approving

the active substance S-abscisic acid, in accordance with Regulation (EC) No 1107/2009 of the European

Parliament and of the Council concerning the placing of plant protection products on the market, and amending

the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L 48, 19.2.2014, p. 1).

13zzzu.{1058}32014 R 0192: Commission Implementing Regulation (EU) No 192/2014 of 27 February 2014 approving

the active substance 1,4-dimethylnaphthalene, in accordance with Regulation (EC) No 1107/2009 of the

European Parliament and of the Council concerning the placing of plant protection products on the market, and

amending the Annex to Implementing Regulation (EU) No 540/2011 (OJ L 59, 28.2.2014, p. 20).

13zzzv.{1059}32014 R 0193: Commission Implementing Regulation (EU) No 193/2014 of 27 February 2014 approving

the active substance amisulbrom, in accordance with Regulation (EC) No 1107/2009 of the European

Parliament and of the Council concerning the placing of plant protection products on the market, and amending

the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L 59, 28.2.2014, p. 25).

13zzzw.{1060}32014 R 0187: Commission Implementing Regulation (EU) No 187/2014 of 26 February 2014 amending

Implementing Regulation (EU) No 540/2011 as regards the conditions of approval of the active substance

methiocarb (OJ L 57, 27.2.2014, p. 24).

13zzzx.{1061}32014 R 0462: Commission Implementing Regulation (EU) No 462/2014 of 5 May 2014 approving the

basic substance Equisetum arvense L., in accordance with Regulation (EC) No 1107/2009 of the European

Parliament and of the Council concerning the placing of plant protection products on the market, and amending

Implementing Regulation (EU) No 540/2011 (OJ L 134, 7.5.2014, p. 28).

{1052} Point inserted by Decision No 207/2014 (OJ L 202, 30.7.2015, p. 92 and EEA Supplement No 43, 30.7.2015, p. 91), e.i.f. 1.6.2015.

Corrigendum to the EU act subsequently taken note of by the EEA Joint Committee on 11.12.2015.

{1053} Point inserted by Decision No 207/2014 (OJ L 202, 30.7.2015, p. 92 and EEA Supplement No 43, 30.7.2015, p. 91), e.i.f. 1.6.2015.

{1054} Point inserted by Decision No 207/2014 (OJ L 202, 30.7.2015, p. 92 and EEA Supplement No 43, 30.7.2015, p. 91), e.i.f. 1.6.2015.

{1055} Point inserted by Decision No 207/2014 (OJ L 202, 30.7.2015, p. 92 and EEA Supplement No 43, 30.7.2015, p. 91), e.i.f. 1.6.2015.

{1056} Point inserted by Decision No 207/2014 (OJ L 202, 30.7.2015, p. 92 and EEA Supplement No 43, 30.7.2015, p. 91), e.i.f. 1.6.2015.

{1057} Point inserted by Decision No 207/2014 (OJ L 202, 30.7.2015, p. 92 and EEA Supplement No 43, 30.7.2015, p. 91), e.i.f. 1.6.2015.

{1058} Point inserted by Decision No 207/2014 (OJ L 202, 30.7.2015, p. 92 and EEA Supplement No 43, 30.7.2015, p. 91), e.i.f. 1.6.2015.

{1059} Point inserted by Decision No 207/2014 (OJ L 202, 30.7.2015, p. 92 and EEA Supplement No 43, 30.7.2015, p. 91), e.i.f. 1.6.2015.

{1060} Point inserted by Decision No 220/2014 (OJ L 230, 3.9.2015, p. 19 and EEA Supplement No 52, 3.9.2015, p. 19), e.i.f. 1.6.2015.

{1061} Point inserted by Decision No 220/2014 (OJ L 230, 3.9.2015, p. 19 and EEA Supplement No 52, 3.9.2015, p. 19), e.i.f. 1.6.2015.

Page 96: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 222

13zzzy.{1062} 32014 R 0485: Commission Implementing Regulation (EU) No 485/2014 of 12 May 2014 approving the

active substance Bacillus pumilus QST 2808, in accordance with Regulation (EC) No 1107/2009 of the

European Parliament and of the Council concerning the placing of plant protection products on the

market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ

L 138, 13.5.2014, p. 65).

13zzzz.{1063} 32014 R 0486: Commission Implementing Regulation (EU) No 486/2014 of 12 May 2014 withdrawing

the approval of the active substance fenbutatin oxide, in accordance with Regulation (EC) No 1107/2009

of the European Parliament and of the Council concerning the placing of plant protection products on the

market, and amending Commission Implementing Regulation (EU) No 540/2011 (OJ L 138, 13.5.2014,

p. 70).

13zzzza.{1064} 32014 R 0496: Commission Implementing Regulation (EU) No 496/2014 of 14 May 2014 approving the

active substance acequinocyl, in accordance with Regulation (EC) No 1107/2009 of the European

Parliament and of the Council concerning the placing of plant protection products on the market, and

amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L 143, 15.5.2014,

p. 1).

13zzzzb.{1065} 32014 R 0504: Commission Implementing Regulation (EU) No 504/2014 of 15 May 2014 amending

Implementing Regulation (EU) No 540/2011 as regards the conditions of approval of the active

substance plant oils/citronella oil (OJ L 145, 16.5.2014, p. 28).

13zzzzc.{1066} 32014 R 0563: Commission Implementing Regulation (EU) No 563/2014 of 23 May 2014 approving the

basic substance chitosan hydrochloride in accordance with Regulation (EC) No 1107/2009 of the

European Parliament and of the Council concerning the placing of plant protection products on the

market, and amending Commission Implementing Regulation (EU) No 540/2011(OJ L 156, 24.5.2014,

p. 5).

13zzzzd.{1067} 32014 R 0517: Commission Implementing Regulation (EU) No 571/2014 of 26 May 2014 approving the

active substance ipconazole, in accordance with Regulation (EC) No 1107/2009 of the European

Parliament and of the Council concerning the placing of plant protection products on the market, and

amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L 157, 27.5.2014,

p. 96).

13zzzze.{1068} 32014 R 0629: Commission Implementing Regulation (EU) No 629/2014 of 12 June 2014 amending

Implementing Regulation (EU) No 540/2011 as regards the conditions of approval of the active

substance methyl nonyl ketone (OJ L 174, 13.6.2014, p. 33).

13zzzzf.{1069} 32014 R 0632: Commission Implementing Regulation (EU) No 632/2014 of 13 May 2014 approving the

active substance flubendiamide, in accordance with Regulation (EC) No 1107/2009 of the European

Parliament and of the Council concerning the placing of plant protection products on the market, and

amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L 175, 14.6.2014,

p. 1).

13zzzzg.{1070} 32014 R 0890: Commission Implementing Regulation (EU) No 890/2014 of 14 August 2014 approving

the active substance metobromuron, in accordance with Regulation (EC) No 1107/2009 of the European

Parliament and of the Council concerning the placing of plant protection products on the market, and

amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L 243, 15.8.2014,

p. 42).

13zzzzh.{1071} 32014 R 0891: Commission Implementing Regulation (EU) No 891/2014 of 14 August 2014 approving

the active substance aminopyralid, in accordance with Regulation (EC) No 1107/2009 of the European

{1062} Point inserted by Decision No 220/2014 (OJ L 230, 3.9.2015, p. 19 and EEA Supplement No 52, 3.9.2015, p. 19), e.i.f. 1.6.2015.

{1063} Point inserted by Decision No 220/2014 (OJ L 230, 3.9.2015, p. 19 and EEA Supplement No 52, 3.9.2015, p. 19), e.i.f. 1.6.2015.

{1064} Point inserted by Decision No 220/2014 (OJ L 230, 3.9.2015, p. 19 and EEA Supplement No 52, 3.9.2015, p. 19), e.i.f. 1.6.2015.

{1065} Point inserted by Decision No 220/2014 (OJ L 230, 3.9.2015, p. 19 and EEA Supplement No 52, 3.9.2015, p. 19), e.i.f. 1.6.2015.

{1066} Point inserted by Decision No 221/2014 (OJ L 230, 3.9.2015, p. 22 and EEA Supplement No 52, 3.9.2015, p. 22), e.i.f. 1.6.2015.

{1067} Point inserted by Decision No 221/2014 (OJ L 230, 3.9.2015, p. 22 and EEA Supplement No 52, 3.9.2015, p. 22), e.i.f. 1.6.2015.

{1068} Point inserted by Decision No 221/2014 (OJ L 230, 3.9.2015, p. 22 and EEA Supplement No 52, 3.9.2015, p. 22), e.i.f. 1.6.2015.

{1069} Point inserted by Decision No 221/2014 (OJ L 230, 3.9.2015, p. 22 and EEA Supplement No 52, 3.9.2015, p. 22), e.i.f. 1.6.215.

{1070} Point inserted by Decision No 271/2014 (OJ L 311, 26.11.2015, p. 22 and EEA Supplement No 71, 26.11.2015, p. 21), e.i.f. 1.6.2015.

{1071} Point inserted by Decision No 271/2014 (OJ L 311, 26.11.2015, p. 22 and EEA Supplement No 71, 26.11.2015, p. 21), e.i.f. 1.6.2015.

Page 97: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 223

Parliament and of the Council concerning the placing of plant protection products on the market, and

amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L 243, 15.8.2014,

p. 47).

13zzzzi.{1072} 32014 R 0916: Commission Implementing Regulation (EU) No 916/2014 of 22 August 2014 approving

the basic substance sucrose in accordance with Regulation (EC) No 1107/2009 of the European

Parliament and of the Council concerning the placing of plant protection products on the market, and

amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L 251, 23.8.2014,

p. 16).

13zzzzj.{1073} 32014 R 0917: Commission Implementing Regulation (EU) No 917/2014 of 22 August 2014 approving

the active substance Streptomyces lydicus strain WYEC 108 in accordance with Regulation (EC)

No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection

products on the market, and amending the Annex to Commission Implementing Regulation (EU)

No 540/2011 (OJ L 251, 23.8.2014, p. 19).

13zzzzk.{1074} 32014 R 0922: Commission Implementing Regulation (EU) No 922/2014 of 25 August 2014 approving

the active substance metaflumizone, in accordance with Regulation (EC) No 1107/2009 of the European

Parliament and of the Council concerning the placing of plant protection products on the market, and

amending the Annex to Implementing Regulation (EU) No 540/2011 (OJ L 252, 26.8.2014, p. 6).

13zzzzl.{1075} 32014 D 0289: Commission Implementing Decision 2014/289/EU of 15 May 2014 allowing Member

States to extend provisional authorisations granted for the active substances pinoxaden and

meptyldinocap (OJ L 147, 17.5.2014, p. 114).

13zzzzm.{1076} 32014 R 1316: Commission Implementing Regulation (EU) No 1316/2014 of 11 December 2014

approving the active substance Bacillus amyloliquefaciens subsp. plantarum strain D747, in accordance

with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the

placing of plant protection products on the market, and amending the Annex to Commission

Implementing Regulation (EU) No 540/2011 and allowing Member States to extend provisional

authorisations granted for that active substance (OJ L 355, 12.12.2014, p. 1).

13zzzzn.{1077} 32014 R 1330: Commission Implementing Regulation (EU) No 1330/2014 of 15 December 2014

approving the active substance meptyldinocap, in accordance with Regulation (EC) No 1107/2009 of the

European Parliament and of the Council concerning the placing of plant protection products on the

market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ

L 359, 16.12.2014, p. 85).

13zzzzo.{1078} 32014 R 1334: Commission Implementing Regulation (EU) No 1334/2014 of 16 December 2014

approving the active substance gamma-cyhalotrin, in accordance with Regulation (EC) No 1107/2009 of

the European Parliament and of the Council concerning the placing of plant protection products on the

market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 and

allowing Member States to extend provisional authorisations granted for that active substance (OJ L 360,

17.12.2014, p. 1).

13zzzzp.{1079} 32015 R 0051: Commission Implementing Regulation (EU) 2015/51 of 14 January 2015 approving the

active substance chromafenozide, in accordance with Regulation (EC) No 1107/2009 of the European

Parliament and of the Council concerning the placing of plant protection products on the market, and

amending the Annex to Commission Implementing Regulation (EU) No 540/2011 and allowing Member

States to extend provisional authorisations granted for that active substance (OJ L 9, 15.1.2015, p. 22).

13zzzzq.{1080} 32015 R 0306: Commission Implementing Regulation (EU) 2015/306 of 26 February 2015 renewing the

approval of the active substance Isaria fumosorosea strain Apopka 97 in accordance with Regulation

{1072} Point inserted by Decision No 271/2014 (OJ L 311, 26.11.2015, p. 22 and EEA Supplement No 71, 26.11.2015, p. 21), e.i.f. 1.6.2015.

{1073} Point inserted by Decision No 271/2014 (OJ L 311, 26.11.2015, p. 22 and EEA Supplement No 71, 26.11.2015, p. 21), e.i.f. 1.6.2015.

{1074} Point inserted by Decision No 271/2014 (OJ L 311, 26.11.2015, p. 22 and EEA Supplement No 71, 26.11.2015, p. 21), e.i.f. 1.6.2015.

{1075} Point inserted by Decision No 274/2014 (OJ L 311, 26.11.2015, p. 27 and EEA Supplement No 71, 26.11.2015, p. 26), e.i.f. 1.6.2015.

{1076} Point inserted by Decision No 95/2015 (OJ L 211, 4.8.2016, p. 33 and EEA Supplement No 42, 4.8.2016, p. 32), e.i.f. 1.6.2015.

{1077} Point inserted by Decision No 95/2015 (OJ L 211, 4.8.2016, p. 33 and EEA Supplement No 42, 4.8.2016, p. 32), e.i.f. 1.6.2015.

{1078} Point inserted by Decision No 95/2015 (OJ L 211, 4.8.2016, p. 33 and EEA Supplement No 42, 4.8.2016, p. 32), e.i.f. 1.6.2015.

{1079} Point inserted by Decision No 95/2015 (OJ L 211, 4.8.2016, p. 33 and EEA Supplement No 42, 4.8.2016, p. 32), e.i.f. 1.6.2015.

{1080} Point inserted by Decision No 154/2015 (OJ L 341, 15.12.2016, p. 48 and EEA Supplement No 69, 15.12.2016, p. 49), e.i.f. 12.6.2015.

Page 98: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 224

(EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant

protection products on the market, and amending the Annex to Commission Implementing Regulation

(EU) No 540/2011 (OJ L 56, 27.2.2015, p. 1).

13zzzzr.{1081} 32015 R 0543: Commission Implementing Regulation (EU) 2015/543 of 1 April 2015 approving the

active substance COS-OGA, in accordance with Regulation (EC) No 1107/2009 of the European

Parliament and of the Council concerning the placing of plant protection products on the market, and

amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L 90, 2.4.2015,

p. 1).

13zzzzs.{1082} 32015 R 0553: Commission Implementing Regulation (EU) 2015/553 of 7 April 2015 approving the

active substance cerevisane, in accordance with Regulation (EC) No 1107/2009 of the European

Parliament and of the Council concerning the placing of plant protection products on the market, and

amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L 92, 8.4.2015,

p. 86).

13zzzzt.{1083} 32015 R 0408: Commission Implementing Regulation (EU) 2015/408 of 11 March 2015 on

implementing Article 80(7) of Regulation (EC) No 1107/2009 of the European Parliament and of the

Council concerning the placing of plant protection products on the market and establishing a list of

candidates for substitution (OJ L 67, 12.3.2015, p. 18), as amended by:

-{1084} 32017 R 2065: Commission Implementing Regulation (EU) 2017/2065 of 13 November

2017 (OJ L 295, 14.11.2017, p. 40).

13zzzzu.{1085} 32015 R 0707: Commission Implementing Regulation (EU) 2015/707 of 30 April 2015 concerning the

non-approval of Rheum officinale root extract as a basic substance in accordance with Regulation (EC)

No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection

products on the market (OJ L 113, 1.5.2015, p. 44).

13zzzzv.{1086} 32015 R 0762: Commission Implementing Regulation (EU) 2015/762 of 12 May 2015 approving the

basic substance calcium hydroxide in accordance with Regulation (EC) No 1107/2009 of the European

Parliament and of the Council concerning the placing of plant protection products on the market, and

amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L 120, 13.5.2015,

p. 6).

13zzzzw.{1087} 32015 R 1115: Commission Implementing Regulation (EU) 2015/1115 of 9 July 2015 renewing the

approval of the active substance pyridate in accordance with Regulation (EC) No 1107/2009 of the

European Parliament and of the Council concerning the placing of plant protection products on the

market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ

L 182, 10.7.2015, p. 22).

13zzzzx.{1088} 32015 R 1154: Commission Implementing Regulation (EU) 2015/1154 of 14 July 2015 renewing the

approval of the active substance sulfosulfuron in accordance with Regulation (EC) No 1107/2009 of the

European Parliament and of the Council concerning the placing of plant protection products on the

market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ

L 187, 15.7.2015, p. 18).

13zzzzy.{1089} 32015 R 1166: Commission Implementing Regulation (EU) 2015/1166 of 15 July 2015 renewing the

approval of the active substance ferric phosphate in accordance with Regulation (EC) No 1107/2009 of

the European Parliament and of the Council concerning the placing of plant protection products on the

market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ

L 188, 16.7.2015, p. 34).

{1081} Point inserted by Decision No 183/2015 (OJ L 8, 12.1.2017, p. 12 and EEA Supplement No 3, 12.1.2017, p. 11), e.i.f. 11.7.2015.

{1082} Point inserted by Decision No 183/2015 (OJ L 8, 12.1.2017, p. 12 and EEA Supplement No 3, 12.1.2017, p. 11), e.i.f. 11.7.2015.

{1083} Point inserted by Decision No 217/2015 (OJ L 85, 30.3.2017, p. 38 and EEA Supplement No 19, 30.3.2017, p. 37), e.i.f. 26.9.2015.

{1084} Indent and words “, as amended by” added by Decision No 89/2018 (OJ L [to be published] and EEA Supplement No [to be published]),

e.i.f. 28.4.2018.

{1085} Point inserted by Decision No 262/2015 (OJ L 161, 22.6.2017, p. 44 and EEA Supplement No 38, 22.6.2017, p. 44), e.i.f. 1.11.2015.

{1086} Point inserted by Decision No 263/2015 (OJ L 161, 22.6.2017, p. 45 and EEA Supplement No 38, 22.6.2017, p. 45), e.i.f. 1.11.2015.

{1087} Point inserted by Decision No 264/2015 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 1.11.2015.

{1088} Point inserted by Decision No 264/2015 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 1.11.2015.

{1089} Point inserted by Decision No 264/2015 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 1.11.2015.

Page 99: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 225

13zzzzz.{1090} 32015 R 1201: Commission Implementing Regulation (EU) 2015/1201 of 22 July 2015 renewing the

approval of the active substance fenhexamid in accordance with Regulation (EC) No 1107/2009 of the

European Parliament and of the Council concerning the placing of plant protection products on the

market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ

L 195, 23.7.2015, p. 37).

13zzzzza.{1091} 32015 R 1107: Commission Implementing Regulation (EU) 2015/1107 of 8 July 2015 approving the

basic substance Salix spp. cortex, in accordance with Regulation (EC) No 1107/2009 of the European

Parliament and of the Council concerning the placing of plant protection products on the market, and

amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L 181, 9.7.2015,

p. 72).

13zzzzzb.{1092} 32015 R 1108: Commission Implementing Regulation (EU) 2015/1108 of 8 July 2015 approving the

basic substance vinegar in accordance with Regulation (EC) No 1107/2009 of the European Parliament

and of the Council concerning the placing of plant protection products on the market, and amending the

Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L 181, 9.7.2015, p. 75), as

amended by:

-{1093} 32019 R 0149: Commission Implementing Regulation (EU) 2019/149 of 30 January 2019

(OJ L 27, 31.1.2019, p. 20).

13zzzzzc.{1094} 32015 R 1116: Commission Implementing Regulation (EU) 2015/1116 of 9 July 2015 approving the

basic substance lecithins, in accordance with Regulation (EC) No 1107/2009 of the European Parliament

and of the Council concerning the placing of plant protection products on the market, and amending the

Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L 182, 10.7.2015, p. 26).

13zzzzzd.{1095} 32015 R 1165: Commission Implementing Regulation (EU) 2015/1165 of 15 July 2015 approving the

active substance halauxifen-methyl, in accordance with Regulation (EC) No 1107/2009 of the European

Parliament and of the Council concerning the placing of plant protection products on the market, and

amending the Annex to Commission Implementing Regulation (EU) No 540/2011(OJ L 188, 16.7.2015,

p. 30).

13zzzzze.{1096} 32015 R 1176: Commission Implementing Regulation (EU) 2015/1176 of 17 July 2015 approving the

active substance Pepino mosaic virus strain CH2 isolate 1906, in accordance with Regulation (EC)

No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection

products on the market, and amending the Annex to Commission Implementing Regulation (EU)

No 540/2011 (OJ L 192, 18.7.2015, p. 1).

13zzzzzf.{1097} 32015 R 1191: Commission Implementing Regulation (EU) 2015/1191 of 20 July 2015 concerning the

non-approval of Artemisia vulgaris L. as a basic substance in accordance with Regulation (EC)

No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection

products on the market (OJ L 193, 21.7.2015, p. 122).

13zzzzzg.{1098} 32015 R 1192: Commission Implementing Regulation (EU) 2015/1192 of 20 July 2015 approving the

active substance terpenoid blend QRD 460, in accordance with Regulation (EC) No 1107/2009 of the

European Parliament and of the Council concerning the placing of plant protection products on the

market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ

L 193, 21.7.2015, p. 124).

13zzzzzh.{1099} 32015 R 1295: Commission Implementing Regulation (EU) 2015/1295 of 27 July 2015 approving the

active substance sulfoxaflor, in accordance with Regulation (EC) No 1107/2009 of the European

{1090} Point inserted by Decision No 264/2015 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 1.11.2015.

{1091} Point inserted by Decision No 265/2015 (OJ L 161, 22.6.2017, p. 48 and EEA Supplement No 38, 22.6.2017, p. 50), e.i.f. 1.11.2015.

{1092} Point inserted by Decision No 265/2015 (OJ L 161, 22.6.2017, p. 48 and EEA Supplement No 38, 22.6.2017, p. 50), e.i.f. 1.11.2015.

{1093} Indent and words “, as amended by:” added by Decision No 229/2019 (OJ L [to be published] and EEA Supplement No [to be published]),

e.i.f. 28.9.2019.

{1094} Point inserted by Decision No 265/2015 (OJ L 161, 22.6.2017, p. 48 and EEA Supplement No 38, 22.6.2017, p. 50), e.i.f. 1.11.2015.

{1095} Point inserted by Decision No 265/2015 (OJ L 161, 22.6.2017, p. 48 and EEA Supplement No 38, 22.6.2017, p. 50), e.i.f. 1.11.2015.

{1096} Point inserted by Decision No 265/2015 (OJ L 161, 22.6.2017, p. 48 and EEA Supplement No 38, 22.6.2017, p. 50), e.i.f. 1.11.2015.

{1097} Point inserted by Decision No 265/2015 (OJ L 161, 22.6.2017, p. 48 and EEA Supplement No 38, 22.6.2017, p. 50), e.i.f. 1.11.2015.

{1098} Point inserted by Decision No 265/2015 (OJ L 161, 22.6.2017, p. 48 and EEA Supplement No 38, 22.6.2017, p. 50), e.i.f. 1.11.2015.

{1099} Point inserted by Decision No 265/2015 (OJ L 161, 22.6.2017, p. 48 and EEA Supplement No 38, 22.6.2017, p. 50), e.i.f. 1.11.2015.

Page 100: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 226

Parliament and of the Council concerning the placing of plant protection products on the market, and

amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L 199, 29.7.2015,

p. 8).

13zzzzzi.{1100} 32015 R 1392: Commission Implementing Regulation (EU) 2015/1392 of 13 August 2015 approving the

basic substance fructose in accordance with Regulation (EC) No 1107/2009 of the European Parliament

and of the Council concerning the placing of plant protection products on the market, and amending the

Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L 215, 14.8.2015, p. 34).

13zzzzzj.{1101} 32015 R 1397: Commission Implementing Regulation (EU) 2015/1397 of 14 August 2015 renewing the

approval of the active substance florasulam in accordance with Regulation (EC) No 1107/2009 of the

European Parliament and of the Council concerning the placing of plant protection products on the

market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ

L 216, 15.8.2015, p. 3).

13zzzzzk.{1102} 32015 R 2046: Commission Implementing Regulation (EU) 2015/2046 of 16 November 2015

concerning the non-approval of Artemisia absinthium L. as a basic substance in accordance with

Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of

plant protection products on the market (OJ L 300, 17.11.2015, p. 6).

13zzzzzl.{1103} 32015 R 2069: Commission Implementing Regulation (EU) 2015/2069 of 17 November 2015 approving

the basic substance sodium hydrogen carbonate in accordance with Regulation (EC) No 1107/2009 of the

European Parliament and of the Council concerning the placing of plant protection products on the

market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ

L 301, 18.11.2015, p. 42).

13zzzzzm.{1104} 32015 R 2082: Commission Implementing Regulation (EU) 2015/2082 of 18 November 2015

concerning the non-approval of Arctium lappa L. (aerial parts) as a basic substance in accordance with

Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of

plant protection products on the market (OJ L 302, 19.11.2015, p. 85).

13zzzzzn.{1105} 32015 R 2083: Commission Implementing Regulation (EU) 2015/2083 of 18 November 2015

concerning the non-approval of Tanacetum vulgare L. as a basic substance in accordance with

Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of

plant protection products on the market (OJ L 302, 19.11.2015, p. 87).

13zzzzzo.{1106} 32015 R 2085: Commission Implementing Regulation (EU) 2015/2085 of 18 November 2015 approving

the active substance mandestrobin, in accordance with Regulation (EC) No 1107/2009 of the European

Parliament and of the Council concerning the placing of plant protection products on the market, and

amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L 302,

19.11.2015, p. 93).

13zzzzzp.{1107} 32015 R 2033: Commission Implementing Regulation (EU) 2015/2033 of 13 November 2015 renewing

the approval of the active substance 2,4-D in accordance with Regulation (EC) No 1107/2009 of the

European Parliament and of the Council concerning the placing of plant protection products on the

market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ

L 298, 14.11.2015, p. 8).

13zzzzzq.{1108} 32015 R 2047: Commission Implementing Regulation (EU) 2015/2047 of 16 November 2015 renewing

the approval of the active substance esfenvalerate, as a candidate for substitution, in accordance with

Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of

plant protection products on the market, and amending the Annex to Commission Implementing

Regulation (EU) No 540/2011 (OJ L 300, 17.11.2015, p. 8).

{1100} Point inserted by Decision No 304/2015 (OJ L 263, 12.10.2017, p. 15 and EEA Supplement No 64, 12.10.2017, p. 18), e.i.f. 12.12.2015.

{1101} Point inserted by Decision No 305/2015 (OJ L 263, 12.10.2017, p. 16 and EEA Supplement No 64, 12.10.2017, p. 20), e.i.f. 12.12.2015.

{1102} Point inserted by Decision No 50/2016 (OJ L 270, 19.10.2017, p. 17 and EEA Supplement No 66, 19.10.2017, p. 17), e.i.f. 19.3.2016.

{1103} Point inserted by Decision No 50/2016 (OJ L 270, 19.10.2017, p. 17 and EEA Supplement No 66, 19.10.2017, p. 17), e.i.f. 19.3.2016.

{1104} Point inserted by Decision No 50/2016 (OJ L 270, 19.10.2017, p. 17 and EEA Supplement No 66, 19.10.2017, p. 17), e.i.f. 19.3.2016.

{1105} Point inserted by Decision No 50/2016 (OJ L 270, 19.10.2017, p. 17 and EEA Supplement No 66, 19.10.2017, p. 17), e.i.f. 19.3.2016.

{1106} Point inserted by Decision No 50/2016 (OJ L 270, 19.10.2017, p. 17 and EEA Supplement No 66, 19.10.2017, p. 17), e.i.f. 19.3.2016.

{1107} Point inserted by Decision No 86/2016 (OJ L 300, 16.11.2017, p. 32 and EEA Supplement No 73, 16.11.2017, p. 36), e.i.f. 30.4.2016.

{1108} Point inserted by Decision No 86/2016 (OJ L 300, 16.11.2017, p. 32 and EEA Supplement No 73, 16.11.2017, p. 36), e.i.f. 30.4.2016.

Page 101: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 227

13zzzzzr.{1109} 32015 R 2084: Commission Implementing Regulation (EU) 2015/2084 of 18 November 2015 approving

the active substance flupyradifurone, in accordance with Regulation (EC) No 1107/2009 of the European

Parliament and of the Council concerning the placing of plant protection products on the market, and

amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L 302,

19.11.2015, p. 89).

13zzzzzs.{1110} 32015 R 2105: Commission Implementing Regulation (EU) 2015/2105 of 20 November 2015 approving

the active substance flumetralin, as a candidate for substitution, in accordance with Regulation (EC) No

1107/2009 of the European Parliament and of the Council concerning the placing of plant protection

products on the market, and amending Commission Implementing Regulation (EU) No 540/2011 (OJ

L 305, 21.11.2015, p. 31).

13zzzzzt.{1111} 32015 R 2198: Commission Implementing Regulation (EU) 2015/2198 of 27 November 2015 approving

the active substance rescalure, in accordance with Regulation (EC) No 1107/2009 of the European

Parliament and of the Council concerning the placing of plant protection products on the market, and

amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L 313,

28.11.2015, p. 35).

13zzzzzu.{1112} 32016 R 0138: Commission Implementing Regulation (EU) 2016/138 of 2 February 2016 concerning the

non-approval of the active substance 3-decen-2-one, in accordance with Regulation (EC) No 1107/2009

of the European Parliament and of the Council concerning the placing of plant protection products on the

market (OJ L 27, 3.2.2016, p. 5).

13zzzzzv.{1113} 32016 R 0139: Commission Implementing Regulation (EU) 2016/139 of 2 February 2016 renewing the

approval of the active substance metsulfuron-methyl, as a candidate for substitution, in accordance with

Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of

plant protection products on the market, and amending the Annex to Implementing Regulation (EU) No

540/2011 (OJ L 27, 3.2.2016, p. 7).

13zzzzzw.{1114} 32016 R 0146: Commission Implementing Regulation (EU) 2016/146 of 4 February 2016 renewing the

approval of the active substance lambda-cyhalothrin, as a candidate for substitution, in accordance with

Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of

plant protection products on the market, and amending the Annex to Implementing Regulation (EU) No

540/2011 (OJ L 30, 5.2.2016, p. 7).

13zzzzzx.{1115} 32016 R 0147: Commission Implementing Regulation (EU) 2016/147 of 4 February 2016 renewing the

approval of the active substance iprovalicarb in accordance with Regulation (EC) No 1107/2009 of the

European Parliament and of the Council concerning the placing of plant protection products on the

market, and amending the Annex to Implementing Regulation (EU) No 540/2011 (OJ L 30, 5.2.2016, p.

12).

13zzzzzy.{1116} 32016 R 0177: Commission Implementing Regulation (EU) 2016/177 of 10 February 2016 approving

the active substance benzovindiflupyr, as a candidate for substitution, in accordance with Regulation

(EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant

protection products on the market, and amending the Annex to Implementing Regulation (EU) No

540/2011 (OJ L 35, 11.2.2016, p. 1).

13zzzzzz.{1117} 32016 R 0182: Commission Implementing Regulation (EU) 2016/182 of 11 February 2016 renewing the

approval of the active substance pyraflufen-ethyl in accordance with Regulation (EC) No 1107/2009 of

the European Parliament and of the Council concerning the placing of plant protection products on the

market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L 37,

12.2.2016, p. 40).

{1109} Point inserted by Decision No 86/2016 (OJ L 300, 16.11.2017, p. 32 and EEA Supplement No 73, 16.11.2017, p. 36), e.i.f. 30.4.2016.

{1110} Point inserted by Decision No 86/2016 (OJ L 300, 16.11.2017, p. 32 and EEA Supplement No 73, 16.11.2017, p. 36), e.i.f. 30.4.2016.

{1111} Point inserted by Decision No 87/2016 (OJ L 300, 16.11.2017, p. 34 and EEA Supplement No 73, 16.11.2017, p. 38), e.i.f. 30.4.2016.

{1112} Point inserted by Decision No 149/2016 (OJ L 73, 15.3.2018, p. 22 and EEA Supplement No 16, 15.3.2018, p. 25), e.i.f. 9.7.2016.

{1113} Point inserted by Decision No 149/2016 (OJ L 73, 15.3.2018, p. 22 and EEA Supplement No 16, 15.3.2018, p. 25), e.i.f. 9.7.2016.

{1114} Point inserted by Decision No 149/2016 (OJ L 73, 15.3.2018, p. 22 and EEA Supplement No 16, 15.3.2018, p. 25), e.i.f. 9.7.2016.

{1115} Point inserted by Decision No 149/2016 (OJ L 73, 15.3.2018, p. 22 and EEA Supplement No 16, 15.3.2018, p. 25), e.i.f. 9.7.2016.

{1116} Point inserted by Decision No 149/2016 (OJ L 73, 15.3.2018, p. 22 and EEA Supplement No 16, 15.3.2018, p. 25), e.i.f. 9.7.2016.

{1117} Point inserted by Decision No 149/2016 (OJ L 73, 15.3.2018, p. 22 and EEA Supplement No 16, 15.3.2018, p. 25), e.i.f. 9.7.2016.

Page 102: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 228

13zzzzzza.{1118} 32016 R 0370: Commission Implementing Regulation (EU) 2016/370 of 15 March 2016 approving the

active substance pinoxaden, in accordance with Regulation (EC) No 1107/2009 of the European

Parliament and of the Council concerning the placing of plant protection products on the market,

amending the Annex to Commission Implementing Regulation (EU) No 540/2011 and allowing the

Member States to extend provisional authorisations granted for that active substance (OJ L 70,

16.3.2016, p. 7).

13zzzzzzb.{1119} 32016 R 0389: Commission Implementing Regulation (EU) 2016/389 of 17 March 2016 renewing the

approval of the active substance acibenzolar-S-methyl in accordance with Regulation (EC) No

1107/2009 of the European Parliament and of the Council concerning the placing of plant protection

products on the market, and amending the Annex to Commission Implementing Regulation (EU) No

540/2011 (OJ L 73, 18.3.2016, p. 77).

13zzzzzzc.{1120} 32016 R 0636: Commission Implementing Regulation (EU) 2016/636 of 22 April 2016 withdrawing the

approval of the active substance Z,Z,Z,Z-7,13,16,19-docosatetraen-1-yl isobutyrate, in accordance with

Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending

Commission Implementing Regulation (EU) No 540/2011 (OJ L 108, 23.4.2016, p. 22).

13zzzzzzd.{1121} 32016 R 0638: Commission Implementing Regulation (EU) 2016/638 of 22 April 2016 withdrawing the

approval of the active substance Z-13-hexadecen-11-yn-1-yl acetate, in accordance with Regulation (EC)

No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing

Regulation (EU) No 540/2011 (OJ L 108, 23.4.2016, p. 28).

13zzzzzze.{1122} 32016 R 0548: Commission Implementing Regulation (EU) 2016/548 of 8 April 2016 approving the

basic substance diammonium phosphate in accordance with Regulation (EC) No 1107/2009 of the

European Parliament and of the Council concerning the placing of plant protection products on the

market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L 95,

9.4.2016, p. 1).

13zzzzzzf.{1123} 32016 R 0560: Commission Implementing Regulation (EU) 2016/560 of 11 April 2016 approving

the basic substance whey in accordance with Regulation (EC) No 1107/2009 of the European Parliament

and of the Council concerning the placing of plant protection products on the market, and amending the

Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L 96, 12.4.2016, p. 23).

13zzzzzzg.{1124} 32016 R 0864: Commission Implementing Regulation (EU) 2016/864 of 31 May 2016 concerning

the non-renewal of approval of the active substance triasulfuron, in accordance with Regulation (EC) No

1107/2009 of the European Parliament and of the Council concerning the placing of plant protection

products on the market, and amending Commission Implementing Regulation (EU) No 540/2011 (OJ L

144, 1.6.2016, p. 32).

13zzzzzzh.{1125} 32016 R 0871: Commission Implementing Regulation (EU) 2016/871 of 1 June 2016 concerning the

non-renewal of approval of the active substance amitrole, in accordance with Regulation (EC) No

1107/2009 of the European Parliament and of the Council concerning the placing of plant protection

products on the market, and amending Commission Implementing Regulation (EU) No 540/2011 (OJ L

145, 2.6.2016, p. 4).

13zzzzzzi.{1126} 32016 R 0872: Commission Implementing Regulation (EU) 2016/872 of 1 June 2016 concerning the

non-renewal of approval of the active substance isoproturon, in accordance with Regulation (EC) No

1107/2009 of the European Parliament and of the Council concerning the placing of plant protection

products on the market, and amending Commission Implementing Regulation (EU) No 540/2011 (OJ L

145, 2.6.2016, p. 7).

{1118} Point inserted by Decision No 181/2016 (OJ L 80, 22.3.2018, p. 25 and EEA Supplement No 19, 22.3.2018, p. 32), e.i.f. 24.9.2016.

{1119} Point inserted by Decision No 182/2016 (OJ L 80, 22.3.2018, p. 26 and EEA Supplement No 19, 22.3.2018, p. 34), e.i.f. 24.9.2016.

{1120} Point inserted by Decision No 183/2016 (OJ L 80, 22.3.2018, p. 27 and EEA Supplement No 19, 22.3.2018, p. 36), e.i.f. 24.9.2016.

{1121} Point inserted by Decision No 183/2016 (OJ L 80, 22.3.2018, p. 27 and EEA Supplement No 19, 22.3.2018, p. 36), e.i.f. 24.9.2016.

{1122} Point inserted by Decision No 236/2016 (OJ L 215, 23.8.2018, p. 33 and EEA Supplement No 56, 23.8.2018, p. 39), e.i.f. 3.12.2016.

{1123} Point inserted by Decision No 236/2016 (OJ L 215, 23.8.2018, p. 33 and EEA Supplement No 56, 23.8.2018, p. 39), e.i.f. 3.12.2016.

{1124} Point inserted by Decision No 237/2016 (OJ L 215, 23.8.2018, p. 35 and EEA Supplement No 56, 23.8.2018, p. 41), e.i.f. 3.12.2016.

{1125} Point inserted by Decision No 237/2016 (OJ L 215, 23.8.2018, p. 35 and EEA Supplement No 56, 23.8.2018, p. 41), e.i.f. 3.12.2016.

{1126} Point inserted by Decision No 237/2016 (OJ L 215, 23.8.2018, p. 35 and EEA Supplement No 56, 23.8.2018, p. 41), e.i.f. 3.12.2016.

Page 103: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 229

13zzzzzzj.{1127} 32016 R 0951: Commission Implementing Regulation (EU) 2016/951 of 15 June 2016 approving

the low-risk active substance Trichoderma atroviride strain SC1, in accordance with Regulation (EC) No

1107/2009 of the European Parliament and of the Council concerning the placing of plant protection

products on the market, and amending the Annex to Commission Implementing Regulation (EU) No

540/2011 (OJ L 159, 16.6.2016, p. 6).

13zzzzzzk.{1128}32016 R 1414: Commission Implementing Regulation (EU) 2016/1414 of 24 August 2016 approving

the active substance cyantraniliprole, in accordance with Regulation (EC) No 1107/2009 of the European

Parliament and of the Council concerning the placing of plant protection products on the market, and

amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L 230, 25.8.2016,

p. 16).

13zzzzzzl.{1129} 32016 R 1423: Commission Implementing Regulation (EU) 2016/1423 of 25 August 2016 renewing

approval of the active substance picolinafen in accordance with Regulation (EC) No 1107/2009 of the

European Parliament and of the Council concerning the placing of plant protection products on the

market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L

231, 26.8.2016, p. 20).

13zzzzzzm.{1130}32016 R 1425: Commission Implementing Regulation (EU) 2016/1425 of 25 August 2016 approving

the active substance isofetamid in accordance with Regulation (EC) No 1107/2009 of the European

Parliament and of the Council concerning the placing of plant protection products on the market, and

amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L 231, 26.8.2016,

p. 30).

13zzzzzzn.{1131}32016 R 1426: Commission Implementing Regulation (EU) 2016/1426 of 25 August 2016 renewing the

approval of the active substance ethofumesate in accordance with Regulation (EC) No 1107/2009 of the

European Parliament and of the Council concerning the placing of plant protection products on the

market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L

231, 26.8.2016, p. 34).

13zzzzzzo.{1132}32016 R 0952: Commission Implementing Regulation (EU) 2016/952 of 15 June 2016 approving the

low-risk active substance Saccharomyces cerevisiae strain LAS02 in accordance with Regulation (EC)

No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection

products on the market, and amending the Annex to Commission Implementing Regulation (EU) No

540/2011 (OJ L 159, 16.6.2016, p. 10).

13zzzzzzp.{1133} 32016 R 1424: Commission Implementing Regulation (EU) 2016/1424 of 25 August 2016 renewing

the approval of the active substance thifensulfuron-methyl in accordance with Regulation (EC) No

1107/2009 of the European Parliament and of the Council concerning the placing of plant protection

products on the market, and amending the Annex to Commission Implementing Regulation (EU) No

540/2011 (OJ L 231, 26.8.2016, p. 25).

13zzzzzzq.{1134}32016 R 1429: Commission Implementing Regulation (EU) 2016/1429 of 26 August 2016 approving

the active substance Bacillus amyloliquefaciens strain MBI 600, in accordance with Regulation (EC) No

1107/2009 of the European Parliament and of the Council concerning the placing of plant protection

products on the market, and amending the Annex to Commission Implementing Regulation (EU) No

540/2011 (OJ L 232, 27.8.2016, p. 1).

13zzzzzzr.{1135} 32016 R 1978: Commission Implementing Regulation (EU) 2016/1978 of 11 November 2016

approving the basic substance sunflower oil in accordance with Regulation (EC) No 1107/2009 of the

European Parliament and of the Council concerning the placing of plant protection products on the

market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L

305, 12.11.2016, p. 23).

{1127} Point inserted by Decision No 238/2016 (OJ L 215, 23.8.2018, p. 37 and EEA Supplement No 56, 23.8.2018, p. 43), e.i.f. 3.12.2016.

{1128} Point inserted by Decision No 30/2017 (OJ L 297, 22.11.2018, p. 38 and EEA Supplement No 78, 22.11.2018, p. 44), e.i.f. 4.2.2017.

{1129} Point inserted by Decision No 30/2017 (OJ L 297, 22.11.2018, p. 38 and EEA Supplement No 78, 22.11.2018, p. 44), e.i.f. 4.2.2017.

{1130} Point inserted by Decision No 30/2017 (OJ L 297, 22.11.2018, p. 38 and EEA Supplement No 78, 22.11.2018, p. 44), e.i.f. 4.2.2017.

{1131} Point inserted by Decision No 30/2017 (OJ L 297, 22.11.2018, p. 38 and EEA Supplement No 78, 22.11.2018, p. 44), e.i.f. 4.2.2017.

{1132} Point inserted by Decision No 55/2017 (OJ L 305, 29.11.2018, p. 21 and EEA Supplement No 81, 29.11.2018, p. 24), e.i.f. 18.3.2017.

{1133} Point inserted by Decision No 55/2017 (OJ L 305, 29.11.2018, p. 21 and EEA Supplement No 81, 29.11.2018, p. 24), e.i.f. 18.3.2017.

{1134} Point inserted by Decision No 55/2017 (OJ L 305, 29.11.2018, p. 21 and EEA Supplement No 81, 29.11.2018, p. 24), e.i.f. 18.3.2017.

{1135} Point inserted by Decision No 56/2017 (OJ L 305, 29.11.2018, p. 23 and EEA Supplement No 81, 29.11.2018, p. 26), e.i.f. 18.3.2017.

Page 104: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 230

13zzzzzzs.{1136} 32016 R 1826: Commission Implementing Regulation (EU) 2016/1826 of 14 October 2016

concerning the non-approval of the active substance tricyclazole, in accordance with Regulation (EC) No

1107/2009 of the European Parliament and of the Council concerning the placing of plant protection

products on the market (OJ L 279, 15.10.2016, p. 88).

13zzzzzzt.{1137} 32017 R 0157: Commission Implementing Regulation (EU) 2017/157 of 30 January 2017 renewing

the approval of the active substance thiabendazole in accordance with Regulation (EC) No 1107/2009 of

the European Parliament and of the Council concerning the placing of plant protection products on the

market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L 25,

31.1.2017, p. 5).

13zzzzzzu.{1138} 32017 R 0239: Commission Implementing Regulation (EU) 2017/239 of 10 February 2017

approving the active substance oxathiapiprolin in accordance with Regulation (EC) No 1107/2009 of the

European Parliament and of the Council concerning the placing of plant protection products on the

market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L 36,

11.2.2017, p. 39).

13zzzzzzv.{1139} 32017 R 0244: Commission Implementing Regulation (EU) 2017/244 of 10 February 2017

concerning the non-renewal of approval of the active substance linuron, in accordance with Regulation

(EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant

protection products on the market, and amending the Annex to Commission Implementing Regulation

(EU) No 540/2011 (OJ L 36, 11.2.2017, p. 54).

13zzzzzzw.{1140}32017 R 0240: Commission Implementing Regulation (EU) 2017/240 of 10 February 2017 concerning

the non-approval of Satureja montana L. essential oil as a basic substance in accordance with Regulation

(EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant

protection products on the market (OJ L 36, 11.2.2017, p. 43).

13zzzzzzx.{1141}32017 R 0241: Commission Implementing Regulation (EU) 2017/241 of 10 February 2017 concerning

the non-approval of Origanum vulgare L. essential oil as a basic substance in accordance with Regulation

(EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant

protection products on the market (OJ L 36, 11.2.2017, p. 45).

13zzzzzzy.{1142}32017 R 0407: Commission Implementing Regulation (EU) 2017/407 of 8 March 2017 renewing the

approval of the active substance iodosulfuron in accordance with Regulation (EC) No 1107/2009 of the

European Parliament and of the Council concerning the placing of plant protection products on the

market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L 63,

9.3.2017, p. 87).

13zzzzzzz.{1143} 32017 R 0357: Commission Implementing Regulation (EU) 2017/357 of 28 February 2017

concerning the non-approval of the active substance cyclaniliprole, in accordance with Regulation (EC)

No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection

products on the market (OJ L 54, 1.3.2017, p. 4).

13zzzzzzza.{1144}32017 R 0358: Commission Implementing Regulation (EU) 2017/358 of 28 February 2017 confirming

the conditions of approval of the active substance acrinathrin, as set out in Implementing Regulation

(EU) No 540/2011 (OJ L 54, 1.3.2017, p. 6).

13zzzzzzzb.{1145}32017 R 0375: Commission Implementing Regulation (EU) 2017/375 of 2 March 2017 renewing the

approval of the active substance prosulfuron, as a candidate for substitution, in accordance with

Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of

{1136} Point inserted by Decision No 132/2017 (OJ L 128, 16.5.2019, p. 24 and EEA Supplement No 40, 16.5.2019, p. 25), e.i.f. 8.7.2017.

{1137} Point inserted by Decision No 133/2017 (OJ L 128, 16.5.2019, p. 26 and EEA Supplement No 40, 16.5.2019, p. 27), e.i.f. 8.7.2017.

{1138} Point inserted by Decision No 133/2017 (OJ L 128, 16.5.2019, p. 26 and EEA Supplement No 40, 16.5.2019, p. 27), e.i.f. 8.7.2017.

{1139} Point inserted by Decision No 133/2017 (OJ L 128, 16.5.2019, p. 26 and EEA Supplement No 40, 16.5.2019, p. 27), e.i.f. 8.7.2017.

{1140} Point inserted by Decision No 134/2017 (OJ L 128, 16.5.2019, p. 28 and EEA Supplement No 40, 16.5.2019, p. 29), e.i.f. 8.7.2017.

{1141} Point inserted by Decision No 134/2017 (OJ L 128, 16.5.2019, p. 28 and EEA Supplement No 40, 16.5.2019, p. 29), e.i.f. 8.7.2017.

{1142} Point inserted by Decision No 134/2017 (OJ L 128, 16.5.2019, p. 28 and EEA Supplement No 40, 16.5.2019, p. 29), e.i.f. 8.7.2017 and

subsequently corrected before publication by Corrigendum of 27.10.2017.

{1143} Point inserted by Decision No 174/2017 (OJ L 174, 27.6.2019, p. 37 and EEA Supplement No 52, 27.6.2019, p. 46), e.i.f. 23.9.2017.

{1144} Point inserted by Decision No 174/2017 (OJ L 174, 27.6.2019, p. 37 and EEA Supplement No 52, 27.6.2019, p. 46), e.i.f. 23.9.2017.

{1145} Point inserted by Decision No 174/2017 (OJ L 174, 27.6.2019, p. 37 and EEA Supplement No 52, 27.6.2019, p. 46), e.i.f. 23.9.2017.

Page 105: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 231

plant protection products on the market, and amending the Annex to Commission Implementing

Regulation (EU) No 540/2011 (OJ L 58, 4.3.2017, p. 3).

13zzzzzzzc.{1146}32017 R 0377: Commission Implementing Regulation (EU) 2017/377 of 3 March 2017 concerning the

non-approval of the active substance Pseudozyma flocculosa strain ATCC 64874 in accordance with

Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of

plant protection products on the market (OJ L 58, 4.3.2017, p. 11).

13zzzzzzzd.{1147}32017 R 0406: Commission Implementing Regulation (EU) 2017/406 of 8 March 2017 approving the

low-risk active substance Mild Pepino Mosaic Virus isolate VX1, in accordance with Regulation (EC)

No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection

products on the market, and amending the Annex to Commission Implementing Regulation (EU) No

540/2011 (OJ L 63, 9.3.2017, p. 83).

13zzzzzzze.{1148}32017 R 0408: Commission Implementing Regulation (EU) 2017/408 of 8 March 2017 approving the

low-risk active substance Mild Pepino Mosaic Virus isolate VC1, in accordance with Regulation (EC)

No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection

products on the market, and amending the Annex to Commission Implementing Regulation (EU) No

540/2011 (OJ L 63, 9.3.2017, p. 91).

13zzzzzzzf.{1149}32017 R 0409: Commission Implementing Regulation (EU) 2017/409 of 8 March 2017 approving the

basic substance hydrogen peroxide in accordance with Regulation (EC) No 1107/2009 of the European

Parliament and of the Council concerning the placing of plant protection products on the market, and

amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L 63, 9.3.2017, p.

95).

13zzzzzzzg.{1150}32017 R 0419: Commission Implementing Regulation (EU) 2017/419 of 9 March 2017 approving the

basic substance Urtica spp. in accordance with Regulation (EC) No 1107/2009 of the European

Parliament and of the Council concerning the placing of plant protection products on the market, and

amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L 64, 10.3.2017,

p. 4).

13zzzzzzzh.{1151}32017 R 0428: Commission Implementing Regulation (EU) 2017/428 of 10 March 2017 approving the

basic substance clayed charcoal in accordance with Regulation (EC) No 1107/2009 of the European

Parliament and of the Council concerning the placing of plant protection products on the market, and

amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L 66, 11.3.2017,

p. 1).

13zzzzzzzi.{1152}32017 R 0725: Commission Implementing Regulation (EU) 2017/725 of 24 April 2017 renewing the

approval of the active substance mesotrione in accordance with Regulation (EC) No 1107/2009 of the

European Parliament and of the Council concerning the placing of plant protection products on the

market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L

107, 25.4.2017, p. 24).

13zzzzzzzj.{1153}32017 R 0753: Commission Implementing Regulation (EU) 2017/753 of 28 April 2017 renewing the

approval of the active substance cyhalofop-butyl in accordance with Regulation (EC) No 1107/2009 of

the European Parliament and of the Council concerning the placing of plant protection products on the

market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L

113, 29.4.2017, p. 24).

13zzzzzzzk.{1154}32017 R 0755: Commission Implementing Regulation (EU) 2017/755 of 28 April 2017 renewing the

approval of the active substance mesosulfuron in accordance with Regulation (EC) No 1107/2009 of the

{1146} Point inserted by Decision No 174/2017 (OJ L 174, 27.6.2019, p. 37 and EEA Supplement No 52, 27.6.2019, p. 46), e.i.f. 23.9.2017.

{1147} Point inserted by Decision No 174/2017 (OJ L 174, 27.6.2019, p. 37 and EEA Supplement No 52, 27.6.2019, p. 46), e.i.f. 23.9.2017.

{1148} Point inserted by Decision No 174/2017 (OJ L 174, 27.6.2019, p. 37 and EEA Supplement No 52, 27.6.2019, p. 46), e.i.f. 23.9.2017.

{1149} Point inserted by Decision No 174/2017 (OJ L 174, 27.6.2019, p. 37 and EEA Supplement No 52, 27.6.2019, p. 46), e.i.f. 23.9.2017.

{1150} Point inserted by Decision No 174/2017 (OJ L 174, 27.6.2019, p. 37 and EEA Supplement No 52, 27.6.2019, p. 46), e.i.f. 23.9.2017.

{1151} Point inserted by Decision No 174/2017 (OJ L 174, 27.6.2019, p. 37 and EEA Supplement No 52, 27.6.2019, p. 46), e.i.f. 23.9.2017 and

subsequently corrected before publication by Corrigendum of 27.10.2017.

{1152} Point inserted by Decision No 175/2017 (OJ L 174, 27.6.2019, p. 41 and EEA Supplement No 52, 27.6.2019, p. 50), e.i.f. 23.9.2017.

{1153} Point inserted by Decision No 175/2017 (OJ L 174, 27.6.2019, p. 41 and EEA Supplement No 52, 27.6.2019, p. 50), e.i.f. 23.9.2017.

{1154} Point inserted by Decision No 175/2017 (OJ L 174, 27.6.2019, p. 41 and EEA Supplement No 52, 27.6.2019, p. 50), e.i.f. 23.9.2017.

Page 106: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 232

European Parliament and of the Council concerning the placing of plant protection products on the

market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L

113, 29.4.2017, p. 35).

13zzzzzzzl.{1155}32017 R 0781: Commission Implementing Regulation (EU) 2017/781 of 5 May 2017 withdrawing the

approval of the active substance methyl nonyl ketone, in accordance with Regulation (EC) No 1107/2009

of the European Parliament and of the Council concerning the placing of plant protection products on the

market, and amending Commission Implementing Regulation (EU) No 540/2011 (OJ L 118, 6.5.2017, p.

1).

13zzzzzzzm.{1156}32017 R 0805: Commission Implementing Regulation (EU) 2017/805 of 11 May 2017 renewing the

approval of the active substance flazasulfuron in accordance with Regulation (EC) No 1107/2009 of the

European Parliament and of the Council concerning the placing of plant protection products on the

market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L

121, 12.5.2017, p. 26).

13zzzzzzzn.{1157}32017 R 0806: Commission Implementing Regulation (EU) 2017/806 of 11 May 2017 approving the

low-risk active substance Bacillus amyloliquefaciens strain FZB24, in accordance with Regulation (EC)

No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection

products on the market, and amending the Annex to Commission Implementing Regulation (EU) No

540/2011 (OJ L 121, 12.5.2017, p. 31).

13zzzzzzzo.{1158}32017 R 0831: Commission Implementing Regulation (EU) 2017/831 of 16 May 2017 approving the

active substance Beauveria bassiana strain 147, in accordance with Regulation (EC) No 1107/2009 of the

European Parliament and of the Council concerning the placing of plant protection products on the

market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L

124, 17.5.2017, p. 27).

13zzzzzzzp.{1159}32017 R 0840: Commission Implementing Regulation (EU) 2017/840 of 17 May 2017 concerning the

non-approval of the active substance orthosulfamuron, in accordance with Regulation (EC) No

1107/2009 of the European Parliament and of the Council concerning the placing of plant protection

products on the market (OJ L 125, 18.5.2017, p. 10).

13zzzzzzzq.{1160}32017 R 0842: Commission Implementing Regulation (EU) 2017/842 of 17 May 2017 renewing the

approval of the low-risk active substance Coniothyrium minitans strain CON/M/91-08 in accordance

with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the

placing of plant protection products on the market, and amending the Annex to Commission

Implementing Regulation (EU) No 540/2011 (OJ L 125, 18.5.2017, p. 16), as corrected by OJ L 2,

5.1.2018, p.15.

13zzzzzzzr.{1161}32017 R 0843: Commission Implementing Regulation (EU) 2017/843 of 17 May 2017 approving the

active substance Beauveria bassiana strain NPP111B005, in accordance with Regulation (EC) No

1107/2009 of the European Parliament and of the Council concerning the placing of plant protection

products on the market, and amending the Annex to Commission Implementing Regulation (EU) No

540/2011 (OJ L 125, 18.5.2017, p. 21).

13zzzzzzzs.{116232012 D : Commission Implementing Regulation (EU) 2017/1113 of 22 June 2017 renewing the

approval of the active substance benzoic acid in accordance with Regulation (EC) No 1107/2009 of the

European Parliament and of the Council concerning the placing of plant protection products on the

market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L

162, 23.6.2017, p. 27).

{1155} Point inserted by Decision No 175/2017 (OJ L 174, 27.6.2019, p. 41 and EEA Supplement No 52, 27.6.2019, p. 50), e.i.f. 23.9.2017.

{1156} Point inserted by Decision No 175/2017 (OJ L 174, 27.6.2019, p. 41 and EEA Supplement No 52, 27.6.2019, p. 50), e.i.f. 23.9.2017.

{1157} Point inserted by Decision No 175/2017 (OJ L 174, 27.6.2019, p. 41 and EEA Supplement No 52, 27.6.2019, p. 50), e.i.f. 23.9.2017.

{1158} Point inserted by Decision No 175/2017 (OJ L 174, 27.6.2019, p. 41 and EEA Supplement No 52, 27.6.2019, p. 50), e.i.f. 23.9.2017.

{1159} Point inserted by Decision No 175/2017 (OJ L 174, 27.6.2019, p. 41 and EEA Supplement No 52, 27.6.2019, p. 50), e.i.f. 23.9.2017.

{1160} Point inserted by Decision No 175/2017 (OJ L 174, 27.6.2019, p. 41 and EEA Supplement No 52, 27.6.2019, p. 50), e.i.f. 23.9.2017 and

subsequently corrected before publication by Corrigendum of 27.10.2017. Corrigendum to the EU act subsequently taken note of by the

EEA Joint Committee on 6.7.2018..

{1161} Point inserted by Decision No 175/2017 (OJ L 174, 27.6.2019, p. 41 and EEA Supplement No 52, 27.6.2019, p. 50), e.i.f. 23.9.2017 and

subsequently corrected before publication by Corrigendum of 27.10.2017.

{1162} Point inserted by Decision No 228/2017 (OJ L 254, 3.10.2019, p. 37 and EEA Supplement No 80, 3.10.2019, p. 39), e.i.f. 16.12.2017.

Page 107: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 233

13zzzzzzzt.{1163}32017 R 1114: Commission Implementing Regulation (EU) 2017/1114 of 22 June 2017 renewing the

approval of the active substance pendimethalin, as a candidate for substitution, in accordance with

Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of

plant protection products on the market, and amending the Annex to Commission Implementing

Regulation (EU) No 540/2011 (OJ L 162, 23.6.2017, p. 32).

13zzzzzzzu.{1164}32017 R 1115: Commission Implementing Regulation (EU) 2017/1115 of 22 June 2017 renewing the

approval of the active substance propoxycarbazone in accordance with Regulation (EC) No 1107/2009 of

the European Parliament and of the Council concerning the placing of plant protection products on the

market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L

162, 23.6.2017, p. 38).

13zzzzzzzv.{1165}32017 R 1125: Commission Implementing Regulation (EU) 2017/1125 of 22 June 2017 withdrawing

the approval of the active substance repellents by smell of animal or plant origin/tall oil pitch, in

accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council

concerning the placing of plant protection products on the market, and amending Commission

Implementing Regulation (EU) No 540/2011 (OJ L 163, 24.6.2017, p. 10).

13zzzzzzzw.{1166}32017 R 1186: Commission Implementing Regulation (EU) 2017/1186 of 3 July 2017 withdrawing

the approval of the active substance repellents by smell of animal or plant origin/tall oil crude, in

accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council

concerning the placing of plant protection products on the market, and amending Commission

Implementing Regulation (EU) No 540/2011 (OJ L 171, 4.7.2017, p. 131).

13zzzzzzzx.{1167}32017 R 1491: Commission Implementing Regulation (EU) 2017/1491 of 21 August 2017 renewing

the approval of the active substance 2,4-DB in accordance with Regulation (EC) No 1107/2009 of the

European Parliament and of the Council concerning the placing of plant protection products on the

market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L

216, 22.8.2017, p. 15).

13zzzzzzzy.{1168}32017 R 1506: Commission Implementing Regulation (EU) 2017/1506 of 28 August 2017 renewing

the approval of the active substance maleic hydrazide in accordance with Regulation (EC) No 1107/2009

of the European Parliament and of the Council concerning the placing of plant protection products on the

market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L

222, 29.8.2017, p. 21).

13zzzzzzzz.{1169}32017 R 1455: Commission Implementing Regulation (EU) 2017/1455 of 10 August 2017 concerning

the non-renewal of approval of the active substance picoxystrobin, in accordance with Regulation (EC)

No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection

products on the market, and amending the Annex to Commission Implementing Regulation (EU) No

540/2011 (OJ L 208, 11.8.2017, p. 28).

13zzzzzzzza.{1170}32017 R 1496: Commission Implementing Regulation (EU) 2017/1496 of 23 August 2017 concerning

the non-renewal of approval of the active substance DPX KE 459 (flupyrsulfuron-methyl), in accordance

with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the

placing of plant protection products on the market, and amending Commission Implementing Regulation

(EU) No 540/2011 (OJ L 218, 24.8.2017, p. 7).

13zzzzzzzzb.{1171}32017 R 1526: Commission Implementing Regulation (EU) 2017/1526 of 6 September 2017

concerning the non-approval of the active substance beta-cypermethrin in accordance with Regulation

(EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant

protection products on the market (OJ L 231, 7.9.2017, p. 1).

{1163} Point inserted by Decision No 228/2017 (OJ L 254, 3.10.2019, p. 37 and EEA Supplement No 80, 3.10.2019, p. 39), e.i.f. 16.12.2017.

{1164} Point inserted by Decision No 228/2017 (OJ L 254, 3.10.2019, p. 37 and EEA Supplement No 80, 3.10.2019, p. 39), e.i.f. 16.12.2017.

{1165} Point inserted by Decision No 228/2017 (OJ L 254, 3.10.2019, p. 37 and EEA Supplement No 80, 3.10.2019, p. 39), e.i.f. 16.12.2017.

{1166} Point inserted by Decision No 228/2017 (OJ L 254, 3.10.2019, p. 37 and EEA Supplement No 80, 3.10.2019, p. 39), e.i.f. 16.12.2017.

{1167} Point inserted by Decision No 16/2018 (OJ L 323, 12.12.2019, p. 31 and EEA Supplement No 98, 12.12.2019, p. 28), e.i.f. 10.2.2018.

{1168} Point inserted by Decision No 16/2018 (OJ L 323, 12.12.2019, p. 31 and EEA Supplement No 98, 12.12.2019, p. 28), e.i.f. 10.2.2018.

{1169} Point inserted by Decision No 54/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 24.3.2018.

{1170} Point inserted by Decision No 54/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 24.3.2018.

{1171} Point inserted by Decision No 54/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 24.3.2018.

Page 108: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 234

13zzzzzzzzc.{1172}32017 R 1529: Commission Implementing Regulation (EU) 2017/1529 of 7 September 2017

approving the basic substance sodium chloride in accordance with Regulation (EC) No 1107/2009 of the

European Parliament and of the Council concerning the placing of plant protection products on the

market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L

232, 8.9.2017, p. 1).

13zzzzzzzzd.{1173}32017 R 1531: Commission Implementing Regulation (EU) 2017/1531 of 7 September 2017

renewing the approval of the active substance imazamox, as a candidate for substitution, in accordance

with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the

placing of plant protection products on the market, and amending the Annex to Commission

Implementing Regulation (EU) No 540/2011 (OJ L 232, 8.9.2017, p. 6).

13zzzzzzzze.{1174}32017 R 2057: Commission Implementing Regulation (EU) 2017/2057 of 10 November 2017

concerning the non-approval of Achillea millefolium L. as a basic substance in accordance with

Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of

plant protection products on the market (OJ L 294, 11.11.2017, p. 27).

13zzzzzzzzf.{1175}32017 R 2065: Commission Implementing Regulation (EU) 2017/2065 of 13 November 2017

confirming the conditions of approval of the active substance 8-hydroxyquinoline, as set out in

Implementing Regulation (EU) No 540/2011 and modifying Implementing Regulation (EU) 2015/408 as

regards the inclusion of the active substance 8-hydroxyquinoline in the list of candidates for substitution

(OJ L 295, 14.11.2017, p. 40).

13zzzzzzzzg.{1176}32017 R 2066: Commission Implementing Regulation (EU) 2017/2066 of 13 November 2017

concerning the approval of mustard seeds powder as a basic substance in accordance with Regulation

(EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant

protection products on the market, and amending the Annex to Commission Implementing Regulation

(EU) No 540/2011 (OJ L 295, 14.11.2017, p. 43).

13zzzzzzzzh.{1177}32017 R 2067: Commission Implementing Regulation (EU) 2017/2067 of 13 November 2017

concerning the non-approval of paprika extract (capsanthin, capsorubin E 160 c) as a basic substance in

accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council

concerning the placing of plant protection products on the market (OJ L 295, 14.11.2017, p. 47).

13zzzzzzzzi.{1178}32017 R 2068: Commission Implementing Regulation (EU) 2017/2068 of 13 November 2017

concerning the non-approval of potassium sorbate as a basic substance in accordance with Regulation

(EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant

protection products on the market (OJ L 295, 14.11.2017, p. 49).

13zzzzzzzzj.{1179}32017 R 2090: Commission Implementing Regulation (EU) 2017/2090 of 14 November 2017

concerning the approval of beer as a basic substance in accordance with Regulation (EC) No 1107/2009

of the European Parliament and of the Council concerning the placing of plant protection products on the

market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L

297, 15.11.2017, p. 22).

13zzzzzzzzk.{1180}32017 R 2091: Commission Implementing Regulation (EU) 2017/2091 of 14 November 2017

concerning the non-renewal of approval of the active substance iprodione, in accordance with Regulation

(EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant

protection products on the market, and amending Commission Implementing Regulation (EU) No

540/2011 (OJ L 297, 15.11.2017, p. 25).

{1172} Point inserted by Decision No 54/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 24.3.2018.

{1173} Point inserted by Decision No 54/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 24.3.2018.

{1174} Point inserted by Decision No 89/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 28.4.2018.

{1175} Point inserted by Decision No 89/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 28.4.2018.

{1176} Point inserted by Decision No 89/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 28.4.2018.

{1177} Point inserted by Decision No 89/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 28.4.2018.

{1178} Point inserted by Decision No 89/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 28.4.2018.

{1179} Point inserted by Decision No 89/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 28.4.2018.

{1180} Point inserted by Decision No 90/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 28.4.2018.

Page 109: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 235

13zzzzzzzzl.{1181}32017 R 2324: Commission Implementing Regulation (EU) 2017/2324 of 12 December 2017

renewing the approval of the active substance glyphosate in accordance with Regulation (EC) No

1107/2009 of the European Parliament and of the Council concerning the placing of plant protection

products on the market, and amending the Annex to Commission Implementing Regulation (EU) No

540/2011 (OJ L 333, 15.12.2017, p. 10).

13zzzzzzzzm.{1182}32018 R 0112: Commission Implementing Regulation (EU) 2018/112 of 24 January 2018 renewing

the approval of the low-risk active substance laminarin in accordance with Regulation (EC) No

1107/2009 of the European Parliament and of the Council concerning the placing of plant protection

products on the market, and amending the Annex to Commission Implementing Regulation (EU) No

540/2011 (OJ L 20, 25.1.2018, p. 3).

13zzzzzzzzn.{1183}32018 R 0113: Commission Implementing Regulation (EU) 2018/113 of 24 January 2018 renewing

the approval of the active substance acetamiprid in accordance with Regulation (EC) No 1107/2009 of

the European Parliament and of the Council concerning the placing of plant protection products on the

market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L 20,

25.1.2018, p. 7).

13zzzzzzzzo.{1184}32018 R 0296: Commission Implementing Regulation (EU) 2018/296 of 27 February 2018

concerning the non-approval of the active substance Reynoutria sachalinensis extract, in accordance with

Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of

plant protection products on the market (OJ L 56, 28.2.2018, p. 31).

13zzzzzzzzp.{1185}32018 R 0309: Commission Implementing Regulation (EU) 2018/309 of 1 March 2018 concerning

the non-renewal of approval of the active substance propineb, in accordance with Regulation (EC) No

1107/2009 of the European Parliament and of the Council concerning the placing of plant protection

products on the market, and amending the Annex to Commission Implementing Regulation (EU) No

540/2011 (OJ L 60, 2.3.2018, p. 16).

13zzzzzzzzq.{1186}32018 R 0660: Commission Implementing Regulation (EU) 2018/660 of 26 April 2018 renewing the

approval of the active substance bentazone in accordance with Regulation (EC) No 1107/2009 of the

European Parliament and of the Council concerning the placing of plant protection products on the

market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L

110, 30.4.2018, p. 122).

13zzzzzzzzr. {1187}32018 R 0679: Commission Implementing Regulation (EU) 2018/679 of 3 May 2018 renewing the

approval of the active substance forchlorfenuron in accordance with Regulation (EC) No 1107/2009 of

the European Parliament and of the Council concerning the placing of plant protection products on the

market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L

114, 4.5.2018, p. 18).

13zzzzzzzzs. {1188}32018 R 0691: Commission Implementing Regulation (EU) 2018/691 of 7 May 2018 approving the

basic substance Talc E553B in accordance with Regulation (EC) No 1107/2009 of the European

Parliament and of the Council concerning the placing of plant protection products on the market, and

amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L 117, 8.5.2018,

p. 6).

13zzzzzzzzt. {1189}32018 R 0692: Commission Implementing Regulation (EU) 2018/692 of 7 May 2018 renewing the

approval of the active substance zoxamide in accordance with Regulation (EC) No 1107/2009 of the

European Parliament and of the Council concerning the placing of plant protection products on the

market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L

117, 8.5.2018, p. 9).

{1181} Point inserted by Decision No 108/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 1.6.2018.

{1182} Point inserted by Decision No 144/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 7.7.2018.

{1183} Point inserted by Decision No 144/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 7.7.2018.

{1184} Point inserted by Decision No 184/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 22.9.2018.

{1185} Point inserted by Decision No 184/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 22.9.2018.

{1186} Point inserted by Decision No 14/2019 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 9.2.2019.

{1187} Point inserted by Decision No 14/2019 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 9.2.2019.

{1188} Point inserted by Decision No 14/2019 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 9.2.2019.

{1189} Point inserted by Decision No 14/2019 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 9.2.2019.

Page 110: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 236

13zzzzzzzzu. {1190}32018 R 0710: Commission Implementing Regulation (EU) 2018/710 of 14 May 2018 renewing the

approval of the active substance silthiofam in accordance with Regulation (EC) No 1107/2009 of the

European Parliament and of the Council concerning the placing of plant protection products on the

market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L

119, 15.5.2018, p. 31).

13zzzzzzzzv. {1191}32018 R 0755: Commission Implementing Regulation (EU) 2018/755 of 23 May 2018 renewing the

approval of the active substance propyzamide, as a candidate for substitution, in accordance with

Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of

plant protection products on the market, and amending the Annex to Commission Implementing

Regulation (EU) No 540/2011 (OJ L 128, 24.5.2018, p. 4).

13zzzzzzzzw.{1192}32018 R 1060: Commission Implementing Regulation (EU) 2018/1060 of 26 July 2018 renewing the

approval of the active substance trifloxystrobin in accordance with Regulation (EC) No 1107/2009 of the

European Parliament and of the Council concerning the placing of plant protection products on the

market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L

190, 27.7.2018, p. 3).

13zzzzzzzzx.{1193}32018 R 1019: Commission Implementing Regulation (EU) 2018/1019 of 18 July 2018 concerning

the non-renewal of approval of the active substance oxasulfuron, in accordance with Regulation (EC) No

1107/2009 of the European Parliament and of the Council concerning the placing of plant protection

products on the market, and amending Commission Implementing Regulation (EU) No 540/2011 (OJ L

183, 19.7.2018, p. 14),

13zzzzzzzzy.{1194}32018 R 1043: Commission Implementing Regulation (EU) 2018/1043 of 24 July 2018 concerning

the non-renewal of approval of the active substance fenamidone, in accordance with Regulation (EC) No

1107/2009 of the European Parliament and of the Council concerning the placing of plant protection

products on the market, and amending Commission Implementing Regulation (EU) No 540/2011 (OJ L

188, 25.7.2018, p. 9),

13zzzzzzzzz.{1195}32018 R 1061: Commission Implementing Regulation (EU) 2018/1061 of 26 July 2018 renewing the

approval of the active substance carfentrazone-ethyl in accordance with Regulation (EC) No 1107/2009

of the European Parliament and of the Council concerning the placing of plant protection products on the

market, and amending Commission Implementing Regulation (EU) No 540/2011 (OJ L 190, 27.7.2018,

p. 8),

13zzzzzzzzza.{1196}32018 R 1075: Commission Implementing Regulation (EU) 2018/1075 of 27 July 2018 renewing the

approval of the active substance Ampelomyces quisqualis strain AQ10, as a low-risk active substance, in

accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council

concerning the placing of plant protection products on the market, and amending the Annex to

Commission Implementing Regulation (EU) No 540/2011 (OJ L 194, 31.7.2018, p. 36),

13zzzzzzzzzb.{1197}32018 R 1278: Commission Implementing Regulation (EU) 2018/1278 of 21 September 2018

approving the low-risk active substance Pasteuria nishizawae Pn1 in accordance with Regulation (EC)

No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection

products on the market, and amending the Annex to Commission Implementing Regulation (EU) No

540/2011 (OJ L 239, 24.9.2018, p. 4).

13zzzzzzzzzc.{1198}32018 R 1264: Commission Implementing Regulation (EU) 2018/1264 of 20 September 2018

renewing the approval of the active substance pethoxamid in accordance with Regulation (EC) No

1107/2009 of the European Parliament and of the Council concerning the placing of plant protection

products on the market, and amending the Annex to Commission Implementing Regulation (EU) No

540/2011 (OJ L 238, 21.9.2018, p. 71).

{1190} Point inserted by Decision No 14/2019 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 9.2.2019.

{1191} Point inserted by Decision No 14/2019 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 9.2.2019.

{1192} Point inserted by Decision No 15/2019 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 9.2.2019.

{1193} Point inserted by Decision No 69/2019 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 30.3.2019.

{1194} Point inserted by Decision No 69/2019 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 30.3.2019.

{1195} Point inserted by Decision No 69/2019 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 30.3.2019.

{1196} Point inserted by Decision No 69/2019 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 30.3.2019.

{1197} Point inserted by Decision No 69/2019 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 30.3.2019.

{1198} Point inserted by Decision No 120/2019 (OJ L [to be published] and EEA supplement No [to be published]), e.i.f. 1.6.2019.

Page 111: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 237

13zzzzzzzzzd.{1199}32018 R 1265: Commission Implementing Regulation (EU) 2018/1265 of 20 September 2018

approving the active substance fenpicoxamid in accordance with Regulation (EC) No 1107/2009 of the

European Parliament and of the Council concerning the placing of plant protection products on the

market, and amending Commission Implementing Regulation (EU) No 540/2011 (OJ L 238, 21.9.2018,

p. 77).

13zzzzzzzzze.{1200}32018 R 1294: Commission Implementing Regulation (EU) 2018/1294 of 26 September 2018

concerning the non-approval of Landes pine tar as a basic substance in accordance with Regulation (EC)

No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection

products on the market (OJ L 243, 27.9.2018, p. 5).

13zzzzzzzzzf.{1201}32018 R 1295: Commission Implementing Regulation (EU) 2018/1295 of 26 September 2018

approving the basic substance Onion oil in accordance with Regulation (EC) No 1107/2009 of the

European Parliament and of the Council concerning the placing of plant protection products on the

market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L

243, 27.9.2018, p. 7).

13zzzzzzzzzg.{1202}32018 R 1500: Commission Implementing Regulation (EU) 2018/1500 of 9 October 2018

concerning the non-renewal of approval of the active substance thiram, and prohibiting the use and sale

of seeds treated with plant protection products containing thiram, in accordance with Regulation (EC) No

1107/2009 of the European Parliament and of the Council concerning the placing of plant protection

products on the market, and amending Commission Implementing Regulation (EU) No 540/2011 (OJ L

254, 10.10.2018, p. 1).

13zzzzzzzzzh.{1203}32018 R 1501: Commission Implementing Regulation (EU) 2018/1501 of 9 October 2018

concerning the non-renewal of approval of the active substance pymetrozine, in accordance with

Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of

plant protection products on the market, and amending Commission Implementing Regulation (EU) No

540/2011 (OJ L 254, 10.10.2018, p. 4).

13zzzzzzzzzi.{1204}32018 R 1532: Commission Implementing Regulation (EU) 2018/1532 of 12 October 2018

concerning the non-renewal of approval of the active substance diquat, in accordance with Regulation

(EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant

protection products on the market, and amending Commission Implementing Regulation (EU) No

540/2011 (OJ L 257, 15.10.2018, p. 10).

13zzzzzzzzzj.{1205}32018 R 1913: Commission Implementing Regulation (EU) 2018/1913 of 6 December 2018

renewing the approval of the active substance tribenuron in accordance with Regulation (EC) No

1107/2009 of the European Parliament and of the Council concerning the placing of plant protection

products on the market, and amending the Annex to Commission Implementing Regulation (EU) No

540/2011 (OJ L 294, 21.11.2018, p. 15).

13zzzzzzzzzk.{1206}32018 R 1914: Commission Implementing Regulation (EU) 2018/1914 of 6 December 2018

concerning the non-renewal of approval of the active substance quinoxyfen, in accordance with

Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of

plant protection products on the market, and amending Commission Implementing Regulation (EU) No

540/2011 (OJ L 311, 7.12.2018, p. 17).

13zzzzzzzzzl.{1207}32018 R 1915: Commission Implementing Regulation (EU) 2018/1915 of 6 December 2018

approving the active substance Metschnikowia fructicola strain NRRL Y-27328 in accordance with

Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of

plant protection products on the market, and amending the Annex to Commission Implementing

Regulation (EU) No 540/2011 (OJ L 311, 7.12.2018, p. 20).

{1199} Point inserted by Decision No 120/2019 (OJ L [to be published] and EEA supplement No [to be published]), e.i.f. 1.6.2019.

{1200} Point inserted by Decision No 120/2019 (OJ L [to be published] and EEA supplement No [to be published]), e.i.f. 1.6.2019.

{1201} Point inserted by Decision No 120/2019 (OJ L [to be published] and EEA supplement No [to be published]), e.i.f. 1.6.2019.

{1202} Point inserted by Decision No 120/2019 (OJ L [to be published] and EEA supplement No [to be published]), e.i.f. 1.6.2019.

{1203} Point inserted by Decision No 120/2019 (OJ L [to be published] and EEA supplement No [to be published]), e.i.f. 1.6.2019.

{1204} Point inserted by Decision No 120/2019 (OJ L [to be published] and EEA supplement No [to be published]), e.i.f. 1.6.2019.

{1205} Point inserted by Decision No 121/2019 (OJ L [to be published] and EEA supplement No [to be published]), e.i.f. 1.6.2019.

{1206} Point inserted by Decision No 121/2019 (OJ L [to be published] and EEA supplement No [to be published]), e.i.f. 1.6.2019.

{1207} Point inserted by Decision No 121/2019 (OJ L [to be published] and EEA supplement No [to be published]), e.i.f. 1.6.2019.

Page 112: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 238

13zzzzzzzzzm{1208}32018 R 1917: Commission Implementing Regulation (EU) 2018/1917 of 6 December 2018

concerning the non-renewal of approval of the active substance flurtamone, in accordance with

Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of

plant protection products on the market, and amending Commission Implementing Regulation (EU) No

540/2011 (OJ L 311, 7.12.2018, p. 27).

13zzzzzzzzzn.{1209}32018 R 1865: Commission Implementing Regulation (EU) 2018/1865 of 28 November 2018

concerning the non-renewal of approval of the active substance propiconazole, in accordance with

Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of

plant protection products on the market, and amending Commission Implementing Regulation (EU) No

540/2011 (OJ L 304, 29.11.2018, p. 6).

13zzzzzzzzzo.{1210}32018 R 1981: Commission Implementing Regulation (EU) 2018/1981 of 13 December 2018

renewing the approval of the active substances copper compounds, as candidates for substitution, in

accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council

concerning the placing of plant protection products on the market, and amending the Annex to

Commission Implementing Regulation (EU) No 540/2011 (OJ L 317, 14.12.2018, p. 16).

13zzzzzzzzzp. {1211}32019 R 0139: Commission Implementing Regulation (EU) 2019/139 of 29 January 2019 approving

the active substance Beauveria bassiana strain IMI389521, in accordance with Regulation (EC) No

1107/2009 of the European Parliament and of the Council concerning the placing of plant protection

products on the market, and amending the Annex to Commission Implementing Regulation (EU) No

540/2011 (OJ L 26, 30.1.2019, p. 4).

13zzzzzzzzzq.{1212}32019 R 0147: Commission Implementing Regulation (EU) 2019/147 of 30 January 2019 approving

the active substance Beauveria bassiana strain PPRI 5339, in accordance with Regulation (EC) No

1107/2009 of the European Parliament and of the Council concerning the placing of plant protection

products on the market, and amending the Annex to Commission Implementing Regulation (EU) No

540/2011 (OJ L 27, 31.1.2019, p. 14).

13zzzzzzzzzr.{1213}32019 R 0148: Commission Implementing Regulation (EU) 2019/148 of 30 January 2019

concerning the non-approval of the active substance propanil, in accordance with Regulation (EC) No

1107/2009 of the European Parliament and of the Council concerning the placing of plant protection

products on the market (OJ L 27, 31.1.2019, p. 18).

13zzzzzzzzzs.{1214} 32019 R 0151: Commission Implementing Regulation (EU) 2019/151 of 30 January 2019 renewing

the approval of the active substance Clonostachys rosea strain J1446 as a low-risk active substance in

accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council

concerning the placing of plant protection products on the market, and amending the Annex to

Commission Implementing Regulation (EU) No 540/2011 (OJ L 27, 31.1.2019, p. 26).

13zzzzzzzzzt.{1215}32019 R 0158: Commission Implementing Regulation (EU) 2019/158 of 31 January 2019 renewing

the approval of the active substance methoxyfenozide, as a candidate for substitution, in accordance with

Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of

plant protection products on the market, and amending the Annex to Commission Implementing

Regulation (EU) No 540/2011 (OJ L 31, 1.2.2019, p. 21).

13zzzzzzzzzu.{1216}32019 R 0337: Commission Implementing Regulation (EU) 2019/337 of 27 February 2019

approving the active substance mefentrifluconazole in accordance with Regulation (EC) No 1107/2009

of the European Parliament and of the Council concerning the placing of plant protection products on the

market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L 60,

28.2.2019, p. 12).

{1208} Point inserted by Decision No 121/2019 (OJ L [to be published] and EEA supplement No [to be published]), e.i.f. 1.6.2019.

{1209} Point inserted by Decision No 122/2019 (OJ L [to be published] and EEA supplement No [to be published]), e.i.f. 1.6.2019.

{1210} Point inserted by Decision No 155/2019 (OJ L [to be published] and EEA supplement No [to be published]), e.i.f. 15.6.2019.

{1211} Point inserted by Decision No 229/2019 (OJ L [to be published] and EEA supplement No [to be published]), e.i.f. 28.9.2019.

{1212} Point inserted by Decision No 229/2019 (OJ L [to be published] and EEA supplement No [to be published]), e.i.f. 28.9.2019.

{1213} Point inserted by Decision No 229/2019 (OJ L [to be published] and EEA supplement No [to be published]), e.i.f. 28.9.2019.

{1214} Point inserted by Decision No 229/2019 (OJ L [to be published] and EEA supplement No [to be published]), e.i.f. 28.9.2019.

{1215} Point inserted by Decision No 229/2019 (OJ L [to be published] and EEA supplement No [to be published]), e.i.f. 28.9.2019.

{1216} Point inserted by Decision No 297/2019 (OJ L [to be published] and EEA supplement No [to be published]), e.i.f. 14.12.2019.

Page 113: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 239

13zzzzzzzzzv.{1217}32019 R 0344: Commission Implementing Regulation (EU) 2019/344 of 28 February 2019

concerning the non-renewal of approval of the active substance ethoprophos, in accordance with

Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of

plant protection products on the market, and amending the Annex to Commission Implementing

Regulation (EU) No 540/2011 (OJ L 62, 1.3.2019, p. 7).

13zzzzzzzzzw.{1218}32019 R 0481: Commission Implementing Regulation (EU) 2019/481 of 22 March 2019 approving

the active substance flutianil, in accordance with Regulation (EC) No 1107/2009 of the European

Parliament and of the Council concerning the placing of plant protection products on the market, and

amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L 82, 25.3.2019,

p. 19).

13zzzzzzzzzx.{1219}32019 R 0677: Commission Implementing Regulation (EU) 2019/677 of 29 April 2019 concerning

the non-renewal of the approval of the active substance chlorothalonil, in accordance with Regulation

(EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant

protection products on the market, and amending Commission Implementing Regulation (EU) No

540/2011 (OJ L 114, 30.4.2019, p. 15).

13zzzzzzzzzy.{1220}32019 R 0706: Commission Implementing Regulation (EU) 2019/706 of 7 May 2019 renewing the

approval of the active substance carvone in accordance with Regulation (EC) No 1107/2009 of the

European Parliament and of the Council concerning the placing of plant protection products on the

market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L

120, 8.5.2019, p. 11).

13zzzzzzzzzz.{1221}32019 R 0717: Commission Implementing Regulation (EU) 2019/717 of 8 May 2019 renewing the

approval of the active substance isoxaflutole in accordance with Regulation (EC) No 1107/2009 of the

European Parliament and of the Council concerning the placing of plant protection products on the

market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L

122, 10.5.2019, p. 44).

14.{1222} 32014 D 0756: Commission Implementing Decision 2014/756/EU of 29 October 2014 concerning

restrictions of the authorisations of biocidal products containing IPBC and propiconazole notified by

Germany in accordance with Directive 98/8/EC of the European Parliament and of the Council (OJ

L 311, 31.10.2014, p. 69).

15.{1223} 32014 D 0757: Commission Implementing Decision 2014/757/EU of 29 October 2014 concerning

restrictions of the authorisation of a biocidal product containing IPBC notified by Germany in

accordance with Directive 98/8/EC of the European Parliament and of the Council (OJ L 311,

31.10.2014, p. 72).

16.{1224} 32014 D 0758: Commission Implementing Decision 2014/758/EU of 29 October 2014 rejecting the

refusal of the authorisation of a biocidal product notified by Germany in accordance with Directive

98/8/EC of the European Parliament and of the Council (OJ L 311, 31.10.2014, p. 75).

17.{1225} 32016 R 0009: Commission Implementing Regulation (EU) 2016/9 of 5 January 2016 on joint

submission of data and data-sharing in accordance with Regulation (EC) No 1907/2006 of the European

Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of

Chemicals (REACH) (OJ L 3, 6.1.2016, p. 41).

{1217} Point inserted by Decision No 297/2019 (OJ L [to be published] and EEA supplement No [to be published]), e.i.f. 14.12.2019.

{1218} Point inserted by Decision No 297/2019 (OJ L [to be published] and EEA supplement No [to be published]), e.i.f. 14.12.2019.

{1219} Point inserted by Decision No 298/2019 (OJ L [to be published] and EEA supplement No [to be published]), e.i.f. 14.12.2019.

{1220} Point inserted by Decision No 298/2019 (OJ L [to be published] and EEA supplement No [to be published]), e.i.f. 14.12.2019.

{1221} Point inserted by Decision No 298/2019 (OJ L [to be published] and EEA supplement No [to be published]), e.i.f. 14.12.2019.

{1222} Point inserted by Decision No 54/2015 (OJ L 129, 19.5.2016, p. 36 and EEA Supplement No 29, 19.5.2016, p. 37), e.i.f. 21.3.2015.

{1223} Point inserted by Decision No 54/2015 (OJ L 129, 19.5.2016, p. 36 and EEA Supplement No 29, 19.5.2016, p. 37), e.i.f. 21.3.2015.

{1224} Point inserted by Decision No 54/2015 (OJ L 129, 19.5.2016, p. 36 and EEA Supplement No 29, 19.5.2016, p. 37), e.i.f. 21.3.2015.

{1225} Point inserted by Decision No 88/2016 (OJ L 300, 16.11.2017, p. 36 and EEA Supplement No 73, 16.11.2017, p. 40), e.i.f. 30.4.2016.

Page 114: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 240

18.{1226} 32016 R 0672: Commission Implementing Regulation (EU) 2016/672 of 29 April 2016 approving

peracetic acid as an existing active substance for use in biocidal products for product-types 1, 2, 3, 4, 5

and 6 (OJ L 116, 30.4.2016, p. 3).

19.{1227} 32016 D 0678: Commission Implementing Decision (EU) 2016/678 of 29 April 2016 pursuant to Article

3(3) of Regulation (EU) No 528/2012 of the European Parliament and of the Council on a product

consisting of dried lavender blossoms contained in a pad placed on the market to repel moths (OJ L 116,

30.4.2016, p. 37).

20.{1228} 32017 D 1532: Commission Implementing Decision (EU) 2017/1532 of 7 September 2017 addressing

questions regarding the comparative assessment of anticoagulant rodenticides in accordance with Article

23(5) of Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L 232,

8.9.2017, p. 11).

21.{1229} 32017 R 2001: Commission Implementing Regulation (EU) 2017/2001 of 8 November 2017 approving

propan-1-ol as an existing active substance for use in biocidal products of product-type 1, 2 and 4 (OJ L

290, 9.11.2017, p. 1).

22.{1230} 32017 R 2002: Commission Implementing Regulation (EU) 2017/2002 of 8 November 2017 approving

L(+) lactic acid as an existing active substance for use in biocidal products of product-types 2, 3 and 4

(OJ L 290, 9.11.2017, p. 4).

23.{1231} 32017 R 2003: Commission Implementing Regulation (EU) 2017/2003 of 8 November 2017 approving

fludioxonil as an active substance for use in biocidal products of product-types 7, 9 and 10 (OJ L 290,

9.11.2017, p. 7).

24.{1232} 32017 R 2004: Commission Implementing Regulation (EU) 2017/2004 of 8 November 2017 approving

2-methylisothiazol-3(2H)-one as an existing active substance for use in biocidal products of product-type

12 (OJ L 290, 9.11.2017, p. 11).

25.{1233} 32017 R 2005: Commission Implementing Regulation (EU) 2017/2005 of 8 November 2017 approving

margosa extract, cold-pressed oil of Azadirachta indica seeds without shells extracted with super-critical

carbon dioxide as an existing active substance for use in biocidal products of product-type 19 (OJ L 290,

9.11.2017, p. 14).

26.{1234} 32017 R 2100: Commission Delegated Regulation (EU) 2017/2100 of 4 September 2017 setting out

scientific criteria for the determination of endocrine-disrupting properties pursuant to Regulation (EU)

No 528/2012 of the European Parliament and Council (OJ L 301, 17.11.2017, p. 1).

ACTS OF WHICH THE CONTRACTING PARTIES SHALL TAKE NOTE

The Contracting Parties take note of the content of the following acts:

1. [ ] {1235}

{1226} Point inserted by Decision No 184/2016 (OJ L 80, 22.3.2018, p. 29 and EEA Supplement No 19, 22.3.2018, p. 38), e.i.f. 24.9.2016.

{1227} Point inserted by Decision No 184/2016 (OJ L 80, 22.3.2018, p. 29 and EEA Supplement No 19, 22.3.2018, p. 38), e.i.f. 24.9.2016.

{1228} Point inserted by Decision No 229/2017 (OJ L 254, 3.10.2019, p. 40 and EEA Supplement No 80, 3.10.2019, p. 42), e.i.f. 16.12.2017.

{1229} Point inserted by Decision No 17/2018 (OJ L 323, 12.12.2019, p. 33 and EEA Supplement No 98, 12.12.2019, p. 30), e.i.f. 10.2.2018.

{1230} Point inserted by Decision No 17/2018 (OJ L 323, 12.12.2019, p. 33 and EEA Supplement No 98, 12.12.2019, p. 30), e.i.f. 10.2.2018.

{1231} Point inserted by Decision No 17/2018 (OJ L 323, 12.12.2019, p. 33 and EEA Supplement No 98, 12.12.2019, p. 30), e.i.f. 10.2.2018.

{1232} Point inserted by Decision No 17/2018 (OJ L 323, 12.12.2019, p. 33 and EEA Supplement No 98, 12.12.2019, p. 30), e.i.f. 10.2.2018.

{1233} Point inserted by Decision No 17/2018 (OJ L 323, 12.12.2019, p. 33 and EEA Supplement No 98, 12.12.2019, p. 30), e.i.f. 10.2.2018.

{1234} Point inserted by Decision No 55/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 24.3.2018.

Page 115: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 241

2. {1236} C/79/82/p. 3: Communication concerning Commission Decision 81/437/EEC of 11 May 1981 laying

down the criteria in accordance with which information relating to the inventory of chemical substances

is supplied by the Member States to the Commission (OJ C 79, 31.3.1982, p. 3).

3. {1237} C/146/90/p. 4: Publication of the EINECS inventory (OJ C 146, 15.6.1990, p. 4).

4.{1238} C/1/93/p. 3: The European Chemical Bureau. Commission communication to the Council and the

European Parliament (OJ C 1, 5.1.1993, p. 3).

5.{1239} C/130/93/p. 1: Communication - Third publication of Elincs (OJ C 130, 10.5.1993, p. 1).

6.{1240} C/130/93/p. 2: Commission Communication pursuant to Article 2 of Commission Decision 85/71/EEC

of 21 December 1984 concerning the list of chemical substances notified pursuant to Council Directive

67/548/EEC on the approximation of the laws, regulations and administrative provisions relating to the

classification, packaging and labelling of dangerous substances (OJ C 130, 10.5.1993, p. 2).

7.{1241} 399 X 0721: Commission Recommendation 1999/721/EC of 12 October 1999 on the results of the risk

evaluation and on the risk reduction strategies for the substances: 2-(2-butoxyethoxy)ethanol; 2-(2-

methoxyethoxy)ethanol; Alkanes, C10-13, chloro; Benzene, C10-13-alkyl derivs. (OJ L 292, 13.11.1999, p.

42).

8.{1242} 32001 H 0194: Commission Recommendation 2001/194/EC of 5 March 2001 on the results of the risk

evaluation and the risk reduction strategies for the substances: diphenylether/pentabromo derivative and

cumene (OJ L 69, 10.3.2001, p. 30).

9.{1243} 32001 H 0838: Commission Recommendation 2001/838/EC of 7 November 2001 on the results of the risk

evaluation and the risk reduction strategies for the substances: acrylaldehyde; dimethyl sulphate; nonylphenol

phenol, 4-nonyl-, branched; tert-butyl methyl ether (OJ L 319, 4.12.2001, p. 30).

10.{1244} 32002 H 0755: Commission Recommendation 2002/755/EC of 16 September 2002 on the results of the risk

evaluation and risk reduction strategy for the substance diphenyl ether, octabromo derivative (OJ L 249,

17.9.2002, p. 27).

11.{1245} 32002 H 0575: Commission Recommendation 2002/575/EC of 4 July 2002 on the results of the risk

evaluation and the risk reduction strategies for the substances: o-anisidine, 1,4-dioxane (OJ L 181, 11.7.2002,

p. 29).

{1235} Text of point 13 (Commission Recommendation 89/542/EEC) deleted by Decision No 144/2005 (OJ L 53, 23.2.2006, p. 40 and EEA

Supplement No 10, 23.2.2005, p. 15), e.i.f. 3.12.2005. Point 13 renumbered point 1 by Decision No 180/2014 (OJ L 202, 30.7.2015, p. 30

and EEA Supplement No 43, 30.7.2015, p. 30), e.i.f. 26.9.2014.

{1236} Point 14 renumbered point 2 by Decision No 180/2014 (OJ L 202, 30.7.2015, p. 30 and EEA Supplement No 43, 30.7.2015, p. 30), e.i.f.

26.9.2014.

{1237} Point 15 renumbered point 3 by Decision No 180/2014 (OJ L 202, 30.7.2015, p. 30 and EEA Supplement No 43, 30.7.2015, p. 30), e.i.f.

26.9.2014.

{1238} Point inserted by Decision No 7/94 (OJ L 160, 28.6.1994, p. 1 and EEA Supplement No 17, 28.6.1994, p. 1), e.i.f. 1.7.1994. Point 16

renumbered point 4 by Decision No 180/2014 (OJ L 202, 30.7.2015, p. 30 and EEA Supplement No 43, 30.7.2015, p. 30), e.i.f. 26.9.2014.

{1239} Point inserted by Decision No 7/94 (OJ L 160, 28.6.1994, p. 1 and EEA Supplement No 17, 28.6.1994, p. 1), e.i.f. 1.7.1994. Point 17

renumbered point 5 by Decision No 180/2014 (OJ L 202, 30.7.2015, p. 30 and EEA Supplement No 43, 30.7.2015, p. 30), e.i.f. 26.9.2014.

{1240} Point inserted by Decision No 7/94 (OJ L 160, 28.6.1994, p. 1 and EEA Supplement No 17, 28.6.1994, p. 1), e.i.f. 1.7.1994. Point 18

renumbered point 6 by Decision No 180/2014 (OJ L 202, 30.7.2015, p. 30 and EEA Supplement No 43, 30.7.2015, p. 30), e.i.f. 26.9.2014.

{1241} Point inserted by Decision No 77/2000 (OJ L 315, 14.12.2000, p. 16 and EEA Supplement No 59, 14.12.2000, p. 15), e.i.f. 3.10.2000. Point

19 renumbered point 7 by Decision No 180/2014 (OJ L 202, 30.7.2015, p. 30 and EEA Supplement No 43, 30.7.2015, p. 30), e.i.f. 26.9.2014.

{1242} Point inserted by Decision No 14/2002 (OJ L 110, 25.4.2002, p. 7 and EEA Supplement No 21, 25.4.2002, p. 6), e.i.f. 2.3.2002. Point 20

renumbered point 8 by Decision No 180/2014 (OJ L 202, 30.7.2015, p. 30 and EEA Supplement No 43, 30.7.2015, p. 30), e.i.f. 26.9.2014.

{1243} Point inserted by Decision No 101/2002 (OJ L 298, 31.10.2002, p. 15 and EEA Supplement No 54, 31.10.2002, p. 13), e.i.f. 13.7.2002. Point

21 renumbered point 9 by Decision No 180/2014 (OJ L 202, 30.7.2015, p. 30 and EEA Supplement No 43, 30.7.2015, p. 30), e.i.f. 26.9.2014.

{1244} Point inserted by Decision No 75/2003 (OJ L 257, 9.10.2003, p. 23 and EEA Supplement No 51, 9.10.2003, p. 13), e.i.f. 21.6.2003. Point 22

renumbered point 10 by Decision No 180/2014 (OJ L 202, 30.7.2015, p. 30 and EEA Supplement No 43, 30.7.2015, p. 30), e.i.f. 26.9.2014.

{1245} Point inserted by Decision No 76/2003 (OJ L 257, 9.10.2003, p. 25 and EEA Supplement No 51, 9.10.2003, p. 14), e.i.f. 21.6.2003. Point 23

renumbered point 11 by Decision No 180/2014 (OJ L 202, 30.7.2015, p. 30 and EEA Supplement No 43, 30.7.2015, p. 30), e.i.f. 26.9.2014.

Page 116: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 242

12.{1246} 32002 H 0576: Commission Recommendation 2002/576/EC of 4 July 2002 on the results of the risk

evaluation for the substances: ethyl acetoacetate, 4-Chloro-o-cresol, Dimethyldioctadecylammonium chloride

(OJ L 181, 11.7.2002, p. 35).

13.{1247} 32004 H 0394: Commission Recommendation 2004/394/EC of 29 April 2004 on the results of the risk

evaluation and the risk reduction strategies for the substances: Acetonitrile; Acrylamide; Acrylonitrile; Acrylic

acid; Butadiene; Hydrogen fluoride; Hydrogen peroxide; Methacrylic acid; Methyl methacrylate; Toluene;

Trichlorobenzene (OJ L 144, 30.4.2004, p. 72), as corrected by OJ L 199, 7.6.2004, p. 41.

14.{1248} 32006 H 0283: Commission Recommendation of 11 April 2006 on risk reduction measures for the substances:

Dibutylphthalate; 3,4-Dichloroaniline; Di-isodecyl phthalate; 1,2-Benzenedicarboxylic acid, di-C9-11-

branched alkyl esters, C10-rich; Di-isononyl phthalate; 1,2-Benzenedicarboxylic acid, di-C8-10-branched

alkyl esters, C9-rich; Ethylenediaminetetraacetate; Methyl acetate; Monochloroacetic acid; n-Pentane;

Tetrasodium ethylenediaminetetraacetate (OJ L 104, 13.4.2006, p. 45).

XVI. COSMETICS

ACTS REFERRED TO

1. [ ] {1249}

1a.{1250} 32009 R 1223: Regulation (EC) No 1223/2009 of the European Parliament and of the Council of 30

November 2009 on cosmetic products (recast) (OJ L 342, 22.12.2009, p. 59), as amended by:

-{1251} 32013 R 0344: Commission Regulation (EU) No 344/2013 of 4 April 2013 (OJ L 114, 25.4.2013,

p. 1), as corrected by OJ L 142, 29.5.2013, p. 10,

-{1252} 32013 R 0483: Commission Regulation (EU) No 483/2013 of 24 May 2013 (OJ L 139, 25.5.2013, p.

8),

-{1253} 32013 R 1197: Commission Regulation (EU) No 1197/2013 of 25 November 2013 (OJ L 315,

26.11.2013, p. 34),

-{1254} 32013 R 0658: Commission Regulation (EU) No 658/2013 of 10 July 2013 (OJ L 190, 11.7.2013, p.

38),

-{1255} 32014 R 0358: Commission Regulation (EU) No 358/2014 of 9 April 2014 (OJ L 107, 10.4.2014,

p. 5),

-{1256} 32014 R 0866: Commission Regulation (EU) No 866/2014 of 8 August 2014 (OJ L 238, 9.8.2014,

p. 3), as corrected by OJ L 254, 28.8.2014, p. 39,

{1246} Point inserted by Decision No 76/2003 (OJ L 257, 9.10.2003, p. 25 and EEA Supplement No 51, 9.10.2003, p. 14), e.i.f. 21.6.2003. Point 24

renumbered point 12 by Decision No 180/2014 (OJ L 202, 30.7.2015, p. 30 and EEA Supplement No 43, 30.7.2015, p. 30), e.i.f. 26.9.2014.

{1247} Point inserted by Decision No 35/2005 (OJ L 198, 28.7.2005, p. 28 and EEA Supplement No 38, 28.7.2005, p. 17), e.i.f. 12.3.2005. Point 25

renumbered point 13 by Decision No 180/2014 (OJ L 202, 30.7.2015, p. 30 and EEA Supplement No 43, 30.7.2015, p. 30), e.i.f. 26.9.2014.

{1248} Point inserted by Decision No 117/2006 (OJ L 333, 30.11.2006, p. 40 and EEA Supplement No 60, 30.11.2006, p. 31), e.i.f. 23.9.2006. Point

26 renumbered point 14 by Decision No 180/2014 (OJ L 202, 30.7.2015, p. 30 and EEA Supplement No 43, 30.7.2015, p. 30), e.i.f.

26.9.2014.

{1249} Text of point 1 (Council Directive 76/768/EEC) deleted with effect from 11.7.2013 by Decision No 49/2013 (OJ L 231, 29.8.2013, p. 23 and

EEA Supplement No 49, 29.8.2013, p. 25), e.i.f. 6.4.2013.

{1250} Point inserted by Decision No 49/2013 (OJ L 231, 29.8.2013, p. 23 and EEA Supplement No 49, 29.8.2013, p. 25), e.i.f. 6.4.2013.

{1251} Indent and words “, as amended by:” , added by Decision No 195/2013 (OJ L [to be published] and EEA Supplement No [to be

published]), e.i.f. 9.11.2013.

{1252} Indent added by Decision No 196/2013 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 9.11.2013.

{1253} Indent added by Decision No 46/2014 (OJ L 256, 28.8.2014, p. 23 and EEA Supplement No 49, 28.8.2014, p. 22), e.i.f. 9.4.2014.

{1254} Indent added by Decision No 125/2014 (OJ L 342, 27.11.2014, p. 24 and EEA Supplement No 71, 27.11.2014, p. 24), e.i.f. 28.6.2014.

{1255} Indent added by Decision No 184/2014 (OJ L 202, 30.7.2015, p. 35 and EEA Supplement No 43, 30.7.2015, p. 35), e.i.f. 26.9.2014.

{1256} Indent added by Decision No 19/2015 (OJ L 93, 7.4.2016, p. 32 and EEA Supplement No 21, 7.4.2016, p. 28), e.i.f. 26.2.2015.

Page 117: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 243

-{1257} 32014 R 1003: Commission Regulation (EU) No 1003/2014 of 18 September 2014 (OJ L 282,

26.9.2014, p. 1),

-{1258} 32014 R 1004: Commission Regulation (EU) No 1004/2014 of 18 September 2014 (OJ L 282,

26.9.2014, p. 5),

-{1259} 32015 R 1190: Commission Regulation (EU) 2015/1190 of 20 July 2015 (OJ L 193, 21.7.2015,

p. 115),

-{1260} 32015 R 1298: Commission Regulation (EU) 2015/1298 of 28 July 2015 (OJ L 199, 29.7.2015,

p. 22),

-{1261} 32016 R 0314: Commission Regulation (EU) 2016/314 of 4 March 2016 (OJ L 60, 5.3.2016, p. 59),

as corrected by OJ L 17, 21.1.2017, p. 52.

-{1262} 32016 R 0621: Commission Regulation (EU) 2016/621 of 21 April 2016 (OJ L 106, 22.4.2016,

p. 4),

-{1263} 32016 R 0622: Commission Regulation (EU) 2016/622 of 21 April 2016 (OJ L 106, 22.4.2016,

p. 7),

-{1264} 32016 R 1120: Commission Regulation (EU) 2016/1120 of 11 July 2016 (OJ L 187, 12.7.2016,

p. 1),

-{1265} 32016 R 1121: Commission Regulation (EU) 2016/1121 of 11 July 2016 (OJ L 187, 12.7.2016,

p. 4),

-{1266} 32016 R 1143: Commission Regulation (EU) 2016/1143 of 13 July 2016 (OJ L 189, 14.7.2016,

p. 40),

-{1267} 32016 R 1198: Commission Regulation (EU) 2016/1198 of 22 July 2016 (OJ L 198, 23.7.2016,

p. 10),

-{1268} 32017 R 0237: Commission Regulation (EU) 2017/237 of 10 February 2017 (OJ L 36, 11.2.2017, p.

12),

-{1269} 32017 R 0238: Commission Regulation (EU) 2017/238 of 10 February 2017 (OJ L 36, 11.2.2017, p.

37),

-{1270} 32017 R 1224: Commission Regulation (EU) 2017/1224 of 6 July 2017 (OJ L 174, 7.7.2017, p. 16),

-{1271} 32017 R 1410: Commission Regulation (EU) 2017/1410 of 2 August 2017 (OJ L 202, 3.8.2017, p.

1),

{1257} Indent added by Decision No 20/2015 (OJ L 93, 7.4.2016, p. 33 and EEA Supplement No 21, 7.4.2016, p. 29), e.i.f. 26.2.2015.

{1258} Indent added by Decision No 20/2015 (OJ L 93, 7.4.2016, p. 33 and EEA Supplement No 21, 7.4.2016, p. 29), e.i.f. 26.2.2015.

{1259} Indent added by Decision No 267/2015 (OJ L 161, 22.6.2017, p. 52 and EEA Supplement No 38, 22.6.2017, p. 54), e.i.f. 1.11.2015.

{1260} Indent added by Decision No 268/2015 (OJ L 161, 22.6.2017, p. 53 and EEA Supplement No 38, 22.6.2017, p. 55), e.i.f. 1.11.2015.

{1261} Indent added by Decision No 119/2016 (OJ L 308, 23.11.2017, p. 22 and EEA Supplement No 76, 23.11.2017, p. 27), e.i.f. 4.6.2016.

Corrigendum to the EU act subsequently taken note of by the EEA Joint Committee on 27.10.2017.

{1262} Indent added by Decision No 150/2016 (OJ L 73, 15.3.2018, p. 25 and EEA Supplement No 16, 15.3.2018, p. 28), e.i.f. 9.7.2016.

{1263} Indent added by Decision No 150/2016 (OJ L 73, 15.3.2018, p. 25 and EEA Supplement No 16, 15.3.2018, p. 28), e.i.f. 9.7.2016.

{1264} Indent added by Decision No 185/2016 (OJ L 80, 22.3.2018, p. 30 and EEA Supplement No 19, 22.3.2018, p. 40), e.i.f. 24.9.2016.

{1265} Indent added by Decision No 185/2016 (OJ L 80, 22.3.2018, p. 30 and EEA Supplement No 19, 22.3.2018, p. 40), e.i.f. 24.9.2016.

{1266} Indent added by Decision No 185/2016 (OJ L 80, 22.3.2018, p. 30 and EEA Supplement No 19, 22.3.2018, p. 40), e.i.f. 24.9.2016.

{1267} Indent added by Decision No 186/2016 (OJ L 80, 22.3.2018, p. 31 and EEA Supplement No 19, 22.3.2018, p. 42), e.i.f. 24.9.2016.

{1268} Indent added by Decision No 135/2017 (OJ L 128, 16.5.2019, p. 30 and EEA Supplement No 40, 16.5.2019, p. 31), e.i.f. 8.7.2017.

{1269} Indent added by Decision No 135/2017 (OJ L 128, 16.5.2019, p. 30 and EEA Supplement No 40, 16.5.2019, p. 31), e.i.f. 8.7.2017.

{1270} Indent added by Decision No 196/2017 (OJ L 219, 22.8.2019, p. 7 and EEA Supplement No 68, 22.8.2019, p. 7), e.i.f. 28.10.2017.

{1271} Indent added by Decision No 230/2017 (OJ L 254, 3.10.2019, p. 41 and EEA Supplement No 80, 3.10.2019, p. 43), e.i.f. 16.12.2017.

Page 118: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 244

-{1272} 32017 R 1413: Commission Regulation (EU) 2017/1413 of 3 August 2017 (OJ L 203, 4.8.2017, p.

1),

-{1273} 32017 R 2228: Commission Regulation (EU) 2017/2228 of 4 December 2017 (OJ L 319, 5.12.2017,

p. 2), as corrected by OJ L 326, 9.12.2017, p. 55,

-{1274} 32018 R 0885: Commission Regulation (EU) 2018/885 of 20 June 2018 (OJ L 158, 21.6.2018, p. 1),

-{1275} 32018 R 0978: Commission Regulation (EU) 2018/978 of 9 July 2018 (OJ L 176, 12.7.2018, p. 3),

as corrected by OJ L 183, 19.7.2018, p. 27,

-{1276} 32018 R 1847: Commission Regulation (EU) 2018/1847 of 26 November 2018 (OJ L 300,

27.22.2018, p. 1),

-{1277} 32019 R 0680: Commission Regulation (EU) 2019/680 of 30 April 2019 (OJ L 115, 2.5.2019, p. 3),

-{1278} 32019 R 0681: Commission Regulation (EU) 2019/681 of 30 April 2019 (OJ L 115, 2.5.2019, p. 5),

-{1279} 32019 R 0698: Commission Regulation (EU) 2019/698 of 30 April 2019 (OJ L 119, 7.5.2019, p.

66),

-{1280} 32019 R 0831: Commission Regulation (EU) 2019/831 of 22 May 2019 (OJ L 137, 23.5.2019, p.

29),

-{1281} 32017 R 0745: Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April

2017 (OJ L 117, 5.5.2017, p. 1), as corrected by OJ L 117, 3.5.2019, p. 9.

1aa.{1282} 32013 D 0674: Commission Implementing Decision 2013/674/EU of 25 November 2013 on Guidelines on

Annex I to Regulation (EC) No 1223/2009 of the European Parliament and of the Council on cosmetic

products (OJ L 315, 26.11.2013, p. 82).

1b. {1283} 32013 R 0655: Commission Regulation (EU) No 655/2013 of 10 July 2013 laying down common criteria for

the justification of claims used in relation to cosmetic products (OJ L 190, 11.7.2013, p. 31).

2. 380 L 1335: First Commission Directive 80/1335/EEC of 22 December 1980 on the approximation of the laws

of the Member States relating to methods of analysis necessary for checking the composition of cosmetic

products (OJ L 383, 31.12.1980, p. 27), as amended by:

- 387 L 0143: Commission Directive 87/143/EEC of 10 February 1987 (OJ L 57, 27.2.1987, p. 56).

3. 382 L 0434: Second Commission Directive 82/434/EEC of 14 May 1982 on the approximation of the laws of

the Member States relating to methods of analysis necessary for checking the composition of cosmetic products

(OJ L 185, 30.6.1982, p. 1), as amended by:

- 390 L 0207: Commission Directive 90/207/EEC of 4 April 1990 (OJ L 108, 28.4.1990, p. 92).

4. 383 L 0514: Third Commission Directive 83/514/EEC of 27 September 1983 on the approximation of the laws

of the Member States relating to methods of analysis necessary for checking the composition of cosmetic

products (OJ L 291, 24.10.1983, p. 9).

{1272} Indent added by Decision No 230/2017 (OJ L 254, 3.10.2019, p. 41 and EEA Supplement No 80, 3.10.2019, p. 43), e.i.f. 16.12.2017.

{1273} Indent added by Decision No 56/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 24.3.2018.

{1274} Indent added by Decision No 187/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 22.9.2018.

{1275} Indent added by Decision No 188/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 22.9.2018.

{1276} Indent added by Decision No 123/2019 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 1.6.2019.

{1277} Indent added by Decision No 230/2019 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 28.9.2019.

{1278} Indent added by Decision No 230/2019 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 28.9.2019.

{1279} Indent added by Decision No 231/2019 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 28.9.2019.

{1280} Indent added by Decision No 232/2019 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 28.9.2019.

{1281} Indent added by Decision No 288/2019 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. pending.

{1282} Point inserted by Decision No 46/2014 (OJ L 256, 28.8.2014, p. 23 and EEA Supplement No 49, 28.8.2014, p. 22), e.i.f. 9.4.2014.

{1283} Point inserted by Decision No 125/2014 (OJ L 342, 27.11.2014, p. 24 and EEA Supplement No 71, 27.11.2014, p. 24), e.i.f. 28.6.2014.

Page 119: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 245

5. 385 L 0490: Fourth Commission Directive 85/490/EEC of 11 October on the approximation of laws of the

Member States relating to methods of analysis necessary for checking the composition of cosmetic products

(OJ L 295, 7.11.1985, p. 30).

6.{1284} 393 L 0073: Fifth Commission Directive 93/73/EEC of 9 September 1993 on the methods of analysis

necessary for checking composition of cosmetic products (OJ L 231, 14.9.1993, p. 34).

7.{1285} 395 L 0032: Sixth Commission Directive 95/32/EC of 7 July 1995 relating to methods of analysis necessary

for checking the composition of cosmetic products (OJ L 178, 28.7.1995, p. 20).

8.{1286} 396 L 0045: Seventh Commission Directive 96/45/EC of 2 July 1996 relating to methods

of analysis necessary for checking the composition of cosmetic products (OJ L 213, 22.8.1996, p. 8.)

9. [ ] {1287}

10.{1288} 396 D 0335: Commission Decision 96/335/EC of 8 May 1996 establishing an inventory and a common

nomenclature of ingredients employed in cosmetic products (OJ L 132, 1.6.1996, p. 1), as amended by:

-{1289} 32006 D 0257: Commission Decision 2006/257/EC of 9 February 2006 (OJ L 97, 5.4.2006, p. 1).

11.{1290} [ ]{1291}

12.{1292} [ ]{1293}

13.{1294} [ ]{1295}

13a.{1296}32019 D 0701: Commission Decision (EU) 2019/701 of 5 April 2019 establishing a glossary of common

ingredient names for use in the labelling of cosmetic products (OJ L 121, 8.5.2019, p. 1).

ACTS OF WHICH THE CONTRACTING PARTIES SHALL TAKE NOTE{1297}

The Contracting Parties take note of the content of the following acts:

{1284} Point inserted by Decision No 7/94 (OJ L 160, 28.6.1994, p. 1 and EEA Supplement No 17, 28.6.1994, p. 1), e.i.f. 1.7.1994.

{1285} Point inserted by Decision No 18/96 (OJ L 124, 23.5.1996, p. 26 and EEA Supplement No 23, 23.5.1996, p. 23), e.i.f. 1.4.1996.

{1286} Point inserted by Decision No 66/97 (OJ L 30, 5.2.1998, p. 37 and EEA Supplement No 5, 5.2.1998, p. 134), e.i.f. 5.10.1997.

{1287} Point 9 (Commission Directive 95/17/EC) inserted by Decision No 30/98 (OJ L 310, 19.11.1998, p. 14 and EEA Supplement No 48,

19.11.1998, p. 222), e.i.f. 1.5.1998; text of point 9 subsequently (Commission Directive 95/17/EC) deleted with effect from 11.7.2013 by

Decision No 49/2013 (OJ L 231, 29.8.2013, p. 23 and EEA Supplement No 49, 29.8.2013, p. 25), e.i.f. 6.4.2013.

{1288} Point 10 (Commission Decision 96/335/EC) inserted by Decision No 102/98 (OJ L 197, 29.7.1999, p. 54 and EEA Supplement No 33,

29.7.1999, p. 10), e.i.f. 31.10.1998 subsequently will be deleted with effect from 8.5.2020 by Decision No 231/2019 (OJ L [to be published]

and EEA Supplement No [to be published]), e.i.f. 28.9.2019.

{1289} Indent and words “, as amended by:” above, added by Decision No 129/2006 (OJ L 366, 21.12.2006, p. 66 and EEA Supplement No 64,

21.12.2006, p. 1), e.i.f. 28.10.2006.

{1290} Point inserted by Decision No 13/2001 (OJ L 117, 26.4.2001, p. 9 and EEA Supplement No 22, 26.4.2001, p. 7), e.i.f. 24.02.2001.

{1291} Point 11 (Commission Directive 2000/41/EC) deleted by Decision No 63/2005 (OJ L 239, 15.9.2005, p. 46 and EEA Supplement No 46,

15.9.2005, p. 28), e.i.f. 30.4.2005.

{1292} Point inserted by Decision No 6/2004 (OJ L 116, 22.4.2004, p. 50 and EEA Supplement No 20, 22.4.2004, p. 9), e.i.f. 7.2.2004. Text of the

Act subsequently corrected by Corrigendum noted in the EEA Joint Committee Meeting on 9.7.2004, (OJ L 58, 26.2.2004, p. 28).

{1293} Point 12 (Commission Directive 2003/80/EC) deleted by Decision No 63/2005 (OJ L 239, 15.9.2005, p. 46 and EEA Supplement No 46,

15.9.2005, p. 28), e.i.f. 30.4.2005.

{1294} Point inserted by Decision No 6/2004 (OJ L 116, 22.4.2004, p. 50 and EEA Supplement No 20, 22.4.2004, p. 9), e.i.f. 7.2.2004. Text of the

Act subsequently corrected by Corrigendum noted in the EEA Joint Committee Meeting on 9.7.2004, (OJ L 58, 26.2.2004, p. 28).

{1295} Point 13 (Commission Directive 2003/83/EC) deleted by Decision No 63/2005 (OJ L 239, 15.9.2005, p. 46 and EEA Supplement No 46,

15.9.2005, p. 28), e.i.f. 30.4.2005.

{1296} Point inserted by Decision No 231/2019 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 28.9.2019.

{1297} Heading and point 14 inserted by Decision No 17/2007 (OJ L 209, 9.8.2007, p. 30 and EEA Supplement No 38, 9.8.2007, p. 22), e.i.f.

28.1.2006.

Page 120: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 246

14. 32006 H 0406: Commission Recommendation 2006/406/EC of 7 June 2006 establishing guidelines on the use

of claims referring to the absence of tests on animals pursuant to Council Directive 76/768/EEC (OJ L 158,

10.6.2006, p. 18).

15.{1298} 32006 H 0647: Commission Recommendation 2006/647/EC of 22 September 2006 on the efficacy of

sunscreen products and the claims made relating thereto (OJ L 265, 26.9.2006, p. 39).

{1298} Point inserted by Decision No 110/2007 (OJ L 047, 21.2.2008, p. 30 and EEA Supplement No 9, 21.2.2008, p. 25), e.i.f. 29.9.2007.

Page 121: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 247

XVII. ENVIRONMENT PROTECTION

ACTS REFERRED TO

1. [ ] {1299}

2. [ ] {1300}

3. [ ] {1301}

4. [ ] {1302}

5. 389 L 0629: Council Directive 89/629/EEC of 4 December 1989 on the limitation of noise emissions from

subsonic jet aeroplanes (OJ No L 363, 13.12.1989, p. 27).

6. [ ] {1303}

[ ] {1304}

6a.{1305} 398 L 0070: Directive 98/70/EC of the European Parliament and of the Council of 13 October 1998 relating to

the quality of petrol and diesel fuels and amending Council Directive 93/12/EEC (OJ L 350, 28.12.1998,

p. 58), as amended by:

-{1306} 32000 L 0071: Commission Directive 2000/71/EC of 7 November 2000 (OJ L 287, 14.11.2000,

p. 46),

-{1307} 32003 L 0017: Directive 2003/17/EC of the European Parliament and of the Council of 3 March

2003 (OJ L 76, 22.3.2003, p. 10),

-{1308} 32011 L 0063: Commission Directive 2011/63/EU of 1 June 2011 (OJ L 147, 2.6.2011, p. 15),

-{1309} 32014 L 0077: Commission Directive 2014/77/EU of 10 June 2014 (OJ L 170. 11.6.2014, p. 62),

-{1310} 32009 L 0030: Directive 2009/30/EC of the European Parliament and of the Council of 23 April

2009 (OJ L 140, 5.6.2009, p. 88),

-{1311} 32015 L 1513: Directive (EU) 2015/1513 of the European Parliament and of the Council of 9

September 2015 (OJ L 239, 15.9.2015, p. 1).

{1299} Text of point 1 and adaptation text (Council Directive 75/716/EEC) deleted by Decision No 80/2013 (OJ L 291, 31.10.2013, p. 39 and EEA

Supplement No 61, 31.10.2013, p. 44), e.i.f. 4.5.2013.

{1300} Text of point 2 (Council Directive 80/51/EEC) deleted by Decision No 8/2009 (OJ L 73, 19.3.2009, p. 42 and EEA Supplement No 16,

19.3.2009, p. 13), e.i.f. 6.2.2009.

{1301} Text of point 3 (Council Directive 85/210/EEC) deleted by Decision No 80/2013 (OJ L 291, 31.10.2013, p. 39 and EEA Supplement No 61,

31.10.2013, p. 44), e.i.f. 4.5.2013.

{1302} Text of point 4 (Council Directive 85/339/EEC) deleted by Decision No 80/2013 (OJ L 291, 31.10.2013, p. 39 and EEA Supplement No 61,

31.10.2013, p. 44), e.i.f. 4.5.2013.

{1303} Point inserted by Decision No 7/94 (OJ L 160, 28.6.1994, p. 1 and EEA Supplement No 17, 28.6.1994, p. 1), e.i.f. 1.7.1994. Text of point 6

(Council Directive 93/12/EEC) deleted by Decision No 270 (OJ L 161, 22.6.2017, p. 55 and EEA Supplement No 38, 22.6.2017, p. 57), e.i.f.

1.11.2015.

{1304} Adaptation text deleted by Decision No 90/2001 (OJ L 251. 20.9.2001, p. 15 and EEA Supplement No 47, 20.9.2001, p. 2), e.i.f. 14.7.2001.

{1305} Point inserted by Decision No 90/2001(OJ L 251. 20.9.2001, p. 15 and EEA Supplement No 47, 20.9.2001, p. 2), e.i.f. 14.7.2001.

{1306} Indent added by Decision No 91/2001 (OJ L 251. 20.9.2001, p. 17 and EEA Supplement No 47, 20.9.2001, p. 4), e.i.f. 14.7.2001.

{1307} Indent added by Decision No 9/2005 (OJ L 161, 23.6.2005, p. 20 and EEA Supplement No 32, 23.6.2005, p. 11), e.i.f. 9.2.2005.

{1308} Indent added by Decision No 74/2013 (OJ L 291, 31.10.2013, p. 31 and EEA Supplement No 61, 31.10.2013, p. 35), e.i.f. 1.11.2015.

{1309} Indent added by Decision No 55/2015 (OJ L 129, 19.5.2016, p. 38 and EEA Supplement No 29, 19.5.2016, p. 39), e.i.f. 1.11.2015.

{1310} Indent added by Decision No 270/2015 (OJ L 161, 22.6.2017, p. 55 and EEA Supplement No 38, 22.6.2017, p. 57), e.i.f. 1.11.2015.

Page 122: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 248

{1312}The provisions of the Directive shall, for the purposes for the present Agreement, be read with the

following adaptations:

(a) In point 4 (outermost regions) of Article 2, the words “Iceland, with regard to all of its territory,”

shall be inserted after the word “departments,”.

(b) In point 1 of Article 6, the words “Article 95(10) of the Treaty” shall be replaced by reference to

“Article 75 of the Agreement”.

(c) In Article 2(5), the word “Iceland” shall be added after the word “Finland” and the word “Norway”

shall be added after the word “Lithuania”.

(d) In Article 3(4), the following subparagraph shall be added after the first subparagraph:

“Iceland may permit the placing on the market, during the summer period, of petrol containing

ethanol or methanol with maximum vapour pressure of 70 kPa, on condition that the ethanol used is

a biofuel or that the greenhouse gas emission saving from the use of methanol fulfils the criteria

specified in Article 7b(2).”

(e) Articles 7a to 7e shall not apply to Liechtenstein.

(f) Article 7b(6) shall not apply to the EFTA States.

6aa. [ ] {1313}

6ab. [ ] {1314}

6ac. [ ] {1315}

6ad. [ ] {1316}

6ae.{1317} 32017 D 0500: Commission Implementing Decision (EU) 2017/500 of 21 March 2017 on recognition of the

‘Bonsucro EU’ voluntary scheme for demonstrating compliance with the sustainability criteria under

Directive 98/70/EC and 2009/28/EC of the European Parliament and of the Council (OJ L 76, 22.3.2017, p.

40).

6af. [ ] {1318}

6ag. [ ] {1319}

{1311} Indent added by Decision No 74/2019 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f pending.

{1312} Adaptation texts c, d, e and f added by Decision No 270/2015 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f.

1.11.2015.

{1313} Point 6aa (Commission Implementing Decision 2011/435/EU) inserted by Decision No 26/2016 (OJ L 189, 20.7.2017, p. 38 and EEA

Supplement No 45, 20.7.2017, p. 41), e.i.f. 6.2.2016 subsequently deleted by Decision No 18/2018 (OJ L 323, 12.12.2019, p. 35 and EEA

Supplement No 98, 12.12.2019, p. 32), e.i.f. 10.2.2018.

{1314} Point 6ab (Commission Implementing Decision 2011/436/EU) inserted by Decision No 26/2016 (OJ L 189, 20.7.2017, p. 38 and EEA

Supplement No 45, 20.7.2017, p. 41), e.i.f. 6.2.2016 subsequently deleted by Decision No 18/2018 (OJ L 323, 12.12.2019, p. 35 and EEA

Supplement No 98, 12.12.2019, p. 32), e.i.f. 10.2.2018.

{1315} Point 6ac (Commission Implementing Decision 2011/437/EU) inserted by Decision No 26/2016 (OJ L 189, 20.7.2017, p. 38 and EEA

Supplement No 45, 20.7.2017, p. 41), e.i.f. 6.2.2016 subsequently deleted by Decision No 18/2018 (OJ L 323, 12.12.2019, p. 35 and EEA

Supplement No 98, 12.12.2019, p. 32), e.i.f. 10.2.2018.

{1316} Point 6ad (Commission Implementing Decision 2011/438/EU) inserted by Decision No 26/2016 (OJ L 189, 20.7.2017, p. 38 and EEA

Supplement No 45, 20.7.2017, p. 41), e.i.f. 6.2.2016 subsequently deleted by Decision No 18/2018 (OJ L 323, 12.12.2019, p. 35 and EEA

Supplement No 98, 12.12.2019, p. 32), e.i.f. 10.2.2018.

{1317} Point 6ae (Commission Implementing Decision 2011/439/EU) inserted by Decision No 26/2016 (OJ L 189, 20.7.2017, p. 38 and EEA

Supplement No 45, 20.7.2017, p. 41), e.i.f. 6.2.2016 and subsequently replaced by Decision No 136/2017 (OJ L 128, 16.5.2019, p. 31 and

EEA Supplement No 40, 16.5.2019, p. 32), e.i.f. 8.7.2017.

{1318} Point 6af (Commission Implementing Decision 2011/440/EU) inserted by Decision No 26/2016 (OJ L 189, 20.7.2017, p. 38 and EEA

Supplement No 45, 20.7.2017, p. 41), e.i.f. 6.2.2016 subsequently deleted by Decision No 18/2018 (OJ L 323, 12.12.2019, p. 35 and EEA

Supplement No 98, 12.12.2019, p. 32), e.i.f. 10.2.2018.

Page 123: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 249

6ah. [ ] {1320}

6ai. [ ] {1321}

6aj. [ ] {1322}

6ak. [ ] {1323}

6al. [ ] {1324}

6am.{1325} 32013 D 0256: Commission Implementing Decision 2013/256/EU of 30 May 2013 on recognition of the

‘Biograce GHG calculation tool’ scheme for demonstrating compliance with the sustainability criteria under

Directives 98/70/EC and 2009/28/EC of the European Parliament and of the Council (OJ L 147, 1.6.2013,

p. 46).

6an.{1326} 32014 D 0006: Commission Implementing Decision 2014/6/EU of 9 January 2014 on recognition of the

‘HVO Renewable Diesel Scheme for Verification of Compliance with the RED sustainability criteria for

biofuels’ for demonstrating compliance with the sustainability criteria under Directives 98/70/EC and

2009/28/EC of the European Parliament and of the Council (OJ L 5, 10.1.2014, p. 3).

6ao.{1327} 32014 D 0324: Commission Implementing Decision 2014/324/EU of 3 June 2014 on recognition of the

‘Gafta Trade Assurance Scheme’ for demonstrating compliance with the sustainability criteria under

Directives 2009/28/EC and 98/70/EC of the European Parliament and of the Council (OJ L 165, 4.6.2014,

p. 53).

6ap.{1328} 32014 D 0325: Commission Implementing Decision 2014/325/EU of 3 June 2014 on recognition of the

‘KZR INiG System’ for demonstrating compliance with the sustainability criteria under Directives 98/70/EC

and 2009/28/EC of the European Parliament and of the Council (OJ L 165, 4.6.2014, p. 56).

6aq.{1329} 32014 D 0666: Commission Implementing Decision 2014/666/EU of 17 September 2014 on recognition of

the ‘Trade Assurance Scheme for Combinable Crops’ for demonstrating compliance with the sustainability

criteria under Directives 98/70/EC and 2009/28/EC of the European Parliament and of the Council (OJ

L 276, 18.9.2014, p. 49).

6ar.{1330} 32014 D 0667: Commission Implementing Decision 2014/667/EU of 17 September 2014 on recognition of

the ‘Universal Feed Assurance Scheme’ for demonstrating compliance with the sustainability criteria under

Directives 98/70/EC and 2009/28/EC of the European Parliament and of the Council (OJ L 276, 18.9.2014,

p. 51).

{1319} Point 6ag (Commission Implementing Decision 2011/441/EU) inserted by Decision No 26/2016 (OJ L 189, 20.7.2017, p. 38 and EEA

Supplement No 45, 20.7.2017, p. 41), e.i.f. 6.2.2016 subsequently deleted by Decision No 18/2018 (OJ L 323, 12.12.2019, p. 35 and EEA

Supplement No 98, 12.12.2019, p. 32), e.i.f. 10.2.2018.

{1320} Point 6ah (Commission Implementing Decision 2012/210/EU) inserted by Decision No 26/2016 (OJ L 189, 20.7.2017, p. 38 and EEA

Supplement No 45, 20.7.2017, p. 41), e.i.f. 6.2.2016 subsequently deleted by Decision No 18/2018 (OJ L 323, 12.12.2019, p. 35 and EEA

Supplement No 98, 12.12.2019, p. 32), e.i.f. 10.2.2018.

{1321} Point 6ai (Commission Implementing Decision 2013/395/EU) inserted by Decision No 26/2016 (OJ L 189, 20.7.2017, p. 38 and EEA

Supplement No 45, 20.7.2017, p. 41), e.i.f. 6.2.2016 subsequently deleted by Decision No 18/2018 (OJ L 323, 12.12.2019, p. 35 and EEA

Supplement No 98, 12.12.2019, p. 32), e.i.f. 10.2.2018.

{1322} Point 6aj (Commission Implementing Decision 2012/432/EU) inserted by Decision No 26/2016 (OJ L 189, 20.7.2017, p. 38 and EEA

Supplement No 45, 20.7.2017, p. 41), e.i.f. 6.2.2016 subsequently replaced by Decision No 231/2017 (OJ L 254, 3.10.2019, p. 42 and EEA

Supplement No 80, 3.10.2019, p. 44), e.i.f. 16.12.2017. Point 6aj (Commission Implementing Decision (EU) 2017/1462) subsequently deleted

by Decision No 18/2018 (OJ L 323, 12.12.2019, p. 35 and EEA Supplement No 98, 12.12.2019, p. 32), e.i.f. 10.2.2018.

{1323} Point 6ak (Commission Implementing Decision 2012/452/EU) inserted by Decision No 26/2016 (OJ L 189, 20.7.2017, p. 38 and EEA

Supplement No 45, 20.7.2017, p. 41), e.i.f. 6.2.2016 subsequently deleted by Decision No 18/2018 (OJ L 323, 12.12.2019, p. 35 and EEA

Supplement No 98, 12.12.2019, p. 32), e.i.f. 10.2.2018.

{1324} Point 6al (Commission Implementing Decision 2012/722/EU) inserted by Decision No 26/2016 (OJ L 189, 20.7.2017, p. 38 and EEA

Supplement No 45, 20.7.2017, p. 41), e.i.f. 6.2.2016 subsequently deleted by Decision No 18/2018 (OJ L 323, 12.12.2019, p. 35 and EEA

Supplement No 98, 12.12.2019, p. 32), e.i.f. 10.2.2018.

{1325} Point inserted by Decision No 26/2016 (OJ L 189, 20.7.2017, p. 38 and EEA Supplement No 45, 20.7.2017, p. 41), e.i.f. 6.2.2016.

{1326} Point inserted by Decision No 26/2016 (OJ L 189, 20.7.2017, p. 38 and EEA Supplement No 45, 20.7.2017, p. 41), e.i.f. 6.2.2016.

{1327} Point inserted by Decision No 26/2016 (OJ L 189, 20.7.2017, p. 38 and EEA Supplement No 45, 20.7.2017, p. 41), e.i.f. 6.2.2016.

{1328} Point inserted by Decision No 26/2016 (OJ L 189, 20.7.2017, p. 38 and EEA Supplement No 45, 20.7.2017, p. 41), e.i.f. 6.2.2016.

{1329} Point inserted by Decision No 26/2016 (OJ L 189, 20.7.2017, p. 38 and EEA Supplement No 45, 20.7.2017, p. 41), e.i.f. 6.2.2016.

{1330} Point inserted by Decision No 26/2016 (OJ L 189, 20.7.2017, p. 38 and EEA Supplement No 45, 20.7.2017, p. 41), e.i.f. 6.2.2016.

Page 124: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 250

6as.{1331} 32015 D 0887: Commission Implementing Decision (EU) 2015/887 of 9 June 2015 on recognition of the

‘Scottish Quality Farm Assured Combinable Crops Limited’ scheme for demonstrating compliance with the

sustainability criteria under Directives 98/70/EC and 2009/28/EC of the European Parliament and of the

Council and repealing Commission Implementing Decision 2012/427/EU (OJ L 144, 10.6.2015, p. 17).

6at.{1332} 32016 D 1361: Commission Implementing Decision (EU) 2016/1361 of 9 August 2016 on recognition of the

‘International Sustainability and Carbon Certification system’ for demonstrating compliance with the

sustainability criteria under Directives 98/70/EC and 2009/28/EC of the European Parliament and of the

Council (OJ L 215, 10.8.2016, p. 33).

6au.{1333} 32016 D 1362: Commission Implementing Decision (EU) 2016/1362 of 9 August 2016 on recognition of the

‘Roundtable on Sustainable Biomaterials EU RED’ for demonstrating compliance with the sustainability

criteria under Directives 98/70/EC and 2009/28/EC of the European Parliament and of the Council (OJ L

215, 10.8.2016, p. 35).

6av.{1334} 32016 D 1433: Commission Implementing Decision (EU) 2016/1433 of 26 August 2016 on recognition of

the ‘Biomass Biofuels Sustainability voluntary scheme’ for demonstrating compliance with the sustainability

criteria under Directive 98/70/EC and 2009/28/EC of the European Parliament and of the Council (OJ L 232,

27.8.2016, p. 13).

6aw.{1335} 32017 D 2164: Commission Implementing Decision (EU) 2017/2164 of 17 November 2017 on recognition

of the ‘RTRS EU RED’ voluntary scheme for demonstrating compliance with the sustainability criteria under

Directives 98/70/EC and 2009/28/EC of the European Parliament and of the Council (OJ L 304, 21.11.2017,

p. 53).

6ax.{1336} 32017 D 2317: Commission Implementing Decision (EU) 2017/2317 of 13 December 2017 on recognition

of the ‘Red Tractor Farm Assurance Combinable Crops & Sugar Beet’ voluntary scheme for demonstrating

compliance with the sustainability criteria under Directives 98/70/EC and 2009/28/EC of the European

Parliament and of the Council (OJ L 331, 14.12.2017, p. 79).

6ay.{1337} 32018 D 1984: Commission Implementing Decision (EU) 2018/1984 of 13 December 2018 on recognition

of the ‘KZR INiG System’ for demonstrating compliance with the sustainability criteria under Directives

98/70/EC and 2009/28/EC of the European Parliament and of the Council (OJ L 317, 14.12.2018, p. 25).

6az.{1338} 32019 D 0142: Commission Implementing Decision (EU) 2019/142 of 29 January 2019 on recognition of

the ‘U.S. Soybean Sustainability Assurance Protocol’ for demonstrating compliance with the sustainability

criteria under Directives 98/70/EC and 2009/28/EC of the European Parliament and of the Council (OJ L 26,

30.1.2019, p. 10).

6aza.{1339} 32018 D 1854: Commission Implementing Decision (EU) 2018/1854 of 27 November 2018 on recognition

of the ‘Better Biomass’ voluntary scheme for demonstrating compliance with the sustainability criteria under

Directives 98/70/EC and 2009/28/EC of the European Parliament and of the Council (OJ L 302, 28.11.2018,

p. 73).

6azb.{1340} 32019 D 1175: Commission Implementing Decision (EU) 2019/1175 of 9 July 2019 on recognition of the

‘Roundtable on Sustainable Palm Oil RED’ voluntary scheme for demonstrating compliance with the

sustainability criteria under Directives 98/70/EC and 2009/28/EC of the European Parliament and of the

Council (OJ L 184, 10.7.2019, p. 21).

{1331} Point inserted by Decision No 26/2016 (OJ L 189, 20.7.2017, p. 38 and EEA Supplement No 45, 20.7.2017, p. 41), e.i.f. 6.2.2016.

{1332} Point inserted by Decision No 31/2017 (OJ L 297, 22.11.2018, p. 40 and EEA Supplement No 78, 22.11.2018, p. 47), e.i.f. 4.2.2017.

{1333} Point inserted by Decision No 31/2017 (OJ L 297, 22.11.2018, p. 40 and EEA Supplement No 78, 22.11.2018, p. 47), e.i.f. 4.2.2017.

{1334} Point inserted by Decision No 32/2017 (OJ L 297, 22.11.2018, p. 41 and EEA Supplement No 78, 22.11.2018, p. 49), e.i.f. 4.2.2017.

{1335} Point inserted by Decision No 18/2018 (OJ L 323, 12.12.2019, p. 35 and EEA Supplement No 98, 12.12.2019, p. 32), e.i.f. 10.2.2018.

{1336} Point inserted by Decision No 57/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 24.3.2018.

{1337} Point inserted by Decision No 156/2019 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 15.6.2019.

{1338} Point inserted by Decision No 157/2019 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 15.6.2019.

{1339} Point inserted by Decision No 255/2019 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 26.10.2019.

{1340} Point inserted by Decision No 256/2019 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 26.10.2019.

Page 125: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 251

6b.{1341} 32002 D 0159: Commission Decision 2002/159/EC of 18 February 2002 on a common format for the

submission of summaries of national fuel quality data (OJ L 53, 23.2.2002, p. 30).

6c.{1342} 32011 D 0013: Commission Decision 2011/13/EU of 12 January 2011 on certain types of information about

biofuels and bioliquids to be submitted by economic operators to Member States (OJ L 9, 13.1.2011,

p. 11).(1)

(1) Listed here for information purposes only; for application see Annex IV on Energy.

6d.{1343} 32014 R 1307: Commission Regulation (EU) No 1307/2014 of 8 December 2014 on defining the criteria and

geographic ranges of highly biodiverse grassland for the purposes of Article 7b(3)(c) of Directive 98/70/EC of

the European Parliament and of the Council relating to the quality of petrol and diesel fuels and Article

17(3)(c) of Directive 2009/28/EC of the European Parliament and of the Council on the promotion of the use

of energy from renewable sources (OJ L 351, 9.12.2014, p. 3).

The provisions of the Regulation shall, for the purposes of this Agreement, be read with the following

adaptation:

By way of derogation to paragraph 8 of Protocol 1 to the EEA Agreement, Article 2 shall not apply to

grasslands situated within the territories of the EFTA States.

6e.{1344} 32015 L 0652: Council Directive (EU) 2015/652 of 20 April 2015 laying down calculation methods

and reporting requirements pursuant to Directive 98/70/EC of the European Parliament and of the

Council relating to the quality of petrol and diesel fuels (OJ L 107, 25.4.2015, p. 26), as corrected

by OJ L 129, 27.5.2015, p. 53.

The provisions of the Directive, shall for the purposes of this Agreement be read with the following

adaptation:

References to other acts in the Directive shall apply to the extent and in the form that those acts are

incorporated into this Agreement.

7.{1345} 394 L 0062: European Parliament and Council Directive 94/62/EC of 20 December 1994 on packaging and

packaging waste (OJ L 365, 31.12.1994, p. 10), as amended by:

-{1346} 32004 L 0012: Directive 2004/12/EC of the European Parliament and of the Council of 11 February

2004 (OJ L 47, 18.2.2004, p. 26),

-{1347} 32005 L 0020: Directive 2005/20/EC of the European Parliament and of the Council of 9 March

2005 (OJ L 70, 16.3.2005, p. 17),

-{1348} 32013 L 0002: Commission Directive 2013/2/EU of 7 February 2013 (OJ L 37, 8.2.2013, p. 10),

-{1349} 32015 L 0720: Directive (EU) 2015/720 of the European Parliament and of the Council of 29 April

2015 (OJ L 115, 6.5.2015, p. 11).

{1341} Point inserted by Decision No 141/2002 (OJ L 19, 23.1.2003, p. 7 and EEA Supplement No 4, 23.1.2003, p. 7), e.i.f. 9.11.2002.

{1342} Point inserted by Decision No 116/2013 (OJ L 318, 28.11.2013, p. 18 and EEA Supplement No 67, 28.11.2013, p. 20), e.i.f. 1.11.2015.

{1343} Point inserted by Decision No 176/2017 (OJ L 174, 27.6.2019, p. 45 and EEA Supplement No 52, 27.6.2019, p. 54), e.i.f. 23.9.2017.

{1344} Point and adaptation text inserted by Decision No 232/2017 (OJ L 254, 3.10.2019, p. 43 and EEA Supplement No 80, 3.10.2019, p. 45), e.i.f.

16.12.2017.

{1345} Point inserted by Decision No 67/95 (OJ L 8, 11.1.1996, p. 38 and EEA Supplement No 2, 11.1.1996, p. 9), e.i.f. 1.12.1995.

{1346} Indent and words “, as amended by:” above, added by Decision No 36/2005 (OJ L 198, 28.7.2005, p. 30 and EEA Supplement No 38,

28.7.2005, p. 18), e.i.f. 12.3.2005.

{1347} Indent added by Decision No 145/2005 (OJ L 53, 23.2.2006, p. 42 and EEA Supplement No 10, 23.2.2005, p. 16), e.i.f. 12.3.2005.

{1348} Indent added by Decision No 197/2013 (OJ L 92, 27.3.2014, p. 23 and EEA Supplement No 19, 27.3.2014, p. 26), e.i.f. 9.11.2013.

{1349} Indent added by Decision No 242/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 1.8.2019.

Page 126: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 252

{1350}The transitional arrangements set out in the Annexes to the Act of Accession of 16 April 2003 for the

Czech Republic (Annex V, Chapter 7, Section A), Cyprus (Annex VII, Chapter 9, Section B), Latvia (Annex

VIII, Chapter 10, Section B, point 2), Lithuania (Annex IX, Chapter 10, Section B), Hungary (Annex X,

Chapter 8, Section A, point 2), Malta (Annex XI, Chapter 10, Section B, point 2), Poland (Annex XII,

Chapter 13, Section B, point 2), Slovenia (Annex XIII, Chapter 9, Section A) and Slovakia (Annex XIV,

Chapter 9, Section B, point 2) shall apply.

{1351}The transitional arrangements set out in the Annexes to the Act of Accession of 25 April 2005 for

Bulgaria (Annex VI, Chapter 10, Section B, point 2) and Romania (Annex VII, Chapter 9, Section B, point

2), shall apply.

{1352}The provisions of the Directive shall, for the purposes of this Agreement, be read with the following

adaptations:

In Article 6(7), the words “, Iceland” shall be inserted after the word “Ireland” and “, the presence of rural

areas and low population density” shall be inserted after the word “areas”.

7a.{1353} 397 D 0129: Commission Decision 97/129/EC of 28 January 1997 establishing the identification system for

packaging materials pursuant to European Parliament and Council Directive 94/62/EC on packaging and

packaging waste (OJ No L 50, 20.2.1997, p. 28).

7b. [ ]{1354}

7c. [ ] {1355}

7d.{1356} 32001 D 0171: Commission Decision 2001/171/EC of 19 February 2001 establishing the conditions for a

derogation for glass packaging in relation to a heavy metal concentration levels established in Directive

94/62/EC on packaging and packaging waste (OJ L 62, 2.3.2001, p. 20), as amended by:

-{1357} 32006 D 0340: Commission Decision 2006/340/EC of 8 May 2006 (OJ L 125, 12.5.2006, p. 43).

7e.{1358} 32005 D 0270: Commission Decision 2005/270/EC of 22 March 2005 establishing the formats relating to the

database system pursuant to Directive 94/62/EC of the European Parliament and of the Council on packaging

and packaging waste (OJ L 86, 5.4.2005, p. 6).

7f.{1359} 32009 D 0292: Commission Decision 2009/292/EC of 24 March 2009 establishing the conditions for a

derogation for plastic crates and plastic pallets in relation to the heavy metal concentration levels established in

Directive 94/62/EC of the European Parliament and of the Council on packaging and packaging waste (OJ L

79, 25.3.2009, p. 44).

{1350} Text added by the 2004 EEA Enlargement Agreement (OJ L 130, 29.4.2004, p. 3 and EEA Supplement No 23, 29.4.2004, p. 1), e.i.f.

1.5.2004.

{1351} Text added by the 2007 EEA Enlargement Agreement (OJ L 221, 25.8.2007 and EEA Supplement No 39, 26.7.2008), provisionally

applicable as of 1.8.2007, e.i.f. 9.11.2011, the words “or, as the case may be, to the Protocol of Accession of 25 April 2005” subsequently

deleted by the 2014 EEA Enlargement Agreement (OJ L 170, 11.6.2014, p. 5 and EEA Supplement No 58, 9.10.2014, p. 1), provisionally

applicable as of 12.4.2014, e.i.f. pending.

{1352} Text added by Decision No 36/2005 (OJ L 198, 28.7.2005, p. 30 and EEA Supplement No 38, 28.7.2005, p. 18), e.i.f. 12.3.2005.

{1353} Point inserted by Decision No 93/97 (OJ L 193, 9.7.1998, p. 49 and EEA Supplement No 27, 9.7.1998, p. 60), e.i.f. 1.12.1997.

{1354} Point 7b (Commission Decision 97/138/EC) inserted by Decision No 94/97 (OJ L 193, 9.7.1998, p. 50 and EEA Supplement No 27, 9.7.1998,

p. 65), e.i.f. 1.12.1997 and subsequently deleted by Decision No 5/2006 (OJ L 92, 30.3.2006, p. 24 and EEA Supplement No 17, 30.3.2006, p.

6), e.i.f. 28.1.2006.

{1355} Point inserted by Decision No 106/1999 (OJ L 325, 21.12.2000, p. 11 and EEA Supplement No 60, 21.12.2000, p. 212), e.i.f. 25.9.1999

subsequently text of point 7c (Commission Decision 1999/177/EC) deleted by Decision No 80/2013 (OJ L 291, 31.10.2013, p. 39 and EEA

Supplement No 61, 31.10.2013, p. 44), e.i.f. 4.5.2013.

{1356 } Point inserted by Decision No 113/2001 (OJ L 322, 6.12.2001, p. 25 and EEA Supplement No 60, 6.12.2001, p.23), e.i.f. 29.9.2001.

{1357} Indent and words “, as amended by:” above, added by Decision No 18/2007 (OJ L 209, 9.8.2007, p. 32 and EEA Supplement No 38,

9.8.2007, p. 23), e.i.f. 28.4.2007.

{1358 } Point inserted by Decision No 5/2006 (OJ L 92, 30.3.2006, p. 24 and EEA Supplement No 17, 30.3.2006, p. 6), e.i.f. 28.1.2006.

{1359 } Point inserted by Decision No 214/2012 (OJ L 81, 21.3.2013, p. 14 and EEA Supplement No 18, 21.3.2013, p. 16), e.i.f. 8.12.2012.

Page 127: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 253

8.{1360} 394 L 0063: European Parliament and Council Directive 94/63/EC of 20 December 1994 on the control of

volatile organic compound (VOC) emissions resulting from the storage of petrol and its distribution from

terminals to service stations (OJ No L 365, 31.12.1994, p. 24).

{1361}The transitional arrangements set out in the Annexes to the Act of Accession of 16 April 2003 for Estonia

(Annex VI, Chapter 9, Section A), Latvia (Annex VIII, Chapter 10, Section A), Lithuania (Annex IX, Chapter

10, Section A), Malta (Annex XI, Chapter 10, Section A), Poland (Annex XII, Chapter 13, Section A, point 1)

and Slovakia (Annex XIV, Chapter 9, Section A) shall apply.

{1362} The transitional arrangements set out in the Annexes to the Act of Accession of 25 April 2005 for Bulgaria

(Annex VI, Chapter 10, Section A, point 1) and Romania (Annex VII, Chapter 9, Section A), shall apply.

The provisions of the Directive shall, for the purposes of the present Agreement, be read with the following

adaptation:

Paragraph 4 of Annex I shall not apply to existing terminals in Iceland with a throughput of less than 5 000

metric tons per year, which are serviced by ships.

9. {1363} 32004 L 0042: Directive 2004/42/EC of the European Parliament and of the Council of 21 April 2004 on the

limitation of emissions of volatile organic compounds due to the use of organic solvents in certain paints and

varnishes and vehicle refinishing products and amending Directive 1999/13/EC (OJ 143, 30.4.2004, p. 87),

as amended by:

-{1364} 32010 L 0079: Commission Directive 2010/79/EU of 19 November 2010 (OJ L 304, 20.11.2010, p.

18),

-{1365} 32008 L 0112: Directive 2008/112/EC of the European Parliament and of the Council of 16

December 2008 (OJ L 345, 23.12.2008, p. 68).

The provisions of the Directive shall, for the purposes for the present Agreement, be read with the following

adaptation:

In Article 3(4), the words ", and for Iceland for a period of 36 months following the latter date in Annex II, to

finish the Icelandic stocks" shall be inserted after the word "force".

9a. [ ] {1366}

9aa. [ ] {1367}

9b.{1368} 32014 R 0517: Regulation (EU) No 517/2014 of the European Parliament and of the Council of 16 April 2014

on fluorinated greenhouse gases and repealing Regulation (EC) No 842/2006 (OJ L 150, 20.5.2014, p. 195).

{1360} Point inserted by Decision No 50/96 (OJ L 21, 23.1.1997, p. 4 and EEA Supplement No 4, 23.1.1997, p. 16), e.i.f. 1.10.1996.

{1361} Text added by the 2004 EEA Enlargement Agreement (OJ L 130, 29.4.2004, p. 3 and EEA Supplement No 23, 29.4.2004, p. 1), e.i.f.

1.5.2004.

{1362} Text added by the 2007 EEA Enlargement Agreement (OJ L 221, 25.8.2007 and EEA Supplement No 39, 26.7.2008), provisionally

applicable as of 1.8.2007, e.i.f. 9.11.2011, the words “or, as the case may be, to the Protocol of Accession of 25 April 2005” subsequently

deleted by the 2014 EEA Enlargement Agreement (OJ L 170, 11.6.2014, p. 5 and EEA Supplement No 58, 9.10.2014, p. 1), provisionally

applicable as of 12.4.2014, e.i.f. pending.

{1363} Point inserted by Decision No 79/2005 (OJ L 268, 13.10.2005, p. 10 and EEA Supplement No 52, 13.10.2005, p. 5), e.i.f. 11.6.2005.

{1364} Indent and words “, as amended by:” added by Decision No 50/2012 (OJ L 207, 2.8.2012, p. 30 and EEA Supplement No 43, 2.8.2012, p.

36), e.i.f. 31.3.2012.

{1365} Indent added by Decision No 106/2012 (OJ L 270, 4.10.2012, p. 6 and EEA Supplement No 56, 4.10.2012, p. 8), e.i.f. 1.2.2013.

{1366} Point inserted by Decision No 26/2008 (OJ L 182, 10.7.2008, p. 15 and EEA Supplement No 42, 10.7.2008, p. 9), e.i.f. 15.3.2008

subsequently text of point 9a (Commission Decision 2007/205/EC) deleted by Decision No 80/2013 (OJ L 291, 31.10.2013, p. 39 and EEA

Supplement No 61, 31.10.2013, p. 44), e.i.f. 4.5.2013.

{1367} Point inserted by Decision No 132/2011 (OJ L 76, 15.3.2012, p. 16 and EEA Supplement No 15, 15.3.2012, p. 19), e.i.f. 3.12.2011

subsequently text of point 9aa (Commission Decision 2010/693/EU) deleted by Decision No 80/2013 (OJ L 291, 31.10.2013, p. 39 and EEA

Supplement No 61, 31.10.2013, p. 44), e.i.f. 4.5.2013.

{1368} Point 9b (Regulation (EC) No 842/2006 of the European Parliament and of the Council) inserted by Decision No 112/2008 (OJ L 339,

18.12.2008, p. 100 and EEA Supplement No 79, 18.12.2008, p. 8), e.i.f. 1.4.2010 replaced by Decision No 160/2019 ( OJ L [to be published]

and EEA Supplement No [to be published]), e.i.f. 15.6.2019.

Page 128: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 254

The provisions of the Regulation shall, for the purposes of this Agreement, be read with the following

adaptations:

(a) In Article 4(2), as regards the EFTA States, the words “31 December 2016” shall read “one year after

the date of entry into force of Decision of the EEA Joint Committee No 160/2019 of 13 June 2019”.

(b) In Article 5(2), as regards the EFTA States, the words “1 January 2017” shall read “one year after the

date of entry into force of Decision of the EEA Joint Committee No 160/2019 of 13 June 2019”.

(c) In Article 12(3)(c), as regards the EFTA States, the words “1 January 2017” shall read “one year after

the date of entry into force of Decision of the EEA Joint Committee No 160/2019 of 13 June 2019”.

(d) Articles 14 to 19 and Article 25(2) shall not apply.

9ba.{1369} 32015 R 2068: Commission Implementing Regulation (EU) 2015/2068 of 17 November 2015 establishing,

pursuant to Regulation (EU) No 517/2014 of the European Parliament and of the Council, the format of labels

for products and equipment containing fluorinated greenhouse gases (OJ L 301, 18.11.2015, p. 39).

9bb.{1370} 32007 R 1497: Commission Regulation (EC) No 1497/2007 of 18 December 2007 establishing, pursuant to

Regulation (EC) No 842/2006 of the European Parliament and of the Council, standard leakage checking

requirements for stationary fire protection systems containing certain fluorinated greenhouse gases (OJ L 333,

19.12.2007, p. 4).

9bc.{1371} 32007 R 1516: Commission Regulation (EC) No 1516/2007 of 19 December 2007 establishing, pursuant to

Regulation (EC) No 842/2006 of the European Parliament and of the Council, standard leakage checking

requirements for stationary refrigeration, air conditioning and heat pump equipment containing certain

fluorinated greenhouse gases (OJ L 335, 20.12.2007, p. 10).

9bd.{1372} 32015 R 2067: Commission Implementing Regulation (EU) 2015/2067 of 17 November 2015 establishing,

pursuant to Regulation (EU) No 517/2014 of the European Parliament and of the Council, minimum

requirements and the conditions for mutual recognition for the certification of natural persons as regards

stationary refrigeration, air conditioning and heat pump equipment, and refrigeration units of refrigerated

trucks and trailers, containing fluorinated greenhouse gases and for the certification of companies as regards

stationary refrigeration, air conditioning and heat pump equipment, containing fluorinated greenhouse gases

(OJ L 301, 18.11.2015, p. 28).

9be.{1373} 32008 R 0304: Commission Regulation (EC) No 304/2008 of 2 April 2008 establishing, pursuant to

Regulation (EC) No 842/2006 of the European Parliament and of the Council, minimum requirements and the

conditions for mutual recognition for the certification of companies and personnel as regards stationary fire

protection systems and fire extinguishers containing certain fluorinated greenhouse gases (OJ L 92, 3.4.2008,

p. 12).

9bf. {1374} 32015 R 2066: Commission Implementing Regulation (EU) 2015/2066 of 17 November 2015 establishing,

pursuant to Regulation (EU) No 517/2014 of the European Parliament and of the Council, minimum

requirements and the conditions for mutual recognition for the certification of natural persons carrying out

installation, servicing, maintenance, repair or decommissioning of electrical switchgear containing fluorinated

greenhouse gases or recovery of fluorinated greenhouse gases from stationary electrical switchgear (OJ L 301,

18.11.2015, p. 22).

{1369} Point 9ba (Commission Regulation (EC) No 1494/2007) inserted by Decision No 30/2009 (OJ L 130, 28.5.2009, p. 23 and EEA Supplement

No 28, 28.5.2009, p. 21), e.i.f. 1.4.2010 replaced by Decision No 161/2019 (OJ L [to be published] and EEA Supplement No [to be

published]), e.i.f. 15.6.2019.

{1370} Point inserted by Decision No 30/2009 (OJ L 130, 28.5.2009, p. 23 and EEA Supplement No 28, 28.5.2009, p. 21), e.i.f. 1.4.2010.

{1371} Point inserted by Decision No 30/2009 (OJ L 130, 28.5.2009, p. 23 and EEA Supplement No 28, 28.5.2009, p. 21), e.i.f. 1.4.2010.

{1372} Point 9bd (Commission Regulation (EC) No 303/2008) inserted by Decision No 27/2010 (OJ L 143, 10.6.2010, p. 20 and EEA Supplement

No 30, 10.6.2010, p. 26), e.i.f. 1.11.2010 replaced by Decision No 161/2019 (OJ L [to be published] and EEA Supplement No [to be

published]), e.i.f. 15.6.2019.

{1373} Point inserted by Decision No 27/2010 (OJ L 143, 10.6.2010, p. 20 and EEA Supplement No 30, 10.6.2010, p. 26), e.i.f. 1.11.2010.

{1374} Point 9 bf (Commission Regulation (EC) No 305/2008) inserted by Decision No 27/2010 (OJ L 143, 10.6.2010, p. 20 and EEA Supplement

No 30, 10.6.2010, p. 26), e.i.f. 1.11.2010 replaced by Decision No 161/2019 (OJ L [to be published] and EEA Supplement No [to be

published]), e.i.f. 15.6.2019.

Page 129: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 255

9bg. {1375} 32008 R 0306: Commission Regulation (EC) No 306/2008 of 2 April 2008 establishing, pursuant to

Regulation (EC) No 842/2006 of the European Parliament and of the Council, minimum requirements and the

conditions for mutual recognition for the certification of personnel recovering certain fluorinated greenhouse

gas-based solvents from equipment (OJ L 92, 3.4.2008, p. 21), as corrected by OJ L 280, 23.10.2008, p. 38.

9bh. {1376} 32008 R 0307: Commission Regulation (EC) No 307/2008 of 2 April 2008 establishing, pursuant to

Regulation (EC) No 842/2006 of the European Parliament and of the Council, minimum requirements for

training programmes and the conditions for mutual recognition of training attestations for personnel as regards

air-conditioning systems in certain motor vehicles containing certain fluorinated greenhouse gases (OJ L 92,

3.4.2008, p. 25).

9bi. {1377} 32015 R 2065: Commission Implementing Regulation (EU) 2015/2065 of 17 November 2015 establishing,

pursuant to Regulation (EU) No 517/2014 of the European Parliament and of the Council, the format for

notification of the training and certification programmes of the Member States (OJ L 301, 18.11.2015, p. 14).

9c. {1378} 32010 R 0995: Regulation (EU) No 995/2010 of the European Parliament and of the Council of 20 October

2010 laying down the obligations of operators who place timber and timber products on the market (OJ L 295,

12.11.2010, p. 23).

The provisions of the Regulation shall, for the purposes of this Agreement, be read with the following

adaptations:

(a) The first paragraph of Article 3 shall not apply to the EFTA States.

(b) In the second paragraph of Article 3, with regard to the EFTA States, the words “Annex A, B or C to

Regulation (EC) No 338/97” shall read “the relevant parts of the legislation implementing the

Convention on International Trade in Endangered Species of Wild Fauna and Flora in that EFTA

State”.

(c) In Article 8(3), (5) and (6), if monitoring organisations of an EFTA State are concerned and without

prejudice to Protocol 1 to the Agreement, the word “Commission” shall read “the EFTA Surveillance

Authority”.

9ca. {1379} 32012 R 0363: Commission Delegated Regulation (EU) No 363/2012 of 23 February 2012 on the procedural

rules for the recognition and withdrawal of recognition of monitoring organisations as provided for in

Regulation (EU) No 995/2010 of the European Parliament and of the Council laying down the obligations of

operators who place timber and timber products on the market (OJ L 115, 27.4.2012, p. 12).

The provisions of the Regulation shall, for the purposes of this Agreement, be read with the following

adaptation:

If monitoring organisations of an EFTA State are concerned and without prejudice to Protocol 1 to the

Agreement, the word “Commission” shall read “the EFTA Surveillance Authority”.

9cb. {1380} 32012 R 0607: Commission Implementing Regulation (EU) No 607/2012 of 6 July 2012 on the detailed rules

concerning the due diligence system and the frequency and nature of the checks on monitoring organisations as

provided for in Regulation (EU) No 995/2010 of the European Parliament and of the Council laying down the

obligations of operators who place timber and timber products on the market (OJ L 177, 7.7.2012, p. 16).

{1375} Point inserted by Decision No 27/2010 (OJ L 143, 10.6.2010, p. 20 and EEA Supplement No 30, 10.6.2010, p. 26), e.i.f. 1.11.2010.

{1376} Point inserted by Decision No 27/2010 (OJ L 143, 10.6.2010, p. 20 and EEA Supplement No 30, 10.6.2010, p. 26), e.i.f. 1.11.2010.

{1377} Point 9bi (Commission Regulation (EC) No 308/2008) inserted by Decision No 27/2010 (OJ L 143, 10.6.2010, p. 20 and EEA Supplement

No 30, 10.6.2010, p. 26), e.i.f. 1.11.2010 replaced by Decision No 161/2019 (OJ L [to be published] and EEA Supplement No [to be

published]), e.i.f. 15.6.2019.

{1378} Point and adaptation text inserted by Decision No 75/2013 (OJ L 291, 31.10.2013, p. 32 and EEA Supplement No 61, 31.10.2013, p. 36),

e.i.f. 1.5.2015.

{1379} Point and adaptation text inserted by Decision No 75/2013 (OJ L 291, 31.10.2013, p. 32 and EEA Supplement No 61, 31.10.2013, p. 36),

e.i.f. 1.5.2015.

{1380} Point and adaptation text inserted by Decision No 75/2013 (OJ L 291, 31.10.2013, p. 32 and EEA Supplement No 61, 31.10.2013, p. 36),

e.i.f. 1.5.2015.

Page 130: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 256

The provision of the Regulation shall, for the purposes of this Agreement, be read with the following

adaptation:

In Article 6(2)(b), if monitoring organisations of an EFTA State are concerned and without prejudice to

Protocol 1 to the Agreement, the word “Commission” shall read “the EFTA Surveillance Authority”.

ACTS OF WHICH THE CONTRACTING PARTIES SHALL TAKE NOTE {1381}

The Contracting Parties take note of the content of the following acts:

10. 32005 H 0027: Commission Recommendation 2005/27/EC of 12 January 2005 on what, for the purposes of

Directive 98/70/EC of the European Parliament and of the Council concerning petrol and diesel fuels,

constitutes availability of unleaded petrol and diesel fuel with a maximum sulphur content on an appropriately

balanced geographical basis (OJ L 15, 19.1.2005, p. 26).

XVIII. INFORMATION TECHNOLOGY, TELECOMMUNICATION AND

DATA PROCESSING

ACTS REFERRED TO

1. [ ]{1382}

2. [ ]{1383}

3. 389 D 0337: Council Decision 89/337/EEC of 27 April 1989 on high-definition television (OJ No L 142,

25.5.1989, p. 1).

4. [ ]{1384}

4a.{1385} [ ]{1386}

4b.{1387} [ ]{1388}

4c.{1389} [ ]

{1381} Heading and point 10 inserted by Decision No 6/2006 (OJ L 92, 30.3.2006, p. 26 and EEA Supplement No 17, 30.3.2006, p. 7), e.i.f.

28.1.2006.

{1382} Point 1 (Council Directive 86/529/EEC) deleted by Decision No 16/2014 (OJ L 211, 17.7.2014, p. 24 and EEA Supplement No 42, 17.7.2014,

p. 22), e.i.f. 15.2.2014.

{1383} Text of point 2 (Council Decision 87/95/EEC) and adaptation text deleted by Decision No 9/2014 (OJ L 211, 17.7.2014, p. 13 and EEA

Supplement No 42, 17.7.2014, p. 12), e.i.f. 1.8.2014.

{1384} Text of point 4 (Council Directive 91/263/EEC) deleted by Decision No 32/1999 (OJ L 266, 19.10.2000, p.16 and EEA Supplement No 46,

19.10.2000, p.51), e.i.f. 27.3.1999.

{1385} Point inserted by Decision No 7/94 (OJ L 160, 28.6.1994, p. 1 and EEA Supplement No 17, 28.6.1994, p. 1), e.i.f. 1.7.1994, and renumbered

by OJ L 263, 13.10.1994, p. 23.

{1386} Text of point 4a (Commission Decision 94/11/EC) deleted with effect from 10 July 1998 by Decision No 63/98 (OJ L 100, 15.4.1999, p. 50

and EEA Supplement No 16, 15.4.1999, p. 96), e.i.f. 5.7.1998.

{1387} Point inserted by Decision No 7/94 (OJ L 160, 28.6.1994, p. 1 and EEA Supplement No 17, 28.6.1994, p. 1), e.i.f. 1.7.1994, and renumbered

by OJ L 263, 13.10.1994, p. 23.

{1388} Text of point 4b (Commission Decision 94/12/EC) deleted with effect from 10 July 1998 by Decision No 63/98 (OJ L 100, 15.4.1999, p. 50

and EEA Supplement No 16, 15.4.1999, p. 96), e.i.f. 5.7.1998.

{1389} Point inserted by Decision No 39/94 (OJ L 372, 31.12.1994, p. 12 and EEA Supplement No 57, 31.12.1994, p. 114), e.i.f. 1.2.1995. Text of

point 4c (Commission Decision 94/470/EC) deleted by Decision No 115/98 (OJ L 297, 18.11.1999, p.40 and EEA Supplement No 50,

18.11.1999, p. 1), e.i.f. 19.12.1998.

Page 131: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 257

4d.{1390} [ ]

4e.{1391} [ ]

4f.{1392} [ ]

4g.{1393} [ ]

4h.{1394} [ ]

4i. [ ] {1395}

4j. [ ] {1396}

4k. [ ] {1397}

4l. [ ] {1398}

4m.{1399} [ ]{1400}

4n. [ ] {1401}

4o. [ ] {1402}

{1390} Point inserted by Decision No 39/94 (OJ L 372, 31.12.1994, p. 12 and EEA Supplement No 57, 31.12.1994, p. 114), e.i.f. 1.2.1995. Text of

point 4d (Commission Decision 94/471/EC) deleted by Decision No 116/98 (OJ L 297, 18.11.1999, p.42 and EEA Supplement No 50,

18.11.1999, p. 10), e.i.f. 19.12.1998.

{1391} Point inserted by Decision No 39/94 (OJ L 372, 31.12.1994, p. 12 and EEA Supplement No 57, 31.12.1994, p. 114), e.i.f. 1.2.1995. Text of

point 4e (Commission Decision 94/472/EC) deleted by Decision No 116/98 (OJ L 297, 18.11.1999, p.42 and EEA Supplement No 50,

18.11.1999, p. 10), e.i.f. 19.12.1998.

{1392} Point inserted by Decision No 47/95 (OJ L 140, 13.6.1996, p. 43 and EEA Supplement No 25, 13.6.1996, p. 98), e.i.f. 1.7.1995. Text of point

4f (Commission Decision 94/796/EC) deleted by Decision No 117/98 (OJ L 297, 18.11.1999, p.44 and EEA Supplement No 50, 18.11.1999,

p. 18), e.i.f. 19.12.1998.

{1393} Point inserted by Decision No 47/95 (OJ L 140, 13.6.1996, p. 43 and EEA Supplement No 25, 13.6.1996, p. 98), e.i.f. 1.7.1995. Text of point

4g (Commission Decision 94/797/EC) deleted by Decision No 117/98 (OJ L 297, 18.11.1999, p.44 and EEA Supplement No 50, 18.11.1999,

p. 18), e.i.f. 19.12.1998.

{1394} Point inserted by Decision No 47/95 (OJ L 140, 13.6.1996, p. 43 and EEA Supplement No 25, 13.6.1996, p. 98), e.i.f. 1.7.1995. Text of point

4h (Commission Decision 94/821/EC) deleted by Decision No 115/98 (OJ L 297, 18.11.1999, p.40 and EEA Supplement No 50, 18.11.1999,

p. 1), e.i.f. 19.12.1998.

{1395} Point 4i (Directive 95/47/EC) inserted by Decision No 79/96 (OJ L 100, 17.4.1997, p. 68 and EEA Supplement No 16, 17.4.1997, p. 174),

e.i.f. 1.8.1998, and subsequently deleted with effect from 1.11.2004 by Decision No 11/2004 (OJ L 116, 22.4.2004, p. 60 and EEA

Supplement No 20, 22.4.2004, p. 14), e.i.f. 1.11.2004.

{1396} Point inserted by Decision No 3/97 (OJ L 182, 10.7.1997, p. 30 and EEA Supplement No 29, 10.7.1997, p. 2), e.i.f. 1.4.1997. And text of

point 4j (Commission Decision 95/290/EC) subsequently deleted by Decision No 109/1999 (OJ L 325, 21.12.2000, p. 17 and EEA

Supplement No 60, 21.12.2000, p.241), e.i.f. 25.9.1999.

{1397} Point inserted by Decision No 3/97 (OJ L 182, 10.7.1997, p. 30 and EEA Supplement No 29, 10.7.1997, p. 2), e.i.f. 1.4.1997. Text of point 4k

(Commission Decision 95/525/EC) deleted by Decision No 116/98 (OJ L 297, 18.11.1999, p.42 and EEA Supplement No 50, 18.11.1999, p.

10), e.i.f. 19.12.1998.

{1398} Point inserted by Decision No 3/97 (OJ L 182, 10.7.1997, p. 30 and EEA Supplement No 29, 10.7.1997, p. 2), e.i.f. 1.4.1997. Text of point 4l

(Commission Decision 95/526/EC) deleted by Decision No 6/2000 (OJ L 103, 12.4.2001, p. 11 and EEA Supplement No 20, 12.4.2001, p.82),

e.i.f. 5.2.2000.

{1399} Point inserted by Decision No 80/97 (OJ L 134, 7.5.1998, p. 9, and EEA Supplement No 18, 7.5.1998, p. 71), e.i.f. 13.11.1997.

{1400} Text of point 4m (Commission Decision 96/71/EC) deleted with effect from 10 July 1998 by Decision No 61/98 (OJ L 100, 15.4.1999, p. 46

and EEA Supplement No 16, 15.4.1999, p. 79), e.i.f. 5.7.1998.

{1401} Point inserted by Decision No 60/98 (OJ L 100, 15.4.1999, p. 44 and EEA Supplement No 16, 15.4.1999, p. 66), e.i.f. 1.8.1998, and text of

point 4n (Commission Decision 96/629/EC) subsequently deleted by Decision No 110/1999 (OJ L 325, 21.12.2000, p. 19 and EEA

Supplement No 60, 21.12.2000, p.245), e.i.f. 25.9.1999.

{1402} Point 4o (Commission Decision 96/630/EC) inserted by Decision No 60/98 (OJ L 100, 15.4.1999, p. 44 and EEA Supplement No 16,

15.4.1999, p. 66), e.i.f. 1.8.1998 and subsequently deleted by Decision No 16/2014 (OJ L 211, 17.7.2014, p. 24 and EEA Supplement No 42,

17.7.2014, p. 22), e.i.f. 15.2.2014.

Page 132: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 258

4p.{1403} 397 D 0544: Commission Decision 97/544/EC of 9 July 1997 on a common technical regulation for terminal

equipment to be connected to public circuit switched data networks and ONP leased circuits using a CCITT

Recommendation X.21 type interface (OJ L 223, 13.8.1997, p. 18).

4q.{1404} 397 D 0545: Commission Decision 97/545/EC of 9 July 1997 on a common technical regulation for general

attachment requirements for Data Terminal Equipment (DTE) to connect to Packet Switched Public Data

Networks (PSPDNs) offering CCITT Recommendation X.25 interfaces (OJ L 223, 13.8.1997, p. 21).

4r.{1405} 397 D 0486: Commission Decision 97/486/EC of 9 July 1997 on a common technical regulation for the

general attachment requirements for terminal equipment to interface to Open Network Provision (ONP) two-

wire analogue leased lines (OJ L 208, 2.8.1997, p. 44).

4s.{1406} 397 D 0487: Commission Decision 97/487/EC of 9 July 1997 on a common technical regulation for the

general attachment requirements for terminal equipment to interface to Open Network Provision (ONP) four-

wire analogue leased lines (OJ L 208, 2.8.1997, p. 47).

4t.{1407} 397 D 0639: Commission Decision 97/639/EC of 19 September 1997 on a common technical regulation for

the attachment requirements for the terminal equipment interface for connection to 34 Mbit/s digital

unstructured and structured leased lines (OJ L 271, 3.10.1997, p. 16).

4u. [ ]{1408}

4v. [ ] {1409}

4w.{1410} 397 D 0528: Commission Decision 97/528/EC of 9 July 1997 on a common technical regulation for the

general attachment requirements for mobile stations intended to be used with Phase II public digital cellular

telecommunications networks operating in the DCS 1800 band (OJ L 215, 7.8.1997, p. 60).

4x. [ ] {1411}

4y.{1412} 397 D 0520: Commission Decision 97/520/EC of 9 July 1997 on a common technical regulation for the

attachment requirements for the terminal equipment interface for connection to 2 048 kbit/s digital

unstructured ONP leased lines (Amendment 1) (OJ L 215, 7.8.1997, p. 41).

4z.{1413} 397 D 0521: Commission Decision 97/521/EC of 9 July 1997 on a common technical regulation for the

attachment requirements for the terminal equipment interface for connection to 2 048 kbit/s digital structured

ONP leased lines (OJ L 215, 7.8.1997, p. 44).

{1403} Point inserted by Decision No 61/98 (OJ L 100, 15.4.1999, p. 46 and EEA Supplement No 16, 15.4.1999, p. 79), e.i.f. 5.7.1998.

{1404} Point inserted by Decision No 61/98 (OJ L 100, 15.4.1999, p. 46 and EEA Supplement No 16, 15.4.1999, p. 79), e.i.f. 5.7.1998.

{1405} Point inserted by Decision No 62/98 (OJ L 100, 15.4.1999, p. 48 and EEA Supplement No 16, 15.4.1999, p. 86), e.i.f. 5.7.1998.

{1406} Point inserted by Decision No 62/98 (OJ L 100, 15.4.1999, p. 48 and EEA Supplement No 16, 15.4.1999, p. 86), e.i.f. 5.7.1998.

{1407} Point inserted by Decision No 62/98 (OJ L 100, 15.4.1999, p. 48 and EEA Supplement No 16, 15.4.1999, p. 86), e.i.f. 5.7.1998.

{1408} Point 4u (Commission Decision 97/526/EC) inserted by Decision No 63/98 (OJ L 100, 15.4.1999, p. 50 and EEA Supplement No 16,

15.4.1999, p. 96), e.i.f. 5.7.1998 and subsequently deleted by Decision No 16/2014 (OJ L 211, 17.7.2014, p. 24 and EEA Supplement No 42,

17.7.2014, p. 22),e.i.f. 15.2.2014.

{1409} Point inserted by Decision No 63/98 (OJ L 100, 15.4.1999, p. 50 and EEA Supplement No 16, 15.4.1999, p. 96), e.i.f. 5.7.1998, and text of

point 4v (Commission Decision 97/527/EC) subsequently deleted by Decision No 110/1999 (OJ L 325, 21.12.2000, p. 19 and EEA

Supplement No 60, 21.12.2000, p.245), e.i.f. 25.9.1999.

{1410} Point 4w (Commission Decision 97/528/EC) inserted by Decision No 63/98 (OJ L 100, 15.4.1999, p. 50 and EEA Supplement No 16,

15.4.1999, p. 96), e.i.f. 5.7.1998 and subsequently deleted by Decision No 16/2014 (OJ L 211, 17.7.2014, p. 24 and EEA Supplement No 42,

17.7.2014, p. 22), e.i.f. 15.2.2014.

{1411} Point inserted by Decision No 63/98 (OJ L 100, 15.4.1999, p. 50 and EEA Supplement No 16, 15.4.1999, p. 96), e.i.f. 5.7.1998, and text of

point 4x (Commission Decision 97/529/EC) deleted by Decision No 110/1999 (OJ L 325, 21.12.2000, p. 19 and EEA Supplement No 60,

21.12.2000, p.245), e.i.f. 25.09.1999.

{1412} Point inserted by Decision No 115/98 (OJ L 297, 18.11.1999, p.40 and EEA Supplement No 50, 18.11.1999, p. 1), e.i.f. 19.12.1998.

{1413} Point inserted by Decision No 115/98 (OJ L 297, 18.11.1999, p.40 and EEA Supplement No 50, 18.11.1999, p. 1), e.i.f. 19.12.1998.

Page 133: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 259

4za.{1414} 397 D 0522: Commission Decision 97/522/EC of 9 July 1997 on a common technical regulation for the

attachment requirements for the terminal equipment interface for connection to 64 kbit/s digital unrestricted

ONP leased lines (Amendment 1) (OJ L 215, 7.8.1997, p. 46).

4zb.{1415} 397 D 0523: Commission Decision 97/523/EC of 9 July 1997 on a common technical regulation for the

general terminal attachment requirements for digital enhanced cordless telecommunications (DECT) (edition

2) (OJ L 215, 7.8.1997, p. 48).

4zc.{1416} 397 D 0524: Commission Decision 97/524/EC of 9 July 1997 on a common technical regulation for the

telephony application requirements for digital enhanced cordless telecommunications (DECT) (edition 2) (OJ

L 215, 7.8.1997, p. 50), as corrected by OJ L 160, 4.6.1998, p. 47.

4zd.{1417} 397 D 0525: Commission Decision 97/525/EC of 9 July 1997 on a common technical regulation for the

attachment requirements for terminal equipment for digital enhanced cordless telecommunications (DECT)

generic access profile (GAP) applications (OJ L 215, 7.8.1997, p. 52), as corrected by OJ L 160, 4.6.1998, p.

47.

4ze. [ ] {1418}

4zf. [ ] {1419}

4zg. [ ] {1420}

4zga.{1421}32000 D 0637: Commission Decision 2000/637/EC of 22 September 2000 on the application of Article

3(3)(e) of Directive 1999/5/EC to radio equipment covered by the regional arrangement concerning the

radiotelephone service on inland waterways (OJ L 269, 21.10.2000, p. 50).

4zh.{1422} 397 D 0751: Commission Decision 97/751/EC of 31 October 1997 on a common technical regulation for the

attachment requirements for the terminal equipment interface for connection to 140 Mbit/s digital unstructured

and structured leased lines (OJ L 305, 8.11.1997, p. 66).

4zi.{1423} 398 D 0515: Commission Decision 98/515/EC of 17 June 1998 on a common technical Regulation for the

pan-European integrated services digital (ISDN) basic access (Amendment 1) (OJ L 232, 19.8.1998, p. 7).

4zj.{1424} 398 D 0516: Commission Decision 98/516/EC of 17 June 1998 on a common technical Regulation for low

data rate land mobile satellite earth stations (LMES) operating in the 11/12/14 GHz frequency bands (OJ

L 232, 19.8.1998, p. 10).

{1414} Point inserted by Decision No 115/98 (OJ L 297, 18.11.1999, p.40 and EEA Supplement No 50, 18.11.1999, p. 1), e.i.f. 19.12.1998.

{1415} Point inserted by Decision No 116/98 (OJ L 297, 18.11.1999, p.42 and EEA Supplement No 50, 18.11.1999, p. 10), e.i.f. 19.12.1998.

{1416} Point inserted by Decision No 116/98 (OJ L 297, 18.11.1999, p.42 and EEA Supplement No 50, 18.11.1999, p. 10), e.i.f. 19.12.1998.

{1417} Point inserted by Decision No 116/98 (OJ L 297, 18.11.1999, p.42 and EEA Supplement No 50, 18.11.1999, p. 10), e.i.f. 19.12.1998.

{1418} Point inserted by Decision No 117/98 (OJ L 297, 18.11.1999, p.44 and EEA Supplement No 50, 18.11.1999, p. 18), e.i.f. 19.12.1998, and

subsequently deleted by Decision No 107/1999 (OJ L 325, 21.12.2000, p. 13 and EEA Supplement No 60, 21.12.2000, p. 215), e.i.f.

25.9.1999.

{1419} Point inserted by Decision No 117/98 (OJ L 297, 18.11.1999, p.44 and EEA Supplement No 50, 18.11.1999, p. 18), e.i.f. 19.12.1998, and

subsequently deleted by Decision No 107/1999 (OJ L 325, 21.12.2000, p. 13 and EEA Supplement No 60, 21.12.2000, p. 215), e.i.f.

25.9.1999.

{1420} Point inserted by Decision No 32/1999 (OJ L 266, 19.10.2000, p.16 and EEA Supplement No 46, 19.10.2000, p. 51), e.i.f. 27.3.1999. Text

replaced by Decision No 48/2000 (OJ L 237, 21.9.2000, p.58 and EEA Supplement No 42, 21.9.2000, p. 1), e.i.f. 1.6.2000. Text of point 4zg

(Directive 1999/5/EC of the European Parliament and of the Council) deleted with effect from 13 June 2016 by Decision No 89/2016 (OJ L

300, 16.11.2017, p. 37 and EEA Supplement No 73, 16.11.2017, p. 41), e.i.f. 1.1.2017.

{1421} Point inserted by Decision No 89/2016 (OJ L 300, 16.11.2017, p. 37 and EEA Supplement No 73, 16.11.2017, p. 41), e.i.f. 1.1.2017.

{1422} Point inserted by Decision No 65/1999 (OJ L 284, 9.11.2000, p. 49 and EEA Supplement No 51, 9.11.2000, p. 17), e.i.f. 29.5.1999.

{1423} Point inserted by Decision No 107/1999 (OJ L 325, 21.12.2000, p. 13 and EEA Supplement No 60, 21.12.2000, p. 215), e.i.f. 25.9.1999.

{1424} Point inserted by Decision No 108/1999 (OJ L 325, 21.12.2000, p. 15 and EEA Supplement No 60, 21.12.2000, p. 229), e.i.f. 25.9.1999.

Page 134: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 260

4zk.{1425} 398 D 0517: Commission Decision 98/517/EC of 17 June 1998 on a common technical Regulation for satellite

news gathering transportable earth stations (SNG TES) operating in the 11-12/13-14 GHz frequency bands (OJ

L 232, 19.8.1998, p. 12).

4zl.{1426} 398 D 0518: Commission Decision 98/518/EC of 17 June 1998 on a common technical Regulation for ISDN

packet mode using ISDN primary rate access (OJ L 232, 19.8.1998, p. 14).

4zm.{1427} 398 D 0519: Commission Decision 98/519/EC of 17 June 1998 on a common technical Regulation for very

small aperture terminals (VSATs) operating in the 11/12/14 GHz frequency bands (OJ L 232, 19.8.1998, p.

17).

4zn.{1428} 398 D 0520: Commission Decision 98/520/EC of 17 June 1998 on a common technical Regulation for the

pan-European integrated services digital network (ISDN) primary rate access (Amendment 1) (OJ L 232,

19.8.1998, p. 19).

4zo.{1429} 398 D 0521: Commission Decision 98/521/EC of 17 June 1998 on a common technical Regulation for ISDN

packet mode using ISDN basic access (OJ L 232, 19.8.1998, p. 22).

4zp.{1430} 398 D 0522: Commission Decision 98/522/EC of 17 June 1998 on a common technical Regulation for public

land-based enhanced radio message system (ERMES) receiver requirements (second edition) (OJ L 232,

19.8.1998, p. 25).

4zq.{1431} 398 D 0533: Commission Decision 98/533/EC of 3 September 1998 on a common technical Regulation for

Satellite Personal Communications Networks (S-PCN) Mobile Earth Stations (MESs), including handheld

earth stations, for S-PCN operating in the 1,6/2,4 GHz frequency bands under the Mobile Satellite Service

(MSS) (OJ L 247, 5.9.1998, p. 11).

4zr.{1432} 398 D 0534: Commission Decision 98/534/EC of 3 September 1998 on a common technical Regulation for

Satellite Personal Communications Networks (S-PCN) Mobile Earth Stations (MESs), including handheld

earth stations, for S-PCN operating in the 2,0 GHz frequency bands under the Mobile Satellite Service (MSS)

(OJ L 247, 5.9.1998, p. 13).

4zs.{1433} 398 D 0542: Commission Decision 98/542/EC of 4 September 1998 on a common technical regulation for

telephony application requirements for public pan-European cellular digital land-based mobile

communications, phase II (edition 2) (OJ L 254, 16.9.1998, p. 28).

4zt.{1434} 398 D 0543: Commission Decision 98/543/EC of 4 September 1998 on a common technical regulation for

telephony application requirements for mobile stations intended to be used with phase II public digital cellular

telecommunications networks operating in the DCS 1800 band (edition 2) (OJ L 254, 16.9.1998, p. 32).

4zu.{1435} 398 D 0482: Council Decision 98/482/EC of 20 July 1998 on a common technical regulation for the

attachment requirements for connection to the analogue public switched telephone networks (PSTNs) of

terminal equipment (excluding terminal equipment supporting the voice telephony justified case service) in

{1425} Point inserted by Decision No 108/1999 (OJ L 325, 21.12.2000, p. 15 and EEA Supplement No 60, 21.12.2000, p. 229), e.i.f. 25.9.1999.

{1426} Point inserted by Decision No 107/1999 (OJ L 325, 21.12.2000, p. 13 and EEA Supplement No 60, 21.12.2000, p. 215), e.i.f. 25.9.1999.

{1427} Point inserted by Decision No 108/1999 (OJ L 325, 21.12.2000, p. 15 and EEA Supplement No 60, 21.12.2000, p. 229), e.i.f. 25.9.1999.

{1428} Point inserted by Decision No 107/1999 (OJ L 325, 21.12.2000, p. 13 and EEA Supplement No 60, 21.12.2000, p. 215), e.i.f. 25.9.1999.

{1429} Point inserted by Decision No 107/1999 (OJ L 325, 21.12.2000, p. 13 and EEA Supplement No 60, 21.12.2000, p. 215), e.i.f. 25.9.1999.

{1430} Point inserted by Decision No 109/1999 (OJ L 325, 21.12.2000, p. 17 and EEA Supplement No 60, 21.12.2000, p. 241), e.i.f. 25.9.1999.

{1431} Point inserted by Decision No 108/1999 (OJ L 325, 21.12.2000, p. 15 and EEA Supplement No 60, 21.12.2000, p. 229), e.i.f. 25.9.1999.

{1432} Point inserted by Decision No 108/1999 (OJ L 325, 21.12.2000, p. 15 and EEA Supplement No 60, 21.12.2000, p.229), e.i.f. 25.9.1999.

{1433} Point inserted by Decision No 110/1999 (OJ L 325, 21.12.2000, p. 19 and EEA Supplement No 60, 21.12.2000, p.245), e.i.f. 25.9.1999.

{1434} Point inserted by Decision No 110/1999 (OJ L 325, 21.12.2000, p. 19 and EEA Supplement No 60, 21.12.2000, p.245), e.i.f. 25.9.1999.

{1435} Point inserted by Decision No 111/1999 (OJ L 325, 21.12.2000, p. 21 and EEA Supplement No 60, 21.12.2000, p.255), e.i.f. 25.9.1999.

Page 135: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 261

which network addressing, if provided, is by means of dual tone multi-frequency (DTMF) signalling (OJ L

216, 4.8.1998, p. 8).

4zv.{1436} 398 D 0574: Commission Decision 98/574/EC of 16 September 1998 on a common technical regulation for

the general attachment requirements for public pan-European cellular digital land-based mobile

communications, Phase II (Edition II) (OJ L 278, 15.10.1998, p. 30).

4zw.{1437} 398 D 0575: Commission Decision 98/575/EC of 16 September 1998 on a common technical regulation for

the general attachment requirements for mobile stations intended to be used with Phase II public digital

cellular telecommunications networks operating in the GSM 1800 band (Edition 2) (OJ L 278, 15.10.1998, p.

35).

4zx.{1438} 398 D 0576: Commission Decision 98/576/EC of 16 September 1998 on a common technical regulation for

the attachment requirements for terminal equipment to connect to public switched telephone networks

(PSTNs) and incorporating an analogue handset function (OJ L 278, 15.10.1998, p. 40).

4zy.{1439} 398 D 0577: Commission Decision 98/577/EC of 16 September 1998 on a common technical regulation for

very small aperture terminals (VSATs) satellite earth stations operating in the 4 GHz and 6 GHz frequency

bands (OJ L 278, 15.10.1998, p. 43).

4zz.{1440} 398 D 0578: Commission Decision 98/578/EC of 16 September 1998 on a common technical regulation for

low data rate land mobile satellite earth stations (LMES) operating in the 1,5/1,6 GHz frequency bands (OJ L

278, 15.10.1998, p. 46).

4zza.{1441} 398 D 0734: Commission Decision 98/734/EC of 30 November 1998 on a common technical

Regulation for land mobile satellite earth stations (LMES) operating in the 1,5/1,6 GHz frequency bands (OJ L

351, 29.12.1998, p. 37).

4zzb.{1442}399 D 0303: Commission Decision 1999/303/EC of 12 April 1999 on a common technical regulation for

connection to the analogue public switched telephone networks (PSTNs) of terminal equipment supporting the

voice telephony justified case service in which network addressing, if provided, is by means of dual tone multi-

frequency (DTMF) signalling (OJ L 118, 6.5.1999, p. 55).

4zzc.{1443} 399 D 0304: Commission Decision 1999/304/EC of 12 April 1999 on a common technical regulation

for integrated services digital network (ISDN) telephony 3,1 kHz teleservice, attachment requirements for

handset terminals (edition 2) (OJ L 118, 6.5.1999, p. 60).

4zzd.{1444}399 D 0310: Commission Decision 1999/310/EC of 23 April 1999 on a common technical regulation for

digital enhanced cordless telecommunications (DECT) equipment accessing the integrated services digital

network (ISDN) (OJ L 119, 7.5.1999, p. 57).

4zze.{1445}398 D 0535: Commission Decision 98/535/EC of 3 September 1998 on a common technical Regulation for

the terrestrial flight telecommunications system (TFTS) (OJ L 251, 11.9.1998, p. 36).

4zzf.{1446}399 D 0497: Commission Decision 1999/497/EC of 7 July 1999 on a common technical Regulation for digital

enhanced cordless telecommunications (DECT) DECT/GSM dual-mode terminal equipment (OJ L 192,

24.7.1999, p. 58).

{1436} Point inserted by Decision No 112/1999 (OJ L 325, 21.12.2000, p. 23 and EEA Supplement No 60, 21.12.2000, p.260), e.i.f. 25.9.1999.

{1437} Point inserted by Decision No 112/1999 (OJ L 325, 21.12.2000, p. 23 and EEA Supplement No 60, 21.12.2000, p.260), e.i.f. 25.9.1999.

{1438} Point inserted by Decision No 112/1999 (OJ L 325, 21.12.2000, p. 23 and EEA Supplement No 60, 21.12.2000, p.260), e.i.f. 25.9.1999.

{1439} Point inserted by Decision No 112/1999 (OJ L 325, 21.12.2000, p. 23 and EEA Supplement No 60, 21.12.2000, p.260), e.i.f. 25.9.1999.

{1440} Point inserted by Decision No 112/1999 (OJ L 325, 21.12.2000, p. 23 and EEA Supplement No 60, 21.12.2000, p.260), e.i.f. 25.9.1999.

{1441} Point inserted by Decision No 164/1999 (OJ L 61, 1.3.2001, p. 15 and EEA Supplement No 11, 1.3.2001, p. 171), e.i.f. 27.11.1999.

{1442} Point inserted by Decision No 6/2000 (OJ L 103, 12.4.2001, p. 11 and EEA Supplement No 20, 12.4.2001, p. 82), e.i.f. 5.2.2000.

{1443} Point inserted by Decision No 6/2000 (OJ L 103, 12.4.2001, p. 11 and EEA Supplement No 20, 12.4.2001, p. 82), e.i.f. 5.2.2000.

{1444} Point inserted by Decision No 6/2000 (OJ L 103, 12.4.2001, p. 11 and EEA Supplement No 20, 12.4.2001, p. 82), e.i.f. 5.2.2000.

{1445} Point inserted by Decision No 29/2000 (OJ L 141, 15.6.2000, p. 51 and EEA Supplement No 27, 15.6.2000, p. 7), e.i.f. 1.4.2000.

Page 136: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 262

4zzg.{1447} 399 D 0498: Commission Decision 1999/498/EC of 7 July 1999 on a common technical regulation for digital

enhanced cordless telecommunications (DECT) equipment accessing the integrated services digital network

(ISDN) (Version 2) (OJ L 192, 24.7.1999, p. 60).

4zzh.{1448} 399 D 0645: Commission Decision 1999/645/EC of 15 September 1999 on a common technical

Regulation for the attachment requirements for TETRA access to emergency services (OJ L 255, 30.9.1999, p.

40).

4zzi.{1449} 399 D 0511: Commission Decision 1999/511/EC of 7 July 1999 on a common technical Regulation for the

attachment requirements for high speed circuit switched data (HSCSD) multislot mobile stations (OJ L 195,

28.7.1999, p. 34).

4zzj. {1450} 32000 D 0299: Commission Decision 2000/299/EC of 6 April 2000 establishing the initial classification of

radio equipment and telecommunications terminal equipment and associated identifiers (OJ L 97,

19.04.2000, p. 13).

4zzk.{1451} 32001 D 0148: Commission Decision 2001/148/EC of 21 February 2001 on the application of Article 3(3)(e)

of Directive 1999/5/EC to avalanche beacons (OJ L 55, 24.2.2001, p. 65).

4zzl.{1452} [ ] {1453}

4zzm. [ ] {1454}

4zzn.{1455} 32005 D 0053: Commission Decision 2005/53/EC of 25 January 2005 on the application of Article 3(3)(e)

of Directive 1999/5/EC of the European Parliament and of the Council to radio equipment intended to

participate in the Automatic Identification System (AIS) (OJ L 22, 26.1.2005, p. 14).

4zzo.{1456} 32005 D 0631: Commission Decision 2005/631/EC of 29 August 2005 concerning essential requirements as

referred to in Directive 1999/5/EC of the European Parliament and of the Council ensuring access of Cospas-

Sarsat locator beacons to emergency services (OJ L 225, 31.8.2005, p. 28).

4zzp.{1457} 32008 L 0063: Commission Directive 2008/63/EC of 20 June 2008 on competition in the markets in

telecommunications terminal equipment (Codified version) (OJ L 162, 21.6.2008, p. 20) (1).

(1) Listed here for purposes of information only. For application, see Annex XIV on competition.

4zzq.{1458} 32013 D 0638: Commission Decision 2013/638/EU of 12 August 2013 on essential requirements relating to

marine radio communication equipment which is intended to be used on non-SOLAS vessels and to

participate in the Global Maritime Distress and Safety System (GMDSS) (OJ L 296, 7.11.2013, p. 22).

4zzr.{1459} 32014 L 0053: Directive 2014/53/EU of the European Parliament and of the Council of 16 April 2014 on the

harmonisation of the laws of the Member States relating to the making available on the market of radio

equipment and repealing Directive 1999/5/EC (OJ L 153, 22.5.2014, p. 62).

{1446} Point inserted by Decision No 29/2000 (OJ L 141, 15.6.2000, p. 51 and EEA Supplement No 27, 15.6.2000, p. 7), e.i.f. 1.4.2000.

{1447} Point inserted by Decision No 29/2000 (OJ L 141, 15.6.2000, p. 51 and EEA Supplement No 27, 15.6.2000, p. 7), e.i.f. 1.4.2000.

{1448} Point inserted by Decision No 42/2000 (OJ L 141, 15.6.2000, p. 51 and EEA Supplement No 27, 15.6.2000, p. 7), e.i.f. 20.5.2000.

{1449} Point inserted by Decision No 58/2000 (OJ L 237, 21.9.2000, p. 74 and EEA Supplement No 42, 21.9.2000, p. 14), e.i.f. 29.6.2000.

{1450} Point inserted by Decision No 114/2001 (OJ L 322, 6.12.2001, p. 26 and EEA Supplement No 60, 6.12.2001, p.24), e.i.f. 29.9.2001.

{1451} Point inserted by Decision No 127/2002 (OJ L 336, 12.12.2002, p. 27 and EEA Supplement No 61, 12.12.2002, p. 21), e.i.f. 28.9.2002.

{1452} Point inserted by Decision No 24/2004 (OJ L 127, 29.4.2004, p. 130 and EEA Supplement No 22, 29.4.2004, p. 11), e.i.f. 20.3.2004.

{1453} Text of point 4zzl (Commission Decision 2003/213/EC) deleted with effect from 26 July 2005 by Decision No 101/2005 (OJ L 306,

24.11.2005, p. 32 and EEA Supplement No 60, 24.11.2005, p. 20), e.i.f. 9.7.2005.

{1454} Point inserted by Decision No 100/2004 (OJ L 376, 23.12.2004, p. 25 and EEA Supplement No 65, 23.12.2004, p. 18), e.i.f. 10.7.2004. Text

of point 4zzm (Commission Decision 2004/71/EC) subsequently deleted by Decision No 222/2014 (OJ L 230, 3.9.2015, p. 24 and EEA

Supplement No 52, 3.9.2015, p. 24), e.i.f. 1.11.2014.

{1455} Point inserted by Decision No 100/2005 (OJ L 306, 24.11.2005, p. 30 and EEA Supplement No 60, 24.11.2005, p. 19), e.i.f. 9.7.2005.

{1456} Point inserted by Decision No 57/2006 (OJ L 245, 7.9.2006, p. 3 and EEA Supplement No 44, 7.9.2006, p. 3), e.i.f. 3.6.2006.

{1457} Point inserted by Decision No 130/2010 (OJ L 85, 31.3.2011, p. 14 and EEA Supplement No 17, 31.3.2011, p. 4), e.i.f. 11.12.2010.

{1458} Point inserted by Decision No 222/2014 (OJ L 230, 3.9.2015, p. 24 and EEA Supplement No 52, 3.9.2015, p. 24), e.i.f. 1.11.2014.

{1459} Point inserted by Decision No 89/2016 (OJ L 300, 16.11.2017, p. 37 and EEA Supplement No 73, 16.11.2017, p. 41), e.i.f. 1.1.2017.

Page 137: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 263

4zzs.{1460} 32017 R 1354: Commission Implementing Regulation (EU) 2017/1354 of 20 July 2017 specifying how to

present the information provided for in Article 10(10) of Directive 2014/53/EU of the European Parliament

and of the Council (OJ L 190, 21.7.2017, p. 7).

The provisions of the Regulation shall, for the purpose of this Agreement, be read with the following

adaptation:

In Annex II, the following shall be added to the abbreviations:

“Iceland (IS)

Liechtenstein (LI)

Norway (NO)”.

4zzt.{1461} 32019 R 0320: Commission Delegated Regulation (EU) 2019/320 of 12 December 2018 supplementing of

Directive 2014/53/EU of the European Parliament and of the Council with regard to the application of the

essential requirements referred to in Article 3(3)(g) of that Directive in order to ensure caller location in

emergency communications from mobile devices (OJ L 55, 25.2.2019, p. 1).

ACTS OF WHICH THE CONTRACTING PARTIES SHALL TAKE NOTE

The Contracting Parties take note of the content of the following acts:

5. 384 X 0549: Council Recommendation 84/549/EEC of 12 November 1984 concerning the implementation of

harmonization in the field of telecommunications (OJ No L 298, 16.11.1984, p. 49).

6. 389 Y 0511(01): Council Resolution 89/C 117/01 of 27 April 1989 on standardization in the field of

information technology and telecommunications (OJ No C 117, 11.5.1989, p. 1).

XIX. GENERAL PROVISIONS IN THE FIELD OF TECHNICAL BARRIERS TO TRADE

ACTS REFERRED TO

1.{1462} 32015 L 1535: Directive (EU) 2015/1535 of the European Parliament and of the Council of 9 September 2015

laying down a procedure for the provision of information in the field of technical regulations and of rules on

Information Society services (OJ L 241, 17.9.2015, p. 1).

The provisions of the Directive shall, for the purposes of this Agreement, be read with the following

adaptations:

(a) The second subparagraph of Article 1(1)(c) shall be replaced by the following:

“The term ‘technical specification’ also covers production methods and processes used in respect of

products intended for human and animal consumption, and in medicinal products as defined in

Article 1 of Directive 2001/83/EC (as incorporated into point 15 q of Chapter XIII of Annex II to

the Agreement by Decision of the EEA Joint Committee No 82/2002 of 25 June 20021463), as well

as production methods and processes relating to other products, where these have an effect on their

characteristics.”;

(b) The following shall be added to the first subparagraph of Article 5(1):

“A full text of the draft technical regulation notified shall be made available in the original language

as well as in a full translation into one of the official languages of the Union.”;

{1460} Point and adaptation inserted by Decision No 145/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 7.7.2018.

{1461} Point inserted by Decision No 158/2019 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 15.6.2019.

{1462} Text of point 1 replaced by Decision No 146/1999 (OJ L 15, 18.1.2001, p. 40 and EEA Supplement No 3, 18.1.2001, p. 196 (N) and 85 (I)),

e.i.f. 6.11.1999 and subsequently replaced point 1 (Directive 98/34/EC of the European Parliament and of the Council) replaced by

Decision No 75/2019 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f 1.12.2019.

1463 OJ L 266, 3.10.2002, p.32 and EEA Supplement No 49, 3.10.2002, p. 22.

Page 138: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 264

(c) The following subparagraph shall be added to Article 5(1):

“The Commission on behalf of the Union, on the one side, and the EFTA Surveillance Authority or

the EFTA States through the EFTA Surveillance Authority, on the other side, may ask for further

information on a draft technical regulation notified.”;

(d) The following subparagraph shall be added to Article 5(2):

“The comments of the EFTA States shall be forwarded by the EFTA Surveillance Authority to the

Commission in the form of a single coordinated communication and the comments of the Union

shall be forwarded by the Commission to the EFTA Surveillance Authority.”;

(e) The terms “Member State” and “Commission” in Article 6(1), (2) and (7) shall be replaced

respectively by the terms “EFTA State” and “EFTA Surveillance Authority”.

(f) Article 6(3), (4), (5) and (6) shall not apply.

2.{1464} 32012 R 1025: Regulation (EU) No 1025/2012 of the European Parliament and of the Council of 25 October

2012 on European standardisation, amending Council Directives 89/686/EEC and 93/15/EEC and Directives

94/9/EC, 94/25/EC, 95/16/EC, 97/23/EC, 98/34/EC, 2004/22/EC, 2007/23/EC, 2009/23/EC and 2009/105/EC

of the European Parliament and of the Council and repealing Council Decision 87/95/EEC and Decision

No 1673/2006/EC of the European Parliament and of the Council (OJ L 316, 14.11.2012, p. 12).

The provisions of the Regulation shall, for the purposes of this Agreement, be read with the following

adaptation:

In Article 2(7), the words “Article 57 TFEU” shall be replaced by “Article 37 of the EEA Agreement”.

3. [ ]{1465}

3a. [ ]{1466}

3b.{1467} 32008 R 0765: Regulation (EC) No 765/2008 of the European Parliament and of the Council of 9 July 2008

setting out the requirements for accreditation and market surveillance relating to the marketing of products and

repealing Regulation (EEC) No 339/93 (OJ L 218, 13.8.2008, p. 30).

The provisions of the Regulation shall, for the purposes of this Agreement, be read with the following

adaptations:

(a) The following shall be added at the end of Article 4(2):

"Liechtenstein shall also have recourse to the national accreditation body of Switzerland for the

product sectors covered by the Agreement between the European Community and the Swiss

Confederation on mutual recognition in relation to conformity assessment and in respect of which EU

and Swiss requirements are deemed equivalent pursuant to Article 1(2) and (3) of that Agreement".

(b) Products exported from Liechtenstein to the other Contracting Parties may be subjected to border

controls according to Articles 27-29.

3c.{1468} 393 L 0068: Council Directive 93/68/EEC of 22 July 1993 amending Directives 87/404/EEC (simple pressure

vessels), 88/378/EEC (safety of toys), 89/106/EEC (construction products), 89/336/EEC (electromagnetic

{1464} Text of point 2 (Council Decision 89/45/EEC) deleted by Decision No 7/94 (OJ L 160, 28.6.1994, p. 1 and EEA Supplement No 17,

28.6.1994, p. 1), e.i.f. 1.7.1994, with effect from 29 June 1994 and subsequently replaced by Decision No 9/2014 (OJ L 211, 17.7.2014, p. 13

and EEA Supplement No 42, 17.7.2014, p. 12), e.i.f. 1.8.2014.

{1465} Text of point 3 (Council Decision 90/683/EEC) deleted by Decision No 7/94 (OJ L 160, 28.6.1994, p. 1 and EEA Supplement No 17,

28.6.1994, p. 1), e.i.f. 1.7.1994.

{1466} Text of point 3a (Council Directive 92/59/EEC) deleted with effect from 15 January 2004 by Decision No 9/2003 (OJ L 94, 10.4.2003, p. 59

and EEA Supplement No 19, 10.4.2003, p. 12), e.i.f. 1.3.2003.

{1467} Point 3b (Council Reg. (EEC) No 339/93) inserted by Decision No 7/94 (OJ L 160, 28.6.1994, p. 1 and EEA Supplement No 17, 28.6.1994,

p. 1), e.i.f. 1.7.1994, and subsequently replaced by Decision No 126/2012 (OJ L 309, 8.11.2012, p. 4 and EEA Supplement No 63, 8.11.2012,

p. 5), e.i.f. 1.4.2013.

{1468} Point inserted by Decision No 7/94 (OJ L 160, 28.6.1994, p. 1 and EEA Supplement No 17, 28.6.1994, p. 1), e.i.f. 1.7.1994.

Page 139: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 265

compatibility), 89/392/EEC (machinery), 89/686/EEC (personal protective equipment), 90/384/EEC (non-

automatic weighing instruments), 90/385/EEC (active implantable medicinal devices), 90/396/EEC

(appliances burning gaseous fuels), 91/263/EEC (telecommunications terminal equipment), 92/42/EEC (new

hot-water boilers fired with liquid or gaseous fuels) and 73/23/EEC (electrical equipment designed for use

within certain voltage limits) (OJ No L 220, 30.8.1993, p. 1).

3d.{1469} 32008 D 0768: Decision No 768/2008/EC of the European Parliament and of the Council of 9 July 2008 on a

common framework for the marketing of products, and repealing Council Decision 93/465/EEC (OJ L 218,

13.8.2008, p. 82).

3e.{1470} 394 L 0011: Directive 94/11/EC of the European Parliament and the Council of 23 March 1994 on the

approximation of the laws, regulation and administrative provisions of the Member States relating to labelling

of the materials used in the main components of footwear for sale to the consumer (OJ No L 100, 19.4.1994,

p. 37), as amended by:

-{1471} 1 03 T: Act concerning the conditions of accession of the Czech Republic, the Republic of Estonia,

the Republic of Cyprus, the Republic of Latvia, the Republic of Lithuania, the Republic of Hungary,

the Republic of Malta, the Republic of Poland, the Republic of Slovenia and the Slovak Republic

and the adjustments to the Treaties on which the European Union is founded adopted on 16 April

2003 (OJ L 236, 23.9.2003, p. 33),

-{1472} 32006 L 0096: Council Directive 2006/96/EC of 20 November 2006 (OJ L 363, 20.12.2006, p. 81),

-{1473} 32013 L 0015: Council Directive 2013/15/EU of 13 May 2013 (OJ L 158, 10.6.2013, p. 172).

The provisions of the Directive shall, for the purposes of the present Agreement, be read with the following

adaptations:

(a) In Annex I, point 1(a) the following shall be added to the list of written indications concerning

"upper":

IS Efri hluti

N Overdel

[ ]{1474}

(b) In Annex I, point 1(b) the following shall be added to the list of written indications concerning

"lining and sock":

IS Fóður og bindsóli

N Fôr og bindsåle

[ ]{1475}

(c) in Annex I, point 1(c) the following shall be added to the list of written indications concerning

"outer sole":

IS Slitsóli

N Yttersåle

{1469} Point 3d (Council Decision No 93/465/EEC) inserted by Decision No 7/94 (OJ L 160, 28.6.1994, p. 1 and EEA Supplement No 17,

28.6.1994, p. 1), e.i.f. 1.7.1994, and subsequently replaced by Decision No 126/2012 (OJ L 309, 8.11.2012, p. 4 and EEA Supplement No 63,

8.11.2012, p. 5), e.i.f. 1.4.2013.

{1470} Point inserted by Decision No 16/94 (OJ L 325, 17.12.1994, p. 67 and EEA Supplement No 50, 17.12.1994, p. 42), e.i.f. 1.3.1995.

{1471} Indent and words “, as amended by:” above, added by the 2004 EEA Enlargement Agreement (OJ L 130, 29.4.2004, p. 3 and EEA

Supplement No 23, 29.4.2004, p. 1), e.i.f. 1.5.2004.

{1472} Indent added by Decision No 132/2007 (OJ L 100, 10.4.2008, p. 1 and EEA Supplement No 19, 10.4.2008, p.1), e.i.f. 9.11.2011.

{1473} Indent added by Decision No 159/2014 (OJ L 15, 22.1.2015, p. 87 and EEA Supplement No 5, 22.1.2015, p. 10), e.i.f. pending; it shall apply

from 9.7.2014.

{1474} Words in Finnish and Swedish deleted by Decision 43/2005 (OJ L 198, 28.7.2005, p.45 and EEA Supplement No 38, 28.7.2005, p.26), e.i.f.

12.3.2005.

{1475} Words in Finnish and Swedish deleted by Decision 43/2005 (OJ L 198, 28.7.2005, p.45 and EEA Supplement No 38, 28.7.2005, p.26), e.i.f.

12.3.2005.

Page 140: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 266

[ ]{1476}

(d) In Annex I, point 2(a)(i) the following shall be added to the list of written indications concerning

"leather":

IS Leður

N Lær

[ ]{1477}

(e) In Annex I, point 2(a)(ii) the following shall be added to the list of written indications concerning

"coated leather":

IS Húðað leður

N Belagt lær

[ ]{1478}

(f) In Annex I, point 2(b) the following shall be added to the list of written indications concerning

natural textile materials and synthetic or non-woven textile materials:

IS Textílefni

N Tekstilmaterialer

[ ]{1479}

(g) In Annex I, point 2(c) the following shall be added to the list of written indications concerning "all

other materials":

IS Öll önnur efni

N Andre materialer

[ ]{1480}".

3f.{1481} 32008 R 0764: Regulation (EC) No 764/2008 of the European Parliament and of the Council of 9 July 2008

laying down procedures relating to the application of certain national technical rules to products lawfully

marketed in another Member State and repealing Decision No 3052/95/EC (OJ L 218, 13.8.2008, p. 21).

The provisions of the Regulation shall, for the purposes of this Agreement, be read with the following

adaptations:

The Regulation shall only apply to products covered by Article 8(3) of the Agreement.

The Regulation shall not apply to Liechtenstein in relation to products covered by Annex I, Chapters XII and

XXVII of Annex II and Protocol 47 to the Agreement, as long as the application of the Agreement between the

European Community and the Swiss Confederation on trade in agricultural products is extended to

Liechtenstein.

3g.{1482} 369 L 0493: Council Directive 69/493/EEC of 15 December 1969 on the approximation of the laws of the

Member States relating to crystal glass (OJ No L 326, 29.12.1969, p. 36), as amended by:

{1476} Words in Finnish and Swedish deleted by Decision 43/2005 (OJ L 198, 28.7.2005, p.45 and EEA Supplement No 38, 28.7.2005, p.26), e.i.f.

12.3.2005.

{1477} Words in Finnish and Swedish deleted by Decision 43/2005 (OJ L 198, 28.7.2005, p.45 and EEA Supplement No 38, 28.7.2005, p.26), e.i.f.

12.3.2005.

{1478} Words in Finnish and Swedish deleted by Decision 43/2005 (OJ L 198, 28.7.2005, p.45 and EEA Supplement No 38, 28.7.2005, p.26), e.i.f.

12.3.2005.

{1479} Words in Finnish and Swedish deleted by Decision 43/2005 (OJ L 198, 28.7.2005, p.45 and EEA Supplement No 38, 28.7.2005, p.26), e.i.f.

12.3.2005.

{1480} Words in Finnish and Swedish deleted by Decision 43/2005 (OJ L 198, 28.7.2005, p.45 and EEA Supplement No 38, 28.7.2005, p.26), e.i.f.

12.3.2005.

{1481} Point 3f (Decision No 3052/95/EC) inserted by Decision No 16/97 (OJ L 182, 10.7.1997, p. 49 and EEA Supplement No 29, 10.7.1997, p.

70), e.i.f. 1.12.1998 and subsequently replaced by Decision No 126/2012 (OJ L 309, 8.11.2012, p. 4 and EEA Supplement No 63, 8.11.2012,

p. 5), e.i.f. 1.4.2013.

{1482} Point inserted by Decision No 95/97 (OJ L 193, 9.7.1998, p. 51 and EEA Supplement No 27, 9.7.1998, p. 75), e.i.f. 10.12.1997.

Page 141: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 267

-{1483} 1 03 T: Act concerning the conditions of accession of the Czech Republic, the Republic of Estonia,

the Republic of Cyprus, the Republic of Latvia, the Republic of Lithuania, the Republic of Hungary,

the Republic of Malta, the Republic of Poland, the Republic of Slovenia and the Slovak Republic

and the adjustments to the Treaties on which the European Union is founded adopted on 16 April

2003 (OJ L 236, 23.9.2003, p. 33),

-{1484} 1 94 N: Act concerning the conditions of accession of the Republic of Austria, the Republic of

Finland and the Kingdom of Sweden and the adjustments of the Treaties on which the European

Union is founded (OJ C 241, 29.8.1994, p. 21 as amended by OJ L 1, 1.1.1995, p. 1),

-{1485} 32006 L 0096: Council Directive 2006/96/EC of 20 November 2006 (OJ L 363, 20.12.2006, p. 81).

3h.{1486} 32001 L 0095: Directive 2001/95/EC of the European Parliament and of the Council of 3 December 2001 on

general product safety (OJ L 11, 15.1.2002, p. 4), as amended by:

-{1487} 32008 R 0765: Regulation (EC) No 765/2008 of the European Parliament and of the Council of 9

July 2008 (OJ L 218, 13.8.2008, p. 30).

3i.{1488} 32005 D 0323: Commission Decision 2005/323/EC of 21 April 2005 on the safety requirements to be met by

the European standards for floating leisure articles for use on or in the water pursuant to Directive 2001/95/EC

of the European Parliament and of the Council (OJ L 104, 23.4.2005, p. 39).

3j.{1489} 32005 D 0718: Commission Decision 2005/718/EC of 13 October 2005 on compliance of certain standards

with the general safety requirement of Directive 2001/95/EC of the European Parliament and of the Council

and the publication of their references in the Official Journal (OJ L 271, 15.10.2005, p. 51).

3k.{1490} 32006 D 0502: Commission Decision 2006/502/EC of 11 May 2006 requiring Member States to take

measures to ensure that only lighters which are child-resistant are placed on the market and to prohibit the

placing on the market of novelty lighters (OJ L 198, 20.7.2006, p. 41), as amended by:

-{1491} 32007 D 0231: Commission Decision 2007/231/EC of 12 April 2007 (OJ L 99, 14.4.2007, p. 16),

-{1492} 32008 D 0322: Commission Decision 2008/322/EC of 18 April 2008 (OJ L 109, 19.4.2008, p. 40),

-{1493} 32009 D 0298: Commission Decision 2009/298/EC of 26 March 2009 (OJ L 81, 27.3.2009, p. 23),

-{1494} 32010 D 0157: Commission Decision 2010/157/EU of 12 March 2010 (OJ L 67, 17.3.2010, p. 9),

{1483} Indent and words “, as amended by:” above, added by the 2004 EEA Enlargement Agreement (OJ L 130, 29.4.2004, p. 3 and EEA

Supplement No 23, 29.4.2004, p. 1), e.i.f. 1.5.2004.

{1484} Indent added by Decision No 43/2005 (OJ L 198, 28.7.2005, p.45 and EEA Supplement No 38, 28.7.2005, p.26), e.i.f. 12.03.2005.

{1485} Indent added by Decision No 132/2007 (OJ L 100, 10.4.2008, p. 1 and EEA Supplement No 19, 10.4.2008, p.1), e.i.f. 9.11.2011.

{1486} Point inserted by Decision No 9/2003 (OJ L 94, 10.4.2003, p. 59 and EEA Supplement No 19, 10.4.2003, p. 12), e.i.f. 1.3.2004.

{1487} Indent and words “, as amended by:” added by Decision No 126/2012 (OJ L 309, 8.11.2012, p. 4 and EEA Supplement No 63, 8.11.2012, p.

5), e.i.f. 1.4.2013.

{1488} Point inserted by Decision No 7/2006 (OJ L 92, 30.3.2006, p. 28 and EEA Supplement No 17, 30.3.2006, p. 8), e.i.f. 28.1.2006.

{1489} Point inserted by Decision No 83/2006 (OJ L 289, 19.10.2006, p. 15 and EEA Supplement No 52, 19.10.2006, p. 13), e.i.f. 8.7.2006.

{1490} Point inserted by Decision No 19/2007 (OJ L 209, 9.8.2007, p. 34 and EEA Supplement No 38, 9.8.2007, p. 24), e.i.f. 28.4.2007.

{1491} Indent and words “, as amended by:” added by Decision No 117/2010 (OJ L 58, 3.3.2011, p. 74 and EEA Supplement No 12, 3.3.2011,

p. 14), e.i.f. 11.11.2010.

{1492} Indent and words “, as amended by:” added by Decision No 117/2010 (OJ L 58, 3.3.2011, p. 74 and EEA Supplement No 12, 3.3.2011,

p. 14), e.i.f. 11.11.2010.

{1493} Indent and words “, as amended by:” added by Decision No 117/2010 (OJ L 58, 3.3.2011, p. 74 and EEA Supplement No 12, 3.3.2011,

p. 14), e.i.f. 11.11.2010.

{1494} Indent and words “, as amended by:” added by Decision No 117/2010 (OJ L 58, 3.3.2011, p. 74 and EEA Supplement No 12, 3.3.2011,

p. 14), e.i.f. 11.11.2010.

Page 142: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 268

-{1495} 32012 D 0053: Commission Implementing Decision 2012/53/EU of 27 January 2012 (OJ L 27,

31.1.2012, p. 24),

-{1496} 32014 D 0061: Commission Implementing Decision 2014/61/EU of 5 February 2014 (OJ L 38,

7.2.2014, p. 43),

-{1497} 32015 D 0249: Commission Implementing Decision (EU) 2015/249 of 10 February 2015 (OJ L 41,

17.2.2015, p. 41),

-{1498} 32016 D 0575: Commission Implementing Decision (EU) 2016/575 of 29 March 2016 (OJ L 98,

14.4.2016, p. 4).

3l. {1499} 32008 D 0264: Commission Decision 2008/264/EC of 25 March 2008 on the fire safety requirements to be

met by European standards for cigarettes pursuant to Directive 2001/95/EC of the European Parliament and of

the Council (OJ L 83, 26.3.2008, p. 35).

3m. {1500} 32008 D 0357: Commission Decision 2008/357/EC of 23 April 2008 on specific child safety requirements to

be met by European standards for lighters pursuant to Directive 2001/95/EC of the European Parliament and

of the Council (OJ L 120, 7.5.2008, p. 11).

3n.{1501} 32009 D 0251: Commission Decision 2009/251/EC of 17 March 2009 requiring Member States to ensure that

products containing the biocide dimethylfumarate are not placed or made available on the market (OJ L 74,

20.3.2009, p. 32), as amended by:

- 32010 D 0153: Commission Decision 2010/153/EU of 11 March 2010 (OJ L 63, 12.3.2010, p. 21),

-{1502} 32012 D 0048: Commission Implementing Decision 2012/48/EU of 26 January 2012 (OJ L 26,

28.1.2012, p. 35).

3o. {1503} 32010 D 0011: Commission Decision 2010/11/EU of 7 January 2010 on the safety requirements to be met by

European standards for consumer-mounted childproof locking devices for windows and balcony doors

pursuant to Directive 2001/95/EC of the European Parliament and of the Council (OJ L 4, 8.1.2010, p. 91).

3p.{1504} 32010 D 0376: Commission Decision 2010/376/EU of 2 July 2010 on the safety requirements to be met by

European standards for certain products in the sleep environment of children pursuant to Directive

2001/95/EC of the European Parliament and of the Council (OJ L 170, 6.7.2010, p. 39).

3q.{1505} 32009 L 0043: Directive 2009/43/EC of the European Parliament and of the Council of 6 May 2009

simplifying terms and conditions of transfers of defence-related products within the Community (OJ L 146,

10.6.2009, p. 1), as amended by:

- 32010 L 0080: Commission Directive 2010/80/EU of 22 November 2010 (OJ L 308, 24.11.2010,

p. 11),

- 32012 L 0010: Commission Directive 2012/10/EU of 22 March 2012 (OJ L 85, 24.3.2012, p. 3),

{1495} Indent added by Decision No 37/2013 (OJ L 231, 29.8.2013, p. 11 and EEA Supplement No 49, 29.8.2013, p. 13), e.i.f. 16.3.2013.

{1496} Indent added by Decision No 275/2014 (OJ L 311, 26.11.2015, p. 28 and EEA Supplement No 71, 26.11.2015, p. 27), e.i.f. 13.12.2014.

{1497} Indent added by Decision No 97/2015 (OJ L 211, 4.8.2016, p. 37 and EEA Supplement No 42, 4.8.2016, p. 36), e.i.f. 1.5.2015.

{1498} Indent added by Decision No 210/2016 (OJ L 89, 5.4.2018, p. 13 and EEA Supplement No 22, 5.4.2018, p. 5), e.i.f. 29.10.2016.

{1499} Point inserted by Decision No 138/2009 (OJ L 62, 11.3.2010, p. 31 and EEA Supplement No 12, 11.3.2010, p. 30), e.i.f. 5.12.2009.

{1500} Point inserted by Decision No 138/2009 (OJ L 62, 11.3.2010, p. 31 and EEA Supplement No 12, 11.3.2010, p. 30), e.i.f. 5.12.2009.

{1501} Point and indent inserted by Decision No 118/2010 (OJ L 58, 3.3.2011, p. 75 and EEA Supplement No 12, 3.3.2011, p. 16), e.i.f. 11.11.2010.

{1502} Indent added by Decision No 196/2012 (OJ L 21, 24.1.2013, p. 44 and EEA Supplement No 6, 24.1.2013, p. 10), e.i.f. 1.11.2012.

{1503} Point inserted by Decision No 196/2012 (OJ L 21, 24.1.2013, p. 44 and EEA Supplement No 6, 24.1.2013, p. 10), e.i.f. 1.11.2012.

{1504} Point inserted by Decision No 196/2012 (OJ L 21, 24.1.2013, p. 44 and EEA Supplement No 6, 24.1.2013, p. 10), e.i.f. 1.11.2012.

{1505} Point, two indents and adaptation text inserted by Decision No 111/2013 (OJ L 318, 28.11.2013, p. 12 and EEA Supplement No 67,

28.11.2013, p. 14), e.i.f. 15.6.2013.

Page 143: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 269

-{1506} 32012 L 0047: Commission Directive 2012/47/EU of 14 December 2012 (OJ L 31, 31.1.2013,

p. 43),

-{1507} 32014 L 0018: Commission Directive 2014/18/EU of 29 January 2014 (OJ L 40, 11.2.2014, p. 20),

-{1508} 32014 L 0108: Commission Directive 2014/108/EU of 12 December 2014 (OJ L 359, 16.12.2014,

p. 117),

-{1509} 32016 L 0970: Commission Directive (EU) 2016/970 of 27 May 2016 (OJ L 163, 21.6.2016, p. 1),

-{1510} 32017 L 0433: Commission Directive (EU) 2017/433 of 7 March 2017 (OJ L 70, 15.3.2017, p. 1),

-{1511} 32017 L 2054: Commission Directive (EU) 2017/2054 of 8 November 2017 amending Directive

2009/43/EC of the European Parliament and of the Council (OJ L 311, 25.11.2017, p. 1),

-{1512} 32019 L 0514: Commission Directive (EU) 2019/514 of 14 March 2019 (OJ L 89, 29.3.2019, p. 1).

This Directive shall not apply to Liechtenstein.

The provisions of the Directive shall, for the purposes of the present Agreement, be read with the following

adaptation:

Article 11 shall not apply.

3r.{1513} 32011 D 0477: Commission Decision 2011/477/EU of 27 July 2011 on the safety requirements to be met by

European standards to address certain risks posed to children by internal blinds, corded window coverings and

safety devices pursuant to Directive 2001/95/EC of the European Parliament and of the Council (OJ L 196,

28.7.2011, p. 21).

3s.{1514} 32013 D 0121: Commission Decision 2013/121/EU of 7 March 2013 on the safety requirements to be met by

European standards for certain seats for children pursuant to Directive 2001/95/EC of the European Parliament

and of the Council on general product safety (OJ L 65, 8.3.2013, p. 23).

3t.{1515} 32015 D 0547: Commission Decision (EU) 2015/547 of 1 April 2015 on the safety requirements to be met by

European standards for alcohol-powered flueless fireplaces pursuant to Directive 2001/95/EC of the European

Parliament and of the Council on general product safety (OJ L 90, 2.4.2015, p. 14).

ACTS OF WHICH THE CONTRACTING PARTIES SHALL TAKE NOTE

The Contracting Parties take note of the content of the following acts:

4. C/136/85/p. 2: Conclusions on standardization, approved by the Council on 16 July 1984 (OJ No C 136,

4.6.1985, p. 2).

5. 385 Y 0604(01):Council Resolution 85/C 136/01 of 7 May 1985 on a new approach to technical

harmonization and standards (OJ No C 136, 4.6.1985, p. 1).

{1506} Indent added by Decision No 167/2013 (OJ L 58, 27.2.2014, p. 21 and EEA Supplement No 13, 27.2.2014, p. 23), e.i.f. 9.10.2013.

{1507} Indent added by Decision No 185/2014 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 26.9.2014.

{1508} Indent added by Decision No 184/2015 (OJ L 8, 12.1.2017, p. 14 and EEA Supplement No 3, 12.1.2017, p. 13), e.i.f. 11.7.2015.

{1509} Indent added by Decision No 239/2016 (OJ L 215, 23.8.2018, p. 38 and EEA Supplement No 56, 23.8.2018, p. 45), e.i.f. 3.12.2016.

{1510} Indent added by Decision No 137/2017 (OJ L 128, 16.5.2019, p. 33 and EEA Supplement No 40, 16.5.2019, p. 33), e.i.f. 8.7.2017 and

subsequently corrected before publication by Corrigendum of 27.10.2017.

{1511} Indent added by Decision No 146/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 7.7.2018.

{1512} Indent added by Decision No 159/2019 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 15.6.2019.

{1513} Point inserted by Decision No 112/2013 (OJ L 318, 28.11.2013, p. 14 and EEA Supplement No 67, 28.11.2013, p. 16), e.i.f. 15.6.2013.

{1514} Point inserted by Decision No 84/2014 (OJ L 310, 30.10.2014, p. 37 and EEA Supplement No 63, 30.10.2014, p. 28), e.i.f. 17.5.2014.

{1515} Point inserted by Decision No 185/2015 (OJ L 8, 12.1.2017, p. 15 and EEA Supplement No 3, 12.1.2017, p. 14), e.i.f. 11.7.2015.

Page 144: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 270

6. 386 Y 1001(01): Commission communication concerning the non-respect of certain provisions of Council

Directive 83/189/EEC of 28 March laying down a procedure for the provision of information in the field of

technical standards and regulations (OJ No C 245, 1.10.1986, p. 4).

7. C/67/89/p. 3: Commission Communication concerning the publication in the Official Journal of the European

Communities of the titles of draft technical regulations notified by the Member States pursuant to Council

Directive 83/189/EEC, as amended by Council Directive 88/182/EEC (OJ No C 67, 17.3.1989, p. 3).

8. 390 Y 0116(01): Council Resolution of 21 December 1989 on a global approach to conformity assessment (OJ

No C 10, 16.1.90, p. 1).

9. 590 DC 0456:Commission Green Paper on the development of European Standardization: action for faster

technological integration in Europe (OJ No C 20, 28.1.1991, p. 1).

10.{1516} 392 Y 0709(01): Council Resolution of 18 June 1992 on the role of European standardization in the European

economy (OJ No C 173, 9.7.1992, p. 1).

11.{1517} 392 X 0579: Commission Recommendation 92/579/EEC of 27 November 1992 calling upon Member States to

set up the infrastructures needed to identify dangerous products at the external frontiers (OJ No L 374,

22.12.1992, p. 66).

12.{1518} C/179/94/p.1: Council Resolution of 16 June 1994 on the development of administrative cooperation in the

implementation and enforcement of Community legislation in the internal market (OJ No C 179, 1.7.1994,

p.1).

13.{1519} 96/C 224/02: Council Resolution of 8 July 1996 on cooperation between administrations for the enforcement

of legislation on the internal market (OJ C 224, 1.8.1996, p. 3).

14.{1520} 96/C 224/03: Council Resolution of 8 July 1996 on legislative and administrative simplification in the field of

the internal market (OJ C 224, 1.8.1996, p. 5).

15.{1521} 32011 H 0024: Commission Recommendation 2011/24/EU of 11 January 2011 on the certification of defence

undertakings under Article 9 of Directive 2009/43/EC of the European Parliament and of the Council

simplifying terms and conditions of transfers of defence-related products within the Community (OJ L 11,

15.1.2011, p. 62).

16. {1522} 32016 H 2123: Commission Recommendation (EU) 2016/2123 of 30 November 2016 on the harmonisation of

the scope of and conditions for general transfer licences for armed forces and contracting authorities as

referred to in point (a) of Article 5(2) of Directive 2009/43/EC of the European Parliament and of the Council

(OJ L 329, 3.12.2016, p. 101).

17. 32016 H 2124: Commission Recommendation (EU) 2016/2124 of 30 November 2016 on the harmonisation of

the scope of and conditions for general transfer licences for certified recipients as referred to in Article 9 of

Directive 2009/43/EC of the European Parliament and of the Council (OJ L 329, 3.12.2016, p. 105).

{1516} Point inserted by Decision No 7/94 (OJ L 160, 28.6.1994, p. 1 and EEA Supplement No 17, 28.6.1994, p. 1), e.i.f. 1.7.1994.

{1517} Point inserted by Decision No 7/94 (OJ L 160, 28.6.1994, p. 1 and EEA Supplement No 17, 28.6.1994, p. 1), e.i.f. 1.7.1994.

{1518} Point inserted by Decision No 41/94 (OJ L 372, 31.12.1994, p. 16 and EEA Supplement No 57, 31.12.1994, p. 133), e.i.f. 1.2.1995.

{1519} Point inserted by Decision No 64/98 (OJ L 100, 15.4.1999, p. 52 and EEA Supplement No 16, 15.4.1999, p. 113), e.i.f. 15.7.1998 and

subsequently corrected by Corrigendum noted in the EEA Joint Committee Meeting on 4.10.2013.

{1520} Point inserted by Decision No 64/98 (OJ L 100, 15.4.1999, p. 52 and EEA Supplement No 16, 15.4.1999, p. 113), e.i.f. 15.7.1998 and

subsequently corrected by Corrigendum noted in the EEA Joint Committee Meeting on 4.10.2013.

{1521} Point inserted by Decision No 111/2013 (OJ L 318, 28.11.2013, p. 12 and EEA Supplement No 67, 28.11.2013, p. 14), e.i.f. 15.6.2013.

{1522} Point inserted by Decision No 58/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 24.3.2018.

Page 145: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 271

XX. FREE MOVEMENT OF GOODS – GENERAL

ACTS REFERRED TO{1523}

1. 398 R 2679: Council Regulation (EC) No 2679/98 of 7 December 1998 on the functioning of the internal

market in relation to the free movement of goods among the Member States (OJ L 337, 12.12.1998, p. 8).

ACTS OF WHICH THE CONTRACTING PARTIES SHALL TAKE NOTE

The Contracting Parties take note of the content of the following acts:

2.{1524} 380 Y 1003(01): Communication from the Commission concerning the consequences of the judgment given

by the Court of Justice of the European Communities on 20 February 1979 in Case 120/78 ("Cassis de Dijon")

(OJ No C 256, 3.10.80, p. 2).

3.{1525} 585 PC 0310: Commission Communication on the completion of the Internal Market COM (85) 310 Final

("White Paper").

4.{1526} 32000 Y 0519(2): Council Resolution 2000/C 141/02 of 28 October 1999 on mutual recognition (OJ C 141,

19.5.2000, p. 5).

5.{1527} [ ]

6.{1528} 498 X 1212(01): Resolution of the Council and the representatives of the governments of the Member States,

meeting within the Council of 7 December 1998 on the free movement of goods (OJ L 337, 12.12.1998, p.10).

7.{1529} 32009 H 0524: Commission Recommendation 2009/524/EC of 29 June 2009 on measures to improve the

functioning of the single market (OJ L 176, 7.7.2009, p. 17).

XXI. CONSTRUCTION PRODUCTS

ACTS REFERRED TO

1. {1530} 32011 R 0305: Regulation (EU) No 305/2011 of the European Parliament and of the Council of 9 March 2011

laying down harmonised conditions for the marketing of construction products and repealing Council

Directive 89/106/EEC (OJ L 88, 4.4.2011, p. 5), as amended by:

{1523} Heading and point inserted by Decision No 71/2004 (OJ L 349, 25.11.2004, p. 26 and EEA Supplement No 59, 25.11.2004, p. 4), e.i.f.

1.7.2005.

{1524} Point renumbered by Decision No 71/2004 (OJ L349, 25.11.2004, p. 26 and EEA Supplement No 59, 25.11.2004, p. 4), e.i.f. 1.7.2005.

{1525} Point renumbered by Decision No 71/2004 (OJ L 349, 25.11.2004, p. 26 and EEA Supplement No 59, 25.11.2004, p. 4), e.i.f. 1.7.2005.

{1526} Point inserted by Decision No 15/2002 (OJ L 110, 25.4.2002, p. 9 and EEA Supplement No 21, 25.4.2002, p.7), e.i.f. 2.3.2002, and

subsequently renumbered by Decision No 71/2004 (OJ L 349, 25.11.2004, p. 26 and EEA Supplement No 59, 25.11.2004, p. 4), e.i.f.

1.7.2005.

{1527} Point inserted by Decision No 102/2002 (OJ L 298, 31.10.2002, p. 17 and EEA Supplement No 54, 31.10.2002, p. 14), e.i.f. 13.7.2002, and

subsequently renumbered by Decision No 71/2004 (OJ L 349, 25.11.2004, p. 26 and EEA Supplement No 59, 25.11.2004, p. 4), e.i.f.

1.7.2005. Text of point 5 (Commission Recommendation 2001/893/EC) deleted by Decision No 241/2016 (OJ L 215, 23.8.2018, p. 40 and

EEA Supplement No 56, 23.8.2018, p. 48), e.i.f. 3.12.2016.

{1528} Point inserted by Decision No 71/2004 (OJ L 349, 25.11.2004, p. 26 and EEA Supplement No 59, 25.11.2004, p. 4), e.i.f. 1.7.2005.

{1529} Point inserted by Decision No 49/2010 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 1.5.2010.

{1530} Text of Point 1 (Council Directive 89/106/EEC) replaced by Decision No 113/2013 (OJ L 318, 28.11.2013, p. 15 and EEA Supplement No

67, 28.11.2013, p. 17), e.i.f. 28.5.2014.

Page 146: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 272

-{1531} 32014 R 0574: Commission Delegated Regulation (EU) No 574/2014 of 21 February 2014 (OJ L

159, 28.5.2014, p. 41).

-{1532} 32014 R 0568: Commission Delegated Regulation (EU) No 568/2014 of 18 February 2014 (OJ L

157, 27.5.2014, p. 76).

1a.{1533} 31995 D 0467: Commission Decision 95/467/EC of 24 October 1995 implementing Article 20 (2) of Council

Directive 89/106/EEC on construction products (OJ L 268, 10.11.1995, p. 29), as amended by:

- 32001 D 0596: Commission Decision 2001/596/EC of 8 January 2001 (OJ L 209, 2.8.2001, p. 33),

- 32010 D 0679: Commission Decision 2010/679/EU of 8 November 2010 (OJ L 292, 10.11.2010, p.

55).

1b.{1534} 31996 D 0577: Commission Decision 96/577/EC of 24 June 1996 on the procedure for attesting the

conformity of construction products pursuant to Article 20 (2) of Council Directive 89/106/EEC as regards

fixed fire-fighting systems (OJ L 254, 8.10.1996, p. 44).

1c.{1535} 31996 D 0578: Commission Decision 96/578/EC of 24 June 1996 on the procedure for attesting the

conformity of construction products pursuant to Article 20 (2) of Council Directive 89/106/EEC as regards

sanitary appliances (OJ L 254, 8.10.1996, p.49), as amended by:

- 32001 D 0596: Commission Decision 2001/596/EC of 8 January 2001 (OJ L 209, 2.8.2001, p. 33).

1d.{1536} 31996 D 0579: Commission Decision 96/579/EC of 24 June 1996 on the procedure for attesting the

conformity of construction products pursuant to Article 20 (2) of Council Directive 89/106/EEC as regards

circulation fixtures (OJ L 254, 8.10.1996, p. 52), as amended by:

- 31999 D 0453: Commission Decision 1999/453/EC of 18 June 1999 (OJ L 178, 14.7.1999, p. 50).

1e.{1537} 31996 D 0580: Commission Decision 96/580/EC of 24 June 1996 on the procedure for attesting the

conformity of construction products pursuant to Article 20 (2) of Council Directive 89/106/EEC as regards

curtain walling (OJ L 254, 8.10.1996, p. 56), as amended by:

- 32001 D 0596: Commission Decision 2001/596/EC of 8 January 2001 (OJ L 209, 2.8.2001, p. 33).

1f. [ ] {1538}

1g.{1539} 31996 D 0582: Commission Decision 96/582/EC of 24 June on the procedure for attesting the conformity of

construction products pursuant to Article 20 (2) of Council Directive 89/106/EEC as regards structural

sealant glazing systems and metal anchors for concrete (OJ L 254, 8.10.1996, p. 62).

{1531} Indent and words “, as amended by:” added by Decision No 21/2015 (OJ L 93, 7.4.2016, p. 35 and EEA Supplement No 21, 7.4.2016,

p. 30), e.i.f. 26.2.2015.

{1532} Indent added by Decision No 22/2015 (OJ L 93, 7.4.2016, p. 36 and EEA Supplement No 21, 7.4.2016, p. 31), e.i.f. 26.2.2015.

{1533} Point and indents previously incorporated under point 1 (Council Directive 89/106/EEC) and erroneously repealed by Decision No

113/2013 (OJ L 318, 28.11.2013, p. 15 and EEA Supplement No 67, 28.11.2013, p. 17), and subsequently reincoporated by Decision No

98/2015 (OJ L 211, 4.8.2016, p. 38 and EEA Supplement No 42, 4.8.2016, p. 37), e.i.f. 1.5.2015.

{1534} Point previously incorporated under point 1 (Council Directive 89/106/EEC) and erroneously repealed by Decision No 113/2013 (OJ L 318,

28.11.2013, p. 15 and EEA Supplement No 67, 28.11.2013, p. 17), and subsequently reincoporated by Decision No 98/2015 (OJ L 211,

4.8.2016, p. 38 and EEA Supplement No 42, 4.8.2016, p. 37), e.i.f. 1.5.2015.

{1535} Point and indent previously incorporated under point 1 (Council Directive 89/106/EEC) and erroneously repealed by Decision No 113/2013

(OJ L 318, 28.11.2013, p. 15 and EEA Supplement No 67, 28.11.2013, p. 17), and subsequently reincoporated by Decision No 98/2015 (OJ

L 211, 4.8.2016, p. 38 and EEA Supplement No 42, 4.8.2016, p. 37), e.i.f. 1.5.2015.

{1536} Point and indent previously incorporated under point 1 (Council Directive 89/106/EEC) and erroneously repealed by Decision No 113/2013

(OJ L 318, 28.11.2013, p. 15 and EEA Supplement No 67, 28.11.2013, p. 17), and subsequently reincoporated by Decision No 98/2015 (OJ

L 211, 4.8.2016, p. 38 and EEA Supplement No 42, 4.8.2016, p. 37), e.i.f. 1.5.2015.

{1537} Point and indent previously incorporated under point 1 (Council Directive 89/106/EEC) and erroneously repealed by Decision No 113/2013

(OJ L 318, 28.11.2013, p. 15 and EEA Supplement No 67, 28.11.2013, p. 17), and subsequently reincoporated by Decision No 98/2015 (OJ

L 211, 4.8.2016, p. 38 and EEA Supplement No 42, 4.8.2016, p. 37), e.i.f. 1.5.2015.

{1538} Point previously incorporated under point 1 (Council Directive 89/106/EEC) and erroneously repealed by Decision No 113/2013 (OJ L 318,

28.11.2013, p. 15 and EEA Supplement No 67, 28.11.2013, p. 17), and subsequently reincoporated by Decision No 98/2015 (OJ L 211,

4.8.2016, p. 38 and EEA Supplement No 42, 4.8.2016, p. 37), e.i.f. 1.5.2015. Text of point 1f (Commission Decision 96/581/EC) deleted by

Decision No 20/2016 (OJ L 189, 20.7.2017, p. 28 and EEA Supplement No 45, 20.7.2017, p. 31), e.i.f. 6.2.2016.

Page 147: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 273

1h.{1540} 31996 D 0603: Commission Decision 96/603/EC of 4 October 1996 establishing the list of products

belonging to classes A ‘No contribution to fire’ provided for in Decision 94/611/EC implementing Article 20

of Council Directive 89/106/EEC on construction products (OJ L 267, 19.10.1996, p. 23).

1i.{1541} 31997 D 0161: Commission Decision 97/161/EC of 17 February 1997 on the procedure for attesting the

conformity of construction products pursuant to Article 20 (2) of Council Directive 89/106/EEC as regards

metal anchors for use in concrete for fixing lightweight systems (OJ L 62, 4.3.1997, p. 41).

1j.{1542} 31997 D 0176: Commission Decision 97/176/EC of 17 February 1997 on the procedure for attesting the

conformity of construction products pursuant to Article 20 (2) of Council Directive 89/106/EEC as regards

structural timber products and ancillaries (OJ L 73, 14.3.1997, p. 19), as amended by:

- 32001 D 0596: Commission Decision 2001/596/EC of 8 January 2001 (OJ L 209, 2.8.2001, p. 33).

1k.{1543} 31997 D 0177: Commission Decision 97/177/EC of 17 February 1997 on the procedure for attesting the

conformity of construction products pursuant to Article 20 (2) of Council Directive 89/106/EEC as regards

metal injection anchors for use in masonry (OJ L 73, 14.3.1997, p. 24).

1l.{1544} 31997 D 0462: Commission Decision 97/462/EC of 27 June 1997 on the procedure for attesting the

conformity of construction products pursuant to Article 20 (2) of Council Directive 89/106/EEC as regards

wood-based panels (OJ L 198. 25.7.1997, p. 27), as amended by:

- 32001 D 0596: Commission Decision 2001/596/EC of 8 January 2001 (OJ L 209, 2.8.2001, p. 33).

1m.{1545} 31997 D 0463: Commission Decision 97/463/EC of 27 June 1997 on the procedure for attesting the

conformity of construction products pursuant to Article 20 (2) of Council Directive 89/106/EEC as regards

plastic anchors for use in concrete and masonry (OJ L 198, 25.7.1997, p. 31).

1n. [ ] {1546}

1o.{1547} 31997 D 0555: Commission Decision 97/555/EC of 14 July 1997 on the procedure for attesting the

conformity of construction products pursuant to Article 20 (2) of Council Directive 89/106/EEC as regards

cements, building limes and other hydraulic bines ( OJ L 229, 20.8.1997, p. 9), as amended by:

- 32010 D 0683: Commission Decision 2010/683/EU of 9 November 2010 (OJ L 293, 11.11.2010,

p. 60).

{1539} Point previously incorporated under point 1 (Council Directive 89/106/EEC) and erroneously repealed by Decision No 113/2013 (OJ L 318,

28.11.2013, p. 15 and EEA Supplement No 67, 28.11.2013, p. 17), and subsequently reincoporated by Decision No 98/2015 (OJ L 211,

4.8.2016, p. 38 and EEA Supplement No 42, 4.8.2016, p. 37), e.i.f. 1.5.2015.

{1540} Point previously incorporated under point 1 (Council Directive 89/106/EEC) and erroneously repealed by Decision No 113/2013 (OJ L 318,

28.11.2013, p. 15 and EEA Supplement No 67, 28.11.2013, p. 17), and subsequently reincoporated by Decision No 98/2015 (OJ L 211,

4.8.2016, p. 38 and EEA Supplement No 42, 4.8.2016, p. 37), e.i.f. 1.5.2015.

{1541} Point previously incorporated under point 1 (Council Directive 89/106/EEC) and erroneously repealed by Decision No 113/2013 (OJ L 318,

28.11.2013, p. 15 and EEA Supplement No 67, 28.11.2013, p. 17), and subsequently reincoporated by Decision No 98/2015 (OJ L 211,

4.8.2016, p. 38 and EEA Supplement No 42, 4.8.2016, p. 37), e.i.f. 1.5.2015.

{1542} Point and indent previously incorporated under point 1 (Council Directive 89/106/EEC) and erroneously repealed by Decision No 113/2013

(OJ L 318, 28.11.2013, p. 15 and EEA Supplement No 67, 28.11.2013, p. 17), and subsequently reincoporated by Decision No 98/2015 (OJ

L 211, 4.8.2016, p. 38 and EEA Supplement No 42, 4.8.2016, p. 37), e.i.f. 1.5.2015.

{1543} Point previously incorporated under point 1 (Council Directive 89/106/EEC) and erroneously repealed by Decision No 113/2013 (OJ L 318,

28.11.2013, p. 15 and EEA Supplement No 67, 28.11.2013, p. 17), and subsequently reincoporated by Decision No 98/2015 (OJ L 211,

4.8.2016, p. 38 and EEA Supplement No 42, 4.8.2016, p. 37), e.i.f. 1.5.2015.

{1544} Point and indent previously incorporated under point 1 (Council Directive 89/106/EEC) and erroneously repealed by Decision No 113/2013

(OJ L 318, 28.11.2013, p. 15 and EEA Supplement No 67, 28.11.2013, p. 17), and subsequently reincoporated by Decision No 98/2015 (OJ

L 211, 4.8.2016, p. 38 and EEA Supplement No 42, 4.8.2016, p. 37), e.i.f. 1.5.2015.

{1545} Point previously incorporated under point 1 (Council Directive 89/106/EEC) and erroneously repealed by Decision No 113/2013 (OJ L 318,

28.11.2013, p. 15 and EEA Supplement No 67, 28.11.2013, p. 17), and subsequently reincoporated by Decision No 98/2015 (OJ L 211,

4.8.2016, p. 38 and EEA Supplement No 42, 4.8.2016, p. 37), e.i.f. 1.5.2015.

{1546} Point previously incorporated under point 1 (Council Directive 89/106/EEC) and erroneously repealed by Decision No 113/2013 (OJ L 318,

28.11.2013, p. 15 and EEA Supplement No 67, 28.11.2013, p. 17), and subsequently reincoporated by Decision No 98/2015 (OJ L 211,

4.8.2016, p. 38 and EEA Supplement No 42, 4.8.2016, p. 37), e.i.f. 1.5.2015 and subsequently corrected before publication by Corrigendum

of 11.12.2015. Text of point 1n (Commission Decision 97/464/EC) deleted by Decision No 20/2016 (OJ L 189, 20.7.2017, p. 28 and EEA

Supplement No 45, 20.7.2017, p. 31), e.i.f. 6.2.2016.

{1547} Point and indent previously incorporated under point 1 (Council Directive 89/106/EEC) and erroneously repealed by Decision No 113/2013

(OJ L 318, 28.11.2013, p. 15 and EEA Supplement No 67, 28.11.2013, p. 17), and subsequently reincoporated by Decision No 98/2015 (OJ

L 211, 4.8.2016, p. 38 and EEA Supplement No 42, 4.8.2016, p. 37), e.i.f. 1.5.2015.

Page 148: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 274

1p.{1548} 31997 D 0556: Commission Decision 97/556/EC of 14 July 1997 on the procedure for attesting the

conformity of construction products pursuant to Article 20 (2) of Council Directive 89/106/EEC as regards

external thermal insulation composite systems/kits with rendering (ETICS) (OJ L 229, 20.8.1997, p. 14), as

amended by:

- 32001 D 0596: Commission Decision 2001/596/EC of 8 January 2001 (OJ L 209, 2.8.2001, p. 33),

- 32011 D 0014: Commission Decision 2011/14/EU of 13 January 2011 (OJ L 10, 14.1.2011, p. 5).

1q.{1549} 31997 D 0638: Commission Decision 97/638/EC of 19 September 1997 on the procedure for attesting the

conformity of construction products pursuant to Article 20 (2) of Council Directive 89/106/EEC as regards

fasteners for structural timber (OJ L 268, 1.10.1997, p. 36).

1r.{1550} 31997 D 0740: Commission Decision 97/740/EC of 14 October 1997 on the procedure for attesting the

conformity of construction products pursuant to Article 20 (2) of Council Directive 89/106/EEC as regards

masonry and related products (OJ L 299, 4.11.1997, p. 42), as amended by:

- 32001 D 0596: Commission Decision 2001/596/EC of 8 January 2001 (OJ L 209, 2.8.2001, p. 33).

1s.{1551} 31997 D 0808: Commission Decision 97/808/EC of 20 November 1997 on the procedure for attesting the

conformity of construction products pursuant to Article 20 (2) of Council Directive 89/106/EEC as regards

floorings (OJ L 331, 3.12.1997, p. 18), as amended by:

- 31999 D 0453: Commission Decision 1999/453/EC of 18 June 1999 (OJ L 178, 14.7.1999, p. 50),

- 32001 D 0596: Commission Decision 2001/596/EC of 8 January 2001 (OJ L 209, 2.8.2001, p. 33),

- 32006 D 0190: Commission Decision 2006/190/EC of 1 March 2006 (OJ L 66, 8.3.2006, p. 47).

1t.{1552} 31998 D 0143: Commission Decision 98/143/EC of 3 February 1998 on the procedure for attesting the

conformity of construction products pursuant to Article 20(2) of Council Directive 89/106/EEC as regards

systems of mechanically fastened flexible roof waterproofing membranes (OJ L 42, 14.2.1998, p. 58).

1u.{1553} 31998 D 0213: Commission Decision 98/213/EC of 9 March 1998 on the procedure for attesting the

conformity of construction products pursuant to Article 20(2) of Council Directive 89/106/EEC as regards

internal partition kits (OJ L 80, 18.3.1998, p. 41), as amended by:

- 32001 D 0596: Commission Decision 2001/596/EC of 8 January 2001 (OJ L 209, 2.8.2001, p. 33),

- 32012 D 0201: Commission Implementing Decision 2012/201/EU of 26 March 2012 (OJ L 109,

21.4.2012, p. 20).

1v.{1554} 31998 D 0214: Commission Decision 98/214/EC of 9 March 1998 on the procedure for attesting the

conformity of construction products pursuant to Article 20(2) of Council Directive 89/106/EEC as regards

structural metallic products and ancillaries (OJ L 80, 18.3.1998, p. 46), as amended by:

{1548} Point and indents previously incorporated under point 1 (Council Directive 89/106/EEC) and erroneously repealed by Decision No

113/2013 (OJ L 318, 28.11.2013, p. 15 and EEA Supplement No 67, 28.11.2013, p. 17), and subsequently reincoporated by Decision No

98/2015 (OJ L 211, 4.8.2016, p. 38 and EEA Supplement No 42, 4.8.2016, p. 37), e.i.f. 1.5.2015.

{1549} Point previously incorporated under point 1 (Council Directive 89/106/EEC) and erroneously repealed by Decision No 113/2013 (OJ L 318,

28.11.2013, p. 15 and EEA Supplement No 67, 28.11.2013, p. 17), and subsequently reincoporated by Decision No 98/2015 (OJ L 211,

4.8.2016, p. 38 and EEA Supplement No 42, 4.8.2016, p. 37), e.i.f. 1.5.2015.

{1550} Point and indent previously incorporated under point 1 (Council Directive 89/106/EEC) and erroneously repealed by Decision No 113/2013

(OJ L 318, 28.11.2013, p. 15 and EEA Supplement No 67, 28.11.2013, p. 17), and subsequently reincoporated by Decision No 98/2015 (OJ

L 211, 4.8.2016, p. 38 and EEA Supplement No 42, 4.8.2016, p. 37), e.i.f. 1.5.2015.

{1551} Point and indents previously incorporated under point 1 (Council Directive 89/106/EEC) and erroneously repealed by Decision No

113/2013 (OJ L 318, 28.11.2013, p. 15 and EEA Supplement No 67, 28.11.2013, p. 17), and subsequently reincoporated by Decision No

98/2015 (OJ L 211, 4.8.2016, p. 38 and EEA Supplement No 42, 4.8.2016, p. 37), e.i.f. 1.5.2015.

{1552} Point previously incorporated under point 1 (Council Directive 89/106/EEC) and erroneously repealed by Decision No 113/2013 (OJ L 318,

28.11.2013, p. 15 and EEA Supplement No 67, 28.11.2013, p. 17), and subsequently reincoporated by Decision No 98/2015 (OJ L 211,

4.8.2016, p. 38 and EEA Supplement No 42, 4.8.2016, p. 37), e.i.f. 1.5.2015.

{1553} Point and indents previously incorporated under point 1 (Council Directive 89/106/EEC) and erroneously repealed by Decision No

113/2013 (OJ L 318, 28.11.2013, p. 15 and EEA Supplement No 67, 28.11.2013, p. 17), and subsequently reincoporated by Decision No

98/2015 (OJ L 211, 4.8.2016, p. 38 and EEA Supplement No 42, 4.8.2016, p. 37), e.i.f. 1.5.2015.

{1554} Point and indent previously incorporated under point 1 (Council Directive 89/106/EEC) and erroneously repealed by Decision No 113/2013

(OJ L 318, 28.11.2013, p. 15 and EEA Supplement No 67, 28.11.2013, p. 17), and subsequently reincoporated by Decision No 98/2015 (OJ

L 211, 4.8.2016, p. 38 and EEA Supplement No 42, 4.8.2016, p. 37), e.i.f. 1.5.2015.

Page 149: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 275

- 32001 D 0596: Commission Decision 2001/596/EC of 8 January 2001 (OJ L 209, 2.8.2001, p. 33).

1w.{1555} 31998 D 0279: Commission Decision 98/279/EC of 5 December 1997 on the procedure for attesting the

conformity of construction products pursuant to Article 20(2) of Council Directive 89/106/EEC as regards

non load-bearing permanent shuttering kits/systems based on hollow blocks or panels of insulating materials

and, sometimes, concrete (OJ L 127, 29.4.1998, p. 26), as amended by:

- 32001 D 0596: Commission Decision 2001/596/EC of 8 January 2001 (OJ L 209, 2.8.2001, p. 33).

1x.{1556} 31998 D 0436: Commission Decision 98/436/EC of 22 June 1998 on the procedure for attesting the

conformity of construction products pursuant to Article 20(2) of Council Directive 89/106/EEC as regards

roof coverings, rooflights, roof windows and ancillary products (OJ L 194, 10.7.1998, p. 30), as amended by:

- 32001 D 0596: Commission Decision 2001/596/EC of 8 January 2001 (OJ L 209, 2.8.2001, p. 33).

1y.{1557} 31998 D 0437: Commission Decision 98/437/EC of 30 June 1998 on the procedure for attesting the

conformity of construction products pursuant to Article 20(2) of Council Directive 89/106/EEC as regards

internal and external wall and ceiling finishes (OJ L 194, 10.7.1998, p. 39), as amended by:

- 32001 D 0596: Commission Decision 2001/596/EC of 8 January 2001 (OJ L 209, 2.8.2001, p. 33).

1z.{1558} 31998 D 0456: Commission Decision 98/456/EC of 3 July 1998 on the procedure for attesting the

conformity of construction products pursuant to Article 20(2) of Council Directive 89/106/EEC as regards

post-tensioning kits for the prestressing of structures (OJ L 201, 17.7.1998, p. 112).

1za.{1559} 31998 D 0457: Commission Decision 98/457/EC of 3 July 1998 concerning the test of the Single Burning

Item (SBI) referred to in Decision 94/611/EC implementing Article 20 of Council Directive 89/106/EEC on

construction products (OJ L 201, 17.7.1998, p. 114).

1zb.{1560} 31998 D 0598: Commission Decision 98/598/EC of 9 October 1998 on the procedure for attesting the

conformity of construction products pursuant to Article 20(2) of Council Directive 89/106/EEC as regards

aggregates (OJ L 287, 24.10.1998, p. 25).

1zc.{1561} 31998 D 0599: Commission Decision 98/599/EC of 12 October 1998 on the procedure for attesting the

conformity of construction products pursuant to Article 20(2) of Council Directive 89/106/EEC as regards

liquid applied roof waterproofing kits (OJ L 287, 24.10.1998, p. 30), as amended by:

- 32001 D 0596: Commission Decision 2001/596/EC of 8 January 2001 (OJ L 209, 2.8.2001, p. 33).

1zd.{1562} 31998 D 0600: Commission Decision 98/600/EC of 12 October 1998 on the procedure for attesting the

conformity of construction products pursuant to Article 20(2) of Council Directive 89/106/EEC as regards

self-supporting translucent roof kits (except glass-based kits) (OJ L 287, 24.10.1998, p. 35), as amended by:

{1555} Point and indent previously incorporated under point 1 (Council Directive 89/106/EEC) and erroneously repealed by Decision No 113/2013

(OJ L 318, 28.11.2013, p. 15 and EEA Supplement No 67, 28.11.2013, p. 17), and subsequently reincoporated by Decision No 98/2015 (OJ

L 211, 4.8.2016, p. 38 and EEA Supplement No 42, 4.8.2016, p. 37), e.i.f. 1.5.2015.

{1556} Point and indent previously incorporated under point 1 (Council Directive 89/106/EEC) and erroneously repealed by Decision No 113/2013

(OJ L 318, 28.11.2013, p. 15 and EEA Supplement No 67, 28.11.2013, p. 17), and subsequently reincoporated by Decision No 98/2015 (OJ

L 211, 4.8.2016, p. 38 and EEA Supplement No 42, 4.8.2016, p. 37), e.i.f. 1.5.2015.

{1557} Point and indent previously incorporated under point 1 (Council Directive 89/106/EEC) and erroneously repealed by Decision No 113/2013

(OJ L 318, 28.11.2013, p. 15 and EEA Supplement No 67, 28.11.2013, p. 17), and subsequently reincoporated by Decision No 98/2015 (OJ

L 211, 4.8.2016, p. 38 and EEA Supplement No 42, 4.8.2016, p. 37), e.i.f. 1.5.2015.

{1558} Point previously incorporated under point 1 (Council Directive 89/106/EEC) and erroneously repealed by Decision No 113/2013 (OJ L 318,

28.11.2013, p. 15 and EEA Supplement No 67, 28.11.2013, p. 17), and subsequently reincoporated by Decision No 98/2015 (OJ L 211,

4.8.2016, p. 38 and EEA Supplement No 42, 4.8.2016, p. 37), e.i.f. 1.5.2015.

{1559} Point previously incorporated under point 1 (Council Directive 89/106/EEC) and erroneously repealed by Decision No 113/2013 (OJ L 318,

28.11.2013, p. 15 and EEA Supplement No 67, 28.11.2013, p. 17), and subsequently reincoporated by Decision No 98/2015 (OJ L 211,

4.8.2016, p. 38 and EEA Supplement No 42, 4.8.2016, p. 37), e.i.f. 1.5.2015.

{1560} Point previously incorporated under point 1 (Council Directive 89/106/EEC) and erroneously repealed by Decision No 113/2013 (OJ L 318,

28.11.2013, p. 15 and EEA Supplement No 67, 28.11.2013, p. 17), and subsequently reincoporated by Decision No 98/2015 (OJ L 211,

4.8.2016, p. 38 and EEA Supplement No 42, 4.8.2016, p. 37), e.i.f. 1.5.2015.

{1561} Point and indent previously incorporated under point 1 (Council Directive 89/106/EEC) and erroneously repealed by Decision No 113/2013

(OJ L 318, 28.11.2013, p. 15 and EEA Supplement No 67, 28.11.2013, p. 17), and subsequently reincoporated by Decision No 98/2015 (OJ

L 211, 4.8.2016, p. 38 and EEA Supplement No 42, 4.8.2016, p. 37), e.i.f. 1.5.2015.

{1562} Point and indent previously incorporated under point 1 (Council Directive 89/106/EEC) and erroneously repealed by Decision No 113/2013

(OJ L 318, 28.11.2013, p. 15 and EEA Supplement No 67, 28.11.2013, p. 17), and subsequently reincoporated by Decision No 98/2015 (OJ

L 211, 4.8.2016, p. 38 and EEA Supplement No 42, 4.8.2016, p. 37), e.i.f. 1.5.2015 and subsequently corrected before publication by

Corrigendum of 11.12.2015.

Page 150: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 276

- 32001 D 0596: Commission Decision 2001/596/EC of 8 January 2001 (OJ L 209, 2.8.2001, p. 33).

1ze.{1563} 31998 D 0601: Commission Decision 98/601/EC of 13 October 1998 on the procedure for attesting the

conformity of construction products pursuant to Article 20(2) of Council Directive 89/106/EEC as regards

road construction products (OJ L 287, 24.10.1998, p. 41), as amended by:

- 32001 D 0596: Commission Decision 2001/596/EC of 8 January 2001 (OJ L 209, 2.8.2001, p. 33).

1zf.{1564} 31999 D 0089: Commission Decision 1999/89/EC of 25 January 1999 on the procedure for attesting the

conformity of construction products pursuant to Article 20(2) of Council Directive 89/106/EEC as regards

prefabricated stair kits (OJ L 29, 3.2.1999, p. 34), as amended by:

- 32001 D 0596: Commission Decision 2001/596/EC of 8 January 2001 (OJ L 209, 2.8.2001, p. 33).

1zg.{1565} 31999 D 0090: Commission Decision 1999/90/EC of 25 January 1999 on the procedure for attesting the

conformity of construction products pursuant to Article 20(2) of Council Directive 89/106/EEC as regards

membranes (OJ L 29, 3.2.1999, p. 38), as amended by:

- 32001 D 0596: Commission Decision 2001/596/EC of 8 January 2001 (OJ L 209, 2.8.2001, p. 33).

1zh.{1566} 31999 D 0091: Commission Decision 1999/91/EC of 25 January 1999 on the procedure for attesting the

conformity of construction products pursuant to Article 20(2) of Council Directive 89/106/EEC as regards

thermal insulating products (OJ L 29, 3.2.1999, p. 44), as amended by:

- 32001 D 0596: Commission Decision 2001/596/EC of 8 January 2001 (OJ L 209, 2.8.2001, p. 33).

1zi.{1567} 31999 D 0092: Commission Decision 1999/92/EC of 25 January 1999 on the procedure for attesting the

conformity of construction products pursuant to Article 20(2) of Council Directive 89/106/EEC as regards

light composite wood-based beams and columns (OJ L 29, 3.2.1999, p. 49).

1zj.{1568} 31999 D 0093: Commission Decision 1999/93/EC of 25 January 1999 on the procedure for attesting the

conformity of construction products pursuant to Article 20(2) of Council Directive 89/106/EEC as regards

doors, windows, shutters, blinds, gates and related building hardware (OJ L 29, 3.2.1999, p. 51), as amended

by:

- 32011 D 0246: Commission Decision 2011/246/EU of 18 April 2011 (OJ L 103, 19.4.2011, p. 114).

1zk.{1569} 31999 D 0094: Commission Decision 1999/94/EC of 25 January 1999 on the procedure for attesting the

conformity of construction products pursuant to Article 20(2) of Council Directive 89/106/EEC as regards

precast normal/lightweight/autoclaved aerated concrete products (OJ L 29, 3.2.1999, p. 55), as amended by:

- 32012 D 0202: Commission Implementing Decision 2012/202/EU of 29 March 2012 (OJ L 109,

21.4.2012, p. 22).

{1563} Point and indent previously incorporated under point 1 (Council Directive 89/106/EEC) and erroneously repealed by Decision No 113/2013

(OJ L 318, 28.11.2013, p. 15 and EEA Supplement No 67, 28.11.2013, p. 17), and subsequently reincoporated by Decision No 98/2015 (OJ

L 211, 4.8.2016, p. 38 and EEA Supplement No 42, 4.8.2016, p. 37), e.i.f. 1.5.2015.

{1564} Point and indent previously incorporated under point 1 (Council Directive 89/106/EEC) and erroneously repealed by Decision No 113/2013

(OJ L 318, 28.11.2013, p. 15 and EEA Supplement No 67, 28.11.2013, p. 17), and subsequently reincoporated by Decision No 98/2015 (OJ

L 211, 4.8.2016, p. 38 and EEA Supplement No 42, 4.8.2016, p. 37), e.i.f. 1.5.2015.

{1565} Point and indent previously incorporated under point 1 (Council Directive 89/106/EEC) and erroneously repealed by Decision No 113/2013

(OJ L 318, 28.11.2013, p. 15 and EEA Supplement No 67, 28.11.2013, p. 17), and subsequently reincoporated by Decision No 98/2015 (OJ

L 211, 4.8.2016, p. 38 and EEA Supplement No 42, 4.8.2016, p. 37), e.i.f. 1.5.2015.

{1566} Point and indent previously incorporated under point 1 (Council Directive 89/106/EEC) and erroneously repealed by Decision No 113/2013

(OJ L 318, 28.11.2013, p. 15 and EEA Supplement No 67, 28.11.2013, p. 17), and subsequently reincoporated by Decision No 98/2015 (OJ

L 211, 4.8.2016, p. 38 and EEA Supplement No 42, 4.8.2016, p. 37), e.i.f. 1.5.2015.

{1567} Point previously incorporated under point 1 (Council Directive 89/106/EEC) and erroneously repealed by Decision No 113/2013 (OJ L 318,

28.11.2013, p. 15 and EEA Supplement No 67, 28.11.2013, p. 17), and subsequently reincoporated by Decision No 98/2015 (OJ L 211,

4.8.2016, p. 38 and EEA Supplement No 42, 4.8.2016, p. 37), e.i.f. 1.5.2015.

{1568} Point and indent previously incorporated under point 1 (Council Directive 89/106/EEC) and erroneously repealed by Decision No 113/2013

(OJ L 318, 28.11.2013, p. 15 and EEA Supplement No 67, 28.11.2013, p. 17), and subsequently reincoporated by Decision No 98/2015 (OJ

L 211, 4.8.2016, p. 38 and EEA Supplement No 42, 4.8.2016, p. 37), e.i.f. 1.5.2015.

{1569} Point and indent previously incorporated under point 1 (Council Directive 89/106/EEC) and erroneously repealed by Decision No 113/2013

(OJ L 318, 28.11.2013, p. 15 and EEA Supplement No 67, 28.11.2013, p. 17), and subsequently reincoporated by Decision No 98/2015 (OJ

L 211, 4.8.2016, p. 38 and EEA Supplement No 42, 4.8.2016, p. 37), e.i.f. 1.5.2015.

Page 151: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 277

1zl.{1570} 31999 D 0454: Commission Decision 1999/454/EC of 22 June 1999 on the procedure for attesting the

conformity of construction products pursuant to Article 20(2) of Council Directive 89/106/EEC as regards

fire stopping, fire sealing and fire protective products (OJ L 178, 14.7.1999, p. 52), as amended by:

- 32001 D 0596: Commission Decision 2001/596/EC of 8 January 2001 (OJ L 209, 2.8.2001, p. 33).

1zm.{1571} 31999 D 0455: Commission Decision 1999/455/EC of 22 June 1999 on the procedure for attesting the

conformity of construction products pursuant to Article 20(2) of Council Directive 89/106/EEC as regards

timber frame and log prefabricated building kits (OJ L 178, 14.7.1999, p. 56).

1zn.{1572} 31999 D 0469: Commission Decision 1999/469/EC of 25 June 1999 on the procedure for attesting the

conformity of construction products pursuant to Article 20(2) of Council Directive 89/106/EEC as regards

products related to concrete, mortar and grout (OJ L 184, 17.7.1999, p. 27), as amended by:

- 32001 D 0596: Commission Decision 2001/596/EC of 8 January 2001 (OJ L 209, 2.8.2001, p. 33).

1zo.{1573} 31999 D 0470: Commission Decision 1999/470/EC of 29 June 1999 on the procedure for attesting the

conformity of construction products pursuant to Article 20(2) of Council Directive 89/106/EEC as regards

construction adhesives (OJ L 184, 17.7.1999, p. 32), as amended by:

- 32001 D 0596: Commission Decision 2001/596/EC of 8 January 2001 (OJ L 209, 2.8.2001, p. 33).

1zp.{1574} 31999 D 0471: Commission Decision 1999/471/EC of 29 June 1999 on the procedure for attesting the

conformity of construction products pursuant to Article 20(2) of Council Directive 89/106/EEC as regards

space heating appliances (OJ L 184, 17.7.1999, p. 37), as amended by:

- 32001 D 0596: Commission Decision 2001/596/EC of 8 January 2001 (OJ L 209, 2.8.2001, p. 33).

1zq.{1575} 31999 D 0472: Commission Decision 1999/472/EC of 1 July 1999 on the procedure for attesting the

conformity of construction products pursuant to Article 20(2) of Council Directive 89/106/EEC as regards

pipes, tanks and ancillaries not in contact with water intended for human consumption (OJ L 184, 17.7.1999,

p. 42), as amended by:

- 32001 D 0596: Commission Decision 2001/596/EC of 8 January 2001 (OJ L 209, 2.8.2001, p. 33).

1zr. [ ] {1576}

1zs.{1577} 32000 D 0245: Commission Decision 2000/245/EC of 2 February 2000 on the procedure for attesting the

conformity of construction products pursuant to Article 20(4) of Council Directive 89/106/EEC as regards

flat glass, profiled glass and glass block products (OJ L 77, 28.3.2000, p. 13), as amended by:

- 32001 D 0596: Commission Decision 2001/596/EC of 8 January 2001 (OJ L 209, 2.8.2001, p. 33).

{1570} Point and indent previously incorporated under point 1 (Council Directive 89/106/EEC) and erroneously repealed by Decision No 113/2013

(OJ L 318, 28.11.2013, p. 15 and EEA Supplement No 67, 28.11.2013, p. 17), and subsequently reincoporated by Decision No 98/2015 (OJ

L 211, 4.8.2016, p. 38 and EEA Supplement No 42, 4.8.2016, p. 37), e.i.f. 1.5.2015.

{1571} Point previously incorporated under point 1 (Council Directive 89/106/EEC) and erroneously repealed by Decision No 113/2013 (OJ L 318,

28.11.2013, p. 15 and EEA Supplement No 67, 28.11.2013, p. 17), and subsequently reincoporated by Decision No 98/2015 (OJ L 211,

4.8.2016, p. 38 and EEA Supplement No 42, 4.8.2016, p. 37), e.i.f. 1.5.2015.

{1572} Point and indent previously incorporated under point 1 (Council Directive 89/106/EEC) and erroneously repealed by Decision No 113/2013

(OJ L 318, 28.11.2013, p. 15 and EEA Supplement No 67, 28.11.2013, p. 17), and subsequently reincoporated by Decision No 98/2015 (OJ

L 211, 4.8.2016, p. 38 and EEA Supplement No 42, 4.8.2016, p. 37), e.i.f. 1.5.2015.

{1573} Point and indent previously incorporated under point 1 (Council Directive 89/106/EEC) and erroneously repealed by Decision No 113/2013

(OJ L 318, 28.11.2013, p. 15 and EEA Supplement No 67, 28.11.2013, p. 17), and subsequently reincoporated by Decision No 98/2015 (OJ

L 211, 4.8.2016, p. 38 and EEA Supplement No 42, 4.8.2016, p. 37), e.i.f. 1.5.2015.

{1574} Point and indent previously incorporated under point 1 (Council Directive 89/106/EEC) and erroneously repealed by Decision No 113/2013

(OJ L 318, 28.11.2013, p. 15 and EEA Supplement No 67, 28.11.2013, p. 17), and subsequently reincoporated by Decision No 98/2015 (OJ

L 211, 4.8.2016, p. 38 and EEA Supplement No 42, 4.8.2016, p. 37), e.i.f. 1.5.2015.

{1575} Point and indent previously incorporated under point 1 (Council Directive 89/106/EEC) and erroneously repealed by Decision No 113/2013

(OJ L 318, 28.11.2013, p. 15 and EEA Supplement No 67, 28.11.2013, p. 17), and subsequently reincoporated by Decision No 98/2015 (OJ

L 211, 4.8.2016, p. 38 and EEA Supplement No 42, 4.8.2016, p. 37), e.i.f. 1.5.2015.

{1576} Point and indents previously incorporated under point 1 (Council Directive 89/106/EEC) and erroneously repealed by Decision No

113/2013 (OJ L 318, 28.11.2013, p. 15 and EEA Supplement No 67, 28.11.2013, p. 17), and subsequently reincoporated by Decision No

98/2015 (OJ L 211, 4.8.2016, p. 38 and EEA Supplement No 42, 4.8.2016, p. 37), e.i.f. 1.5.2015. Text of point 1zr (Commission Decision

2000/147/EC) deleted by Decision No 120/2016 (OJ L 308, 23.11.2017, p. 23 and EEA Supplement No 76, 23.11.2017, p. 28), e.i.f. 4.6.2016.

{1577} Point and indent previously incorporated under point 1 (Council Directive 89/106/EEC) and erroneously repealed by Decision No 113/2013

(OJ L 318, 28.11.2013, p. 15 and EEA Supplement No 67, 28.11.2013, p. 17), and subsequently reincoporated by Decision No 98/2015 (OJ

L 211, 4.8.2016, p. 38 and EEA Supplement No 42, 4.8.2016, p. 37), e.i.f. 1.5.2015.

Page 152: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 278

1zt.{1578} 32000 D 0273: Commission Decision 2000/273/EC of 27 March 2000 on the procedure for attesting the

conformity of construction products pursuant to Article 20(2) of Council Directive 89/106/EEC as regards

seven products for European Technical Approvals without Guideline (OJ L 86, 7.4.2000, p. 15), as amended

by:

- 32001 D 0596: Commission Decision 2001/596/EC of 8 January 2001 (OJ L 209, 2.8.2001, p. 33).

1zu.{1579} 32000 D 0367: Commission Decision 2000/367/EC of 3 May 2000 implementing Council Directive

89/106/EEC as regards the classification of the resistance to fire performance of construction products,

construction works and parts thereof (OJ L 133, 6.6.2000, p. 26), as amended by:

- 32011 D 0232: Commission Decision 2011/232/EU of 11 April 2011 (OJ L 97, 12.4.2011, p. 49).

1zv.{1580} 32000 D 0447: Commission Decision 2000/447/EC of 13 June 2000 on the procedure for attesting the

conformity of construction products pursuant to Article 20(2) of Council Directive 89/106/EEC as regards

prefabricated wood-based load-bearing stressed skin panels and self-supporting composite lightweight panels

(OJ L 180, 19.7.2000, p. 40), as amended by:

- 32001 D 0596: Commission Decision 2001/596/EC of 8 January 2001 (OJ L 209, 2.8.2001, p. 33).

1zw.{1581} 32000 D 0553: Commission Decision 2000/553/EC of 6 September 2000 implementing Council Directive

89/106/EEC as regards the external fire performance of roof coverings (OJ L 235, 19.9.2000, p. 19).

1zx.{1582} 32000 D 0606: Commission Decision 2000/606/EC of 26 September 2000 on the procedure for attesting the

conformity of construction products pursuant to Article 20(2) of Council Directive 89/106/EEC as regards

six products for European Technical Approvals without Guideline (OJ L 258, 12.10.2000, p. 38).

1zy.{1583} 32001 D 0019: Commission Decision 2001/19/EC of 20 December 2000 on the procedure for attesting the

conformity of construction products pursuant to Article 20(2) of Council Directive 89/106/EEC as regards

expansion joints for road bridges (OJ L 5, 10.1.2001, p. 6).

1zz.{1584} 32001 D 0308: Commission Decision 2001/308/EC of 31 January 2001 on the procedure for attesting the

conformity of construction products pursuant to Article 20(2) of Council Directive 89/106/EEC as regards

vetures (OJ L 107, 18.4.2001, p. 25).

1zza.{1585} 32001 D 0671: Commission Decision 2001/671/EC of 21 August 2001 implementing Council Directive

89/106/EEC as regards the classification of the external fire performance of roofs and roof coverings (OJ L

235, 4.9.2001, p. 20), as amended by:

- 32005 D 0823: Commission Decision 2005/823/EC of 22 November 2005 (OJ L 307, 25.11.2005, p.

53).

{1578} Point and indent previously incorporated under point 1 (Council Directive 89/106/EEC) and erroneously repealed by Decision No 113/2013

(OJ L 318, 28.11.2013, p. 15 and EEA Supplement No 67, 28.11.2013, p. 17), and subsequently reincoporated by Decision No 98/2015 (OJ

L 211, 4.8.2016, p. 38 and EEA Supplement No 42, 4.8.2016, p. 37), e.i.f. 1.5.2015.

{1579} Point and indent previously incorporated under point 1 (Council Directive 89/106/EEC) and erroneously repealed by Decision No 113/2013

(OJ L 318, 28.11.2013, p. 15 and EEA Supplement No 67, 28.11.2013, p. 17), and subsequently reincoporated by Decision No 98/2015 (OJ

L 211, 4.8.2016, p. 38 and EEA Supplement No 42, 4.8.2016, p. 37), e.i.f. 1.5.2015.

{1580} Point and indent previously incorporated under point 1 (Council Directive 89/106/EEC) and erroneously repealed by Decision No 113/2013

(OJ L 318, 28.11.2013, p. 15 and EEA Supplement No 67, 28.11.2013, p. 17), and subsequently reincoporated by Decision No 98/2015 (OJ

L 211, 4.8.2016, p. 38 and EEA Supplement No 42, 4.8.2016, p. 37), e.i.f. 1.5.2015.

{1581} Point previously incorporated under point 1 (Council Directive 89/106/EEC) and erroneously repealed by Decision No 113/2013 (OJ L 318,

28.11.2013, p. 15 and EEA Supplement No 67, 28.11.2013, p. 17), and subsequently reincoporated by Decision No 98/2015 (OJ L 211,

4.8.2016, p. 38 and EEA Supplement No 42, 4.8.2016, p. 37), e.i.f. 1.5.2015.

{1582} Point previously incorporated under point 1 (Council Directive 89/106/EEC) and erroneously repealed by Decision No 113/2013 (OJ L 318,

28.11.2013, p. 15 and EEA Supplement No 67, 28.11.2013, p. 17), and subsequently reincoporated by Decision No 98/2015 (OJ L 211,

4.8.2016, p. 38 and EEA Supplement No 42, 4.8.2016, p. 37), e.i.f. 1.5.2015.

{1583} Point previously incorporated under point 1 (Council Directive 89/106/EEC) and erroneously repealed by Decision No 113/2013 (OJ L 318,

28.11.2013, p. 15 and EEA Supplement No 67, 28.11.2013, p. 17), and subsequently reincoporated by Decision No 98/2015 (OJ L 211,

4.8.2016, p. 38 and EEA Supplement No 42, 4.8.2016, p. 37), e.i.f. 1.5.2015.

{1584} Point previously incorporated under point 1 (Council Directive 89/106/EEC) and erroneously repealed by Decision No 113/2013 (OJ L 318,

28.11.2013, p. 15 and EEA Supplement No 67, 28.11.2013, p. 17), and subsequently reincoporated by Decision No 98/2015 (OJ L 211,

4.8.2016, p. 38 and EEA Supplement No 42, 4.8.2016, p. 37), e.i.f. 1.5.2015.

{1585} Point and indent previously incorporated under point 1 (Council Directive 89/106/EEC) and erroneously repealed by Decision No 113/2013

(OJ L 318, 28.11.2013, p. 15 and EEA Supplement No 67, 28.11.2013, p. 17), and subsequently reincoporated by Decision No 98/2015 (OJ

L 211, 4.8.2016, p. 38 and EEA Supplement No 42, 4.8.2016, p. 37), e.i.f. 1.5.2015.

Page 153: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 279

1zzb.{1586} 32002 D 0359: Commission Decision 2002/359/EC of 13 May 2002 on the procedure for attesting the

conformity of construction products in contact with water intended for human consumption, pursuant to

Article 20(2) of Council Directive 89/106/EEC (OJ L 127, 14.5.2002, p. 16).

1zzc.{1587} 32003 D 0639: Commission Decision 2003/639/EC of 4 September 2003 on the procedure for attesting the

conformity of construction products pursuant to Article 20(2) of Council Directive 89/106/EEC as regards

pins for structural joints (OJ L 226, 10.9.2003, p. 18).

1zzd.{1588} 32003 D 0640: Commission Decision 2003/640/EC of 4 September 2003 on the procedure for attesting the

conformity of construction products pursuant to Article 20(2) of Council Directive 89/106/EEC as regards

kits for exterior wall claddings (OJ L 226, 10.9.2003, p. 21).

1zze.{1589} 32003 D 0655: Commission Decision 2003/655/EC of 12 September 2003 on the procedure for attesting the

conformity of construction products pursuant to Article 20(2) of Council Directive 89/106/EEC as regards

watertight covering kits for wetroom floors and walls (OJ L 231, 17.9.2003, p. 12).

1zzf.{1590} 32003 D 0656: Commission Decision 2003/656/EC of 12 September 2003 on the procedure for attesting the

conformity of construction products pursuant to Article 20(2) of Council Directive 89/106/EEC as regards

seven products for European technical approvals without Guideline (OJ L 231, 17.9.2003, p. 15).

1zzg.{1591} 32015 D 1936: Commission Delegated Decision (EU) 2015/1936 of 8 July 2015 on the applicable systems to

assess and verify constancy of performance of ventilation ducts and pipes for air ventilation pursuant to

Regulation (EU) No 305/2011 of the European Parliament and of the Council (OJ L 282, 28.10.2015, p. 34).

1zzh.{1592} 32015 D 1958: Commission Delegated Decision (EU) 2015/1958 of 1 July 2015 on the applicable systems to

assess and verify constancy of performance of geosynthetics and related products pursuant to Regulation

(EU) No 305/2011 of the European Parliament and of the Council (OJ L 284, 30.10.2015, p. 181).

1zzi.{1593} 32015 D 1959: Commission Delegated Decision (EU) 2015/1959 of 1 July 2015 on the applicable systems to

assess and verify constancy of performance of wastewater engineering products pursuant to Regulation (EU)

No 305/2011 of the European Parliament and of the Council (OJ L 284, 30.10.2015, p. 184).

1zzj.{1594} 32016 R 0364: Commission Delegated Regulation (EU) 2016/364 of 1 July 2015 on the classification of the

reaction to fire performance of construction products pursuant to Regulation (EU) No 305/2011 of the

European Parliament and of the Council (OJ L 68, 15.3.2016, p. 4).

1zzk. {1595} 32017 R 0959: Commission Delegated Regulation (EU) 2017/959 of 24 February 2017 on the classification

of horizontal settlement and short-term water absorption performance for in situ formed loose fill cellulose

(LFCI) thermal insulation products under EN 15101-1 pursuant to Regulation (EU) No 305/2011 of the

European Parliament and of the Council (OJ L 145, 8.6.2017, p. 1).

1zzl. {1596} 32017 R 1475: Commission Delegated Regulation (EU) 2017/1475 of 26 January 2017 on the classification

of frost resistance performance for clay tiles under EN 1304 pursuant to Regulation (EU) No 305/2011 of the

European Parliament and of the Council (OJ L 211, 17.8.2017, p. 1).

{1586} Point previously incorporated under point 1 (Council Directive 89/106/EEC) and erroneously repealed by Decision No 113/2013 (OJ L 318,

28.11.2013, p. 15 and EEA Supplement No 67, 28.11.2013, p. 17), and subsequently reincoporated by Decision No 98/2015 (OJ L 211,

4.8.2016, p. 38 and EEA Supplement No 42, 4.8.2016, p. 37), e.i.f. 1.5.2015.

{1587} Point previously incorporated under point 1 (Council Directive 89/106/EEC) and erroneously repealed by Decision No 113/2013 (OJ L 318,

28.11.2013, p. 15 and EEA Supplement No 67, 28.11.2013, p. 17), and subsequently reincoporated by Decision No 98/2015 (OJ L 211,

4.8.2016, p. 38 and EEA Supplement No 42, 4.8.2016, p. 37), e.i.f. 1.5.2015.

{1588} Point previously incorporated under point 1 (Council Directive 89/106/EEC) and erroneously repealed by Decision No 113/2013 (OJ L 318,

28.11.2013, p. 15 and EEA Supplement No 67, 28.11.2013, p. 17), and subsequently reincoporated by Decision No 98/2015 (OJ L 211,

4.8.2016, p. 38 and EEA Supplement No 42, 4.8.2016, p. 37), e.i.f. 1.5.2015.

{1589} Point previously incorporated under point 1 (Council Directive 89/106/EEC) and erroneously repealed by Decision No 113/2013 (OJ L 318,

28.11.2013, p. 15 and EEA Supplement No 67, 28.11.2013, p. 17), and subsequently reincoporated by Decision No 98/2015 (OJ L 211,

4.8.2016, p. 38 and EEA Supplement No 42, 4.8.2016, p. 37), e.i.f. 1.5.2015.

{1590} Point previously incorporated under point 1 (Council Directive 89/106/EEC) and erroneously repealed by Decision No 113/2013 (OJ L 318,

28.11.2013, p. 15 and EEA Supplement No 67, 28.11.2013, p. 17), and subsequently reincoporated by Decision No 98/2015 (OJ L 211,

4.8.2016, p. 38 and EEA Supplement No 42, 4.8.2016, p. 37), e.i.f. 1.5.2015.

{1591} Point inserted by Decision No 20/2016 (OJ L 189, 20.7.2017, p. 28 and EEA Supplement No 45, 20.7.2017, p. 31), e.i.f. 6.2.2016.

{1592} Point inserted by Decision No 20/2016 (OJ L 189, 20.7.2017, p. 28 and EEA Supplement No 45, 20.7.2017, p. 31), e.i.f. 6.2.2016.

{1593} Point inserted by Decision No 20/2016 (OJ L 189, 20.7.2017, p. 28 and EEA Supplement No 45, 20.7.2017, p. 31), e.i.f. 6.2.2016.

{1594} Point inserted by Decision No 120/2016 (OJ L 308, 23.11.2017, p. 23 and EEA Supplement No 76, 23.11.2017, p. 28), e.i.f. 4.6.2016.

{1595} Point inserted by Decision No 233/2017 (OJ L 254, 3.10.2019, p. 44 and EEA Supplement No 80, 3.10.2019, p. 46), e.i.f. 16.12.2017.

{1596} Point inserted by Decision No 234/2017 (OJ L 254, 3.10.2019, p. 45 and EEA Supplement No 80, 3.10.2019, p. 47), e.i.f. 16.12.2017.

Page 154: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 280

1zzm. {1597} 32018 D 0779: Commission Delegated Decision (EU) 2018/779 of 19 February 2018 on the applicable

systems to assess and verify constancy of performance of metal-faced sandwich panels for structural use

pursuant to Regulation (EU) No 305/2011 of the European Parliament and of the Council (OJ L 131,

29.5.2018, p. 23).

1zzn. {1598} 32018 D 0771: Commission Delegated Decision (EU) 2018/771 of 25 January 2018 on the applicable system

to assess and verify constancy of performance of anchor devices used for construction works and intended to

prevent persons from falling from a height or to arrest falls from a height pursuant to Regulation (EU) No

305/2011 of the European Parliament and of the Council (OJ L 129, 25.5.2018, p. 82).

2.{1599} 394 D 0023: Commission Decision 94/23/EC of 17 January 1994 on common procedural rules for European

technical approval (OJ L 17, 20.1.1994, p.34).

The provisions of this Decision shall, for the purposes of the present Agreement, be read with the following

adaptations:

(a) The second paragraph of chapter 3.2.2. of the Annex shall be replaced by the following:

'If consensus is achieved in the Technical Board on applications according to Article 8.2a of the

CDP, then the appropriate information is sent with the approval of the President of EOTA to the

EEA Joint Committee to obtain authority to issue ETAs. If consensus cannot be achieved in the

Technical Board it will be passed to the Executive Commission for decision, as to whether it should

be submitted to the EEA Joint Committee.'

(b) In the third paragraph of chapter 3.2.2. of the Annex the term 'Commission of the EC' shall be

replaced by the term 'EEA Joint Committee'.

(c) In the last sentence of chapter 3.2.5. of the Annex the words 'shall be referred to the Standing

Committee on Construction (the Directive, Article 9.2) via the Commission of the EC.' shall be

replaced by 'shall be referred to the EEA Joint Committee.'

2a.{1600} 397 D 0571: Commission Decision 97/571/EC of 22 July 1997 on the general format of European Technical

Approval for construction products (OJ L 236, 27.8.1997, p. 7).

2b.{1601} 32005 D 0403: Commission Decision 2005/403/EC of 25 May 2005 establishing the classes of external fire

performance of roofs and roof coverings for certain construction products as provided for by Council

Directive 89/106/EEC (OJ L 135, 28.5.2005, p. 37).

2c.{1602} 32005 D 0484: Commission Decision 2005/484/EC of 4 July 2005 on the procedure for attesting the

conformity of construction products pursuant to Article 20(2) of Council Directive 89/106/EEC as regards

cold storage building kits and cold storage building envelope kits (OJ L 173, 6.7.2005, p. 15).

2d.{1603} 32005 D 0610: Commission Decision 2005/610/EC of 9 August 2005 establishing the classes of reaction-to-

fire performance for certain construction products (OJ L 208, 11.8.2005, p. 21), as amended by:

-{1604} 32017 R 1227: Commission Delegated Regulation (EU) 2017/1227 of 20 March 2017 (OJ L 177,

8.7.2017, p. 1).

{1597} Point inserted by Decision No 189/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 22.9.2018.

{1598} Point inserted by Decision No 243/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 6.12.2018.

{1599} Point inserted by Decision No 42/94 (OJ L 372, 31.12.1994, p. 17 and EEA Supplement No 57, 31.12.1994, p. 137), e.i.f. 1.2.1995.

{1600} Point inserted by Decision No 19/1999 (OJ L 148, 22.6.2000, p. 44 and EEA Supplement No 28, 22.6.2000, p. 224), e.i.f. 27.2.1999.

{1601} Point inserted by Decision No 84/2006 (OJ L 289, 19.10.2006, p. 17 and EEA Supplement No 52, 19.10.2006, p. 14), e.i.f. 8.7.2006.

{1602} Point inserted by Decision No 84/2006 (OJ L 289, 19.10.2006, p. 17 and EEA Supplement No 52, 19.10.2006, p. 14), e.i.f. 8.7.2006.

{1603} Point inserted by Decision No 84/2006 (OJ L 289, 19.10.2006, p. 17 and EEA Supplement No 52, 19.10.2006, p. 14), e.i.f. 8.7.2006.

{1604} Indent and words “, as amended by;” added by Decision No 235/2017 (OJ L 254, 3.10.2019, p. 46 and EEA Supplement No 80, 3.10.2019,

p. 48), e.i.f. 16.12.2017.

Page 155: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 281

2e.{1605} 32003 D 0043: Commission Decision 2003/43/EC of 17 January 2003 establishing the classes of reaction-to-

fire performance for certain construction products (OJ L 13, 18.1.2003, p. 35), as corrected by OJ L 33,

8.2.2003, p. 44, as amended by:

- 32003 D 0593: Commission Decision 2003/593/EC of 7 August 2003 (OJ L 201, 8.8.2003, p. 25),

- 32006 D 0673: Commission Decision 2006/673/EC of 5 October 2006 (OJ L 276, 7.10.2006, p. 77),

- 32007 D 0348: Commission Decision 2007/348/EC of 15 May 2007 (OJ L 131, 23.5.2007, p. 21).

2f.{1606} 32006 D 0213: Commission Decision 2006/213/EC of 6 March 2006 establishing the classes of reaction-to-

fire performance for certain construction products as regards wood flooring and solid wood panelling and

cladding (OJ L 79, 16.3.2006, p. 27).

2g.{1607} 32006 D 0600: Commission Decision 2006/600/EC of 4 September 2006 establishing the classes of external

fire performance for certain construction products as regards double skin metal faced sandwich panels for

roofs (OJ L 244, 7.9.2006, p. 24).

2h.{1608} 32010 D 0081: Commission Decision 2010/81/EU of 9 February 2010 establishing the classes of reaction to-

fire performance for certain construction products as regards adhesives for ceramic tiles (OJ L 38, 11.2.2010,

p. 9).

2i.{1609} 32010 D 0082: Commission Decision 2010/82/EU of 9 February 2010 establishing the classes of reaction-to-

fire performance for certain construction products as regards decorative wallcoverings in roll and panel form

(OJ L 38, 11.2.2010, p. 11).

2j.{1610} 32010 D 0083: Commission Decision 2010/83/EU of 9 February 2010 establishing the classes of reaction-to-

fire performance for certain construction products as regards air drying jointing compounds (OJ L 38,

11.2.2010, p. 13).

2k.{1611} 32010 D 0085: Commission Decision 2010/85/EU of 9 February 2010 establishing the classes of reaction-to-

fire performance for certain construction products as regards cementitious screeds, calcium sulphate screeds

and synthetic resin floor screeds (OJ L 38, 11.2.2010, p. 17).

2l.{1612} 32010 D 0737: Commission Decision 2010/737/EU of 2 December 2010 establishing the classes of reaction-

to-fire performance for certain construction products as regards steel sheets with polyester coating and with

plastisol coating (OJ L 317, 3.12.2010, p. 39).

2m.{1613} 32010 D 0738: Commission Decision 2010/738/EU of 2 December 2010 establishing the classes of reaction-

to-fire performance for certain construction products as regards fibrous gypsum plaster casts (OJ L 317,

3.12.2010, p. 42).

2n.{1614} 32011 D 0019: Commission Decision 2011/19/EU of 14 January 2011 on the procedure for attesting the

conformity of construction products pursuant to Article 20(2) of Council Directive 89/106/EEC as regards

sealants for non-structural use in joints in buildings and pedestrian walkways (OJ L 11, 15.1.2011, p. 49).

2o.{1615} 32011 D 0284: Commission Decision 2011/284/EU of 12 May 2011 on the procedure for attesting the

conformity of construction products pursuant to Article 20(2) of Council Directive 89/106/EEC as regards

power, control and communication cables (OJ L 131, 18.5.2011, p. 22).

{1605} Point inserted by Decision No 9/2008 (OJ L 154, 12.6.2008, p. 17 and EEA Supplement No 33, 12.6.2008, p. 14), e.i.f. 2.2.2008.

{1606} Point inserted by Decision No 9/2008 (OJ L 154, 12.6.2008, p. 17 and EEA Supplement No 33, 12.6.2008, p. 14), e.i.f. 2.2.2008.

{1607} Point inserted by Decision No 9/2008 (OJ L 154, 12.6.2008, p. 17 and EEA Supplement No 33, 12.6.2008, p. 14), e.i.f. 2.2.2008.

{1608} Point inserted by Decision No 197/2012 (OJ L 21, 24.1.2013, p. 45 and EEA Supplement No 6, 24.1.2013, p. 12), e.i.f. 1.11.2012.

{1609} Point inserted by Decision No 197/2012 (OJ L 21, 24.1.2013, p. 45 and EEA Supplement No 6, 24.1.2013, p. 12), e.i.f. 1.11.2012.

{1610} Point inserted by Decision No 197/2012 (OJ L 21, 24.1.2013, p. 45 and EEA Supplement No 6, 24.1.2013, p. 12), e.i.f. 1.11.2012.

{1611} Point inserted by Decision No 197/2012 (OJ L 21, 24.1.2013, p. 45 and EEA Supplement No 6, 24.1.2013, p. 12), e.i.f. 1.11.2012.

{1612} Point inserted by Decision No 197/2012 (OJ L 21, 24.1.2013, p. 45 and EEA Supplement No 6, 24.1.2013, p. 12), e.i.f. 1.11.2012.

{1613} Point inserted by Decision No 197/2012 (OJ L 21, 24.1.2013, p. 45 and EEA Supplement No 6, 24.1.2013, p. 12), e.i.f. 1.11.2012.

{1614} Point inserted by Decision No 197/2012 (OJ L 21, 24.1.2013, p. 45 and EEA Supplement No 6, 24.1.2013, p. 12), e.i.f. 1.11.2012.

Page 156: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 282

2p.{1616} 32014 R 0157: Commission Delegated Regulation (EU) No 157/2014 of 30 October 2013 on the conditions

for making a declaration of performance on construction products available on a website (OJ L 52,

21.2.2014, p. 1).

2q.{1617} 32013 R 1062: Commission Implementing Regulation (EU) No 1062/2013 of 30 October 2013 on the format

of the European Technical Assessment for construction products (OJ L 289, 31.10.2013, p. 42).

2r.{1618} 32014 R 1291: Commission Delegated Regulation (EU) No 1291/2014 of 16 July 2014 on the conditions for

classification, without testing, of wood-based panels under EN 13986 and solid wood panelling and cladding

under EN 14915 with regard to their fire protection ability, when used for wall and ceiling covering (OJ

L 349, 5.12.2014, p. 25).

2s.{1619} 32014 R 1292: Commission Delegated Regulation (EU) No 1292/2014 of 17 July 2014 on the conditions for

classification, without testing, of certain uncoated wood floorings under EN 14342 with regard to their

reaction to fire (OJ L 349, 5.12.2014, p. 27).

2t.{1620} 32014 R 1293: Commission Delegated Regulation (EU) No 1293/2014 of 17 July 2014 on the conditions for

classification, without testing, of metal lath and beads for internal plastering covered by the harmonised

standard EN 13658-1, metal lath and beads for external rendering covered by the harmonised standard EN

13658-2 and metal beads and feature profiles covered by the harmonised standard EN 14353, with regard to

their reaction to fire (OJ L 349, 5.12.2014, p. 29).

2u.{1621} 32017 R 1227: Commission Delegated Regulation (EU) 2017/1227 of 20 March 2017 on the conditions for

classification, without testing, of glued laminated timber products covered by the harmonised standard EN

14080 and structural finger jointed solid timber products covered by the harmonised standard EN 15497 with

regard to their reaction to fire and amending Decision 2005/610/EC (OJ L 177, 8.7.2017, p. 1).

2v.{1622} 32017 R 1228: Commission Delegated Regulation (EU) 2017/1228 of 20 March 2017 on the conditions for

classification, without testing, of external renders and internal plasters based on organic binders covered by

the harmonised standard EN 15824 and rendering and plastering mortars covered by the harmonised standard

EN 998-1 with regard to their reaction to fire (OJ L 177, 8.7.2017, p. 4).

2w. {1623} 32017 R 2293: Commission Delegated Regulation (EU) 2017/2293 of 3 August 2017 on the conditions for

classification, without testing, of cross laminated timber products covered by the harmonised standard EN

16351 and laminated veneer lumber products covered by the harmonised standard EN 14374 with regard to

their reaction to fire (OJ L 329, 13.12.2017, p. 1).’

ACTS OF WHICH THE CONTRACTING PARTIES SHALL TAKE NOTE{1624}

The Contracting Parties take note of the content of the following acts:

3. C/62/94/p.1: Communication of the Commission with regard to the interpretative documents of Council

Directive 89/106/EEC (OJ C 62, 28.2.1994, p.1).

4. {1625} 32003 H 0887: Commission Recommendation 2003/887/EC of 11 December 2003 on the implementation

and use of Eurocodes for construction works and structural construction products (OJ L 332, 19.12.2003,

p. 62).

{1615} Point inserted by Decision No 197/2012 (OJ L 21, 24.1.2013, p. 45 and EEA Supplement No 6, 24.1.2013, p. 12), e.i.f. 1.11.2012.

{1616} Point inserted by Decision No 23/2015 (OJ L 93, 7.4.2016, p. 37 and EEA Supplement No 21, 7.4.2016, p. 32), e.i.f. 26.2.2015.

{1617} Point inserted by Decision No 24/2015 (OJ L 93, 7.4.2016, p. 38 and EEA Supplement No 21, 7.4.2016, p. 33), e.i.f. 26.2.2015.

{1618} Point inserted by Decision No 56/2015 (OJ L 129, 19.5.2016, p. 39 and EEA Supplement No 29, 19.5.2016, p. 40), e.i.f. 21.3.2015.

{1619} Point inserted by Decision No 56/2015 (OJ L 129, 19.5.2016, p. 39 and EEA Supplement No 29, 19.5.2016, p. 40), e.i.f. 21.3.2015.

{1620} Point inserted by Decision No 56/2015 (OJ L 129, 19.5.2016, p. 39 and EEA Supplement No 29, 19.5.2016, p. 40), e.i.f. 21.3.2015.

{1621} Point inserted by Decision No 235/2017 (OJ L 254, 3.10.2019, p. 46 and EEA Supplement No 80, 3.10.2019, p. 48), e.i.f. 16.12.2017.

{1622} Point inserted by Decision No 235/2017 (OJ L 254, 3.10.2019, p. 46 and EEA Supplement No 80, 3.10.2019, p. 48), e.i.f. 16.12.2017.

{1623} Point inserted by Decision No 59/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 24.3.2018.

{1624} Heading and point 3 inserted by Decision No 43/94 (OJ L 372, 31.12.1994, p. 19 and EEA Supplement No 57, 31.12.1994, p. 146), e.i.f.

1.2.1995.

{1625} Point inserted by Decision No 80/2005 (OJ L 268, 13.10.2005, p. 12 and EEA Supplement No 52, 13.10.2005, p. 6), e.i.f. 11.6.2005.

Page 157: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 283

XXII. PERSONAL PROTECTIVE EQUIPMENT

ACTS REFERRED TO

1. [ ]{1626}

2. {1627} 32016 R 0425: Regulation (EU) 2016/425 of the European Parliament and of the Council of 9 March 2016 on

personal protective equipment and repealing Council Directive 89/686/EEC (OJ L 81, 31.3.2016, p. 51).

ACTS OF WHICH THE CONTRACTING PARTIES SHALL TAKE NOTE{1628}

The Contracting Parties take note of the content of the following acts:

2. C/44/92/p. 13: Commission Communication in the framework of the implementation of the "New Approach"

Directives, "Personal Protective Equipment" Council Directive 89/686/EEC of 21 December 1989

(OJ No C 44, 19.2.1993, p.13).

3. C/240/92/p. 6: Commission Communication in the framework of the implementation of Council Directive

89/686/EEC in relation to personal protective equipment (OJ No C 240, 19.9.1992, p. 6).

4. C/345/93/p. 8: Commission Communication in the framework of the implementation of Council

Directive 89/686/EEC of 21 December 1989 in relation to personal protective equipment, as amended by the

Council Directives 93/68/EEC and 93/95/EEC (OJ No C 345, 23.12.1993, p. 8).

XXIII. TOYS

ACTS REFERRED TO

1. [ ] {1629}

1a.{1630} 32009 L 0048: Directive 2009/48/EC of the European Parliament and of the Council of 18 June 2009 on the

safety of toys (OJ L 170, 30.6.2009, p. 1), as amended by:

- {1631} 32012 L 0007: Commission Directive 2012/7/EU of 2 March 2012 (OJ L 64, 3.3.2012, p. 7),

{1626} Text of Act subsequently corrected by Corrigendum noted in the EEA Joint Committee Meeting on the 10.2.2012. Point 1 (Council

Directive 89/686/EEC) subsequently deleted with effect from 21 April 2018 by Decision No 19/2018 (OJ L 323, 12.12.2019, p. 37 and EEA

Supplement No 98, 12.12.2019, p. 34), e.i.f. 10.2.2018.

{1627} Point inserted by Decision No 19/2018 (OJ L 323, 12.12.2019, p. 37 and EEA Supplement No 98, 12.12.2019, p. 34), e.i.f. 10.2.2018.

{1628} Heading and points 2, 3 and 4 inserted by Decision No 7/94 (OJ L 160, 28.6.1994, p. 1 and EEA Supplement No 17, 28.6.1994, p. 1), e.i.f.

1.7.1994.

{1629} Point 1 (Council Directive 88/378/EEC) deleted with effect from 20.7.2013. by Decision No 127/2012 (OJ L 309, 8.11.2012, p. 6 and EEA

Supplement No 63, 8.11.2012, p. 7), e.i.f. 1.4.2013.

{1630} Point inserted by Decision No 127/2012 (OJ L 309, 8.11.2012, p. 6 and EEA Supplement No 63, 8.11.2012, p. 7), e.i.f. 1.4.2013.

Page 158: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 284

- {1632} 32013 R 0681: Commission Regulation (EU) No 681/2013 of 17 July 2013 (OJ L 195, 18.7.2013,

p.16).

-{1633} 32014 L 0079: Commission Directive 2014/79/EU of 20 June 2014 (OJ L 182, 21.6.2014, p. 49),

-{1634} 32014 L 0081: Commission Directive 2014/81/EU of 23 June 2014 (OJ L 183, 24.6.2014, p. 49),

-{1635} 32014 L 0084: Commission Directive 2014/84/EU of 30 June 2014 (OJ L 192, 1.7.2014, p. 49),

-{1636} 32015 L 2115: Commission Directive (EU) 2015/2115 of 23 November 2015 (OJ L 306,

24.11.2015, p. 17),

-{1637} 32015 L 2116: Commission Directive (EU) 2015/2116 of 23 November 2015 (OJ L 306,

24.11.2015, p. 20),

-{1638} 32015 L 2117: Commission Directive (EU) 2015/2117 of 23 November 2015 (OJ L 306,

24.11.2015, p. 23),

-{1639} 32017 L 0738: Council Directive (EU) 2017/738 of 27 March 2017 (OJ L 110, 27.4.2017, p. 6),

-{1640} 32017 L 0898: Commission Directive (EU) 2017/898 of 24 May 2017 (OJ L 138, 25.5.2017, p.

128),

-{1641} 32017 L 0774: Commission Directive (EU) 2017/774 of 3 May 2017 (OJ L 115, 4.5.2017, p. 47).

-{1642} 32018 L 0725: Commission Directive (EU) 2018/725 of 16 May 2018 (OJ L 122, 17.5.2018, p. 29).

ACTS OF WHICH THE CONTRACTING PARTIES SHALL TAKE NOTE{1643}

The Contracting Parties take note of the content of the following acts:

2. C/87/93/p. 3: Commission Communication pursuant to Article 9(2) of Council Directive 88/378/EEC

regarding the list of bodies approved by the Member States responsible for carrying out the

EC type-examination referred to in Articles 8(2) and 10 of that Directive (OJ No C 87, 27.3.1993, p. 3).

3. C/155/89/p. 2: Commission Communication in the framework of the implementation of Council

Directive 88/378/EEC of 3 May 1989 concerning the approximation of the laws of the Member States

referring to the safety of toys (OJ No C 155, 23.6.1989, p. 2).

4.{1644} C/237/93/p. 2: Commission Communication in the framework of the implementation of Council Directive

88/378/EEC in relation to safety of toys (OJ No C 237, 1.9.1993, p. 2).

{1631} Indent and words “, as amended by:” added by Decision No 114/2013 (OJ L 318, 28.11.2013, p. 16 and EEA Supplement No 67,

28.11.2013, p. 18), e.i.f. 1.4.2014.

{1632} Indent added by Decision No 85/2014 (OJ L 310, 30.10.2014, p. 38 and EEA Supplement No 63, 30.10.2014, p. 29), e.i.f. 17.5.2014.

{1633} Indent added by Decision No 276/2014 (OJ L 311, 26.11.2015, p. 29 and EEA Supplement No 71, 26.11.2015, p. 28), e.i.f. 13.12.2014.

{1634} Indent added by Decision No 277/2014 (OJ L 311, 26.11.2015, p. 30 and EEA Supplement No 71, 26.11.2015, p. 29), e.i.f. 13.12.2014.

{1635} Indent added by Decision No 278/2014 (OJ L 311, 26.11.2015, p. 31 and EEA Supplement No 71, 26.11.2015, p. 30), e.i.f. 13.12.2014.

{1636} Indent added by Decision No 21/2016 (OJ L 189, 20.7.2017, p. 30 and EEA Supplement No 45, 20.7.2017, p. 33), e.i.f. 6.2.2016.

{1637} Indent added by Decision No 21/2016 (OJ L 189, 20.7.2017, p. 30 and EEA Supplement No 45, 20.7.2017, p. 33), e.i.f. 6.2.2016.

{1638} Indent added by Decision No 21/2016 (OJ L 189, 20.7.2017, p. 30 and EEA Supplement No 45, 20.7.2017, p. 33), e.i.f. 6.2.2016.

{1639} Indent added by Decision No 177/2017 (OJ L 174, 27.6.2019, p. 46 and EEA Supplement No 52, 27.6.2019, p. 56), e.i.f. 23.9.2017.

{1640} Indent added by Decision No 177/2017 (OJ L 174, 27.6.2019, p. 46 and EEA Supplement No 52, 27.6.2019, p. 56), e.i.f. 23.9.2017.

{1641} Indent added by Decision No 178/2017 (OJ L 174, 27.6.2019, p. 47 and EEA Supplement No 52, 27.6.2019, p. 57), e.i.f. 23.9.2017.

{1642} Indent added by Decision No 190/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 22.9.2018.

{1643} Heading and points 2, 3 and 4 inserted by Decision No 7/94 (OJ L 160, 28.6.1994, p. 1 and EEA Supplement No 17, 28.6.1994, p. 1), e.i.f.

1.7.1994.

Page 159: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 285

XXIV. MACHINERY

ACTS REFERRED TO

1. [ ] {1645}

1a.{1646} 397 L 0068: Directive 97/68/EC of the European Parliament and of the Council of 16 December 1997 on the

approximation of the laws of the Member States relating to measures against the emission of gaseous and

particulate pollutants from internal combustion engines to be installed in non-road mobile machinery (OJ L 59,

27.2.1998, p. 1), as amended by:

-{1647} 32001 L 0063: Commission Directive 2001/63/EC of 17 August 2001 (OJ L 227, 23.8.2001, p. 41),

-{1648} 32002 L 0088: Directive 2002/88/EC of the European Parliament and of the Council of 9 December

(OJ L 35, 11.2.2003, p. 28),

-{1649} 1 03 T: Act concerning the conditions of accession of the Czech Republic, the Republic of Estonia,

the Republic of Cyprus, the Republic of Latvia, the Republic of Lithuania, the Republic of Hungary,

the Republic of Malta, the Republic of Poland, the Republic of Slovenia and the Slovak Republic

and the adjustments to the Treaties on which the European Union is founded adopted on 16 April

2003 (OJ L 236, 23.9.2003, p. 33),

-{1650} 32004 L 0026: Directive 2004/26/EC of the European Parliament and of the Council of 21 April

2004 (OJ L 146, 30.4.2004, p. 1), as corrected by OJ L 225, 25.6.2004, p. 3,

-{1651} 32006 L 0096: Council Directive 2006/96/EC of 20 November 2006 (OJ L 363, 20.12.2006, p. 81),

-{1652} 32006 L 0105: Council Directive 2006/105/EC of 20 November 2006 (OJ L 363, 20.12.2006,

p. 368), as corrected by, OJ L 80, 21.3.2007, p. 15,

-{1653} 32010 L 0026: Commission Directive 2010/26/EU of 31 March 2010 (OJ L 86, 1.4.2010, p. 29),

-{1654} 32011 L 0088: Directive 2011/88/EU of the European Parliament and of the Council of 16

November 2011 (OJ L 305, 23.11.2011, p. 1),

-{1655} 32012 L 0046: Commission Directive 2012/46/EU of 6 December 2012 (OJ L 353, 21.12.2012,

p. 80).

{1644} Point inserted by Decision No 12/94 (OJ L 292, 12.11.1994, p. 39 and EEA Supplement No 45, 12.11.1994, p. 1), e.i.f. 1.2.1995.

{1645} Point replaced by Decision No 94/1999 (OJ L 296, 23.11.2000, p. 60 and EEA Supplement No 55, 23.11.2000 p. 109), e.i.f. 17.7.1999. Text

of point 1 (Directive 98/37/EC of the European Parliament and of the Council) deleted with effect from 29 December 2009 by Decision No

6/2007 (OJ L 209, 9.8.2007, p. 11 and EEA Supplement No 38, 9.8.2007, p. 9), e.i.f. 28.4.2007.

{1646} Point inserted by Decision No 115/1999 (OJ L 325, 21.12.2000, p. 29 and EEA Supplement No 60, 21.12.2000, p. 311), e.i.f. 31.12.1999.

{1647} Indent and words “, as amended by:” above, added by Decision No 128/2002 (OJ L 336, 12.12.2002, p. 28 and EEA Supplement No 61,

12.12.2002, p. 22), e.i.f. 5.10.2002

{1648} Indent added by Decision No 151/2003 (OJ L 41, 12.02.2004, p. 41 and EEA Supplement No 7, 12.02.2004, p. 30), e.i.f. 8.11.2003.

{1649} Indent added by the 2004 EEA Enlargement Agreement (OJ L 130, 29.4.2004, p. 3 and EEA Supplement No 23, 29.4.2004, p. 1), e.i.f.

1.5.2004.

{1650} Indent added by Decision No 30/2006 (OJ L 147, 1.6.2006, p. 46 and EEA Supplement No 28, 1.6.2006, p. 16), e.i.f. 11.3.2006.

{1651} Indent added by Decision No 132/2007 (OJ L 100, 10.4.2008, p. 1 and EEA Supplement No 19, 10.4.2008, p.1), e.i.f. 9.11.2011.

{1652} Indent added by Decision No 132/2007 (OJ L 100, 10.4.2008, p. 1 and EEA Supplement No 19, 10.4.2008, p.1), e.i.f. 9.11.2011, text of the

Act subsequently corrected by Corrigendum noted in the EEA Joint Committee Meeting on 1.2.2008.

{1653} Indent added by Decision No 76/2013 (OJ L 291, 31.10.2013, p. 34 and EEA Supplement No 61, 31.10.2013, p. 38), e.i.f. 4.5.2013.

{1654} Indent added by Decision No 126/2014 (OJ L 342, 27.11.2014, p. 26 and EEA Supplement No 71, 27.11.2014, p. 25), e.i.f. 28.6.2014.

{1655} Indent added by Decision No 186/2014 (OJ L 202, 30.7.2015, p. 37 and EEA Supplement No 43, 30.7.2015, p. 37), e.i.f. 26.9.2014.

Page 160: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 286

1b. [ ]{1656}

1c.{1657} 32006 L 0042: Directive 2006/42/EC of the European Parliament and of the Council of 17 May 2006 on

machinery, and amending Directive 95/16/EC (recast) (OJ L 157, 9.6.2006, p. 24), as corrected by OJ L 76,

16.3.2007, p. 35, as amended by:

-{1658} 32009 L 0127: Directive 2009/127/EC of the European Parliament and of the Council of 21 October

2009 (OJ L 310, 25.11.2009, p. 29),

-{1659} 32013 R 0167: Regulation (EU) No 167/2013 of the European Parliament and of the Council of 5

February 2013 (OJ L 60, 2.3.2013, p. 1).

1d.{1660} 32012 D 0032: Commission Decision 2012/32/EU of 19 January 2012 requiring Member States to prohibit the

placing on the market of flail-type cutting attachments for portable hand-held brush cutters (OJ L 18,

21.1.2012, p. 5).

1e.{1661} 32016 R 0424: Regulation (EU) 2016/424 of the European Parliament and of the Council of 9 March 2016 on

cableway installations and repealing Directive 2000/9/EC (OJ L 81, 31.3.2016, p. 1), as corrected by OJ L 266,

30.9.2016, p. 8.

1f. {1662} 32017 R 0654: Commission Delegated Regulation (EU) 2017/654 of 19 December 2016 supplementing

Regulation (EU) 2016/1628 of the European Parliament and of the Council with regard to technical and

general requirements relating to emission limits and type-approval for internal combustion engines for non-

road mobile machinery (OJ L 102, 13.4.2017, p. 1), as amended by:

-{1663} 32018 R 0236: Commission Delegated Regulation (EU) 2018/236 of 20 December 2017 (OJ L 50,

22.2.2018, p. 1).

1g. {1664} 32017 R 0655: Commission Delegated Regulation (EU) 2017/655 of 19 December 2016 supplementing

Regulation (EU) 2016/1628 of the European Parliament and of the Council with regard to monitoring of

gaseous pollutant emissions from in-service internal combustion engines installed in non-road mobile

machinery (OJ L 102, 13.4.2017, p. 334), as amended by:

-{1665} 32018 R 0987: Commission Delegated Regulation (EU) 2018/987 of 27 April 2018 (OJ L 182,

18.7.2018, p. 40).

1h. {1666} 32017 R 0656: Commission Implementing Regulation (EU) 2017/656 of 19 December 2016 laying down the

administrative requirements relating to emission limits and type-approval of internal combustion engines for

non-road mobile machinery in accordance with Regulation (EU) 2016/1628 of the European Parliament and of

the Council (OJ L 102, 13.4.2017, p. 364), as amended by:

-{1667} 32018 R 0988: Commission Implementing Regulation (EU) 2018/988 of 27 April 2018 (OJ L 182,

18.7.2018, p. 46).

{1656} Point inserted by Decision No 115/2001 (OJ L 322, 6.12.2001, p. 27 and EEA Supplement No 60, 21.12.2001, p.25), e.i.f. 1.7.2002 and

subsequently deleted with effect from 21 April 2018 by Decision No 60/2018 (OJ L [to be published] and EEA Supplement No [to be

published]), e.i.f. 24.3.2018.

{1657} Point inserted by Decision No 6/2007 (OJ L 209, 9.8.2007, p.11), e.i.f. 28.4.2007.

{1658} Indent and words “, as amended by:” added by Decision No 279/2014 (OJ L 311, 26.11.2015, p. 32 and EEA Supplement No 71,

26.11.2015, p. 31), e.i.f. 1.6.2015.

{1659} Indent added by Decision No 9/2015 (OJ L 93, 7.4.2016, p. 15 and EEA Supplement No 21, 7.4.2016, p. 13), e.i.f. 1.1.2016.

{1660} Point inserted by Decision No 168/2013 (OJ L 58, 27.2.2014, p. 22 and EEA Supplement No 13, 27.2.2014, p. 24), e.i.f. 9.10.2013.

{1661} Point inserted by Decision No 60/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 24.3.2018.

{1662} Point inserted by Decision No 61/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. pending.

{1663} Indent added by Decision No 211/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. pending and subsequently

corrected [before publication] by Corrigendum of 13.6.2019.

{1664} Point inserted by Decision No 61/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. pending.

{1665} Indent and words “as amended by:” added by Decision No 70/2019 (OJ L [to be published] and EEA Supplement No [to be published]),

e.i.f. 30.3.2019.

{1666} Point inserted by Decision No 61/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. pending.

{1667} Indent and words “as amended by:” added by Decision No 71/2018 (OJ L [to be published] and EEA Supplement No [to be published]),

e.i.f. 30.3.2019.

Page 161: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 287

ACTS OF WHICH THE CONTRACTING PARTIES SHALL TAKE NOTE{1668}

The Contracting Parties take note of the content of the following acts:

2. C/157/92/p. 4: Commission Communication in the framework of the implementation of Council Directive

89/392/EEC of 14 June 1989, in relation to machinery, modified by Council Directive 91/368/EEC

(OJ No C 157, 24.6.1992, p. 4).

3. C/229/93/p. 3: Commission Communication in the framework of the implementation of Council Directive

89/392/EEC of 14 June 1989 in relation to machinery, as amended by Directive 91/368/EEC (OJ No C 229,

25.8.1993, p. 3).

4.{1669} C/253/94/p.3: Dates of application of Council Directive 89/392/EEC of 14 June 1989 - amended by Directives

91/368/EEC, 93/44/EEC and 93/68/EEC - on the approximation of the laws of the Member States relating to

machinery, roll-over protection structures (ROPS) and falling-object protection structures (OJ No C 253,

10.9.1994, p.3).

XXV. TOBACCO

ACTS REFERRED TO

1.{1670} [..]

2.{1671} [..]

3.{1672} 32001 L 0037: Directive 2001/37/EC of the European Parliament and of the Council of 5 June 2001 on the

approximation of the laws, regulations and administrative provisions of the Member States concerning the

manufacture, presentation and sale of tobacco products (OJ L 194, 18.7.2001, p. 26), as amended by:

-{1673} 32012 L 0009: Commission Directive 2012/9/EU of 7 March 2012 (OJ L 69, 8.3.2012, p. 15), as

amended by:

-{1674} 32014 L 0039: Commission Directive 2014/39/EU of 12 March 2014 (OJ L 73, 13.3.2014,

p. 3).

{1668} Heading and points 2 and 3 inserted by Decision No 7/94 (OJ L 160, 28.6.1994, p. 1 and EEA Supplement No 17, 28.6.1994, p. 1), e.i.f.

1.7.1994.

{1669} Point inserted by Decision No 17/95 (OJ L 83, 13.4.1995, p. 48 and EEA Supplement No 13, 13.4.1995, p. 32), e.i.f. 1.4.1995.

{1670} Text of point 1 (Council Directive 89/622/EEC), as amended, deleted by Decision No 10/2003 (OJ L 94, 10.4.2003, p. 61 and EEA

Supplement No 19, 10.4.2003, p. 13), e.i.f. 1.7.2003.

{1671} Text of point 2 (Council Directive 90/239/EEC) deleted by Decision No 10/2003 (OJ L 94, 10.4.2003, p. 61 and EEA Supplement No 19,

10.4.2003, p. 13), e.i.f. 1.7.2003.

{1672} Point inserted by Decision No 10/2003 (OJ L 94, 10.4.2003, p. 61 and EEA Supplement No 19, 10.4.2003, p. 13), e.i.f. 1.7.2003.

{1673} Indent and words “, as amended by:” added by Decision No 215/2012 (OJ L 81, 21.3.2013, p. 15 and EEA Supplement No 18, 21.3.2013,

p. 17), e.i.f. 8.12.2012.

{1674} Sub-indent and words “, as amended by:” added by Decision No 269/2015 (OJ L 161, 22.6.2017, p. 54 and EEA Supplement No 38,

22.6.2017, p. 56), e.i.f. 1.11.2015.

Page 162: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 288

-{1675} 32015 L 1139: Commission Directive (EU) 2015/1139 of 13 July 2015 (OJ L 185,

14.7.2015, p. 15).

The provisions of Directive (EU) 2015/1139 shall, for the purposes of this Agreement, be

read with the following adaptations:

In Article 1(1) the words “20 May 2016” shall, as regards the EFTA States, read “the date

of the entry into force of the EEA Joint Committee Decision incorporating Directive

2014/40/EU of the European Parliament and of the Council into the EEA Agreement”.

In Article 1(2) the words “20 May 2017” shall, as regards the EFTA States, read “one year

after the date of the entry into force of the EEA Joint Committee Decision incorporating

Directive 2014/40/EU of the European Parliament and of the Council into the EEA

Agreement”.

{1676}The transitional arrangements set out in the Annexes to the Act of Accession of 25 April 2005 for

Bulgaria (Annex VI, Chapter 7), shall apply.

The provisions of the Directive shall, for the purposes of the present Agreement, be read with the following

adaptation:

(a) The prohibition in Article 8 shall not apply to the placing on the market in Norway of the product

defined in Article 2(4). However, this derogation shall not apply to the prohibition of sales of "snus"

in forms resembling food products. Furthermore, Norway shall apply an export ban on the product

defined in Article 2(4) to all Contracting Parties to the present Agreement, with the exception of

Sweden.

3a.{1677} 32015 D 1735: Commission Implementing Decision (EU) 2015/1735 of 24 September 2015 on the precise

position of the general warning and the information message on roll-your-own tobacco marketed in pouches

(OJ L 252, 29.9.2015, p. 49).

3b.{1678} 32015 D 1842: Commission Implementing Decision (EU) 2015/1842 of 9 October 2015 on the technical

specifications for the layout, design and shape of the combined health warnings for tobacco products for

smoking (OJ L 267, 14.10.2015, p. 5).

4. {1679} 32003 D 0641: Commission Decision 2003/641/EC of 5 September 2003 on the use of colour photographs or

other illustrations as health warnings on tobacco packages (OJ L 226, 10.9.2003, p. 24).

5.{1680} 32003 L 0033: Directive 2003/33/EC of the European Parliament and of the Council of 26 May 2003 on the

approximation of the laws, regulations and administrative provisions of the Member States relating to the

advertising and sponsorship of tobacco products (OJ L 152, 20.6.2003, p. 16), as corrected by OJ L 67,

5.3.2004, p. 34.

{1675} Sub-indent and adaptation text added by Decision No 51/2016 (OJ L 270, 19.10.2017, p. 19 and EEA Supplement No 66, 19.10.2017, p. 20),

e.i.f. 19.3.2016.

{1676} Text added by the 2007 EEA Enlargement Agreement (OJ L 221, 25.8.2007 and EEA Supplement No 39, 26.7.2008), provisionally

applicable as of 1.8.2007, e.i.f. 9.11.2011, the words “or, as the case may be, to the Protocol of Accession of 25 April 2005” subsequently

deleted by the 2014 EEA Enlargement Agreement (OJ L 170, 11.6.2014, p. 5 and EEA Supplement No 58, 9.10.2014, p. 1), provisionally

applicable as of 12.4.2014, e.i.f. pending.

{1677} Point inserted by Decision No 90/2016 (OJ L 300, 16.11.2017, p. 39 and EEA Supplement No 73, 16.11.2017, p. 43), e.i.f. pending.

{1678} Point inserted by Decision No 90/2016 (OJ L 300, 16.11.2017, p. 39 and EEA Supplement No 73, 16.11.2017, p. 43), e.i.f. pending.

{1679} Point inserted by Decision No 28/2004 (OJ L 127, 29.4.2004, p. 136 and EEA Supplement No 22, 29.4.2004, p. 16), e.i.f. 20.3.2004.

{1680} Point inserted by Decision No 150/2006 (OJ L 89, 29.3.2007, p. 21 and EEA Supplement No 15, 29.3.2007, p. 17), e.i.f. 1.10.2007.

Page 163: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 289

XXVI. ENERGY

ACTS REFERRED TO

1. [ ] {1681}

XXVII. SPIRIT DRINKS

Contracting Parties shall authorise imports and marketing of spirit drinks which are in conformity with the Community

legislation as listed in this Chapter. For all other purposes, EFTA States may continue to apply their national legislation.

{1682} This Chapter shall not apply to Liechtenstein as long as the application of the Agreement between the European

Community and the Swiss Confederation on trade in agricultural products is extended to Liechtenstein.

ACTS REFERRED TO:

1. [ ] {1683}

2. [ ] {1684}

3. [ ] {1685}

4.{1686} 391 R 3664: Commission Regulation (EEC) No 3664/91 of 16 December 1991 laying down transitional

measures for aromatized wines, aromatized wine-based drinks and aromatized wine-product cocktails (OJ No

L 348, 17.12.1991, p. 53), as amended by:

- 392 R 0351: Commission Regulation (EEC) No 351/92 of 13 February 1992 (OJ No L 37,

14.2.1992, p. 9),

- 392 R 1914: Commission Regulation (EEC) No 1914/92 of 10 July 1992 (OJ No L 192, 11.7.1992,

p. 39),

- 392 R 3568: Commission Regulation (EEC) No 3568/92 of 10 December 1992 (OJ No L 362,

11.12.1992, p. 47),

- 393 R 1791: Commission Regulation (EEC) No 1791/93 of 30 June 1993 (OJ No L 163, 6.7.1993,

p. 20).

{1681} Text of point 1 (Council Directive 85/536/EEC) deleted by Decision No 225/2014 (OJ L 230, 3.9.2015, p. 28 and EEA Supplement No 52,

3.9.2015, p. 28), e.i.f. 1.11.2014.

{1682} Text added by Decision No 97/2007 (OJ L 047, 21.2.2008, p. 3 and EEA Supplement No 9, 21.2.2008, p. 2), e.i.f. 28.9.2007.

{1683} Text of point 1 (Council Regulation (EEC) No 1576/89) deleted by Decision No 90/2012 (OJ L 248, 13.9.2012, p. 27 and EEA Supplement

No 50, 13.9.2012, p. 32), e.i.f. 1.5.2012.

{1684} Text of point 2 (Commisson Regulation (EEC) No 1014/90) deleted by Decision No 90/2012 (OJ L 248, 13.9.2012, p. 27 and EEA

Supplement No 50, 13.9.2012, p. 32), e.i.f. 1.5.2012.

{1685} Text of point 3 (Council Regulation (EEC) No 1601/91) deleted by Decision No 306/2015 (OJ L 263, 12.10.2017, p. 18 and EEA Supplement

No 64, 12.10.2017, p. 22), e.i.f. 12.12.2015.

{1686} Point inserted by Decision No 7/94 (OJ L 160, 28.6.1994, p. 1 and EEA Supplement No 17, 28.6.1994, p. 1), e.i.f. 1.7.1994.

Page 164: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 290

5.{1687} 392 R 1238: Commission Regulation (EEC) No 1238/92 of 8 May 1992 determining the Community methods

applicable in the wine sector for the analysis of neutral alcohol (OJ No L 130, 15.5.1992, p. 13).

6.{1688} 392 R 2009: Commission Regulation (EEC) No 2009/92 of 20 July 1992 determining Community analysis

methods for ethyl alcohol of agricultural origin used in the preparation of spirit drinks, aromatized wines,

aromatized wine-based drinks and aromatized wine-product cocktails (OJ No L 203, 21.7.1992, p. 10).

7.{1689} 396 R 2215: Commission Regulation (EC) No 2215/96 of 20 November 1996 providing for derogating

measures in respect of “Glühwein” (OJ No L 296, 21.11.1996, p. 30).

8.{1690} 32000 R 2870: Commission Regulation (EC) No 2870/2000 of 19 December 2000 laying down Community

reference methods for the analysis of spirit drinks (OJ L 333, 29.12.2000, p. 20), as amended by:

- {1691} 32002 R 2091: Commission Regulation (EC) No 2091/2002 of 26 November 2002 (OJ L 322,

27.11.2002, p. 11),

- {1692} 32016 R 0635: Commission Implementing Regulation (EU) 2016/635 of 22 April 2016 (OJ L 108,

23.4.2016, p. 1).

9.{1693} 32008 R 0110: Regulation (EC) No 110/2008 of the European Parliament and of the Council of 15 January

2008 on the definition, description, presentation, labelling and the protection of geographical indications of

spirit drinks and repealing Council Regulation (EEC) No 1576/89 (OJ L 39, 13.2.2008, p. 16), as amended by:

- 32008 R 1334: Regulation (EC) No 1334/2008 of the European Parliament and of the Council of 16

December 2008 (OJ L 354, 31.12.2008, p. 34),

-{1694} 32012 R 0164: Commission Regulation (EU) No 164/2012 of 24 February 2012 (OJ L 53,

25.2.2012, p. 1),

-{1695} 1 2012 J003: Act concerning the conditions of accession of the Republic of Croatia and the

adjustments to the Treaty on European Union, the Treaty on the Functioning of the European Union

and the Treaty establishing the European Atomic Energy Community, adopted on 9 December 2011

(OJ L 112, 24.4.2012, p. 21),

-{1696} 32013 R 1065: Commission Regulation (EU) No 1065/2013 of 30 October 2013 (OJ L 289,

31.10.2013, p. 48),

-{1697} 32014 R 0097: Commission Regulation (EU) No 97/2014 of 3 February 2014 (OJ L 33, 4.2.2014,

p. 1),

-{1698} 32014 R 0098: Commission Regulation (EU) No 98/2014 of 3 February 2014 (OJ L 33, 4.2.2014,

p. 3),

-{1699} 32014 R 0426: Commission Regulation (EU) No 426/2014 of 25 April 2014 (OJ L 125, 26.4.2014,

p. 55),

{1687} Point inserted by Decision No 7/94 (OJ L 160, 28.6.1994, p. 1 and EEA Supplement No 17, 28.6.1994, p. 1), e.i.f. 1.7.1994.

{1688} Point inserted by Decision No 7/94 (OJ L 160, 28.6.1994, p. 1 and EEA Supplement No 17, 28.6.1994, p. 1), e.i.f. 1.7.1994.

{1689} Point inserted by Decision No 101/97 (OJ L 193, 9.7.1998, p. 61 and EEA Supplement No 27, 9.7.1998, p. 117), e.i.f. 16.12.1997.

{1690} Point inserted by Decision No 92/2001 (OJ L 251, 20.9.2001, p. 18 and EEA Supplement No 47, 20.9.2001, p. 5), e.i.f. 14.7.2001.

{1691} Indent and words “, as amended by:” above added by Decision No 44/2003 (OJ L 193, 31.7.2003, p. 12 and EEA Supplement No 39,

31.7.2003, p. 9), e.i.f. 17.5.2003.

{1692} Indent added by Decision No 57/2017 (OJ L 305, 29.11.2018, p. 24 and EEA Supplement No 81, 29.11.2018, p. 28), e.i.f. 18.3.2017.

{1693} Point, indent and adaptation text inserted by Decision No 90/2012 (OJ L 248, 13.9.2012, p. 27 and EEA Supplement No 50, 13.9.2012, p.

32), e.i.f. 1.5.2012.

{1694} Indent added by Decision No 198/2013 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 9.11.2013.

{1695} Indent added by Decision No 159/2014 (OJ L 15, 22.1.2015, p. 87 and EEA Supplement No 5, 22.1.2015, p. 10), e.i.f. pending; it shall apply

from 9.7.2014.

{1696} Indent added by Decision No 223/2014 (OJ L 230, 3.9.2015, p. 25 and EEA Supplement No 52, 3.9.2015, p. 25), e.i.f. 1.11.2014.

{1697} Indent added by Decision No 223/2014 (OJ L 230, 3.9.2015, p. 25 and EEA Supplement No 52, 3.9.2015, p. 25), e.i.f. 1.11.2014.

{1698} Indent added by Decision No 223/2014 (OJ L 230, 3.9.2015, p. 25 and EEA Supplement No 52, 3.9.2015, p. 25), e.i.f. 1.11.2014.

Page 165: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 291

-{1700} 32015 R 0210: Commission Regulation (EU) 2015/210 of 10 February 2015 (OJ L 35, 11.2.2015,

p. 16),

-{1701} 32016 R 0235: Commission Regulation (EU) 2016/235 of 18 February 2016 (OJ L 44, 19.2.2016, p.

7),

-{1702} 32018 R 0175: Commission Regulation (EU) 2018/175 of 2 February 2018 (OJ L 32, 6.2.2018, p.

48),

-{1703} 32016 R 1067: Commission Regulation (EU) 2016/1067 of 1 July 2016 (OJ L 178, 2.7.2016, p.1),

-{1704} 32018 R 1098: Commission Regulation (EU) 2018/1098 of 2 August 2018 (OJ L 197, 3.8.2018, p.

7),

-{1705} 32019 R 0335: Commission Regulation (EU) 2019/335 of 27 February 2019 (OJ L 60, 28.2.2019, p.

3),

-{1706} 32019 R 0674: Commission Regulation (EU) 2019/674 of 29 April 2019 (OJ L 114, 30.4.2019, p.

7),

-{1707} 32018 R 1850: Commission Regulation (EU) 2018/1850 of 21 November 2018 (OJ L 302,

28.11.2018, p. 1),

-{1708} 32018 R 1871: Commission Regulation (EU) 2018/1871 of 23 November 2018 (OJ L 306,

30.11.2018, p. 7).

The provisions of the Regulation shall, for the purposes of this Agreement, be read with the following

adaptations:

(a) The provisions of the Regulation shall not prejudice the right of the EFTA States to prohibit, on a

non-discriminatory basis, the placing on their national market of spirit drinks for direct human

consumption which exceed an alcoholic strength of 60%.

(b) The EFTA States shall be invited to send observers to the meetings of the Committee for Spirit

Drinks, as referred to in Article 25, dealing with matters which fall within acts referred to in the

Agreement. The representatives of the EFTA States shall participate fully in the work of the

Committee, but shall not have the right to vote.

(c) Paragraph 4d) of Protocol 1 to the Agreement shall not apply to Chapter III of the Regulation.

(d) The following shall be added in Annex III:

Product category Geographical indication Country of

origin

{1699} Indent added by Decision No 223/2014 (OJ L 230, 3.9.2015, p. 25 and EEA Supplement No 52, 3.9.2015, p. 25), e.i.f. 1.11.2014.

{1700} Indent added by Decision No 22/2016 (OJ L 189, 20.7.2017, p. 32 and EEA Supplement No 45, 20.7.2017, p. 35), e.i.f. 6.2.2016.

{1701} Indent added by Decision No 240/2016 (OJ L 215, 23.8.2018, p. 39 and EEA Supplement No 56, 23.8.2018, p. 46), e.i.f. 3.12.2016.

{1702} Indent added by Decision No 91/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 28.4.2018.

{1703} Indent added by Decision No 299/2019 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 14.12.2019.

{1704} Indent added by Decision No 299/2019 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 14.12.2019.

{1705} Indent added by Decision No 299/2019 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 14.12.2019.

{1706} Indent added by Decision No 299/2019 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 14.12.2019.

{1707} Indent added by Decision No 300/2019 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 14.12.2019.

{1708} Indent added by Decision No 300/2019 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 14.12.2019.

Page 166: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 292

15. Vodka Íslenskt Vodka/Icelandic Vodka

Norsk Vodka/Norwegian Vodka

Iceland

Norway

24. Akvavit/aquavit ÍslensktBrennivín/Icelandic Aquavit

Norsk akevitt/Norsk Aquavit/Norsk

Akvavit/Norwegian Aquavit

Iceland

Norway

Other spirit drinks The geographical indications mentioned under

this point concern products which are not

defined in the Regulation. Therefore, they must

be completed with the sales description “spirit

drink”.

The EFTA States producing these spirit drinks

shall inform the other Contracting Parties of the

national definitions of these products.

9a.{1709} 32013 R 0716: Commission Implementing Regulation (EU) No 716/2013 of 25 July 2013 laying down rules

for the application of Regulation (EC) No 110/2008 of the European Parliament and of the Council on the

definition, description, presentation, labelling and the protection of geographical indications of spirit drinks

(OJ L 201, 26.7.2013, p. 21).

9b.{1710} 32014 R 0251: Regulation (EU) No 251/2014 of the European Parliament and of the Council of 26 February

2014 on the definition, description, presentation, labelling and the protection of geographical indications of

aromatized wine products and repealing Council Regulation (EEC) No 1601/91 (OJ L 84, 20.3.2014, p. 14).

The provisions of the Regulation shall, for the purposes of this Agreement, be read with the following

adaptations:

The EFTA States concerned shall be invited to send observers to the meetings of the Committee on aromatised

wine products, as referred to in Article 34, dealing with matters which fall within the acts referred to in the

Agreement. The representatives of the EFTA States shall participate fully in the work of the Committee, but

shall not have the right to vote.

9ba.{1711} 32017 R 0670: Commission Delegated Regulation (EU) 2017/670 of 31 January 2017 supplementing

Regulation (EU) No 251/2014 of the European Parliament and of the Council as regards the authorised

production processes for obtaining aromatised wine products (OJ L 97, 8.4.2017, p. 5).

10. [ ] {1712}

11.{1713} 32016 H 0022: Commission Recommendation (EU) 2016/22 of 7 January 2016 on the prevention and

reduction of ethyl carbamate contamination in stone fruit spirits and stone fruit marc spirits, repealing

Recommendation 2010/133/EU (OJ L 6, 9.1.2016, p. 8).

{1709} Point inserted by Decision No 223/2014 (OJ L 230, 3.9.2015, p. 25 and EEA Supplement No 52, 3.9.2015, p. 25), e.i.f. 1.11.2014.

{1710} Point inserted by Decision No 306/2015 (OJ L 263, 12.10.2017, p. 18 and EEA Supplement No 64, 12.10.2017, p. 22), e.i.f. 12.12.2015.

{1711} Point inserted by Decision No 179/2017 (OJ L 174, 27.6.2019, p. 48 and EEA Supplement No 52, 27.6.2019, p. 58), e.i.f. 23.9.2017.

{1712} Point 10 (Commission Recommendation 2010/133/EU) inserted by Decision No 90/2012 (OJ L 248, 13.9.2012, p. 27 and EEA Supplement

No 50, 13.9.2012, p. 32), e.i.f. 1.5.2012 subsequently deleted by Decision No 236/2017 (OJ L 254, 3.10.2019, p. 48 and EEA Supplement No

80, 3.10.2019, p. 50), e.i.f. 16.12.2017.

{1713} Point inserted by Decision No 236/2017 (OJ L 254, 3.10.2019, p. 48 and EEA Supplement No 80, 3.10.2019, p. 50), e.i.f. 16.12.2017.

Page 167: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 293

XXVIII. CULTURAL GOODS {1714}

ACTS REFERRED TO

1. [ ] {1715}

2.{1716} 32014 L 0060: Directive 2014/60/EU of the European Parliament and of the Council of 15 May 2014 on the

return of cultural objects unlawfully removed from the territory of a Member State and amending Regulation

(EU) No 1024/2012 (OJ L 159, 28.5.2014, p. 1), as corrected by OJ L 147, 12.6.2015, p. 24.

The provisions of the Directive shall, for the purposes of this Agreement, be read with the following

adaptations:

In Article 14, the reference to “on or after 1 January 1993” shall with regard to Iceland and Norway read “on

or after 1 January 1995” and with regard to Liechtenstein read “on or after 1 May 1995”.

XXIX. EXPLOSIVES FOR CIVIL USE {1717}

ACTS REFERRED TO

1.{1718} 32014 L 0028: Directive 2014/28/EU of the European Parliament and of the Council of 26 February 2014 on

the harmonisation of the laws of the Member States relating to the making available on the market and

supervision of explosives for civil uses (recast) (OJ L 96, 29.3.2014, p. 1).

2.{1719} 32004 D 0388: Commission Decision 2004/388/EC of 15 April 2004 on an Intra-Community transfer of

explosives document (OJ L 120, 24.4.2004, p. 43), as amended by:

-{1720} 32010 D 0347: Commission Decision 2010/347/EU of 19 June 2010 (OJ L 155, 22.6.2010, p. 54).

3. {1721} [ ]

4.{1722} 32013 L 0029: Directive 2013/29/EU of the European Parliament and of the Council of 12 June 2013 on the

harmonisation of the laws of the Member States relating to the making available on the market of pyrotechnic

articles (recast) (OJ L 178, 28.6.2013, p. 27).

{1714} Chapter and point 1 inserted by Decision No 7/94 (OJ L 160, 28.6.1994, p. 1 and EEA Supplement No 17, 28.6.1994, p. 1), e.i.f. 1.7.1994.

{1715} Text of point 1 (Council Directive 93/7/EEC) to be deleted by Decision No 121/2016 (OJ L 308, 23.11.2017, p. 25 and EEA Supplement No

76, 23.11.2017, p. 30), e.i.f. 1.7.2017.

{1716} Point inserted by Decision No 121/2016 (OJ L 308, 23.11.2017, p. 25 and EEA Supplement No 76, 23.11.2017, p. 30), e.i.f. 1.7.2017 and

subsequently corrected by Corrigendum of 8.7.2016.

{1717} Chapter and point 1 inserted by Decision No 7/94 (OJ L 160, 28.6.1994, p. 1 and EEA Supplement No 17, 28.6.1994, p. 1), e.i.f. 1.7.1994.

{1718} Text of point 1 (Council Directive 93/15/EEC) replaced by Decision 187/2016 (OJ L 80, 22.3.2018, p. 32 and EEA Supplement No 19,

22.3.2018, p. 43), e.i.f. 24.9.2016.

{1719} Point inserted by Decision No 8/2006 (OJ L 92, 30.3.2006, p. 29 and EEA Supplement No 17, 30.3.2006, p. 9), e.i.f. 28.1.2006.

{1720} Indent and words “, as amended by:” added by Decision No 216/2012 (OJ L 81, 21.3.2013, p. 16 and EEA Supplement No 18, 21.3.2013, p.

18), e.i.f. 8.12.2012.

{1721} Text of point 3 (Commission Directive 2004/57/EC) deleted by Decision 187/2016 (OJ L 80, 22.3.2018, p. 32 and EEA Supplement No 19,

22.3.2018, p. 43), e.i.f. 24.9.2016.

Page 168: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 294

4a.{1723} 32014 L 0058: Commission Implementing Directive 2014/58/EU of 16 April 2014 setting up, pursuant to

Directive 2007/23/EC of the European Parliament and of the Council, a system for the traceability of

pyrotechnic articles (OJ L 115, 17.4.2014, p. 28).

5.{1724} 32008 L 0043: Commission Directive 2008/43/EC of 4 April 2008 setting up, pursuant to Council Directive

93/15/EEC, a system for the identification and traceability of explosives for civil uses (OJ L 94, 5.4.2008,

p.8), as amended by:

- {1725} 32012 L 0004: Commission Directive 2012/4/EU of 22 February 2012 (OJ L 50, 23.2.2012, p. 18).

6.{1726} 32013 R 0098: Regulation (EU) No 98/2013 of the European Parliament and of the Council of 15 January

2013 on the marketing and use of explosives precursors (OJ L 39, 9.2.2013, p. 1), as amended by, as corrected

by OJ L 315, 30.11.2017, p. 78:

-{1727} 32017 R 0214: Commission Delegated Regulation (EU) 2017/214 of 30 November 2016 (OJ L 34,

9.2.2017, p. 1),

-{1728} 32017 R 0215: Commission Delegated Regulation (EU) 2017/215 of 30 November 2016 (OJ L 34,

9.2.2017, p. 3),

-{1729} 32017 R 0216: Commission Delegated Regulation (EU) 2017/216 of 30 November 2016 (OJ L 34,

9.2.2017, p. 5).

{1730} ACTS OF WHICH THE CONTRACTING PARTIES SHALL TAKE NOTE

The Contracting Parties take note of the content of the following acts:

1. 32017 H 1936: Commission Recommendation (EU) 2017/1936 of 18 October 2017 on immediate steps to prevent

misuse of explosives precursors (OJ L 273, 24.10.2017, p. 12).’

XXX. MEDICAL DEVICES {1731}

ACTS REFERRED TO

1.{1732} 393 L 0042: Council Directive 93/42/EEC of 14 June 1993 concerning medical devices (OJ No L 169,

12.7.1993, p. 1), as amended by:

{1722} Point inserted by Decision No 119/2010 (OJ L 58, 3.3.2011, p. 76 and EEA Supplement No 12, 3.3.2011, p. 18), e.i.f. 1.11.2012. Text of

point 4 (Directive 2007/23/EC of the European Parliament and of the Council) replaced by Decision No 23/2016 (OJ L 189, 20.7.2017, p. 33

and EEA Supplement No 45, 20.7.2017, p. 36), e.i.f. 6.2.2016.

{1723} Point inserted by Decision No 25/2015 (OJ L 93, 7.4.2016, p. 39 and EEA Supplement No 21, 7.4.2016, p. 34), e.i.f. 1.1.2016.

{1724} Point inserted by Decision No 119/2010 (OJ L 58, 3.3.2011, p. 76 and EEA Supplement No 12, 3.3.2011, p. 18), e.i.f. 1.11.2012.

{1725} Indent and words “, as amended by:” added by Decision No 226/2013 (OJ L 154, 21.5.2014, p. 24 and EEA Supplement No 29, 21.5.2014,

p. 23), e.i.f. 1.7.2014.

{1726} Point inserted by Decision No 269/2014 (OJ L 311, 26.11.2015, p. 20 and EEA Supplement No 71, 26.11.2015, p. 19), e.i.f. 1.8.2015.

Corrigendum to the EU act subsequently taken note of by the EEA Joint Committee on 6.7.2018.

{1727} Indent and words “, as amended by” added by Decision No 109/2018 (OJ L [to be published] and EEA Supplement No [to be published]),

e.i.f. 1.6.2018.

{1728} Indent added by Decision No 109/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 1.6.2018.

{1729} Indent added by Decision No 109/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 1.6.2018.

{1730} Heading, the words “The Contracting Parties take note of the content of the following acts:” and point added by Decision No 191/2018 (OJ

L [to be published] and EEA Supplement No [to be published]), e.i.f. 22.9.2018.

{1731} Chapter and point 1 inserted by Decision No 7/94 (OJ L 160, 28.6.1994, p. 1 and EEA Supplement No 17, 28.6.1994, p. 1), e.i.f. 1.7.1994.

{1732} Text of point 1 (Council Directive 93/42/EEC) to be deleted with effect from 26.5.2020 by Decision 288/2019 (OJ L [to be published] and

EEA Supplement No [to be published]), e.i.f. pending.

Page 169: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 295

-{1733} 398 L 0079: Directive 98/79/EC of the European Parliament and of the Council of 27 October 1998

(OJ L 331, 7.12.1998, p. 1), as corrected by OJ L 22, 29.1.1999, p. 75,

-{1734} 32001 L 0104: Directive 2001/104/EC of the European Parliament and of the Council of 7

December 2001 (OJ L 6, 10.1.2002, p. 50),

-{1735} 32000 L 0070: Directive 2000/70/EC of the European Parliament and of the Council of 16

November 2000 (OJ L 313, 13.12.2000, p. 22),

-{1736} 32007 L 0047: Directive 2007/47/EC of the European Parliament and of the Council of 5 September

2007 (OJ L 247, 21.9.2007, p. 21).

2.{1737} 398 L 0079: Directive 98/79/EC of the European Parliament and of the Council of 27 October 1998 on in

vitro diagnostic medical devices (OJ L 331, 7.12.1998, p. 1), as corrected by OJ L 22, 29.1.1999, p. 75, as

amended by:

-{1738} 32011 L 0100: Commission Directive 2011/100/EU of 20 December 2011 (OJ L 341, 22.12.2011, p.

50).

{1739}The transitional arrangements set out in the Annexes to the Act of Accession of 16 April 2003 for Poland

(Annex XII, Chapter 1, Point 3), shall apply.

3.{1740} 32002 D 0364: Commission Decision 2002/364/EC of 7 May 2002 on common technical specifications for in

vitro-diagnostic medical devices (OJ L 131, 16.5.2002, p. 17), as amended by:

-{1741}[ ]

-{1742} 32009 D 0886: Commission Decision 2009/886/EC of 27 November 2009 (OJ L 318, 4.12.2009, p.

25), as corrected by OJ L 348, 29.12.2009, p. 94,

-{1743} 32011 D 0869: Commission Decision 2011/869/EU of 20 December 2011 (OJ L 341, 22.12.2011, p.

63).

4.{1744} 32003 L 0012: Commission Directive 2003/12/EC of 3 February 2003 on the reclassification of breast

implants in the framework of Directive 93/42/EEC concerning medical devices (OJ L 28, 4.2.2003, p. 43).

5. [ ] {1745}

{1733} Indent inserted by Decision No 166/1999 (OJ L 61, 1.3.2001, p. 17 and EEA Supplement No 11, 1.3.2001, p. 180), e.i.f. 1.7.2000.

{1734} Indent inserted by Decision No 129/2002 (OJ L 336, 12.12.2002, p. 29 and EEA Supplement No 61, 12.12.2002, p. 23), e.i.f. 5.10.2002.

{1735} Indent added by Decision No 90/2003 (OJ L 272, 23.10.2003, p. 26 and EEA Supplement No 54, 23.10.2003, p. 5), e.i.f. 12.7.2003.

{1736} Indent added by Decision No 125/2009 (OJ L 62, 11.3.2010, p. 11and EEA Supplement No 12, 11.3.2010, p. 10), e.i.f. 5.12.2009.

{1737} Point 2 (Directive 98/79/EC of the European Parliament and of the Council) inserted by Decision No 166/1999 (OJ L 61, 1.3.2001, p. 17

and EEA Supplement No 11, 1.3.2001, p. 180), e.i.f. 1.7.2000 and subsequently deleted with effect from the dates referred to in Article 112

of Regulation (EU) 2017/746 by Decision 301/2019 (OJ L [to be published] and EEA Supplement [to be published]), e.i.f. pending

{1738} Indent and words “, as amended by:” added by Decision No 164/2012 (OJ L 341, 13.12.2012, p. 15 and EEA Supplement No 70,

13.12.2012, p. 18), e.i.f. 1.11.2012.

{1739} Text added by the 2004 EEA Enlargement Agreement (OJ L 130, 29.4.2004, p. 3 and EEA Supplement No 23, 29.4.2004, p. 1), e.i.f.

1.5.2004.

{1740} Point inserted by Decision No 110/2003 (OJ L 331, 18.12.2003, p. 24 and EEA Supplement No 64, 18.12.2003, p. 16), e.i.f. 27.9.2003.

{1741} First indent in point 3 (Commission Decision 2009/108/EC) deleted by Decision No 164/2012 (OJ L 341, 13.12.2012, p. 15 and EEA

Supplement No 70, 13.12.2012, p. 18), e.i.f. 1.11.2012.

{1742} Indent added by Decision No 164/2012 (OJ L 341, 13.12.2012, p. 15 and EEA Supplement No 70, 13.12.2012, p. 18), e.i.f. 1.11.2012.

{1743} Indent added by Decision No 164/2012 (OJ L 341, 13.12.2012, p. 15 and EEA Supplement No 70, 13.12.2012, p. 18), e.i.f. 1.11.2012.

{1744} Point inserted by Decision No 175/2003 (OJ L 88, 25.3.2004, p. 51 and EEA Supplement No 15, 25.3.2004, p. 13), e.i.f. 6.12.2003.

{1745} Point 5 (Commission Directive 2003/32/EC) inserted by Decision No 72/2004 (OJ L 349, 25.11.2004, p. 29 and EEA Supplement No 59,

25.11.2004, p. 6), e.i.f. 9.6.2004 subsequently be deleted with effect from 29.8.2013 by Decision No 141/2013 (OJ L [to be published] and

EEA Supplement No [to be published]), e.i.f. 16.7.2013.

Page 170: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 296

5a.{1746} 32012 R 0722: Commission Regulation (EU) No 722/2012 of 8 August 2012 concerning particular requirements

as regards the requirements laid down in Council Directives 90/385/EEC and 93/42/EEC with respect to active

implantable medical devices and medical devices manufactured utilising tissues of animal origin (OJ L 212,

9.8.2012, p. 3).

6.{1747} 32005 L 0050: Commission Directive 2005/50/EC of 11 August 2005 on the reclassification of hip, knee and

shoulder joint replacements in the framework of Council Directive 93/42/EEC concerning medical devices (OJ

L 210, 12.8.2005, p. 41).

7.{1748} 390 L 0385: Council Directive 90/385/EEC of 20 June 1990 on the approximation of the laws of the Member

States relating to active implantable medical devices (OJ No L 189, 20.7.1990, p. 17), as amended by:

- 393 L 0042: Council Directive 93/42/EEC of 14 June 1993 (OJ No L 169, 12.7.1993, p. 1),

- 393 L 0068: Council Directive 93/68/EEC of 22 July 1993 (OJ No L 200, 30.8.1993, p. 1),

- 32007 L 0047: Directive 2007/47/EC of the European Parliament and of the Council of 5 September

2007 (OJ L 247, 21.9.2007, p. 21).

8.{1749} 32010 D 0227: Commission Decision 2010/227/EU of 19 April 2010 on the European Databank on Medical

Devices (Eudamed) (OJ L 102, 23.4.2010, p. 45).

9.{1750} 32012 R 0207: Commission Regulation (EU) No 207/2012 of 9 March 2012 on electronic instructions for use

of medical devices (OJ L 72, 10.3.2012, p. 28).

10.{1751} 32013 R 0920: Commission Implementing Regulation (EU) No 920/2013 of 24 September 2013 on the

designation and the supervision of notified bodies under Council Directive 90/385/EEC on active implantable

medical devices and Council Directive 93/42/EEC on medical devices (OJ L 253, 25.9.2013, p. 8).

11.{1752} 32017 R 0745: Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on

medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No

1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC (OJ L 117, 5.5.2017, p. 1), as

corrected by OJ L 117, 3.5.2019, p. 9.

The provisions of the Regulation shall, for the purposes of this Agreement, be read with the following

adaptations:

(a) The EFTA States shall participate fully in the Medical Device Coordination Group (‘MDCG’)

established under Article 103, but shall not have the right to vote.

(b) The EFTA States shall participate in the European database on medical devices (Eudamed) set up by

the Commission as referred to in Article 33.

12.{1753} 32017 R 0746: Regulation (EU) 2017/746 of the European Parliament and of the Council of 5 April

2017 on in vitro diagnostic medical devices and repealing Directive 98/79/EC and Commission

Decision 2010/227/EU (OJ L 117, 5.5.2017, p. 176), as corrected by OJ L 117, 3.5.2019, p. 11.

{1746} Point inserted by Decision No 141/2013 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 16.7.2013.

{1747} Point inserted by Decision No 31/2006 (OJ L 147, 1.6.2006, p. 48 and EEA Supplement No 28, 1.6.2006, p. 17), e.i.f. 11.3.2006.

{1748} Point 7 (Council Directive 90/385/EEC) inserted by Decision No 125/2009 (OJ L 62, 11.3.2010, p. 11 and EEA Supplement No 12,

11.3.2010, p. 10), e.i.f. 5.12.2009 subsequently deleted with effect from 26.5.2020 by Decision No 288/2019 (OJ L [to be published] and

EEA Supplement [to be published]), e.i.f. pending.

{1749} Point 8 (Commission Decision 2010/227/EU) inserted by Decision No 131/2011 (OJ L 76, 15.3.2012, p. 15 and EEA Supplement No 15,

15.3.2012, p. 18), e.i.f. 3.12.2011 and subsequently deleted with effect from the dates referred to in Article 112 of Regulation (EU) 2017/746

by Decision 301/2019 (OJ L [to be published] and EEA Supplement [to be published]), e.i.f. pending

{1750} Point inserted by Decision No 198/2012 (OJ L 21, 24.1.2013, p. 48 and EEA Supplement No 6, 24.1.2013, p. 16), e.i.f. 1.11.2012.

{1751} Point inserted by Decision No 218/2015 (OJ L 85, 30.3.2017, p. 39 and EEA Supplement No 19, 30.3.2017, p. 38), e.i.f. 26.9.2015.

{1752} Point and adaptation text inserted by Decision No 288/2019 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f.

pending.

{1753} Point inserted by Decision No 301/2019 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. pending.

Page 171: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 297

ACTS OF WHICH THE CONTRACTING PARTIES SHALL TAKE NOTE{1754}

The Contracting Parties take note of the content of the following acts:

1. 32013 H 0172: Commission Recommendation 2013/172/EU of 5 April 2013 on a common framework for a

unique device identification system of medical devices in the Union (OJ L 99, 9.4.2013, p. 17).

2.{1755} 32013 H 0473: Commission Recommendation 2013/473/EU of 24 September 2013 on the audits and

assessments performed by notified bodies in the field of medical devices (OJ L 253, 25.9.2013, p. 27).

{1754} Heading and point 1 inserted by Decision No 41/2014 (OJ L 256, 28.8.2014, p. 14 and EEA Supplement No 49, 28.8.2014, p. 14), e.i.f.

9.4.2014.

{1755} Point inserted by Decision No 218/2015 (OJ L 85, 30.3.2017, p. 39 and EEA Supplement No 19, 30.3.2017, p. 38), e.i.f. 26.9.2015.

Page 172: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 298

XXXI. RECREATIONAL CRAFT{1756}

ACTS REFERRED TO

1. [ ] {1757}

2. {1758} 32013 L 0053: Directive 2013/53/EU of the European Parliament and of the Council of 20 November 2013 on

recreational craft and personal watercraft and repealing Directive 94/25/EC (OJ L 354, 28.12.2013, p. 90), as

corrected by OJ L 297, 13.11.2015, p. 9.

3. {1759} 32017 R 0001: Commission Implementing Regulation (EU) 2017/1 of 3 January 2017 on procedures for

watercraft identification under Directive 2013/53/EU of the European Parliament and of the Council on

recreational craft and personal watercraft (OJ L 1, 4.1.2017, p. 1).

XXXII. MARINE EQUIPMENT{1760}

ACTS REFERRED TO

1. [ ] {1761}

2. {1762} 32014 L 0090: Directive 2014/90/EU of the European Parliament and of the Council of 23 July 2014 on

marine equipment and repealing Council Directive 96/98/EC (OJ L 257, 28.8.2014, p. 146), as corrected by OJ

L 146, 11.6.2018, p. 8.

3. {1763} 32019 R 1397: Commission Implementing Regulation (EU) 2019/1397 of 6 August 2019 on design,

construction and performance requirements and testing standards for marine equipment and repealing

Implementing Regulation (EU) 2018/773 (OJ L 237, 13.9.2019, p. 1.).

4. {1764} 32018 R 0414: Commission Delegated Regulation (EU) 2018/414 of 9 January 2018 supplementing Directive

2014/90/EU of the European Parliament and of the Council as regards the identification of specific items of

marine equipment which can benefit from electronic tagging (OJ L 75, 19.3.2018, p. 3).

5. {1765} 32018 R 0608: Commission Implementing Regulation (EU) 2018/608 of 19 April 2018 laying down technical

criteria for electronic tags for marine equipment (OJ L 101, 20.4.2018, p. 64).

{1756} Chapter and point 1 added by Decision No 44/94 (OJ L 372, 31.12.1994, p. 20 and EEA Supplement No 57, 31.12.1994, p. 147), e.i.f.

1.2.1995.

{1757} Text of point 1 (Directive 94/25/EC of the European Parliament and of the Council) deleted with effect from 18.1.2016 by Decision No

224/2014 (OJ L 230, 3.9.2015, p. 27 and EEA Supplement No 52, 3.9.2015, p. 27), e.i.f. 1.11.2014.

{1758} Point inserted by Decision No 224/2014 (OJ L 230, 3.9.2015, p. 27 and EEA Supplement No 52, 3.9.2015, p. 27), e.i.f. 1.11.2014.

Corrigendum to the EU act subsequently taken note of by the EEA Joint Committee on 11.12.2015.

{1759} Point inserted by Decision No 58/2017 (OJ L 305, 29.11.2018, p. 25 and EEA Supplement No 81, 29.11.2018, p. 30), e.i.f. 18.3.2016.

{1760} Chapter and point 1 added by Decision No 119/98 (OJ L 297, 18.11.1999, p. 47 and EEA Supplement No 50, 18.11.1999, p. 38), e.i.f.

19.12.1998.

{1761} Text of point 1 (Council Directive 96/98/EC) deleted with effect from 18.9.2016 by Decision No 163/2016 (OJ L 73, 15.3.2018, p. 38 and

EEA Supplement No 16, 15.3.2018, p. 43), e.i.f. 27.8.2016.

{1762} Point inserted by Decision No 163/2016 (OJ L 73, 15.3.2018, p. 38 and EEA Supplement No 16, 15.3.2018, p. 43), e.i.f. 27.8.2016.

Corrigendum to the EU act subsequently taken note of by the EEA Joint Committee on 5.12.2018.

{1763} Point 3 (Commission Implementing Regulation (EU) 2017/306) inserted by Decision No 138/2017 (OJ L 128, 16.5.2019, p. 34 and EEA

Supplement No 40, 16.5.2019, p. 34), e.i.f. 8.7.2017 and subsequently replaced by (Commission Implementing Regulation (EU) 2018/773)

Decision No 110/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 1.6.2018 and subsequently replaced by

Decision No 233/2019 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 28.9.2019.

{1764} Point inserted by Decision No 147/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 7.7.2018

{1765} Point inserted by Decision No 244/2018 (OJ L [to be published] and EEA Supplement No [to be published]), e.i.f. 6.12.2018

Page 173: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 299

___________________

Page 174: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 300

APPENDIX 1{1766}

ENERGY LABELS

SECTION 1{1767} [ ]

{1766} Appendix and heading added by Decision No 22/98 (OJ L 342, 17.12.1998, p. 32 and EEA Supplement No 52, 17.12.1998, p. 1), e.i.f.

1.4.1998.

{1767} Section 1 (Commission Directive 94/2/EC) and heading added by Decision No 22/98 (OJ L 342, 17.12.1998, p. 32 and EEA Supplement No

52, 17.12.1998, p. 1), e.i.f. 1.4.1998. The following labels correspond to the labels previously contained in former adaptation a) to the first

indent of point 4 of Chapter IV, subsequently reinserted as point 4a by Decision No 22/98 subsequently deleted by Decision No 218/2012

(OJ L 81, 21.3.2013, p. 18 and EEA Supplement No 18, 21.3.2013, p. 21), e.i.f. 1.6.2013.

Page 175: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 301

SECTION 2{1768} [ ]

{1768} Section 2 (Commission Directive 95/12/EC) and heading added by Decision No 22/98 (OJ L 342, 17.12.1998, p. 32 and EEA Supplement

No 52, 17.12.1998, p. 1), e.i.f. 1.4.1998. The following labels correspond to the labels previously contained in former adaptation a) to the

second indent of point 4 of Chapter IV, subsequently reinserted as point 4b by Decision No 22/98 subsequently deleted by Decision No

218/2012 (OJ L 81, 21.3.2013, p. 18 and EEA Supplement No18, 21.3.2013, p. 21), e.i.f. 1.6.2013.

Page 176: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 302

SECTION 3{1769} [ ]

{1769} Section and heading added by Decision No 22/98 (OJ L 342, 17.12.1998, p. 32 and EEA Supplement No 52, 17.12.1998, p. 1), e.i.f. 1.4.1998.

The following labels correspond to the labels previously contained in former adaptation a) to the third indent of point 4 of Chapter IV,

subsequently reinserted as point 4c by Decision No 22/98, subsequently deleted by Decision No 10/2013 ( OJ L 144, 30.5.2013, p. 14 and

EEA Supplement No 31, 30.5.2013, p.16), e.i.f. 1.6.2013.

Page 177: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 303

SECTION 4{1770}

Commission Directive 96/60/EC

(household combined washer-driers)

{1770} Section, including heading and labels, added by Decision No 22/98 (OJ L 342, 17.12.1998, p. 32 and EEA Supplement No 52, 17.12.1998, p.

1), e.i.f. 1.4.1998.

Page 178: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 304

Page 179: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 305

Page 180: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 306

SECTION 5{1771} [ ]

{1771} Section 5 (Commission Directive 97/17/EC), including heading and labels, added by Decision No 29/1999 (OJ L 266, 19.10.2000, p.5 and

EEA Supplement No 46, 19.10.2000, p.5), e.i.f. 27.3.1999 subsequently deleted by Decision No 218/2012 (OJ L 81, 21.3.2013, p. 18 and

EEA Supplement No 18, 21.3.2013, p. 21), e.i.f. 1.6.2013.

Page 181: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 307

Page 182: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 308

Page 183: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 309

SECTION 6{1772}

Commission Directive 2002/40/EC

(household electric ovens)

{1772} Section, including heading, added by Decision No 141/2003 (OJ L 41, 12.02.2004, p. 11 and EEA Supplement No 7, 12.02.2004, p. 9), e.i.f.

8.11.2003.

Page 184: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 310

XYZ

Lo g o

X.YZ

Slæm nýtni

Orka

Stærð: Lítill Meðal Stór

Norm EN 50304RafmagnsbökunarofnarTilskipun 2002/40/EB um orkumerkingar

Notkunarrými (lítrar)

Framleiðandi

Gerð

Rafmagnsbökunarofn

Orkunotkun (kWh)

(miðað við staðalálag)

Góð nýtni

IS

(dB(A) re 1 pW)

Hávaði

Hefðbundinn

Blástursofn

X.YZHitun:

Nánari upplýsingar er að finna í bæklingum sem fylgja vörunum

Page 185: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 311

XYZ

Lo g o

X.YZ

Slæm nýtni

Orka

Stærð: Lítill Meðal Stór

Norm EN 50304RafmagnsbökunarofnarTilskipun 2002/40/EB um orkumerkingar

Notkunarrými (lítrar)

Framleiðandi

Gerð

Rafmagnsbökunarofn

Orkunotkun (kWh)

(miðað við staðalálag)

Góð nýtni

IS

(dB(A) re 1 pW)

Hávaði

Hefðbundinn

Blástursofn

X.YZHitun:

Nánari upplýsingar er að finna í bæklingum sem fylgja vörunum

5 mm 73 mm 33 mm 5 mm

41

mm

90

m

m3

9

mm

10

mm

25

m

m4

4

mm

Page 186: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 312

XYZ

Lo g o

X.YZ

Lavt energi forbruk

Ene rg i

Type: Liten Middels stor Stor

Standard EN 50304Elektriske stekeovnerDirektiv 2002/40/EF om energimerking

Nettovolum (liter)

Merke

Modell

Elektrisk stekeovn

Energiforbruk (kWh)

(basert på standardbelastning)

Høyt energi forbruk

NO

(dB(A) re 1 pW)

Lydnivå (støy)

Tradisjonell oppvarming

Varmluft

X.YZOppvarmingsfunksjon:

Produktbrosjyrene inneholder ytterligere opplysninger

Page 187: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 313

XYZ

Lo g o

X.YZ

Lavt energi forbruk

Ene rg i

Type: Liten Middels stor Stor

Standard EN 50304Elektriske stekeovnerDirektiv 2002/40/EF om energimerking

Nettovolum (liter)

Merke

Modell

Elektrisk stekeovn

Energiforbruk (kWh)

(basert på standardbelastning)

Høyt energi forbruk

NO

(dB(A) re 1 pW)

Lydnivå (støy)

Tradisjonell oppvarming

Varmluft

X.YZOppvarmingsfunksjon:

Produktbrosjyrene inneholder ytterligere opplysninger

5 mm 73 mm 33 mm 5 mm

41

mm

90

m

m3

9

mm

10

mm

25

m

m4

4

mm

Page 188: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 314

SECTION 7{1773} [ ]

{1773} Section 7 (Commission Directive 2002/31/EC) inserted by Decision No 123/2004 (OJ L 64, 10.3.2005, p. 20 and EEA Supplement No 12,

10.3.2005, p. 13), e.i.f. 25.9.2004, deleted with effect, at the earliest, from the 1.1.2013 by Decision No 219/2012 (OJ L 81, 21.3.2013, p. 20

and EEA Supplement No 18, 21.3.2013, p. 24), e.i.f. 1.6.2013.

Page 189: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 315

APPENDIX 2{1774}

ENERGY TABLES

SECTION 1{1775} [ ]

{1774} Appendix and heading added by Decision No 22/98 (OJ L 342, 17.12.1998, p. 32 and EEA Supplement No 52, 17.12.1998, p. 1), e.i.f.

1.4.1998.

{1775} Section 1(Commission Directive 94/2/EC) and heading added by Decision No 22/98 (OJ L 342, 17.12.1998, p. 32 and EEA Supplement No

52, 17.12.1998, p. 1), e.i.f. 1.4.1998. The following tables correspond to the tables previously contained in former adaptation b) to the first

indent of point 4 of Chapter IV, subsequently reinserted as point 4a by Decision No 22/98, subsequently deleted by Decision No 218/2012

(OJ L 81, 21.3.2013, p. 18 and EEA Supplement No 18, 21.3.2013, p. 21), e.i.f. 1.6.2013.

Page 190: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 316

SECTION 2{1776} [ ]

{1776} Section 2 (Commission Directive 95/12/EC) and heading added by Decision No 22/98 (OJ L 342, 17.12.1998, p. 32 and EEA Supplement

No 52, 17.12.1998, p. 1), e.i.f. 1.4.1998. The following tables correspond to the tables previously contained in former adaptation b) to the

second indent of point 4 of Chapter IV, subsequently reinserted as point 4b by Decision No 22/98, subsequently deleted by Decision No

218/2012 (OJ L 81, 21.3.2013, p. 18 and EEA Supplement No 18, 21.3.2013, p. 21), e.i.f. 1.6.2013.

Page 191: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 317

SECTION 3{1777} [ ]

{1777} Section and heading added by Decision No 22/98 (OJ L 342, 17.12.1998, p. 32 and EEA Supplement No 52, 17.12.1998, p. 1), e.i.f. 1.4.1998.

The following tables correspond to the tables previously contained in former adaptation b) to the third indent of point 4 of Chapter IV,

subsequently reinserted as point 4c by Decision No 22/98, subsequently deleted by Decision No 10/2013 (OJ L 144, 30.5.2013, p. 14 and

EEA Supplement No 31, 30.5.2013, p.16), e.i.f. 1.6.2013.

Page 192: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 318

SECTION 4{1778}

Commission Directive 96/60/EC

(household combined washer-driers)

Note EN NO IS

Label Fiche Mail order

Annex I Annex II Annex III

Energy Energi Orka

Washer-drier Kombinert vaske- og

tørkemaskin

Þvottavél – þurrkari

I 1 Manufacturer Merke Framleiðandi

II 2 Model Modell Gerð

More efficient Lavt forbruk Góð nýtni

Less efficient Høyt forbruk Slæm nýtni

3 1 Energy efficiency

class ...... on a scale of

A (more efficient)

to G (less efficient)

Relativ energibruk

....... på skalaen A

(lavt forbruk

til G (høyt forbruk)

Orkunýtniflokkur ......

á kvarðanum

A (góð nýtni)

til G (slæm nýntni)

V Energy consumption Energiforbruk Orkunotkun

V kWh kWh KWh

5 2 Energy consumption

for washing, spinning

and drying

Energibruk til

vasking,

sentrifugering og

tørking

Orkunotkun við þvott,

þeytivindingu og

þurrkun

(To wash and dry a

full capacity wash

load at 60 ºC)

(ved 60 ºC vasking og

tørking med full

kapasitetsutnyttelse)

(Til að þvo og þurrka

þvott á 60 ºC-

þvottalotu miðað við

leyfilegt ámarksmagn

taus)

VI Washing (only) kWh Vask og

sentrifugering kWh

Þvottur og

þeytivinding kWh

6 3 Energy consumption

for washing and

spinning only

Energibruk pr vask og

sentrifugering alene

Orkunotkun við þvott

og þeytivindingu

eingöngu

Actual consumption

will depend on how

the appliance is used

Den faktiske energi-

bruken avhenger av

hvordan vaske- og

tørkemaskinen brukes

Raunnotkun fer eftir

því hvernig tækið er

notað

VII Washing performance

A (higher)

G (lower)

Vaskeevne

A (høy)

G (lav)

Þvottahæfni

A (meiri) til

G (minni)

7 4 Washing performance

class ...... on a scale of

A (higher) to

G (lower)

Vaskeevne ...... på

skalaen fra

A (høy) til

G (lav)

Þvottahæfnisflokkur...

......á kvarðanum

A (meiri) til

G (minni)

{1778} Section, including heading and tables, added by Decision No 22/98 (OJ L 342, 17.12.1998, p. 32 and EEA Supplement No 52, 17.12.1998, p.

1), e.i.f. 1.4.1998.

Page 193: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 319

Note EN NO IS

Label Fiche Mail order

Annex I Annex II Annex II

8 5 Water remaining after

spin ...% (as a

proportion of dry

weight of wash)

Restvanninnhold etter

sentrifugering ....% (i

forhold til vekten av

tørt tøy)

Leifar raka að lokinni

þeytivindingu...%

(hlutfall af þurrvigt

þvottar)

VIII 9 6 Spin speed

(rpm)

Sentrifugerings-

hastighet (omdr/min)

Snúningshraði vindu

(snún. á mín.)

IX/X 10/11 7/8 Capacity

(cotton) kg

Kapasitet

(bomull) kg

Afköst

(baðmull) kg

X 10 7 Washing Vasking Þvottur

IX 11 8 Drying Tørking Þurrkun

XI Water consumption

(total)

Vannforbruk (totalt) Vatnsnotkun (alls)

12 9 Water consumption

washing, spinning and

drying

Vannforbruk vasking,

sentrifugering og

tørking

Vatnsnotkun við

þvott, þeytivindingu

og þurrkun

13 10 Water consumption

for washing and

spinning only

Vannforbruk til vask-

og sentrifugering

alene

Vatnsnotkun við þvott

og þeytivindingu

eingöngu

14 Washing and drying

time

Vaske- og tørketid Þvotta- og þurrktími

16 11 Estimated annual

consumption for a 4-

person household,

always using the drier

(200 cycles)

Anslått årlig forbruk

for en husstand på fire

personer som alltid

tørker tøyet i

maskinen (200

ganger)

Áætluð ársnotkun

fyrir fjögurra manna

fjölskyldu sem ætíð

notar þurrkara (200

þvottalotur)

17 12 Estimated annual

consumption for a 4-

person household,

never using the drier

(200 cycles)

Anslått årlig forbruk

for en husstand på fire

personer som aldri

tørker tøyet i

maskinen (200

ganger)

Áætluð ársnotkun

fyrir fjögurra manna

fjölskyldu sem aldrei

notar þurrkara (200

þvottalotur)

XII 18 13 Noise

(dB(A) re 1 pW)

Lydnivå

dB(A) (Støy)

Hávaði

(dB(A) re 1 pW)

18 13 Washing Vasking Þvottur

18 13 Spinning Sentrifugering Þeytivinding

18 13 Drying Tørking Þurrkun

Further information is

contained in product

brochures

Produktbrosjyrene

inneholder ytterligere

opplysninger

Nánari upplýsingar er

að finna í bæklingum

sem fylgja vörunum

Norm EN 50229

Europeisk standard

EN 50229

Staðall EN 50229

Washer-drier Label

Directive 96/60/EC

Direktiv 96/60/EF om

energimerking av

kombinerte vaske- og

tørkemaskiner

Tilskipun 96/60/EB

um merkingar

þvottavéla-þurrkara

Page 194: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 320

SECTION 5{1779} [ ]

{1779} Section 5 (Commission Directive 97/17/EC), including heading and tables, added by Decision No 29/1999 (OJ L 266, 19.10.2000, p.5 and

EEA Supplement No 46, 19.10.2000, p.5), e.i.f. 27.3.1999, subsequently deleted by Decision No 218/2012 (OJ L 81, 21.3.2013, p. 18 and

EEA Supplement No 18, 21.3.2013, p. 21), e.i.f. 1.6.2013.

Page 195: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 321

SECTION 6{1780}

Commission Directive 2002/40/EC

(household electric ovens)

Note

Label

Annex I

Fiche

Annex II

Mail order

Annex III EN IS NO

Energy Orka Energi

Electric oven Rafmagnsbökunarofn Elektrisk stekeovn

I 1 1 Manufacturer Framleiðandi Merke

II 2 1 Model Gerð Modell

More efficient Góð nýtni Lavt energiforbruk

Less efficient Slæm nýtni Høyt energiforbruk

3 2 Energy efficiency

class … on a scale of

A (more efficient) to

G (less efficient)

Orkunýtniflokkur …á

kvarðanum A (góð

nýtni) til G (slæm

nýtni)

Klassifisering av

energieeffektivitet

etter en skala fra A

(lavt energiforbruk) til

G (høyt nergiforbruk)

Baking area Bökunarrými Stekeoverflate

V 5 3 Energy consumption Orkunotkun Energiforbruk

{1780} Section, including heading and tables, added by Decision No 141/2003 (OJ L 41, 12.02.2004, p. 11 and EEA Supplement No 7, 12.02.2004,

p. 9), e.i.f. 11.8.2003.

Page 196: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 322

Note

Label

Annex I

Fiche

Annex II

Mail order

Annex III EN IS NO

V 5 3 kWh kWh kWh

V 5 3 Heating function Hitun Oppvarmingsfunksjon

V 5 3 Conventional Hefðbundinn Tradisjonell

oppvarming

V 5 3 Forced air convection Blástursofn Varmluft

V 5 3 Based on standard

load

Miðað við staðalálag Basert på

standardbelastning

VI 6 4 Usable volume(litres) Notkunarrými (lítrar) Nettovolum (liter)

VII 7 5 Size Stærð Type

VII 7 5 Small Lítill Liten

VII 7 5 Medium Meðal Middels stor

VII 7 5 Large Stór Stor

8 Time to cook standard

load

Bökunartími við

staðalálag

Koketid ved

standardbelastning

VIII 9 6 Noise (dB(A)re 1 pW) Hávaði (dB(A) re 1

pW)

Lydnivå (støy) (dB(A)

re 1 pW)

Further information is

contained in product

brochures

Nánari upplýsingar er

að finna í bæklingum

sem fylgja vörunum

Produktbrosjyrene

inneholder ytterligere

opplysninger

11 The area of the largest

baking sheet

Stærð stærstu

bökunarplötu

Arealet til den største

stekeplaten

Norm

EN 50304

Norm

EN 50304

Standard

EN 50304

Energy Label

Directive 2002/40/EC

of electric ovens

Tilskipun 2002/40/EB

um orkumerkingar

rafmagnsbökunarofna

Direktiv 2002/40/EF

om energimerking av

elektriske stekeovner

Page 197: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 323

SECTION 7{1781} [ ]

{1781} Section 7 (Commission Directive 2002/31/EC), including heading and tables, added by Decision No 123/2004 (OJ L 64, 10.3.2005, p. 20 and

EEA Supplement No 12, 10.3.2005, p. 13), e.i.f. 25.9.2004, deleted with effect, at the earliest, from the 1.1.2013 by Decision No 219/2012

OJ L 81, 21.3.2013, p. 20 and EEA Supplement No 18, 21.3.2013, p. 24), e.i.f. 1.6.2013.

Page 198: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 324

APPENDIX 3{1782}

APPENDIX 4{1783}

APPENDIX 5{1784}

HAZARD AND PRECAUTIONARY STATEMENTS IN ICELANDIC

The following shall be added to Annex III to Regulation (EC) No 1272/2008:

No. Icelandic

H200 Óstöðugt, sprengifimt efni.

H201 Sprengifimt efni, hætta á alsprengingu.

H202 Sprengifimt efni, mikil hætta á sprengibroti.

H203 Sprengifimt efni, hætta á bruna, höggbylgju eða sprengibrotum.

H204 Hætta á bruna eða sprengibrotum.

H205 Hætta á alsprengingu í bruna.

H220 Afar eldfim lofttegund.

H221 Eldfim lofttegund.

H222 Úðabrúsi með afar eldfimum efnum.

H223 Úðabrúsi með eldfimum efnum.

H224 Afar eldfimur vökvi og gufa.

H225 Mjög eldfimur vökvi og gufa.

H226 Eldfimur vökvi og gufa.

H228 Eldfimt, fast efni.

H240 Sprengifimt við hitun.

H241 Eldfimt eða sprengifimt við hitun.

H242 Eldfimt við hitun.

H250 Kviknar í sjálfkrafa við snertingu við loft.

H251 Sjálfhitandi, hætta á sjálfsíkviknun.

H252 Sjálfhitandi í miklu efnismagni, hætta á sjálfsíkviknun.

H260 Í snertingu við vatn myndast eldfimar lofttegundir sem er hætt við sjálfsíkviknun.

H261 Eldfimar lofttegundir myndast við snertingu við vatn

H270 Getur valdið eða aukið bruna, eldmyndandi (oxandi).

H271 Getur valdið bruna eða sprengingu, mjög eldmyndandi (oxandi).

H272 Getur aukið bruna, eldmyndandi (oxandi).

H280 Inniheldur lofttegund undir þrýstingi, getur sprungið við hitun.

{1782} Appendix and heading added by Decision No 59/2004 (OJ L 277, 26.8.2004, p. 30 and EEA Supplement No 43, 26.8.2004, p. 25), e.i.f.

27.4.2004, subsequently deleted with effect from 1 June 2015 by Decision No 106/2012(OJ L 270, 4.10.2012, p. 6 and EEA Supplement No

56, 4.10.2012, p. 8), e.i.f. 1.2.2013.

{1783} Appendix and heading added by Decision No 59/2004 (OJ L 277, 26.8.2004, p. 30 and EEA Supplement No 43, 26.8.2004, p. 25), e.i.f.

27.4.2004 and deleted with effect from 1 June 2015 by Decision No 106/2012 (OJ L 270, 4.10.2012, p. 6 and EEA Supplement No 56,

4.10.2012, p. 8), e.i.f. 1.2.2013.

{1784} Appendix and heading added by Decision No 106/2012 (OJ L 270, 4.10.2012, p. 6 and EEA Supplement No 56, 4.10.2012, p. 8), e.i.f.

1.2.2013.

Page 199: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 325

No. Icelandic

H281 Inniheldur kælda lofttegund, getur valdið kalsárum.

H290 Getur verið ætandi fyrir málma.

H300 Banvænt við inntöku.

H301 Eitrað við inntöku.

H302 Hættulegt við inntöku.

H304 Getur verið banvænt við inntöku ef það kemst í öndunarveg.

H310 Banvænt í snertingu við húð.

H311 Eitrað í snertingu við húð.

H312 Hættulegt í snertingu við húð.

H314 Veldur alvarlegum bruna á húð og augnskaða.

H315 Veldur húðertingu.

H317 Getur valdið ofnæmisviðbrögðum í húð.

H318 Veldur alvarlegum augnskaða.

H319 Veldur alvarlegri augnertingu.

H330 Banvænt við innöndun.

H331 Eitrað við innöndun.

H332 Hættulegt við innöndun.

H334 Getur valdið ofnæmis- eða asmaeinkennum eða öndunarerfiðleikum við innöndun.

H335 Getur valdið ertingu í öndunarfærum.

H336 Getur valdið sljóleika eða svima.

H340 Getur valdið erfðagöllum (tilgreinið váhrifaleið ef sannað hefur verið svo óyggjandi

sé að engin önnur váhrifaleið hefur þessa hættu í för með sér).

H341 Grunað um að valda erfðagöllum (tilgreinið váhrifaleið ef sannað hefur verið svo

óyggjandi sé að engin önnur váhrifaleið hefur þessa hættu í för með sér).

H350 Getur valdið krabbameini (tilgreinið váhrifaleið ef sannað hefur verið svo

óyggjandi sé að engin önnur váhrifaleið hefur þessa hættu í för með sér).

H351 Grunað um að valda krabbameini (tilgreinið váhrifaleið ef sannað hefur verið svo

óyggjandi sé að engin önnur váhrifaleið hefur þessa hættu í för með sér).

H360 Getur haft skaðleg áhrif á frjósemi eða börn í móðurkviði (tilgreinið sérstök áhrif ef

þau eru kunn) (tilgreinið váhrifaleið ef sannað hefur verið svo óyggjandi sé að

engin önnur váhrifaleið hefur þessa hættu í för með sér).

H361 Grunað um að hafa skaðleg áhrif á frjósemi eða börn í móðurkviði (tilgreinið

sérstök áhrif ef þau eru kunn) (tilgreinið váhrifaleið ef sannað hefur verið svo

óyggjandi sé að engin önnur váhrifaleið hefur þessa hættu í för með sér).

H362 Getur skaðað börn á brjósti.

Page 200: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 326

No. Icelandic

H370 Skaðar líffæri (eða tilgreinið öll líffæri sem verða fyrir áhrifum, ef þau eru kunn)

(tilgreinið váhrifaleið ef sannað hefur verið svo óyggjandi sé að engin önnur

váhrifaleið hefur þessa hættu í för með sér).

H371 Getur skaðað líffæri (eða tilgreinið öll líffæri sem verða fyrir áhrifum, ef þau eru

kunn) (tilgreinið váhrifaleið ef sannað hefur verið svo óyggjandi sé að engin önnur

váhrifaleið hefur þessa hættu í för með sér).

H372 Skaðar líffæri (tilgreinið öll líffæri sem verða fyrir áhrifum, ef þau eru kunn) við

langvinn eða endurtekin váhrif (tilgreinið váhrifaleið ef sannað hefur verið svo

óyggjandi sé að engin önnur váhrifaleið hefur þessa hættu í för með sér).

H373 Getur skaðað líffæri (tilgreinið öll líffæri sem verða fyrir áhrifum, ef þau eru kunn)

við langvinn eða endurtekin váhrif (tilgreinið váhrifaleið ef sannað hefur verið svo

óyggjandi sé að engin önnur váhrifaleið hefur þessa hættu í för með sér).

H400 Mjög eitrað lífi í vatni.

H410 Mjög eitrað lífi í vatni, hefur langvinn áhrif.

H411 Eitrað lífi í vatni, hefur langvinn áhrif.

H412 Skaðlegt lífi í vatni, hefur langvinn áhrif.

H413 Getur valdið langvinnum, skaðlegum áhrifum á líf í vatni.

H350i Getur valdið krabbameini við innöndun.

H360F Getur haft skaðleg áhrif á frjósemi.

H360D Getur haft skaðleg áhrif á börn í móðurkviði.

H361f Grunað um að hafa skaðleg áhrif á frjósemi.

H361d Grunað um að hafa skaðleg áhrif á börn í móðurkviði.

H360FD Getur haft skaðleg áhrif á frjósemi. Getur haft skaðleg áhrif á börn í móðurkviði.

H361fd Grunað um að hafa skaðleg áhrif á frjósemi. Grunað um að hafa skaðleg áhrif á

börn í móðurkviði.

H360Fd Getur haft skaðleg áhrif á frjósemi. Grunað um að hafa skaðleg áhrif á börn í

móðurkviði.

H360Df Getur haft skaðleg áhrif á börn í móðurkviði. Grunað um að hafa skaðleg áhrif á

frjósemi.

EUH 001 Sprengifimt sem þurrefni.

EUH 006 Sprengifimt með og án andrúmslofts.

EUH 014 Hvarfast kröftuglega við vatn

EUH 018 Getur myndað eldfimar eða sprengifimar blöndur af efnagufu og andrúmslofti við

notkun.

EUH 019 Getur myndað sprengifim efnasambönd (peroxíð).

EUH 044 Sprengifimt við hitun í lokuðu rými.

EUH 029 Myndar eitraða lofttegund í snertingu við vatn.

EUH 031 Myndar eitraða lofttegund í snertingu við sýru.

EUH 032 Myndar mjög eitraða lofttegund í snertingu við sýru.

EUH 066 Endurtekin snerting getur valdið þurri eða sprunginni húð.

Page 201: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 327

No. Icelandic

EUH 070 Eitrað í snertingu við augu.

EUH 071 Ætandi fyrir öndunarfærin.

EUH 059 Hættulegt ósonlaginu.

EUH 201/201A Inniheldur blý. Notist ekki á yfirborð hluta sem ætla má að börn tyggi eða sjúgi.

Varúð! Inniheldur blý.

EUH 202 Sýanóakrýlat. Hætta. Límist við húð og augu á nokkrum sekúndum. Geymist þar

sem börn ná ekki til.

EUH 203 Inniheldur sexgilt króm. Getur framkallað ofnæmisviðbrögð.

EUH 204 Inniheldur ísósýanöt. Getur framkallað ofnæmisviðbrögð.

EUH 205 Inniheldur epoxýefnisþætti. Getur framkallað ofnæmisviðbrögð.

EUH 206 Varúð! Notist ekki með öðrum vörum. Getur gefið frá sér hættulegar lofttegundir

(klór).

EUH 207 Varúð! Inniheldur kadmíum. Hættulegar gufur myndast við notkun. Sjá upplýsingar

frá framleiðanda. Farið eftir öryggisleiðbeiningunum.

EUH 208 Inniheldur (heiti næmandi efnis). Getur framkallað ofnæmisviðbrögð.

EUH 209/ 209A Getur orðið mjög eldfimt við notkun. Getur orðið eldfimt við notkun

EUH 210 Öryggisblað er fáanlegt sé um það beðið.

EUH 401 Fylgið notkunarleiðbeiningum til að varast hættu fyrir heilbrigði manna og

umhverfið.

The following shall be added to Part 2 of Annex IV of Regulation (EC) No 1272/2008:

No. Icelandic

P101 Ef leita þarf læknis skal hafa ílát eða merkimiða tiltæk.

P102 Geymist þar sem börn ná ekki til.

P103 Lesið merkimiðann fyrir notkun.

P201 Aflið sérstakra leiðbeininga fyrir notkun.

P202 Nauðsynlegt er að lesa og skilja allar viðvaranir áður en efnið er

notað.

P210 Haldið frá hitagjöfum, neistagjöfum, opnum eldi og heitum flötum. —

Reykingar bannaðar.

P211 Má ekki úða á opinn eld eða annan íkveikjuvald.

P220 Má ekki nota eða geyma í námunda við fatnað/.../brennanleg efni.

P221 Gætið þess að blanda efninu ekki saman við brennanleg efni/...

P222 Má ekki komast í snertingu við andrúmsloft.

P223 Má alls ekki komast í snertingu við vatn vegna hættu á kröftugu

hvarfi og leiftureldi.

P230 Haldið röku með....

P231 Meðhöndlið undir óhvarfgjarnri lofttegund.

Page 202: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 328

No. Icelandic

P232 Verjið gegn raka.

P233 Ílát skal vera vel lukt.

P234 Má aðeins geyma í upprunalegu íláti.

P235 Geymist á köldum stað.

P240 Jarðtengið/spennujafnið ílát og viðtökubúnað.

P241 Notið sprengiheld rafföng/loftræstibúnað/lýsingu/...

P242 Notið ekki verkfæri sem mynda neista.

P243 Gerið varúðarráðstafanir gegn stöðurafmagni

P244 Gætið þess að ekki sé feiti og olía á þrýstingslokum.

P250 Má ekki verða fyrir hnjaski/höggi/..../núningi

P251 Þrýstihylki: Ekki má gata eða brenna hylki jafnvel þótt þau séu tóm.

P260 Andið ekki að ykkur ryki/reyk/lofttegund/úða/gufu/ýringi.

P261 Gætið þess að anda ekki inn ryki/reyk/lofttegund/úða/gufu/ýringi.

P262 Má ekki koma í augu eða á húð eða föt.

P263 Forðist alla snertingu við efnið meðan á meðgöngu og brjóstagjöf

stendur.

P264 Þvoið...vandlega eftir meðhöndlun.

P270 Neytið ekki matar, drykkjar eða tóbaks við notkun þessarar vöru.

P271 Notið eingöngu utandyra eða í vel loftræstu rými.

P272 Ekki skal farið með vinnuföt af vinnustað hafi þau óhreinkast af

efninu.

P273 Forðist losun út í umhverfið.

P280 Notið hlífðarhanska/hlífðarfatnað/augnhlífar/andlitshlífar.

P281 Notið tilskildar persónuhlífar.

P282 Klæðist kuldaeinangrandi hönskum/andlitshlífum/augnhlífum.

P283 Klæðist brunaþolnum/eldþolnum/eldtefjandi fatnaði.

P284 Notið öndunarhlífar.

P285 Notið öndunarhlífar ef loftræsting er ófullnægjandi.

P231 +

P232

Meðhöndlið undir óhvarfgjarnri lofttegund. Verjið gegn raka.

P235 +

P410

Geymist á köldum stað. Hlífið við sólarljósi.

P301 EFTIR INNTÖKU:

P302 BERIST EFNIÐ Á HÚÐ:

P303 BERIST EFNIÐ Á HÚÐ (eða í hár):

P304 EFTIR INNÖNDUN:

Page 203: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 329

No. Icelandic

P305 BERIST EFNIÐ Í AUGU:

P306 EF EFNIÐ FER Á FÖT:

P307 EF um váhrif er að ræða:

P308 EF um váhrif eða hugsanleg váhrif er að ræða:

P309 EF um váhrif er að ræða eða ef lasleika verður vart:

P310 Hringið umsvifalaust í EITRUNARMIÐSTÖÐ eða lækni.

P311 Hringið í EITRUNARMIÐSTÖÐ eða lækni.

P312 Hringið í EITRUNARMIÐSTÖÐ eða lækni ef lasleika verður vart.

P313 Leitið læknis.

P314 Leitið læknis ef lasleika verður vart.

P315 Leitið umsvifalaust læknis.

P320 Brýnt er að fá sérstaka meðferð (sjá .... á þessum merkimiða).

P321 Sérstök meðferð (sjá .... á þessum merkimiða).

P322 Sérstakar ráðstafanir (sjá .... á þessum merkimiða).

P330 Skolið munninn.

P331 EKKI framkalla uppköst.

P332 Ef efnið ertir húð:

P333 Ef efnið ertir húð eða útbrot koma fram:

P334 Sökkvið í kalt vatn/vefjið með blautu sárabindi.

P335 Dustið lausar agnir af húðinni.

P336 Vermið kalna líkamshluta með volgu vatni. Ekki nudda skaddaða

svæðið.

P337 Ef augnerting er viðvarandi:

P338 Fjarlægið snertilinsur ef það er auðvelt. Skolið áfram.

P340 Flytjið viðkomandi í ferskt loft og látið hann hvílast í stellingu sem

léttir öndun.

P341 Ef viðkomandi á erfitt með öndun skal flytja hann í ferskt loft og láta

hann hvílast í stellingu sem léttir öndun.

P342 Ef vart verður einkenna frá öndunarvegi:

P350 Þvoið varlega með mikilli sápu og vatni.

P351 Þvoið varlega með mikilli sápu og vatni.

P352 Þvoið með mikilli sápu og vatni.

P353 Skolið húðina með vatni/Farið í sturtu.

P360 Föt og húð, sem óhreinkast af efninu, skal skola strax með miklu vatni

áður en farið er úr fötunum.

P361 Farið strax úr fötum sem óhreinkast af efninu.

P362 Farið úr fötum, sem óhreinkast af efninu, og þvoið fyrir næstu notkun.

Page 204: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 330

No. Icelandic

P363 Þvoið föt, sem óhreinkast af efninu, fyrir næstu notkun.

P370 Ef eldur kemur upp:

P371 Þegar um mikinn eld og mikið efnismagn er að ræða:

P372 Sprengihætta ef eldur kemur upp.

P373 EKKI reyna að slökkva eld ef hann kemst að sprengifimum efnum.

P374 Beitið eðlilegum varúðarráðstöfunum við slökkvistörf og verið í

hæfilegri fjarlægð frá eldinum.

P375 Verið í fjarlægð frá eldinum við slökkvistörf vegna sprengihættu.

P376 Stöðvið leka ef það er óhætt.

P377 Eldur í lekandi gasi: Reynið ekki að slökkva eldinn nema hægt sé að

stöðva lekann á öruggan máta.

P378 Notið ... til að slökkva eldinn.

P380 Rýmið svæðið.

P381 Fjarlægið alla íkveikjuvalda ef það er óhætt.

P390 Sogið upp allt sem hellist niður til að afstýra eignatjóni.

P391 Safnið upp því sem hellist niður.

P301 +

P310

EFTIR INNTÖKU: Hringið umsvifalaust í EITRUNARMIÐSTÖÐ

eða lækni.

P301 +

P312

EFTIR INNTÖKU: Hringið í EITRUNARMIÐSTÖÐ eða lækni ef

lasleika verður vart.

P301 +

P330 +

P331

EFTIR INNTÖKU: Skolið munninn. EKKI framkalla uppköst.

P302 +

P334

BERIST EFNIÐ Á HÚÐ: Sökkvið í kalt vatn/vefjið með blautu

sárabindi.

P302 +

P350

BERIST EFNIÐ Á HÚÐ: Þvoið varlega með mikilli sápu og vatni.

P302 +

P352

BERIST EFNIÐ Á HÚÐ: Þvoið með mikilli sápu og vatni

P303 +

P361 +

P353

BERIST EFNIÐ Á HÚÐ (eða í hár): Farið strax úr fötum sem

óhreinkast af efninu. Skolið húðina með vatni/Farið í sturtu.

P304 +

P340

EFTIR INNÖNDUN: Flytjið viðkomandi í ferskt loft og látið hann

hvílast í stellingu sem léttir öndun.

P304 +

P341

EFTIR INNÖNDUN: Ef viðkomandi á erfitt með öndun skal flytja

hann í ferskt loft og láta hann hvílast í stellingu sem léttir öndun.

Page 205: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 331

No. Icelandic

P305 +

P351 +

P338

BERIST EFNIÐ Í AUGU: Skolið varlega með vatni í nokkrar

mínútur. Fjarlægið snertilinsur ef það er auðvelt. Skolið áfram.

P306 +

P360

EF EFNIÐ FER Á FÖT: Föt og húð, sem óhreinkast af efninu, skal

skola strax með miklu vatni áður en farið er úr fötunum.

P307 +

P311

EFum váhrif er að ræða: Hringið í EITRUNARMIÐSTÖÐ eða lækni.

P308 +

P313

EF um váhrif eða hugsanleg váhrif er að ræða: Leitið læknis.

P309 +

P311

EF um váhrif er að ræða eða ef lasleika verður vart: Hringið í

EITRUNARMIÐSTÖÐ eða lækni.

P332 +

P313

Ef efnið ertir húð: Leitið læknis.

P333 +

P313

Ef efnið ertir húð eða útbrot koma fram: Leitið læknis.

P335 +

P334

Dustið lausar agnir af húðinni. Sökkvið í kalt vatn/vefjið með blautu

sárabindi.

P337 +

P313

Ef augnerting er viðvarandi: Leitið læknis.

P342 +

P311

Ef vart verður einkenna frá öndunarvegi: Hringið í

EITRUNARMIÐSTÖÐ eða lækni.

P370 +

P376

Ef eldur kemur upp: Stöðvið leka ef það er óhætt.

P370 +

P378

Ef eldur kemur upp: Notið ... til að slökkva eldinn.

P370 +

P380

Ef eldur kemur upp: Rýmið svæðið.

P370 +

P380 +

P375

Ef eldur kemur upp: Rýmið svæðið. Verið í fjarlægð frá eldinum við

slökkvistörf vegna sprengihættu.

P371 +

P380 +

P375

Þegar um mikinn eld og mikið efnismagn er að ræða: Rýmið svæðið.

Verið í fjarlægð frá eldinum við slökkvistörf vegna sprengihættu.

P401 Geymist ...

P402 Geymist á þurrum stað.

P403 Geymist á vel loftræstum stað.

P404 Geymist í lokuðu íláti.

P405 Geymist á læstum stað.

P406 Geymist í tæringarþolnu/...íláti með tæringarþolnu innra lagi.

Page 206: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 332

No. Icelandic

P407 Hafið loftbil á milli stafla/vörubretta.

P410 Hlífið við sólarljósi.

P411 Geymist við hitastig sem er ekki hærra en … oC/… oF.

P412 Setjið ekki í hærri hita en 50 oC/122 oF.

P413 Ef búlkavara vegur meira en ... kg/... pund skal ekki geyma hana í

hærri hita en… oC/… oF.

P420 Má ekki geyma hjá öðru efni.

P422 Geymið innihald undir ...

P402 +

P404

Geymist á þurrum stað. Geymist í lokuðu íláti.

P403 +

P233

Geymist á vel loftræstum stað. Ílát vera vel lukt.

P403 +

P235

Geymist á vel-loftræstum stað. Geymist á köldum stað.

P410 +

P403

Hlífið við sólarljósi. Geymist á vel loftræstum stað.

P410 +

P412

Hlífið við sólarljósi. Hlífið við hærri hita en 50 oC/122 oF.

P411 +

P235

Geymist á köldum stað við hitastig sem er ekki hærra en … oC/… oF.

P501 Fargið innihaldi/íláti hjá ...

APPENDIX 6{1785}

HAZARD AND PRECAUTIONARY STATEMENTS IN NORWEGIAN

The following shall be added to Annex III to Regulation (EC) No 1272/2008:

No. Norwegian

H200 Ustabile eksplosive varer.

H201 Eksplosjonsfarlig; fare for masseeksplosjon.

H202 Eksplosjonsfarlig; stor fare for utkast av fragmenter.

H203 Eksplosjonsfarlig; fare for brann, trykkbølge eller utkast av fragmenter.

H204 Fare for brann eller utkast av fragmenter.

H205 Fare for masseeksplosjon ved brann.

H220 Ekstremt brannfarlig gass.

H221 Brannfarlig gass.

{1785} Appendix and heading added by Decision No 106/2012 (OJ L 270, 4.10.2012, p. 6 and EEA Supplement No 56, 4.10.2012, p. 8), e.i.f.

1.2.2013.

Page 207: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 333

No. Norwegian

H222 Ekstremt brannfarlig aerosol.

H223 Brannfarlig aerosol.

H224 Ekstremt brannfarlig væske og damp.

H225 Meget brannfarlig væske og damp.

H226 Brannfarlig væske og damp.

H228 Brannfarlig fast stoff.

H240 Eksplosjonsfarlig ved oppvarming.

H241 Brann- eller eksplosjonsfarlig ved oppvarming.

H242 Brannfarlig ved oppvarming.

H250 Selvantenner ved kontakt med luft.

H251 Selvopphetende; kan selvantenne.

H252 Selvopphetende i store mengder; kan selvantenne.

H260 Ved kontakt med vann utvikles brannfarlige gasser som kan selvantenne.

H261 Ved kontakt med vann utvikles brannfarlige gasser.

H270 Kan forårsake eller forsterke brann; oksiderende.

H271 Kan forårsake brann eller eksplosjon; sterkt oksiderende.

H272 Kan forsterke brann; oksiderende.

H280 Inneholder gass under trykk; kan eksplodere ved oppvarming.

H281 Inneholder nedkjølt gass; kan forårsake alvorlige forfrysninger.

H290 Kan være etsende for metaller.

H300 Dødelig ved svelging.

H301 Giftig ved svelging.

H302 Farlig ved svelging.

H304 Kan være dødelig ved svelging om det kommer ned i luftveiene.

H310 Dødelig ved hudkontakt.

H311 Giftig ved hudkontakt.

H312 Farlig ved hudkontakt.

H314 Gir alvorlige etseskader på hud og øyne.

H315 Irriterer huden.

H317 Kan utløse en allergisk hudreaksjon.

H318 Gir alvorlig øyeskade.

H319 Gir alvorlig øyeirritasjon.

H330 Dødelig ved innånding.

H331 Giftig ved innånding.

H332 Farlig ved innånding.

H334 Kan gi allergi eller astmasymptomer eller pustevansker ved innånding.

H335 Kan forårsake irritasjon av luftveiene.

H336 Kan forårsake døsighet eller svimmelhet.

H340 Kan gi genetiske skader <Angi opptaksvei dersom det med sikkerhet er fastlått at

ingen andre opptaksveier er årsak til faren>.

H341 Mistenkes å kunne gi genetiske skader <Angi opptaksvei dersom det med sikkerhet

er fastlått at ingen andre opptaksveier er årsak til faren>.

Page 208: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 334

No. Norwegian

H350 Kan forårsake kreft <Angi opptaksvei dersom det med sikkerhet er fastlått at ingen

andre opptaksveier er årsak til faren>.

H351 Mistenkes for å kunne forårsake kreft <Angi opptaksvei dersom det med sikkerhet

er fastlått at ingen andre opptaksveier er årsak til faren>.

H360 Kan skade forplantningsevnen eller gi fosterskader <Angi særlige virkninger

dersom disse er kjent.> <Angi opptaksvei dersom det med sikkerhet er fastlått at

ingen andre opptaksveier er årsak til faren>.

H361 Mistenkes for å kunne skade forplantningsevnen eller gi fosterskader <Angi særlige

virkninger dersom disse er kjent.> <Angi opptaksvei dersom det med sikkerhet er

fastlått at ingen andre opptaksveier er årsak til faren>

H362 Kan skade barn som ammes.

H370 Forårsaker organskader <eller angi alle organer som påvirkes dersom disse er

kjent.> <Angi opptaksvei dersom det med sikkerhet er fastlått at ingen andre

opptaksveier er årsak til faren>.

H371 Kan forårsake organskader <eller angi alle organer som påvirkes dersom disse er

kjent.> <Angi opptaksvei dersom det med sikkerhet er fastlått at ingen andre

opptaksveier er årsak til faren>.

H372 Forårsaker organskader <eller angi alle organer som påvirkes dersom disse er

kjent.> ved langvarig eller gjentatt eksponering <Angi opptaksvei dersom det med

sikkerhet er at ingen andre opptaksveier er årsak til faren>.

H373 Kan forårsake organskader <eller angi alle organer som påvirkes dersom disse er

kjent.> ved langvarig eller gjentatt eksponering <Angi opptaksvei dersom det med

sikkerhet er at ingen andre opptaksveier er årsak til faren>.

H400 Meget giftig for liv i vann.

H410 Meget giftig, med langtidsvirkning, for liv i vann.

H411 Giftig, med langtidsvirkning, for liv i vann.

H412 Skadelig, med langtidsvirkning, for liv i vann.

H413 Kan forårsake skadelige langtidsvirkninger for liv i vann.

H350i Kan forårsake kreft ved innånding.

H360F Kan skade forplantningsevnen.

H360D Kan gi fosterskader.

H361f Mistenkes for å kunne skade forplantningsevnen.

H361d Mistenkes for å kunne gi fosterskader.

H360FD Kan skade forplantningsevnen. Kan gi fosterskader.

H361fd Mistenkes for å kunne skade forplantningsevnen. Mistenkes for å kunne gi

fosterskader.

H360Fd Kan skade forplantningsevnen. Mistenkes for å kunne gi fosterskader.

H360Df Kan gi fosterskader. Mistenkes for å kunne skade forplantningsevnen.

EUH 001 Eksplosjonsfarlig i tørr tilstand.

EUH 006 Eksplosjonsfarlig ved og uten kontakt med luft.

EUH 014 Reagerer voldsomt med vann.

Page 209: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 335

No. Norwegian

EUH 018 Ved bruk kan brennbar damp/eksplosive damp-luft-blandinger dannes.

EUH 019 Kan danne eksplosive peroksider.

EUH 044 Eksplosjonsfarlig ved oppvarming i lukket rom.

EUH 029 Ved kontakt med vann utvikles giftig gass.

EUH 031 Ved kontakt med syrer utvikles giftig gass.

EUH 032 Ved kontakt med syrer utvikles meget giftig gass.

EUH 066 Gjentatt eksponering kan gi tørr eller sprukket hud.

EUH 070 Giftig ved øyekontakt.

EUH 071 Etsende for luftveiene.

EUH 059 Farlig for ozonlaget.

EUH 201/201A Inneholder bly. Må ikke brukes på gjenstander som barn vil kunne tygge eller suge

på. Advarsel! Inneholder bly.

EUH 202 Cyanoakrylat. Fare. Klistrer sammen hud og øyne på sekunder. Oppbevares

utilgjengelig for barn.

EUH 203 Inneholder krom (VI). Kan gi en allergisk reaksjon.

EUH 204 Inneholder isocyanater. Kan gi en allergisk reaksjon.

EUH 205 Inneholder epoksyforbindelser. Kan gi en allergisk reaksjon.

EUH 206 Advarsel! Må ikke brukes sammen med andre produkter. Kan frigjøre farlige gasser

(klor).

EUH 207 Advarsel! Inneholder kadmium. Det utvikles farlige gasser under bruk. Se

informasjon fra produsenten. Følg sikkerhetsinstruksjonene.

EUH 208 Inneholder <navn på sensibiliserende stoff>. Kan gi en allergisk reaksjon.

EUH 209/ 209A Kan bli meget brannfarlig ved bruk. Kan bli brannfarlig ved bruk.

EUH 210 Sikkerhetsdatablad er tilgjengelig på anmodning.

EUH 401 Bruksanvisningen må følges, slik at man unngår risiko for menneskers helse og

miljøet.

The following shall be added to Part 2 of Annex IV to Regulation (EC) No 1272/2008:

No. Norwegian

P101 Dersom det er nødvendig med legehjelp, ha produktets beholder eller

etikett for hånden.

P102 Oppbevares utilgjengelig for barn.

P103 Les etiketten før bruk.

P201 Innhent særskilt instruks før bruk.

P202 Skal ikke håndteres før alle advarsler er lest og oppfattet.

P210 Holdes vekk fra varme/gnister/åpen flamme/varme overflater. —

Røyking forbudt.

P211 Ikke spray mot åpen flamme eller annen tennkilde.

P220 Må ikke brukes/oppbevares i nærheten av tøy /…/ brennbare

materialer.

Page 210: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 336

No. Norwegian

P221 Må ikke blandes med brennbare stoffer.

P222 Unngå kontakt med luft.

P223 Unngå all kontakt med vann, på grunn av fare for voldsom reaksjon

og eksplosjonsaktig brann.

P230 Holdes fuktet med …

P231 Håndteres under inertgass.

P232 Beskyttes mot fuktighet.

P233 Hold beholderen tett lukket.

P234 Oppbevares bare i originalbeholder.

P235 Oppbevares kjølig.

P240 Beholder og mottaksutstyr jordes/potensialutlignes.

P241 Bruk elektrisk materiell /ventilasjonsmateriell/belysningsmateriell

som er eksplosjonssikkert.

P242 Bruk bare verktøy som ikke avgir gnister.

P243 Treff tiltak mot statisk elektrisitet.

P244 Reduksjonsventiler skal holdes fri for fett og olje.

P250 Må ikke utsettes for sliping/støt/…/friksjon.

P251 Beholder under trykk: Må ikke punkteres eller brennes, selv ikke etter

bruk.

P260 Ikke innånd støv/røyk/gass/tåke/damp/aerosoler.

P261 Unngå innånding av støv/røyk/gass/tåke/damp/aerosoler.

P262 Må ikke komme i kontakt med øyne, huden eller klær.

P263 Unngå kontakt under graviditet/amming.

P264 Vask … grundig etter bruk.

P270 Ikke spis, drikk eller røyk ved bruk av produktet.

P271 Brukes bare utendørs eller i et godt ventilert område.

P272 Tilsølte arbeidsklær må ikke fjernes fra arbeidsplassen.

P273 Unngå utslipp til miljøet.

P280 Benytt vernehansker /verneklær/vernebriller/ansiktsskjerm.

P281 Bruk påkrevd personlig verneutstyr.

P282 Bruk kuldeisolerende hansker /visir/øyevern.

P283 Benytt brannbestandige/flammehemmende klær.

P284 Bruk åndedrettsvern.

P285 Ved utilstrekkelig ventilasjon skal åndedrettsvern benyttes.

Page 211: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 337

No. Norwegian

P231 +

P232

Håndteres under inertgass. Beskyttes mot fuktighet.

P235 +

P410

Oppbevares kjølig. Beskyttes mot sollys.

P301 VED SVELGING:

P302 VED HUDKONTAKT:

P303 VED HUDKONTAKT (eller håret):

P304 VED INNÅNDING:

P305 VED KONTAKT MED ØYNENE

P306 VED KONTAKT MED KLÆR:

P307 Ved eksponering:

P308 Ved eksponering eller mistanke om eksponering:

P309 Ved eksponering eller ubehag:

P310 Kontakt umiddelbart et GIFTINFORMASJONSSENTER eller lege.

P311 Kontakt et GIFTINFORMASJONSSENTER eller lege.

P312 Kontakt et GIFTINFORMASJONSSENTER eller lege ved ubehag.

P313 Søk legehjelp.

P314 Søk legehjelp ved ubehag.

P315 Søk legehjelp umiddelbart.

P320 Særlig behandling kreves umiddelbart (se … på etiketten).

P321 Særlig behandling (se … på etiketten).

P322 Særlige tiltak (se … på etiketten).

P330 Skyll munnen.

P331 IKKE framkall brekning.

P332 Ved hudirritasjon:

P333 Ved hudirritasjon eller utslett:

P334 Skyll i kaldt vann / anvend våt kompress.

P335 Børst bort løse partikler fra huden.

P336 Varm opp frostskadede legemsdeler med lunkent vann. Ikke gni på

det skadede området.

P337 Ved vedvarende øyeirritasjon:

P338 Fjern eventuelle kontaktlinser dersom dette enkelt lar seg gjøre.

Fortsett skyllingen.

P340 Flytt personen til frisk luft og sørg for at vedkommende hviler i en

stilling som letter åndedrettet.

P341 Ved pustevansker, flytt personen til frisk luft og sørg for at

vedkommende hviler i en stilling som letter åndedrettet.

Page 212: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 338

No. Norwegian

P342 Ved symptomer i luftveiene:

P350 Vask forsiktig med mye såpe og vann.

P351 Skyll forsiktig med vann i flere minutter.

P352 Vask med mye såpe og vann.

P353 Skyll/dusj huden med vann.

P360 Skyll umiddelbart tilsølte klær og hud med mye vann før klærne

fjernes.

P361 Tilsølte klær må fjernes straks.

P362 Tilsølte klær må fjernes og vaskes før de brukes på nytt.

P363 Tilsølte klær må vaskes før de brukes på nytt.

P370 Ved brann:

P371 Ved større brann og store mengder:

P372 Eksplosjonsfare ved brann.

P373 IKKE bekjemp brannen når den når eksplosive varer.

P374 Bekjemp brannen med normal forsiktighet på behørig avstand.

P375 Bekjemp brannen på avstand på grunn av eksplosjonsfare.

P376 Stopp lekkasje dersom dette kan gjøres på en sikker måte.

P377 Brann ved gasslekkasje: Ikke slukk med mindre lekkasjen kan stanses

på en sikker måte.

P378 Slukk med:....

P380 Evakuer området.

P381 Fjern alle tennkilder dersom dette kan gjøres på en sikker måte.

P390 Absorber spill for å hindre materiell skade.

P391 Samle opp spill.

P301 +

P310

VED SVELGING: Kontakt umiddelbart et

GIFTINFORMASJONSSENTER eller lege.

P301 +

P312

VED SVELGING: Kontakt et GIFTINFORMASJONSSENTER eller

lege ved ubehag.

P301 +

P330 +

P331

VED SVELGING: Skyll munnen. IKKE framkall brekning.

P302 +

P334

VED HUDKONTAKT: Skyll i kaldt vann / anvend våt kompress.

P302 +

P350

VED HUDKONTAKT: Vask forsiktig med mye såpe og vann.

Page 213: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 339

No. Norwegian

P302 +

P352

VED HUDKONTAKT: Vask med mye såpe og vann.

P303 +

P361 +

P353

VED HUDKONTAKT (eller håret): Tilsølte klær må fjernes straks.

Skyll/dusj huden med vann.

P304 +

P340

VED INNÅNDING: Flytt personen til frisk luft og sørg for at

vedkommende hviler i en stilling som letter åndedrettet.

P304 +

P341

VED INNÅNDING: Ved pustevansker, flytt personen til frisk luft og

sørg for at vedkommende hviler i en stilling som letter åndedrettet.

P305 +

P351 +

P338

VED KONTAKT MED ØYNENE: Skyll forsiktig med vann i flere

minutter. Fjern eventuelle kontaktlinser dersom dette enkelt lar seg

gjøre. Fortsett skyllingen.

P306 +

P360

VED KONTAKT MED KLÆR: Skyll umiddelbart tilsølte klær og

hud med mye vann før klærne fjernes.

P307 +

P311

Ved eksponering: Kontakt et GIFTINFORMASJONSSENTER eller

lege.

P308 +

P313

Ved eksponering eller mistanke om eksponering: Søk legehjelp.

P309 +

P311

Ved eksponering eller ubehag: Kontakt et

GIFTINFORMASJONSSENTER eller lege.

P332 +

P313

Ved hudirritasjon: Søk legehjelp.

P333 +

P313

Ved hudirritasjon eller utslett: Søk legehjelp.

P335 +

P334

Børst bort løse partikler fra huden. Skyll i kaldt vann / anvend våt

kompress.

P337 +

P313

Ved vedvarende øyeirritasjon: Søk legehjelp.

P342 +

P311

Ved symptomer i luftveiene: Kontakt et

GIFTINFORMASJONSSENTER eller lege.

P370 +

P376

Ved brann: Stopp lekkasje dersom dette kan gjøres på en sikker måte.

P370 +

P378

Ved brann: Slukk med …

P370 +

P380

Ved brann: Evakuer området.

P370 +

P380 +

P375

Ved brann: Evakuer området. Bekjemp brannen på avstand på grunn

av eksplosjonsfare.

Page 214: ANNEX II TECHNICAL REGULATIONS, STANDARDS, TESTING … · Standards, Testing and Certification - Part I XIII. MEDICINAL PRODUCTS The EFTA Surveillance Authority may designate, according

13.12.2019 - EEA AGREEMENT - ANNEX II – p. 340

No. Norwegian

P371 +

P380 +

P375

Ved større brann og store mengder: Evakuer området. Bekjemp

brannen på avstand på grunn av eksplosjonsfare.

P401 Oppbevares …

P402 Oppbevares tørt.

P403 Oppbevares på et godt ventilert sted.

P404 Oppbevares i lukket beholder.

P405 Oppbevares innelåst.

P406 Oppbevares i korrosjonsbestandig/… beholder med

korrosjonsbestandig indre belegg.

P407 Se til at det er luft mellom stabler/paller.

P410 Beskyttes mot sollys.

P411 Oppbevares ved en temperatur som ikke er høyere enn ...°C /... °F.

P412 Må ikke utsettes for temperaturer høyere enn 50 °C /122 °F.

P413 Bulkmengder på over ...kg/...lbs oppbevares ved en temperatur som

ikke er høyere enn ...°C /... °F.

P420 Må oppbevares adskilt fra andre materialer.

P422 Oppbevar innholdet under …

P402 +

P404

Oppbevares tørt. Oppbevares i lukket beholder.

P403 +

P233

Oppbevares på et godt ventilert sted. Hold beholderen tett lukket.

P403 +

P235

Oppbevares på et godt ventilert sted. Oppbevares kjølig.

P410 +

P403

Beskyttes mot sollys. Oppbevares på et godt ventilert sted.

P410 +

P412

Beskyttes mot sollys. Må ikke utsettes for temperaturer høyere enn 50

°C /122 °F.

P411 +

P235

Oppbevares ved en temperatur som ikke er høyere enn ...°C /... °F.

Oppbevares kjølig.

P501 Innhold/beholder leveres til …